ss_d,ss_rgnsm,src_d,tss_d,dc_d,b_frmt,src_ss_d,dscrptn,ss_sbclllr_frctn,ss_tp,ss_strn,rltnshp_tp,cnfdnc_scr,crtd_b,chmbl_d,cll_d,vrnt_d
7524,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,A,,N,1,Intermediate,CHEMBL618647,,
7525,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,A,,N,1,Intermediate,CHEMBL618648,,
7526,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,A,,N,1,Intermediate,CHEMBL618649,,
7527,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,A,,N,1,Intermediate,CHEMBL618650,,
7528,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,A,,N,1,Intermediate,CHEMBL618651,,
7529,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,A,,N,1,Intermediate,CHEMBL876497,,
7530,Rattus norvegicus,1,2048.0,9866,BAO_0000218,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,A,,N,1,Intermediate,CHEMBL618652,,
7531,Rattus norvegicus,1,2048.0,9866,BAO_0000218,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,A,,N,1,Intermediate,CHEMBL618653,,
7532,Rattus norvegicus,1,2048.0,9866,BAO_0000218,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,A,,N,1,Intermediate,CHEMBL618654,,
7533,Rattus norvegicus,1,,6351,BAO_0000218,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,A,,N,1,Intermediate,CHEMBL618655,,
7534,Rattus norvegicus,1,,1465,BAO_0000218,,Compound was tested for solubility in water,,A,,N,1,Intermediate,CHEMBL618656,,
7535,,1,,5182,BAO_0000100,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,P,,U,0,Intermediate,CHEMBL618657,,
7536,Rattus norvegicus,1,,17847,BAO_0000218,,Solubility was determined,,A,,N,1,Intermediate,CHEMBL618658,,
7537,Rattus norvegicus,1,,15339,BAO_0000218,,solubility in water (ug/mL) at 37 degree C.,,A,,N,1,Intermediate,CHEMBL618659,,
7538,Rattus norvegicus,1,,5202,BAO_0000218,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,A,,N,1,Intermediate,CHEMBL618660,,
7539,Rattus norvegicus,1,,1088,BAO_0000218,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,A,,N,1,Intermediate,CHEMBL618661,,
7540,Rattus norvegicus,1,,3169,BAO_0000218,,Half life in rats,,A,,N,1,Intermediate,CHEMBL873807,,
7541,Rattus norvegicus,1,,5353,BAO_0000218,,Half life in Dawley rat,,A,,N,1,Intermediate,CHEMBL618662,,
7542,Rattus norvegicus,1,,2864,BAO_0000218,,Half life period after 3 mg/kg iv administration,,A,,N,1,Intermediate,CHEMBL618663,,
7543,Rattus norvegicus,1,,2864,BAO_0000218,,Half life period after 3 mg/kg iv administration in rat,,A,,N,1,Intermediate,CHEMBL618664,,
7544,Rattus norvegicus,1,,2864,BAO_0000218,,Half life period after 3 mg/kg iv administration in the rat,,A,,N,1,Intermediate,CHEMBL618665,,
7545,Rattus norvegicus,1,,6362,BAO_0000218,,Half life period in female Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL876498,,
7546,Rattus norvegicus,1,,6249,BAO_0000218,,Half life period in rat,,A,,N,1,Intermediate,CHEMBL618666,,
7547,Rattus norvegicus,1,,3169,BAO_0000218,,Half-life in rats was determined,,A,,N,1,Intermediate,CHEMBL620440,,
7548,Rattus norvegicus,1,,3169,BAO_0000218,,Half-life in rats with metabolic oxidation,,A,,N,1,Intermediate,CHEMBL620441,,
7549,Rattus norvegicus,1,,3169,BAO_0000218,,Half-life in rats,,A,,N,1,Intermediate,CHEMBL620442,,
7550,Rattus norvegicus,1,,17260,BAO_0000218,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,A,,N,1,Intermediate,CHEMBL620443,,
7551,Rattus norvegicus,1,,17260,BAO_0000218,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,A,,N,1,Intermediate,CHEMBL620444,,
7552,Rattus norvegicus,1,,17260,BAO_0000218,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,A,,N,1,Intermediate,CHEMBL620445,,
7553,Rattus norvegicus,1,,17260,BAO_0000218,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,A,,N,1,Intermediate,CHEMBL620446,,
7554,Rattus norvegicus,1,1969.0,2879,BAO_0000218,,Biological half-life measured in plasma of rat,,A,,N,1,Intermediate,CHEMBL620447,,
7555,Rattus norvegicus,1,1969.0,2879,BAO_0000218,,Biological half-life measured in plasma of rat; 22-25,,A,,N,1,Intermediate,CHEMBL621129,,
7556,Rattus norvegicus,1,1969.0,2879,BAO_0000218,,Biological half-life measured in plasma of rat; 9-16,,A,,N,1,Intermediate,CHEMBL621130,,
7557,Rattus norvegicus,1,,3184,BAO_0000218,,Compound was evaluated for its half life when administered intravenously in rat,,A,,N,1,Intermediate,CHEMBL873808,,
7558,Rattus norvegicus,1,,4891,BAO_0000218,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,A,,N,1,Intermediate,CHEMBL876598,,
7559,Rattus norvegicus,1,,429,BAO_0000218,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,A,,N,1,Intermediate,CHEMBL621131,,
7560,Rattus norvegicus,1,,5656,BAO_0000218,,Half life (T1/2) after oral administration in rat,,A,,N,1,Intermediate,CHEMBL621132,,
7561,Rattus norvegicus,1,,4413,BAO_0000218,,Half life of compound after iv administration of 20 mg/kg dose in rat,,A,,N,1,Intermediate,CHEMBL621133,,
7562,Rattus norvegicus,1,,3598,BAO_0000218,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,A,,N,1,Expert,CHEMBL621312,,
7563,Rattus norvegicus,1,,17267,BAO_0000218,,Half life of compound was determined in rat,,A,,N,1,Intermediate,CHEMBL621313,,
7564,Rattus norvegicus,1,178.0,4727,BAO_0000218,,Half life of compound was determined in rat blood,,A,,N,1,Intermediate,CHEMBL621314,,
7565,Rattus norvegicus,1,,17651,BAO_0000218,,Half life at 1 mg/kg was determined in rat,,A,,N,1,Intermediate,CHEMBL621315,,
7566,Rattus norvegicus,1,,17651,BAO_0000218,,Half life at 10 mg/kg was determined in rat,,A,,N,1,Intermediate,CHEMBL621316,,
7567,Rattus norvegicus,1,,401,BAO_0000218,,Half life in rats,,A,,N,1,Intermediate,CHEMBL621317,,
7568,Rattus norvegicus,1,,4942,BAO_0000218,,Half life in rats in hours,,A,,N,1,Intermediate,CHEMBL621318,,
7569,Rattus norvegicus,1,,17735,BAO_0000218,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,A,,N,1,Intermediate,CHEMBL621319,,
7570,Rattus norvegicus,1,,6056,BAO_0000218,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL621377,,
7571,Rattus norvegicus,1,,5213,BAO_0000218,,Half life was determined,,A,,N,1,Intermediate,CHEMBL621378,,
7572,Rattus norvegicus,1,,6616,BAO_0000218,,Half life after i.v. administration,,A,,N,1,Intermediate,CHEMBL876599,,
7573,Rattus norvegicus,1,,5937,BAO_0000218,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,A,,N,1,Intermediate,CHEMBL621379,,
7574,Rattus norvegicus,1,1969.0,5819,BAO_0000218,,Half life in rat plasma,,A,,N,1,Intermediate,CHEMBL621380,,
7575,Rattus norvegicus,1,1969.0,5819,BAO_0000218,,Half life in rat plasma; Not detected,,A,,N,1,Intermediate,CHEMBL621381,,
7576,Rattus norvegicus,1,,6803,BAO_0000218,,Half life in rats,,A,,N,1,Intermediate,CHEMBL618515,,
7577,Rattus norvegicus,1,,17804,BAO_0000218,,Half life period of compound was determined after peroral administration,,A,,N,1,Intermediate,CHEMBL618516,,
7578,Rattus norvegicus,1,,17804,BAO_0000218,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,A,,N,1,Intermediate,CHEMBL618517,,
7579,Rattus norvegicus,1,,5948,BAO_0000218,,Half life period in rat,,A,,N,1,Intermediate,CHEMBL618518,,
7580,Rattus norvegicus,1,,1916,BAO_0000218,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,A,,N,1,Intermediate,CHEMBL618519,,
7581,Rattus norvegicus,1,,1916,BAO_0000218,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,A,,N,1,Intermediate,CHEMBL618698,,
7582,Rattus norvegicus,1,,1916,BAO_0000218,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,A,,N,1,Intermediate,CHEMBL618862,,
7583,Rattus norvegicus,1,,4890,BAO_0000218,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL618863,,
7584,Rattus norvegicus,1,,17764,BAO_0000218,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,A,,N,1,Intermediate,CHEMBL618864,,
7585,Rattus norvegicus,1,,4727,BAO_0000218,,Half life time in rat the dose of 2 mg/kg,,A,,N,1,Intermediate,CHEMBL618865,,
7586,Rattus norvegicus,1,,17509,BAO_0000218,,Half-life 24 hr after 10 mg/kg iv administration in rats,,A,,N,1,Intermediate,CHEMBL618866,,
7587,Rattus norvegicus,1,,17509,BAO_0000218,,Half-life 24 hr after 2 mg/kg iv administration in rats,,A,,N,1,Intermediate,CHEMBL618867,,
7588,Rattus norvegicus,1,,6597,BAO_0000218,,Half-life consistent with the observed metabolic steady state in rats,,A,,N,1,Intermediate,CHEMBL875828,,
7589,Rattus norvegicus,1,,17735,BAO_0000218,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,A,,N,1,Intermediate,CHEMBL618868,,
7590,Rattus norvegicus,1,,6597,BAO_0000218,,Half-life for oxidative metabolic stability was determined using male human,,A,,N,1,Intermediate,CHEMBL618869,,
7591,Rattus norvegicus,1,,17670,BAO_0000218,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,A,,N,1,Intermediate,CHEMBL618870,,
7592,Rattus norvegicus,1,1969.0,1696,BAO_0000218,,Half-life in rat plasma,,A,,N,1,Intermediate,CHEMBL618871,,
7593,Rattus norvegicus,1,1969.0,1742,BAO_0000218,,Half-life in rat plasma was determined,,A,,N,1,Intermediate,CHEMBL618872,,
7594,Rattus norvegicus,1,,17800,BAO_0000218,,Half-life in rats was determined,,A,,N,1,Intermediate,CHEMBL873816,,
7595,,1,,12923,BAO_0000218,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,A,,U,0,Autocuration,CHEMBL618873,,
7596,,1,,11954,BAO_0000019,,Area under curve after oral dose of 0.1 mg//kg,,A,,U,0,Autocuration,CHEMBL621602,,
7597,,1,,11954,BAO_0000218,,Area under curve after oral dose of 0.3 mg/kg,,A,,U,0,Autocuration,CHEMBL621603,,
7598,,1,,11954,BAO_0000218,,Area under curve after oral dose of 1 mg/kg,,A,,U,0,Autocuration,CHEMBL621604,,
7599,,1,,11954,BAO_0000218,,Area under curve after oral dose of 10 mg/kg,,A,,U,0,Autocuration,CHEMBL621605,,
7600,,1,,11954,BAO_0000218,,Area under curve after oral dose of 23.4 mg/kg,,A,,U,0,Autocuration,CHEMBL621606,,
7601,,1,,11954,BAO_0000218,,Area under curve after oral dose of 3 mg/kg,,A,,U,0,Autocuration,CHEMBL621607,,
7602,,1,,11954,BAO_0000218,,Area under curve after oral dose of 3.87 mg/kg,,A,,U,0,Autocuration,CHEMBL621608,,
7603,,1,,5237,BAO_0000019,,Area under curve was determined,,A,,U,0,Autocuration,CHEMBL621609,,
7604,,1,,4026,BAO_0000218,,Area under curve at a dose of 10 mg/kg,,A,,U,0,Autocuration,CHEMBL621610,,
7605,Rattus norvegicus,1,,5237,BAO_0000218,,Area under curve was determined; ND=No data,,A,,N,1,Intermediate,CHEMBL621611,,
7606,Rattus norvegicus,1,,14793,BAO_0000218,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,A,,N,1,Intermediate,CHEMBL621612,,
7607,Rattus norvegicus,1,,14793,BAO_0000218,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,A,,N,1,Intermediate,CHEMBL622308,,
7608,Rattus norvegicus,1,,14793,BAO_0000218,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,A,,N,1,Intermediate,CHEMBL622309,,
7609,Rattus norvegicus,1,,14793,BAO_0000218,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,A,,N,1,Intermediate,CHEMBL622310,,
7610,Rattus norvegicus,1,,14793,BAO_0000218,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,A,,N,1,Intermediate,CHEMBL622311,,
7611,Rattus norvegicus,1,,14793,BAO_0000218,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,A,,N,1,Intermediate,CHEMBL622312,,
7612,Rattus norvegicus,1,,14793,BAO_0000218,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,A,,N,1,Intermediate,CHEMBL622931,,
7613,Rattus norvegicus,1,,14793,BAO_0000218,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,A,,N,1,Intermediate,CHEMBL622932,,
7614,Rattus norvegicus,1,1969.0,14793,BAO_0000218,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,A,,N,1,Intermediate,CHEMBL622736,,
7615,Rattus norvegicus,1,1969.0,14793,BAO_0000218,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,A,,N,1,Intermediate,CHEMBL622737,,
7616,Rattus norvegicus,1,1969.0,14793,BAO_0000218,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,A,,N,1,Intermediate,CHEMBL622738,,
7617,Rattus norvegicus,1,1969.0,14793,BAO_0000218,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,A,,N,1,Intermediate,CHEMBL622739,,
7618,Rattus norvegicus,1,1969.0,14793,BAO_0000218,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,A,,N,1,Intermediate,CHEMBL622740,,
7619,Rattus norvegicus,1,1969.0,14793,BAO_0000218,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,A,,N,1,Intermediate,CHEMBL622741,,
7620,Rattus norvegicus,1,1969.0,14793,BAO_0000218,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,A,,N,1,Intermediate,CHEMBL622742,,
7621,Rattus norvegicus,1,1969.0,14793,BAO_0000218,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,A,,N,1,Intermediate,CHEMBL622743,,
7622,Mus musculus,1,1969.0,11637,BAO_0000218,,AUC in mice,,A,,N,1,Intermediate,CHEMBL622744,,
7623,,1,,11149,BAO_0000019,,Area under curve was measured from the graph obtained from concentration Vs time,,A,,U,0,Autocuration,CHEMBL624134,,
7624,,1,,10016,BAO_0000019,,Area under curve value of compound per hour after oral administration,,A,,U,0,Autocuration,CHEMBL624135,,
7625,Rattus norvegicus,1,,17796,BAO_0000218,,Area under curve was determined after oral administration in rats,,A,,N,1,Intermediate,CHEMBL624136,,
7626,Rattus norvegicus,1,,17796,BAO_0000218,,Area under curve was determined after oral administration in rats; No data,,A,,N,1,Intermediate,CHEMBL624137,,
7627,Rattus norvegicus,1,,17796,BAO_0000218,,Area under curve was determined after oral administration in rats;No data,,A,,N,1,Intermediate,CHEMBL624320,,
7628,Canis lupus familiaris,1,,12923,BAO_0000218,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,A,,N,1,Intermediate,CHEMBL624321,,
7629,Rattus norvegicus,1,,15372,BAO_0000218,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL624322,,
7630,Rattus norvegicus,1,,15372,BAO_0000218,,Area under curve was determined for the compound after iv dose of 5.06 in rats,,A,,N,1,Intermediate,CHEMBL624323,,
7631,Rattus norvegicus,1,,15372,BAO_0000218,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL624324,,
7632,Rattus norvegicus,1,,15372,BAO_0000218,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL624325,,
7633,Rattus norvegicus,1,,15372,BAO_0000218,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL624326,,
7634,Rattus norvegicus,1,,15372,BAO_0000218,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL624327,,
7635,Rattus norvegicus,1,,15372,BAO_0000218,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL624328,,
7636,Canis lupus familiaris,1,,14169,BAO_0000218,,Area under curve was determined in Dogs after peroral administration,,A,,N,1,Intermediate,CHEMBL627848,,
7637,Rattus norvegicus,1,,14169,BAO_0000218,,Area under curve was determined in Rats after peroral administration,,A,,N,1,Intermediate,CHEMBL627849,,
7638,Rattus norvegicus,1,,14258,BAO_0000218,,Area under curve was determined in carotid blood of rat when administered intradermally,,A,,N,1,Intermediate,CHEMBL627850,,
7639,Rattus norvegicus,1,,14258,BAO_0000218,,Area under curve was determined in portal blood of rat when administered intradermally,,A,,N,1,Intermediate,CHEMBL627851,,
7640,Mus musculus,1,,15011,BAO_0000218,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,A,,N,1,Intermediate,CHEMBL627852,,
7641,Mus musculus,1,,15011,BAO_0000218,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,A,,N,1,Intermediate,CHEMBL627853,,
7642,Mus musculus,1,,15011,BAO_0000218,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,A,,N,1,Intermediate,CHEMBL627854,,
7643,Mus musculus,1,,15011,BAO_0000218,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,A,,N,1,Intermediate,CHEMBL627855,,
7644,Mus musculus,1,,15011,BAO_0000218,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,A,,N,1,Intermediate,CHEMBL627856,,
7645,Mus musculus,1,,15011,BAO_0000218,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,A,,N,1,Intermediate,CHEMBL875339,,
7646,Mus musculus,1,,15011,BAO_0000218,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,A,,N,1,Intermediate,CHEMBL627857,,
7647,Rattus norvegicus,1,2106.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL627858,,
7648,Rattus norvegicus,1,178.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627859,,
7649,Rattus norvegicus,1,955.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627860,,
7650,Rattus norvegicus,1,948.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627019,,
7651,Rattus norvegicus,1,2107.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627020,,
7652,Rattus norvegicus,1,2048.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627021,,
7653,Rattus norvegicus,1,2385.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627022,,
7654,Rattus norvegicus,1,,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627023,,
7655,Rattus norvegicus,1,2106.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627024,,
7656,Rattus norvegicus,1,2046.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627025,,
7657,Rattus norvegicus,1,2113.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627026,,
7658,Rattus norvegicus,1,178.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627027,,
7659,Rattus norvegicus,1,955.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627028,,
7660,Rattus norvegicus,1,948.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627029,,
7661,Rattus norvegicus,1,2113.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627030,,
7662,Rattus norvegicus,1,2107.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627031,,
7663,Rattus norvegicus,1,2048.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627032,,
7664,Rattus norvegicus,1,2385.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627033,,
7665,Rattus norvegicus,1,,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627034,,
7666,Rattus norvegicus,1,2106.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627035,,
7667,Rattus norvegicus,1,2046.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627036,,
7668,Rattus norvegicus,1,178.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL875340,,
7669,Rattus norvegicus,1,948.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627037,,
7670,Rattus norvegicus,1,2113.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627038,,
7671,Rattus norvegicus,1,2107.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627039,,
7672,Rattus norvegicus,1,2385.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL627040,,
7673,Rattus norvegicus,1,2106.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL624663,,
7674,Rattus norvegicus,1,2046.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL625963,,
7675,Rattus norvegicus,1,955.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL876799,,
7676,Rattus norvegicus,1,2048.0,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL626133,,
7677,Rattus norvegicus,1,,10130,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,A,,N,1,Intermediate,CHEMBL626134,,
7678,Rattus norvegicus,1,,6295,BAO_0000218,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,A,,N,1,Intermediate,CHEMBL626135,,
7679,Rattus norvegicus,1,,6296,BAO_0000218,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,A,,N,1,Intermediate,CHEMBL626136,,
7680,Rattus norvegicus,1,,6296,BAO_0000218,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,A,,N,1,Intermediate,CHEMBL626137,,
7681,Rattus norvegicus,1,,6295,BAO_0000218,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,A,,N,1,Intermediate,CHEMBL626138,,
7682,Rattus norvegicus,1,,6296,BAO_0000218,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,A,,N,1,Intermediate,CHEMBL626139,,
7683,Rattus norvegicus,1,,17260,BAO_0000218,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,A,,N,1,Intermediate,CHEMBL626140,,
7684,Rattus norvegicus,1,,17260,BAO_0000218,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,A,,N,1,Intermediate,CHEMBL626141,,
7685,Rattus norvegicus,1,,17686,BAO_0000218,,C24h in rat p.o. at 20 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL626142,,
7686,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,A,,N,1,Intermediate,CHEMBL627930,,
7687,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,A,,N,1,Intermediate,CHEMBL627931,,
7688,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,A,,N,1,Intermediate,CHEMBL627932,,
7689,Rattus norvegicus,1,2106.0,9866,BAO_0000218,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,A,,N,1,Intermediate,CHEMBL627933,,
7690,Rattus norvegicus,1,2106.0,9866,BAO_0000218,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,A,,N,1,Intermediate,CHEMBL627934,,
7691,Rattus norvegicus,1,2106.0,9866,BAO_0000218,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,A,,N,1,Intermediate,CHEMBL627935,,
7692,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL627936,,
7693,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL627937,,
7694,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL627938,,
7695,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,A,,N,1,Intermediate,CHEMBL627939,,
7696,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL627940,,
7697,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL627941,,
7698,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,A,,N,1,Intermediate,CHEMBL876800,,
7699,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL627942,,
7700,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL627943,,
7701,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,A,,N,1,Intermediate,CHEMBL627944,,
7702,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,A,,N,1,Intermediate,CHEMBL627945,,
7703,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,A,,N,1,Intermediate,CHEMBL628584,,
7704,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,A,,N,1,Intermediate,CHEMBL628585,,
7705,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,A,,N,1,Intermediate,CHEMBL628586,,
7706,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,A,,N,1,Intermediate,CHEMBL628587,,
7707,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,A,,N,1,Intermediate,CHEMBL628588,,
7708,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,A,,N,1,Intermediate,CHEMBL628589,,
7709,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,A,,N,1,Intermediate,CHEMBL625304,,
7710,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,A,,N,1,Intermediate,CHEMBL625305,,
7711,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,A,,N,1,Intermediate,CHEMBL625306,,
7712,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,A,,N,1,Intermediate,CHEMBL625307,,
7713,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,A,,N,1,Intermediate,CHEMBL625308,,
7714,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,A,,N,1,Intermediate,CHEMBL627740,,
7715,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,A,,N,1,Intermediate,CHEMBL627741,,
7716,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,A,,N,1,Intermediate,CHEMBL627742,,
7717,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,A,,N,1,Intermediate,CHEMBL627743,,
7718,Rattus norvegicus,1,178.0,9866,BAO_0000218,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,A,,N,1,Intermediate,CHEMBL627744,,
7719,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL627745,,
7720,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL627746,,
7721,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL627747,,
7722,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,A,,N,1,Intermediate,CHEMBL876810,,
7723,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL627748,,
7724,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL627749,,
7725,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,A,,N,1,Intermediate,CHEMBL627750,,
7726,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL618728,,
7727,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL618729,,
7728,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,A,,N,1,Intermediate,CHEMBL618730,,
7729,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,A,,N,1,Intermediate,CHEMBL618731,,
7730,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,A,,N,1,Intermediate,CHEMBL618732,,
7731,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,A,,N,1,Intermediate,CHEMBL618733,,
7732,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,A,,N,1,Intermediate,CHEMBL618734,,
7733,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,A,,N,1,Intermediate,CHEMBL618735,,
7734,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,A,,N,1,Intermediate,CHEMBL876602,,
7735,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,A,,N,1,Intermediate,CHEMBL618736,,
7736,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,A,,N,1,Intermediate,CHEMBL618737,,
7737,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,A,,N,1,Intermediate,CHEMBL618738,,
7738,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,A,,N,1,Intermediate,CHEMBL618739,,
7739,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,A,,N,1,Intermediate,CHEMBL618740,,
7740,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,A,,N,1,Intermediate,CHEMBL618741,,
7741,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,A,,N,1,Intermediate,CHEMBL618742,,
7742,Rattus norvegicus,1,10000001.0,9866,BAO_0000218,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,A,,N,1,Intermediate,CHEMBL618743,,
7743,Rattus norvegicus,1,1969.0,17752,BAO_0000218,,Half-life from rat plasma at a single oral dose of 25 mg/kg,,A,,N,1,Intermediate,CHEMBL618744,,
7744,Rattus norvegicus,1,,5610,BAO_0000218,,Half-life in male rat,,A,,N,1,Intermediate,CHEMBL618745,,
7745,Rattus norvegicus,1,,5939,BAO_0000218,,Half-life in rat after peroral administration at 10 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL620479,,
7746,Rattus norvegicus,1,,5939,BAO_0000218,,Half-life in rat after peroral administration at 5 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL620480,,
7747,Rattus norvegicus,1,,17771,BAO_0000218,,Half-life in rat at a dose of 3 mg/kg,,A,,N,1,Intermediate,CHEMBL620481,,
7748,Rattus norvegicus,1,,1974,BAO_0000218,,Half-life was evaluated in rats,,A,,N,1,Intermediate,CHEMBL620482,,
7749,Rattus norvegicus,1,,4239,BAO_0000218,,Half-life was measured in rat,,A,,N,1,Intermediate,CHEMBL876603,,
7750,Rattus norvegicus,1,,6681,BAO_0000218,,Half-life period for the compound was determined in rats at 50 mg/kg dose,,A,,N,1,Intermediate,CHEMBL620483,,
7751,Rattus norvegicus,1,,17752,BAO_0000218,,Half-life period in rats after intravenous administration at 5 mg/kg,,A,,N,1,Intermediate,CHEMBL620484,,
7752,Rattus norvegicus,1,,6046,BAO_0000218,,Half-life period in rat at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL620485,,
7753,Rattus norvegicus,1,,6685,BAO_0000218,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL620486,,
7754,Rattus norvegicus,1,,6685,BAO_0000218,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,A,,N,1,Intermediate,CHEMBL620487,,
7755,Rattus norvegicus,1,,6685,BAO_0000218,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,A,,N,1,Intermediate,CHEMBL620488,,
7756,Rattus norvegicus,1,,4727,BAO_0000218,,Half-life time in rat the dose of 2 mg/kg,,A,,N,1,Intermediate,CHEMBL620489,,
7757,Rattus norvegicus,1,,1088,BAO_0000218,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,A,,N,1,Intermediate,CHEMBL620490,,
7758,Rattus norvegicus,1,,5610,BAO_0000218,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,A,,N,1,Intermediate,CHEMBL620491,,
7759,Rattus norvegicus,1,1969.0,3032,BAO_0000218,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,A,,N,1,Intermediate,CHEMBL876604,,
7760,Rattus norvegicus,1,,5199,BAO_0000218,,Oral half life was determined,,A,,N,1,Intermediate,CHEMBL620492,,
7761,Rattus norvegicus,1,,14941,BAO_0000218,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,A,,N,1,Intermediate,CHEMBL620493,,
7762,Rattus norvegicus,1,,4408,BAO_0000218,,Pharmacokinetic property (t1/2) in rat,,A,,N,1,Intermediate,CHEMBL620494,,
7763,Rattus norvegicus,1,1969.0,2552,BAO_0000218,,Plasma elimination half-life was determined,,A,,N,1,Intermediate,CHEMBL620495,,
7764,Rattus norvegicus,1,1969.0,5199,BAO_0000218,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,A,,N,1,Intermediate,CHEMBL620496,,
7765,Rattus norvegicus,1,1969.0,15662,BAO_0000218,,Plasma half life was observed after intravenous administration in rat,,A,,N,1,Intermediate,CHEMBL620497,,
7766,Rattus norvegicus,1,1969.0,1465,BAO_0000218,,Plasma half-life was determined,,A,,N,1,Intermediate,CHEMBL620498,,
7767,Rattus norvegicus,1,1969.0,1446,BAO_0000218,,Plasma half-life following oral administration in Fisher rats,,A,,N,1,Intermediate,CHEMBL620499,,
7768,Rattus norvegicus,1,1969.0,6824,BAO_0000218,,Plasma half-life in rat,,A,,N,1,Intermediate,CHEMBL620500,,
7769,Rattus norvegicus,1,1969.0,17533,BAO_0000218,,Plasmatic Half-life after intravenous administration to rat,,A,,N,1,Intermediate,CHEMBL873809,,
7770,Rattus norvegicus,1,,5979,BAO_0000218,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,A,,N,1,Intermediate,CHEMBL620501,,
7771,Rattus norvegicus,1,,4689,BAO_0000218,,Terminal half life after intravenous administration (1 mg/kg) in rat,,A,,N,1,Intermediate,CHEMBL620502,,
7772,Rattus norvegicus,1,,4689,BAO_0000218,,Terminal half life in Rat at a oral dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL620503,,
7773,Rattus norvegicus,1,,2463,BAO_0000218,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,A,,N,1,Intermediate,CHEMBL620504,,
7774,Rattus norvegicus,1,,4883,BAO_0000218,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL876605,,
7775,Rattus norvegicus,1,,4883,BAO_0000218,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL620505,,
7776,Rattus norvegicus,1,1969.0,15662,BAO_0000218,,plasma half life was observed after intravenous administration in rat,,A,,N,1,Intermediate,CHEMBL873811,,
7777,Rattus norvegicus,1,,3598,BAO_0000218,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,A,,N,1,Expert,CHEMBL624016,,
7778,Rattus norvegicus,1,,4576,BAO_0000218,,Half life of compound determined in rat,,A,,N,1,Intermediate,CHEMBL624017,,
7779,Rattus norvegicus,1,,4576,BAO_0000218,,Mean residence time determined in rat,,A,,N,1,Intermediate,CHEMBL624018,,
7780,Rattus norvegicus,1,,4576,BAO_0000218,,Plasma half life determined in rat,,A,,N,1,Intermediate,CHEMBL624019,,
7781,Rattus norvegicus,1,955.0,4910,BAO_0000218,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,A,,N,1,Intermediate,CHEMBL624020,,
7782,Rattus norvegicus,1,,4891,BAO_0000218,,Compound was evaluated for pharmacokinetic parameter maximum time period,,A,,N,1,Intermediate,CHEMBL624201,,
7783,Rattus norvegicus,1,,429,BAO_0000218,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,A,,N,1,Intermediate,CHEMBL872528,,
7784,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL624202,,
7785,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL624203,,
7786,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL624350,,
7787,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL621320,,
7788,Rattus norvegicus,1,,17582,BAO_0000218,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,A,,N,1,Intermediate,CHEMBL621321,,
7789,Rattus norvegicus,1,,4026,BAO_0000218,,Maximum time (Tmax) required to reach Cmax in rats,,A,,N,1,Intermediate,CHEMBL621322,,
7790,Rattus norvegicus,1,,4890,BAO_0000218,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL621323,,
7791,Rattus norvegicus,1,,6571,BAO_0000218,,Maximum time of clearance of compound in rats after peroral administration,,A,,N,1,Intermediate,CHEMBL621324,,
7792,Rattus norvegicus,1,,4727,BAO_0000218,,Maximum time at the dose of 2 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL621325,,
7793,Rattus norvegicus,1,1969.0,17651,BAO_0000218,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,A,,N,1,Intermediate,CHEMBL875837,,
7794,Rattus norvegicus,1,1969.0,17651,BAO_0000218,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL621326,,
7795,Rattus norvegicus,1,,14465,BAO_0000218,,Tmax in Guinea pig (PO dose),,A,,N,1,Intermediate,CHEMBL621327,,
7796,Rattus norvegicus,1,,14941,BAO_0000218,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,A,,N,1,Intermediate,CHEMBL621328,,
7797,Rattus norvegicus,1,,5960,BAO_0000218,,Pharmacokinetic parameter (Tmax) in rat,,A,,N,1,Intermediate,CHEMBL621329,,
7798,Rattus norvegicus,1,,5022,BAO_0000218,,Pharmacokinetic parameter (Tmax) was estimated,,A,,N,1,Intermediate,CHEMBL621330,,
7799,Rattus norvegicus,1,,4408,BAO_0000218,,Pharmacokinetic property (Tmax) in rat,,A,,N,1,Intermediate,CHEMBL621331,,
7800,Rattus norvegicus,1,,5983,BAO_0000218,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,A,,N,1,Intermediate,CHEMBL621332,,
7801,Rattus norvegicus,1,,4689,BAO_0000218,,T max in Rat at a oral dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL621333,,
7802,Rattus norvegicus,1,,2792,BAO_0000218,,T max was determined at 10 mg/kg po dose in rats,,A,,N,1,Intermediate,CHEMBL621334,,
7803,Mus musculus,1,,15011,BAO_0000218,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,A,,N,1,Intermediate,CHEMBL621335,,
7804,Canis lupus familiaris,1,,14180,BAO_0000218,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,A,,N,1,Intermediate,CHEMBL621336,,
7805,Rattus norvegicus,1,,14180,BAO_0000218,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,A,,N,1,Intermediate,CHEMBL621337,,
7806,Canis lupus familiaris,1,,14599,BAO_0000218,,Area under curve was measured after i.v. administration into Beagle dog.,,A,,N,1,Intermediate,CHEMBL621338,,
7807,Canis lupus familiaris,1,,14599,BAO_0000218,,Area under curve was measured after iv administration into Beagle dog,,A,,N,1,Intermediate,CHEMBL875838,,
7808,Canis lupus familiaris,1,,14599,BAO_0000218,,Area under curve was measured after po administration into Beagle dog,,A,,N,1,Intermediate,CHEMBL621339,,
7809,Canis lupus familiaris,1,,14599,BAO_0000218,,Area under curve was measured after po administration into Beagle dog.,,A,,N,1,Intermediate,CHEMBL621340,,
7810,,1,,15675,BAO_0000218,,Area under curve was measured at peroral dose of 3 mg/kg,,A,,U,0,Autocuration,CHEMBL621341,,
7811,,1,,12706,BAO_0000019,,Area under curve was measured by using concentration Vs time,,A,,U,0,Autocuration,CHEMBL621342,,
7812,,1,,12706,BAO_0000019,,Area under curve was measured by using concentration Vs time; not tested,,A,,U,0,Autocuration,CHEMBL621343,,
7813,Mus musculus,1,,9750,BAO_0000218,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,A,,N,1,Intermediate,CHEMBL621344,,
7814,Mus musculus,1,,9750,BAO_0000218,,Area under curve(AUC) was measured in mice after oral administration.,,A,,N,1,Intermediate,CHEMBL621345,,
7815,,1,,14691,BAO_0000019,,Area under curve(AUC) value of the compound,,A,,U,0,Autocuration,CHEMBL621346,,
7816,,1,,14691,BAO_0000218,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,A,,U,0,Autocuration,CHEMBL621347,,
7817,Canis lupus familiaris,1,,14691,BAO_0000218,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,A,,N,1,Intermediate,CHEMBL621348,,
7818,,1,178.0,2939,BAO_0000019,,Area under curve(carotid artery) was determined by the availability in blood,,A,,U,0,Autocuration,CHEMBL621349,,
7819,,1,178.0,2939,BAO_0000019,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,A,,U,0,Autocuration,CHEMBL621350,,
7820,,1,178.0,2939,BAO_0000019,,Area under curve(carotid artery) was determined by the availability in blood; No data,,A,,U,0,Autocuration,CHEMBL875839,,
7821,,1,178.0,2939,BAO_0000019,,Area under curve(portal vein) was determined by the availability in blood,,A,,U,0,Autocuration,CHEMBL620211,,
7822,,1,178.0,2939,BAO_0000019,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,A,,U,0,Autocuration,CHEMBL620212,,
7823,,1,178.0,2939,BAO_0000019,,Area under curve(portal vein) was determined by the availability in blood; No data,,A,,U,0,Autocuration,CHEMBL620213,,
7824,Macaca mulatta,1,1969.0,9552,BAO_0000218,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,A,,N,1,Intermediate,CHEMBL620214,,
7825,Macaca mulatta,1,1969.0,9552,BAO_0000218,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,A,,N,1,Intermediate,CHEMBL620215,,
7826,Macaca mulatta,1,1969.0,9552,BAO_0000218,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,A,,N,1,Intermediate,CHEMBL620216,,
7827,Canis lupus familiaris,1,1969.0,9552,BAO_0000218,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,A,,N,1,Intermediate,CHEMBL620888,,
7828,Canis lupus familiaris,1,1969.0,9552,BAO_0000218,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,A,,N,1,Intermediate,CHEMBL620889,,
7829,,1,1969.0,9552,BAO_0000019,,Area under plasma concentration vs time curve observed in rats for 0-3 h,,A,,U,0,Autocuration,CHEMBL620890,,
7830,Rattus norvegicus,1,1969.0,11911,BAO_0000218,,Area under plasma time curve determined in male rat,,A,,N,1,Intermediate,CHEMBL620891,,
7831,,1,,16618,BAO_0000019,,Area under the MAP curve measured over 5 min.,,A,,U,0,Autocuration,CHEMBL620892,,
7832,Mus musculus,1,,14387,BAO_0000218,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,A,,N,1,Intermediate,CHEMBL621079,,
7833,Mus musculus,1,,14387,BAO_0000218,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,A,,N,1,Intermediate,CHEMBL621080,,
7834,Canis lupus familiaris,1,,12836,BAO_0000218,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL621081,,
7835,Cricetinae,1,,12836,BAO_0000218,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL621082,,
7836,Rattus norvegicus,1,,12836,BAO_0000218,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL621083,,
7837,Canis lupus familiaris,1,,14339,BAO_0000218,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,A,,N,1,Intermediate,CHEMBL621084,,
7838,Canis lupus familiaris,1,,14339,BAO_0000218,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,A,,N,1,Intermediate,CHEMBL621085,,
7839,Canis lupus familiaris,1,,14339,BAO_0000218,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,A,,N,1,Intermediate,CHEMBL621086,,
7840,Canis lupus familiaris,1,,10524,BAO_0000218,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,A,,N,1,Intermediate,CHEMBL621087,,
7841,Canis lupus familiaris,1,,9994,BAO_0000218,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,A,,N,1,Intermediate,CHEMBL622607,,
7842,Canis lupus familiaris,1,,11325,BAO_0000218,,Serum AUC in marmosets (IV dose),,A,,N,1,Intermediate,CHEMBL622608,,
7843,,1,,12536,BAO_0000019,,Area under the curve after intravenous administration at a dose of 10 umol/kg,,A,,U,0,Autocuration,CHEMBL624481,,
7844,,1,,12536,BAO_0000019,,Area under the curve after intravenous administration at a dose of 2 umol/kg,,A,,U,0,Autocuration,CHEMBL624482,,
7845,,1,,12536,BAO_0000019,,Area under the curve after intravenous administration at a dose of 4 umol/kg,,A,,U,0,Autocuration,CHEMBL624483,,
7846,,1,,12536,BAO_0000019,,Area under the curve after intravenous administration at a dose of 40 umol/kg,,A,,U,0,Autocuration,CHEMBL624484,,
7847,,1,,12536,BAO_0000019,,Area under the curve after intravenous administration at a dose of 5 umol/kg,,A,,U,0,Autocuration,CHEMBL624485,,
7848,Rattus norvegicus,1,,15556,BAO_0000218,,Area under the curve for fumarate salt was evaluated in F344 Rats.,,A,,N,1,Intermediate,CHEMBL624486,,
7849,,1,,2809,BAO_0000019,,Area under the curve for the compound was calculated.,,A,,U,0,Autocuration,CHEMBL624487,,
7850,,1,,9511,BAO_0000019,,Area under the curve in concentration/ time,,A,,U,0,Autocuration,CHEMBL624488,,
7851,Rattus norvegicus,1,,12818,BAO_0000218,,Area under the curve administered intraintestinal in rats.,,A,,N,1,Intermediate,CHEMBL624489,,
7852,Rattus norvegicus,1,,12818,BAO_0000218,,Area under the curve administered intravenously in rats.,,A,,N,1,Intermediate,CHEMBL625184,,
7853,,1,,15118,BAO_0000019,,Area under the curve during intravenous administration,,A,,U,0,Autocuration,CHEMBL625185,,
7854,,1,,15118,BAO_0000019,,Area under the curve during intravenous administration; Not determined,,A,,U,0,Autocuration,CHEMBL875954,,
7855,,1,,15118,BAO_0000019,,Area under the curve during systemic administration,,A,,U,0,Autocuration,CHEMBL625186,,
7856,,1,,15118,BAO_0000019,,Area under the curve during systemic administration; Not determined,,A,,U,0,Autocuration,CHEMBL625187,,
7857,,1,,2632,BAO_0000019,,Area under the curve was calculated for the compound.,,A,,U,0,Autocuration,CHEMBL625188,,
7858,Canis lupus familiaris,1,,14346,BAO_0000218,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,A,,N,1,Intermediate,CHEMBL625189,,
7859,Canis lupus familiaris,1,,14346,BAO_0000218,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,A,,N,1,Intermediate,CHEMBL625190,,
7860,Rattus norvegicus,1,,14346,BAO_0000218,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,A,,N,1,Intermediate,CHEMBL621733,,
7861,Rattus norvegicus,1,,14346,BAO_0000218,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,A,,N,1,Intermediate,CHEMBL621734,,
7862,Rattus norvegicus,1,,11149,BAO_0000218,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,A,,N,1,Intermediate,CHEMBL621735,,
7863,Rattus norvegicus,1,1969.0,17796,BAO_0000218,,Clearance of the drug was measured in the plasma of rat; No data,,A,,N,1,Intermediate,CHEMBL621736,,
7864,Rattus norvegicus,1,1969.0,5247,BAO_0000218,,The pharmacokinetic parameter plasma clearance in vivo in rats,,A,,N,1,Intermediate,CHEMBL621737,,
7865,Rattus norvegicus,1,,4727,BAO_0000218,,Plasma clearance at the dose of 2 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL621738,,
7866,Rattus norvegicus,1,,5654,BAO_0000218,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,A,,N,1,Intermediate,CHEMBL622806,,
7867,Rattus norvegicus,1,,5654,BAO_0000218,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,A,,N,1,Intermediate,CHEMBL623519,,
7868,Rattus norvegicus,1,,17260,BAO_0000218,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,A,,N,1,Intermediate,CHEMBL623520,,
7869,Rattus norvegicus,1,,17065,BAO_0000218,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,A,,N,1,Intermediate,CHEMBL623521,,
7870,Rattus norvegicus,1,,17671,BAO_0000218,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,A,,N,1,Intermediate,CHEMBL623522,,
7871,Rattus norvegicus,1,,6672,BAO_0000218,,Clearance rate in rat,,A,,N,1,Intermediate,CHEMBL623523,,
7872,Rattus norvegicus,1,,6673,BAO_0000218,,Clearance rate in rat,,A,,N,1,Intermediate,CHEMBL623690,,
7873,Rattus norvegicus,1,,5978,BAO_0000218,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL623691,,
7874,Rattus norvegicus,1,,5978,BAO_0000218,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL623692,,
7875,Rattus norvegicus,1,,5978,BAO_0000218,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL623693,,
7876,Rattus norvegicus,1,,5978,BAO_0000218,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL623694,,
7877,Rattus norvegicus,1,,4413,BAO_0000218,,Clearance of compound after iv administration of 20 mg/kg dose in rat,,A,,N,1,Intermediate,CHEMBL623695,,
7878,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,A,,N,1,Intermediate,CHEMBL623696,,
7879,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,A,,N,1,Intermediate,CHEMBL623697,,
7880,Macaca mulatta,1,1969.0,5005,BAO_0000218,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,A,,U,0,Intermediate,CHEMBL623698,,
7881,Rattus norvegicus,1,1969.0,5005,BAO_0000218,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,A,,U,0,Intermediate,CHEMBL623699,,
7882,Rattus norvegicus,1,,15765,BAO_0000218,,Mean (%CV) PK parameters for CL(mL/min/kg).,,A,,N,1,Intermediate,CHEMBL623700,,
7883,Rattus norvegicus,1,,3747,BAO_0000218,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,A,,N,1,Intermediate,CHEMBL623701,,
7884,Rattus norvegicus,1,1969.0,16366,BAO_0000218,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,A,,N,1,Intermediate,CHEMBL623702,,
7885,Rattus norvegicus,1,,4199,BAO_0000218,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,A,,N,1,Intermediate,CHEMBL623703,,
7886,Rattus norvegicus,1,,17267,BAO_0000218,,Plasma clearance in rat was determined,,A,,N,1,Intermediate,CHEMBL623704,,
7887,Rattus norvegicus,1,,6535,BAO_0000218,,Plasma clearance in rat after administration of 2 mg/kg iv,,A,,N,1,Intermediate,CHEMBL623705,,
7888,Rattus norvegicus,1,,6535,BAO_0000218,,Plasma clearance in rat after administration of 2 mg/kg iv,,A,,N,1,Intermediate,CHEMBL623706,,
7889,Rattus norvegicus,1,,5041,BAO_0000218,,Plasma clearance was determined,,A,,N,1,Intermediate,CHEMBL623707,,
7890,Rattus norvegicus,1,,5960,BAO_0000218,,Plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL623708,,
7891,Rattus norvegicus,1,,5937,BAO_0000218,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,A,,N,1,Intermediate,CHEMBL623709,,
7892,Rattus norvegicus,1,,5871,BAO_0000218,,Plasma clearance in rat by iv administration,,A,,N,1,Intermediate,CHEMBL623710,,
7893,Rattus norvegicus,1,,5874,BAO_0000218,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,A,,N,1,Intermediate,CHEMBL623711,,
7894,Rattus norvegicus,1,,6504,BAO_0000218,,Plasma clearance in rat p.o.,,A,,N,1,Intermediate,CHEMBL623712,,
7895,Rattus norvegicus,1,,6803,BAO_0000218,,Plasma clearance in rats,,A,,N,1,Intermediate,CHEMBL623713,,
7896,Rattus norvegicus,1,,5041,BAO_0000218,,Plasma clearance was determined; ND denotes no data,,A,,N,1,Intermediate,CHEMBL623714,,
7897,Rattus norvegicus,1,,5041,BAO_0000218,,Plasma clearance was determined; ND denotes not determined,,A,,N,1,Intermediate,CHEMBL623715,,
7898,Rattus norvegicus,1,,1916,BAO_0000218,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,A,,N,1,Intermediate,CHEMBL623716,,
7899,Rattus norvegicus,1,,5199,BAO_0000218,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,A,,N,1,Intermediate,CHEMBL622980,,
7900,Rattus norvegicus,1,,16367,BAO_0000218,,Plasma administration to rats,,A,,N,1,Intermediate,CHEMBL622981,,
7901,Rattus norvegicus,1,,6362,BAO_0000218,,Plasma clearance of the compound in female Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL622982,,
7902,Rattus norvegicus,1,,15662,BAO_0000218,,Plasma clearance was observed after intravenous administration in rat,,A,,N,1,Intermediate,CHEMBL622983,,
7903,Rattus norvegicus,1,,6215,BAO_0000218,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,A,,N,1,Intermediate,CHEMBL622984,,
7904,Rattus norvegicus,1,,1466,BAO_0000218,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,A,,N,1,Intermediate,CHEMBL622985,,
7905,Rattus norvegicus,1,1969.0,15662,BAO_0000218,,plasma clearance was observed after intravenous administration in rat,,A,,N,1,Intermediate,CHEMBL623631,,
7906,Rattus norvegicus,1,,4723,BAO_0000218,,In vivo CL/F determined,,A,,N,1,Intermediate,CHEMBL623632,,
7907,Rattus norvegicus,1,1969.0,2792,BAO_0000218,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,A,,N,1,Intermediate,CHEMBL623633,,
7908,Rattus norvegicus,1,1969.0,2792,BAO_0000218,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,A,,N,1,Intermediate,CHEMBL623634,,
7909,Rattus norvegicus,1,,5213,BAO_0000218,,Compound was tested for the lower blood clearance in rat,,A,,N,1,Intermediate,CHEMBL623635,,
7910,Rattus norvegicus,1,,4687,BAO_0000218,,Evaluated for the low clearance in rat (in vivo),,A,,N,1,Intermediate,CHEMBL621195,,
7911,Rattus norvegicus,1,,3371,BAO_0000218,,Pharmacokinetic property (CLb)of the compound was determined in rat,,A,,N,1,Intermediate,CHEMBL621196,,
7912,Rattus norvegicus,1,,4690,BAO_0000218,,Rapid clearance after intravenous administration in rat was determined,,A,,N,1,Intermediate,CHEMBL875287,,
7913,Rattus norvegicus,1,,5702,BAO_0000218,,Clearance measured in rat,,A,,N,1,Intermediate,CHEMBL621197,,
7914,Rattus norvegicus,1,1969.0,740,BAO_0000218,,Compound was evaluated for plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL621198,,
7915,Rattus norvegicus,1,1969.0,4853,BAO_0000218,,Low plasma clearance was calculated in rat,,A,,N,1,Intermediate,CHEMBL621199,,
7916,Rattus norvegicus,1,,5789,BAO_0000218,,Pharmacokinetic property (Clp) in rat,,A,,N,1,Intermediate,CHEMBL621200,,
7917,Rattus norvegicus,1,,4527,BAO_0000218,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,A,,N,1,Intermediate,CHEMBL621201,,
7918,Rattus norvegicus,1,,4527,BAO_0000218,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,A,,N,1,Intermediate,CHEMBL621202,,
7919,Rattus norvegicus,1,,6518,BAO_0000218,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL621203,,
7920,Rattus norvegicus,1,,6518,BAO_0000218,,Plasma clearance after IV dosing at 1 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL621204,,
7921,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL621205,,
7922,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL621206,,
7923,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL621207,,
7924,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL621208,,
7925,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,A,,N,1,Intermediate,CHEMBL621209,,
7926,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL876484,,
7927,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,A,,N,1,Intermediate,CHEMBL621210,,
7928,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL621211,,
7929,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL621212,,
7930,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,A,,N,1,Intermediate,CHEMBL621213,,
7931,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,A,,N,1,Intermediate,CHEMBL621214,,
7932,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,A,,N,1,Intermediate,CHEMBL621215,,
7933,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,A,,N,1,Intermediate,CHEMBL621216,,
7934,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,A,,N,1,Intermediate,CHEMBL621217,,
7935,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,A,,N,1,Intermediate,CHEMBL621218,,
7936,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,A,,N,1,Intermediate,CHEMBL621219,,
7937,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,A,,N,1,Intermediate,CHEMBL621220,,
7938,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,A,,N,1,Intermediate,CHEMBL621221,,
7939,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,A,,N,1,Intermediate,CHEMBL621222,,
7940,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,A,,N,1,Intermediate,CHEMBL621223,,
7941,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,A,,N,1,Intermediate,CHEMBL876485,,
7942,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,A,,N,1,Intermediate,CHEMBL621224,,
7943,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,A,,N,1,Intermediate,CHEMBL621225,,
7944,Rattus norvegicus,1,948.0,9866,BAO_0000218,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,A,,N,1,Intermediate,CHEMBL621226,,
7945,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL621227,,
7946,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL621228,,
7947,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL621229,,
7948,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,A,,N,1,Intermediate,CHEMBL621230,,
7949,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,A,,N,1,Intermediate,CHEMBL621231,,
7950,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL621232,,
7951,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,A,,N,1,Intermediate,CHEMBL621233,,
7952,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL621234,,
7953,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,A,,N,1,Intermediate,CHEMBL621235,,
7954,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,A,,N,1,Intermediate,CHEMBL621236,,
7955,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,A,,N,1,Intermediate,CHEMBL621237,,
7956,Rattus norvegicus,1,2113.0,9866,BAO_0000218,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,A,,N,1,Intermediate,CHEMBL876486,,
7957,Rattus norvegicus,1,160.0,9866,BAO_0000218,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,A,,N,1,Intermediate,CHEMBL622436,,
7958,Rattus norvegicus,1,160.0,9866,BAO_0000218,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,A,,N,1,Intermediate,CHEMBL622437,,
7959,Rattus norvegicus,1,160.0,9866,BAO_0000218,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,A,,N,1,Intermediate,CHEMBL622438,,
7960,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,A,,N,1,Intermediate,CHEMBL622439,,
7961,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,A,,N,1,Intermediate,CHEMBL622440,,
7962,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,A,,N,1,Intermediate,CHEMBL622441,,
7963,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL622442,,
7964,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL622443,,
7965,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL622444,,
7966,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL622445,,
7967,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,A,,N,1,Intermediate,CHEMBL622446,,
7968,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,A,,N,1,Intermediate,CHEMBL622447,,
7969,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL622448,,
7970,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,A,,N,1,Intermediate,CHEMBL622449,,
7971,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,A,,N,1,Intermediate,CHEMBL622450,,
7972,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,A,,N,1,Intermediate,CHEMBL622451,,
7973,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,A,,N,1,Intermediate,CHEMBL622452,,
7974,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,A,,N,1,Intermediate,CHEMBL622453,,
7975,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,A,,N,1,Intermediate,CHEMBL622454,,
7976,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,A,,N,1,Intermediate,CHEMBL622455,,
7977,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,A,,N,1,Intermediate,CHEMBL876024,,
7978,Rattus norvegicus,1,,2792,BAO_0000218,,T max was determined at 3 mg/kg po dose in rats,,A,,N,1,Intermediate,CHEMBL622456,,
7979,Rattus norvegicus,1,,15078,BAO_0000218,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL622457,,
7980,Rattus norvegicus,1,,15078,BAO_0000218,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL622458,,
7981,Rattus norvegicus,1,,15022,BAO_0000218,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,A,,N,1,Intermediate,CHEMBL622459,,
7982,Rattus norvegicus,1,,15022,BAO_0000218,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,A,,N,1,Intermediate,CHEMBL873343,,
7983,Rattus norvegicus,1,,15022,BAO_0000218,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,A,,N,1,Intermediate,CHEMBL622460,,
7984,Rattus norvegicus,1,1969.0,4576,BAO_0000218,,Time for maximum plasma concentration determined in rat,,A,,N,1,Intermediate,CHEMBL622461,,
7985,Rattus norvegicus,1,1969.0,6681,BAO_0000218,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,A,,N,1,Intermediate,CHEMBL622462,,
7986,Rattus norvegicus,1,,16365,BAO_0000218,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,A,,N,1,Intermediate,CHEMBL622463,,
7987,Rattus norvegicus,1,,16365,BAO_0000218,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,A,,N,1,Intermediate,CHEMBL622464,,
7988,Rattus norvegicus,1,,16365,BAO_0000218,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,A,,N,1,Intermediate,CHEMBL622465,,
7989,Rattus norvegicus,1,,16365,BAO_0000218,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,A,,N,1,Intermediate,CHEMBL622466,,
7990,Rattus norvegicus,1,,16365,BAO_0000218,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,A,,N,1,Intermediate,CHEMBL622467,,
7991,Rattus norvegicus,1,1969.0,6824,BAO_0000218,,Time of maximum plasma concentration in rat,,A,,N,1,Intermediate,CHEMBL622468,,
7992,Rattus norvegicus,1,1969.0,6685,BAO_0000218,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL876025,,
7993,Rattus norvegicus,1,1969.0,6685,BAO_0000218,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,A,,N,1,Intermediate,CHEMBL622469,,
7994,Rattus norvegicus,1,1969.0,6685,BAO_0000218,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,A,,N,1,Intermediate,CHEMBL622470,,
7995,Rattus norvegicus,1,,15662,BAO_0000218,,Time required to reach maximum concentration (Cmax) after oral administration in rat,,A,,N,1,Intermediate,CHEMBL622471,,
7996,Rattus norvegicus,1,1969.0,1742,BAO_0000218,,Time required to reach maximum concentration in rat plasma,,A,,N,1,Intermediate,CHEMBL622472,,
7997,Rattus norvegicus,1,1969.0,2774,BAO_0000218,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,A,,N,1,Intermediate,CHEMBL622473,,
7998,Rattus norvegicus,1,1969.0,5199,BAO_0000218,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL624282,,
7999,Rattus norvegicus,1,1969.0,12873,BAO_0000218,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL624283,,
8000,Rattus norvegicus,1,1969.0,12873,BAO_0000218,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL624284,,
8001,Rattus norvegicus,1,1969.0,1916,BAO_0000218,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,A,,N,1,Intermediate,CHEMBL624285,,
8002,Rattus norvegicus,1,,16367,BAO_0000218,,Time to reach Cmax after oral administration to rats,,A,,N,1,Intermediate,CHEMBL624286,,
8003,Rattus norvegicus,1,,16366,BAO_0000218,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,A,,N,1,Intermediate,CHEMBL624287,,
8004,Rattus norvegicus,1,,216,BAO_0000218,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,A,,N,1,Intermediate,CHEMBL624288,,
8005,Rattus norvegicus,1,1969.0,6410,BAO_0000218,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,A,,N,1,Intermediate,CHEMBL624289,,
8006,Rattus norvegicus,1,1969.0,6410,BAO_0000218,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,A,,N,1,Intermediate,CHEMBL873344,,
8007,Rattus norvegicus,1,,6215,BAO_0000218,,Tmax after peroral administration (10 mg/kg) was determined in rat,,A,,N,1,Intermediate,CHEMBL619623,,
8008,Rattus norvegicus,1,,3598,BAO_0000218,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,A,,N,1,Expert,CHEMBL621399,,
8009,Rattus norvegicus,1,,4527,BAO_0000218,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,A,,N,1,Intermediate,CHEMBL621400,,
8010,Rattus norvegicus,1,,17670,BAO_0000218,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,A,,N,1,Intermediate,CHEMBL621401,,
8011,Rattus norvegicus,1,,1465,BAO_0000218,,Tmax was determined,,A,,N,1,Intermediate,CHEMBL621402,,
8012,Rattus norvegicus,1,,2552,BAO_0000218,,Tmax was determined,,A,,N,1,Intermediate,CHEMBL621403,,
8013,Rattus norvegicus,1,,5656,BAO_0000218,,Tmax after oral administration in rat,,A,,N,1,Intermediate,CHEMBL621121,,
8014,Rattus norvegicus,1,,17764,BAO_0000218,,Tmax after peroral administration in rats at 2.4 uM/kg,,A,,N,1,Intermediate,CHEMBL872525,,
8015,Rattus norvegicus,1,,5610,BAO_0000218,,Tmax in male rat,,A,,N,1,Intermediate,CHEMBL621122,,
8016,Rattus norvegicus,1,,6046,BAO_0000218,,Tmax in rat at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL621123,,
8017,Rattus norvegicus,1,,5874,BAO_0000218,,Tmax in rat by po administration at a dose of 40 mg/kg,,A,,N,1,Intermediate,CHEMBL621124,,
8018,Rattus norvegicus,1,,17596,BAO_0000218,,Tmax in rats,,A,,N,1,Intermediate,CHEMBL621125,,
8019,Rattus norvegicus,1,,17804,BAO_0000218,,Tmax was measured in rats after peroral administration at 5 mg/kg,,A,,N,1,Intermediate,CHEMBL621126,,
8020,Rattus norvegicus,1,,1908,BAO_0000218,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,A,,N,1,Intermediate,CHEMBL621127,,
8021,Rattus norvegicus,1,,2959,BAO_0000218,,Tmax value after administration of 20 mg/Kg oral dose in rat,,A,,N,1,Intermediate,CHEMBL621128,,
8022,Rattus norvegicus,1,,6757,BAO_0000218,,Tmax value at a dose of 10 mg/kg in male SD rats,,A,,N,1,Intermediate,CHEMBL618263,,
8023,Rattus norvegicus,1,,6757,BAO_0000218,,Tmax value at a dose of 100 mg/kg in male SD rats,,A,,N,1,Intermediate,CHEMBL618264,,
8024,Rattus norvegicus,1,,6757,BAO_0000218,,Tmax value at a dose of 50 mg/kg in male SD rats,,A,,N,1,Intermediate,CHEMBL618265,,
8025,Rattus norvegicus,1,1969.0,4186,BAO_0000218,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,A,,N,1,Intermediate,CHEMBL618266,,
8026,Rattus norvegicus,1,,15662,BAO_0000218,,time required to reach maximum concentration (Cmax) after oral administration in rat,,A,,N,1,Intermediate,CHEMBL618267,,
8027,Rattus norvegicus,1,1088.0,429,BAO_0000218,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,A,,N,1,Intermediate,CHEMBL618450,,
8028,Rattus norvegicus,1,1088.0,429,BAO_0000218,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,A,,N,1,Intermediate,CHEMBL618451,,
8029,Rattus norvegicus,1,,5546,BAO_0000218,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,A,,N,1,Intermediate,CHEMBL618452,,
8030,Rattus norvegicus,1,1088.0,3173,BAO_0000218,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,A,,N,1,Intermediate,CHEMBL618453,,
8031,Rattus norvegicus,1,1088.0,3173,BAO_0000218,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,A,,N,1,Intermediate,CHEMBL618454,,
8032,Rattus norvegicus,1,1088.0,3173,BAO_0000218,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,A,,N,1,Intermediate,CHEMBL618455,,
8033,Rattus norvegicus,1,,4257,BAO_0000218,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,A,,N,1,Intermediate,CHEMBL618456,,
8034,Rattus norvegicus,1,,6011,BAO_0000218,,Compound distribution in rat tissues was determined,,A,,N,1,Intermediate,CHEMBL618457,,
8035,Rattus norvegicus,1,,5472,BAO_0000218,,Volume of distribution was evaluated in rat,,A,,N,1,Intermediate,CHEMBL618458,,
8036,Rattus norvegicus,1,,14346,BAO_0000218,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,A,,N,1,Intermediate,CHEMBL618459,,
8037,Rattus norvegicus,1,,14346,BAO_0000218,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,A,,N,1,Intermediate,CHEMBL876733,,
8038,Canis lupus familiaris,1,,14346,BAO_0000218,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,A,,N,1,Intermediate,CHEMBL618460,,
8039,Rattus norvegicus,1,,14346,BAO_0000218,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,A,,N,1,Intermediate,CHEMBL618461,,
8040,,1,,15469,BAO_0000019,,Area under the curve was determined after oral administration (300 uM/Kg),,A,,U,0,Autocuration,CHEMBL618462,,
8041,Rattus norvegicus,1,,14346,BAO_0000218,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,A,,N,1,Intermediate,CHEMBL618463,,
8042,Rattus norvegicus,1,,14346,BAO_0000218,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,A,,N,1,Intermediate,CHEMBL618464,,
8043,Rattus norvegicus,1,,14346,BAO_0000218,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,A,,N,1,Intermediate,CHEMBL618465,,
8044,Rattus norvegicus,1,,14346,BAO_0000218,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,A,,N,1,Intermediate,CHEMBL618466,,
8045,Rattus norvegicus,1,,14346,BAO_0000218,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,A,,N,1,Intermediate,CHEMBL618467,,
8046,Rattus norvegicus,1,,15372,BAO_0000218,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL618468,,
8047,Canis lupus familiaris,1,1969.0,12935,BAO_0000218,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,A,,N,1,Intermediate,CHEMBL618469,,
8048,Canis lupus familiaris,1,1969.0,12935,BAO_0000218,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL618470,,
8049,,1,,14813,BAO_0000218,,Plasma drug AUC in rat (PO dose),,A,,U,0,Autocuration,CHEMBL618471,,
8050,Mus musculus,1,,15792,BAO_0000218,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,A,,N,1,Intermediate,CHEMBL618472,,
8051,,1,,3579,BAO_0000218,,Area under was determined at a dose of 30 mg/kg,,A,,U,0,Autocuration,CHEMBL618473,,
8052,Mustela putorius furo,1,,12487,BAO_0000218,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,A,,N,1,Intermediate,CHEMBL621699,,
8053,Rattus norvegicus,1,,12487,BAO_0000218,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,A,,N,1,Intermediate,CHEMBL621700,,
8054,Rattus norvegicus,1,,12487,BAO_0000218,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,A,,N,1,Intermediate,CHEMBL621701,,
8055,Mustela putorius furo,1,,12487,BAO_0000218,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,A,,N,1,Intermediate,CHEMBL621702,,
8056,Canis lupus familiaris,1,,12487,BAO_0000218,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,A,,N,1,Intermediate,CHEMBL621703,,
8057,Canis lupus familiaris,1,,12487,BAO_0000218,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,A,,N,1,Intermediate,CHEMBL621704,,
8058,Rattus norvegicus,1,,12902,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,A,,N,1,Intermediate,CHEMBL624259,,
8059,Rattus norvegicus,1,,12902,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,A,,N,1,Intermediate,CHEMBL624260,,
8060,Rattus norvegicus,1,,12902,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,A,,N,1,Intermediate,CHEMBL624430,,
8061,Rattus norvegicus,1,,12902,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,A,,N,1,Intermediate,CHEMBL624431,,
8062,Rattus norvegicus,1,,12902,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,A,,N,1,Intermediate,CHEMBL624432,,
8063,Rattus norvegicus,1,,12902,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,A,,N,1,Intermediate,CHEMBL624433,,
8064,Rattus norvegicus,1,,12902,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,A,,N,1,Intermediate,CHEMBL624434,,
8065,Rattus norvegicus,1,,12902,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,A,,N,1,Intermediate,CHEMBL624435,,
8066,Mus musculus,1,,12745,BAO_0000218,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,A,,N,1,Intermediate,CHEMBL618570,,
8067,Mus musculus,1,,12745,BAO_0000218,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,A,,N,1,Intermediate,CHEMBL618571,,
8068,Mus musculus,1,,12745,BAO_0000218,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,A,,N,1,Intermediate,CHEMBL618572,,
8069,Mus musculus,1,,12745,BAO_0000218,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,A,,N,1,Intermediate,CHEMBL618573,,
8070,Mus musculus,1,,12745,BAO_0000218,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,A,,N,1,Intermediate,CHEMBL619267,,
8071,Mus musculus,1,,12745,BAO_0000218,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,A,,N,1,Intermediate,CHEMBL619431,,
8072,Mus musculus,1,,12745,BAO_0000218,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,A,,N,1,Intermediate,CHEMBL619432,,
8073,Mus musculus,1,,12745,BAO_0000218,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,A,,N,1,Intermediate,CHEMBL619433,,
8074,,1,1969.0,13298,BAO_0000218,,AUC in mice after oral dose (50 mg/kg),,A,,U,0,Autocuration,CHEMBL619434,,
8075,Mus musculus,1,1977.0,12226,BAO_0000218,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,A,,N,1,Intermediate,CHEMBL619435,,
8076,,1,1969.0,12634,BAO_0000019,,AUC (0-4 hr) ug/ml/h,,A,,U,0,Autocuration,CHEMBL619436,,
8077,Rattus norvegicus,1,,14810,BAO_0000218,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,A,,N,1,Intermediate,CHEMBL619437,,
8078,,1,,13889,BAO_0000218,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,A,,U,0,Autocuration,CHEMBL619438,,
8079,Mus musculus,1,,10018,BAO_0000218,,Compound was evaluated for Area under curve in mice,,A,,N,1,Intermediate,CHEMBL619439,,
8080,Rattus norvegicus,1,,8758,BAO_0000218,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,A,,N,1,Intermediate,CHEMBL619440,,
8081,,1,,8758,BAO_0000218,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,F,,U,0,Autocuration,CHEMBL619441,,
8082,Rattus norvegicus,1,,8758,BAO_0000218,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,A,,N,1,Intermediate,CHEMBL619442,,
8083,,1,,2249,BAO_0000019,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,A,,U,0,Autocuration,CHEMBL875156,,
8084,,1,,2249,BAO_0000019,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,A,,U,0,Autocuration,CHEMBL619443,,
8085,,1,,2249,BAO_0000019,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,A,,U,0,Autocuration,CHEMBL619444,,
8086,,1,,2249,BAO_0000019,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,A,,U,0,Autocuration,CHEMBL623464,,
8087,Mus musculus,1,,15115,BAO_0000218,,Compound was evaluated for area under curve when administered through oral route in mouse,,A,,N,1,Intermediate,CHEMBL623465,,
8088,Rattus norvegicus,1,,6518,BAO_0000218,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,A,,N,1,Intermediate,CHEMBL623466,,
8089,Rattus norvegicus,1,,6518,BAO_0000218,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,A,,N,1,Intermediate,CHEMBL623467,,
8090,Rattus norvegicus,1,,6249,BAO_0000218,,Plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL623468,,
8091,Rattus norvegicus,1,,2463,BAO_0000218,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,A,,N,1,Intermediate,CHEMBL622660,,
8092,Rattus norvegicus,1,,4969,BAO_0000218,,Plasma clearance rate in Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL622661,,
8093,Rattus norvegicus,1,,17720,BAO_0000218,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,F,,N,1,Intermediate,CHEMBL622662,,
8094,Rattus norvegicus,1,,3457,BAO_0000218,,Pharmacokinetic property (total body clearance) in rat,,A,,N,1,Intermediate,CHEMBL622663,,
8095,Rattus norvegicus,1,,5983,BAO_0000218,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,A,,N,1,Intermediate,CHEMBL622664,,
8096,Rattus norvegicus,1,,6295,BAO_0000218,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,A,,N,1,Intermediate,CHEMBL622665,,
8097,Rattus norvegicus,1,,6296,BAO_0000218,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,A,,N,1,Intermediate,CHEMBL622666,,
8098,Rattus norvegicus,1,,17686,BAO_0000218,,Cl in rat i.v. at 2 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL621615,,
8099,Rattus norvegicus,1,,17764,BAO_0000218,,Clearance of compound after intravenous administration in rats at 24 uM/kg,,A,,N,1,Intermediate,CHEMBL621616,,
8100,Rattus norvegicus,1,,5503,BAO_0000218,,Clearance was determined,,A,,N,1,Intermediate,CHEMBL621617,,
8101,Rattus norvegicus,1,,4368,BAO_0000218,,Clearance by intravenous administration of 3.4 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL621618,,
8102,Rattus norvegicus,1,,6005,BAO_0000218,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL621619,,
8103,Rattus norvegicus,1,,5031,BAO_0000218,,Clearance rate after i.v. administration in rats,,A,,N,1,Intermediate,CHEMBL621620,,
8104,Rattus norvegicus,1,,4890,BAO_0000218,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL621786,,
8105,Rattus norvegicus,1,,5182,BAO_0000218,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,A,,N,1,Intermediate,CHEMBL621787,,
8106,Rattus norvegicus,1,,5979,BAO_0000218,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,A,,N,1,Intermediate,CHEMBL621788,,
8107,Rattus norvegicus,1,,5656,BAO_0000218,,Clearance (Cl) after oral administration in rat,,A,,N,1,Intermediate,CHEMBL621789,,
8108,Rattus norvegicus,1,,17804,BAO_0000218,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,A,,N,1,Intermediate,CHEMBL621790,,
8109,Rattus norvegicus,1,1969.0,4839,BAO_0000218,,Compound was tested for plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL621791,,
8110,Rattus norvegicus,1,,5041,BAO_0000218,,In vitro microsome metabolism clearance in rat was determined,Microsomes,A,,N,1,Intermediate,CHEMBL621792,,
8111,Rattus norvegicus,1,,5041,BAO_0000218,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Microsomes,A,,N,1,Intermediate,CHEMBL621793,,
8112,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL621794,,
8113,Rattus norvegicus,1,1969.0,5496,BAO_0000218,,In vivo plasma clearance was determined,,A,,N,1,Intermediate,CHEMBL621795,,
8114,Rattus norvegicus,1,,5739,BAO_0000218,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,A,,N,1,Intermediate,CHEMBL621796,,
8115,Rattus norvegicus,1,2107.0,5676,BAO_0000218,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,,A,,N,1,Intermediate,CHEMBL621797,401.0,
8116,Rattus norvegicus,1,,4239,BAO_0000218,,Pharmacokinetic property (Plasma clearance) was measured in rat,,A,,N,1,Intermediate,CHEMBL621798,,
8117,Rattus norvegicus,1,,5676,BAO_0000218,,Pharmacokinetic property (clearance) in rat i.v.,,A,,N,1,Intermediate,CHEMBL621799,,
8118,Rattus norvegicus,1,,1918,BAO_0000218,,"Plasma Clearance was evaluated in rats, iv",,A,,N,1,Intermediate,CHEMBL621800,,
8119,Rattus norvegicus,1,,17800,BAO_0000218,,Plasma clearance (in vivo) in rats was determined,,A,,N,1,Intermediate,CHEMBL621801,,
8120,Rattus norvegicus,1,,6056,BAO_0000218,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL621802,,
8121,Rattus norvegicus,1,,5496,BAO_0000218,,Plasma clearance was determined,,A,,N,1,Intermediate,CHEMBL618596,,
8122,Rattus norvegicus,1,,5939,BAO_0000218,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL618597,,
8123,Rattus norvegicus,1,,5939,BAO_0000218,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL618598,,
8124,Rattus norvegicus,1,,17752,BAO_0000218,,Plasma clearance in rats,,A,,N,1,Intermediate,CHEMBL618599,,
8125,Rattus norvegicus,1,,4576,BAO_0000218,,Plasma clearance rate determined in rat,,A,,N,1,Intermediate,CHEMBL618600,,
8126,Rattus norvegicus,1,,6011,BAO_0000218,,Plasma clearance was determined in rat,,A,,N,1,Intermediate,CHEMBL618601,,
8127,Rattus norvegicus,1,,5510,BAO_0000218,,Plasma clearance was determined,,A,,N,1,Intermediate,CHEMBL618602,,
8128,Rattus norvegicus,1,,5948,BAO_0000218,,Plasma clearance value in rat,,A,,N,1,Intermediate,CHEMBL618603,,
8129,Rattus norvegicus,1,2107.0,6125,BAO_0000218,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,A,,N,1,Intermediate,CHEMBL618604,,
8130,Rattus norvegicus,1,,4839,BAO_0000218,,Clearance in rat,,A,,N,1,Intermediate,CHEMBL618605,,
8131,Rattus norvegicus,1,,17686,BAO_0000218,,Total body clearance in rat i.v. at 2 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL618606,,
8132,Rattus norvegicus,1,,6571,BAO_0000218,,Clearance of compound in rats after intravenous administration,,A,,N,1,Intermediate,CHEMBL618607,,
8133,Rattus norvegicus,1,,3364,BAO_0000218,,Clearance after iv administration to rats,,A,,N,1,Intermediate,CHEMBL618608,,
8134,Rattus norvegicus,1,,13569,BAO_0000218,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,A,,N,1,Intermediate,CHEMBL618609,,
8135,Rattus norvegicus,1,,13569,BAO_0000218,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,A,,N,1,Intermediate,CHEMBL618610,,
8136,Rattus norvegicus,1,,13569,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,A,,N,1,Intermediate,CHEMBL618611,,
8137,Rattus norvegicus,1,,13569,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,A,,N,1,Intermediate,CHEMBL618612,,
8138,Rattus norvegicus,1,,13569,BAO_0000218,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,A,,N,1,Intermediate,CHEMBL618613,,
8139,Rattus norvegicus,1,,13569,BAO_0000218,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,A,,N,1,Intermediate,CHEMBL621076,,
8140,Rattus norvegicus,1,,13569,BAO_0000218,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,A,,N,1,Intermediate,CHEMBL621077,,
8141,Rattus norvegicus,1,,17670,BAO_0000218,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,A,,N,1,Intermediate,CHEMBL621078,,
8142,Rattus norvegicus,1,,5970,BAO_0000218,,Clearance in rat,,A,,N,1,Intermediate,CHEMBL621251,,
8143,Rattus norvegicus,1,,6495,BAO_0000218,,Clearance in rat after oral administration at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL621252,,
8144,Rattus norvegicus,1,,4590,BAO_0000218,,Clearance in rat.,,A,,N,1,Intermediate,CHEMBL621253,,
8145,Rattus norvegicus,1,,6193,BAO_0000218,,Clearance rate following an oral dose of 20 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL621254,,
8146,Rattus norvegicus,1,,2832,BAO_0000218,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,A,,N,1,Intermediate,CHEMBL621255,,
8147,Rattus norvegicus,1,1969.0,1052,BAO_0000218,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,A,,N,1,Intermediate,CHEMBL621256,,
8148,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,A,,N,1,Intermediate,CHEMBL621257,,
8149,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,A,,N,1,Intermediate,CHEMBL621258,,
8150,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,A,,N,1,Intermediate,CHEMBL621259,,
8151,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,A,,N,1,Intermediate,CHEMBL621260,,
8152,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,A,,N,1,Intermediate,CHEMBL876494,,
8153,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,A,,N,1,Intermediate,CHEMBL621261,,
8154,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,A,,N,1,Intermediate,CHEMBL621262,,
8155,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,A,,N,1,Intermediate,CHEMBL621263,,
8156,Rattus norvegicus,1,2107.0,9866,BAO_0000218,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,A,,N,1,Intermediate,CHEMBL621264,,
8157,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL621265,,
8158,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,A,,N,1,Intermediate,CHEMBL621266,,
8159,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL621267,,
8160,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL621268,,
8161,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,A,,N,1,Intermediate,CHEMBL621269,,
8162,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,A,,N,1,Intermediate,CHEMBL621270,,
8163,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,A,,N,1,Intermediate,CHEMBL621271,,
8164,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,A,,N,1,Intermediate,CHEMBL621272,,
8165,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,A,,N,1,Intermediate,CHEMBL621273,,
8166,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,A,,N,1,Intermediate,CHEMBL621274,,
8167,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,A,,N,1,Intermediate,CHEMBL876495,,
8168,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,A,,N,1,Intermediate,CHEMBL621275,,
8169,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,A,,N,1,Intermediate,CHEMBL621276,,
8170,Rattus norvegicus,1,2385.0,9866,BAO_0000218,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,A,,N,1,Intermediate,CHEMBL621277,,
8171,Rattus norvegicus,1,160.0,9866,BAO_0000218,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,A,,N,1,Intermediate,CHEMBL621278,,
8172,Rattus norvegicus,1,160.0,9866,BAO_0000218,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,A,,N,1,Intermediate,CHEMBL621279,,
8173,Rattus norvegicus,1,160.0,9866,BAO_0000218,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,A,,N,1,Intermediate,CHEMBL621280,,
8174,Rattus norvegicus,1,2106.0,9866,BAO_0000218,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL621281,,
8175,Rattus norvegicus,1,2106.0,9866,BAO_0000218,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,A,,N,1,Intermediate,CHEMBL621282,,
8176,Rattus norvegicus,1,2106.0,9866,BAO_0000218,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,A,,N,1,Intermediate,CHEMBL621283,,
8177,Rattus norvegicus,1,2106.0,9866,BAO_0000218,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,A,,N,1,Intermediate,CHEMBL621284,,
8178,Rattus norvegicus,1,2106.0,9866,BAO_0000218,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,A,,N,1,Intermediate,CHEMBL621285,,
8179,Rattus norvegicus,1,2106.0,9866,BAO_0000218,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,A,,N,1,Intermediate,CHEMBL621286,,
8180,Rattus norvegicus,1,2106.0,9866,BAO_0000218,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,A,,N,1,Intermediate,CHEMBL623220,,
8181,Rattus norvegicus,1,2106.0,9866,BAO_0000218,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,A,,N,1,Intermediate,CHEMBL623221,,
8182,Rattus norvegicus,1,2106.0,9866,BAO_0000218,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,A,,N,1,Intermediate,CHEMBL876029,,
8183,Rattus norvegicus,1,945.0,9866,BAO_0000218,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,A,,N,1,Intermediate,CHEMBL623222,,
8184,Rattus norvegicus,1,945.0,9866,BAO_0000218,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,A,,N,1,Intermediate,CHEMBL623223,,
8185,Rattus norvegicus,1,945.0,9866,BAO_0000218,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,A,,N,1,Intermediate,CHEMBL621445,,
8186,Rattus norvegicus,1,178.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621446,,
8187,Rattus norvegicus,1,178.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621447,,
8188,Rattus norvegicus,1,178.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL619681,,
8189,Rattus norvegicus,1,178.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL619682,,
8190,Rattus norvegicus,1,178.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL619683,,
8191,Rattus norvegicus,1,955.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL619684,,
8192,Rattus norvegicus,1,955.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL619685,,
8193,Rattus norvegicus,1,955.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL619686,,
8194,Rattus norvegicus,1,955.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL619687,,
8195,Rattus norvegicus,1,955.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL619688,,
8196,Rattus norvegicus,1,948.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL619689,,
8197,Rattus norvegicus,1,948.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL619690,,
8198,Rattus norvegicus,1,948.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL619691,,
8199,Rattus norvegicus,1,,6062,BAO_0000218,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL619692,,
8200,Rattus norvegicus,1,,3598,BAO_0000218,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,A,,N,1,Expert,CHEMBL619693,,
8201,Rattus norvegicus,1,,1908,BAO_0000218,,Vc value after IV dose at a dose of 5 mg/kg in rats.,,A,,N,1,Intermediate,CHEMBL619694,,
8202,Rattus norvegicus,1,,17596,BAO_0000218,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,A,,N,1,Intermediate,CHEMBL619695,,
8203,Rattus norvegicus,1,,4891,BAO_0000218,,Compound was evaluated for pharmacokinetic parameter volume of distribution,,A,,N,1,Intermediate,CHEMBL619696,,
8204,Rattus norvegicus,1,,740,BAO_0000218,,Compound was evaluated for volume of distribution in rat,,A,,N,1,Intermediate,CHEMBL619697,,
8205,Rattus norvegicus,1,,16366,BAO_0000218,,Steady state volume distribution was determined; steady state(ss),,A,,N,1,Intermediate,CHEMBL619698,,
8206,Rattus norvegicus,1,,3364,BAO_0000218,,Steady state volume of distribution after iv administration to rats,,A,,N,1,Intermediate,CHEMBL619699,,
8207,Rattus norvegicus,1,,2552,BAO_0000218,,Steady state volume of distribution dosing at 3 mg/kg iv,,A,,N,1,Intermediate,CHEMBL619700,,
8208,Rattus norvegicus,1,,406,BAO_0000218,,The compound was evaluated for volume of distribution in rat,,A,,N,1,Intermediate,CHEMBL619701,,
8209,Rattus norvegicus,1,,12500,BAO_0000218,,The compound was tested for volume of distribution in rat,,A,,N,1,Intermediate,CHEMBL619702,,
8210,Rattus norvegicus,1,,12500,BAO_0000218,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,A,,N,1,Intermediate,CHEMBL620335,,
8211,Rattus norvegicus,1,,5656,BAO_0000218,,Volume distribution (VD) after oral administration in rat,,A,,N,1,Intermediate,CHEMBL620336,,
8212,Rattus norvegicus,1,,17671,BAO_0000218,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,A,,N,1,Intermediate,CHEMBL620337,,
8213,Rattus norvegicus,1,,1094,BAO_0000218,,Volume distribution in rat,,A,,N,1,Intermediate,CHEMBL620520,,
8214,Rattus norvegicus,1,,5833,BAO_0000218,,Volume distribution in rat,,A,,N,1,Intermediate,CHEMBL620521,,
8215,Rattus norvegicus,1,,5939,BAO_0000218,,Volume distribution in rat after peroral administration at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL875825,,
8216,Rattus norvegicus,1,,5939,BAO_0000218,,Volume distribution in rat after peroral administration at 5 mg/kg,,A,,N,1,Intermediate,CHEMBL620522,,
8217,Rattus norvegicus,1,,6005,BAO_0000218,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL620523,,
8218,Rattus norvegicus,1,,1696,BAO_0000218,,Volume of distribution in rat.,,A,,N,1,Intermediate,CHEMBL620524,,
8219,Rattus norvegicus,1,,6672,BAO_0000218,,Volume of distribution in rat,,A,,N,1,Intermediate,CHEMBL620525,,
8220,Rattus norvegicus,1,,6673,BAO_0000218,,Volume of distribution in rat,,A,,N,1,Intermediate,CHEMBL620526,,
8221,Rattus norvegicus,1,,5871,BAO_0000218,,Volume of distribution in rat by iv administration,,A,,N,1,Intermediate,CHEMBL620527,,
8222,Rattus norvegicus,1,,6803,BAO_0000218,,Volume of distribution in rats,,A,,N,1,Intermediate,CHEMBL620528,,
8223,Rattus norvegicus,1,,5199,BAO_0000218,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,A,,N,1,Intermediate,CHEMBL620529,,
8224,Rattus norvegicus,1,,4727,BAO_0000218,,Volume distribution at the dose of 2 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL620530,,
8225,Rattus norvegicus,1,,16367,BAO_0000218,,Steady state volume of distribution was determined,,A,,N,1,Intermediate,CHEMBL620531,,
8226,Macaca mulatta,1,,5005,BAO_0000218,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,A,,U,0,Intermediate,CHEMBL620532,,
8227,Rattus norvegicus,1,,5005,BAO_0000218,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,A,,U,0,Intermediate,CHEMBL620533,,
8228,Rattus norvegicus,1,,5005,BAO_0000218,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,A,,U,0,Intermediate,CHEMBL620534,,
8229,Rattus norvegicus,1,,15765,BAO_0000218,,Mean (%CV) PK parameters for Vdss(mL/kg).,,A,,N,1,Intermediate,CHEMBL620535,,
8230,Rattus norvegicus,1,,2792,BAO_0000218,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,A,,N,1,Intermediate,CHEMBL875826,,
8231,Rattus norvegicus,1,,2792,BAO_0000218,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,A,,N,1,Intermediate,CHEMBL620536,,
8232,Rattus norvegicus,1,,5334,BAO_0000218,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL620537,,
8233,Rattus norvegicus,1,,5334,BAO_0000218,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,A,,N,1,Intermediate,CHEMBL618526,,
8234,Rattus norvegicus,1,,5739,BAO_0000218,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,A,,N,1,Intermediate,CHEMBL618527,,
8235,Rattus norvegicus,1,,5789,BAO_0000218,,Pharmacokinetic property (Vdss) in rat,,A,,N,1,Intermediate,CHEMBL618528,,
8236,Rattus norvegicus,1,,4239,BAO_0000218,,Pharmacokinetic property (vdss) was measured in rat,,A,,N,1,Intermediate,CHEMBL618529,,
8237,Rattus norvegicus,1,,4709,BAO_0000218,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL618530,,
8238,Rattus norvegicus,1,,6642,BAO_0000218,,Volume of distribution in rat,,A,,N,1,Intermediate,CHEMBL618531,,
8239,Rattus norvegicus,1,,5247,BAO_0000218,,The pharmacokinetic parameter volume of distribution in vivo in rats,,A,,N,1,Intermediate,CHEMBL618532,,
8240,Rattus norvegicus,1,,17720,BAO_0000218,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,F,,N,1,Intermediate,CHEMBL618533,,
8241,Rattus norvegicus,1,,17686,BAO_0000218,,Vdss in rat i.v. at 2 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL618534,,
8242,Rattus norvegicus,1,,4689,BAO_0000218,,Volume distribution after intravenous administration (1 mg/kg) in rat,,A,,N,1,Intermediate,CHEMBL618535,,
8243,Rattus norvegicus,1,,5654,BAO_0000218,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,A,,N,1,Intermediate,CHEMBL618536,,
8244,Rattus norvegicus,1,,5654,BAO_0000218,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,A,,N,1,Intermediate,CHEMBL618537,,
8245,Rattus norvegicus,1,,4527,BAO_0000218,,Volume distribution at a dose of 10 uM/kg in rat was determined,,A,,N,1,Intermediate,CHEMBL618538,,
8246,Rattus norvegicus,1,,4521,BAO_0000218,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,A,,N,1,Intermediate,CHEMBL618539,,
8247,Rattus norvegicus,1,,6057,BAO_0000218,,Volume distribution was calculated in rat,,A,,N,1,Intermediate,CHEMBL618540,,
8248,Rattus norvegicus,1,,5510,BAO_0000218,,Volume distribution was determined,,A,,N,1,Intermediate,CHEMBL618541,,
8249,Rattus norvegicus,1,,2938,BAO_0000218,,Volume of distribution after intravenous administration was evaluated in rat,,A,,N,1,Intermediate,CHEMBL618542,,
8250,Rattus norvegicus,1,,6679,BAO_0000218,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,A,,N,1,Intermediate,CHEMBL622544,,
8251,Rattus norvegicus,1,,6685,BAO_0000218,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,A,,N,1,Intermediate,CHEMBL622545,,
8252,Rattus norvegicus,1,,6685,BAO_0000218,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,A,,N,1,Intermediate,CHEMBL622546,,
8253,Rattus norvegicus,1,,6685,BAO_0000218,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,A,,N,1,Intermediate,CHEMBL622547,,
8254,Rattus norvegicus,1,,5145,BAO_0000218,,Volume of distribution in steady state was determined in rat,,A,,N,1,Intermediate,CHEMBL622548,,
8255,Rattus norvegicus,1,,6467,BAO_0000218,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,A,,N,1,Intermediate,CHEMBL622549,,
8256,Rattus norvegicus,1,,6467,BAO_0000218,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,A,,N,1,Intermediate,CHEMBL622550,,
8257,Mus musculus,1,,15115,BAO_0000218,,Compound was evaluated for area under curve when administered through oral route to mouse,,A,,N,1,Intermediate,CHEMBL622551,,
8258,Rattus norvegicus,1,,8758,BAO_0000218,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,A,,N,1,Intermediate,CHEMBL622552,,
8259,Rattus norvegicus,1,,8758,BAO_0000218,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,A,,N,1,Intermediate,CHEMBL622553,,
8260,,1,,8267,BAO_0000218,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,F,,U,0,Autocuration,CHEMBL622554,,
8261,Canis lupus familiaris,1,,8267,BAO_0000218,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,A,,N,1,Intermediate,CHEMBL622555,,
8262,Mus musculus,1,,14239,BAO_0000218,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,A,,N,1,Intermediate,CHEMBL622556,,
8263,Mus musculus,1,,14239,BAO_0000218,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,A,,N,1,Intermediate,CHEMBL622557,,
8264,Mus musculus,1,178.0,10754,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,A,,N,1,Intermediate,CHEMBL622558,,
8265,Mus musculus,1,178.0,10754,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,A,,N,1,Intermediate,CHEMBL622559,,
8266,Canis lupus familiaris,1,,10754,BAO_0000218,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,A,,N,1,Intermediate,CHEMBL622560,,
8267,Rattus norvegicus,1,,14681,BAO_0000218,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,A,,N,1,Intermediate,CHEMBL622561,,
8268,Rattus norvegicus,1,,14681,BAO_0000218,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,A,,N,1,Intermediate,CHEMBL622562,,
8269,Rattus norvegicus,1,,14681,BAO_0000218,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,A,,N,1,Intermediate,CHEMBL622563,,
8270,,1,,13118,BAO_0000019,,Concentration of compound in Central nervous system,,A,,U,0,Autocuration,CHEMBL622564,,
8271,,1,,13118,BAO_0000019,,Concentration of compound in Central nervous system; Not detectable,,A,,U,0,Autocuration,CHEMBL622565,,
8272,Mus musculus,1,,13318,BAO_0000218,,"Concentration of diester in the blood, following oral administration in mice",,A,,N,1,Intermediate,CHEMBL622566,,
8273,Mus musculus,1,,13318,BAO_0000218,,"Concentration of monoester in the blood, following oral administration in mice",,A,,N,1,Intermediate,CHEMBL624515,,
8274,Mus musculus,1,,13318,BAO_0000218,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,A,,N,1,Intermediate,CHEMBL624516,,
8275,,1,,15692,BAO_0000019,,Evaluated for Pharmacokinetic property: Area under the curve,,A,,U,0,Autocuration,CHEMBL624517,,
8276,Mus musculus,1,,14839,BAO_0000218,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,A,,N,1,Intermediate,CHEMBL624518,,
8277,Macaca fascicularis,1,,14839,BAO_0000218,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,A,,N,1,Intermediate,CHEMBL624519,,
8278,Macaca fascicularis,1,,14839,BAO_0000218,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,A,,N,1,Intermediate,CHEMBL624520,,
8279,Macaca fascicularis,1,,14839,BAO_0000218,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,A,,N,1,Intermediate,CHEMBL624521,,
8280,Macaca fascicularis,1,,14839,BAO_0000218,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,A,,N,1,Intermediate,CHEMBL624522,,
8281,Macaca fascicularis,1,,14839,BAO_0000218,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,A,,N,1,Intermediate,CHEMBL624523,,
8282,Macaca fascicularis,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,A,,N,1,Intermediate,CHEMBL624409,,
8283,Macaca fascicularis,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,A,,N,1,Intermediate,CHEMBL624410,,
8284,Macaca fascicularis,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,A,,N,1,Intermediate,CHEMBL624411,,
8285,Macaca fascicularis,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,A,,N,1,Intermediate,CHEMBL623531,,
8286,Macaca fascicularis,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,A,,N,1,Intermediate,CHEMBL623532,,
8287,Macaca fascicularis,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,A,,N,1,Intermediate,CHEMBL623533,,
8288,Macaca fascicularis,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,A,,N,1,Intermediate,CHEMBL623534,,
8289,Mus musculus,1,,14839,BAO_0000218,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,A,,N,1,Intermediate,CHEMBL623535,,
8290,Mus musculus,1,,14839,BAO_0000218,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,A,,N,1,Intermediate,CHEMBL623536,,
8291,Mus musculus,1,,14839,BAO_0000218,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,A,,N,1,Intermediate,CHEMBL623537,,
8292,Mus musculus,1,,14839,BAO_0000218,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,A,,N,1,Intermediate,CHEMBL623538,,
8293,Mus musculus,1,,14839,BAO_0000218,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,A,,N,1,Intermediate,CHEMBL623539,,
8294,Mus musculus,1,,14839,BAO_0000218,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,A,,N,1,Intermediate,CHEMBL623540,,
8295,Mus musculus,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,A,,N,1,Intermediate,CHEMBL623541,,
8296,Mus musculus,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,A,,N,1,Intermediate,CHEMBL623542,,
8297,Mus musculus,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,A,,N,1,Intermediate,CHEMBL623543,,
8298,Mus musculus,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,A,,N,1,Intermediate,CHEMBL623544,,
8299,Mus musculus,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,A,,N,1,Intermediate,CHEMBL623545,,
8300,Mus musculus,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,A,,N,1,Intermediate,CHEMBL623546,,
8301,Rattus norvegicus,1,1969.0,5408,BAO_0000218,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL623547,,
8302,Rattus norvegicus,1,,6827,BAO_0000218,,High i.v. clearance in Dawley rats,,A,,N,1,Intermediate,CHEMBL623548,,
8303,Rattus norvegicus,1,2107.0,17538,BAO_0000218,,In vitro clearance in rat liver microsomes,Microsomes,A,,N,1,Intermediate,CHEMBL623549,,
8304,Rattus norvegicus,1,2107.0,6331,BAO_0000218,,Intrinsic clearance in rat liver microsomes was determined,Microsomes,A,,N,1,Intermediate,CHEMBL623550,,
8305,Rattus norvegicus,1,2107.0,5948,BAO_0000218,,Intrinsic clearance in rat hepatocytes was determined,,A,,N,1,Intermediate,CHEMBL875276,401.0,
8306,Rattus norvegicus,1,,4026,BAO_0000218,,Plasma Clearance was determined,,A,,N,1,Intermediate,CHEMBL621872,,
8307,Rattus norvegicus,1,,6647,BAO_0000218,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,A,,N,1,Intermediate,CHEMBL621873,,
8308,Rattus norvegicus,1,,1696,BAO_0000218,,Plasma clearance in rat.,,A,,N,1,Intermediate,CHEMBL621874,,
8309,Rattus norvegicus,1,,6597,BAO_0000218,,Plasma clearance in rats,,A,,N,1,Intermediate,CHEMBL621875,,
8310,Rattus norvegicus,1,,347,BAO_0000218,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,A,,N,1,Intermediate,CHEMBL621876,,
8311,Rattus norvegicus,1,,16423,BAO_0000218,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,A,,N,1,Intermediate,CHEMBL621877,,
8312,Rattus norvegicus,1,,2879,BAO_0000218,,Plasma clearance was measured in rat,,A,,N,1,Intermediate,CHEMBL621878,,
8313,Rattus norvegicus,1,,4883,BAO_0000218,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,A,,N,1,Intermediate,CHEMBL621879,,
8314,Rattus norvegicus,1,1969.0,5328,BAO_0000218,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,A,,N,1,Intermediate,CHEMBL621880,,
8315,Rattus norvegicus,1,,5160,BAO_0000218,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,A,,N,1,Intermediate,CHEMBL621881,,
8316,Rattus norvegicus,1,,17582,BAO_0000218,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,A,,N,1,Intermediate,CHEMBL621882,,
8317,Rattus norvegicus,1,,17651,BAO_0000218,,Total clearance at 1 mg/kg was determined in rat,,A,,N,1,Intermediate,CHEMBL875283,,
8318,Rattus norvegicus,1,,17651,BAO_0000218,,Total clearance at 10 mg/kg was determined in rat,,A,,N,1,Intermediate,CHEMBL621883,,
8319,Rattus norvegicus,1,,6596,BAO_0000218,,Clearance in rat,,A,,N,1,Intermediate,CHEMBL621884,,
8320,Rattus norvegicus,1,,4796,BAO_0000218,,Plasma clearance rate determined in rats,,A,,N,1,Intermediate,CHEMBL621885,,
8321,Rattus norvegicus,1,,6850,BAO_0000218,,Clearance of compound in rat was evaluated,,A,,N,1,Intermediate,CHEMBL621886,,
8322,Rattus norvegicus,1,1969.0,5932,BAO_0000218,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL621887,,
8323,Rattus norvegicus,1,,3371,BAO_0000218,,Pharmacokinetic property (blood clearance) in rat,,A,,N,1,Intermediate,CHEMBL621888,,
8324,Rattus norvegicus,1,,2083,BAO_0000218,,Plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL621889,,
8325,Rattus norvegicus,1,,4942,BAO_0000218,,Plasma clearance in rats,,A,,N,1,Intermediate,CHEMBL621890,,
8326,Rattus norvegicus,1,2107.0,6838,BAO_0000218,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Microsomes,A,,N,1,Intermediate,CHEMBL621891,,
8327,Rattus norvegicus,1,,5353,BAO_0000218,,Clearance in Dawley rat,,A,,N,1,Intermediate,CHEMBL621892,,
8328,Rattus norvegicus,1,,6641,BAO_0000218,,Clearance rat,,A,,N,1,Intermediate,CHEMBL621893,,
8329,Rattus norvegicus,1,,6641,BAO_0000218,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,A,,N,1,Intermediate,CHEMBL621894,,
8330,Rattus norvegicus,1,,6641,BAO_0000218,,Clearance rat; Not determined,,A,,N,1,Intermediate,CHEMBL621895,,
8331,Rattus norvegicus,1,,6444,BAO_0000218,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,A,,N,1,Intermediate,CHEMBL875284,,
8332,Rattus norvegicus,1,,6444,BAO_0000218,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,A,,N,1,Intermediate,CHEMBL618699,,
8333,Rattus norvegicus,1,,6444,BAO_0000218,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,A,,N,1,Intermediate,CHEMBL618700,,
8334,Rattus norvegicus,1,,6211,BAO_0000218,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL618701,,
8335,Rattus norvegicus,1,1969.0,12873,BAO_0000218,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,A,,N,1,Intermediate,CHEMBL876600,,
8336,Rattus norvegicus,1,,6570,BAO_0000218,,Clearance of compound in rat after 1 mg/kg i.v. administration,,A,,N,1,Intermediate,CHEMBL618702,,
8337,Rattus norvegicus,1,,3341,BAO_0000218,,Compound was evaluated for Hepatic clearance in rat,,A,,N,1,Intermediate,CHEMBL618703,,
8338,Rattus norvegicus,1,,4891,BAO_0000218,,In vivo clearance after 5 mg/kg dose,,A,,N,1,Intermediate,CHEMBL618704,,
8339,Rattus norvegicus,1,1969.0,1094,BAO_0000218,,Compound was tested for plasma clearance in rats,,A,,N,1,Intermediate,CHEMBL618705,,
8340,Rattus norvegicus,1,,2938,BAO_0000218,,Hepatic clearance after intravenous administration was evaluated in rat,,A,,N,1,Intermediate,CHEMBL618706,,
8341,Rattus norvegicus,1,,17853,BAO_0000218,,Lower clearance in rat (i.v.) at 0.5 mpk,,A,,N,1,Intermediate,CHEMBL618707,,
8342,Rattus norvegicus,1,1969.0,6049,BAO_0000218,,Pharmacokinetic parameter expressed as plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL618708,,
8343,Rattus norvegicus,1,,5789,BAO_0000218,,Pharmacokinetic property (Clp) in rat,,A,,N,1,Intermediate,CHEMBL618709,,
8344,Rattus norvegicus,1,,4514,BAO_0000218,,Plasma clearance in Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL618710,,
8345,Rattus norvegicus,1,,6448,BAO_0000218,,Plasma clearance (Clp) in rat,,A,,N,1,Intermediate,CHEMBL618711,,
8346,Rattus norvegicus,1,,6062,BAO_0000218,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL618712,,
8347,Rattus norvegicus,1,,5710,BAO_0000218,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,A,,N,1,Intermediate,CHEMBL618713,,
8348,Rattus norvegicus,1,,4709,BAO_0000218,,Plasma clearance after intravenous administration of 1 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL618714,,
8349,Rattus norvegicus,1,,4521,BAO_0000218,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,A,,N,1,Intermediate,CHEMBL618715,,
8350,Rattus norvegicus,1,,1742,BAO_0000218,,Plasma clearance in rat was determined,,A,,N,1,Intermediate,CHEMBL618716,,
8351,Rattus norvegicus,1,,6057,BAO_0000218,,Plasma clearance measured in rat,,A,,N,1,Intermediate,CHEMBL876601,,
8352,Rattus norvegicus,1,,6057,BAO_0000218,,Plasma clearance was calculated in rat,,A,,N,1,Intermediate,CHEMBL618717,,
8353,Rattus norvegicus,1,,5145,BAO_0000218,,Plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL618718,,
8354,Rattus norvegicus,1,,5833,BAO_0000218,,Plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL618719,,
8355,Rattus norvegicus,1,,6453,BAO_0000218,,Plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL618720,,
8356,Rattus norvegicus,1,,6640,BAO_0000218,,Plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL618721,,
8357,Rattus norvegicus,1,,6305,BAO_0000218,,Plasma clearance in rats,,A,,N,1,Intermediate,CHEMBL621477,,
8358,Rattus norvegicus,1,,6642,BAO_0000218,,Plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL621478,,
8359,Rattus norvegicus,1,,5472,BAO_0000218,,Plasma clearance was evaluated in rat,,A,,N,1,Intermediate,CHEMBL621479,,
8360,Rattus norvegicus,1,,5472,BAO_0000218,,Plasma clearance was evaluated in rat; Not tested,,A,,N,1,Intermediate,CHEMBL621480,,
8361,Rattus norvegicus,1,,5144,BAO_0000218,,Plasma clearance rate was determined for the compound in rat,,A,,N,1,Intermediate,CHEMBL621481,,
8362,Rattus norvegicus,1,,6685,BAO_0000218,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,A,,N,1,Intermediate,CHEMBL621482,,
8363,Rattus norvegicus,1,,6685,BAO_0000218,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,A,,N,1,Intermediate,CHEMBL621483,,
8364,Rattus norvegicus,1,,6685,BAO_0000218,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,A,,N,1,Intermediate,CHEMBL621484,,
8365,Rattus norvegicus,1,948.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621485,,
8366,Rattus norvegicus,1,948.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621486,,
8367,Rattus norvegicus,1,160.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621487,,
8368,Rattus norvegicus,1,160.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621488,,
8369,Rattus norvegicus,1,160.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621489,,
8370,Rattus norvegicus,1,160.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621490,,
8371,Rattus norvegicus,1,160.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621491,,
8372,Rattus norvegicus,1,2113.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621492,,
8373,Rattus norvegicus,1,2113.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621493,,
8374,Rattus norvegicus,1,2113.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621494,,
8375,Rattus norvegicus,1,2113.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621495,,
8376,Rattus norvegicus,1,2113.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621496,,
8377,Rattus norvegicus,1,2107.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621497,,
8378,Rattus norvegicus,1,2107.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621498,,
8379,Rattus norvegicus,1,2107.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL621499,,
8380,Rattus norvegicus,1,2107.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL618634,,
8381,Rattus norvegicus,1,2107.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL618635,,
8382,Rattus norvegicus,1,2048.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL618636,,
8383,Rattus norvegicus,1,2048.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL619737,,
8384,Rattus norvegicus,1,2048.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL619738,,
8385,Rattus norvegicus,1,2048.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL624329,,
8386,Rattus norvegicus,1,2048.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL624330,,
8387,Rattus norvegicus,1,2385.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL624331,,
8388,Rattus norvegicus,1,2385.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL624332,,
8389,Rattus norvegicus,1,2385.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL624333,,
8390,Rattus norvegicus,1,2385.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL624334,,
8391,Rattus norvegicus,1,2385.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL624335,,
8392,Rattus norvegicus,1,2106.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620016,,
8393,Rattus norvegicus,1,2106.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620169,,
8394,Rattus norvegicus,1,2106.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620170,,
8395,Rattus norvegicus,1,2106.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620171,,
8396,Rattus norvegicus,1,2106.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620172,,
8397,Rattus norvegicus,1,945.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620173,,
8398,Rattus norvegicus,1,945.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620174,,
8399,Rattus norvegicus,1,945.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620175,,
8400,Rattus norvegicus,1,945.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620176,,
8401,Rattus norvegicus,1,945.0,13950,BAO_0000218,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620177,,
8402,Rattus norvegicus,1,2037.0,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620178,,
8403,Rattus norvegicus,1,2037.0,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620179,,
8404,Rattus norvegicus,1,,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620180,,
8405,Rattus norvegicus,1,,6570,BAO_0000218,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,A,,N,1,Intermediate,CHEMBL620181,,
8406,Rattus norvegicus,1,,6571,BAO_0000218,,Volume of distribution of compound in rats after intravenous administration,,A,,N,1,Intermediate,CHEMBL620182,,
8407,Rattus norvegicus,1,,6453,BAO_0000218,,Volume of distribution in rat,,A,,N,1,Intermediate,CHEMBL620183,,
8408,Rattus norvegicus,1,,6444,BAO_0000218,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,A,,N,1,Intermediate,CHEMBL620184,,
8409,Rattus norvegicus,1,,6444,BAO_0000218,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,A,,N,1,Intermediate,CHEMBL620185,,
8410,Rattus norvegicus,1,,6444,BAO_0000218,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,A,,N,1,Intermediate,CHEMBL620186,,
8411,Rattus norvegicus,1,,5353,BAO_0000218,,Volume of distribution was determined in Dawley rat,,A,,N,1,Intermediate,CHEMBL620187,,
8412,Rattus norvegicus,1,,5334,BAO_0000218,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL620188,,
8413,Rattus norvegicus,1,,5334,BAO_0000218,,Volume of distribution was reported in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL620189,,
8414,Rattus norvegicus,1,,6641,BAO_0000218,,Volumes of distribution in rat after peroral administration,,A,,N,1,Intermediate,CHEMBL620190,,
8415,Rattus norvegicus,1,,6641,BAO_0000218,,Volumes of distribution in rat after po administration,,A,,N,1,Intermediate,CHEMBL620191,,
8416,Rattus norvegicus,1,,6641,BAO_0000218,,Volumes of distribution in rat after po administration; Not determined,,A,,N,1,Intermediate,CHEMBL620192,,
8417,Rattus norvegicus,1,,5676,BAO_0000218,,Pharmacokinetic property (Volume) in rat i.v.,,A,,N,1,Intermediate,CHEMBL620193,,
8418,Rattus norvegicus,1,,6410,BAO_0000218,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,A,,N,1,Intermediate,CHEMBL620194,,
8419,Rattus norvegicus,1,,17670,BAO_0000218,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,A,,N,1,Intermediate,CHEMBL876730,,
8420,Rattus norvegicus,1,,6495,BAO_0000218,,Volume distribution in rat after oral administration at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL620195,,
8421,Rattus norvegicus,1,,5408,BAO_0000218,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL620196,,
8422,Rattus norvegicus,1,,4883,BAO_0000218,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,A,,N,1,Intermediate,CHEMBL620197,,
8423,Rattus norvegicus,1,,6647,BAO_0000218,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,A,,N,1,Intermediate,CHEMBL620198,,
8424,Rattus norvegicus,1,,6495,BAO_0000218,,Volume of distribution in rats,,A,,N,1,Intermediate,CHEMBL620199,,
8425,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,A,,N,1,Intermediate,CHEMBL620200,,
8426,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,A,,N,1,Intermediate,CHEMBL620201,,
8427,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL620202,,
8428,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL620203,,
8429,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,A,,N,1,Intermediate,CHEMBL620204,,
8430,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL620205,,
8431,Rattus norvegicus,1,,5960,BAO_0000218,,Pharmacokinetic parameter (Vss) in rat,,A,,N,1,Intermediate,CHEMBL624664,,
8432,Rattus norvegicus,1,,5676,BAO_0000218,,Pharmacokinetic property (Volume) in rat i.v.,,A,,N,1,Intermediate,CHEMBL624665,,
8433,Rattus norvegicus,1,,5948,BAO_0000218,,Pharmacokinetic property (Vss) in rat,,A,,N,1,Intermediate,CHEMBL624666,,
8434,Rattus norvegicus,1,,5979,BAO_0000218,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,A,,N,1,Intermediate,CHEMBL624667,,
8435,Rattus norvegicus,1,,5978,BAO_0000218,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL624668,,
8436,Rattus norvegicus,1,,5978,BAO_0000218,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL624669,,
8437,Rattus norvegicus,1,,5978,BAO_0000218,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL624670,,
8438,Rattus norvegicus,1,,5978,BAO_0000218,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL624671,,
8439,Rattus norvegicus,1,,6448,BAO_0000218,,Steady state volume distribution in rat,,A,,N,1,Intermediate,CHEMBL624672,,
8440,Rattus norvegicus,1,1969.0,12873,BAO_0000218,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,A,,N,1,Intermediate,CHEMBL624673,,
8441,Rattus norvegicus,1,,4576,BAO_0000218,,Steady state volume of distribution determined in rat,,A,,N,1,Intermediate,CHEMBL624674,,
8442,Rattus norvegicus,1,,17582,BAO_0000218,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,A,,N,1,Intermediate,CHEMBL624675,,
8443,Rattus norvegicus,1,,1466,BAO_0000218,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,A,,N,1,Intermediate,CHEMBL621728,,
8444,Rattus norvegicus,1,,5182,BAO_0000218,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,A,,N,1,Intermediate,CHEMBL621729,,
8445,Rattus norvegicus,1,,5182,BAO_0000218,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,A,,N,1,Intermediate,CHEMBL621730,,
8446,Rattus norvegicus,1,,6535,BAO_0000218,,Volume distribution in rat after administration of 2 mg/kg iv,,A,,N,1,Intermediate,CHEMBL621731,,
8447,Rattus norvegicus,1,,6535,BAO_0000218,,Volume distribution in rat after administration of 2 mg/kg iv,,A,,N,1,Intermediate,CHEMBL621732,,
8448,Rattus norvegicus,1,,5041,BAO_0000218,,Volume in steady state distribution value was determined,,A,,N,1,Intermediate,CHEMBL621908,,
8449,Rattus norvegicus,1,,5041,BAO_0000218,,Volume in steady state distribution value was determined; ND denotes no data,,A,,N,1,Intermediate,CHEMBL875347,,
8450,Rattus norvegicus,1,,5041,BAO_0000218,,Volume in steady state distribution value was determined; ND denotes not determined,,A,,N,1,Intermediate,CHEMBL621909,,
8451,Rattus norvegicus,1,,17065,BAO_0000218,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,A,,N,1,Intermediate,CHEMBL621910,,
8452,Rattus norvegicus,1,,6597,BAO_0000218,,Volume of distribution at steady state was evaluated in rats,,A,,N,1,Intermediate,CHEMBL621911,,
8453,Rattus norvegicus,1,,15662,BAO_0000218,,Volume of distribution at steady state was observed after intravenous administration in rat,,A,,N,1,Intermediate,CHEMBL621912,,
8454,Rattus norvegicus,1,,6485,BAO_0000218,,Volume of distribution in steady state was determined in rat,,A,,N,1,Intermediate,CHEMBL621913,,
8455,Rattus norvegicus,1,,17655,BAO_0000218,,Volume of distribution in steady state was determined in rat,,A,,N,1,Intermediate,CHEMBL621914,,
8456,Rattus norvegicus,1,,6616,BAO_0000218,,Volume of distribution after i.v. administration,,A,,N,1,Intermediate,CHEMBL621915,,
8457,Rattus norvegicus,1,,1916,BAO_0000218,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,A,,N,1,Intermediate,CHEMBL621916,,
8458,Mus musculus,1,2107.0,16438,BAO_0000218,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,A,,N,1,Intermediate,CHEMBL621917,,
8459,Mus musculus,1,2107.0,16438,BAO_0000218,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,A,,N,1,Intermediate,CHEMBL621918,,
8460,Mus musculus,1,2106.0,16438,BAO_0000218,,Biodistribution of compound (oxidized form) in spleen tissue,,A,,N,1,Intermediate,CHEMBL621919,,
8461,Mus musculus,1,2106.0,16438,BAO_0000218,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,A,,N,1,Intermediate,CHEMBL621920,,
8462,Mus musculus,1,2106.0,16438,BAO_0000218,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,A,,N,1,Intermediate,CHEMBL621921,,
8463,Mus musculus,1,2106.0,16438,BAO_0000218,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,A,,N,1,Intermediate,CHEMBL622401,,
8464,Mus musculus,1,2106.0,16438,BAO_0000218,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,A,,N,1,Intermediate,CHEMBL875348,,
8465,Mus musculus,1,2106.0,16438,BAO_0000218,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,A,,N,1,Intermediate,CHEMBL622402,,
8466,Mus musculus,1,178.0,16438,BAO_0000218,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,A,,N,1,Intermediate,CHEMBL622403,,
8467,Mus musculus,1,178.0,16438,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,A,,N,1,Intermediate,CHEMBL622404,,
8468,Mus musculus,1,955.0,16438,BAO_0000218,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,A,,N,1,Intermediate,CHEMBL622405,,
8469,Mus musculus,1,955.0,16438,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,A,,N,1,Intermediate,CHEMBL622406,,
8470,Mus musculus,1,955.0,16438,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,A,,N,1,Intermediate,CHEMBL622407,,
8471,Mus musculus,1,948.0,16438,BAO_0000218,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,A,,N,1,Intermediate,CHEMBL622408,,
8472,Mus musculus,1,948.0,16438,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,A,,N,1,Intermediate,CHEMBL622409,,
8473,Mus musculus,1,948.0,16438,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,A,,N,1,Intermediate,CHEMBL622410,,
8474,Mus musculus,1,2113.0,16438,BAO_0000218,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,A,,N,1,Intermediate,CHEMBL622411,,
8475,Mus musculus,1,2113.0,16438,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,A,,N,1,Intermediate,CHEMBL627864,,
8476,Mus musculus,1,2113.0,16438,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,A,,N,1,Intermediate,CHEMBL627865,,
8477,Mus musculus,1,2107.0,16438,BAO_0000218,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,A,,N,1,Intermediate,CHEMBL627866,,
8478,Mus musculus,1,2107.0,16438,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,A,,N,1,Intermediate,CHEMBL627751,,
8479,Mus musculus,1,2106.0,16438,BAO_0000218,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,A,,N,1,Intermediate,CHEMBL627752,,
8480,Mus musculus,1,2106.0,16438,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,A,,N,1,Intermediate,CHEMBL627753,,
8481,Mus musculus,1,2106.0,16438,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,A,,N,1,Intermediate,CHEMBL627754,,
8482,Mus musculus,1,,12467,BAO_0000218,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,A,,N,1,Intermediate,CHEMBL627755,,
8483,Mus musculus,1,955.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627756,,
8484,Mus musculus,1,955.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627757,,
8485,Mus musculus,1,955.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627758,,
8486,Mus musculus,1,955.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627759,,
8487,Mus musculus,1,955.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627760,,
8488,Mus musculus,1,955.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627761,,
8489,Mus musculus,1,948.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL876811,,
8490,Mus musculus,1,948.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627762,,
8491,Mus musculus,1,948.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627763,,
8492,Mus musculus,1,948.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627764,,
8493,Mus musculus,1,948.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627765,,
8494,Mus musculus,1,948.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627766,,
8495,Mus musculus,1,2113.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627767,,
8496,Mus musculus,1,2113.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627768,,
8497,Mus musculus,1,2113.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL628422,,
8498,Mus musculus,1,2113.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL628423,,
8499,Rattus norvegicus,1,,5089,BAO_0000218,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,A,,N,1,Intermediate,CHEMBL628424,,
8500,Rattus norvegicus,1,,5089,BAO_0000218,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,A,,N,1,Intermediate,CHEMBL628425,,
8501,Rattus norvegicus,1,,4257,BAO_0000218,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,A,,N,1,Intermediate,CHEMBL628426,,
8502,Rattus norvegicus,1,,6679,BAO_0000218,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,A,,N,1,Intermediate,CHEMBL628427,,
8503,Rattus norvegicus,1,,5546,BAO_0000218,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,A,,N,1,Intermediate,CHEMBL626938,,
8504,Rattus norvegicus,1,,6141,BAO_0000218,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL626939,,
8505,Rattus norvegicus,1,,5334,BAO_0000218,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL626940,,
8506,Rattus norvegicus,1,,5334,BAO_0000218,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL626941,,
8507,Rattus norvegicus,1,,5334,BAO_0000218,,Plasma clearance was reported in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL626942,,
8508,Rattus norvegicus,1,,4689,BAO_0000218,,Plasma clearance after intravenous administration (1 mg/kg) in rat,,A,,N,1,Intermediate,CHEMBL876812,,
8509,Rattus norvegicus,1,,6848,BAO_0000218,,Plasma clearance of compound in rats was evaluated,,A,,N,1,Intermediate,CHEMBL626943,,
8510,Rattus norvegicus,1,,6848,BAO_0000218,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,A,,N,1,Intermediate,CHEMBL626944,,
8511,Rattus norvegicus,1,,6467,BAO_0000218,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,A,,N,1,Intermediate,CHEMBL626945,,
8512,Rattus norvegicus,1,,6467,BAO_0000218,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,A,,N,1,Intermediate,CHEMBL626946,,
8513,Rattus norvegicus,1,,4956,BAO_0000218,,Plasma clearance rate in Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL626856,,
8514,Rattus norvegicus,1,,5529,BAO_0000218,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,A,,N,1,Intermediate,CHEMBL626857,,
8515,Rattus norvegicus,1,1969.0,406,BAO_0000218,,The compound was evaluated for plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL626858,,
8516,Rattus norvegicus,1,1969.0,17655,BAO_0000218,,Total plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL627018,,
8517,Rattus norvegicus,1,178.0,3293,BAO_0000218,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,A,,N,1,Intermediate,CHEMBL625331,,
8518,Rattus norvegicus,1,178.0,4075,BAO_0000218,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,A,,N,1,Intermediate,CHEMBL625332,,
8519,Rattus norvegicus,1,,2792,BAO_0000218,,C max was determined at 10 mg/kg po dose in rats,,A,,N,1,Intermediate,CHEMBL877590,,
8520,Rattus norvegicus,1,,2792,BAO_0000218,,C max was determined at 3 mg/kg po dose in rats,,A,,N,1,Intermediate,CHEMBL625333,,
8521,Rattus norvegicus,1,,17594,BAO_0000218,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL625334,,
8522,Rattus norvegicus,1,,17594,BAO_0000218,,Cmax after single intravenous bolus of 1 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL625335,,
8523,Rattus norvegicus,1,,4762,BAO_0000218,,Cmax of compound at 5 mg/kg after po administration was determined in rat,,A,,N,1,Intermediate,CHEMBL625336,,
8524,Rattus norvegicus,1,,17509,BAO_0000218,,Cmax 24 hr after 10 mg/kg oral administration in rats,,A,,N,1,Intermediate,CHEMBL625337,,
8525,Rattus norvegicus,1,,17509,BAO_0000218,,Cmax 24 hr after 2 mg/kg oral administration in rats,,A,,N,1,Intermediate,CHEMBL625338,,
8526,Rattus norvegicus,1,1969.0,1466,BAO_0000218,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,A,,N,1,Intermediate,CHEMBL625339,,
8527,Rattus norvegicus,1,,6535,BAO_0000218,,Cmax in rat after administration of 2 mg/kg iv,,A,,N,1,Intermediate,CHEMBL625340,,
8528,Rattus norvegicus,1,,6535,BAO_0000218,,Cmax in rat after administration of 2 mg/kg iv,,A,,N,1,Intermediate,CHEMBL625341,,
8529,Rattus norvegicus,1,,3169,BAO_0000218,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL622687,,
8530,Rattus norvegicus,1,1969.0,6515,BAO_0000218,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,A,,N,1,Intermediate,CHEMBL622688,,
8531,Rattus norvegicus,1,178.0,11149,BAO_0000218,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,A,,N,1,Intermediate,CHEMBL622689,,
8532,Rattus norvegicus,1,178.0,11149,BAO_0000218,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,A,,N,1,Intermediate,CHEMBL620295,,
8533,Rattus norvegicus,1,,17858,BAO_0000218,,Cmax after 10 mg/kg oral administration in rat,,A,,N,1,Intermediate,CHEMBL620296,,
8534,Rattus norvegicus,1,,6518,BAO_0000218,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,A,,N,1,Intermediate,CHEMBL620297,,
8535,Rattus norvegicus,1,,6518,BAO_0000218,,Cmax after IV dosing at 1 mg/kg in rat; no data,,A,,N,1,Intermediate,CHEMBL620298,,
8536,Rattus norvegicus,1,,4426,BAO_0000218,,Cmax after oral administration at 20 mpk in rats,,A,,N,1,Intermediate,CHEMBL620299,,
8537,Rattus norvegicus,1,,4426,BAO_0000218,,Cmax after oral administration at 20 mpk in rats; Not performed.,,A,,N,1,Intermediate,CHEMBL620300,,
8538,Rattus norvegicus,1,,4426,BAO_0000218,,Cmax after oral administration at 20 mpk in rats d; Not performed.,,A,,N,1,Intermediate,CHEMBL620301,,
8539,Rattus norvegicus,1,,5656,BAO_0000218,,Cmax after oral administration in rat,,A,,N,1,Intermediate,CHEMBL620302,,
8540,Rattus norvegicus,1,,6518,BAO_0000218,,Cmax after oral administration at a dose of 2 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL620303,,
8541,Rattus norvegicus,1,,6518,BAO_0000218,,Cmax after oral administration at a dose of 4 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL620304,,
8542,Rattus norvegicus,1,,6113,BAO_0000218,,Cmax in rats after 20 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL620305,,
8543,Rattus norvegicus,1,,17764,BAO_0000218,,Cmax after peroral administration in rats at 2.4 uM/kg,,A,,N,1,Intermediate,CHEMBL620306,,
8544,Rattus norvegicus,1,,4756,BAO_0000218,,Cmax at the dose of 2 mg/Kg administered perorally in rats,,A,,N,1,Intermediate,CHEMBL620307,,
8545,Rattus norvegicus,1,,4756,BAO_0000218,,Cmax at the dose of 5 mg/Kg administered perorally in rats,,A,,N,1,Intermediate,CHEMBL620308,,
8546,Rattus norvegicus,1,,6402,BAO_0000218,,Cmax by administering at 20 mg/kg p.o. in rats,,A,,N,1,Intermediate,CHEMBL620309,,
8547,Rattus norvegicus,1,,5610,BAO_0000218,,Cmax in male rat,,A,,N,1,Intermediate,CHEMBL620310,,
8548,Rattus norvegicus,1,,5207,BAO_0000218,,Cmax in rat,,A,,N,1,Intermediate,CHEMBL620311,,
8549,Rattus norvegicus,1,,6011,BAO_0000218,,Cmax in rat,,A,,N,1,Intermediate,CHEMBL620312,,
8550,Rattus norvegicus,1,,6504,BAO_0000218,,Cmax in rat,,A,,N,1,Intermediate,CHEMBL620313,,
8551,Rattus norvegicus,1,,6046,BAO_0000218,,Cmax in rat at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL620314,,
8552,Rattus norvegicus,1,,6504,BAO_0000218,,Cmax in rat at the dose of 1 mg/kg i.v.,,A,,N,1,Intermediate,CHEMBL620315,,
8553,Rattus norvegicus,1,,5874,BAO_0000218,,Cmax in rat by po administration at a dose of 40 mg/kg,,A,,N,1,Intermediate,CHEMBL620316,,
8554,Rattus norvegicus,1,,17686,BAO_0000218,,Cmax in rat p.o. at 20 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL620317,,
8555,Rattus norvegicus,1,,5836,BAO_0000218,,Cmax in rats,,A,,N,1,Intermediate,CHEMBL620318,,
8556,Rattus norvegicus,1,,17596,BAO_0000218,,Cmax in rats,,A,,N,1,Intermediate,CHEMBL620319,,
8557,Rattus norvegicus,1,,16423,BAO_0000218,,Cmax was evaluated after 20 uM/kg of peroral administration,,A,,N,1,Intermediate,CHEMBL620320,,
8558,Rattus norvegicus,1,,17804,BAO_0000218,,Cmax was measured in rats after peroral administration at 3 mg/kg,,A,,N,1,Intermediate,CHEMBL620321,,
8559,Rattus norvegicus,1,,1908,BAO_0000218,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,A,,N,1,Intermediate,CHEMBL620322,,
8560,Rattus norvegicus,1,,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620323,,
8561,Rattus norvegicus,1,1870.0,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620324,,
8562,Rattus norvegicus,1,1870.0,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620325,,
8563,Rattus norvegicus,1,10000000.0,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620326,,
8564,Rattus norvegicus,1,10000000.0,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620327,,
8565,Rattus norvegicus,1,,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620328,,
8566,Rattus norvegicus,1,,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620329,,
8567,Rattus norvegicus,1,1891.0,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620330,,
8568,Rattus norvegicus,1,1891.0,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL875286,,
8569,Rattus norvegicus,1,,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620331,,
8570,Rattus norvegicus,1,,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620332,,
8571,Rattus norvegicus,1,2435.0,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620333,,
8572,Rattus norvegicus,1,2435.0,13950,BAO_0000218,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,A,,N,1,Intermediate,CHEMBL620334,,
8573,Rattus norvegicus,1,178.0,16434,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL621015,,
8574,Rattus norvegicus,1,178.0,16434,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL621016,,
8575,Rattus norvegicus,1,178.0,16434,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL621191,,
8576,Rattus norvegicus,1,178.0,16434,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL621192,,
8577,Rattus norvegicus,1,178.0,16434,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL621193,,
8578,Rattus norvegicus,1,178.0,16434,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL621194,,
8579,Rattus norvegicus,1,178.0,16434,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL624204,,
8580,Rattus norvegicus,1,178.0,16434,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL624205,,
8581,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL624206,,
8582,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL624207,,
8583,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL624208,,
8584,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL624209,,
8585,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL624210,,
8586,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL624211,,
8587,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL624212,,
8588,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL624213,,
8589,Rattus norvegicus,1,178.0,16434,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,,N,1,Intermediate,CHEMBL876611,,
8590,Rattus norvegicus,1,178.0,16434,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,A,,N,1,Intermediate,CHEMBL624214,,
8591,Rattus norvegicus,1,178.0,16434,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,,N,1,Intermediate,CHEMBL624215,,
8592,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL624216,,
8593,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL624217,,
8594,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL624218,,
8595,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL624219,,
8596,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL624220,,
8597,Rattus norvegicus,1,178.0,16435,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL624221,,
8598,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL624222,,
8599,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL624223,,
8600,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL624224,,
8601,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL624225,,
8602,Rattus norvegicus,1,,17764,BAO_0000218,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,A,,N,1,Intermediate,CHEMBL622420,,
8603,Rattus norvegicus,1,,5031,BAO_0000218,,Volume of steady state distribution after i.v. administration in rats,,A,,N,1,Intermediate,CHEMBL622421,,
8604,Rattus norvegicus,1,,6215,BAO_0000218,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,A,,N,1,Intermediate,CHEMBL622422,,
8605,Rattus norvegicus,1,,17671,BAO_0000218,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,A,,N,1,Intermediate,CHEMBL622423,,
8606,Rattus norvegicus,1,,17752,BAO_0000218,,Vss was determined,,A,,N,1,Intermediate,CHEMBL622424,,
8607,Rattus norvegicus,1,,6596,BAO_0000218,,Vss in rat,,A,,N,1,Intermediate,CHEMBL622425,,
8608,Rattus norvegicus,1,,16423,BAO_0000218,,Vss was evaluated after 10 uM/kg of intra arterial administration,,A,,N,1,Intermediate,CHEMBL876612,,
8609,Rattus norvegicus,1,,15662,BAO_0000218,,volume of distribution at steady state was observed after intravenous administration in rat,,A,,N,1,Intermediate,CHEMBL622426,,
8610,Rattus norvegicus,1,,6062,BAO_0000218,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL622427,,
8611,Rattus norvegicus,1,,5874,BAO_0000218,,Pharmacokinetic (PK) parameter Vz in rat,,A,,N,1,Intermediate,CHEMBL622428,,
8612,Rattus norvegicus,1,,4942,BAO_0000218,,Volume distribution in rats,,A,,N,1,Intermediate,CHEMBL622429,,
8613,Rattus norvegicus,1,,17796,BAO_0000218,,Volume of distribution in rat; No data,,A,,N,1,Intermediate,CHEMBL622430,,
8614,Rattus norvegicus,1,,4890,BAO_0000218,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL622431,,
8615,Rattus norvegicus,1,2116.0,15765,BAO_0000218,,% absorption predicted from in vitro rat ileum transport studies,,A,,N,1,Intermediate,CHEMBL622432,,
8616,Rattus norvegicus,1,,13569,BAO_0000218,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,A,,N,1,Intermediate,CHEMBL622433,,
8617,Rattus norvegicus,1,,13569,BAO_0000218,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,A,,N,1,Intermediate,CHEMBL622434,,
8618,Rattus norvegicus,1,,13569,BAO_0000218,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,A,,N,1,Intermediate,CHEMBL622435,,
8619,Rattus norvegicus,1,,13569,BAO_0000218,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL618748,,
8620,Rattus norvegicus,1,,13569,BAO_0000218,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,A,,N,1,Intermediate,CHEMBL618749,,
8621,Rattus norvegicus,1,,13569,BAO_0000218,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,A,,N,1,Intermediate,CHEMBL618750,,
8622,Rattus norvegicus,1,,13569,BAO_0000218,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,A,,N,1,Intermediate,CHEMBL618751,,
8623,Rattus norvegicus,1,,13569,BAO_0000218,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,A,,N,1,Intermediate,CHEMBL618752,,
8624,Rattus norvegicus,1,,4576,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL618753,,
8625,Rattus norvegicus,1,1969.0,750,BAO_0000218,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,A,,N,1,Intermediate,CHEMBL618754,,
8626,Rattus norvegicus,1,,750,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL618755,,
8627,Rattus norvegicus,1,,4590,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL618756,,
8628,Rattus norvegicus,1,,1716,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL618757,,
8629,Rattus norvegicus,1,,1974,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL618758,,
8630,Rattus norvegicus,1,,4502,BAO_0000218,,Oral bioavailability in rat (dose 30 mg/kg),,A,,N,1,Intermediate,CHEMBL621088,,
8631,Rattus norvegicus,1,,3371,BAO_0000218,,Pharmacokinetic property (cLogP) in rat,,A,,N,1,Intermediate,CHEMBL621089,,
8632,Rattus norvegicus,1,178.0,9099,BAO_0000218,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,F,,N,1,Intermediate,CHEMBL621090,,
8633,Rattus norvegicus,1,178.0,9099,BAO_0000218,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,F,,N,1,Intermediate,CHEMBL621091,,
8634,Rattus norvegicus,1,,4590,BAO_0000218,,Clearance in rat.,,A,,N,1,Intermediate,CHEMBL876731,,
8635,Rattus norvegicus,1,,3184,BAO_0000218,,Compound was evaluated for its clearance when administered intravenously in rat,,A,,N,1,Intermediate,CHEMBL621092,,
8636,Rattus norvegicus,1,,16456,BAO_0000218,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL621093,,
8637,Rattus norvegicus,1,,4199,BAO_0000218,,Blood: Brain distribution ratio is determined in rat,,A,,N,1,Intermediate,CHEMBL621094,,
8638,Rattus norvegicus,1,,4199,BAO_0000218,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,A,,N,1,Intermediate,CHEMBL621095,,
8639,Rattus norvegicus,1,,4199,BAO_0000218,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,A,,N,1,Intermediate,CHEMBL621096,,
8640,Rattus norvegicus,1,2113.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL621097,,
8641,Rattus norvegicus,1,,7449,BAO_0000218,,Percent dose excreted in 0-48 hours administered ip to male rat,,F,,N,1,Intermediate,CHEMBL621098,,
8642,Rattus norvegicus,1,2037.0,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL621099,,
8643,Rattus norvegicus,1,2037.0,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL621100,,
8644,Rattus norvegicus,1,2037.0,11977,BAO_0000218,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,,N,1,Intermediate,CHEMBL621101,,
8645,Rattus norvegicus,1,2037.0,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL621102,,
8646,Rattus norvegicus,1,2037.0,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL876732,,
8647,Rattus norvegicus,1,,11977,BAO_0000218,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL621103,,
8648,Rattus norvegicus,1,,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL621104,,
8649,Rattus norvegicus,1,,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,,N,1,Intermediate,CHEMBL621105,,
8650,Rattus norvegicus,1,,11977,BAO_0000218,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL621106,,
8651,Rattus norvegicus,1,,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL621107,,
8652,Rattus norvegicus,1,,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL621108,,
8653,Rattus norvegicus,1,,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL621109,,
8654,Mus musculus,1,2113.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL621110,,
8655,Mus musculus,1,2113.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL621111,,
8656,Mus musculus,1,2107.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL622541,,
8657,Mus musculus,1,2107.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL622542,,
8658,Mus musculus,1,2107.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL622543,,
8659,Mus musculus,1,2107.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL624412,,
8660,Mus musculus,1,2107.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL624413,,
8661,Mus musculus,1,2107.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL624414,,
8662,Mus musculus,1,2048.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL624415,,
8663,Mus musculus,1,2048.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL624416,,
8664,Mus musculus,1,2048.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL624417,,
8665,Mus musculus,1,2048.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL624418,,
8666,Mus musculus,1,2048.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL624419,,
8667,Mus musculus,1,2048.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL624420,,
8668,Mus musculus,1,2385.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL624421,,
8669,Mus musculus,1,2385.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL624422,,
8670,Mus musculus,1,2385.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL624423,,
8671,Mus musculus,1,2385.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL625123,,
8672,Mus musculus,1,2385.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL625124,,
8673,Mus musculus,1,2385.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL625125,,
8674,Mus musculus,1,14.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL625126,,
8675,Mus musculus,1,14.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626947,,
8676,Mus musculus,1,14.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626948,,
8677,Mus musculus,1,14.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626949,,
8678,Mus musculus,1,14.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626950,,
8679,Mus musculus,1,14.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626951,,
8680,Mus musculus,1,2106.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626952,,
8681,Mus musculus,1,2106.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626953,,
8682,Mus musculus,1,2106.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626954,,
8683,Mus musculus,1,2106.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626955,,
8684,Mus musculus,1,2106.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626956,,
8685,Mus musculus,1,2106.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626957,,
8686,Mus musculus,1,178.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626958,,
8687,Mus musculus,1,178.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626959,,
8688,Mus musculus,1,178.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626960,,
8689,Mus musculus,1,178.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL626961,,
8690,Mus musculus,1,178.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627589,,
8691,Mus musculus,1,178.0,17208,BAO_0000218,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,A,,N,1,Intermediate,CHEMBL627590,,
8692,Mus musculus,1,,3132,BAO_0000218,,Time taken for EC90 was determined when tested in mouse,,A,,N,1,Intermediate,CHEMBL627591,,
8693,Mus musculus,1,,3132,BAO_0000218,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,A,,N,1,Intermediate,CHEMBL627592,,
8694,Mus musculus,1,,16597,BAO_0000218,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,A,,N,1,Intermediate,CHEMBL627593,,
8695,Mus musculus,1,,5727,BAO_0000218,,Half life in mice,,A,,N,1,Intermediate,CHEMBL627594,,
8696,Mus musculus,1,,5302,BAO_0000218,,Half life period in mouse after 10 mg/Kg dose,,A,,N,1,Intermediate,CHEMBL876813,,
8697,Mus musculus,1,,5302,BAO_0000218,,Half life period in mouse after 10 mg/kg dose,,A,,N,1,Intermediate,CHEMBL627595,,
8698,Mus musculus,1,,6348,BAO_0000218,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,A,,N,1,Intermediate,CHEMBL627596,,
8699,Rattus norvegicus,1,,5964,BAO_0000218,,Cmax value at 5 mg/kg po was determined in rat,,A,,N,1,Intermediate,CHEMBL627597,,
8700,Rattus norvegicus,1,,6078,BAO_0000218,,Cmax value evaluated in rat,,A,,N,1,Intermediate,CHEMBL627598,,
8701,Rattus norvegicus,1,955.0,5206,BAO_0000218,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,A,,N,1,Intermediate,CHEMBL627599,,
8702,Rattus norvegicus,1,,2959,BAO_0000218,,Cmax value after administration of 20 mg/Kg oral dose in rat,,A,,N,1,Intermediate,CHEMBL627600,,
8703,Rattus norvegicus,1,,5964,BAO_0000218,,Cmax value at 1 mg/kg po in rat,,A,,N,1,Intermediate,CHEMBL627601,,
8704,Rattus norvegicus,1,,5964,BAO_0000218,,Cmax value at 5 mg/kg po in rat,,A,,N,1,Intermediate,CHEMBL627776,,
8705,Rattus norvegicus,1,,6757,BAO_0000218,,Cmax value at a dose of 10 mg/kg in male SD rats,,A,,N,1,Intermediate,CHEMBL627777,,
8706,Rattus norvegicus,1,,6757,BAO_0000218,,Cmax value at a dose of 100 mg/kg in male SD rats,,A,,N,1,Intermediate,CHEMBL627778,,
8707,Rattus norvegicus,1,,6757,BAO_0000218,,Cmax value at a dose of 50 mg/kg in male SD rats,,A,,N,1,Intermediate,CHEMBL627779,,
8708,Rattus norvegicus,1,,17617,BAO_0000218,,Cmax value in rats at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL876814,,
8709,Rattus norvegicus,1,,1445,BAO_0000218,,Cmax value was evaluated in rats at a dose of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL627780,,
8710,Rattus norvegicus,1,,6082,BAO_0000218,,Cmax value was determined after peroral administration of 20 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627781,,
8711,Rattus norvegicus,1,,1446,BAO_0000218,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,A,,N,1,Intermediate,CHEMBL627782,,
8712,Rattus norvegicus,1,1969.0,5407,BAO_0000218,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,A,,N,1,Intermediate,CHEMBL627783,,
8713,Rattus norvegicus,1,1969.0,2690,BAO_0000218,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,A,,N,1,Intermediate,CHEMBL627784,,
8714,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,A,,N,1,Intermediate,CHEMBL627785,,
8715,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,A,,N,1,Intermediate,CHEMBL627786,,
8716,Rattus norvegicus,1,1969.0,4891,BAO_0000218,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,A,,N,1,Intermediate,CHEMBL627787,,
8717,Rattus norvegicus,1,1969.0,2807,BAO_0000218,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,A,,N,1,Intermediate,CHEMBL627788,,
8718,Rattus norvegicus,1,1969.0,2807,BAO_0000218,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,A,,N,1,Intermediate,CHEMBL626579,,
8719,Rattus norvegicus,1,1969.0,2807,BAO_0000218,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,A,,N,1,Intermediate,CHEMBL626580,,
8720,Rattus norvegicus,1,,3634,BAO_0000218,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL876815,,
8721,Rattus norvegicus,1,1969.0,1881,BAO_0000218,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,A,,N,1,Intermediate,CHEMBL626581,,
8722,Rattus norvegicus,1,1969.0,1881,BAO_0000218,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,A,,N,1,Intermediate,CHEMBL626582,,
8723,Rattus norvegicus,1,,429,BAO_0000218,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,A,,N,1,Intermediate,CHEMBL626583,,
8724,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL626205,,
8725,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL626206,,
8726,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL626207,,
8727,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL623882,,
8728,Rattus norvegicus,1,,17582,BAO_0000218,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,A,,N,1,Intermediate,CHEMBL623883,,
8729,Rattus norvegicus,1,,17582,BAO_0000218,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL623884,,
8730,Rattus norvegicus,1,1969.0,3032,BAO_0000218,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,A,,N,1,Intermediate,CHEMBL623885,,
8731,Rattus norvegicus,1,1969.0,6295,BAO_0000218,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,A,,N,1,Intermediate,CHEMBL623886,,
8732,Rattus norvegicus,1,,6619,BAO_0000218,,Maximal concentration in rat was determined,,A,,N,1,Intermediate,CHEMBL623887,,
8733,Rattus norvegicus,1,,6616,BAO_0000218,,Maximal concentration after i.v. administration,,A,,N,1,Intermediate,CHEMBL623888,,
8734,Rattus norvegicus,1,1969.0,3249,BAO_0000218,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL623889,,
8735,Rattus norvegicus,1,1969.0,17791,BAO_0000218,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,A,,N,1,Intermediate,CHEMBL623890,,
8736,Rattus norvegicus,1,1969.0,17791,BAO_0000218,,Cmax in rat plasma after oral dose (50 mg/Kg),,A,,N,1,Intermediate,CHEMBL623891,,
8737,Rattus norvegicus,1,1969.0,1360,BAO_0000218,,Maximal plasma concentration was determined.,,A,,N,1,Intermediate,CHEMBL623892,,
8738,Rattus norvegicus,1,1969.0,2552,BAO_0000218,,Maximal plasma drug concentration was determined,,A,,N,1,Intermediate,CHEMBL623893,,
8739,Rattus norvegicus,1,,6571,BAO_0000218,,Maximal concentration in rats after peroral administration,,A,,N,1,Intermediate,CHEMBL877616,,
8740,Rattus norvegicus,1,,6570,BAO_0000218,,Maximum concentration in rat after 2 mg/kg peroral administration,,A,,N,1,Intermediate,CHEMBL623894,,
8741,Rattus norvegicus,1,1969.0,6567,BAO_0000218,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,A,,N,1,Intermediate,CHEMBL623895,,
8742,Rattus norvegicus,1,,3031,BAO_0000218,,Maximum concentration of compound in rat was evaluated.,,A,,N,1,Intermediate,CHEMBL623896,,
8743,Rattus norvegicus,1,,3436,BAO_0000218,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL623897,,
8744,Rattus norvegicus,1,,3436,BAO_0000218,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL623898,,
8745,Rattus norvegicus,1,,2083,BAO_0000218,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,A,,N,1,Intermediate,CHEMBL623899,,
8746,Rattus norvegicus,1,,3436,BAO_0000218,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL623900,,
8747,Rattus norvegicus,1,,4527,BAO_0000218,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,A,,N,1,Intermediate,CHEMBL623901,,
8748,Rattus norvegicus,1,,1974,BAO_0000218,,Maximum concentration was evaluated in rats,,A,,N,1,Intermediate,CHEMBL623902,,
8749,Rattus norvegicus,1,1359.0,3307,BAO_0000218,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,A,,N,1,Intermediate,CHEMBL623903,,
8750,Rattus norvegicus,1,1969.0,3307,BAO_0000218,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,A,,N,1,Intermediate,CHEMBL623904,,
8751,Rattus norvegicus,1,1969.0,1916,BAO_0000218,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,A,,N,1,Intermediate,CHEMBL877617,,
8752,Rattus norvegicus,1,,1500,BAO_0000218,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL623905,,
8753,Rattus norvegicus,1,,1500,BAO_0000218,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL623906,,
8754,Rattus norvegicus,1,1969.0,4186,BAO_0000218,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,A,,N,1,Intermediate,CHEMBL623907,,
8755,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL623908,,
8756,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL623909,,
8757,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL623910,,
8758,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL623911,,
8759,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL623912,,
8760,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL624616,,
8761,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL624617,,
8762,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL624618,,
8763,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL624619,,
8764,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL624794,,
8765,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL624795,,
8766,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL623921,,
8767,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,,N,1,Intermediate,CHEMBL623922,,
8768,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,A,,N,1,Intermediate,CHEMBL623923,,
8769,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,,N,1,Intermediate,CHEMBL623924,,
8770,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL623925,,
8771,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL623926,,
8772,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL623927,,
8773,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL623928,,
8774,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL623929,,
8775,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL623930,,
8776,Rattus norvegicus,1,955.0,16434,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL623931,,
8777,Rattus norvegicus,1,955.0,16434,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL622165,,
8778,Rattus norvegicus,1,955.0,16434,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL621249,,
8779,Rattus norvegicus,1,955.0,16434,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL621250,,
8780,Rattus norvegicus,1,955.0,16434,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL621448,,
8781,Rattus norvegicus,1,955.0,16434,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL621449,,
8782,Rattus norvegicus,1,955.0,16434,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL621450,,
8783,Rattus norvegicus,1,955.0,16434,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL621451,,
8784,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL621452,,
8785,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL621453,,
8786,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL621454,,
8787,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL621455,,
8788,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL621456,,
8789,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL625145,,
8790,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL875847,,
8791,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL625146,,
8792,Rattus norvegicus,1,955.0,16434,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,,N,1,Intermediate,CHEMBL625147,,
8793,Rattus norvegicus,1,955.0,16434,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,A,,N,1,Intermediate,CHEMBL625148,,
8794,Rattus norvegicus,1,955.0,16434,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,,N,1,Intermediate,CHEMBL625149,,
8795,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL625150,,
8796,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL625151,,
8797,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL625152,,
8798,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL625153,,
8799,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL625154,,
8800,Rattus norvegicus,1,955.0,16435,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL625155,,
8801,Rattus norvegicus,1,,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,,N,1,Intermediate,CHEMBL625156,,
8802,Rattus norvegicus,1,,11977,BAO_0000218,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624354,,
8803,Rattus norvegicus,1,10000000.0,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624355,,
8804,Rattus norvegicus,1,10000000.0,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624356,,
8805,Rattus norvegicus,1,10000000.0,11977,BAO_0000218,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624357,,
8806,Rattus norvegicus,1,10000000.0,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624358,,
8807,Rattus norvegicus,1,2435.0,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624359,,
8808,Rattus norvegicus,1,2435.0,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624360,,
8809,Rattus norvegicus,1,2435.0,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,,N,1,Intermediate,CHEMBL624361,,
8810,Rattus norvegicus,1,2435.0,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624362,,
8811,Rattus norvegicus,1,2435.0,11977,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624363,,
8812,Rattus norvegicus,1,178.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624364,,
8813,Rattus norvegicus,1,178.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624365,,
8814,Rattus norvegicus,1,178.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624366,,
8815,Rattus norvegicus,1,178.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624367,,
8816,Rattus norvegicus,1,955.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624368,,
8817,Rattus norvegicus,1,955.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL624369,,
8818,Rattus norvegicus,1,955.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,,N,1,Intermediate,CHEMBL624370,,
8819,Rattus norvegicus,1,955.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL625069,,
8820,Rattus norvegicus,1,955.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL625070,,
8821,Rattus norvegicus,1,948.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL626051,,
8822,Rattus norvegicus,1,948.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL626052,,
8823,Rattus norvegicus,1,948.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,,N,1,Intermediate,CHEMBL626053,,
8824,Rattus norvegicus,1,948.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL626054,,
8825,Rattus norvegicus,1,948.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL626055,,
8826,Rattus norvegicus,1,2113.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL626056,,
8827,Rattus norvegicus,1,2113.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL626057,,
8828,Rattus norvegicus,1,2113.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL625193,,
8829,Rattus norvegicus,1,2113.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL625194,,
8830,Rattus norvegicus,1,2107.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL625195,,
8831,Rattus norvegicus,1,2107.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL625196,,
8832,Rattus norvegicus,1,2107.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,,N,1,Intermediate,CHEMBL625197,,
8833,Rattus norvegicus,1,2107.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL625198,,
8834,Rattus norvegicus,1,2107.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL627929,,
8835,Rattus norvegicus,1,2048.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL627074,,
8836,Rattus norvegicus,1,2048.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL627075,,
8837,Rattus norvegicus,1,2048.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,,N,1,Intermediate,CHEMBL627076,,
8838,Rattus norvegicus,1,2048.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL627077,,
8839,Rattus norvegicus,1,2048.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL627078,,
8840,Rattus norvegicus,1,2385.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,A,,N,1,Intermediate,CHEMBL627079,,
8841,Mus musculus,1,,4573,BAO_0000218,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,A,,N,1,Intermediate,CHEMBL873824,,
8842,Mus musculus,1,1969.0,3132,BAO_0000218,,Half life in mouse plasma was determined at dose 25 mg/kg,,A,,N,1,Intermediate,CHEMBL627080,,
8843,Mus musculus,1,,17718,BAO_0000218,,Half life was determined,,A,,N,1,Intermediate,CHEMBL627081,,
8844,Mus musculus,1,,17728,BAO_0000218,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,A,,N,1,Intermediate,CHEMBL627082,,
8845,Mus musculus,1,,5961,BAO_0000218,,Half-life in male mice after 1 mg/kg intravenous dose,,A,,N,1,Intermediate,CHEMBL627083,,
8847,Mus musculus,1,1969.0,17731,BAO_0000218,,Half life in mice plasma,,A,,N,1,Intermediate,CHEMBL627085,,
8848,Mus musculus,1,,17592,BAO_0000218,,Half life in mouse,,A,,N,1,Intermediate,CHEMBL627086,,
8849,Mus musculus,1,1969.0,3132,BAO_0000218,,Half life in mouse plasma at dose 25 mg/kg,,A,,N,1,Intermediate,CHEMBL627087,,
8850,Mus musculus,1,,17729,BAO_0000218,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,A,,N,1,Intermediate,CHEMBL627088,,
8851,Mus musculus,1,,17729,BAO_0000218,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,A,,N,1,Intermediate,CHEMBL627089,,
8852,Mus musculus,1,,17729,BAO_0000218,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,A,,N,1,Intermediate,CHEMBL627090,,
8853,Mus musculus,1,,3277,BAO_0000218,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,A,,N,1,Intermediate,CHEMBL627091,,
8854,Mus musculus,1,,3760,BAO_0000218,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,A,,N,1,Intermediate,CHEMBL627092,,
8855,Mus musculus,1,,3760,BAO_0000218,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,A,,N,1,Intermediate,CHEMBL876785,,
8856,Mus musculus,1,,2862,BAO_0000218,,Half-life by iv administration in mouse,,A,,N,1,Intermediate,CHEMBL627093,,
8857,Mus musculus,1,,2862,BAO_0000218,,Half-life by oral administration in mouse,,A,,N,1,Intermediate,CHEMBL627094,,
8858,Mus musculus,1,,5980,BAO_0000218,,Half-life in mice,,A,,N,1,Intermediate,CHEMBL627095,,
8859,Mus musculus,1,955.0,6159,BAO_0000218,,Half-life using mouse brain homogenate,,A,,N,1,Intermediate,CHEMBL627096,,
8860,Mus musculus,1,,6254,BAO_0000218,,Half-life was measured in mice,,A,,N,1,Intermediate,CHEMBL627097,,
8861,Mus musculus,1,,6062,BAO_0000218,,Half-life was measured in mouse after an iv dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL627098,,
8862,Mus musculus,1,178.0,1574,BAO_0000218,,Half-life period was determined in mouse blood,,A,,N,1,Intermediate,CHEMBL627099,,
8863,Mus musculus,1,955.0,56,BAO_0000218,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,A,,N,1,Intermediate,CHEMBL627100,,
8864,Mus musculus,1,1969.0,993,BAO_0000218,,Plasma half life in mouse,,A,,N,1,Intermediate,CHEMBL627101,,
8865,Mus musculus,1,,6652,BAO_0000218,,Stability of the peptide in the presence of mouse serum,,A,,N,1,Intermediate,CHEMBL627102,,
8866,Mus musculus,1,,17852,BAO_0000218,,Terminal half life of compound was determined in mouse,,A,,N,1,Intermediate,CHEMBL627103,,
8867,Mus musculus,1,,2675,BAO_0000218,,Terminal half life was evaluated in mice after intravenous administration,,A,,N,1,Intermediate,CHEMBL627104,,
8868,Mus musculus,1,,2675,BAO_0000218,,Terminal half life was evaluated in mice after oral administration,,A,,N,1,Intermediate,CHEMBL627105,,
8869,Mus musculus,1,,499,BAO_0000218,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,A,,N,1,Intermediate,CHEMBL876786,,
8870,Mus musculus,1,,499,BAO_0000218,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,A,,N,1,Intermediate,CHEMBL873825,,
8871,Mus musculus,1,,499,BAO_0000218,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,A,,N,1,Intermediate,CHEMBL627106,,
8872,Mus musculus,1,,14239,BAO_0000218,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,A,,N,1,Intermediate,CHEMBL626336,,
8873,Mus musculus,1,,5506,BAO_0000218,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,A,,N,1,Intermediate,CHEMBL877462,,
8874,Mus musculus,1,,5506,BAO_0000218,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,A,,N,1,Intermediate,CHEMBL626337,,
8875,Mus musculus,1,,17734,BAO_0000218,,Half life after intraperitoneal administration of 100 mg/kg in mice,,A,,N,1,Intermediate,CHEMBL626338,,
8876,Mus musculus,1,,17728,BAO_0000218,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,A,,N,1,Intermediate,CHEMBL626339,,
8877,Mus musculus,1,,17728,BAO_0000218,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,A,,N,1,Intermediate,CHEMBL626340,,
8878,Mus musculus,1,,17728,BAO_0000218,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,A,,N,1,Intermediate,CHEMBL625377,,
8879,Mus musculus,1,,17728,BAO_0000218,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,A,,N,1,Intermediate,CHEMBL625378,,
8880,Mus musculus,1,,17728,BAO_0000218,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,A,,N,1,Intermediate,CHEMBL625379,,
8881,Sus scrofa,1,,14294,BAO_0000251,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Microsomes,A,,U,0,Autocuration,CHEMBL625380,,
8882,Sus scrofa,1,,14294,BAO_0000251,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Microsomes,A,,U,0,Autocuration,CHEMBL625381,,
8883,Sus scrofa,1,,6056,BAO_0000019,,Stability to porcine renal DHP-I,,A,,U,0,Autocuration,CHEMBL625382,,
8884,Sus scrofa,1,,1317,BAO_0000218,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,A,,U,0,Autocuration,CHEMBL873828,,
8885,Sus scrofa,1,,1317,BAO_0000218,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,A,,U,0,Autocuration,CHEMBL625383,,
8886,Sus scrofa,1,,5229,BAO_0000019,,Half-life of the parent prodrug in porcine esterase solution,,A,,U,0,Autocuration,CHEMBL625384,,
8887,Sus scrofa,1,,4231,BAO_0000019,,"First order rate constant, k was determined in in pig liver Esterase",,A,,U,0,Autocuration,CHEMBL625385,,
8888,Sus scrofa,1,2107.0,4231,BAO_0000221,,Half life of the in pig liver Esterase,,A,,U,0,Autocuration,CHEMBL625386,,
8889,Sus scrofa,1,2107.0,5318,BAO_0000221,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,A,,U,0,Autocuration,CHEMBL623571,,
8890,Sus scrofa,1,2107.0,5318,BAO_0000221,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,A,,U,0,Autocuration,CHEMBL623572,,
8891,Sus scrofa,1,2107.0,5318,BAO_0000221,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,A,,U,0,Autocuration,CHEMBL623573,,
8892,Sus scrofa,1,2107.0,3305,BAO_0000221,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,A,,U,0,Autocuration,CHEMBL623574,,
8893,Sus scrofa,1,2107.0,3305,BAO_0000221,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,A,,U,0,Autocuration,CHEMBL623575,,
8894,Sus scrofa,1,2107.0,2842,BAO_0000221,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,A,,U,0,Autocuration,CHEMBL623749,,
8895,Sus scrofa,1,2107.0,2842,BAO_0000221,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,A,,U,0,Autocuration,CHEMBL623750,,
8896,Sus scrofa,1,2107.0,889,BAO_0000221,,Half-life in vitro in pig liver,,A,,U,0,Autocuration,CHEMBL623751,,
8897,Sus scrofa,1,2107.0,1904,BAO_0000221,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,A,,U,0,Autocuration,CHEMBL623752,,
8898,Rattus norvegicus,1,1969.0,4186,BAO_0000218,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,A,,N,1,Intermediate,CHEMBL623753,,
8899,Rattus norvegicus,1,1969.0,2774,BAO_0000218,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,A,,N,1,Intermediate,CHEMBL623754,,
8900,Rattus norvegicus,1,1969.0,1742,BAO_0000218,,Maximum concentration in rat plasma was determined,,A,,N,1,Intermediate,CHEMBL623755,,
8901,Rattus norvegicus,1,,3169,BAO_0000218,,Maximum concentration in rats,,A,,N,1,Intermediate,CHEMBL623756,,
8902,Rattus norvegicus,1,,3169,BAO_0000218,,Maximum concentration in rats at 1-2 hours,,A,,N,1,Intermediate,CHEMBL623757,,
8903,Rattus norvegicus,1,,2081,BAO_0000218,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,A,,N,1,Intermediate,CHEMBL623758,,
8904,Rattus norvegicus,1,955.0,3307,BAO_0000218,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,A,,N,1,Intermediate,CHEMBL623759,,
8905,Rattus norvegicus,1,,4727,BAO_0000218,,Maximum concentration at the dose of 2 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL623760,,
8906,Rattus norvegicus,1,,6597,BAO_0000218,,Maximum concentration was evaluated in rats,,A,,N,1,Intermediate,CHEMBL623761,,
8907,Rattus norvegicus,1,1969.0,16365,BAO_0000218,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,A,,N,1,Intermediate,CHEMBL623762,,
8908,Rattus norvegicus,1,1969.0,16365,BAO_0000218,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,A,,N,1,Intermediate,CHEMBL877594,,
8909,Rattus norvegicus,1,1969.0,16365,BAO_0000218,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,A,,N,1,Intermediate,CHEMBL623763,,
8910,Rattus norvegicus,1,1969.0,16365,BAO_0000218,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,A,,N,1,Intermediate,CHEMBL623764,,
8911,Rattus norvegicus,1,1969.0,16365,BAO_0000218,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,A,,N,1,Intermediate,CHEMBL623765,,
8912,Rattus norvegicus,1,178.0,2591,BAO_0000218,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,A,,N,1,Intermediate,CHEMBL623766,,
8913,Rattus norvegicus,1,178.0,2591,BAO_0000218,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,A,,N,1,Intermediate,CHEMBL623767,,
8914,Rattus norvegicus,1,178.0,2591,BAO_0000218,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,A,,N,1,Intermediate,CHEMBL623768,,
8915,Rattus norvegicus,1,1969.0,5978,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL623769,,
8916,Rattus norvegicus,1,1969.0,5978,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL623770,,
8917,Rattus norvegicus,1,1969.0,5978,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL623771,,
8918,Rattus norvegicus,1,1969.0,5978,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL623772,,
8919,Rattus norvegicus,1,1969.0,5978,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL623773,,
8920,Rattus norvegicus,1,1969.0,5978,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL623774,,
8921,Rattus norvegicus,1,1969.0,5978,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL623775,,
8922,Rattus norvegicus,1,,14465,BAO_0000218,,Cmax in rat (PO dose),,A,,N,1,Intermediate,CHEMBL623776,,
8923,Rattus norvegicus,1,1969.0,4723,BAO_0000218,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,A,,N,1,Intermediate,CHEMBL622191,,
8924,Rattus norvegicus,1,1969.0,4723,BAO_0000218,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,A,,N,1,Intermediate,CHEMBL622192,,
8925,Rattus norvegicus,1,1969.0,4576,BAO_0000218,,Maximum plasma concentration determined in rat,,A,,N,1,Intermediate,CHEMBL622193,,
8926,Rattus norvegicus,1,1969.0,12873,BAO_0000218,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL622194,,
8927,Rattus norvegicus,1,1969.0,12873,BAO_0000218,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL622195,,
8928,Rattus norvegicus,1,1969.0,6824,BAO_0000218,,Maximum plasma concentration in rat,,A,,N,1,Intermediate,CHEMBL622196,,
8929,Rattus norvegicus,1,1969.0,17065,BAO_0000218,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,A,,N,1,Intermediate,CHEMBL622197,,
8930,Rattus norvegicus,1,1969.0,2932,BAO_0000218,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,A,,N,1,Intermediate,CHEMBL622198,,
8931,Rattus norvegicus,1,1969.0,2932,BAO_0000218,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,A,,N,1,Intermediate,CHEMBL622199,,
8932,Rattus norvegicus,1,1969.0,2879,BAO_0000218,,Maximum plasma concentration of compound was measured in rat,,A,,N,1,Intermediate,CHEMBL622200,,
8933,Rattus norvegicus,1,1969.0,2864,BAO_0000218,,Maximum plasma concentration after 20 mg/kg oral administration in rat,,A,,N,1,Intermediate,CHEMBL622201,,
8934,Rattus norvegicus,1,1969.0,16367,BAO_0000218,,Maximum plasma concentration after oral administration to rats,,A,,N,1,Intermediate,CHEMBL623990,,
8935,Rattus norvegicus,1,1969.0,17717,BAO_0000218,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,A,,N,1,Intermediate,CHEMBL623991,,
8936,Rattus norvegicus,1,1969.0,17717,BAO_0000218,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,A,,N,1,Intermediate,CHEMBL623992,,
8937,Rattus norvegicus,1,1969.0,17717,BAO_0000218,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,A,,N,1,Intermediate,CHEMBL623993,,
8938,Rattus norvegicus,1,1969.0,17717,BAO_0000218,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,A,,N,1,Intermediate,CHEMBL623994,,
8939,Rattus norvegicus,1,1969.0,17720,BAO_0000218,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,F,,N,1,Intermediate,CHEMBL623995,,
8940,Rattus norvegicus,1,1969.0,17720,BAO_0000218,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,F,,N,1,Intermediate,CHEMBL623996,,
8941,Rattus norvegicus,1,1969.0,17720,BAO_0000218,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,F,,N,1,Intermediate,CHEMBL623997,,
8942,Rattus norvegicus,1,1969.0,4516,BAO_0000218,,Maximum plasma concentration dosed orally in rats,,A,,N,1,Intermediate,CHEMBL623998,,
8943,Rattus norvegicus,1,1969.0,4516,BAO_0000218,,Maximum plasma concentration dosed orally in rats after 6 hours,,A,,N,1,Intermediate,CHEMBL623999,,
8944,Rattus norvegicus,1,1969.0,4516,BAO_0000218,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,A,,N,1,Intermediate,CHEMBL624000,,
8945,Rattus norvegicus,1,1969.0,5199,BAO_0000218,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL624001,,
8946,Rattus norvegicus,1,1969.0,17538,BAO_0000218,,Maximum plasma concentration in rat after po administration,,A,,N,1,Intermediate,CHEMBL624002,,
8947,Rattus norvegicus,1,1969.0,6685,BAO_0000218,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL624003,,
8948,Rattus norvegicus,1,1969.0,6685,BAO_0000218,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,A,,N,1,Intermediate,CHEMBL624004,,
8949,Rattus norvegicus,1,948.0,16434,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL624005,,
8950,Rattus norvegicus,1,948.0,16434,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL624006,,
8951,Rattus norvegicus,1,948.0,16434,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL624007,,
8952,Rattus norvegicus,1,948.0,16434,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL624008,,
8953,Rattus norvegicus,1,948.0,16434,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL624009,,
8954,Rattus norvegicus,1,948.0,16434,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL874387,,
8955,Rattus norvegicus,1,948.0,16434,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL624010,,
8956,Rattus norvegicus,1,948.0,16434,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL624011,,
8957,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL624012,,
8958,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL624013,,
8959,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL624736,,
8960,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL624737,,
8961,Rattus norvegicus,1,948.0,16434,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,,N,1,Intermediate,CHEMBL624738,,
8962,Rattus norvegicus,1,948.0,16434,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,A,,N,1,Intermediate,CHEMBL624739,,
8963,Rattus norvegicus,1,948.0,16434,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,,N,1,Intermediate,CHEMBL624740,,
8964,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL624896,,
8965,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL624897,,
8966,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL624108,,
8967,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL624109,,
8968,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL624110,,
8969,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL624111,,
8970,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL624112,,
8971,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL624113,,
8972,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL619709,,
8973,Rattus norvegicus,1,948.0,16435,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL619710,,
8974,Rattus norvegicus,1,2113.0,16434,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL619711,,
8975,Rattus norvegicus,1,2113.0,16434,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL619712,,
8976,Rattus norvegicus,1,2113.0,16434,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL619713,,
8977,Rattus norvegicus,1,2113.0,16434,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL619714,,
8978,Rattus norvegicus,1,2113.0,16434,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL619715,,
8979,Rattus norvegicus,1,2113.0,16434,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL619716,,
8980,Rattus norvegicus,1,2113.0,16434,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL619717,,
8981,Rattus norvegicus,1,2113.0,16434,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL619718,,
8982,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL619719,,
8983,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL875329,,
8984,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL619720,,
8985,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL619721,,
8986,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL619722,,
8987,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL619723,,
8988,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL619724,,
8989,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL619725,,
8990,Rattus norvegicus,1,2113.0,16434,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,,N,1,Intermediate,CHEMBL619726,,
8991,Rattus norvegicus,1,2113.0,16434,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,A,,N,1,Intermediate,CHEMBL619727,,
8992,Rattus norvegicus,1,2113.0,16434,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,,N,1,Intermediate,CHEMBL619728,,
8993,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL619729,,
8994,Rattus norvegicus,1,2385.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL619730,,
8995,Rattus norvegicus,1,2385.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL619731,,
8996,Rattus norvegicus,1,2385.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,,N,1,Intermediate,CHEMBL619732,,
8997,Rattus norvegicus,1,2385.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL619733,,
8998,Rattus norvegicus,1,2385.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL619734,,
8999,Rattus norvegicus,1,14.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL619735,,
9000,Rattus norvegicus,1,14.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL875330,,
9001,Rattus norvegicus,1,14.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,,N,1,Intermediate,CHEMBL628465,,
9002,Rattus norvegicus,1,14.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL628466,,
9003,Rattus norvegicus,1,14.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL628467,,
9004,Rattus norvegicus,1,2106.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL628468,,
9005,Rattus norvegicus,1,2106.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL628469,,
9006,Rattus norvegicus,1,2106.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,,N,1,Intermediate,CHEMBL628470,,
9007,Rattus norvegicus,1,2106.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL628471,,
9008,Rattus norvegicus,1,2106.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL628472,,
9009,Rattus norvegicus,1,2046.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL625191,,
9010,Rattus norvegicus,1,2046.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL625192,,
9011,Rattus norvegicus,1,2046.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,,N,1,Intermediate,CHEMBL875337,,
9012,Rattus norvegicus,1,2046.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL626341,,
9013,Rattus norvegicus,1,2046.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL626342,,
9014,Rattus norvegicus,1,2107.0,11977,BAO_0000218,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,,N,1,Intermediate,CHEMBL621943,,
9015,Rattus norvegicus,1,,3748,BAO_0000218,,Half life in rats,,A,,N,1,Intermediate,CHEMBL621944,,
9016,Rattus norvegicus,1,,15765,BAO_0000218,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,A,,N,1,Intermediate,CHEMBL621945,,
9017,Rattus norvegicus,1,,4871,BAO_0000218,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,A,,N,1,Intermediate,CHEMBL621946,,
9018,Rattus norvegicus,1,,4871,BAO_0000218,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,A,,N,1,Intermediate,CHEMBL621947,,
9019,Rattus norvegicus,1,,4872,BAO_0000218,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,A,,N,1,Intermediate,CHEMBL621948,,
9020,Rattus norvegicus,1,,4872,BAO_0000218,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,A,,N,1,Intermediate,CHEMBL621949,,
9021,Rattus norvegicus,1,,5413,BAO_0000218,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,A,,N,1,Intermediate,CHEMBL621950,,
9022,Rattus norvegicus,1,,5413,BAO_0000218,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,A,,N,1,Intermediate,CHEMBL621951,,
9023,Rattus norvegicus,1,178.0,15272,BAO_0000218,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,A,,N,1,Intermediate,CHEMBL621952,,
9024,Rattus norvegicus,1,2107.0,4689,BAO_0000218,,Stability (%) in rat liver microsomes,,A,,N,1,Intermediate,CHEMBL621953,,
9025,Rattus norvegicus,1,,6057,BAO_0000218,,Area under curve was calculated after intravenous administration,,A,,N,1,Intermediate,CHEMBL621954,,
9026,Rattus norvegicus,1,,6057,BAO_0000218,,Area under the curve was calculated after iv administration in rat,,A,,N,1,Intermediate,CHEMBL621955,,
9027,Rattus norvegicus,1,,6057,BAO_0000218,,Area under the curve was calculated in rat after peroral administration,,A,,N,1,Intermediate,CHEMBL621956,,
9028,Rattus norvegicus,1,,6211,BAO_0000218,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL621957,,
9029,Rattus norvegicus,1,,5710,BAO_0000218,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,A,,N,1,Intermediate,CHEMBL621958,,
9030,Rattus norvegicus,1,,5710,BAO_0000218,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,A,,N,1,Intermediate,CHEMBL621959,,
9031,Rattus norvegicus,1,,17853,BAO_0000218,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,A,,N,1,Intermediate,CHEMBL621960,,
9032,Rattus norvegicus,1,,17853,BAO_0000218,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,A,,N,1,Intermediate,CHEMBL621961,,
9033,Rattus norvegicus,1,,15765,BAO_0000218,,p value of the compound,,A,,N,1,Intermediate,CHEMBL621962,,
9034,Rattus norvegicus,1,,15765,BAO_0000218,,p value of the compound,,F,,N,1,Intermediate,CHEMBL876787,,
9035,Rattus norvegicus,1,,15765,BAO_0000218,,p value of the compound,,A,,N,1,Intermediate,CHEMBL621963,,
9036,Rattus norvegicus,1,945.0,6175,BAO_0000218,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,A,,N,1,Intermediate,CHEMBL622637,,
9037,Rattus norvegicus,1,945.0,6175,BAO_0000218,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,A,,N,1,Intermediate,CHEMBL622638,,
9038,Rattus norvegicus,1,945.0,6175,BAO_0000218,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,A,,N,1,Intermediate,CHEMBL626561,,
9039,Oryctolagus cuniculus,1,,7991,BAO_0000019,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,F,,U,0,Autocuration,CHEMBL626562,,
9040,Oryctolagus cuniculus,1,,429,BAO_0000218,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,A,,U,0,Autocuration,CHEMBL626563,,
9041,Oryctolagus cuniculus,1,,429,BAO_0000218,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,A,,U,0,Autocuration,CHEMBL626564,,
9042,Oryctolagus cuniculus,1,,6253,BAO_0000218,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,A,,U,0,Autocuration,CHEMBL626565,,
9043,Oryctolagus cuniculus,1,,6253,BAO_0000218,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,A,,U,0,Autocuration,CHEMBL626566,,
9044,Oryctolagus cuniculus,1,,3615,BAO_0000218,,Clearance rate in rabbits,,A,,U,0,Autocuration,CHEMBL626567,,
9045,Oryctolagus cuniculus,1,,4059,BAO_0000218,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,A,,U,0,Autocuration,CHEMBL626568,,
9046,Oryctolagus cuniculus,1,,5124,BAO_0000218,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,A,,U,0,Autocuration,CHEMBL626569,,
9047,Oryctolagus cuniculus,1,,5124,BAO_0000218,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,A,,U,0,Autocuration,CHEMBL626570,,
9048,Oryctolagus cuniculus,1,,5124,BAO_0000218,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,A,,U,0,Autocuration,CHEMBL626571,,
9049,Oryctolagus cuniculus,1,,429,BAO_0000218,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,A,,U,0,Autocuration,CHEMBL626572,,
9050,Oryctolagus cuniculus,1,1969.0,4059,BAO_0000218,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,A,,U,0,Autocuration,CHEMBL626573,,
9051,Oryctolagus cuniculus,1,2107.0,9659,BAO_0000251,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Microsomes,A,,U,0,Autocuration,CHEMBL626574,,
9052,Oryctolagus cuniculus,1,2107.0,9659,BAO_0000251,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Microsomes,A,,U,0,Autocuration,CHEMBL626575,,
9053,Oryctolagus cuniculus,1,,3639,BAO_0000218,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,A,,U,0,Autocuration,CHEMBL626576,,
9054,Oryctolagus cuniculus,1,,3639,BAO_0000218,,Dose at which bioavailability of perorally administered compound was tested in rabbit,,A,,U,0,Autocuration,CHEMBL626577,,
9055,Oryctolagus cuniculus,1,,3639,BAO_0000218,,The compound was tested for its bioavailability in rabbit (by oral dosage).,,A,,U,0,Autocuration,CHEMBL626578,,
9056,Oryctolagus cuniculus,1,,5124,BAO_0000218,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,A,,U,0,Autocuration,CHEMBL625263,,
9057,Oryctolagus cuniculus,1,,5124,BAO_0000218,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,A,,U,0,Autocuration,CHEMBL625264,,
9058,Oryctolagus cuniculus,1,,5124,BAO_0000218,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,A,,U,0,Autocuration,CHEMBL625265,,
9059,Oryctolagus cuniculus,1,,14294,BAO_0000251,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Microsomes,A,,U,0,Autocuration,CHEMBL625266,,
9060,Oryctolagus cuniculus,1,,14294,BAO_0000251,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Microsomes,A,,U,0,Autocuration,CHEMBL876796,,
9061,Oryctolagus cuniculus,1,,429,BAO_0000218,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,A,,U,0,Autocuration,CHEMBL625267,,
9062,Oryctolagus cuniculus,1,1969.0,5124,BAO_0000218,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,A,,U,0,Autocuration,CHEMBL625268,,
9063,Oryctolagus cuniculus,1,1969.0,5124,BAO_0000218,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,A,,U,0,Autocuration,CHEMBL625269,,
9064,Oryctolagus cuniculus,1,1969.0,5124,BAO_0000218,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,A,,U,0,Autocuration,CHEMBL624689,,
9065,Oryctolagus cuniculus,1,,429,BAO_0000218,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,A,,U,0,Autocuration,CHEMBL624690,,
9066,Oryctolagus cuniculus,1,1088.0,429,BAO_0000218,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,A,,U,0,Autocuration,CHEMBL624691,,
9067,Oryctolagus cuniculus,1,1088.0,429,BAO_0000218,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,A,,U,0,Autocuration,CHEMBL624692,,
9068,Oryctolagus cuniculus,1,,4059,BAO_0000218,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,A,,U,0,Autocuration,CHEMBL624693,,
9069,Oryctolagus cuniculus,1,,4137,BAO_0000218,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,A,,U,0,Autocuration,CHEMBL624694,,
9070,Oryctolagus cuniculus,1,,11672,BAO_0000221,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,A,,U,0,Autocuration,CHEMBL877596,,
9071,Oryctolagus cuniculus,1,,12886,BAO_0000019,,Time within which only 10% of the drug was degraded,,A,,U,0,Autocuration,CHEMBL624695,,
9072,Oryctolagus cuniculus,1,2107.0,3853,BAO_0000221,,Half life period in rabbit liver homogenate,,A,,U,0,Autocuration,CHEMBL624696,,
9073,Oryctolagus cuniculus,1,,3615,BAO_0000019,,Half life value in rabbits,,A,,U,0,Autocuration,CHEMBL624697,,
9074,Oryctolagus cuniculus,1,178.0,6253,BAO_0000218,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,A,,U,0,Autocuration,CHEMBL624698,,
9075,Oryctolagus cuniculus,1,178.0,6253,BAO_0000218,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,A,,U,0,Autocuration,CHEMBL624699,,
9076,Oryctolagus cuniculus,1,,6077,BAO_0000218,,Half-life period in rabbits following intravenous administration at 2 mg/kg,,A,,U,0,Autocuration,CHEMBL624700,,
9077,Rattus norvegicus,1,1969.0,17617,BAO_0000218,,AUC 0-8 hr value in rats at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL622903,,
9078,Rattus norvegicus,1,1969.0,17594,BAO_0000218,,AUC after administration at 2000 mg/kg/day in rats,,A,,N,1,Intermediate,CHEMBL622904,,
9079,Rattus norvegicus,1,1969.0,6149,BAO_0000218,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,A,,N,1,Intermediate,CHEMBL622905,,
9080,Rattus norvegicus,1,1969.0,17260,BAO_0000218,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,A,,N,1,Intermediate,CHEMBL622906,,
9081,Rattus norvegicus,1,1969.0,17260,BAO_0000218,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,A,,N,1,Intermediate,CHEMBL622907,,
9082,Rattus norvegicus,1,1969.0,6644,BAO_0000218,,AUC in rat after oral administration at 10.5 mg/kg dose,,A,,N,1,Intermediate,CHEMBL622908,,
9083,Rattus norvegicus,1,1969.0,6644,BAO_0000218,,AUC in rat after oral administration at 11.2 mg/kg dose,,A,,N,1,Intermediate,CHEMBL622909,,
9084,Rattus norvegicus,1,1969.0,6644,BAO_0000218,,AUC in rat after oral administration at 9.7 mg/kg dose,,A,,N,1,Intermediate,CHEMBL622910,,
9085,Rattus norvegicus,1,955.0,6495,BAO_0000218,,AUC in rat brain after oral administration at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL622911,,
9086,Rattus norvegicus,1,1969.0,6504,BAO_0000218,,AUC in rat p.o.,,A,,N,1,Intermediate,CHEMBL622912,,
9087,Rattus norvegicus,1,1969.0,17686,BAO_0000218,,AUC in rat p.o. at 20 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL622913,,
9088,Rattus norvegicus,1,1969.0,6495,BAO_0000218,,AUC in rat plasma after oral administration at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL622914,,
9089,Rattus norvegicus,1,1969.0,216,BAO_0000218,,AUC in rats,,A,,N,1,Intermediate,CHEMBL622915,,
9090,Rattus norvegicus,1,1969.0,1908,BAO_0000218,,AUC value after IV dose at a dose of 5 mg/kg in rats.,,A,,N,1,Intermediate,CHEMBL622916,,
9091,Rattus norvegicus,1,1969.0,1908,BAO_0000218,,AUC value after oral dose at a dose of 10 mg/kg in rats.,,A,,N,1,Intermediate,CHEMBL622917,,
9092,Rattus norvegicus,1,1969.0,6685,BAO_0000218,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,A,,N,1,Intermediate,CHEMBL622918,,
9093,Rattus norvegicus,1,1969.0,216,BAO_0000218,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,A,,N,1,Intermediate,CHEMBL622919,,
9094,Rattus norvegicus,1,1969.0,6049,BAO_0000218,,Maximum plasma concentration was evaluated in rat,,A,,N,1,Intermediate,CHEMBL622920,,
9095,Rattus norvegicus,1,1969.0,2463,BAO_0000218,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,A,,N,1,Intermediate,CHEMBL622921,,
9096,Rattus norvegicus,1,1969.0,6679,BAO_0000218,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,A,,N,1,Intermediate,CHEMBL622922,,
9097,Rattus norvegicus,1,1969.0,6681,BAO_0000218,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,A,,N,1,Intermediate,CHEMBL622923,,
9098,Rattus norvegicus,1,1969.0,4890,BAO_0000218,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL877604,,
9099,Rattus norvegicus,1,1969.0,6410,BAO_0000218,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,A,,N,1,Intermediate,CHEMBL622924,,
9100,Rattus norvegicus,1,1969.0,6410,BAO_0000218,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,A,,N,1,Intermediate,CHEMBL622925,,
9101,Rattus norvegicus,1,1969.0,16366,BAO_0000218,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,A,,N,1,Intermediate,CHEMBL622926,,
9102,Rattus norvegicus,1,1969.0,6227,BAO_0000218,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL623625,,
9103,Rattus norvegicus,1,1969.0,3598,BAO_0000218,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,A,,N,1,Expert,CHEMBL623626,,
9104,Rattus norvegicus,1,1969.0,1465,BAO_0000218,,Maximum plasma drug concentration was determined,,A,,N,1,Intermediate,CHEMBL623627,,
9105,Rattus norvegicus,1,,4368,BAO_0000218,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL623628,,
9106,Rattus norvegicus,1,1969.0,15662,BAO_0000218,,Mean peak plasma concentration was observed after intravenous administration in rat,,A,,N,1,Intermediate,CHEMBL623629,,
9107,Rattus norvegicus,1,1969.0,15662,BAO_0000218,,Mean peak plasma concentration was observed after oral administration in rat,,A,,N,1,Intermediate,CHEMBL623630,,
9108,Rattus norvegicus,1,,5355,BAO_0000218,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL623804,,
9109,Rattus norvegicus,1,,5355,BAO_0000218,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL623805,,
9110,Rattus norvegicus,1,1969.0,1567,BAO_0000218,,Peak oral plasma concentration was determined in rats by oral administration,,A,,N,1,Intermediate,CHEMBL623806,,
9111,Rattus norvegicus,1,1969.0,4026,BAO_0000218,,Peak plasma concentration (Cmax) was determined,,A,,N,1,Intermediate,CHEMBL623807,,
9112,Rattus norvegicus,1,1969.0,6193,BAO_0000218,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL623808,,
9113,Rattus norvegicus,1,1969.0,4026,BAO_0000218,,Peak plasma concentration (Cmax) in rats,,A,,N,1,Intermediate,CHEMBL623809,,
9114,Rattus norvegicus,1,1969.0,6485,BAO_0000218,,Peak plasma concentration at 1 mg/kg peroral administration,,A,,N,1,Intermediate,CHEMBL623810,,
9115,Rattus norvegicus,1,1969.0,17655,BAO_0000218,,Peak plasma concentration in rat,,A,,N,1,Intermediate,CHEMBL623811,,
9116,Rattus norvegicus,1,1969.0,14941,BAO_0000218,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,A,,N,1,Intermediate,CHEMBL623812,,
9117,Rattus norvegicus,1,,5394,BAO_0000218,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL877605,,
9118,Rattus norvegicus,1,,4408,BAO_0000218,,Pharmacokinetic property (Cmax) in rat,,A,,N,1,Intermediate,CHEMBL623813,,
9119,Rattus norvegicus,1,,5983,BAO_0000218,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,A,,N,1,Intermediate,CHEMBL623814,,
9120,Rattus norvegicus,1,,4878,BAO_0000218,,Cmax in rat after 3mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL623815,,
9121,Rattus norvegicus,1,,5862,BAO_0000218,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,A,Sprague-Dawley,N,1,Intermediate,CHEMBL623816,,
9122,Rattus norvegicus,1,,4517,BAO_0000218,,Cmax in rats after 20 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL623145,,
9123,Rattus norvegicus,1,1969.0,5932,BAO_0000218,,Cmax in rat plasma after 30mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL623146,,
9124,Rattus norvegicus,1,1969.0,5436,BAO_0000218,,Plasma concentration after oral administration of 100 mg/kg to rats,,A,,N,1,Intermediate,CHEMBL623147,,
9125,Rattus norvegicus,1,955.0,4910,BAO_0000218,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,A,,N,1,Intermediate,CHEMBL623042,,
9126,Rattus norvegicus,1,,4950,BAO_0000218,,Tested for the Cmax in rat at 10 mg/kg per orally,,A,,N,1,Intermediate,CHEMBL623043,,
9127,Rattus norvegicus,1,,15078,BAO_0000218,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL623044,,
9128,Rattus norvegicus,1,,15078,BAO_0000218,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL623045,,
9129,Rattus norvegicus,1,,3360,BAO_0000218,,Bioavailability as oral Cmax in rats at 30 mins,,A,,N,1,Intermediate,CHEMBL623046,,
9130,Rattus norvegicus,1,,3360,BAO_0000218,,Bioavailability as oral Cmax in rats at 6hr,,A,,N,1,Intermediate,CHEMBL623226,,
9131,Rattus norvegicus,1,,15022,BAO_0000218,,The maximum concentration of compound was measured at the dose of 100 umol/kg,,A,,N,1,Intermediate,CHEMBL623227,,
9132,Rattus norvegicus,1,,15022,BAO_0000218,,The maximum concentration of compound was measured at the dose of 300 umol/kg,,A,,N,1,Intermediate,CHEMBL623228,,
9133,Rattus norvegicus,1,,15022,BAO_0000218,,The maximum concentration of compound was measured at the dose of 30 umol/kg,,A,,N,1,Intermediate,CHEMBL623229,,
9134,Rattus norvegicus,1,1969.0,5160,BAO_0000218,,The maximum plasma levels for the compounds were determined by LC-MS.,,A,,N,1,Intermediate,CHEMBL623230,,
9135,Rattus norvegicus,1,1969.0,15662,BAO_0000218,,mean peak plasma concentration was observed after intravenous administration in rat,,A,,N,1,Intermediate,CHEMBL623231,,
9136,Rattus norvegicus,1,1969.0,15662,BAO_0000218,,mean peak plasma concentration was observed after oral administration in rat,,A,,N,1,Intermediate,CHEMBL623232,,
9137,Rattus norvegicus,1,,4709,BAO_0000218,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL623233,,
9138,Rattus norvegicus,1,,3535,BAO_0000218,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,A,,N,1,Intermediate,CHEMBL623234,,
9139,Rattus norvegicus,1,,3535,BAO_0000218,,Concentration in plasma (portal) following oral dose in rats at 1 hr,,A,,N,1,Intermediate,CHEMBL623235,,
9140,Rattus norvegicus,1,,3535,BAO_0000218,,Concentration in plasma (portal) following oral dose in rats at 2 hr,,A,,N,1,Intermediate,CHEMBL623236,,
9141,Rattus norvegicus,1,,3535,BAO_0000218,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,A,,N,1,Intermediate,CHEMBL623237,,
9142,Rattus norvegicus,1,,3535,BAO_0000218,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,A,,N,1,Intermediate,CHEMBL623238,,
9143,Rattus norvegicus,1,,3535,BAO_0000218,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,A,,N,1,Intermediate,CHEMBL623239,,
9144,Rattus norvegicus,1,1969.0,5005,BAO_0000218,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,A,,U,0,Intermediate,CHEMBL623240,,
9145,Rattus norvegicus,1,1898.0,6326,BAO_0000218,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,A,,N,1,Intermediate,CHEMBL623241,,
9146,Rattus norvegicus,1,1898.0,6326,BAO_0000218,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,A,,N,1,Intermediate,CHEMBL623242,,
9147,Rattus norvegicus,1,,6326,BAO_0000218,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,A,,N,1,Intermediate,CHEMBL874394,,
9148,Rattus norvegicus,1,,6326,BAO_0000218,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,A,,N,1,Intermediate,CHEMBL623243,,
9149,Rattus norvegicus,1,,17411,BAO_0000218,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL623244,,
9150,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL623245,,
9151,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL623246,,
9152,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL623247,,
9153,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL623248,,
9154,Rattus norvegicus,1,2113.0,16435,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL623249,,
9155,Rattus norvegicus,1,2107.0,16434,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL625072,,
9156,Rattus norvegicus,1,2107.0,16434,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL625073,,
9157,Rattus norvegicus,1,2107.0,16434,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL625074,,
9158,Rattus norvegicus,1,2107.0,16434,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL625075,,
9159,Rattus norvegicus,1,2107.0,16434,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL625076,,
9160,Rattus norvegicus,1,2107.0,16434,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL625077,,
9161,Rattus norvegicus,1,2107.0,16434,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL625078,,
9162,Rattus norvegicus,1,2107.0,16434,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL874395,,
9163,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL625079,,
9164,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL625080,,
9165,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL625081,,
9166,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL625082,,
9167,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL625083,,
9168,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL625084,,
9169,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL625085,,
9170,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL625086,,
9171,Rattus norvegicus,1,2107.0,16434,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,,N,1,Intermediate,CHEMBL625087,,
9172,Rattus norvegicus,1,2107.0,16434,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,A,,N,1,Intermediate,CHEMBL625088,,
9173,Rattus norvegicus,1,2107.0,16434,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,,N,1,Intermediate,CHEMBL622205,,
9174,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL622206,,
9175,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL622207,,
9176,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL622366,,
9177,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL622367,,
9178,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL875331,,
9179,Rattus norvegicus,1,2107.0,16435,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL622368,,
9180,Rattus norvegicus,1,2048.0,16434,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL622369,,
9181,Rattus norvegicus,1,2048.0,16434,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL622370,,
9182,Rattus norvegicus,1,2048.0,16434,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL622371,,
9183,Rattus norvegicus,1,2048.0,16434,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL622372,,
9184,Rattus norvegicus,1,2048.0,16434,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL622373,,
9185,Rattus norvegicus,1,2048.0,16434,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL622374,,
9186,Rattus norvegicus,1,2048.0,16434,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL622375,,
9187,Rattus norvegicus,1,2048.0,16434,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL622376,,
9188,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL622377,,
9189,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL622378,,
9190,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL622379,,
9191,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL622380,,
9192,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL622381,,
9193,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL622382,,
9194,Rattus norvegicus,1,2048.0,16434,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,A,,N,1,Intermediate,CHEMBL622383,,
9195,Rattus norvegicus,1,945.0,6175,BAO_0000218,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,A,,N,1,Intermediate,CHEMBL875332,,
9196,Rattus norvegicus,1,945.0,6175,BAO_0000218,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,A,,N,1,Intermediate,CHEMBL622384,,
9197,Rattus norvegicus,1,945.0,6175,BAO_0000218,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,A,,N,1,Intermediate,CHEMBL622385,,
9198,Rattus norvegicus,1,945.0,6175,BAO_0000218,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,A,,N,1,Intermediate,CHEMBL622386,,
9199,Rattus norvegicus,1,,10839,BAO_0000218,,The compound was tested for the plasma binding in rat,,A,,N,1,Intermediate,CHEMBL622387,,
9200,Rattus norvegicus,1,,16459,BAO_0000218,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,A,,N,1,Intermediate,CHEMBL622388,,
9201,Rattus norvegicus,1,,16459,BAO_0000218,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,A,,N,1,Intermediate,CHEMBL622389,,
9202,Rattus norvegicus,1,,16459,BAO_0000218,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,A,,N,1,Intermediate,CHEMBL622390,,
9203,Rattus norvegicus,1,,16459,BAO_0000218,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,A,,N,1,Intermediate,CHEMBL622391,,
9204,Rattus norvegicus,1,,16459,BAO_0000218,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,A,,N,1,Intermediate,CHEMBL622392,,
9205,Rattus norvegicus,1,,16459,BAO_0000218,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,A,,N,1,Intermediate,CHEMBL622393,,
9206,Rattus norvegicus,1,,3278,BAO_0000218,,Plasma level at 2 hr after administration of the compound,,A,,N,1,Intermediate,CHEMBL622394,,
9207,Rattus norvegicus,1,,3278,BAO_0000218,,plasma level at 2 hr after administration of the compound,,A,,N,1,Intermediate,CHEMBL622395,,
9208,Rattus norvegicus,1,1977.0,4684,BAO_0000218,,Stability in rat serum measured as % recovery at 1 min,,A,,N,1,Intermediate,CHEMBL622396,,
9209,Rattus norvegicus,1,1977.0,4684,BAO_0000218,,Stability in rat serum measured as % recovery at 10 min,,A,,N,1,Intermediate,CHEMBL624894,,
9210,Rattus norvegicus,1,1977.0,4684,BAO_0000218,,Stability in rat serum measured as % recovery at 10 mins,,A,,N,1,Intermediate,CHEMBL624895,,
9211,Rattus norvegicus,1,1977.0,4684,BAO_0000218,,Stability in rat serum measured as % recovery at 2 hr,,A,,N,1,Intermediate,CHEMBL624058,,
9212,Rattus norvegicus,1,1977.0,4684,BAO_0000218,,Stability in rat serum measured as % recovery at 3 min,,A,,N,1,Intermediate,CHEMBL624059,,
9213,Rattus norvegicus,1,1977.0,4684,BAO_0000218,,Stability in rat serum measured as % recovery at 3 mins,,A,,N,1,Intermediate,CHEMBL624060,,
9214,Rattus norvegicus,1,1977.0,4684,BAO_0000218,,Stability in rat serum measured as % recovery at 5 min,,A,,N,1,Intermediate,CHEMBL624061,,
9215,Rattus norvegicus,1,1977.0,4684,BAO_0000218,,Stability in rat serum measured as % recovery at 5 mins,,A,,N,1,Intermediate,CHEMBL624062,,
9216,Rattus norvegicus,1,,16456,BAO_0000218,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL624063,,
9217,Rattus norvegicus,1,,16456,BAO_0000218,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL624064,,
9218,Rattus norvegicus,1,1969.0,723,BAO_0000218,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,A,,N,1,Intermediate,CHEMBL624065,,
9219,Rattus norvegicus,1,1969.0,723,BAO_0000218,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,A,,N,1,Intermediate,CHEMBL624066,,
9220,Rattus norvegicus,1,,5160,BAO_0000218,,Half life tested in mature male rat at a dose of 30 mg/kg,,A,,N,1,Intermediate,CHEMBL877490,,
9221,Rattus norvegicus,1,,4709,BAO_0000218,,Half life after intravenous administration of 1 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL874442,,
9222,Rattus norvegicus,1,,5633,BAO_0000218,,Half life period after administration (30 mg/kg) in rat,,A,,N,1,Intermediate,CHEMBL626890,,
9223,Rattus norvegicus,1,,5302,BAO_0000218,,Half life period in rat after 5 mg/Kg dose,,A,,N,1,Intermediate,CHEMBL626891,,
9224,Rattus norvegicus,1,,5302,BAO_0000218,,Half life period in rat after 5 mg/kg dose,,A,,N,1,Intermediate,CHEMBL626892,,
9225,Rattus norvegicus,1,,17791,BAO_0000218,,Half life period was determined,,A,,N,1,Intermediate,CHEMBL626893,,
9226,Rattus norvegicus,1,,17791,BAO_0000218,,Half life period was evaluated in rat,,A,,N,1,Intermediate,CHEMBL626894,,
9227,Rattus norvegicus,1,,17791,BAO_0000218,,Half life period was evaluated in rat; 0.5-1.0,,A,,N,1,Intermediate,CHEMBL626895,,
9228,Rattus norvegicus,1,,17791,BAO_0000218,,Half life period was evaluated in rat; 5.9-7.5,,A,,N,1,Intermediate,CHEMBL626896,,
9229,Rattus norvegicus,1,1969.0,14512,BAO_0000218,,Half-life in rat plasma,,A,,N,1,Intermediate,CHEMBL626897,,
9230,Rattus norvegicus,1,,6230,BAO_0000218,,Half-life time in rat was determined,,A,,N,1,Intermediate,CHEMBL626898,,
9231,Rattus norvegicus,1,,3364,BAO_0000218,,Terminal half-life after iv administration to rats,,A,,N,1,Intermediate,CHEMBL626899,,
9232,Rattus norvegicus,1,,6874,BAO_0000218,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,A,,N,1,Intermediate,CHEMBL626900,,
9233,Rattus norvegicus,1,,857,BAO_0000218,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,A,,N,1,Intermediate,CHEMBL626901,,
9234,Rattus norvegicus,1,,858,BAO_0000218,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,A,,N,1,Intermediate,CHEMBL626902,,
9235,Rattus norvegicus,1,,858,BAO_0000218,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,A,,N,1,Intermediate,CHEMBL626903,,
9236,Rattus norvegicus,1,,5355,BAO_0000218,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL874443,,
9237,Rattus norvegicus,1,,5355,BAO_0000218,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL626904,,
9238,Rattus norvegicus,1,,6305,BAO_0000218,,Half life in rats,,A,,N,1,Intermediate,CHEMBL626905,,
9239,Rattus norvegicus,1,1969.0,13501,BAO_0000218,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,A,,N,1,Intermediate,CHEMBL873830,,
9240,Rattus norvegicus,1,,17594,BAO_0000218,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL626906,,
9241,Rattus norvegicus,1,1969.0,4186,BAO_0000218,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,A,,N,1,Intermediate,CHEMBL631076,,
9242,Rattus norvegicus,1,1969.0,2932,BAO_0000218,,Biological half-life was measured in plasma of rats,,A,,N,1,Intermediate,CHEMBL631077,,
9243,Rattus norvegicus,1,,17065,BAO_0000218,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,A,,N,1,Intermediate,CHEMBL631078,,
9244,Rattus norvegicus,1,,15765,BAO_0000218,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,A,,N,1,Intermediate,CHEMBL631079,,
9245,Rattus norvegicus,1,,2713,BAO_0000218,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,A,,N,1,Intermediate,CHEMBL631080,,
9246,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,A,,N,1,Intermediate,CHEMBL631081,,
9247,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,A,,N,1,Intermediate,CHEMBL631239,,
9248,Rattus norvegicus,1,1969.0,740,BAO_0000218,,Compound was evaluated for plasma half life in rat,,A,,N,1,Intermediate,CHEMBL631240,,
9249,Rattus norvegicus,1,1969.0,6597,BAO_0000218,,AUC value at a dose of 5 mg/kg (p.o.) in rats,,A,,N,1,Intermediate,CHEMBL631241,,
9250,Rattus norvegicus,1,1969.0,2959,BAO_0000218,,AUC value after administration of 20 mg/Kg oral dose in rat,,A,,N,1,Intermediate,CHEMBL631242,,
9251,Rattus norvegicus,1,1969.0,17594,BAO_0000218,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL631243,,
9252,Rattus norvegicus,1,1969.0,17596,BAO_0000218,,AUC0-96 after administration at 50 mg/kg,,A,,N,1,Intermediate,CHEMBL874444,,
9253,Rattus norvegicus,1,1969.0,17594,BAO_0000218,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL631244,,
9254,Rattus norvegicus,1,,3293,BAO_0000218,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,A,,N,1,Intermediate,CHEMBL631245,,
9255,Rattus norvegicus,1,,6757,BAO_0000218,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,A,,N,1,Intermediate,CHEMBL627162,,
9256,Rattus norvegicus,1,,6757,BAO_0000218,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,A,,N,1,Intermediate,CHEMBL627163,,
9257,Rattus norvegicus,1,,6757,BAO_0000218,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,A,,N,1,Intermediate,CHEMBL627164,,
9258,Rattus norvegicus,1,2113.0,5979,BAO_0000218,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,A,,N,1,Intermediate,CHEMBL627165,,
9259,Rattus norvegicus,1,,5979,BAO_0000218,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,A,,N,1,Intermediate,CHEMBL627166,,
9260,Rattus norvegicus,1,,5979,BAO_0000218,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,A,,N,1,Intermediate,CHEMBL627167,,
9261,Rattus norvegicus,1,,4026,BAO_0000218,,Area under curve (AUC) at a dose of 30 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL627822,,
9262,Rattus norvegicus,1,,5355,BAO_0000218,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL627823,,
9263,Rattus norvegicus,1,,5355,BAO_0000218,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL627824,,
9264,Rattus norvegicus,1,,5355,BAO_0000218,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL627825,,
9265,Rattus norvegicus,1,,5633,BAO_0000218,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,A,,N,1,Intermediate,CHEMBL627826,,
9266,Rattus norvegicus,1,,1716,BAO_0000218,,Area under curve (Pharmacokinetic property) was determined,,A,,N,1,Intermediate,CHEMBL627827,,
9267,Rattus norvegicus,1,,1716,BAO_0000218,,Area under curve (Pharmacokinetic property) of the compound; Not determined,,A,,N,1,Intermediate,CHEMBL627828,,
9268,Rattus norvegicus,1,,4689,BAO_0000218,,Area under curve after intravenous administration (1 mg/kg) in rat,,A,,N,1,Intermediate,CHEMBL627829,,
9269,Rattus norvegicus,1,,4527,BAO_0000218,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,A,,N,1,Intermediate,CHEMBL627830,,
9270,Rattus norvegicus,1,,4527,BAO_0000218,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,A,,N,1,Intermediate,CHEMBL627831,,
9271,Rattus norvegicus,1,,15662,BAO_0000218,,Area under curve in male SD rats was observed after oral administration in rat,,A,,N,1,Intermediate,CHEMBL627832,,
9272,Rattus norvegicus,1,,4413,BAO_0000218,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,A,,N,1,Intermediate,CHEMBL627833,,
9273,Rattus norvegicus,1,,3598,BAO_0000218,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,A,,N,1,Expert,CHEMBL627834,,
9274,Rattus norvegicus,1,,3598,BAO_0000218,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,A,,N,1,Expert,CHEMBL628004,,
9275,Rattus norvegicus,1,,5964,BAO_0000218,,Area under curve at 5 mg/kg po was determined in rat,,A,,N,1,Intermediate,CHEMBL628005,,
9276,Rattus norvegicus,1,,4689,BAO_0000218,,Area under curve in Rat at a oral dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL628006,,
9277,Rattus norvegicus,1,,4186,BAO_0000218,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,A,,N,1,Intermediate,CHEMBL628007,,
9278,Rattus norvegicus,1,,5510,BAO_0000218,,Area under curve was determined,,A,,N,1,Intermediate,CHEMBL625676,,
9279,Rattus norvegicus,1,,17858,BAO_0000218,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,A,,N,1,Intermediate,CHEMBL631309,,
9280,Rattus norvegicus,1,,17804,BAO_0000218,,Area under curve after intravenous administration at 3 mg/kg,,A,,N,1,Intermediate,CHEMBL631310,,
9281,Rattus norvegicus,1,,6106,BAO_0000218,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,A,,N,1,Intermediate,CHEMBL631311,,
9282,Rattus norvegicus,1,,5964,BAO_0000218,,Area under curve at 4 hr in rat,,A,,N,1,Intermediate,CHEMBL631312,,
9283,Rattus norvegicus,1,,4026,BAO_0000218,,Area under curve at a dose of 30 mg/kg,,A,,N,1,Intermediate,CHEMBL631313,,
9284,Rattus norvegicus,1,,4756,BAO_0000218,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,A,,N,1,Intermediate,CHEMBL631314,,
9285,Rattus norvegicus,1,,4756,BAO_0000218,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,A,,N,1,Intermediate,CHEMBL631315,,
9286,Rattus norvegicus,1,,5862,BAO_0000218,,Area under curve for a 2-mpk po dose in SD rats,,A,,N,1,Intermediate,CHEMBL631316,,
9287,Rattus norvegicus,1,,5862,BAO_0000218,,Area under curve in SD rats,,A,,N,1,Intermediate,CHEMBL631317,,
9288,Rattus norvegicus,1,,6644,BAO_0000218,,Area under curve in rat after oral administration at 13 mg/kg dose,,A,,N,1,Intermediate,CHEMBL874471,,
9289,Rattus norvegicus,1,,5871,BAO_0000218,,Area under curve in rat by po administration at 0-24 hr,,A,,N,1,Intermediate,CHEMBL631318,,
9290,Rattus norvegicus,1,1969.0,5919,BAO_0000218,,Area under curve in rat plasma,,A,,N,1,Intermediate,CHEMBL631319,,
9291,Rattus norvegicus,1,,5939,BAO_0000218,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL631320,,
9292,Rattus norvegicus,1,,5939,BAO_0000218,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,A,,N,1,Intermediate,CHEMBL631321,,
9293,Rattus norvegicus,1,,10,BAO_0000218,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,A,,N,1,Intermediate,CHEMBL631322,,
9294,Rattus norvegicus,1,,11149,BAO_0000218,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,A,,N,1,Intermediate,CHEMBL631323,,
9295,Rattus norvegicus,1,,5302,BAO_0000218,,Area under curve value in rat at a dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL631324,,
9296,Rattus norvegicus,1,,17796,BAO_0000218,,Area under curve was determined after oral administration in rats,,A,,N,1,Intermediate,CHEMBL631325,,
9297,Rattus norvegicus,1,,4890,BAO_0000218,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL631326,,
9298,Rattus norvegicus,1,,6011,BAO_0000218,,Area under curve was determined after peroral administration in rat,,A,,N,1,Intermediate,CHEMBL631327,,
9299,Rattus norvegicus,1,,5375,BAO_0000218,,Area under curve was determined at a dose 30 mpk administered orally.,,A,,N,1,Intermediate,CHEMBL631328,,
9300,Rattus norvegicus,1,,17764,BAO_0000218,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,A,,N,1,Intermediate,CHEMBL631329,,
9301,Rattus norvegicus,1,,4368,BAO_0000218,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627217,,
9302,Rattus norvegicus,1,,5610,BAO_0000218,,Area under curve was determined in male rat,,A,,N,1,Intermediate,CHEMBL626352,,
9303,Rattus norvegicus,1,,5833,BAO_0000218,,Area under curve was determined in rat after PO administration,,A,,N,1,Intermediate,CHEMBL626353,,
9304,Rattus norvegicus,1,,4257,BAO_0000218,,Area under curve was determined in rat after a 3 mg/kg of oral dose,,A,,N,1,Intermediate,CHEMBL626354,,
9305,Rattus norvegicus,1,,5937,BAO_0000218,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,A,,N,1,Intermediate,CHEMBL626355,,
9306,Rattus norvegicus,1,,5932,BAO_0000218,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,A,,N,1,Intermediate,CHEMBL626356,,
9307,Rattus norvegicus,1,,5932,BAO_0000218,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,A,,N,1,Intermediate,CHEMBL626357,,
9308,Rattus norvegicus,1,,17411,BAO_0000218,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL626358,,
9309,Rattus norvegicus,1,,17411,BAO_0000218,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL626359,,
9310,Rattus norvegicus,1,1969.0,17771,BAO_0000218,,Peak plasma concentration in rat at a dose of 3 mg/kg,,A,,N,1,Intermediate,CHEMBL626360,,
9311,Rattus norvegicus,1,,1628,BAO_0000218,,Plasma concentration at 2 hr in rats was evaluated.,,A,,N,1,Intermediate,CHEMBL626361,,
9312,Rattus norvegicus,1,,1628,BAO_0000218,,Plasma concentration at 2 hr in rats was evaluated; Not available,,A,,N,1,Intermediate,CHEMBL626362,,
9313,Rattus norvegicus,1,,17411,BAO_0000218,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL626363,,
9314,Rattus norvegicus,1,,4910,BAO_0000218,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,A,,N,1,Intermediate,CHEMBL626970,,
9315,Rattus norvegicus,1,,4910,BAO_0000218,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,A,,N,1,Intermediate,CHEMBL626971,,
9316,Rattus norvegicus,1,1969.0,4910,BAO_0000218,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,A,,N,1,Intermediate,CHEMBL626972,,
9317,Rattus norvegicus,1,1969.0,4910,BAO_0000218,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,A,,N,1,Intermediate,CHEMBL626973,,
9318,Rattus norvegicus,1,1969.0,4910,BAO_0000218,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,A,,N,1,Intermediate,CHEMBL626974,,
9319,Rattus norvegicus,1,1969.0,4910,BAO_0000218,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,A,,N,1,Intermediate,CHEMBL874592,,
9320,Rattus norvegicus,1,,5510,BAO_0000218,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,A,,N,1,Intermediate,CHEMBL626975,,
9321,Rattus norvegicus,1,,5510,BAO_0000218,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,A,,N,1,Intermediate,CHEMBL626976,,
9322,Rattus norvegicus,1,,5510,BAO_0000218,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,A,,N,1,Intermediate,CHEMBL626977,,
9323,Rattus norvegicus,1,,5510,BAO_0000218,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,A,,N,1,Intermediate,CHEMBL626978,,
9324,Rattus norvegicus,1,,16427,BAO_0000218,,PK study was carried to determine the relative absorption ranking in rat.,,A,,N,1,Intermediate,CHEMBL626979,,
9325,Rattus norvegicus,1,1969.0,4689,BAO_0000218,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL626980,,
9326,Rattus norvegicus,1,178.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,A,,N,1,Intermediate,CHEMBL626981,,
9327,Rattus norvegicus,1,178.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,A,,N,1,Intermediate,CHEMBL626982,,
9328,Rattus norvegicus,1,178.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,A,,N,1,Intermediate,CHEMBL626983,,
9329,Rattus norvegicus,1,178.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,A,,N,1,Intermediate,CHEMBL622522,,
9330,Rattus norvegicus,1,178.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,A,,N,1,Intermediate,CHEMBL622523,,
9331,Rattus norvegicus,1,178.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,A,,N,1,Intermediate,CHEMBL622524,,
9332,Rattus norvegicus,1,955.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,A,,N,1,Intermediate,CHEMBL622525,,
9333,Rattus norvegicus,1,955.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,A,,N,1,Intermediate,CHEMBL622526,,
9334,Rattus norvegicus,1,955.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,A,,N,1,Intermediate,CHEMBL619849,,
9335,Rattus norvegicus,1,955.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,A,,N,1,Intermediate,CHEMBL619850,,
9336,Rattus norvegicus,1,955.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,A,,N,1,Intermediate,CHEMBL623864,,
9337,Rattus norvegicus,1,955.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,A,,N,1,Intermediate,CHEMBL623865,,
9338,Rattus norvegicus,1,948.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,A,,N,1,Intermediate,CHEMBL623866,,
9339,Rattus norvegicus,1,948.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,A,,N,1,Intermediate,CHEMBL623867,,
9340,Rattus norvegicus,1,948.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,A,,N,1,Intermediate,CHEMBL877615,,
9341,Rattus norvegicus,1,948.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,A,,N,1,Intermediate,CHEMBL623868,,
9342,Rattus norvegicus,1,948.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,A,,N,1,Intermediate,CHEMBL623869,,
9343,Rattus norvegicus,1,948.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,A,,N,1,Intermediate,CHEMBL623870,,
9344,Rattus norvegicus,1,2048.0,16434,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,A,,N,1,Intermediate,CHEMBL623871,,
9345,Rattus norvegicus,1,2048.0,16434,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,,N,1,Intermediate,CHEMBL623872,,
9346,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL622129,,
9347,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL622130,,
9348,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL622131,,
9349,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL622132,,
9350,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL622133,,
9351,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL622134,,
9352,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL622135,,
9353,Rattus norvegicus,1,2048.0,16435,BAO_0000218,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL622136,,
9354,Rattus norvegicus,1,2385.0,16434,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL622137,,
9355,Rattus norvegicus,1,2385.0,16434,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL622138,,
9356,Rattus norvegicus,1,2385.0,16434,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL623017,,
9357,Rattus norvegicus,1,2385.0,16434,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL623018,,
9358,Rattus norvegicus,1,2385.0,16434,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL623019,,
9359,Rattus norvegicus,1,2385.0,16434,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL623020,,
9360,Rattus norvegicus,1,2385.0,16434,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL623021,,
9361,Rattus norvegicus,1,2385.0,16434,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL623022,,
9362,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL623023,,
9363,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL623024,,
9364,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL623025,,
9365,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL620545,,
9366,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL620546,,
9367,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL620547,,
9368,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL620548,,
9369,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL620549,,
9370,Rattus norvegicus,1,2385.0,16434,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,,N,1,Intermediate,CHEMBL620550,,
9371,Rattus norvegicus,1,2385.0,16434,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,A,,N,1,Intermediate,CHEMBL620551,,
9372,Rattus norvegicus,1,2385.0,16434,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,,N,1,Intermediate,CHEMBL620552,,
9373,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL620553,,
9374,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL620554,,
9375,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL875845,,
9376,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL620555,,
9377,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL620556,,
9378,Rattus norvegicus,1,2385.0,16435,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL620557,,
9379,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL620558,,
9380,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL620559,,
9381,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL622939,,
9382,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL622940,,
9383,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL622941,,
9384,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL622942,,
9385,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL622943,,
9386,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL622944,,
9387,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL622945,,
9388,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL622946,,
9389,Rattus norvegicus,1,,3341,BAO_0000218,,Compound was evaluated for terminal half life in rat,,A,,N,1,Intermediate,CHEMBL622947,,
9390,Rattus norvegicus,1,1969.0,3634,BAO_0000218,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,A,,N,1,Intermediate,CHEMBL622948,,
9391,Rattus norvegicus,1,1969.0,3634,BAO_0000218,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,A,,N,1,Intermediate,CHEMBL622949,,
9392,Rattus norvegicus,1,,4839,BAO_0000218,,Compound was tested for its half life in rat,,A,,N,1,Intermediate,CHEMBL622950,,
9393,Macaca mulatta,1,1969.0,5005,BAO_0000218,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,A,,U,0,Intermediate,CHEMBL622951,,
9394,Rattus norvegicus,1,1969.0,5005,BAO_0000366,,Compound was tested for its plasma half life in Sprague Dawley rats,,A,,U,0,Intermediate,CHEMBL622952,,
9395,Rattus norvegicus,1,1969.0,5005,BAO_0000366,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,A,,U,0,Intermediate,CHEMBL622953,,
9396,Rattus norvegicus,1,1969.0,1094,BAO_0000218,,Compound was tested for plasma half-life period in rat,,A,,N,1,Intermediate,CHEMBL873818,,
9397,Rattus norvegicus,1,,5031,BAO_0000218,,Elimination half life after i.v. administration of compound in rats,,A,,N,1,Intermediate,CHEMBL622954,,
9398,Rattus norvegicus,1,,6518,BAO_0000218,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL622955,,
9399,Rattus norvegicus,1,,6518,BAO_0000218,,Elimination half-life after IV dosing at 1 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL875229,,
9400,Rattus norvegicus,1,,6518,BAO_0000218,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL622956,,
9401,Rattus norvegicus,1,,6518,BAO_0000218,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL622957,,
9402,Rattus norvegicus,1,955.0,5408,BAO_0000218,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,A,,N,1,Intermediate,CHEMBL622958,,
9403,Rattus norvegicus,1,1969.0,5408,BAO_0000218,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,A,,N,1,Intermediate,CHEMBL622959,,
9404,Rattus norvegicus,1,955.0,5408,BAO_0000218,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,A,,N,1,Intermediate,CHEMBL622960,,
9405,Rattus norvegicus,1,1969.0,5408,BAO_0000218,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,A,,N,1,Intermediate,CHEMBL622961,,
9406,Rattus norvegicus,1,,4687,BAO_0000218,,Evaluated for the half life in rat (in vivo),,A,,N,1,Intermediate,CHEMBL622962,,
9407,Rattus norvegicus,1,,6640,BAO_0000218,,Hafl life in rat,,A,,N,1,Intermediate,CHEMBL622963,,
9408,Rattus norvegicus,1,,6640,BAO_0000218,,Hafl life rat,,A,,N,1,Intermediate,CHEMBL622964,,
9409,Rattus norvegicus,1,,6641,BAO_0000218,,Hafl life rat,,A,,N,1,Intermediate,CHEMBL622965,,
9410,Rattus norvegicus,1,,6640,BAO_0000218,,Hafl life rat; Not determined,,A,,N,1,Intermediate,CHEMBL622966,,
9411,Rattus norvegicus,1,,6641,BAO_0000218,,Hafl life rat; Not determined,,A,,N,1,Intermediate,CHEMBL622967,,
9412,Rattus norvegicus,1,2113.0,17411,BAO_0000218,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL622968,,
9413,Rattus norvegicus,1,2107.0,17411,BAO_0000218,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL622969,,
9414,Rattus norvegicus,1,2048.0,17411,BAO_0000218,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL875327,,
9415,Rattus norvegicus,1,,6570,BAO_0000218,,Half life in rat after 1 mg/kg i.v. administration,,A,,N,1,Intermediate,CHEMBL628638,,
9416,Rattus norvegicus,1,,6570,BAO_0000218,,Half life in rat after 2 mg/kg peroral administration,,A,,N,1,Intermediate,CHEMBL628639,,
9417,Rattus norvegicus,1,,17411,BAO_0000218,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL625840,,
9418,Rattus norvegicus,1,,4722,BAO_0000218,,Half life of 10 mg/kg oral dose determined in rats,,A,,N,1,Intermediate,CHEMBL625841,,
9419,Rattus norvegicus,1,,5978,BAO_0000218,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL625842,,
9420,Rattus norvegicus,1,,5978,BAO_0000218,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL625843,,
9421,Rattus norvegicus,1,,5978,BAO_0000218,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL625844,,
9422,Rattus norvegicus,1,,5978,BAO_0000218,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL873822,,
9423,Rattus norvegicus,1,,5978,BAO_0000218,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL625845,,
9424,Rattus norvegicus,1,,5978,BAO_0000218,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL627059,,
9425,Rattus norvegicus,1,,5978,BAO_0000218,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL627060,,
9426,Rattus norvegicus,1,,5978,BAO_0000218,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL627061,,
9427,Rattus norvegicus,1,,4762,BAO_0000218,,Half life of compound at 5 mg/kg after po administration was determined in rat,,A,,N,1,Intermediate,CHEMBL627709,,
9428,Rattus norvegicus,1,,5327,BAO_0000218,,Half life of compound determined after intravenous administration to rat,,A,,N,1,Intermediate,CHEMBL627710,,
9429,Rattus norvegicus,1,,4847,BAO_0000218,,Half life of compound was determined in rat,,A,,N,1,Intermediate,CHEMBL627711,,
9430,Rattus norvegicus,1,1969.0,17720,BAO_0000218,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,A,,N,1,Intermediate,CHEMBL627712,,
9431,Rattus norvegicus,1,,4723,BAO_0000218,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,A,,N,1,Intermediate,CHEMBL627713,,
9432,Rattus norvegicus,1,,4723,BAO_0000218,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,A,,N,1,Intermediate,CHEMBL627714,,
9433,Macaca fascicularis,1,,4256,BAO_0000218,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,A,,U,0,Intermediate,CHEMBL627889,,
9434,Rattus norvegicus,1,,4256,BAO_0000218,,Half life determined in rat by intravenous administration,,A,,U,0,Intermediate,CHEMBL627890,,
9435,Rattus norvegicus,1,,4722,BAO_0000218,,Half life determined in rats after iv administration,,A,,N,1,Intermediate,CHEMBL627891,,
9436,Rattus norvegicus,1,1969.0,6535,BAO_0000218,,Half life in rat plasma after administration of 2 mg/kg iv,,A,,N,1,Intermediate,CHEMBL627892,,
9437,Rattus norvegicus,1,1969.0,6535,BAO_0000218,,Half life in rat plasma after administration of 2 mg/kg iv,,A,,N,1,Intermediate,CHEMBL627893,,
9438,Rattus norvegicus,1,1969.0,1435,BAO_0000218,,Half life in rat plasma was determined,,A,,N,1,Intermediate,CHEMBL627894,,
9439,Rattus norvegicus,1,1969.0,1435,BAO_0000218,,Half life in rat plasma was determined; NA means not applicable,,A,,N,1,Intermediate,CHEMBL627895,,
9440,Rattus norvegicus,1,,5206,BAO_0000218,,Half life in rat was tested,,A,,N,1,Intermediate,CHEMBL627896,,
9441,Rattus norvegicus,1,1969.0,6080,BAO_0000218,,Half life measured in rat plasma,,A,,N,1,Intermediate,CHEMBL627897,,
9442,Rattus norvegicus,1,,4449,BAO_0000218,,Half life recorded in rats,,A,,N,1,Intermediate,CHEMBL627898,,
9443,Rattus norvegicus,1,,6057,BAO_0000218,,Half life was calculated,,A,,N,1,Intermediate,CHEMBL627899,,
9444,Rattus norvegicus,1,,6057,BAO_0000218,,Half life was calculated in rat,,A,,N,1,Intermediate,CHEMBL873823,,
9445,Rattus norvegicus,1,,3747,BAO_0000218,,Half life was determined,,A,,N,1,Intermediate,CHEMBL627900,,
9446,Rattus norvegicus,1,,17858,BAO_0000218,,Half life after 10 mg/kg oral administration in rat,,A,,N,1,Intermediate,CHEMBL627901,,
9447,Rattus norvegicus,1,,16365,BAO_0000218,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,A,,N,1,Intermediate,CHEMBL627902,,
9448,Rattus norvegicus,1,,16365,BAO_0000218,,Half life after administering orally a dose of 30 mg/kg,,A,,N,1,Intermediate,CHEMBL627903,,
9449,Rattus norvegicus,1,,5031,BAO_0000218,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,A,,N,1,Intermediate,CHEMBL627904,,
9450,Rattus norvegicus,1,,4722,BAO_0000218,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,A,,N,1,Intermediate,CHEMBL627905,,
9451,Rattus norvegicus,1,,6078,BAO_0000218,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627906,,
9452,Rattus norvegicus,1,,6078,BAO_0000218,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627907,,
9453,Rattus norvegicus,1,,6078,BAO_0000218,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL876783,,
9454,Rattus norvegicus,1,,6078,BAO_0000218,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,A,,N,1,Intermediate,CHEMBL627908,,
9455,Rattus norvegicus,1,,17065,BAO_0000218,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,A,,N,1,Intermediate,CHEMBL627909,,
9456,Rattus norvegicus,1,,1353,BAO_0000218,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,A,,N,1,Intermediate,CHEMBL627910,,
9457,Rattus norvegicus,1,,1353,BAO_0000218,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,A,,N,1,Intermediate,CHEMBL627911,,
9458,Rattus norvegicus,1,,1353,BAO_0000218,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,A,,N,1,Intermediate,CHEMBL627912,,
9459,Rattus norvegicus,1,,1353,BAO_0000218,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,A,,N,1,Intermediate,CHEMBL627913,,
9460,Rattus norvegicus,1,,1353,BAO_0000218,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,A,,N,1,Intermediate,CHEMBL627914,,
9461,Rattus norvegicus,1,,16423,BAO_0000218,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,A,,N,1,Intermediate,CHEMBL627915,,
9462,Rattus norvegicus,1,,16423,BAO_0000218,,Area under the curve was evaluated after 20 uM/kg of peroral administration,,A,,N,1,Intermediate,CHEMBL627916,,
9463,Rattus norvegicus,1,,6062,BAO_0000218,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL627917,,
9464,Rattus norvegicus,1,,6056,BAO_0000218,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627918,,
9465,Rattus norvegicus,1,,5182,BAO_0000218,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,A,,N,1,Intermediate,CHEMBL627919,,
9466,Rattus norvegicus,1,,6410,BAO_0000218,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,A,,N,1,Intermediate,CHEMBL627920,,
9467,Rattus norvegicus,1,,6410,BAO_0000218,,Area under the curve was evaluated at an oral dose of 30 mg/kg,,A,,N,1,Intermediate,CHEMBL627921,,
9468,Rattus norvegicus,1,,4723,BAO_0000218,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,A,,N,1,Intermediate,CHEMBL627922,,
9469,Rattus norvegicus,1,,4723,BAO_0000218,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,A,,N,1,Intermediate,CHEMBL876784,,
9470,Rattus norvegicus,1,,4723,BAO_0000218,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,A,,N,1,Intermediate,CHEMBL627923,,
9471,Rattus norvegicus,1,,4723,BAO_0000218,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,A,,N,1,Intermediate,CHEMBL626208,,
9472,Rattus norvegicus,1,,4723,BAO_0000218,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,A,,N,1,Intermediate,CHEMBL626209,,
9473,Rattus norvegicus,1,,4723,BAO_0000218,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,A,,N,1,Intermediate,CHEMBL626210,,
9474,Rattus norvegicus,1,1969.0,2463,BAO_0000218,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,A,,N,1,Intermediate,CHEMBL627994,,
9475,Rattus norvegicus,1,,4709,BAO_0000218,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627995,,
9476,Rattus norvegicus,1,,4075,BAO_0000218,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,A,,N,1,Intermediate,CHEMBL627996,,
9477,Rattus norvegicus,1,,5394,BAO_0000218,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,A,,N,1,Intermediate,CHEMBL627997,,
9478,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,A,,N,1,Intermediate,CHEMBL627998,,
9479,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,A,,N,1,Intermediate,CHEMBL628640,,
9480,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,A,,N,1,Intermediate,CHEMBL628641,,
9481,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,A,,N,1,Intermediate,CHEMBL628642,,
9482,Rattus norvegicus,1,,17791,BAO_0000218,,Compound was evaluated for area under the curve expressed as (h*ug/ml),,A,,N,1,Intermediate,CHEMBL628643,,
9483,Rattus norvegicus,1,,2591,BAO_0000218,,Compound was tested for area under curve in rat,,A,,N,1,Intermediate,CHEMBL628644,,
9484,Rattus norvegicus,1,,6567,BAO_0000218,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,A,,N,1,Intermediate,CHEMBL628645,,
9485,Rattus norvegicus,1,,6211,BAO_0000218,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL628646,,
9486,Rattus norvegicus,1,,5529,BAO_0000218,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,A,,N,1,Intermediate,CHEMBL628647,,
9487,Rattus norvegicus,1,,5408,BAO_0000218,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,A,,N,1,Intermediate,CHEMBL628648,,
9488,Rattus norvegicus,1,,5408,BAO_0000218,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,A,,N,1,Intermediate,CHEMBL625358,,
9489,Rattus norvegicus,1,,5408,BAO_0000218,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,A,,N,1,Intermediate,CHEMBL625359,,
9490,Rattus norvegicus,1,,5408,BAO_0000218,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,A,,N,1,Intermediate,CHEMBL625360,,
9491,Rattus norvegicus,1,,429,BAO_0000218,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,A,,N,1,Intermediate,CHEMBL625361,,
9492,Rattus norvegicus,1,,429,BAO_0000218,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,A,,N,1,Intermediate,CHEMBL625362,,
9493,Rattus norvegicus,1,,429,BAO_0000218,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,A,,N,1,Intermediate,CHEMBL625363,,
9494,Rattus norvegicus,1,,4796,BAO_0000218,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,A,,N,1,Intermediate,CHEMBL625364,,
9495,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL625365,,
9496,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL625366,,
9497,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL625367,,
9498,Rattus norvegicus,1,2113.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,A,,N,1,Intermediate,CHEMBL625368,,
9499,Rattus norvegicus,1,2113.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,A,,N,1,Intermediate,CHEMBL625369,,
9500,Rattus norvegicus,1,2113.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,A,,N,1,Intermediate,CHEMBL625370,,
9501,Rattus norvegicus,1,2113.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,A,,N,1,Intermediate,CHEMBL625371,,
9502,Rattus norvegicus,1,2113.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,A,,N,1,Intermediate,CHEMBL625372,,
9503,Rattus norvegicus,1,2113.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,A,,N,1,Intermediate,CHEMBL625373,,
9504,Rattus norvegicus,1,2107.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,A,,N,1,Intermediate,CHEMBL625374,,
9505,Rattus norvegicus,1,2107.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,A,,N,1,Intermediate,CHEMBL877593,,
9506,Rattus norvegicus,1,2107.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,A,,N,1,Intermediate,CHEMBL625375,,
9507,Rattus norvegicus,1,2107.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,A,,N,1,Intermediate,CHEMBL625376,,
9508,Rattus norvegicus,1,2107.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,A,,N,1,Intermediate,CHEMBL621973,,
9509,Rattus norvegicus,1,2107.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,A,,N,1,Intermediate,CHEMBL621974,,
9510,Rattus norvegicus,1,2048.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,A,,N,1,Intermediate,CHEMBL621975,,
9511,Rattus norvegicus,1,2048.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,A,,N,1,Intermediate,CHEMBL622166,,
9512,Rattus norvegicus,1,2048.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,A,,N,1,Intermediate,CHEMBL622167,,
9513,Rattus norvegicus,1,2048.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,A,,N,1,Intermediate,CHEMBL622168,,
9514,Rattus norvegicus,1,2048.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,A,,N,1,Intermediate,CHEMBL622169,,
9515,Rattus norvegicus,1,2048.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,A,,N,1,Intermediate,CHEMBL622170,,
9516,Rattus norvegicus,1,2046.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,A,,N,1,Intermediate,CHEMBL622171,,
9517,Rattus norvegicus,1,2046.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,A,,N,1,Intermediate,CHEMBL622172,,
9518,Rattus norvegicus,1,2046.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,A,,N,1,Intermediate,CHEMBL622173,,
9519,Rattus norvegicus,1,2046.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,A,,N,1,Intermediate,CHEMBL622174,,
9520,Rattus norvegicus,1,2046.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,A,,N,1,Intermediate,CHEMBL622175,,
9521,Rattus norvegicus,1,2046.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,A,,N,1,Intermediate,CHEMBL622176,,
9522,Rattus norvegicus,1,2046.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,A,,N,1,Intermediate,CHEMBL622177,,
9523,Rattus norvegicus,1,2046.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,A,,N,1,Intermediate,CHEMBL622178,,
9524,Rattus norvegicus,1,2046.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,A,,N,1,Intermediate,CHEMBL622179,,
9525,Rattus norvegicus,1,2046.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,A,,N,1,Intermediate,CHEMBL622180,,
9526,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL622181,,
9527,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL622182,,
9528,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL622183,,
9529,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL622184,,
9530,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL622185,,
9531,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL622186,,
9532,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,,N,1,Intermediate,CHEMBL622187,,
9533,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,A,,N,1,Intermediate,CHEMBL625002,,
9534,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,A,,N,1,Intermediate,CHEMBL622090,,
9535,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL622091,,
9536,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL622092,,
9537,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL622093,,
9538,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL622094,,
9539,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL622095,,
9540,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL622264,,
9541,Rattus norvegicus,1,2106.0,16434,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL622265,,
9542,Rattus norvegicus,1,2106.0,16434,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL622266,,
9543,Rattus norvegicus,1,2106.0,16434,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL622267,,
9544,Rattus norvegicus,1,2106.0,16434,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL622268,,
9545,Rattus norvegicus,1,2106.0,16434,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL622269,,
9546,Rattus norvegicus,1,2106.0,16434,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL625071,,
9547,Rattus norvegicus,1,2106.0,16434,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL621621,,
9548,Rattus norvegicus,1,2106.0,16434,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL621622,,
9549,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL621623,,
9550,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL621624,,
9551,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL621625,,
9552,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL621626,,
9553,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL621627,,
9554,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL621628,,
9555,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL875328,,
9556,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL621629,,
9557,Rattus norvegicus,1,2106.0,16434,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,,N,1,Intermediate,CHEMBL621630,,
9558,Rattus norvegicus,1,2106.0,16434,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,A,,N,1,Intermediate,CHEMBL621631,,
9559,Rattus norvegicus,1,2106.0,16434,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,,N,1,Intermediate,CHEMBL621632,,
9560,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL621633,,
9561,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL621634,,
9562,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL621635,,
9563,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL621636,,
9564,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL621637,,
9565,Rattus norvegicus,1,2106.0,16435,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL621638,,
9566,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL618883,,
9567,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL618884,,
9568,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL628627,,
9569,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL628628,,
9570,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL628629,,
9571,Rattus norvegicus,1,,16365,BAO_0000218,,Half life after administering orally a dose of 3 mg/kg,,A,,N,1,Intermediate,CHEMBL628630,,
9572,Rattus norvegicus,1,,16365,BAO_0000218,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,A,,N,1,Intermediate,CHEMBL628631,,
9573,Rattus norvegicus,1,,16365,BAO_0000218,,Half life after administering intravenously a dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL628632,,
9574,Rattus norvegicus,1,,526,BAO_0000218,,Half life after oral dosing in rats,,A,,N,1,Intermediate,CHEMBL628633,,
9575,Rattus norvegicus,1,,16365,BAO_0000218,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,A,,N,1,Intermediate,CHEMBL628634,,
9576,Rattus norvegicus,1,,4368,BAO_0000218,,Half life by intravenous administration of 3.4 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627789,,
9577,Rattus norvegicus,1,,3371,BAO_0000218,,Half life in rat,,A,,N,1,Intermediate,CHEMBL627790,,
9578,Rattus norvegicus,1,,6448,BAO_0000218,,Half life in rat,,A,,N,1,Intermediate,CHEMBL627791,,
9579,Rattus norvegicus,1,,6453,BAO_0000218,,Half life in rat,,A,,N,1,Intermediate,CHEMBL627792,,
9580,Rattus norvegicus,1,,4353,BAO_0000218,,Half life in rat after intravenous administration of the compound,,A,,N,1,Intermediate,CHEMBL627793,,
9581,Rattus norvegicus,1,1969.0,4353,BAO_0000218,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,A,,N,1,Intermediate,CHEMBL627794,,
9582,Rattus norvegicus,1,,4353,BAO_0000218,,Half life in rat after po administration of the compound,,A,,N,1,Intermediate,CHEMBL627795,,
9583,Rattus norvegicus,1,,4353,BAO_0000218,,Half life in rat after po administration of the compound; ND means Not determined,,A,,N,1,Intermediate,CHEMBL627796,,
9584,Rattus norvegicus,1,1969.0,4353,BAO_0000218,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,A,,N,1,Intermediate,CHEMBL875335,,
9585,Rattus norvegicus,1,1969.0,4353,BAO_0000218,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,A,,N,1,Intermediate,CHEMBL627797,,
9586,Rattus norvegicus,1,,5789,BAO_0000218,,Half life in rat i.v.,,A,,N,1,Intermediate,CHEMBL627798,,
9587,Rattus norvegicus,1,,17686,BAO_0000218,,Half life in rat i.v. at 2 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL627799,,
9588,Rattus norvegicus,1,,6495,BAO_0000218,,Half life in rats,,A,,N,1,Intermediate,CHEMBL627800,,
9589,Rattus norvegicus,1,,484,BAO_0000218,,Half life in rats after intravenous administration,,A,,N,1,Intermediate,CHEMBL627801,,
9590,Rattus norvegicus,1,,6467,BAO_0000218,,Half life in rats at the dose of 1.0 mpk by i.v. administration,,A,,N,1,Intermediate,CHEMBL627802,,
9591,Rattus norvegicus,1,,6642,BAO_0000218,,Half life in rat,,A,,N,1,Expert,CHEMBL627803,,
9592,Rattus norvegicus,1,,16367,BAO_0000218,,Half life was evaluated after intravenous administration to rats,,A,,N,1,Intermediate,CHEMBL873820,,
9593,Rattus norvegicus,1,,1369,BAO_0000218,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,A,,N,1,Intermediate,CHEMBL627804,,
9594,Rattus norvegicus,1,,5472,BAO_0000218,,Half life was evaluated in rat,,A,,N,1,Intermediate,CHEMBL627805,,
9595,Rattus norvegicus,1,,6049,BAO_0000218,,Half life was evaluated in rat,,A,,N,1,Intermediate,CHEMBL627806,,
9596,Rattus norvegicus,1,,5472,BAO_0000218,,Half life was evaluated in rat; Not tested,,A,,N,1,Intermediate,CHEMBL627107,,
9597,Rattus norvegicus,1,,16366,BAO_0000218,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,A,,N,1,Intermediate,CHEMBL627108,,
9598,Rattus norvegicus,1,,11149,BAO_0000218,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,A,,N,1,Intermediate,CHEMBL627109,,
9599,Rattus norvegicus,1,178.0,11149,BAO_0000218,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,A,,N,1,Intermediate,CHEMBL627110,,
9600,Primates,1,,2891,BAO_0000218,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,A,,U,0,Intermediate,CHEMBL627111,,
9601,Primates,1,,2891,BAO_0000218,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,A,,U,0,Intermediate,CHEMBL627112,,
9602,Rattus norvegicus,1,,2891,BAO_0000218,,Half life was measured in rat at dose of 30 mg/kg by iv administration,,A,,U,0,Intermediate,CHEMBL627113,,
9603,Rattus norvegicus,1,,2891,BAO_0000218,,Half life was measured in rat at dose of 30 mg/kg by po administration,,A,,U,0,Intermediate,CHEMBL627114,,
9604,Rattus norvegicus,1,,4026,BAO_0000218,,Half life (t1/2) was determined,,A,,N,1,Intermediate,CHEMBL627115,,
9605,Rattus norvegicus,1,,4527,BAO_0000218,,Half life period at a dose of 10 uM/kg in rat was determined,,A,,N,1,Intermediate,CHEMBL627116,,
9606,Rattus norvegicus,1,,4527,BAO_0000218,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,A,,N,1,Intermediate,CHEMBL627117,,
9607,Rattus norvegicus,1,,5503,BAO_0000218,,Half life period was determined,,A,,N,1,Intermediate,CHEMBL627118,,
9608,Rattus norvegicus,1,,4426,BAO_0000218,,Half life period after intravenous administration at 20 mpk in rats,,A,,N,1,Intermediate,CHEMBL627119,,
9609,Rattus norvegicus,1,,4426,BAO_0000218,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,A,,N,1,Intermediate,CHEMBL627120,,
9610,Rattus norvegicus,1,,6109,BAO_0000218,,Half life period after intravenous administration in rat,,A,,N,1,Intermediate,CHEMBL626922,,
9611,Rattus norvegicus,1,,5654,BAO_0000218,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,A,,N,1,Intermediate,CHEMBL626923,,
9612,Rattus norvegicus,1,,5654,BAO_0000218,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,A,,N,1,Intermediate,CHEMBL626924,,
9613,Rattus norvegicus,1,1969.0,4755,BAO_0000218,,Half life period in 80% rat plasma at 37 degree Centigrade,,A,,N,1,Intermediate,CHEMBL626925,,
9614,Rattus norvegicus,1,,5862,BAO_0000218,,Half life period in SD rats,,A,,N,1,Intermediate,CHEMBL626926,,
9615,Rattus norvegicus,1,1969.0,1515,BAO_0000218,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,A,,N,1,Intermediate,CHEMBL626927,,
9616,Rattus norvegicus,1,1969.0,1515,BAO_0000218,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,A,,N,1,Intermediate,CHEMBL626928,,
9617,Rattus norvegicus,1,1969.0,1515,BAO_0000218,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,A,,N,1,Intermediate,CHEMBL626929,,
9618,Rattus norvegicus,1,1969.0,1515,BAO_0000218,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,A,,N,1,Intermediate,CHEMBL626930,,
9619,Rattus norvegicus,1,,5960,BAO_0000218,,Half life period in rat,,A,,N,1,Intermediate,CHEMBL626931,,
9620,Rattus norvegicus,1,,6103,BAO_0000218,,Half life period in rat,,A,,N,1,Intermediate,CHEMBL626932,,
9621,Rattus norvegicus,1,,6317,BAO_0000218,,Half life period in rat,,A,,N,1,Intermediate,CHEMBL626933,,
9622,Rattus norvegicus,1,,6644,BAO_0000218,,Half life period in rat after oral administration at 10.5 mg/kg dose,,A,,N,1,Intermediate,CHEMBL873826,,
9623,Rattus norvegicus,1,,6644,BAO_0000218,,Half life period in rat after oral administration at 11.2 mg/kg dose,,A,,N,1,Intermediate,CHEMBL626934,,
9624,Rattus norvegicus,1,,6644,BAO_0000218,,Half life period in rat after oral administration at 13 mg/kg dose,,A,,N,1,Intermediate,CHEMBL626935,,
9625,Rattus norvegicus,1,,6644,BAO_0000218,,Half life period in rat after oral administration at 9.7 mg/kg dose,,A,,N,1,Intermediate,CHEMBL626936,,
9626,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL626937,,
9627,Rattus norvegicus,1,,6295,BAO_0000218,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,A,,N,1,Intermediate,CHEMBL625906,,
9628,Rattus norvegicus,1,,6296,BAO_0000218,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,A,,N,1,Intermediate,CHEMBL625907,,
9629,Rattus norvegicus,1,,16427,BAO_0000218,,PK study was carried to determine AUC (area under curve) value in rat,,A,,N,1,Intermediate,CHEMBL625908,,
9630,Rattus norvegicus,1,,16367,BAO_0000218,,Pharmacokinetic parameter AUC after intravenous administration to rats,,A,,N,1,Intermediate,CHEMBL625909,,
9631,Rattus norvegicus,1,,16367,BAO_0000218,,Pharmacokinetic parameter AUC after oral administration to rats,,A,,N,1,Intermediate,CHEMBL625910,,
9632,Rattus norvegicus,1,,16365,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,A,,N,1,Intermediate,CHEMBL625911,,
9633,Rattus norvegicus,1,,16365,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,A,,N,1,Intermediate,CHEMBL625912,,
9634,Rattus norvegicus,1,,16365,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,A,,N,1,Intermediate,CHEMBL626538,,
9635,Rattus norvegicus,1,,16365,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,A,,N,1,Intermediate,CHEMBL876794,,
9636,Rattus norvegicus,1,,16365,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,A,,N,1,Intermediate,CHEMBL626539,,
9637,Rattus norvegicus,1,,16365,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,A,,N,1,Intermediate,CHEMBL626540,,
9638,Rattus norvegicus,1,,5394,BAO_0000218,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,A,,N,1,Intermediate,CHEMBL626541,,
9639,Rattus norvegicus,1,,5394,BAO_0000218,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL626542,,
9640,Rattus norvegicus,1,,2792,BAO_0000218,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,A,,N,1,Intermediate,CHEMBL626543,,
9641,Rattus norvegicus,1,,2792,BAO_0000218,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,A,,N,1,Intermediate,CHEMBL626544,,
9642,Rattus norvegicus,1,,2792,BAO_0000218,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,A,,N,1,Intermediate,CHEMBL626545,,
9643,Rattus norvegicus,1,,2792,BAO_0000218,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,A,,N,1,Intermediate,CHEMBL626546,,
9644,Rattus norvegicus,1,,5334,BAO_0000218,,Pharmacokinetic parameter area under curve was reported,,A,,N,1,Intermediate,CHEMBL626547,,
9645,Rattus norvegicus,1,,4408,BAO_0000218,,Pharmacokinetic property (AUC) in rat,,A,,N,1,Intermediate,CHEMBL626548,,
9646,Rattus norvegicus,1,,5983,BAO_0000218,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,A,,N,1,Intermediate,CHEMBL626549,,
9647,Rattus norvegicus,1,,4397,BAO_0000218,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,A,,N,1,Intermediate,CHEMBL626550,,
9648,Rattus norvegicus,1,,4397,BAO_0000218,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,A,,N,1,Intermediate,CHEMBL626551,,
9649,Rattus norvegicus,1,,5491,BAO_0000218,,Pharmacokinetic property was determined,,A,,N,1,Intermediate,CHEMBL623777,,
9650,Rattus norvegicus,1,,5491,BAO_0000218,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,A,,N,1,Intermediate,CHEMBL623778,,
9651,Rattus norvegicus,1,,5491,BAO_0000218,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,A,,N,1,Intermediate,CHEMBL623779,,
9652,Rattus norvegicus,1,1969.0,4199,BAO_0000218,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,A,,N,1,Intermediate,CHEMBL623780,,
9653,Rattus norvegicus,1,1969.0,4199,BAO_0000218,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,A,,N,1,Intermediate,CHEMBL622015,,
9654,Rattus norvegicus,1,1969.0,4199,BAO_0000218,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,A,,N,1,Intermediate,CHEMBL622016,,
9655,Rattus norvegicus,1,,5173,BAO_0000218,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,A,,N,1,Intermediate,CHEMBL622017,,
9656,Rattus norvegicus,1,,5173,BAO_0000218,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,A,,N,1,Intermediate,CHEMBL622018,,
9657,Rattus norvegicus,1,,5173,BAO_0000218,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,A,,N,1,Intermediate,CHEMBL622019,,
9658,Rattus norvegicus,1,,5173,BAO_0000218,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,A,,N,1,Intermediate,CHEMBL622020,,
9659,Rattus norvegicus,1,,16366,BAO_0000218,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,A,,N,1,Intermediate,CHEMBL622021,,
9660,Rattus norvegicus,1,,16366,BAO_0000218,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,A,,N,1,Intermediate,CHEMBL622022,,
9661,Rattus norvegicus,1,,5327,BAO_0000218,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,A,,N,1,Intermediate,CHEMBL622023,,
9662,Rattus norvegicus,1,,6681,BAO_0000218,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,A,,N,1,Intermediate,CHEMBL622024,,
9663,Rattus norvegicus,1,,12873,BAO_0000218,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,A,,N,1,Intermediate,CHEMBL622693,,
9664,Rattus norvegicus,1,,12873,BAO_0000218,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,A,,N,1,Intermediate,CHEMBL622694,,
9665,Rattus norvegicus,1,,6685,BAO_0000218,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL622695,,
9666,Rattus norvegicus,1,,6685,BAO_0000218,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,A,,N,1,Intermediate,CHEMBL622696,,
9667,Rattus norvegicus,1,,6685,BAO_0000218,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,A,,N,1,Intermediate,CHEMBL622697,,
9668,Rattus norvegicus,1,,6619,BAO_0000218,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,A,,N,1,Intermediate,CHEMBL622874,,
9669,Rattus norvegicus,1,,6619,BAO_0000218,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,A,,N,1,Intermediate,CHEMBL622875,,
9670,Rattus norvegicus,1,,10363,BAO_0000218,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,A,,N,1,Intermediate,CHEMBL622876,,
9671,Rattus norvegicus,1,,4796,BAO_0000218,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,A,,N,1,Intermediate,CHEMBL622877,,
9672,Rattus norvegicus,1,,4910,BAO_0000218,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,A,,N,1,Intermediate,CHEMBL622878,,
9673,Rattus norvegicus,1,1969.0,4910,BAO_0000218,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,A,,N,1,Intermediate,CHEMBL622879,,
9674,Rattus norvegicus,1,,4839,BAO_0000218,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,A,,N,1,Intermediate,CHEMBL877602,,
9675,Rattus norvegicus,1,,15078,BAO_0000218,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL622880,,
9676,Rattus norvegicus,1,,15078,BAO_0000218,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL622881,,
9677,Rattus norvegicus,1,,15078,BAO_0000218,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL622882,,
9678,Rattus norvegicus,1,,15078,BAO_0000218,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL622883,,
9679,Rattus norvegicus,1,2046.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,A,,N,1,Intermediate,CHEMBL622884,,
9680,Rattus norvegicus,1,2046.0,11450,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,A,,N,1,Intermediate,CHEMBL622885,,
9681,Rattus norvegicus,1,,8151,BAO_0000218,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,A,,N,1,Intermediate,CHEMBL622886,,
9682,Rattus norvegicus,1,,8151,BAO_0000218,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,A,,N,1,Intermediate,CHEMBL622887,,
9683,Rattus norvegicus,1,1088.0,8151,BAO_0000218,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,A,,N,1,Intermediate,CHEMBL622888,,
9684,Rattus norvegicus,1,178.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622889,,
9685,Rattus norvegicus,1,178.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL622890,,
9686,Rattus norvegicus,1,178.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622891,,
9687,Rattus norvegicus,1,178.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL877603,,
9688,Rattus norvegicus,1,955.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622892,,
9689,Rattus norvegicus,1,955.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL622893,,
9690,Rattus norvegicus,1,955.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622894,,
9691,Rattus norvegicus,1,955.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL622895,,
9692,Rattus norvegicus,1,955.0,8677,BAO_0000218,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,A,,N,1,Intermediate,CHEMBL622896,,
9693,Rattus norvegicus,1,948.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622897,,
9694,Rattus norvegicus,1,948.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622898,,
9695,Rattus norvegicus,1,948.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL622899,,
9696,Rattus norvegicus,1,2113.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622900,,
9697,Rattus norvegicus,1,2113.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL624114,,
9698,Rattus norvegicus,1,2113.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL624115,,
9699,Rattus norvegicus,1,2113.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL624116,,
9700,Rattus norvegicus,1,2107.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL624117,,
9701,Rattus norvegicus,1,2107.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL624118,,
9702,Rattus norvegicus,1,2107.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL624119,,
9703,Rattus norvegicus,1,2107.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL624120,,
9704,Rattus norvegicus,1,2048.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL624121,,
9705,Rattus norvegicus,1,2048.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL624122,,
9706,Rattus norvegicus,1,2048.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL624123,,
9707,Rattus norvegicus,1,2048.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL624124,,
9708,Rattus norvegicus,1,2385.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL624125,,
9709,Rattus norvegicus,1,2385.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL624126,,
9710,Rattus norvegicus,1,2385.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL624127,,
9711,Rattus norvegicus,1,2385.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL624128,,
9712,Rattus norvegicus,1,14.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL624129,,
9713,Rattus norvegicus,1,14.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL624130,,
9714,Rattus norvegicus,1,14.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622340,,
9715,Rattus norvegicus,1,14.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL622341,,
9716,Rattus norvegicus,1,160.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622342,,
9717,Rattus norvegicus,1,160.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL622343,,
9718,Rattus norvegicus,1,160.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622344,,
9719,Rattus norvegicus,1,160.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL622345,,
9720,Rattus norvegicus,1,2106.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622346,,
9721,Rattus norvegicus,1,2106.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL622347,,
9722,Rattus norvegicus,1,2106.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622348,,
9723,Rattus norvegicus,1,2106.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL622349,,
9724,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,A,,N,1,Intermediate,CHEMBL622350,,
9725,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL622351,,
9726,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL622352,,
9727,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL622353,,
9728,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL622354,,
9729,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL622355,,
9730,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL622356,,
9731,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,,N,1,Intermediate,CHEMBL622357,,
9732,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,,N,1,Intermediate,CHEMBL622358,,
9733,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,,N,1,Intermediate,CHEMBL622359,,
9734,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,,N,1,Intermediate,CHEMBL874393,,
9735,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,,N,1,Intermediate,CHEMBL622872,,
9736,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,A,,N,1,Intermediate,CHEMBL622873,,
9737,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,,N,1,Intermediate,CHEMBL623047,,
9738,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL623048,,
9739,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL623049,,
9740,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL623050,,
9741,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,,N,1,Intermediate,CHEMBL623051,,
9742,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL623052,,
9743,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL626343,,
9744,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,,N,1,Intermediate,CHEMBL626344,,
9745,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,,N,1,Intermediate,CHEMBL626345,,
9746,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,,N,1,Intermediate,CHEMBL626346,,
9747,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,,N,1,Intermediate,CHEMBL626347,,
9748,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,A,,N,1,Intermediate,CHEMBL626348,,
9749,Rattus norvegicus,1,,16434,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,,N,1,Intermediate,CHEMBL626349,,
9750,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,F,,N,1,Intermediate,CHEMBL626350,,
9751,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL626351,,
9752,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL627650,,
9753,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,F,,N,1,Intermediate,CHEMBL627651,,
9754,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,,N,1,Intermediate,CHEMBL627652,,
9755,Rattus norvegicus,1,,16435,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,,N,1,Intermediate,CHEMBL627653,,
9756,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,A,,N,1,Intermediate,CHEMBL627654,,
9757,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,A,,N,1,Intermediate,CHEMBL627835,,
9758,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,A,,N,1,Intermediate,CHEMBL627836,,
9759,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,A,,N,1,Intermediate,CHEMBL627837,,
9760,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,A,,N,1,Intermediate,CHEMBL627838,,
9761,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,A,,N,1,Intermediate,CHEMBL875338,,
9762,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,A,,N,1,Intermediate,CHEMBL627839,,
9763,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,A,,N,1,Intermediate,CHEMBL627840,,
9764,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,A,,N,1,Intermediate,CHEMBL627841,,
9765,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,A,,N,1,Intermediate,CHEMBL627842,,
9766,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,A,,N,1,Intermediate,CHEMBL627843,,
9767,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,A,,N,1,Intermediate,CHEMBL627844,,
9768,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,A,,N,1,Intermediate,CHEMBL627845,,
9769,Rattus norvegicus,1,,5874,BAO_0000218,,Half life period in rat by iv administration at a dose of 3 mg/kg,,A,,N,1,Intermediate,CHEMBL627846,,
9770,Rattus norvegicus,1,1969.0,1515,BAO_0000218,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,A,,N,1,Intermediate,CHEMBL627847,,
9771,Rattus norvegicus,1,1969.0,1515,BAO_0000218,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,A,,N,1,Intermediate,CHEMBL873821,,
9772,Rattus norvegicus,1,1969.0,1515,BAO_0000218,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,A,,N,1,Intermediate,CHEMBL626079,,
9773,Rattus norvegicus,1,1969.0,1515,BAO_0000218,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,A,,N,1,Intermediate,CHEMBL626080,,
9774,Rattus norvegicus,1,1969.0,5491,BAO_0000218,,Half life period was evaluated in rat plasma,,A,,N,1,Intermediate,CHEMBL626081,,
9775,Rattus norvegicus,1,1969.0,5491,BAO_0000218,,Half life period was evaluated in rat plasma; Not tested,,A,,N,1,Intermediate,CHEMBL875344,,
9776,Rattus norvegicus,1,,1918,BAO_0000218,,Half life period was evaluated in rats,,A,,N,1,Intermediate,CHEMBL626082,,
9777,Rattus norvegicus,1,,1918,BAO_0000218,,"Half life period was evaluated in rats, iv",,A,,N,1,Intermediate,CHEMBL626250,,
9778,Rattus norvegicus,1,,6113,BAO_0000218,,Half life period after intravenous administration at 5 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL626251,,
9779,Rattus norvegicus,1,,5546,BAO_0000218,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,A,,N,1,Intermediate,CHEMBL626252,,
9780,Rattus norvegicus,1,,5553,BAO_0000218,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL626253,,
9781,Rattus norvegicus,1,1969.0,4188,BAO_0000218,,Half life stability of compound was evaluated in rat plasma,,A,,N,1,Intermediate,CHEMBL626254,,
9782,Rattus norvegicus,1,,6215,BAO_0000218,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,A,,N,1,Intermediate,CHEMBL626255,,
9783,Rattus norvegicus,1,,6141,BAO_0000218,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL626256,,
9784,Rattus norvegicus,1,,5182,BAO_0000218,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,A,,N,1,Intermediate,CHEMBL626257,,
9785,Rattus norvegicus,1,,5182,BAO_0000218,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,A,,N,1,Intermediate,CHEMBL626258,,
9786,Rattus norvegicus,1,,5710,BAO_0000218,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,A,,N,1,Intermediate,CHEMBL626259,,
9787,Rattus norvegicus,1,,5789,BAO_0000218,,Half in rat i.v.,,A,,N,1,Intermediate,CHEMBL626260,,
9788,Rattus norvegicus,1,,6011,BAO_0000218,,Half period in rat after intravenous administration,,A,,N,1,Intermediate,CHEMBL875345,,
9789,Rattus norvegicus,1,,17594,BAO_0000218,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL626261,,
9790,Rattus norvegicus,1,2107.0,12357,BAO_0000218,,Half-life measured in in vitro Cathepsin B assay in rat liver,,A,,N,1,Intermediate,CHEMBL626262,,
9791,Rattus norvegicus,1,,5210,BAO_0000218,,Half-life of compound was determined in rats,,A,,N,1,Intermediate,CHEMBL626263,,
9792,Rattus norvegicus,1,,17596,BAO_0000218,,Half-life at 10 mg/kg in rat upon intravenous administration,,A,,N,1,Intermediate,CHEMBL625270,,
9793,Rattus norvegicus,1,,6672,BAO_0000218,,Half-life determined in rat,,A,,N,1,Intermediate,CHEMBL625271,,
9794,Rattus norvegicus,1,,6673,BAO_0000218,,Half-life determined in rat,,A,,N,1,Intermediate,CHEMBL625272,,
9795,Rattus norvegicus,1,955.0,4910,BAO_0000218,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,A,,N,1,Intermediate,CHEMBL625273,,
9796,Rattus norvegicus,1,1969.0,3741,BAO_0000218,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,A,,N,1,Intermediate,CHEMBL625274,,
9797,Rattus norvegicus,1,,17671,BAO_0000218,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,A,,N,1,Intermediate,CHEMBL625275,,
9798,Rattus norvegicus,1,1969.0,4910,BAO_0000218,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,A,,N,1,Intermediate,CHEMBL625276,,
9799,Rattus norvegicus,1,1969.0,17537,BAO_0000218,,Half-life in rat plasma,,A,,N,1,Intermediate,CHEMBL625277,,
9800,Rattus norvegicus,1,1969.0,4965,BAO_0000218,,Half-life in rat plasma was determined,,A,,N,1,Intermediate,CHEMBL625278,,
9801,Rattus norvegicus,1,1969.0,17537,BAO_0000218,,Half-life in rat plasma; Not tested,,A,,N,1,Intermediate,CHEMBL625279,,
9802,Rattus norvegicus,1,1977.0,6124,BAO_0000218,,Half-life in rat serum,,A,,N,1,Intermediate,CHEMBL625280,,
9803,Rattus norvegicus,1,1977.0,6124,BAO_0000218,,Half-life in rat serum; na is not available,,A,,N,1,Intermediate,CHEMBL876797,,
9804,Rattus norvegicus,1,,6078,BAO_0000218,,Half-life was calculated in rat,,A,,N,1,Intermediate,CHEMBL625281,,
9805,Rattus norvegicus,1,1969.0,17668,BAO_0000218,,Half-life was calculated in rat plasma,,A,,N,1,Intermediate,CHEMBL873827,,
9806,Rattus norvegicus,1,,3185,BAO_0000218,,Half-life was determined,,A,,N,1,Intermediate,CHEMBL625282,,
9807,Rattus norvegicus,1,,4883,BAO_0000218,,Half-life was determined,,A,,N,1,Intermediate,CHEMBL625283,,
9808,Rattus norvegicus,1,,2959,BAO_0000218,,Half-life after administration of 20 mg/Kg oral dose in rat,,A,,N,1,Intermediate,CHEMBL625284,,
9809,Rattus norvegicus,1,,4029,BAO_0000218,,Half-life after administration of 3.2 mg/kg intravenously in male rat,,A,,N,1,Intermediate,CHEMBL625285,,
9810,Rattus norvegicus,1,,4029,BAO_0000218,,Half-life after intravenous administration in female rat,,A,,N,1,Intermediate,CHEMBL625286,,
9811,Rattus norvegicus,1,,4029,BAO_0000218,,Half-life after intravenous administration in male rat,,A,,N,1,Intermediate,CHEMBL625287,,
9812,Rattus norvegicus,1,,6180,BAO_0000218,,Half-life after intravenous dose in rat,,A,,N,1,Intermediate,CHEMBL625288,,
9813,Rattus norvegicus,1,2107.0,1557,BAO_0000218,,Half-life in a rat liver homogenate preparation,,A,,N,1,Intermediate,CHEMBL625289,,
9814,Rattus norvegicus,1,1969.0,12500,BAO_0000218,,Half-life in plasma of rat,,A,,N,1,Intermediate,CHEMBL625290,,
9815,Rattus norvegicus,1,1969.0,12500,BAO_0000218,,Half-life in plasma of rat at dose of 3-10 mgkg,,A,,N,1,Intermediate,CHEMBL876798,,
9816,Rattus norvegicus,1,,5064,BAO_0000218,,Half-life in rat,,A,,N,1,Intermediate,CHEMBL625291,,
9817,Rattus norvegicus,1,,5145,BAO_0000218,,Half-life in rat,,A,,N,1,Intermediate,CHEMBL625292,,
9818,Rattus norvegicus,1,,5147,BAO_0000218,,Half-life in rat,,A,,N,1,Intermediate,CHEMBL625293,,
9819,Rattus norvegicus,1,,5833,BAO_0000218,,Half-life in rat,,A,,N,1,Intermediate,CHEMBL622832,,
9820,Rattus norvegicus,1,,6596,BAO_0000218,,Half-life in rat,,A,,N,1,Intermediate,CHEMBL622833,,
9821,Rattus norvegicus,1,,17655,BAO_0000218,,Half-life in rat,,A,,N,1,Intermediate,CHEMBL622834,,
9822,Rattus norvegicus,1,,6495,BAO_0000218,,Half-life in rat after oral administration at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL622835,,
9823,Rattus norvegicus,1,,17538,BAO_0000218,,Half-life in rat after po administration at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL622836,,
9824,Rattus norvegicus,1,,17538,BAO_0000218,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,A,,N,1,Intermediate,CHEMBL622837,,
9825,Rattus norvegicus,1,,10,BAO_0000218,,Half-life in rat at 3 mg/kg dose administered intravenously,,A,,N,1,Intermediate,CHEMBL622838,,
9826,Rattus norvegicus,1,955.0,17669,BAO_0000218,,Half-life in rat brain homogenate,,A,,N,1,Intermediate,CHEMBL622839,,
9827,Rattus norvegicus,1,1969.0,17065,BAO_0000218,,Half-life in rat plasma,,A,,N,1,Intermediate,CHEMBL622840,,
9828,Rattus norvegicus,1,,4333,BAO_0000218,,Half-life in rats,,A,,N,1,Intermediate,CHEMBL622841,,
9829,Rattus norvegicus,1,,6827,BAO_0000218,,Half-life in Dawley rats,,A,,N,1,Intermediate,CHEMBL622842,,
9830,Rattus norvegicus,1,1969.0,889,BAO_0000218,,Half-life in vitro in rat plasma,,A,,N,1,Intermediate,CHEMBL622843,,
9831,Rattus norvegicus,1,1969.0,889,BAO_0000218,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,A,,N,1,Intermediate,CHEMBL622844,,
9832,Rattus norvegicus,1,,3747,BAO_0000218,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,A,,N,1,Intermediate,CHEMBL622845,,
9833,Rattus norvegicus,1,,15022,BAO_0000218,,The area under the curve of compound was measured at the dose of 100 umol/kg,,A,,N,1,Intermediate,CHEMBL622846,,
9834,Rattus norvegicus,1,,15022,BAO_0000218,,The area under the curve of compound was measured at the dose of 300 umol/kg,,A,,N,1,Intermediate,CHEMBL622847,,
9835,Rattus norvegicus,1,,15022,BAO_0000218,,The area under the curve of compound was measured at the dose of 30 umol/kg,,A,,N,1,Intermediate,CHEMBL622848,,
9836,Rattus norvegicus,1,,3360,BAO_0000218,,Bioavailability as oral AUC in rats,,A,,N,1,Intermediate,CHEMBL622849,,
9837,Rattus norvegicus,1,1969.0,5334,BAO_0000218,,The plasma concentration versus time curve (AUC) was determined,,A,,N,1,Intermediate,CHEMBL622850,,
9838,Rattus norvegicus,1,,17411,BAO_0000218,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL876807,,
9839,Rattus norvegicus,1,,17411,BAO_0000218,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL622851,,
9840,Rattus norvegicus,1,,17411,BAO_0000218,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL622852,,
9841,Rattus norvegicus,1,,6570,BAO_0000218,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,A,,N,1,Intermediate,CHEMBL622853,,
9842,Rattus norvegicus,1,,6570,BAO_0000218,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,A,,N,1,Intermediate,CHEMBL622854,,
9843,Rattus norvegicus,1,,17411,BAO_0000218,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL622855,,
9844,Rattus norvegicus,1,1969.0,14941,BAO_0000218,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,A,,N,1,Intermediate,CHEMBL622856,,
9845,Rattus norvegicus,1,1969.0,14941,BAO_0000218,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,A,,N,1,Intermediate,CHEMBL622857,,
9846,Rattus norvegicus,1,1969.0,17538,BAO_0000218,,AUC in rat after po administration at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL622858,,
9847,Rattus norvegicus,1,1969.0,17752,BAO_0000218,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,A,,N,1,Intermediate,CHEMBL622859,,
9848,Rattus norvegicus,1,,17509,BAO_0000218,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,A,,N,1,Intermediate,CHEMBL622860,,
9849,Rattus norvegicus,1,,17509,BAO_0000218,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,A,,N,1,Intermediate,CHEMBL622861,,
9850,Rattus norvegicus,1,,17509,BAO_0000218,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,A,,N,1,Intermediate,CHEMBL622862,,
9851,Rattus norvegicus,1,,17509,BAO_0000218,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,A,,N,1,Intermediate,CHEMBL622863,,
9852,Rattus norvegicus,1,,17509,BAO_0000218,,Area under curve value 6 hr after po administration in rat,,A,,N,1,Intermediate,CHEMBL623817,,
9853,Rattus norvegicus,1,,17717,BAO_0000218,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,A,,N,1,Intermediate,CHEMBL623818,,
9854,Rattus norvegicus,1,,17717,BAO_0000218,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,A,,N,1,Intermediate,CHEMBL623819,,
9855,Rattus norvegicus,1,,17717,BAO_0000218,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,A,,N,1,Intermediate,CHEMBL623820,,
9856,Rattus norvegicus,1,,17717,BAO_0000218,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,A,,N,1,Intermediate,CHEMBL623821,,
9857,Rattus norvegicus,1,1969.0,6642,BAO_0000218,,AUC normalized for dose (AUCN) in rat,,A,,N,1,Intermediate,CHEMBL623822,,
9858,Rattus norvegicus,1,,6640,BAO_0000218,,Area under curve in rat after p.o. administration,,A,,N,1,Intermediate,CHEMBL623823,,
9859,Rattus norvegicus,1,,6641,BAO_0000218,,Area under curve in rat after p.o. administration,,A,,N,1,Intermediate,CHEMBL623824,,
9860,Rattus norvegicus,1,,6641,BAO_0000218,,Area under curve in rat after p.o. administration; Not determined,,A,,N,1,Intermediate,CHEMBL623825,,
9861,Rattus norvegicus,1,,6641,BAO_0000218,,Area under curve in rat after peroral administration,,A,,N,1,Intermediate,CHEMBL622070,,
9862,Rattus norvegicus,1,,3603,BAO_0000218,,Area under curve (carotid artery) value of the compound,,A,,N,1,Intermediate,CHEMBL622071,,
9863,Rattus norvegicus,1,,3550,BAO_0000218,,Bioavailability expressed as the area under curve of rat carotid artery,,A,,N,1,Intermediate,CHEMBL622072,,
9864,Rattus norvegicus,1,,15662,BAO_0000218,,Area under curve in male SD rats was observed after intravenous administration in rat,,A,,N,1,Intermediate,CHEMBL622073,,
9865,Rattus norvegicus,1,,17720,BAO_0000218,,Area under curve of the compound was determined,,A,,N,1,Intermediate,CHEMBL622074,,
9866,Rattus norvegicus,1,,5407,BAO_0000218,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,A,,N,1,Intermediate,CHEMBL622075,,
9867,Rattus norvegicus,1,1969.0,17752,BAO_0000218,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,A,,N,1,Intermediate,CHEMBL622076,,
9868,Rattus norvegicus,1,1969.0,17752,BAO_0000218,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,A,,N,1,Intermediate,CHEMBL622077,,
9869,Rattus norvegicus,1,,3603,BAO_0000218,,Area under curve (portal vein) value of the compound,,A,,N,1,Intermediate,CHEMBL622078,,
9870,Rattus norvegicus,1,,3550,BAO_0000218,,Bioavailability expressed as the area under curve of rat portal vein,,A,,N,1,Intermediate,CHEMBL622079,,
9871,Rattus norvegicus,1,1969.0,17655,BAO_0000218,,Area Under plasma concentration time curve in rat upon peroral administration,,A,,N,1,Intermediate,CHEMBL622080,,
9872,Rattus norvegicus,1,,17582,BAO_0000218,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL877612,,
9873,Rattus norvegicus,1,,17582,BAO_0000218,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL622081,,
9874,Rattus norvegicus,1,,17791,BAO_0000218,,Compound was evaluated for oral bioavailability in rats,,A,,N,1,Intermediate,CHEMBL622082,,
9875,Rattus norvegicus,1,,17791,BAO_0000218,,Compound was evaluated for oral bioavailability in rats after iv administration,,A,,N,1,Intermediate,CHEMBL622083,,
9876,Rattus norvegicus,1,,17791,BAO_0000218,,Compound was evaluated for oral bioavailability in rats; 30-80,,A,,N,1,Intermediate,CHEMBL622084,,
9877,Rattus norvegicus,1,,17791,BAO_0000218,,Compound was evaluated for oral bioavailability in rats; 50-60,,A,,N,1,Intermediate,CHEMBL622085,,
9878,Rattus norvegicus,1,,17791,BAO_0000218,,Compound was evaluated for oral bioavailability in rats; no data,,A,,N,1,Intermediate,CHEMBL622086,,
9879,Rattus norvegicus,1,,17791,BAO_0000218,,Compound was evaluated for oral bioavailability in rats; peptide,,A,,N,1,Intermediate,CHEMBL622087,,
9880,Rattus norvegicus,1,178.0,7768,BAO_0000218,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,A,,N,1,Intermediate,CHEMBL622088,,
9881,Rattus norvegicus,1,178.0,7768,BAO_0000218,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,A,,N,1,Intermediate,CHEMBL622089,,
9882,Rattus norvegicus,1,178.0,7768,BAO_0000218,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,A,,N,1,Intermediate,CHEMBL623685,,
9883,Rattus norvegicus,1,178.0,7768,BAO_0000218,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,A,,N,1,Intermediate,CHEMBL623686,,
9884,Rattus norvegicus,1,945.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL623687,,
9885,Rattus norvegicus,1,945.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL623688,,
9886,Rattus norvegicus,1,945.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL623689,,
9887,Rattus norvegicus,1,945.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL622485,,
9888,Rattus norvegicus,1,2046.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622486,,
9889,Rattus norvegicus,1,2046.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL877613,,
9890,Rattus norvegicus,1,2046.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622487,,
9891,Rattus norvegicus,1,2046.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL622488,,
9892,Rattus norvegicus,1,948.0,8677,BAO_0000218,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,A,,N,1,Intermediate,CHEMBL622489,,
9893,Rattus norvegicus,1,1088.0,6899,BAO_0000218,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,A,,N,1,Intermediate,CHEMBL622490,,
9894,Rattus norvegicus,1,1088.0,6899,BAO_0000218,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,A,,N,1,Intermediate,CHEMBL622491,,
9895,Rattus norvegicus,1,2107.0,6899,BAO_0000218,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,A,,N,1,Intermediate,CHEMBL622492,,
9896,Rattus norvegicus,1,1088.0,6899,BAO_0000218,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,A,,N,1,Intermediate,CHEMBL622493,,
9897,Rattus norvegicus,1,1088.0,6899,BAO_0000218,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,A,,N,1,Intermediate,CHEMBL622494,,
9898,Rattus norvegicus,1,2385.0,8677,BAO_0000218,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,A,,N,1,Intermediate,CHEMBL622495,,
9899,Rattus norvegicus,1,,6899,BAO_0000218,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,A,,N,1,Intermediate,CHEMBL622496,,
9900,Rattus norvegicus,1,1088.0,6899,BAO_0000218,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,A,,N,1,Intermediate,CHEMBL622497,,
9901,Rattus norvegicus,1,,2189,BAO_0000218,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,A,,N,1,Intermediate,CHEMBL622498,,
9902,Rattus norvegicus,1,1088.0,2189,BAO_0000218,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,A,,N,1,Intermediate,CHEMBL624918,,
9903,Rattus norvegicus,1,1088.0,2189,BAO_0000218,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,A,,N,1,Intermediate,CHEMBL624919,,
9904,Rattus norvegicus,1,178.0,10839,BAO_0000218,,Biodistribution of compound in rat blood after 5 min of administration,,A,,N,1,Intermediate,CHEMBL624920,,
9905,Rattus norvegicus,1,178.0,10839,BAO_0000218,,Biodistribution of compound in rat blood after 5 min of administration.,,A,,N,1,Intermediate,CHEMBL624921,,
9906,Rattus norvegicus,1,955.0,10839,BAO_0000218,,Biodistribution of compound in rat brain after 5 min of administration,,A,,N,1,Intermediate,CHEMBL624922,,
9907,Rattus norvegicus,1,948.0,10839,BAO_0000218,,Biodistribution of compound in rat heart after 5 min of administration,,A,,N,1,Intermediate,CHEMBL624923,,
9908,Rattus norvegicus,1,948.0,10839,BAO_0000218,,Biodistribution of compound in rat heart after 5 min of administration.,,A,,N,1,Intermediate,CHEMBL624924,,
9909,Rattus norvegicus,1,2113.0,10839,BAO_0000218,,Biodistribution of compound in rat kidney after 5 min of administration,,A,,N,1,Intermediate,CHEMBL624925,,
9910,Rattus norvegicus,1,2113.0,10839,BAO_0000218,,Biodistribution of compound in rat kidney after 5 min of administration.,,A,,N,1,Intermediate,CHEMBL624926,,
9911,Rattus norvegicus,1,2107.0,10839,BAO_0000218,,Biodistribution of compound in rat liver after 5 min of administration,,A,,N,1,Intermediate,CHEMBL624927,,
9912,Rattus norvegicus,1,2107.0,10839,BAO_0000218,,Biodistribution of compound in rat liver after 5 min of administration.,,A,,N,1,Intermediate,CHEMBL874402,,
9913,Rattus norvegicus,1,2048.0,10839,BAO_0000218,,Biodistribution of compound in rat lung after 5 min of administration,,A,,N,1,Intermediate,CHEMBL624928,,
9914,Rattus norvegicus,1,2048.0,10839,BAO_0000218,,Biodistribution of compound in rat lung after 5 min of administration.,,A,,N,1,Intermediate,CHEMBL624929,,
9915,Rattus norvegicus,1,2385.0,10839,BAO_0000218,,Biodistribution of compound in rat muscle after 5 min of administration,,A,,N,1,Intermediate,CHEMBL624930,,
9916,Rattus norvegicus,1,2385.0,10839,BAO_0000218,,Biodistribution of compound in rat muscle after 5 min of administration.,,A,,N,1,Intermediate,CHEMBL624931,,
9917,Rattus norvegicus,1,948.0,4043,BAO_0000218,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,,N,1,Intermediate,CHEMBL624932,,
9918,Rattus norvegicus,1,948.0,4043,BAO_0000218,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,,N,1,Intermediate,CHEMBL624933,,
9919,Rattus norvegicus,1,2107.0,4043,BAO_0000218,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,,N,1,Intermediate,CHEMBL624934,,
9920,Rattus norvegicus,1,2107.0,4043,BAO_0000218,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,,N,1,Intermediate,CHEMBL624935,,
9921,Rattus norvegicus,1,,4043,BAO_0000218,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,,N,1,Intermediate,CHEMBL624936,,
9922,Rattus norvegicus,1,,4043,BAO_0000218,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,,N,1,Intermediate,CHEMBL624937,,
9923,Rattus norvegicus,1,2106.0,4043,BAO_0000218,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,,N,1,Intermediate,CHEMBL624938,,
9924,Rattus norvegicus,1,2106.0,4043,BAO_0000218,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,,N,1,Intermediate,CHEMBL624939,,
9925,Rattus norvegicus,1,,4043,BAO_0000218,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,,N,1,Intermediate,CHEMBL624940,,
9926,Rattus norvegicus,1,,4043,BAO_0000218,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,,N,1,Intermediate,CHEMBL874403,,
9927,Rattus norvegicus,1,,1446,BAO_0000218,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,A,,N,1,Intermediate,CHEMBL624941,,
9928,Rattus norvegicus,1,1088.0,9971,BAO_0000218,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,A,,N,1,Intermediate,CHEMBL624942,,
9929,Rattus norvegicus,1,1088.0,9971,BAO_0000218,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,A,,N,1,Intermediate,CHEMBL624943,,
9930,Rattus norvegicus,1,,5765,BAO_0000218,,% Bioavailability after 1 day of the drug administration in rats,,A,,N,1,Intermediate,CHEMBL624944,,
9931,Rattus norvegicus,1,,5765,BAO_0000218,,% Bioavailability after 4 day of the drug administration in rats,,A,,N,1,Intermediate,CHEMBL624945,,
9932,Rattus norvegicus,1,,4257,BAO_0000218,,Absolute bioavailability was evaluated in rat,,A,,N,1,Intermediate,CHEMBL624946,,
9933,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,A,,N,1,Intermediate,CHEMBL624947,,
9934,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,A,,N,1,Intermediate,CHEMBL624948,,
9935,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,A,,N,1,Intermediate,CHEMBL624949,,
9936,Rattus norvegicus,1,2113.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,A,,N,1,Intermediate,CHEMBL622025,,
9937,Rattus norvegicus,1,2113.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,A,,N,1,Intermediate,CHEMBL622026,,
9938,Rattus norvegicus,1,2113.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,A,,N,1,Intermediate,CHEMBL622027,,
9939,Rattus norvegicus,1,2113.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,A,,N,1,Intermediate,CHEMBL622028,,
9940,Rattus norvegicus,1,2107.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,A,,N,1,Intermediate,CHEMBL622029,,
9941,Rattus norvegicus,1,2107.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,A,,N,1,Intermediate,CHEMBL622208,,
9942,Rattus norvegicus,1,2107.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,A,,N,1,Intermediate,CHEMBL622209,,
9943,Rattus norvegicus,1,2107.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,A,,N,1,Intermediate,CHEMBL622210,,
9944,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,A,,N,1,Intermediate,CHEMBL622211,,
9945,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,A,,N,1,Intermediate,CHEMBL622212,,
9946,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,A,,N,1,Intermediate,CHEMBL622213,,
9947,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,A,,N,1,Intermediate,CHEMBL874404,,
9948,Rattus norvegicus,1,2385.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,A,,N,1,Intermediate,CHEMBL620452,,
9949,Rattus norvegicus,1,2385.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,A,,N,1,Intermediate,CHEMBL620453,,
9950,Rattus norvegicus,1,2385.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,A,,N,1,Intermediate,CHEMBL620454,,
9951,Rattus norvegicus,1,2385.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,A,,N,1,Intermediate,CHEMBL624067,,
9952,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,A,,N,1,Intermediate,CHEMBL624068,,
9953,Rattus norvegicus,1,992.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,A,,N,1,Intermediate,CHEMBL624069,,
9954,Rattus norvegicus,1,992.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,A,,N,1,Intermediate,CHEMBL624070,,
9955,Rattus norvegicus,1,992.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,A,,N,1,Intermediate,CHEMBL624071,,
9956,Rattus norvegicus,1,995.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,A,,N,1,Intermediate,CHEMBL624072,,
9957,Rattus norvegicus,1,995.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,A,,N,1,Intermediate,CHEMBL624073,,
9958,Rattus norvegicus,1,995.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,A,,N,1,Intermediate,CHEMBL624788,,
9959,Rattus norvegicus,1,995.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,A,,N,1,Intermediate,CHEMBL624789,,
9960,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,A,,N,1,Intermediate,CHEMBL624790,,
9961,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,A,,N,1,Intermediate,CHEMBL624791,,
9962,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,A,,N,1,Intermediate,CHEMBL624792,,
9963,Rattus norvegicus,1,,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,A,,N,1,Intermediate,CHEMBL624793,,
9964,Rattus norvegicus,1,2385.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,A,,N,1,Intermediate,CHEMBL877491,,
9965,Rattus norvegicus,1,2385.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,A,,N,1,Intermediate,CHEMBL624957,,
9966,Rattus norvegicus,1,2385.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,A,,N,1,Intermediate,CHEMBL624958,,
9967,Rattus norvegicus,1,2385.0,13091,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,A,,N,1,Intermediate,CHEMBL624959,,
9968,Rattus norvegicus,1,,11977,BAO_0000218,,Dissociation constant was determined,,A,,N,1,Intermediate,CHEMBL624960,,
9969,Rattus norvegicus,1,,14941,BAO_0000218,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,A,,N,1,Intermediate,CHEMBL624961,,
9970,Rattus norvegicus,1,,15078,BAO_0000218,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL624962,,
9971,Rattus norvegicus,1,,15078,BAO_0000218,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL624963,,
9972,Rattus norvegicus,1,,4755,BAO_0000218,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,A,,N,1,Intermediate,CHEMBL624964,,
9973,Rattus norvegicus,1,,589,BAO_0000218,,LogP value was evaluated in the in situ rat gut perfusion assay,,A,,N,1,Intermediate,CHEMBL624965,,
9974,Rattus norvegicus,1,,17582,BAO_0000218,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,A,,N,1,Intermediate,CHEMBL624966,,
9975,Rattus norvegicus,1,,5031,BAO_0000218,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,A,,N,1,Intermediate,CHEMBL624967,,
9976,Rattus norvegicus,1,,17764,BAO_0000218,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,A,,N,1,Intermediate,CHEMBL624968,,
9977,Rattus norvegicus,1,,17720,BAO_0000218,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,A,,N,1,Intermediate,CHEMBL624969,,
9978,Rattus norvegicus,1,,2862,BAO_0000218,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,F,,N,1,Expert,CHEMBL624970,,
9979,Rattus norvegicus,1,,16423,BAO_0000218,,Half-life was evaluated after 10 uM/kg of intra arterial administration,,A,,N,1,Intermediate,CHEMBL624971,,
9980,Rattus norvegicus,1,,16423,BAO_0000218,,Half-life was evaluated after 20 uM/kg of peroral administration,,A,,N,1,Intermediate,CHEMBL624972,,
9981,Rattus norvegicus,1,,6005,BAO_0000218,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL624973,,
9982,Rattus norvegicus,1,1969.0,2938,BAO_0000218,,Half-life was evaluated in plasma of rat,,A,,N,1,Intermediate,CHEMBL624974,,
9983,Rattus norvegicus,1,,6410,BAO_0000218,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,A,,N,1,Intermediate,CHEMBL624975,,
9984,Rattus norvegicus,1,,6410,BAO_0000218,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,A,,N,1,Intermediate,CHEMBL877492,,
9985,Rattus norvegicus,1,,6062,BAO_0000218,,Half-life was measured in rat after an iv dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL624976,,
9986,Rattus norvegicus,1,,6571,BAO_0000218,,Half-life period of compound in rats after peroral administration,,A,,N,1,Intermediate,CHEMBL624977,,
9987,Rattus norvegicus,1,1969.0,3136,BAO_0000218,,Half-life period of compound was measured in rat plasma.,,A,,N,1,Intermediate,CHEMBL626848,,
9988,Rattus norvegicus,1,1969.0,3136,BAO_0000218,,Half-life period of compound was measured in rat plasma; ND is not determined,,A,,N,1,Intermediate,CHEMBL626849,,
9989,Rattus norvegicus,1,1969.0,3136,BAO_0000218,,Half-life period of compound was measured in rat plasma; not determined,,A,,N,1,Intermediate,CHEMBL626850,,
9990,Rattus norvegicus,1,,4521,BAO_0000218,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,A,,N,1,Intermediate,CHEMBL626851,,
9991,Rattus norvegicus,1,,5871,BAO_0000218,,Half-life period in rat by iv administration,,A,,N,1,Intermediate,CHEMBL626852,,
9992,Rattus norvegicus,1,,6077,BAO_0000218,,Half-life period in rats following intravenous administration at 2 mg/kg,,A,,N,1,Intermediate,CHEMBL626853,,
9993,Rattus norvegicus,1,,6679,BAO_0000218,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,A,,N,1,Intermediate,CHEMBL626854,,
9994,Rattus norvegicus,1,,5144,BAO_0000218,,Half-life period was determined for the compound in rat,,A,,N,1,Intermediate,CHEMBL627486,,
9995,Rattus norvegicus,1,,4498,BAO_0000218,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,A,,N,1,Intermediate,CHEMBL627487,,
9996,Rattus norvegicus,1,,4498,BAO_0000218,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,A,,N,1,Intermediate,CHEMBL627488,,
9997,Rattus norvegicus,1,,1908,BAO_0000218,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,A,,N,1,Intermediate,CHEMBL627489,,
9998,Rattus norvegicus,1,,6211,BAO_0000218,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL627490,,
9999,Rattus norvegicus,1,,5529,BAO_0000218,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,A,,N,1,Intermediate,CHEMBL873829,,
10000,Rattus norvegicus,1,,6444,BAO_0000218,,Half-life was determined in rat at a dose of 1 mpk i.v.,,A,,N,1,Intermediate,CHEMBL627655,,
10001,Rattus norvegicus,1,,6444,BAO_0000218,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,A,,N,1,Intermediate,CHEMBL625994,,
10002,Rattus norvegicus,1,,6444,BAO_0000218,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,A,,N,1,Intermediate,CHEMBL625995,,
10003,Rattus norvegicus,1,,5207,BAO_0000218,,Half-life in rat,,A,,N,1,Intermediate,CHEMBL625996,,
10004,Rattus norvegicus,1,1969.0,530,BAO_0000218,,In vitro half life in rat plasma,,A,,N,1,Intermediate,CHEMBL625850,,
10005,Rattus norvegicus,1,1969.0,1116,BAO_0000218,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,A,,N,1,Intermediate,CHEMBL625851,,
10006,Rattus norvegicus,1,,3219,BAO_0000218,,In vitro half life in rat,,A,,N,1,Intermediate,CHEMBL625852,,
10007,Rattus norvegicus,1,,6109,BAO_0000218,,In vivo half life period after intravenous administration in rat,,A,,N,1,Intermediate,CHEMBL625853,,
10008,Rattus norvegicus,1,,17582,BAO_0000218,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,A,,N,1,Intermediate,CHEMBL625854,,
10009,Rattus norvegicus,1,,17582,BAO_0000218,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,A,,N,1,Intermediate,CHEMBL874450,,
10010,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL625855,,
10011,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL625856,,
10012,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL625857,,
10013,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL873831,,
10014,Rattus norvegicus,1,,17853,BAO_0000218,,Longer half-life in rat (i.v.) at 0.5 mpk,,A,,N,1,Intermediate,CHEMBL625858,,
10015,Rattus norvegicus,1,,17853,BAO_0000218,,Longer half-life in rat (p.o.) at 2.0 mpk,,A,,N,1,Intermediate,CHEMBL625859,,
10016,Rattus norvegicus,1,,3457,BAO_0000218,,Pharmacokinetic property (half life) in rat,,A,,N,1,Intermediate,CHEMBL625860,,
10017,Rattus norvegicus,1,,2792,BAO_0000218,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,A,,N,1,Intermediate,CHEMBL625861,,
10018,Rattus norvegicus,1,,2792,BAO_0000218,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,A,,N,1,Intermediate,CHEMBL625862,,
10019,Rattus norvegicus,1,,2792,BAO_0000218,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,A,,N,1,Intermediate,CHEMBL625863,,
10020,Rattus norvegicus,1,,2792,BAO_0000218,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,A,,N,1,Intermediate,CHEMBL625864,,
10021,Rattus norvegicus,1,,5739,BAO_0000218,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,A,,N,1,Intermediate,CHEMBL625865,,
10022,Rattus norvegicus,1,,15765,BAO_0000218,,Pharmacokinetic half time was determined intravenously in rats.,,A,,N,1,Intermediate,CHEMBL625866,,
10023,Rattus norvegicus,1,1969.0,6567,BAO_0000218,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,A,,N,1,Intermediate,CHEMBL625867,,
10024,Rattus norvegicus,1,1969.0,2448,BAO_0000218,,Plasma half life of hydrolysis of the compound,,A,,N,1,Intermediate,CHEMBL625868,,
10025,Rattus norvegicus,1,1969.0,5423,BAO_0000218,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,A,,N,1,Intermediate,CHEMBL625869,,
10026,Rattus norvegicus,1,1969.0,4853,BAO_0000218,,Plasma half life period was calculated in rat,,A,,N,1,Intermediate,CHEMBL874451,,
10027,Rattus norvegicus,1,1969.0,4514,BAO_0000218,,Plasma half-life in Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL625870,,
10028,Rattus norvegicus,1,1969.0,4514,BAO_0000218,,Plasma half-life in Sprague-Dawley rats; Not determined,,A,,N,1,Intermediate,CHEMBL625871,,
10029,Rattus norvegicus,1,1969.0,1500,BAO_0000218,,Plasma half-life in rats,,A,,N,1,Intermediate,CHEMBL625872,,
10030,Rattus norvegicus,1,1969.0,1500,BAO_0000218,,Plasma half-life in rats; <MQL,,A,,N,1,Intermediate,CHEMBL625873,,
10031,Rattus norvegicus,1,1969.0,5334,BAO_0000218,,Plasma half-life period (0-8 h) was determined,,A,,N,1,Intermediate,CHEMBL625874,,
10032,Rattus norvegicus,1,1969.0,5334,BAO_0000218,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL625875,,
10033,Rattus norvegicus,1,1969.0,5334,BAO_0000218,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL625876,,
10034,Rattus norvegicus,1,1969.0,5334,BAO_0000218,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL631258,,
10035,Rattus norvegicus,1,1969.0,4956,BAO_0000218,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,A,,N,1,Intermediate,CHEMBL631259,,
10036,Rattus norvegicus,1,1969.0,4956,BAO_0000218,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,A,,N,1,Intermediate,CHEMBL631260,,
10037,Rattus norvegicus,1,178.0,7768,BAO_0000218,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,A,,N,1,Intermediate,CHEMBL631261,,
10038,Rattus norvegicus,1,178.0,7768,BAO_0000218,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,A,,N,1,Intermediate,CHEMBL631262,,
10039,Rattus norvegicus,1,178.0,7768,BAO_0000218,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,A,,N,1,Intermediate,CHEMBL631263,,
10040,Rattus norvegicus,1,,7768,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,A,,N,1,Intermediate,CHEMBL631264,,
10041,Rattus norvegicus,1,,7768,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,A,,N,1,Intermediate,CHEMBL631265,,
10042,Rattus norvegicus,1,,7768,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,A,,N,1,Intermediate,CHEMBL631266,,
10043,Rattus norvegicus,1,,7768,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,A,,N,1,Intermediate,CHEMBL631267,,
10044,Rattus norvegicus,1,,7768,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,A,,N,1,Intermediate,CHEMBL631268,,
10045,Rattus norvegicus,1,,7768,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,A,,N,1,Intermediate,CHEMBL631269,,
10046,Rattus norvegicus,1,,7768,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,A,,N,1,Intermediate,CHEMBL631270,,
10047,Rattus norvegicus,1,948.0,7768,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,A,,N,1,Intermediate,CHEMBL631271,,
10048,Rattus norvegicus,1,948.0,7768,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,A,,N,1,Intermediate,CHEMBL631272,,
10049,Rattus norvegicus,1,948.0,7768,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,A,,N,1,Intermediate,CHEMBL631273,,
10050,Rattus norvegicus,1,948.0,7768,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,A,,N,1,Intermediate,CHEMBL631274,,
10051,Rattus norvegicus,1,948.0,7768,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,A,,N,1,Intermediate,CHEMBL631275,,
10052,Rattus norvegicus,1,948.0,7768,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,A,,N,1,Intermediate,CHEMBL626984,,
10053,Rattus norvegicus,1,948.0,7768,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,A,,N,1,Intermediate,CHEMBL626985,,
10054,Rattus norvegicus,1,2107.0,7768,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,A,,N,1,Intermediate,CHEMBL626986,,
10055,Rattus norvegicus,1,2107.0,7768,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,A,,N,1,Intermediate,CHEMBL626987,,
10056,Rattus norvegicus,1,2107.0,7768,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,A,,N,1,Intermediate,CHEMBL626988,,
10057,Rattus norvegicus,1,2107.0,7768,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,A,,N,1,Intermediate,CHEMBL626989,,
10058,Rattus norvegicus,1,2107.0,7768,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,A,,N,1,Intermediate,CHEMBL626990,,
10059,Rattus norvegicus,1,2107.0,7768,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,A,,N,1,Intermediate,CHEMBL626991,,
10060,Rattus norvegicus,1,2107.0,7768,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,A,,N,1,Intermediate,CHEMBL626992,,
10061,Rattus norvegicus,1,2048.0,7768,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,A,,N,1,Intermediate,CHEMBL626993,,
10062,Rattus norvegicus,1,2048.0,7768,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,A,,N,1,Intermediate,CHEMBL874593,,
10063,Rattus norvegicus,1,2048.0,7768,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,A,,N,1,Intermediate,CHEMBL626994,,
10064,Rattus norvegicus,1,2048.0,7768,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,A,,N,1,Intermediate,CHEMBL626995,,
10065,Rattus norvegicus,1,2048.0,7768,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,A,,N,1,Intermediate,CHEMBL626190,,
10066,Rattus norvegicus,1,2048.0,7768,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,A,,N,1,Intermediate,CHEMBL626191,,
10067,Rattus norvegicus,1,2048.0,7768,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,A,,N,1,Intermediate,CHEMBL626364,,
10068,Rattus norvegicus,1,2046.0,7768,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,A,,N,1,Intermediate,CHEMBL626365,,
10069,Rattus norvegicus,1,2046.0,7768,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,A,,N,1,Intermediate,CHEMBL626366,,
10070,Rattus norvegicus,1,2046.0,7768,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,A,,N,1,Intermediate,CHEMBL626367,,
10071,Rattus norvegicus,1,2046.0,7768,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,A,,N,1,Intermediate,CHEMBL626368,,
10072,Rattus norvegicus,1,2046.0,7768,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,A,,N,1,Intermediate,CHEMBL626369,,
10073,Rattus norvegicus,1,2046.0,7768,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,A,,N,1,Intermediate,CHEMBL626370,,
10074,Rattus norvegicus,1,,4498,BAO_0000218,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,A,,N,1,Intermediate,CHEMBL626371,,
10075,Rattus norvegicus,1,,4498,BAO_0000218,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,A,,N,1,Intermediate,CHEMBL626372,,
10076,Rattus norvegicus,1,,3603,BAO_0000218,,Bioavailability after a dose of 10 mg/kg p.o.,,A,,N,1,Intermediate,CHEMBL626373,,
10077,Rattus norvegicus,1,,6215,BAO_0000218,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,A,,N,1,Intermediate,CHEMBL626374,,
10078,Rattus norvegicus,1,,5710,BAO_0000218,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,A,,N,1,Intermediate,CHEMBL626375,,
10079,Rattus norvegicus,1,,5710,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,A,,N,1,Intermediate,CHEMBL626376,,
10080,Rattus norvegicus,1,,5676,BAO_0000218,,Bioavailability in rat po was determined,,A,,N,1,Intermediate,CHEMBL626377,,
10081,Rattus norvegicus,1,,17667,BAO_0000218,,Bioavailability of compound at 10 mg/kg in rat after oral administration,,A,,N,1,Intermediate,CHEMBL626378,,
10082,Rattus norvegicus,1,,17667,BAO_0000218,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,A,,N,1,Intermediate,CHEMBL626379,,
10083,Rattus norvegicus,1,,6848,BAO_0000218,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL626380,,
10084,Rattus norvegicus,1,,6848,BAO_0000218,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL626381,,
10085,Rattus norvegicus,1,,17267,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL626382,,
10086,Rattus norvegicus,1,,6362,BAO_0000218,,Bioavailability in rat (Sprague-Dawley) (female),,A,,N,1,Intermediate,CHEMBL626383,,
10087,Rattus norvegicus,1,,17671,BAO_0000218,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,A,,N,1,Intermediate,CHEMBL874652,,
10088,Rattus norvegicus,1,,17671,BAO_0000218,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,A,,N,1,Intermediate,CHEMBL626384,,
10089,Rattus norvegicus,1,,4333,BAO_0000218,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,A,,N,1,Intermediate,CHEMBL626385,,
10090,Rattus norvegicus,1,,6077,BAO_0000218,,Bioavailability in rat at an oral dose of 2 mg/kg,,A,,N,1,Intermediate,CHEMBL626386,,
10091,Rattus norvegicus,1,,3278,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL626387,,
10092,Rattus norvegicus,1,,5964,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL626388,,
10093,Rattus norvegicus,1,,4884,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL626389,,
10094,Rattus norvegicus,1,,4905,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL626390,,
10095,Rattus norvegicus,1,,4884,BAO_0000218,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,A,,N,1,Intermediate,CHEMBL626391,,
10096,Rattus norvegicus,1,,6850,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL626392,,
10097,Rattus norvegicus,1,,2864,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL626393,,
10098,Rattus norvegicus,1,,5780,BAO_0000218,,Bioavailability was determined in rat,,A,,N,1,Intermediate,CHEMBL623026,,
10099,Rattus norvegicus,1,,1465,BAO_0000218,,Bioavailability,,A,,N,1,Intermediate,CHEMBL623027,,
10100,Rattus norvegicus,1,,5199,BAO_0000218,,Bioavailability,,A,,N,1,Intermediate,CHEMBL623028,,
10101,Rattus norvegicus,1,,5765,BAO_0000218,,Bioavailability in rat after 1 day dosing,,A,,N,1,Intermediate,CHEMBL623029,,
10102,Rattus norvegicus,1,,5765,BAO_0000218,,Bioavailability in rat after 4 day dosing,,A,,N,1,Intermediate,CHEMBL623030,,
10103,Rattus norvegicus,1,,6518,BAO_0000218,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,A,,N,1,Intermediate,CHEMBL623031,,
10104,Rattus norvegicus,1,,6518,BAO_0000218,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,A,,N,1,Intermediate,CHEMBL623032,,
10105,Rattus norvegicus,1,,6518,BAO_0000218,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL623033,,
10106,Rattus norvegicus,1,,6518,BAO_0000218,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL623034,,
10107,Rattus norvegicus,1,,2083,BAO_0000218,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,A,,N,1,Intermediate,CHEMBL623035,,
10108,Rattus norvegicus,1,,17260,BAO_0000218,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,A,,N,1,Intermediate,CHEMBL623036,,
10109,Rattus norvegicus,1,,4956,BAO_0000218,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL623037,,
10110,Rattus norvegicus,1,,4368,BAO_0000218,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL623038,,
10111,Rattus norvegicus,1,1969.0,17752,BAO_0000218,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,A,,N,1,Intermediate,CHEMBL874385,,
10112,Rattus norvegicus,1,,1446,BAO_0000218,,Bioavailability in rat (Fisher) (fasted),,A,,N,1,Intermediate,CHEMBL623039,,
10113,Primates,1,,2891,BAO_0000218,,Bioavailability in monkey after po administration of 10 mg/kg dose,,A,,U,0,Intermediate,CHEMBL623040,,
10114,Primates,1,,2891,BAO_0000218,,Oral bioavailability in monkey (dose 10 mg/kg),,A,,U,0,Intermediate,CHEMBL623041,,
10115,Rattus norvegicus,1,,6672,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623741,,
10116,Rattus norvegicus,1,,6673,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623742,,
10117,Rattus norvegicus,1,,17655,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623743,,
10118,Rattus norvegicus,1,,17796,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623744,,
10119,Rattus norvegicus,1,,17853,BAO_0000218,,Bioavailability in rat (dose 2.0 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL623745,,
10120,Rattus norvegicus,1,,4521,BAO_0000218,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,A,,N,1,Intermediate,CHEMBL623746,,
10121,Rattus norvegicus,1,,4940,BAO_0000218,,Oral bioavailability in rat (dose 5 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL623747,,
10122,Rattus norvegicus,1,,2891,BAO_0000218,,Bioavailability in rat after po administration of 30 mg/kg dose,,A,,U,0,Intermediate,CHEMBL623748,,
10123,Rattus norvegicus,1,,2891,BAO_0000218,,Bioavailability in rat after po administration of 30 mg/kg dose,,A,,U,0,Intermediate,CHEMBL623916,,
10124,Rattus norvegicus,1,,4521,BAO_0000218,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,A,,N,1,Intermediate,CHEMBL623917,,
10125,Rattus norvegicus,1,,17686,BAO_0000218,,Bioavailability in rat (dose 2 mg/kg i.v.),,A,,N,1,Intermediate,CHEMBL623918,,
10126,Rattus norvegicus,1,,17796,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL874386,,
10127,Rattus norvegicus,1,1969.0,17796,BAO_0000218,,Bioavailability in rat; Only traces detected in rat plasma,,A,,N,1,Intermediate,CHEMBL623919,,
10128,Rattus norvegicus,1,,5064,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623920,,
10129,Rattus norvegicus,1,,5147,BAO_0000218,,Bioavailability upon oral administration of compound,,A,,N,1,Intermediate,CHEMBL623148,,
10130,Rattus norvegicus,1,,1916,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,A,,N,1,Intermediate,CHEMBL623149,,
10131,Rattus norvegicus,1,,6049,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623150,,
10132,Rattus norvegicus,1,,1445,BAO_0000218,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,A,,N,1,Intermediate,CHEMBL623151,,
10133,Rattus norvegicus,1,,1445,BAO_0000218,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,A,,N,1,Intermediate,CHEMBL623152,,
10134,Rattus norvegicus,1,,2862,BAO_0000218,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,F,,N,1,Expert,CHEMBL623153,,
10135,Rattus norvegicus,1,,2862,BAO_0000218,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,F,,N,1,Expert,CHEMBL623154,,
10136,Rattus norvegicus,1,,4194,BAO_0000218,,In vitro and metabolic stability was determined,,A,,N,1,Intermediate,CHEMBL623155,,
10137,Rattus norvegicus,1,,4194,BAO_0000218,,In vitro metabolic stability in rat hepatocytes,,A,,N,1,Intermediate,CHEMBL623156,,
10138,Rattus norvegicus,1,,5486,BAO_0000218,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,A,,N,1,Intermediate,CHEMBL623157,,
10139,Rattus norvegicus,1,2107.0,17582,BAO_0000218,,Metabolic rate for compound was observed in rat hepatocytes,,A,,N,1,Intermediate,CHEMBL623158,401.0,
10140,Rattus norvegicus,1,,5600,BAO_0000218,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,A,,N,1,Intermediate,CHEMBL623159,,
10141,Rattus norvegicus,1,,14294,BAO_0000218,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,A,,N,1,Intermediate,CHEMBL874390,,
10142,Rattus norvegicus,1,,14294,BAO_0000218,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,A,,N,1,Intermediate,CHEMBL623160,,
10143,Rattus norvegicus,1,,14294,BAO_0000218,,Metabolism of compound in rat S9 microsomes; Trace,,A,,N,1,Intermediate,CHEMBL623161,,
10144,Rattus norvegicus,1,,17847,BAO_0000218,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,A,,N,1,Intermediate,CHEMBL623162,,
10145,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,A,,N,1,Intermediate,CHEMBL623163,,
10146,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,A,,N,1,Intermediate,CHEMBL623164,,
10147,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,A,,N,1,Intermediate,CHEMBL623165,,
10148,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,A,,N,1,Intermediate,CHEMBL623166,,
10149,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,A,,N,1,Intermediate,CHEMBL624983,,
10150,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,A,,N,1,Intermediate,CHEMBL624984,,
10151,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,A,,N,1,Intermediate,CHEMBL624985,,
10152,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,A,,N,1,Intermediate,CHEMBL622970,,
10153,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,A,,N,1,Intermediate,CHEMBL622971,,
10154,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,A,,N,1,Intermediate,CHEMBL622972,,
10155,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,A,,N,1,Intermediate,CHEMBL622973,,
10156,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,A,,N,1,Intermediate,CHEMBL622974,,
10157,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,A,,N,1,Intermediate,CHEMBL622975,,
10158,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,A,,N,1,Intermediate,CHEMBL622976,,
10159,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,A,,N,1,Intermediate,CHEMBL622977,,
10160,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,A,,N,1,Intermediate,CHEMBL624351,,
10161,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,A,,N,1,Intermediate,CHEMBL624352,,
10162,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,A,,N,1,Intermediate,CHEMBL624353,,
10163,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,A,,N,1,Intermediate,CHEMBL622397,,
10164,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,A,,N,1,Intermediate,CHEMBL622398,,
10165,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,A,,N,1,Intermediate,CHEMBL622399,,
10166,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,A,,N,1,Intermediate,CHEMBL622400,,
10167,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,A,,N,1,Intermediate,CHEMBL628428,,
10168,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,A,,N,1,Intermediate,CHEMBL628590,,
10169,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,A,,N,1,Intermediate,CHEMBL628591,,
10170,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,A,,N,1,Intermediate,CHEMBL628592,,
10171,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,A,,N,1,Intermediate,CHEMBL628593,,
10172,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,A,,N,1,Intermediate,CHEMBL875333,,
10173,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,A,,N,1,Intermediate,CHEMBL628594,,
10174,Rattus norvegicus,1,1969.0,4969,BAO_0000218,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,A,,N,1,Intermediate,CHEMBL628595,,
10175,Rattus norvegicus,1,1969.0,6737,BAO_0000218,,Stability in rat plasma was determined,,A,,N,1,Intermediate,CHEMBL628596,,
10176,Rattus norvegicus,1,1969.0,6737,BAO_0000218,,Stability in rat plasma was determined; ND= no data,,A,,N,1,Intermediate,CHEMBL628597,,
10177,Rattus norvegicus,1,1969.0,5089,BAO_0000218,,Tested for plasma half life period in rat (0-8 hr),,A,,N,1,Intermediate,CHEMBL628598,,
10178,Rattus norvegicus,1,1969.0,5089,BAO_0000218,,Tested for plasma half life period in rat (0-8 hr); Not determined,,A,,N,1,Intermediate,CHEMBL628599,,
10179,Rattus norvegicus,1,,1466,BAO_0000218,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,A,,N,1,Intermediate,CHEMBL628600,,
10180,Rattus norvegicus,1,,1466,BAO_0000218,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,A,,N,1,Intermediate,CHEMBL628601,,
10181,Rattus norvegicus,1,,4950,BAO_0000218,,Tested for the half life in rat,,A,,N,1,Intermediate,CHEMBL628602,,
10182,Rattus norvegicus,1,,2412,BAO_0000218,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,A,,N,1,Intermediate,CHEMBL628603,,
10183,Rattus norvegicus,1,,2412,BAO_0000218,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,A,,N,1,Intermediate,CHEMBL628604,,
10184,Rattus norvegicus,1,,2412,BAO_0000218,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,A,,N,1,Intermediate,CHEMBL628605,,
10185,Rattus norvegicus,1,,2412,BAO_0000218,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,A,,N,1,Intermediate,CHEMBL628606,,
10186,Rattus norvegicus,1,,2412,BAO_0000218,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,A,,N,1,Intermediate,CHEMBL628607,,
10187,Rattus norvegicus,1,,15022,BAO_0000218,,The biological half life the compound was measured at the dose of 100 umol/kg,,A,,N,1,Intermediate,CHEMBL628608,,
10188,Rattus norvegicus,1,,15022,BAO_0000218,,The biological half life the compound was measured at the dose of 30 umol/kg,,A,,N,1,Intermediate,CHEMBL628609,,
10189,Rattus norvegicus,1,1969.0,406,BAO_0000218,,The compound was evaluated for plasma half life period in rat,,A,,N,1,Intermediate,CHEMBL628610,,
10190,Rattus norvegicus,1,,15078,BAO_0000218,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL873819,,
10191,Rattus norvegicus,1,,15078,BAO_0000218,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL628611,,
10192,Rattus norvegicus,1,,5247,BAO_0000218,,The pharmacokinetic parameter half-life period in vivo in rats,,A,,N,1,Intermediate,CHEMBL628612,,
10193,Rattus norvegicus,1,,5041,BAO_0000218,,"The pharmacokinetic property, Half-life was determined",,A,,N,1,Intermediate,CHEMBL628613,,
10194,Rattus norvegicus,1,,5041,BAO_0000218,,"The pharmacokinetic property, Half-life in rat in vivo",,A,,N,1,Intermediate,CHEMBL628614,,
10195,Rattus norvegicus,1,,5041,BAO_0000218,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,A,,N,1,Intermediate,CHEMBL628615,,
10196,Rattus norvegicus,1,,5041,BAO_0000218,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,A,,N,1,Intermediate,CHEMBL628616,,
10197,Rattus norvegicus,1,1969.0,3918,BAO_0000218,,The plasma half life period in rats,,A,,N,1,Intermediate,CHEMBL627924,,
10198,Rattus norvegicus,1,2107.0,2906,BAO_0000218,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,A,,N,1,Intermediate,CHEMBL627925,,
10199,Rattus norvegicus,1,,6467,BAO_0000218,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,A,,N,1,Intermediate,CHEMBL627926,,
10200,Rattus norvegicus,1,,5510,BAO_0000218,,t1/2 (apparent elimination)of the compound was determined,,A,,N,1,Intermediate,CHEMBL627927,,
10201,Rattus norvegicus,1,,3788,BAO_0000218,,t1/2 value in rat,,A,,N,1,Intermediate,CHEMBL627928,,
10202,Rattus norvegicus,1,,17796,BAO_0000218,,Half life in rat,,A,,N,1,Intermediate,CHEMBL627539,,
10203,Rattus norvegicus,1,1969.0,12873,BAO_0000218,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,A,,N,1,Intermediate,CHEMBL876790,,
10204,Rattus norvegicus,1,,5983,BAO_0000218,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,A,,N,1,Intermediate,CHEMBL858186,,
10205,Rattus norvegicus,1,,15765,BAO_0000218,,Half-life period in fasted rats,,A,,N,1,Intermediate,CHEMBL627540,,
10206,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,A,,N,1,Intermediate,CHEMBL627541,,
10207,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,A,,N,1,Intermediate,CHEMBL627715,,
10208,Rattus norvegicus,1,,429,BAO_0000218,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,A,,N,1,Intermediate,CHEMBL627716,,
10209,Rattus norvegicus,1,,17655,BAO_0000218,,Maximum time required to achieve Cmax was determined in rat,,A,,N,1,Intermediate,CHEMBL627717,,
10210,Rattus norvegicus,1,,17717,BAO_0000218,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,A,,N,1,Intermediate,CHEMBL627718,,
10211,Rattus norvegicus,1,,17717,BAO_0000218,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,A,,N,1,Intermediate,CHEMBL627719,,
10212,Rattus norvegicus,1,,17717,BAO_0000218,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,A,,N,1,Intermediate,CHEMBL627720,,
10213,Rattus norvegicus,1,,6570,BAO_0000218,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,A,,N,1,Intermediate,CHEMBL627721,,
10214,Rattus norvegicus,1,,6570,BAO_0000218,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,A,,N,1,Intermediate,CHEMBL627722,,
10215,Rattus norvegicus,1,,5978,BAO_0000218,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL627723,,
10216,Rattus norvegicus,1,,5978,BAO_0000218,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL626058,,
10217,Rattus norvegicus,1,,5978,BAO_0000218,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL626059,,
10218,Rattus norvegicus,1,,5978,BAO_0000218,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL626060,,
10219,Rattus norvegicus,1,1969.0,17720,BAO_0000218,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,A,,N,1,Intermediate,CHEMBL626061,,
10220,Rattus norvegicus,1,,4723,BAO_0000218,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,A,,N,1,Intermediate,CHEMBL876791,,
10221,Rattus norvegicus,1,,4723,BAO_0000218,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,A,,N,1,Intermediate,CHEMBL626062,,
10222,Rattus norvegicus,1,,4756,BAO_0000218,,Tmax at the dose of 2 mg/Kg administered perorally in rats,,A,,N,1,Intermediate,CHEMBL626063,,
10223,Rattus norvegicus,1,,4756,BAO_0000218,,Tmax at the dose of 5 mg/Kg administered perorally in rats,,A,,N,1,Intermediate,CHEMBL626064,,
10224,Rattus norvegicus,1,1969.0,17720,BAO_0000218,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,A,,N,1,Intermediate,CHEMBL626065,,
10225,Rattus norvegicus,1,1969.0,17720,BAO_0000218,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,A,,N,1,Intermediate,CHEMBL626066,,
10226,Rattus norvegicus,1,,1466,BAO_0000218,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,A,,N,1,Intermediate,CHEMBL626067,,
10227,Rattus norvegicus,1,,7449,BAO_0000218,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,F,,N,1,Intermediate,CHEMBL626068,,
10228,Rattus norvegicus,1,,7449,BAO_0000218,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,F,,N,1,Intermediate,CHEMBL626069,,
10229,Rattus norvegicus,1,,7449,BAO_0000218,,Percent total excretion of 3-methoxyacetaminophen glucuronide,,F,,N,1,Intermediate,CHEMBL626070,,
10230,Rattus norvegicus,1,,7449,BAO_0000218,,Percent total excretion of N-methoxyacetaminophen glucuronide,,F,,N,1,Intermediate,CHEMBL626071,,
10231,Rattus norvegicus,1,,7449,BAO_0000218,,Percent total excretion of N-methoxyacetaminophen sulfate,,F,,N,1,Intermediate,CHEMBL626072,,
10232,Rattus norvegicus,1,,7449,BAO_0000218,,Percent total excretion of acetaminophen,,F,,N,1,Intermediate,CHEMBL626073,,
10233,Rattus norvegicus,1,2046.0,7768,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,A,,N,1,Intermediate,CHEMBL626741,,
10234,Rattus norvegicus,1,,17655,BAO_0000218,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,A,,N,1,Intermediate,CHEMBL626742,,
10235,Rattus norvegicus,1,,17735,BAO_0000218,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,A,,N,1,Intermediate,CHEMBL626743,,
10236,Rattus norvegicus,1,,5960,BAO_0000218,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,A,,N,1,Intermediate,CHEMBL876792,,
10237,Rattus norvegicus,1,,17735,BAO_0000218,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,A,,N,1,Intermediate,CHEMBL626744,,
10238,Rattus norvegicus,1,,7116,BAO_0000218,,Compound was tested for antidiuretic activity in rats,,A,,N,1,Intermediate,CHEMBL626745,,
10239,Rattus norvegicus,1,1969.0,4878,BAO_0000218,,AUC in rat after 3mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL626746,,
10240,Rattus norvegicus,1,,5939,BAO_0000218,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL626747,,
10241,Rattus norvegicus,1,,5939,BAO_0000218,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,A,,N,1,Intermediate,CHEMBL626748,,
10242,Rattus norvegicus,1,,16367,BAO_0000218,,Bioavailability administered orally at a dose of 10 mg/kg to rats,,A,,N,1,Intermediate,CHEMBL626749,,
10243,Rattus norvegicus,1,,16366,BAO_0000218,,Oral Bioavailability was determined,,A,,N,1,Intermediate,CHEMBL626750,,
10244,Rattus norvegicus,1,,4426,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL626751,,
10245,Rattus norvegicus,1,,4426,BAO_0000218,,Oral bioavailability in rat; Not performed.,,A,,N,1,Intermediate,CHEMBL626913,,
10246,Rattus norvegicus,1,,5041,BAO_0000218,,Bioavailability,,A,,N,1,Intermediate,CHEMBL626914,,
10247,Rattus norvegicus,1,,5041,BAO_0000218,,Bioavailability was determined; ND denotes no data,,A,,N,1,Intermediate,CHEMBL626915,,
10248,Rattus norvegicus,1,,1500,BAO_0000218,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL626916,,
10249,Rattus norvegicus,1,,1500,BAO_0000218,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL626917,,
10250,Rattus norvegicus,1,,17409,BAO_0000218,,Binding towards rat plasma protein at 10 uM,,A,,N,1,Intermediate,CHEMBL626918,,
10251,Rattus norvegicus,1,,17409,BAO_0000218,,Binding towards rat plasma protein at 100 uM,,A,,N,1,Intermediate,CHEMBL626919,,
10252,Rattus norvegicus,1,,2959,BAO_0000218,,Bioavailability in rat (dose 20 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL626920,,
10253,Rattus norvegicus,1,,13501,BAO_0000218,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,A,,N,1,Intermediate,CHEMBL621976,,
10254,Rattus norvegicus,1,,6567,BAO_0000218,,Bioavailability in rat after 5 mg/kg oral gavage,,A,,N,1,Intermediate,CHEMBL877599,,
10255,Rattus norvegicus,1,,6571,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL621977,,
10256,Rattus norvegicus,1,,6715,BAO_0000218,,Bioavailability in rat (dose 1 mg/kg i.v.),,A,,N,1,Intermediate,CHEMBL621978,,
10257,Rattus norvegicus,1,,6715,BAO_0000218,,Bioavailability in rat (dose 3 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL621979,,
10258,Rattus norvegicus,1,,2932,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL621980,,
10259,Rattus norvegicus,1,,4171,BAO_0000218,,Bioavailability of the compound in rats after administration of 30 mg/kg,,A,,N,1,Intermediate,CHEMBL621981,,
10260,Rattus norvegicus,1,,17509,BAO_0000218,,Bioavailability after administration of 10 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL621982,,
10261,Rattus norvegicus,1,,17509,BAO_0000218,,Bioavailability after administration of 2 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL882953,,
10262,Rattus norvegicus,1,,4527,BAO_0000218,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,A,,N,1,Intermediate,CHEMBL621983,,
10263,Rattus norvegicus,1,,4026,BAO_0000218,,Bioavailability in dogs was determined; high,,A,,N,1,Intermediate,CHEMBL621984,,
10264,Rattus norvegicus,1,,6659,BAO_0000218,,Bioavailability in monkey after intravenous administration at 1 mpk,,A,,N,1,Intermediate,CHEMBL621985,,
10265,Rattus norvegicus,1,,6659,BAO_0000218,,Bioavailability in monkey after peroral administration at 10 mpk,,A,,N,1,Intermediate,CHEMBL621986,,
10266,Rattus norvegicus,1,,6659,BAO_0000218,,Bioavailability in rat after intravenous administration at 1 mpk,,A,,N,1,Intermediate,CHEMBL621987,,
10267,Rattus norvegicus,1,,6659,BAO_0000218,,Bioavailability in rat after intravenous administration at 2 mpk,,F,,N,1,Intermediate,CHEMBL877600,,
10268,Rattus norvegicus,1,,6659,BAO_0000218,,Bioavailability in rat after peroral administration at 30 mpk,,A,,N,1,Intermediate,CHEMBL621988,,
10269,Rattus norvegicus,1,,6659,BAO_0000218,,Bioavailability in rat after peroral administration at at 100 mpk,,F,,N,1,Intermediate,CHEMBL621989,,
10270,Rattus norvegicus,1,,6597,BAO_0000218,,Bioavailability in rats was evaluated,,A,,N,1,Intermediate,CHEMBL621990,,
10271,Rattus norvegicus,1,,1202,BAO_0000218,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,A,,N,1,Intermediate,CHEMBL621991,,
10272,Rattus norvegicus,1,,1202,BAO_0000218,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,A,,N,1,Intermediate,CHEMBL621992,,
10273,Rattus norvegicus,1,,1202,BAO_0000218,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,A,,N,1,Intermediate,CHEMBL621993,,
10274,Rattus norvegicus,1,,1202,BAO_0000218,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,A,,N,1,Intermediate,CHEMBL621994,,
10275,Rattus norvegicus,1,,5207,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL621995,,
10276,Rattus norvegicus,1,,5970,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL621996,,
10277,Rattus norvegicus,1,,17538,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg),,A,,N,1,Intermediate,CHEMBL621997,,
10278,Rattus norvegicus,1,,17538,BAO_0000218,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,A,,N,1,Intermediate,CHEMBL621998,,
10279,Rattus norvegicus,1,,1466,BAO_0000218,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,A,,N,1,Intermediate,CHEMBL621999,,
10280,Rattus norvegicus,1,,2879,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622000,,
10281,Rattus norvegicus,1,,2879,BAO_0000218,,Bioavailability was measured in rat after oral administration; 2-4,,A,,N,1,Intermediate,CHEMBL622001,,
10282,Rattus norvegicus,1,,2879,BAO_0000218,,Bioavailability was measured in rat after oral administration; 3-7,,A,,N,1,Intermediate,CHEMBL622002,,
10283,Rattus norvegicus,1,,3777,BAO_0000218,,Bioavailability in rat (intraduodenal administration),,A,,N,1,Intermediate,CHEMBL622003,,
10284,Rattus norvegicus,1,,3777,BAO_0000218,,Bioavailability in rat (intraduodenal administration),,A,,N,1,Intermediate,CHEMBL877601,,
10285,Rattus norvegicus,1,,3777,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL624871,,
10286,Rattus norvegicus,1,,3777,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622004,,
10287,Rattus norvegicus,1,,5423,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL882954,,
10288,Rattus norvegicus,1,,16365,BAO_0000218,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,A,,N,1,Intermediate,CHEMBL622005,,
10289,Rattus norvegicus,1,,16365,BAO_0000218,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,A,,N,1,Intermediate,CHEMBL622006,,
10290,Rattus norvegicus,1,,4239,BAO_0000218,,Bioavailability was measured in rat,,A,,N,1,Intermediate,CHEMBL622007,,
10291,Rattus norvegicus,1,,5438,BAO_0000218,,Bioavailability was reported,,A,,N,1,Intermediate,CHEMBL622008,,
10292,Rattus norvegicus,1,,5334,BAO_0000218,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,A,,N,1,Intermediate,CHEMBL622009,,
10293,Rattus norvegicus,1,,5334,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,A,,N,1,Intermediate,CHEMBL622010,,
10294,Rattus norvegicus,1,,4199,BAO_0000218,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,A,,N,1,Intermediate,CHEMBL622011,,
10295,Rattus norvegicus,1,,4199,BAO_0000218,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,A,,N,1,Intermediate,CHEMBL622012,,
10296,Rattus norvegicus,1,,4199,BAO_0000218,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,A,,N,1,Intermediate,CHEMBL622013,,
10297,Rattus norvegicus,1,,4890,BAO_0000218,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL622014,,
10298,Rattus norvegicus,1,,2792,BAO_0000218,,Bioavailability was determined at 3 mg/kg po dose in rats,,A,,N,1,Intermediate,CHEMBL624749,,
10299,Rattus norvegicus,1,,5529,BAO_0000218,,Oral bioavailability in rat (dose 2 mg/kg),,A,,N,1,Intermediate,CHEMBL624750,,
10300,Rattus norvegicus,1,,6685,BAO_0000218,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL624751,,
10301,Rattus norvegicus,1,,6685,BAO_0000218,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,A,,N,1,Intermediate,CHEMBL624752,,
10302,Rattus norvegicus,1,,6685,BAO_0000218,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,A,,N,1,Intermediate,CHEMBL624753,,
10303,Rattus norvegicus,1,,6005,BAO_0000218,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL624754,,
10304,Rattus norvegicus,1,,6410,BAO_0000218,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,A,,N,1,Intermediate,CHEMBL624755,,
10305,Rattus norvegicus,1,,6410,BAO_0000218,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,A,,N,1,Intermediate,CHEMBL624756,,
10306,Rattus norvegicus,1,,6103,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL624757,,
10307,Rattus norvegicus,1,,6410,BAO_0000218,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,A,,N,1,Intermediate,CHEMBL624758,,
10308,Rattus norvegicus,1,,6410,BAO_0000218,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,A,,N,1,Intermediate,CHEMBL622270,,
10309,Rattus norvegicus,1,,5353,BAO_0000218,,Bioavailability in rat (Sprague-Dawley),,A,,N,1,Intermediate,CHEMBL622271,,
10310,Rattus norvegicus,1,,4727,BAO_0000218,,Bioavailability in rat at the dose of 2 mg/kg,,A,,N,1,Intermediate,CHEMBL622272,,
10311,Rattus norvegicus,1,,17804,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622273,,
10312,Rattus norvegicus,1,,5809,BAO_0000218,,Bioavailability in rat (cannulated) (dose 2 mg/kg),,A,,N,1,Intermediate,CHEMBL622274,,
10313,Rattus norvegicus,1,,17804,BAO_0000218,,Bioavailability value of compound in rats was determined after peroral administration,,A,,N,1,Intermediate,CHEMBL622275,,
10314,Rattus norvegicus,1,,3634,BAO_0000218,,Oral bioavailability in rat (dose 20 mg/kg),,A,,N,1,Intermediate,CHEMBL622276,,
10315,Rattus norvegicus,1,,3341,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622277,,
10316,Rattus norvegicus,1,,2690,BAO_0000218,,Oral bioavailability in rat (dose 5 mg/kg),,A,,N,1,Intermediate,CHEMBL622278,,
10317,Rattus norvegicus,1,,3184,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622279,,
10318,Rattus norvegicus,1,,740,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622280,,
10319,Rattus norvegicus,1,,1806,BAO_0000218,,Compound was evaluated for oral bioavailability in rats; 15-27 %,,A,,N,1,Intermediate,CHEMBL624083,,
10320,Rattus norvegicus,1,,4891,BAO_0000218,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,A,,N,1,Intermediate,CHEMBL624084,,
10321,Rattus norvegicus,1,,3634,BAO_0000218,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,A,,N,1,Intermediate,CHEMBL624085,,
10322,Rattus norvegicus,1,,64,BAO_0000218,,Compound was tested for bioavailability in rats,,A,,N,1,Intermediate,CHEMBL624086,,
10323,Rattus norvegicus,1,,4839,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL624087,,
10324,Rattus norvegicus,1,,1094,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL624088,,
10325,Macaca mulatta,1,,5005,BAO_0000218,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,A,,U,0,Intermediate,CHEMBL624089,,
10326,Rattus norvegicus,1,,5005,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,A,,U,0,Intermediate,CHEMBL624090,,
10327,Rattus norvegicus,1,,4687,BAO_0000218,,Evaluated for the bioavailability in rat (in vivo),,A,,N,1,Intermediate,CHEMBL624091,,
10328,Rattus norvegicus,1,,17804,BAO_0000218,,F value of compound in rats was determined after peroral administration,,A,,N,1,Intermediate,CHEMBL624092,,
10329,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL624093,,
10330,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL624094,,
10331,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL624095,,
10332,Rattus norvegicus,1,,5974,BAO_0000218,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL624096,,
10333,Rattus norvegicus,1,,1088,BAO_0000218,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,A,,N,1,Intermediate,CHEMBL624097,,
10334,Rattus norvegicus,1,,1742,BAO_0000218,,Maximum fall in carotid flow in rat,,A,,N,1,Intermediate,CHEMBL624098,,
10335,Rattus norvegicus,1,,4689,BAO_0000218,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,A,,N,1,Intermediate,CHEMBL874392,,
10336,Rattus norvegicus,1,,2463,BAO_0000218,,Oral bioavailability in rat (dose 5 mg/kg),,A,,N,1,Intermediate,CHEMBL624099,,
10337,Rattus norvegicus,1,,5654,BAO_0000218,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,A,,N,1,Intermediate,CHEMBL624100,,
10338,Rattus norvegicus,1,,5654,BAO_0000218,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,A,,N,1,Intermediate,CHEMBL624101,,
10339,Rattus norvegicus,1,,6874,BAO_0000218,,Oral bioavailability in rat (male Wistar),,A,,N,1,Intermediate,CHEMBL624102,,
10340,Rattus norvegicus,1,,5633,BAO_0000218,,Oral bioavailability after administration (30 mg/kg) in rat; good,,A,,N,1,Intermediate,CHEMBL624103,,
10341,Rattus norvegicus,1,,5496,BAO_0000218,,Oral bioavailability at the dose of 2 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL624104,,
10342,Rattus norvegicus,1,,2358,BAO_0000218,,Oral bioavailability determined in rats,,A,,N,1,Intermediate,CHEMBL624105,,
10343,Rattus norvegicus,1,,16456,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL624106,,
10344,Rattus norvegicus,1,,5302,BAO_0000218,,Oral bioavailability in rat (dose single 10 mg/kg),,A,,N,1,Intermediate,CHEMBL624107,,
10345,Rattus norvegicus,1,,5302,BAO_0000218,,Oral bioavailability in rat (dose single 10 mg/kg),,A,,N,1,Intermediate,CHEMBL623943,,
10346,Rattus norvegicus,1,,5302,BAO_0000218,,Oral bioavailability in rat (dose 5 mg/kg,,A,,N,1,Intermediate,CHEMBL623944,,
10347,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,A,,N,1,Intermediate,CHEMBL623945,,
10348,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,A,,N,1,Intermediate,CHEMBL623946,,
10349,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,A,,N,1,Intermediate,CHEMBL623947,,
10350,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,A,,N,1,Intermediate,CHEMBL623948,,
10351,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,A,,N,1,Intermediate,CHEMBL623949,,
10352,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,A,,N,1,Intermediate,CHEMBL623950,,
10353,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,A,,N,1,Intermediate,CHEMBL874398,,
10354,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,A,,N,1,Intermediate,CHEMBL623951,,
10355,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,A,,N,1,Intermediate,CHEMBL623952,,
10356,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,A,,N,1,Intermediate,CHEMBL623953,,
10357,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,A,,N,1,Intermediate,CHEMBL623954,,
10358,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,A,,N,1,Intermediate,CHEMBL623955,,
10359,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,A,,N,1,Intermediate,CHEMBL623956,,
10360,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,A,,N,1,Intermediate,CHEMBL627807,,
10361,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,A,,N,1,Intermediate,CHEMBL627808,,
10362,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,A,,N,1,Intermediate,CHEMBL627809,,
10363,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,A,,N,1,Intermediate,CHEMBL627810,,
10364,Rattus norvegicus,1,,11020,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,A,,N,1,Intermediate,CHEMBL627811,,
10365,Rattus norvegicus,1,,11020,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,A,,N,1,Intermediate,CHEMBL627812,,
10366,Rattus norvegicus,1,,11020,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,A,,N,1,Intermediate,CHEMBL627813,,
10367,Rattus norvegicus,1,,11020,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,A,,N,1,Intermediate,CHEMBL627814,,
10368,Rattus norvegicus,1,,11020,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,A,,N,1,Intermediate,CHEMBL875336,,
10369,Rattus norvegicus,1,,11020,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,A,,N,1,Intermediate,CHEMBL627815,,
10370,Rattus norvegicus,1,,11020,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,A,,N,1,Intermediate,CHEMBL627816,,
10371,Rattus norvegicus,1,,11020,BAO_0000218,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,A,,N,1,Intermediate,CHEMBL627817,,
10372,Rattus norvegicus,1,,11020,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,A,,N,1,Intermediate,CHEMBL627818,,
10373,Rattus norvegicus,1,,11020,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,A,,N,1,Intermediate,CHEMBL627819,,
10374,Rattus norvegicus,1,,11020,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,A,,N,1,Intermediate,CHEMBL627820,,
10375,Rattus norvegicus,1,,11020,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,A,,N,1,Intermediate,CHEMBL627821,,
10376,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,A,,N,1,Intermediate,CHEMBL628464,,
10377,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,A,,N,1,Intermediate,CHEMBL626239,,
10378,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,A,,N,1,Intermediate,CHEMBL626240,,
10379,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,A,,N,1,Intermediate,CHEMBL626241,,
10380,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,A,,N,1,Intermediate,CHEMBL626242,,
10381,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,A,,N,1,Intermediate,CHEMBL626243,,
10382,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,A,,N,1,Intermediate,CHEMBL626244,,
10383,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,A,,N,1,Intermediate,CHEMBL626907,,
10384,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,A,,N,1,Intermediate,CHEMBL626908,,
10385,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,A,,N,1,Intermediate,CHEMBL626909,,
10386,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,A,,N,1,Intermediate,CHEMBL626910,,
10387,Rattus norvegicus,1,,7449,BAO_0000218,,Percent total excretion of acetaminophen cysteine conjugate,,F,,N,1,Intermediate,CHEMBL875342,,
10388,Rattus norvegicus,1,,7449,BAO_0000218,,Percent total excretion of acetaminophen glucuronide,,F,,N,1,Intermediate,CHEMBL626911,,
10389,Rattus norvegicus,1,,7449,BAO_0000218,,Percent total excretion of acetaminophen sulfate,,F,,N,1,Intermediate,CHEMBL626912,,
10390,Rattus norvegicus,1,,7449,BAO_0000218,,Percent total excretion of acetaminophen-mercapturic acid,,F,,N,1,Intermediate,CHEMBL627065,,
10391,Rattus norvegicus,1,1088.0,3172,BAO_0000218,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,A,,N,1,Intermediate,CHEMBL627066,,
10392,Rattus norvegicus,1,,16456,BAO_0000218,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL627067,,
10393,ratrat,1,2385.0,10839,BAO_0000218,,Biodistribution of compound in rat muscle after 5 min of administration,,A,,U,0,Autocuration,CHEMBL627068,,
10394,ratrat,1,2385.0,10839,BAO_0000218,,Biodistribution of compound in rat muscle after 5 min of administration.,,A,,U,0,Autocuration,CHEMBL627069,,
10395,Ovis aries,1,,5334,BAO_0000218,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,A,,U,0,Autocuration,CHEMBL627070,,
10396,Ovis aries,1,,5334,BAO_0000218,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,A,,U,0,Autocuration,CHEMBL627071,,
10397,Ovis aries,1,,5334,BAO_0000218,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,A,,U,0,Autocuration,CHEMBL627072,,
10398,Ovis aries,1,,5334,BAO_0000218,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,A,,U,0,Autocuration,CHEMBL627073,,
10399,Ovis aries,1,,5334,BAO_0000218,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,A,,U,0,Autocuration,CHEMBL625387,,
10400,Ovis aries,1,,5334,BAO_0000218,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,A,,U,0,Autocuration,CHEMBL625388,,
10401,Ovis aries,1,1969.0,5334,BAO_0000218,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,A,,U,0,Autocuration,CHEMBL625389,,
10402,Ovis aries,1,1969.0,5334,BAO_0000218,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,A,,U,0,Autocuration,CHEMBL875343,,
10403,Serpentes,1,,1735,BAO_0000218,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,A,,N,1,Intermediate,CHEMBL876795,,
10404,Serpentes,1,,1469,BAO_0000218,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,A,,N,1,Intermediate,CHEMBL626552,,
10405,Serpentes,1,,1336,BAO_0000218,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,A,,N,1,Intermediate,CHEMBL626553,,
10406,Homo sapiens,1,1969.0,12403,BAO_0000366,,The human biological plasma half life of the compound,,A,,U,0,Autocuration,CHEMBL626554,,
10407,Rattus norvegicus,1,1088.0,8151,BAO_0000218,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,A,,N,1,Intermediate,CHEMBL626555,,
10408,Rattus norvegicus,1,,8004,BAO_0000218,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,A,,N,1,Intermediate,CHEMBL626556,,
10409,Rattus norvegicus,1,,8004,BAO_0000218,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,A,,N,1,Intermediate,CHEMBL626557,,
10410,Rattus norvegicus,1,,8004,BAO_0000218,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,A,,N,1,Intermediate,CHEMBL626558,,
10411,Rattus norvegicus,1,,8004,BAO_0000218,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,A,,N,1,Intermediate,CHEMBL626559,,
10412,Rattus norvegicus,1,,8004,BAO_0000218,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,A,,N,1,Intermediate,CHEMBL626560,,
10413,Rattus norvegicus,1,,8004,BAO_0000218,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,A,,N,1,Intermediate,CHEMBL876803,,
10414,Rattus norvegicus,1,,8004,BAO_0000218,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,A,,N,1,Intermediate,CHEMBL627964,,
10415,Rattus norvegicus,1,,8004,BAO_0000218,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,A,,N,1,Intermediate,CHEMBL627965,,
10416,Rattus norvegicus,1,,8004,BAO_0000218,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,A,,N,1,Intermediate,CHEMBL627966,,
10417,Rattus norvegicus,1,,8004,BAO_0000218,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,A,,N,1,Intermediate,CHEMBL627967,,
10418,Rattus norvegicus,1,,8004,BAO_0000218,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,A,,N,1,Intermediate,CHEMBL627968,,
10419,Rattus norvegicus,1,,8004,BAO_0000218,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,A,,N,1,Intermediate,CHEMBL627969,,
10420,Rattus norvegicus,1,,8004,BAO_0000218,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,A,,N,1,Intermediate,CHEMBL627970,,
10421,Rattus norvegicus,1,178.0,8004,BAO_0000218,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,A,,N,1,Intermediate,CHEMBL627971,,
10422,Rattus norvegicus,1,178.0,8004,BAO_0000218,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,A,,N,1,Intermediate,CHEMBL627972,,
10423,Homo sapiens,1,,15917,BAO_0000357,,Dissociation constant against binding to human cyclophilin A,,B,,D,9,Expert,CHEMBL856029,,
10424,Bos taurus,1,,12396,BAO_0000019,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,B,,H,8,Expert,CHEMBL627973,,
10425,,1,,7065,BAO_0000019,,-Log C was determined by performing the electroshock minimum test,,A,,U,0,Autocuration,CHEMBL627974,,
10426,,1,,7065,BAO_0000019,,-Log C was determined by performing the foot shock test,,A,,U,0,Autocuration,CHEMBL627975,,
10427,,1,,7065,BAO_0000019,,-Log C was determined by performing the incl screen test,,A,,U,0,Autocuration,CHEMBL627976,,
10428,,1,,7065,BAO_0000019,,-Log C was determined by performing the maximum electroshock test,,A,,U,0,Autocuration,CHEMBL627977,,
10429,,1,,7065,BAO_0000019,,-Log C was determined by performing the pentylenetetrazole test,,A,,U,0,Autocuration,CHEMBL627978,,
10430,,1,,12415,BAO_0000019,,Tested for experimental arotinoid inhibitory dose,,A,,U,0,Autocuration,CHEMBL627979,,
10431,,1,,10256,BAO_0000019,,Negative log transformed activity,,A,,U,0,Autocuration,CHEMBL876804,,
10432,,1,,7991,BAO_0000019,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,A,,U,0,Autocuration,CHEMBL627980,,
10433,Cavia porcellus,1,,14342,BAO_0000218,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,A,,N,1,Intermediate,CHEMBL627981,,
10434,Cavia porcellus,1,,14342,BAO_0000218,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,A,,N,1,Intermediate,CHEMBL627982,,
10435,Cavia porcellus,1,,14342,BAO_0000218,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,A,,N,1,Intermediate,CHEMBL627983,,
10436,Cavia porcellus,1,2116.0,14342,BAO_0000218,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,A,,N,1,Intermediate,CHEMBL627984,,
10437,,1,,6047,BAO_0000100,,Solubility in water was determined; values expressed as -log,,P,,U,0,Autocuration,CHEMBL627985,,
10438,,1,,17269,BAO_0000019,,Ratio of Kcat to that of Km was determined,,A,,U,0,Autocuration,CHEMBL627986,,
10439,,1,,10026,BAO_0000019,,Observed first order rate constant,,A,,U,0,Autocuration,CHEMBL627987,,
10440,,1,,14583,BAO_0000019,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,A,,U,0,Autocuration,CHEMBL627988,,
10441,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,A,,N,1,Intermediate,CHEMBL627989,,
10442,Rattus norvegicus,1,,2661,BAO_0000218,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,A,,N,1,Intermediate,CHEMBL627990,,
10443,Rattus norvegicus,1,,4029,BAO_0000218,,Oral Bioavailability after administration of 10 mg/kg in male rat,,A,,N,1,Intermediate,CHEMBL876805,,
10444,Rattus norvegicus,1,,17735,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL627991,,
10445,Rattus norvegicus,1,,4576,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL627992,,
10446,Rattus norvegicus,1,,17582,BAO_0000218,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,A,,N,1,Intermediate,CHEMBL627993,,
10447,Rattus norvegicus,1,,17651,BAO_0000218,,Oral bioavailability at 1 mg/kg was determined in rat,,A,,N,1,Intermediate,CHEMBL622817,,
10448,Rattus norvegicus,1,,17651,BAO_0000218,,Oral bioavailability at 10 mg/kg was determined in rat,,A,,N,1,Intermediate,CHEMBL622818,,
10449,Rattus norvegicus,1,,17670,BAO_0000218,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,A,,N,1,Intermediate,CHEMBL622819,,
10450,Rattus norvegicus,1,,5045,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL872267,,
10451,Rattus norvegicus,1,,1696,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622820,,
10452,Rattus norvegicus,1,,17764,BAO_0000218,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,A,,N,1,Intermediate,CHEMBL622821,,
10453,Rattus norvegicus,1,,6448,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622822,,
10454,Rattus norvegicus,1,,6596,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622823,,
10455,Rattus norvegicus,1,,17547,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622824,,
10456,Rattus norvegicus,1,,17771,BAO_0000218,,Oral bioavailability in rat at a dose of 3 mg/kg,,A,,N,1,Intermediate,CHEMBL622825,,
10457,Rattus norvegicus,1,,6495,BAO_0000218,,Oral bioavailability in rat after oral administration at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL622901,,
10458,Rattus norvegicus,1,,4558,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622902,,
10459,Rattus norvegicus,1,,17596,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL621844,,
10460,Rattus norvegicus,1,,6827,BAO_0000218,,Oral bioavailability in Dawley rats,,A,,N,1,Intermediate,CHEMBL621845,,
10461,Rattus norvegicus,1,,4026,BAO_0000218,,Oral bioavailability,,A,,N,1,Intermediate,CHEMBL621846,,
10462,Rattus norvegicus,1,,10,BAO_0000218,,Oral bioavailability in rat (dose 30 mg/kg),,A,,N,1,Intermediate,CHEMBL621847,,
10463,Rattus norvegicus,1,,17717,BAO_0000218,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,A,,N,1,Intermediate,CHEMBL877609,,
10464,Rattus norvegicus,1,,17717,BAO_0000218,,Bioavailability in rat (dose 3 mg/kg i.v.),,A,,N,1,Intermediate,CHEMBL621848,,
10465,Rattus norvegicus,1,,17717,BAO_0000218,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,A,,N,1,Intermediate,CHEMBL621849,,
10466,Rattus norvegicus,1,,17717,BAO_0000218,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL622030,,
10467,Rattus norvegicus,1,,4796,BAO_0000218,,Percent oral bioavailability determined in rats,,A,,N,1,Intermediate,CHEMBL622031,,
10468,Rattus norvegicus,1,,4883,BAO_0000218,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,A,,N,1,Intermediate,CHEMBL622032,,
10469,Rattus norvegicus,1,,2137,BAO_0000218,,The compound was evaluated for bioavailability in rats; 32-51,,A,,N,1,Intermediate,CHEMBL622033,,
10470,Rattus norvegicus,1,,2959,BAO_0000218,,Bioavailability in rat (dose 20 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL622034,,
10471,Rattus norvegicus,1,,1361,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622035,,
10472,Rattus norvegicus,1,,4727,BAO_0000218,,Bioavailability percent in rat at the dose of 2 mg/kg,,A,,N,1,Intermediate,CHEMBL882966,,
10473,Rattus norvegicus,1,,16423,BAO_0000218,,Bioavailability was evaluated after 20 uM/kg of peroral administration,,A,,N,1,Intermediate,CHEMBL622036,,
10474,Rattus norvegicus,1,,5206,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622037,,
10475,Rattus norvegicus,1,,6448,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622038,,
10476,Rattus norvegicus,1,,17723,BAO_0000218,,Bioavailability in rats,,A,,N,1,Intermediate,CHEMBL622039,,
10477,Rattus norvegicus,1,178.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622040,,
10478,Rattus norvegicus,1,178.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622041,,
10479,Rattus norvegicus,1,178.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622042,,
10480,Rattus norvegicus,1,178.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622043,,
10481,Rattus norvegicus,1,178.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622044,,
10482,Rattus norvegicus,1,10000001.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622045,,
10483,Rattus norvegicus,1,10000001.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622046,,
10484,Rattus norvegicus,1,10000001.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622047,,
10485,Rattus norvegicus,1,10000001.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL877610,,
10486,Rattus norvegicus,1,955.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622048,,
10487,Rattus norvegicus,1,955.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622049,,
10488,Rattus norvegicus,1,955.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622050,,
10489,Rattus norvegicus,1,955.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622051,,
10490,Rattus norvegicus,1,,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622052,,
10491,Rattus norvegicus,1,,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622053,,
10492,Rattus norvegicus,1,,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622054,,
10493,Rattus norvegicus,1,,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622055,,
10494,Rattus norvegicus,1,,5237,BAO_0000218,,Oral bioavailability in rats was determined; High,,A,,N,1,Intermediate,CHEMBL622056,,
10495,Rattus norvegicus,1,,5503,BAO_0000218,,Oral bioavailability in the rat was determined,,A,,N,1,Intermediate,CHEMBL622057,,
10496,Rattus norvegicus,1,,15765,BAO_0000218,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,A,,N,1,Intermediate,CHEMBL628008,,
10497,Rattus norvegicus,1,,15660,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,A,,N,1,Intermediate,CHEMBL622058,,
10498,Rattus norvegicus,1,,5978,BAO_0000218,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL622059,,
10499,Rattus norvegicus,1,,5978,BAO_0000218,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL622060,,
10500,Rattus norvegicus,1,,5978,BAO_0000218,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL622061,,
10501,Rattus norvegicus,1,,5978,BAO_0000218,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,,N,1,Intermediate,CHEMBL622062,,
10502,Rattus norvegicus,1,,5656,BAO_0000218,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,A,,N,1,Intermediate,CHEMBL622063,,
10503,Rattus norvegicus,1,,3598,BAO_0000218,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,A,,N,1,Expert,CHEMBL877611,,
10504,Rattus norvegicus,1,,4216,BAO_0000218,,Oral bioavailability of compound in Sprague Dawley rats,,A,,N,1,Intermediate,CHEMBL622064,,
10505,Rattus norvegicus,1,,17839,BAO_0000218,,Oral bioavailability of compound in rat,,A,,N,1,Intermediate,CHEMBL622065,,
10506,Rattus norvegicus,1,,6570,BAO_0000218,,Oral bioavailability in rat (dose 2 mg/kg),,A,,N,1,Intermediate,CHEMBL622066,,
10507,Rattus norvegicus,1,,5334,BAO_0000218,,Oral bioavailability of compound in rat was determined,,A,,N,1,Intermediate,CHEMBL622067,,
10508,Rattus norvegicus,1,,6886,BAO_0000218,,Oral bioavailability of compound in rats,,A,,N,1,Intermediate,CHEMBL622068,,
10509,Rattus norvegicus,1,,5210,BAO_0000218,,Oral bioavailability of compound was determined in rats,,A,,N,1,Intermediate,CHEMBL622069,,
10510,Rattus norvegicus,1,,4170,BAO_0000218,,Oral bioavailability at a dose of 30 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL624796,,
10511,Rattus norvegicus,1,,6028,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg),,A,,N,1,Intermediate,CHEMBL624797,,
10512,Rattus norvegicus,1,,6028,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg),,A,,N,1,Intermediate,CHEMBL623053,,
10513,Rattus norvegicus,1,,6078,BAO_0000218,,Oral bioavailability evaluated in rat,,A,,N,1,Intermediate,CHEMBL623054,,
10514,Rattus norvegicus,1,,6168,BAO_0000218,,Oral bioavailability in fasted rat,,A,,N,1,Intermediate,CHEMBL623055,,
10515,Rattus norvegicus,1,,6168,BAO_0000218,,Oral bioavailability in fed rat,,A,,N,1,Intermediate,CHEMBL623056,,
10516,Rattus norvegicus,1,,5160,BAO_0000218,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,A,,N,1,Intermediate,CHEMBL623057,,
10517,Rattus norvegicus,1,,6057,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623058,,
10518,Rattus norvegicus,1,,6535,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL623059,,
10519,Rattus norvegicus,1,,6535,BAO_0000218,,Oral bioavailability in rat after administration of 10 mg/kg po,,A,,N,1,Intermediate,CHEMBL623060,,
10520,Rattus norvegicus,1,,4194,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623061,,
10521,Rattus norvegicus,1,,6230,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623062,,
10522,Rattus norvegicus,1,,6619,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623063,,
10523,Rattus norvegicus,1,,17607,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623064,,
10524,Rattus norvegicus,1,,4942,BAO_0000218,,Oral bioavailability in ratrs,,A,,N,1,Intermediate,CHEMBL623065,,
10525,Rattus norvegicus,1,,4942,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623066,,
10526,Rattus norvegicus,1,,6646,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623067,,
10527,Rattus norvegicus,1,,5237,BAO_0000218,,Oral bioavailability in rats was determined; High,,A,,N,1,Intermediate,CHEMBL623068,,
10528,Rattus norvegicus,1,,6646,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623069,,
10529,Rattus norvegicus,1,,4449,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623070,,
10530,Rattus norvegicus,1,,6057,BAO_0000218,,Oral bioavailability was calculated in rat,,A,,N,1,Intermediate,CHEMBL623071,,
10531,Rattus norvegicus,1,,2552,BAO_0000218,,Oral bioavailability,,A,,N,1,Intermediate,CHEMBL623072,,
10532,Rattus norvegicus,1,,5496,BAO_0000218,,Oral bioavailability,,A,,N,1,Intermediate,CHEMBL623073,,
10533,Rattus norvegicus,1,,6484,BAO_0000218,,Oral bioavailability,,A,,N,1,Intermediate,CHEMBL623074,,
10534,Rattus norvegicus,1,,6485,BAO_0000218,,Oral bioavailability,,A,,N,1,Intermediate,CHEMBL623075,,
10535,Rattus norvegicus,1,,6616,BAO_0000218,,Oral bioavailability after i.v. administration,,A,,N,1,Intermediate,CHEMBL623076,,
10536,Rattus norvegicus,1,,4969,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,A,,N,1,Intermediate,CHEMBL623077,,
10537,Rattus norvegicus,1,,5862,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley),,A,,N,1,Intermediate,CHEMBL623078,,
10538,Rattus norvegicus,1,,4514,BAO_0000218,,Oral bioavailability in Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL623079,,
10539,Rattus norvegicus,1,,4514,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,A,,N,1,Intermediate,CHEMBL623080,,
10540,Rattus norvegicus,1,,4514,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,A,,N,1,Intermediate,CHEMBL623081,,
10541,Rattus norvegicus,1,,5546,BAO_0000218,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,A,,N,1,Intermediate,CHEMBL623082,,
10542,Rattus norvegicus,1,,6168,BAO_0000218,,Oral bioavailability in fasted rat,,A,,N,1,Intermediate,CHEMBL874400,,
10543,Rattus norvegicus,1,,6168,BAO_0000218,,Oral bioavailability in fed rat,,A,,N,1,Intermediate,CHEMBL623083,,
10544,Rattus norvegicus,1,,3624,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623084,,
10545,Rattus norvegicus,1,,5213,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623085,,
10546,Rattus norvegicus,1,,5496,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623086,,
10547,Rattus norvegicus,1,,5553,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623087,,
10548,Rattus norvegicus,1,,5833,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623088,,
10549,Rattus norvegicus,1,,5836,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623089,,
10550,Rattus norvegicus,1,,5865,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623090,,
10551,Rattus norvegicus,1,,5960,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623091,,
10552,Rattus norvegicus,1,,6249,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623092,,
10553,Rattus norvegicus,1,,6448,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623093,,
10554,Rattus norvegicus,1,,6453,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL874401,,
10555,Rattus norvegicus,1,,6640,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623094,,
10556,Rattus norvegicus,1,,17607,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL623095,,
10557,Rattus norvegicus,1,,5939,BAO_0000218,,Oral bioavailability in rat after peroral administration at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL623096,,
10558,Rattus norvegicus,1,,5939,BAO_0000218,,Oral bioavailability in rat after peroral administration at 5 mg/kg,,A,,N,1,Intermediate,CHEMBL624913,,
10559,Rattus norvegicus,1,,6281,BAO_0000218,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL624914,,
10560,Rattus norvegicus,1,,5874,BAO_0000218,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,A,,N,1,Intermediate,CHEMBL624915,,
10561,Rattus norvegicus,1,,5213,BAO_0000218,,Oral bioavailability in rat; Not measured,,A,,N,1,Intermediate,CHEMBL624916,,
10562,Rattus norvegicus,1,,4964,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL624917,,
10563,Rattus norvegicus,1,,11020,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,A,,N,1,Intermediate,CHEMBL625157,,
10564,Rattus norvegicus,1,2107.0,6251,BAO_0000218,,In vitro metabolic potential in rat liver microsomes,,A,,N,1,Intermediate,CHEMBL625158,,
10565,Rattus norvegicus,1,,1568,BAO_0000218,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,A,,N,1,Intermediate,CHEMBL625159,,
10566,Rattus norvegicus,1,,3032,BAO_0000218,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,A,,N,1,Intermediate,CHEMBL625160,,
10567,Rattus norvegicus,1,,3748,BAO_0000218,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,A,,N,1,Intermediate,CHEMBL625161,,
10568,Rattus norvegicus,1,,401,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL625162,,
10569,Rattus norvegicus,1,,6512,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL625163,,
10570,Rattus norvegicus,1,,17617,BAO_0000218,,Oral bioavailability in rats at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL625164,,
10571,Rattus norvegicus,1,,6679,BAO_0000218,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,A,,N,1,Intermediate,CHEMBL625165,,
10572,Rattus norvegicus,1,,6742,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL625166,,
10573,Rattus norvegicus,1,,589,BAO_0000218,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,A,,N,1,Intermediate,CHEMBL625167,,
10574,Rattus norvegicus,1,,589,BAO_0000218,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,A,,N,1,Intermediate,CHEMBL625168,,
10575,Rattus norvegicus,1,,3185,BAO_0000218,,Plasma clearance of the compound,,A,,N,1,Intermediate,CHEMBL625169,,
10576,Rattus norvegicus,1,,17596,BAO_0000218,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,A,,N,1,Intermediate,CHEMBL626264,,
10577,Rattus norvegicus,1,,2713,BAO_0000218,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,A,,N,1,Intermediate,CHEMBL626265,,
10578,Rattus norvegicus,1,1969.0,12500,BAO_0000218,,The compound was tested for plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL626266,,
10579,Rattus norvegicus,1,1969.0,12500,BAO_0000218,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,A,,N,1,Intermediate,CHEMBL626267,,
10580,Rattus norvegicus,1,,2713,BAO_0000218,,Plasma concentration upon oral administration of 1 mg/Kg in rats,,A,,N,1,Intermediate,CHEMBL626268,,
10581,Rattus norvegicus,1,,1446,BAO_0000218,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,A,,N,1,Intermediate,CHEMBL626269,,
10582,Rattus norvegicus,1,,6227,BAO_0000218,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,A,,N,1,Intermediate,CHEMBL626270,,
10583,Rattus norvegicus,1,,4709,BAO_0000218,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL626271,,
10584,Rattus norvegicus,1,,5510,BAO_0000218,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,A,,N,1,Intermediate,CHEMBL626272,,
10585,Rattus norvegicus,1,,5510,BAO_0000218,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,A,,N,1,Intermediate,CHEMBL626273,,
10586,Rattus norvegicus,1,,5510,BAO_0000218,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,A,,N,1,Intermediate,CHEMBL875346,,
10587,Rattus norvegicus,1,,5510,BAO_0000218,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,A,,N,1,Intermediate,CHEMBL626274,,
10588,Rattus norvegicus,1,,4514,BAO_0000218,,Compound was tested for protein binding in rat plasma,,A,,N,1,Intermediate,CHEMBL626275,,
10589,Rattus norvegicus,1,,2713,BAO_0000218,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,A,,N,1,Intermediate,CHEMBL624646,,
10590,Rattus norvegicus,1,,2713,BAO_0000218,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,A,,N,1,Intermediate,CHEMBL624647,,
10591,Rattus norvegicus,1,2107.0,5340,BAO_0000218,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,A,,N,1,Intermediate,CHEMBL624648,,
10592,Rattus norvegicus,1,,12058,BAO_0000218,,Area under curve ratio was determined (po/iv) in rat,,A,,N,1,Intermediate,CHEMBL624649,,
10593,Rattus norvegicus,1,,11195,BAO_0000218,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL624650,,
10594,Rattus norvegicus,1,,11195,BAO_0000218,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL624651,,
10595,Rattus norvegicus,1,,11195,BAO_0000218,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL624652,,
10596,Rattus norvegicus,1,,6495,BAO_0000218,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,A,,N,1,Intermediate,CHEMBL624653,,
10597,Rattus norvegicus,1,,6078,BAO_0000218,,Ratio of AUCbrain to AUCplasma,,A,,N,1,Intermediate,CHEMBL624654,,
10598,Rattus norvegicus,1,,5656,BAO_0000218,,Ratio of brain to plasma,,A,,N,1,Intermediate,CHEMBL624655,,
10599,Rattus norvegicus,1,,4910,BAO_0000218,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,A,,N,1,Intermediate,CHEMBL624656,,
10600,Rattus norvegicus,1,,4910,BAO_0000218,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,A,,N,1,Intermediate,CHEMBL624657,,
10601,Rattus norvegicus,1,,4910,BAO_0000218,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,A,,N,1,Intermediate,CHEMBL624658,,
10602,Rattus norvegicus,1,,10130,BAO_0000218,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,A,,N,1,Intermediate,CHEMBL624659,,
10603,Rattus norvegicus,1,,10130,BAO_0000218,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,A,,N,1,Intermediate,CHEMBL624660,,
10604,Rattus norvegicus,1,,10130,BAO_0000218,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,A,,N,1,Intermediate,CHEMBL624661,,
10605,Rattus norvegicus,1,,5213,BAO_0000218,,Steady state brain :blood ratio was determined,,A,,N,1,Intermediate,CHEMBL624662,,
10606,Rattus norvegicus,1,,4910,BAO_0000218,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,A,,N,1,Intermediate,CHEMBL625199,,
10607,Rattus norvegicus,1,,4910,BAO_0000218,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,A,,N,1,Intermediate,CHEMBL625200,,
10608,Rattus norvegicus,1,,4910,BAO_0000218,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,A,,N,1,Intermediate,CHEMBL625201,,
10609,Rattus norvegicus,1,,4910,BAO_0000218,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,A,,N,1,Intermediate,CHEMBL625202,,
10610,Rattus norvegicus,1,,2083,BAO_0000218,,Percentage recovery after 3h incubation with rat hapatocytes was determined,,A,,N,1,Intermediate,CHEMBL625203,,
10611,Rattus norvegicus,1,,2082,BAO_0000218,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,A,,N,1,Intermediate,CHEMBL625204,,
10612,Rattus norvegicus,1,,2082,BAO_0000218,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,A,,N,1,Intermediate,CHEMBL625205,,
10613,Rattus norvegicus,1,,6351,BAO_0000218,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL625206,,
10614,,1,,14583,BAO_0000019,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,A,,U,0,Autocuration,CHEMBL625207,,
10615,,1,,14583,BAO_0000019,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,A,,U,0,Autocuration,CHEMBL625208,,
10616,Homo sapiens,1,,4608,BAO_0000218,,In vivo absorption in Caco-2 cell line monolayers was determined,,A,,N,1,Intermediate,CHEMBL625209,495.0,
10617,,1,,13668,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625210,,
10618,Rattus norvegicus,1,,5669,BAO_0000218,,Area under curve was determine after peroral administration at 10 mpk in Rat,,A,,N,1,Intermediate,CHEMBL625211,,
10619,Macaca mulatta,1,,5669,BAO_0000218,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,A,,N,1,Intermediate,CHEMBL625212,,
10620,Rattus norvegicus,1,,5669,BAO_0000218,,Area under curve was determine after peroral administration at 160 mpk in Rat,,A,,N,1,Intermediate,CHEMBL625213,,
10621,Rattus norvegicus,1,,5669,BAO_0000218,,Area under curve was determine after peroral administration at 20 mpk in Rat,,A,,N,1,Intermediate,CHEMBL625214,,
10622,Rattus norvegicus,1,,5669,BAO_0000218,,Area under curve was determine after peroral administration at 50 mpk in Rat,,A,,N,1,Intermediate,CHEMBL874542,,
10623,,1,,6472,BAO_0000100,,Calculated partition coefficient (clogP) (AlogP),,P,,U,0,Autocuration,CHEMBL625215,,
10624,,1,,15106,BAO_0000019,,Activated partial thromboplastin time measured,,A,,U,0,Autocuration,CHEMBL625216,,
10625,,1,,15207,BAO_0000100,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,P,,U,0,Autocuration,CHEMBL625217,,
10626,,1,,15207,BAO_0000100,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,P,,U,0,Autocuration,CHEMBL625218,,
10627,Canis lupus familiaris,1,1969.0,13941,BAO_0000218,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,A,,N,1,Intermediate,CHEMBL622864,,
10628,Rattus norvegicus,1,1969.0,13941,BAO_0000218,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,A,,N,1,Intermediate,CHEMBL622865,,
10629,Rattus norvegicus,1,1969.0,13941,BAO_0000218,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,A,,N,1,Intermediate,CHEMBL622866,,
10630,Canis lupus familiaris,1,1969.0,13941,BAO_0000218,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,A,,N,1,Intermediate,CHEMBL622867,,
10631,Cavia porcellus,1,1969.0,15240,BAO_0000218,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,A,,N,1,Intermediate,CHEMBL876808,,
10632,,1,955.0,10655,BAO_0000019,,AUC in brain,,A,,U,0,Autocuration,CHEMBL627725,,
10633,,1,1977.0,10655,BAO_0000019,,AUC in serum,,A,,U,0,Autocuration,CHEMBL627726,,
10634,,1,1969.0,6504,BAO_0000019,,AUC was determined,,A,,U,0,Autocuration,CHEMBL627727,,
10635,,1,1969.0,10615,BAO_0000019,,AUC of the compound.,,A,,U,0,Autocuration,CHEMBL627728,,
10636,,1,1969.0,10353,BAO_0000019,,AUC value (0-4 hr),,A,,U,0,Autocuration,CHEMBL627729,,
10637,,1,1969.0,14907,BAO_0000019,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,A,,U,0,Autocuration,CHEMBL627730,,
10638,,1,1969.0,14907,BAO_0000019,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,A,,U,0,Autocuration,CHEMBL627731,,
10639,,1,1969.0,14907,BAO_0000019,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,A,,U,0,Autocuration,CHEMBL627732,,
10640,,1,1969.0,14907,BAO_0000019,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,A,,U,0,Autocuration,CHEMBL627733,,
10641,Rattus norvegicus,1,1969.0,16359,BAO_0000218,,AUC(area under curve) was determined after intravenous administration in rats,,A,,N,1,Intermediate,CHEMBL627734,,
10642,Rattus norvegicus,1,1969.0,16359,BAO_0000218,,AUC(area under curve) was determined after oral administration in rats,,A,,N,1,Intermediate,CHEMBL627735,,
10643,Cavia porcellus,1,1969.0,15240,BAO_0000218,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,A,,N,1,Intermediate,CHEMBL627736,,
10644,Rattus norvegicus,1,1969.0,15240,BAO_0000218,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,A,,N,1,Intermediate,CHEMBL876809,,
10645,,1,,15469,BAO_0000019,,Area Under Curve after oral dosing of 100 uM/Kg,,A,,U,0,Autocuration,CHEMBL627737,,
10646,,1,,15469,BAO_0000019,,Area Under Curve after oral dosing of 30 uM/Kg,,A,,U,0,Autocuration,CHEMBL627738,,
10647,,1,,13520,BAO_0000019,,Area Under Curve was measured by ploting the graph between concentration verses time,,A,,U,0,Autocuration,CHEMBL627739,,
10648,Canis lupus familiaris,1,,17025,BAO_0000218,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,A,,N,1,Intermediate,CHEMBL626143,,
10649,Simiiformes,1,,17025,BAO_0000218,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,A,,U,0,Autocuration,CHEMBL626144,,
10650,Oryctolagus cuniculus,1,,17025,BAO_0000218,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,A,,N,1,Intermediate,CHEMBL626145,,
10651,Rattus norvegicus,1,,17025,BAO_0000218,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,A,,N,1,Intermediate,CHEMBL626146,,
10652,Rattus norvegicus,1,178.0,12032,BAO_0000218,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,A,,N,1,Intermediate,CHEMBL626147,,
10653,,1,,10291,BAO_0000019,,Area under curve (AUC) was determined,,A,,U,0,Autocuration,CHEMBL626148,,
10654,,1,,5767,BAO_0000218,,Area under curve (AUC) following ip administration at 1 mg/kg,,A,,U,0,Autocuration,CHEMBL626149,,
10655,,1,,1434,BAO_0000019,,Area under curve (AUC) was determined; ND is Not determined,,A,,U,0,Autocuration,CHEMBL626150,,
10656,Canis lupus familiaris,1,,14925,BAO_0000218,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL626151,,
10657,Canis lupus familiaris,1,,14925,BAO_0000218,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL626152,,
10658,Canis lupus familiaris,1,,14925,BAO_0000218,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL626153,,
10659,,1,,1434,BAO_0000019,,Area under curve (AUR) was determined,,A,,U,0,Autocuration,CHEMBL626154,,
10660,,1,,11883,BAO_0000019,,Area under curve at 1 uM/dg administered intravenously,,A,,U,0,Autocuration,CHEMBL626155,,
10661,,1,,11883,BAO_0000019,,Area under curve at 10 uM/dg administered perorally,,A,,U,0,Autocuration,CHEMBL626156,,
10662,,1,,11883,BAO_0000019,,Area under curve at 2 uM/dg administered intravenously,,A,,U,0,Autocuration,CHEMBL626157,,
10663,,1,,11883,BAO_0000019,,Area under curve at 20 uM/dg administered perorally,,A,,U,0,Autocuration,CHEMBL626158,,
10664,Canis lupus familiaris,1,,15233,BAO_0000218,,Area under curve at a peroral dose of 3 mg/kg in dog,,A,,N,1,Intermediate,CHEMBL626159,,
10665,Rattus norvegicus,1,,15233,BAO_0000218,,Area under curve at a peroral dose of 3 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL626160,,
10666,Canis lupus familiaris,1,,15233,BAO_0000218,,Area under curve at an iv dose of 1 mg/kg in dog,,A,,N,1,Intermediate,CHEMBL626161,,
10667,Rattus norvegicus,1,,15233,BAO_0000218,,Area under curve at an iv dose of 1 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL626162,,
10668,,1,,12978,BAO_0000019,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,A,,U,0,Autocuration,CHEMBL626163,,
10669,,1,,12978,BAO_0000019,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,A,,U,0,Autocuration,CHEMBL626164,,
10670,Mus musculus,1,,11355,BAO_0000218,,Area under curve measured as conc vs time after intravenous administration to mice.,,A,,N,1,Intermediate,CHEMBL626165,,
10671,Mus musculus,1,,11355,BAO_0000218,,Area under curve measured as conc vs time after peroral administration to mice.,,A,,N,1,Intermediate,CHEMBL626166,,
10672,Canis lupus familiaris,1,,12923,BAO_0000218,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,A,,N,1,Intermediate,CHEMBL626167,,
10673,Canis lupus familiaris,1,,12923,BAO_0000218,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,A,,N,1,Intermediate,CHEMBL626168,,
10674,Canis lupus familiaris,1,,12923,BAO_0000218,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,A,,N,1,Intermediate,CHEMBL877463,,
10675,Canis lupus familiaris,1,,12923,BAO_0000218,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,A,,N,1,Intermediate,CHEMBL626169,,
10676,Rattus norvegicus,1,948.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL626170,,
10677,Rattus norvegicus,1,948.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL626171,,
10678,Rattus norvegicus,1,948.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL626172,,
10679,Rattus norvegicus,1,948.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL626173,,
10680,Rattus norvegicus,1,2113.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL626174,,
10681,Rattus norvegicus,1,2113.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL626175,,
10682,Rattus norvegicus,1,2113.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL626176,,
10683,Rattus norvegicus,1,2113.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL626177,,
10684,Rattus norvegicus,1,2113.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622499,,
10685,Rattus norvegicus,1,2107.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622500,,
10686,Rattus norvegicus,1,2107.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622501,,
10687,Rattus norvegicus,1,2107.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622502,,
10688,Rattus norvegicus,1,2107.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL622503,,
10689,Rattus norvegicus,1,2107.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL877614,,
10690,Rattus norvegicus,1,2048.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL624839,,
10691,Rattus norvegicus,1,2048.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL624840,,
10692,Rattus norvegicus,1,2048.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL624841,,
10693,Rattus norvegicus,1,2048.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL624842,,
10694,Rattus norvegicus,1,2385.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL624843,,
10695,Rattus norvegicus,1,2385.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL624844,,
10696,Rattus norvegicus,1,2385.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL624845,,
10697,Rattus norvegicus,1,2385.0,17738,BAO_0000218,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,A,,N,1,Intermediate,CHEMBL621904,,
10698,Rattus norvegicus,1,178.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL621905,,
10699,Rattus norvegicus,1,178.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL874382,,
10700,Rattus norvegicus,1,178.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL621906,,
10701,Rattus norvegicus,1,955.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL621907,,
10702,Rattus norvegicus,1,955.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622096,,
10703,Rattus norvegicus,1,955.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622097,,
10704,Rattus norvegicus,1,948.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622098,,
10705,Rattus norvegicus,1,948.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622099,,
10706,Rattus norvegicus,1,948.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622100,,
10707,Rattus norvegicus,1,2113.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622101,,
10708,Rattus norvegicus,1,2113.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622102,,
10709,Rattus norvegicus,1,2113.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622103,,
10710,Rattus norvegicus,1,2107.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622104,,
10711,Rattus norvegicus,1,2107.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622105,,
10712,Rattus norvegicus,1,2107.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622106,,
10713,Rattus norvegicus,1,2048.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622107,,
10714,Rattus norvegicus,1,2048.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622108,,
10715,Rattus norvegicus,1,2048.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622109,,
10716,Rattus norvegicus,1,2385.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622110,,
10717,Rattus norvegicus,1,2385.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622111,,
10718,Rattus norvegicus,1,2385.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL874383,,
10719,Rattus norvegicus,1,14.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622112,,
10720,Rattus norvegicus,1,14.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622113,,
10721,Rattus norvegicus,1,14.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622114,,
10722,Rattus norvegicus,1,2106.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622115,,
10723,Rattus norvegicus,1,2106.0,11195,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,A,,N,1,Intermediate,CHEMBL622116,,
10724,Rattus norvegicus,1,,6193,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622117,,
10725,Rattus norvegicus,1,,6803,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622118,,
10726,Rattus norvegicus,1,,6647,BAO_0000218,,Oral bioavailability in rats at 6 mg/kg,,A,,N,1,Intermediate,CHEMBL622119,,
10727,Rattus norvegicus,1,,6647,BAO_0000218,,Oral bioavailability in rat (dose 6 mg/kg),,A,,N,1,Intermediate,CHEMBL622120,,
10728,Rattus norvegicus,1,,6647,BAO_0000218,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,A,,N,1,Intermediate,CHEMBL622121,,
10729,Rattus norvegicus,1,,6640,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622122,,
10730,Rattus norvegicus,1,,6641,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622123,,
10731,Rattus norvegicus,1,,6641,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622124,,
10732,Rattus norvegicus,1,,6642,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL622125,,
10733,Rattus norvegicus,1,,5472,BAO_0000218,,Oral bioavailability,,A,,N,1,Intermediate,CHEMBL622126,,
10734,Rattus norvegicus,1,,6141,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,A,,N,1,Intermediate,CHEMBL620455,,
10735,Rattus norvegicus,1,,4390,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL620456,,
10736,Rattus norvegicus,1,,5472,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL620457,,
10737,Rattus norvegicus,1,,5472,BAO_0000218,,Oral bioavailability was evaluated; Not tested,,A,,N,1,Intermediate,CHEMBL620458,,
10738,Rattus norvegicus,1,,5438,BAO_0000218,,Oral bioavailability,,A,,N,1,Intermediate,CHEMBL620459,,
10739,Rattus norvegicus,1,,4883,BAO_0000218,,Oral bioavailability in rat by oral dosing,,A,,N,1,Intermediate,CHEMBL620460,,
10740,Rattus norvegicus,1,,1908,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL620461,,
10741,Rattus norvegicus,1,,4853,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley),,A,,N,1,Intermediate,CHEMBL620462,,
10742,Rattus norvegicus,1,,4853,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,A,,N,1,Intermediate,CHEMBL620463,,
10743,Rattus norvegicus,1,,4853,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,A,,N,1,Intermediate,CHEMBL620464,,
10744,Rattus norvegicus,1,,4853,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,A,,N,1,Intermediate,CHEMBL620465,,
10745,Rattus norvegicus,1,,4853,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL620466,,
10746,Rattus norvegicus,1,,4853,BAO_0000218,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL620467,,
10747,Rattus norvegicus,1,,4853,BAO_0000218,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,A,,N,1,Intermediate,CHEMBL620468,,
10748,Rattus norvegicus,1,,12873,BAO_0000218,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,A,,N,1,Intermediate,CHEMBL620469,,
10749,Rattus norvegicus,1,,12873,BAO_0000218,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,A,,N,1,Intermediate,CHEMBL620470,,
10750,Rattus norvegicus,1,,3169,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL620471,,
10751,Rattus norvegicus,1,,6305,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL620472,,
10752,Rattus norvegicus,1,,4762,BAO_0000218,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,A,,N,1,Intermediate,CHEMBL620473,,
10753,Rattus norvegicus,1,,17847,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL620474,,
10754,Rattus norvegicus,1,,6211,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,A,,N,1,Intermediate,CHEMBL620475,,
10755,Rattus norvegicus,1,,6011,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL620476,,
10756,Rattus norvegicus,1,,6317,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL620477,,
10757,Rattus norvegicus,1,,6644,BAO_0000218,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,A,,N,1,Intermediate,CHEMBL620478,,
10758,Rattus norvegicus,1,,6644,BAO_0000218,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,A,,N,1,Intermediate,CHEMBL618768,,
10759,Rattus norvegicus,1,,6644,BAO_0000218,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,A,,N,1,Intermediate,CHEMBL618769,,
10760,Rattus norvegicus,1,,6644,BAO_0000218,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,A,,N,1,Intermediate,CHEMBL618770,,
10761,Rattus norvegicus,1,,6113,BAO_0000218,,Oral bioavailability (dose 20 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL618771,,
10762,Rattus norvegicus,1,,5937,BAO_0000218,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,A,,N,1,Intermediate,CHEMBL618772,,
10763,Rattus norvegicus,1,,5711,BAO_0000218,,Oral bioavailability in rat at 10 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL618773,,
10764,Rattus norvegicus,1,,17717,BAO_0000218,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,A,,N,1,Intermediate,CHEMBL875842,,
10765,Rattus norvegicus,1,,17717,BAO_0000218,,Bioavailability in rat (dose 3 mg/kg i.v.),,A,,N,1,Intermediate,CHEMBL618774,,
10766,Rattus norvegicus,1,,17717,BAO_0000218,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,A,,N,1,Intermediate,CHEMBL618775,,
10767,Rattus norvegicus,1,,17717,BAO_0000218,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL618776,,
10768,Rattus norvegicus,1,,4722,BAO_0000218,,Percent bioavailability (F) in rats after iv administration,,A,,N,1,Intermediate,CHEMBL618777,,
10769,Rattus norvegicus,1,,4722,BAO_0000218,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL618778,,
10770,Rattus norvegicus,1,,4353,BAO_0000218,,Bioavailability in rat (dose 5 uM/kg p.o.),,A,,N,1,Intermediate,CHEMBL618779,,
10771,Rattus norvegicus,1,,15662,BAO_0000218,,Oral bioavailability,,A,,N,1,Intermediate,CHEMBL618780,,
10772,Rattus norvegicus,1,,4756,BAO_0000218,,Bioavailability in rat (dose 2 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL618781,,
10773,Rattus norvegicus,1,,4756,BAO_0000218,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,A,,N,1,Intermediate,CHEMBL618782,,
10774,Rattus norvegicus,1,,3436,BAO_0000218,,Oral bioavailability in rat (dose 20 mg/kg),,A,,N,1,Intermediate,CHEMBL618783,,
10775,Rattus norvegicus,1,,17800,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL618784,,
10776,Rattus norvegicus,1,,15762,BAO_0000218,,Percent oral bioavailability evaluated in rat,,A,,N,1,Intermediate,CHEMBL618785,,
10777,Rattus norvegicus,1,,5089,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL618786,,
10778,Rattus norvegicus,1,,5089,BAO_0000218,,Percent oral bioavailability in rat; Not determined,,A,,N,1,Intermediate,CHEMBL618787,,
10779,Rattus norvegicus,1,,3185,BAO_0000218,,Oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL618788,,
10780,Rattus norvegicus,1,,5145,BAO_0000218,,Bioavailability in rat,,A,,N,1,Intermediate,CHEMBL618789,,
10781,Rattus norvegicus,1,,3457,BAO_0000218,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,A,,N,1,Intermediate,CHEMBL618790,,
10782,Rattus norvegicus,1,,3457,BAO_0000218,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,A,,N,1,Intermediate,CHEMBL618791,,
10783,Rattus norvegicus,1,,5983,BAO_0000218,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,A,,N,1,Intermediate,CHEMBL875843,,
10784,Rattus norvegicus,1,,5739,BAO_0000218,,Oral bioavailability in rat (dose 20 mg/kg p.o.),,A,,N,1,Intermediate,CHEMBL618792,,
10785,Rattus norvegicus,1,,3579,BAO_0000218,,Cmax at a dose of 30 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL623395,,
10786,Simiiformes,1,,17788,BAO_0000218,,Cmax in monkeys at a dose of 1 mg/kg,,A,,U,0,Autocuration,CHEMBL623396,,
10787,Rattus norvegicus,1,,14956,BAO_0000218,,Cmax in rat,,A,,N,1,Intermediate,CHEMBL623397,,
10788,Rattus norvegicus,1,,17788,BAO_0000218,,Cmax in rats at a dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL623398,,
10789,Mus musculus,1,,9750,BAO_0000218,,Cmax was measured in mice after an oral dose of 50 mg/kg.,,A,,N,1,Intermediate,CHEMBL623399,,
10790,,1,,12767,BAO_0000218,,"Cmax value at a dose of 12.7 uM/kg, po",,A,,U,0,Autocuration,CHEMBL623400,,
10791,,1,,12767,BAO_0000218,,"Cmax value at a dose of 6.3 uM/kg, iv",,A,,U,0,Autocuration,CHEMBL623401,,
10792,,1,,12767,BAO_0000218,,"Cmax value at a dose of 7.1 uM/kg, iv",,A,,U,0,Autocuration,CHEMBL623402,,
10793,,1,,12703,BAO_0000218,,Cmax value of compound was determined after 1 hr,,A,,U,0,Autocuration,CHEMBL623403,,
10794,,1,,15778,BAO_0000218,,Cmax value of the compound,,A,,U,0,Autocuration,CHEMBL623404,,
10795,Rattus norvegicus,1,,12818,BAO_0000218,,Cmax value administered intraintestinal in rats.,,A,,N,1,Intermediate,CHEMBL625997,,
10796,Rattus norvegicus,1,,14964,BAO_0000218,,Cmax value administered perorally was determined in rat; Not determined,,A,,N,1,Intermediate,CHEMBL625998,,
10797,,1,,15808,BAO_0000218,,Cmax value at the dose of 2.3 mg/kg,,A,,U,0,Autocuration,CHEMBL625999,,
10798,,1,,15808,BAO_0000218,,Cmax value at the dose of 5 mg/kg,,A,,U,0,Autocuration,CHEMBL626000,,
10799,,1,,15778,BAO_0000218,,Cmax value in the period of 8 hr after dosing. ,,A,,U,0,Autocuration,CHEMBL626001,,
10800,,1,,3715,BAO_0000218,,Cmax value at a oral dose of 20 mg/kg; Not tested,,A,,U,0,Autocuration,CHEMBL626002,,
10801,,1,,3715,BAO_0000218,,Cmax value at a oral dose of 20 mg/kg,,A,,U,0,Autocuration,CHEMBL626003,,
10802,Rattus norvegicus,1,,1446,BAO_0000218,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,A,,N,1,Intermediate,CHEMBL626004,,
10803,Cavia porcellus,1,,15240,BAO_0000218,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,A,,N,1,Intermediate,CHEMBL626005,,
10804,Rattus norvegicus,1,,15240,BAO_0000218,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,A,,N,1,Intermediate,CHEMBL626006,,
10805,Rattus norvegicus,1,1969.0,14810,BAO_0000218,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,A,,N,1,Intermediate,CHEMBL626007,,
10806,Mus musculus,1,1969.0,14239,BAO_0000218,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,A,,N,1,Intermediate,CHEMBL626008,,
10807,Canis lupus familiaris,1,2107.0,12555,BAO_0000218,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,A,,N,1,Intermediate,CHEMBL626009,,
10808,Canis lupus familiaris,1,,10754,BAO_0000218,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,A,,N,1,Intermediate,CHEMBL626010,,
10809,Mus musculus,1,178.0,10754,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,A,,N,1,Intermediate,CHEMBL626011,,
10810,Mus musculus,1,178.0,10754,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,A,,N,1,Intermediate,CHEMBL626012,,
10811,Mus musculus,1,178.0,10754,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,A,,N,1,Intermediate,CHEMBL626013,,
10812,Mus musculus,1,178.0,10754,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,A,,N,1,Intermediate,CHEMBL626014,,
10813,Mus musculus,1,178.0,10754,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,A,,N,1,Intermediate,CHEMBL877496,,
10814,Canis lupus familiaris,1,,14600,BAO_0000218,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,F,,N,1,Intermediate,CHEMBL626015,,
10815,Canis lupus familiaris,1,,14600,BAO_0000218,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,F,,N,1,Intermediate,CHEMBL626016,,
10816,Canis lupus familiaris,1,,14600,BAO_0000218,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,F,,N,1,Intermediate,CHEMBL626017,,
10817,Canis lupus familiaris,1,1969.0,13543,BAO_0000218,,Bioavailability as maximal plasma concentration in dogs,,A,,N,1,Intermediate,CHEMBL626018,,
10818,Canis lupus familiaris,1,1969.0,13543,BAO_0000218,,Bioavailability as maximal plasma concentration in dogs,,A,,N,1,Intermediate,CHEMBL626692,,
10819,Rattus norvegicus,1,1969.0,13543,BAO_0000218,,Bioavailability as maximal plasma concentration in rats,,A,,N,1,Intermediate,CHEMBL626693,,
10820,Rattus norvegicus,1,1969.0,13543,BAO_0000218,,Bioavailability as maximal plasma concentration in rats,,A,,U,0,Autocuration,CHEMBL626694,,
10821,Canis lupus familiaris,1,178.0,14600,BAO_0000218,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,A,,N,1,Intermediate,CHEMBL626695,,
10822,Canis lupus familiaris,1,178.0,14600,BAO_0000218,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,A,,N,1,Intermediate,CHEMBL626696,,
10823,Canis lupus familiaris,1,178.0,14600,BAO_0000218,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,A,,N,1,Intermediate,CHEMBL626697,,
10824,Canis lupus familiaris,1,178.0,14600,BAO_0000218,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,A,,N,1,Intermediate,CHEMBL626859,,
10825,Canis lupus familiaris,1,178.0,14600,BAO_0000218,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,A,,N,1,Intermediate,CHEMBL626860,,
10826,Canis lupus familiaris,1,178.0,14600,BAO_0000218,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,A,,N,1,Intermediate,CHEMBL626861,,
10827,Rattus norvegicus,1,,14681,BAO_0000218,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,A,,N,1,Intermediate,CHEMBL626296,,
10828,,1,,15905,BAO_0000218,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,A,,U,0,Autocuration,CHEMBL626297,,
10829,,1,1969.0,15905,BAO_0000218,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,A,,U,0,Autocuration,CHEMBL626298,,
10830,Rattus norvegicus,1,1969.0,13304,BAO_0000218,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,A,,N,1,Intermediate,CHEMBL626299,,
10831,Rattus norvegicus,1,1969.0,15137,BAO_0000218,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,A,,N,1,Intermediate,CHEMBL626300,,
10832,Rattus norvegicus,1,1969.0,15137,BAO_0000218,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,A,,N,1,Intermediate,CHEMBL626301,,
10833,Rattus norvegicus,1,1969.0,15137,BAO_0000218,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,A,,N,1,Intermediate,CHEMBL626962,,
10834,Rattus norvegicus,1,1969.0,15137,BAO_0000218,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,A,,N,1,Intermediate,CHEMBL626963,,
10835,Rattus norvegicus,1,1969.0,15137,BAO_0000218,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,A,,N,1,Intermediate,CHEMBL626964,,
10836,Macaca fascicularis,1,1969.0,14839,BAO_0000218,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,A,,N,1,Intermediate,CHEMBL626965,,
10837,Mus musculus,1,1969.0,14839,BAO_0000218,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL626966,,
10838,Mus musculus,1,1969.0,14839,BAO_0000218,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL626967,,
10839,Macaca fascicularis,1,1969.0,14839,BAO_0000218,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,A,,N,1,Intermediate,CHEMBL626968,,
10840,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,A,,N,1,Intermediate,CHEMBL626969,,
10841,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,A,,N,1,Intermediate,CHEMBL627126,,
10842,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,A,,N,1,Intermediate,CHEMBL631276,,
10843,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,A,,N,1,Intermediate,CHEMBL631277,,
10844,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,A,,N,1,Intermediate,CHEMBL631278,,
10845,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,A,,N,1,Intermediate,CHEMBL874457,,
10846,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,A,,N,1,Intermediate,CHEMBL631279,,
10847,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,A,,N,1,Intermediate,CHEMBL631280,,
10848,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,A,,N,1,Intermediate,CHEMBL631281,,
10849,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,A,,N,1,Intermediate,CHEMBL631968,,
10850,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,A,,N,1,Intermediate,CHEMBL631969,,
10851,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,A,,N,1,Intermediate,CHEMBL631970,,
10852,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,A,,N,1,Intermediate,CHEMBL631971,,
10853,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,A,,N,1,Intermediate,CHEMBL631972,,
10854,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,A,,N,1,Intermediate,CHEMBL630435,,
10855,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,A,,N,1,Intermediate,CHEMBL630436,,
10856,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,A,,N,1,Intermediate,CHEMBL630437,,
10857,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,A,,N,1,Intermediate,CHEMBL630438,,
10858,Rattus norvegicus,1,948.0,8418,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,A,,N,1,Intermediate,CHEMBL630439,,
10859,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,A,,N,1,Intermediate,CHEMBL630440,,
10860,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,A,,N,1,Intermediate,CHEMBL630441,,
10861,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,A,,N,1,Intermediate,CHEMBL630442,,
10862,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,A,,N,1,Intermediate,CHEMBL625234,,
10863,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,A,,N,1,Intermediate,CHEMBL625235,,
10864,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,A,,N,1,Intermediate,CHEMBL625236,,
10865,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,A,,N,1,Intermediate,CHEMBL625237,,
10866,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,A,,N,1,Intermediate,CHEMBL626125,,
10867,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,A,,N,1,Intermediate,CHEMBL626126,,
10868,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,A,,N,1,Intermediate,CHEMBL626127,,
10869,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,A,,N,1,Intermediate,CHEMBL626128,,
10870,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,A,,N,1,Intermediate,CHEMBL626129,,
10871,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,A,,N,1,Intermediate,CHEMBL626130,,
10872,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,A,,N,1,Intermediate,CHEMBL626131,,
10873,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,A,,N,1,Intermediate,CHEMBL626132,,
10874,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,A,,N,1,Intermediate,CHEMBL626752,,
10875,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,A,,N,1,Intermediate,CHEMBL626753,,
10876,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,A,,N,1,Intermediate,CHEMBL626754,,
10877,Rattus norvegicus,1,2113.0,8418,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,A,,N,1,Intermediate,CHEMBL626755,,
10878,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,A,,N,1,Intermediate,CHEMBL626756,,
10879,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,A,,N,1,Intermediate,CHEMBL626757,,
10880,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,A,,N,1,Intermediate,CHEMBL626758,,
10881,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,A,,N,1,Intermediate,CHEMBL626759,,
10882,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,A,,N,1,Intermediate,CHEMBL626760,,
10883,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL626394,,
10884,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL626395,,
10885,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL626396,,
10886,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,A,,N,1,Intermediate,CHEMBL626397,,
10887,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,A,,N,1,Intermediate,CHEMBL626398,,
10888,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL626399,,
10889,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL874653,,
10890,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL626400,,
10891,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,A,,N,1,Intermediate,CHEMBL626401,,
10892,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,A,,N,1,Intermediate,CHEMBL626402,,
10893,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,A,,N,1,Intermediate,CHEMBL626403,,
10894,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL626404,,
10895,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL626405,,
10896,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL625529,,
10897,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,A,,N,1,Intermediate,CHEMBL625530,,
10898,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,A,,N,1,Intermediate,CHEMBL625531,,
10899,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,A,,N,1,Intermediate,CHEMBL625532,,
10900,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL625533,,
10901,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL875474,,
10902,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL625534,,
10903,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,A,,N,1,Intermediate,CHEMBL625535,,
10904,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,A,,N,1,Intermediate,CHEMBL625536,,
10905,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,A,,N,1,Intermediate,CHEMBL625537,,
10906,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL625538,,
10907,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL625539,,
10908,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL625540,,
10909,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,A,,N,1,Intermediate,CHEMBL625541,,
10910,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,A,,N,1,Intermediate,CHEMBL625542,,
10911,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,A,,N,1,Intermediate,CHEMBL625543,,
10912,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL625544,,
10913,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL625545,,
10914,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL625546,,
10915,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL625547,,
10916,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL625548,,
10917,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL625549,,
10918,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL625550,,
10919,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL625551,,
10920,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL875475,,
10921,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL625552,,
10922,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL625553,,
10923,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,A,,N,1,Intermediate,CHEMBL625554,,
10924,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,A,,N,1,Intermediate,CHEMBL625555,,
10925,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL625556,,
10926,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL624986,,
10927,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL624987,,
10928,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,A,,N,1,Intermediate,CHEMBL624988,,
10929,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,A,,N,1,Intermediate,CHEMBL624989,,
10930,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,A,,N,1,Intermediate,CHEMBL624990,,
10931,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,A,,N,1,Intermediate,CHEMBL874391,,
10932,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,A,,N,1,Intermediate,CHEMBL624991,,
10933,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,A,,N,1,Intermediate,CHEMBL624992,,
10934,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,A,,N,1,Intermediate,CHEMBL624993,,
10935,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,A,,N,1,Intermediate,CHEMBL624994,,
10936,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,A,,N,1,Intermediate,CHEMBL624995,,
10937,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,A,,N,1,Intermediate,CHEMBL624996,,
10938,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,A,,N,1,Intermediate,CHEMBL624997,,
10939,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,A,,N,1,Intermediate,CHEMBL624998,,
10940,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,A,,N,1,Intermediate,CHEMBL624999,,
10941,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,A,,N,1,Intermediate,CHEMBL882955,,
10942,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,A,,N,1,Intermediate,CHEMBL625000,,
10943,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,A,,N,1,Intermediate,CHEMBL625001,,
10944,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,A,,N,1,Intermediate,CHEMBL625089,,
10945,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,A,,N,1,Intermediate,CHEMBL625090,,
10946,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,A,,N,1,Intermediate,CHEMBL625091,,
10947,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,A,,N,1,Intermediate,CHEMBL625092,,
10948,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,A,,N,1,Intermediate,CHEMBL625093,,
10949,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,A,,N,1,Intermediate,CHEMBL625094,,
10950,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,A,,N,1,Intermediate,CHEMBL625095,,
10951,Canis lupus familiaris,1,,2249,BAO_0000218,,Compound was evaluated for its bioavailability in the dogs,,A,,N,1,Intermediate,CHEMBL625096,,
10952,Rattus norvegicus,1,,2249,BAO_0000218,,Compound was evaluated for its bioavailability in the rats,,A,,N,1,Intermediate,CHEMBL625097,,
10953,,1,,17515,BAO_0000218,,Compound was evaluated for oral bioavailability,,A,,U,0,Autocuration,CHEMBL882956,,
10954,Rattus norvegicus,1,,14541,BAO_0000218,,Compound was evaluated for percentage of Oral bioavailability in rats,,A,,N,1,Intermediate,CHEMBL625098,,
10955,Cavia porcellus,1,,12797,BAO_0000218,,Bioavailability in guinea pig,,A,,U,0,Autocuration,CHEMBL625099,,
10956,Rattus norvegicus,1,,12797,BAO_0000218,,Compound was evaluated for the oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL625100,,
10957,Canis lupus familiaris,1,,12797,BAO_0000218,,Compound was evaluated for the oral bioavailability in dog,,A,,N,1,Intermediate,CHEMBL625101,,
10958,Rattus norvegicus,1,,12797,BAO_0000218,,Compound was evaluated for the oral bioavailability in rat,,A,,N,1,Intermediate,CHEMBL874396,,
10959,Canis lupus familiaris,1,,11727,BAO_0000218,,Bioavailability in dog (dosed i.v.),,F,,U,0,Autocuration,CHEMBL625102,,
10960,Canis lupus familiaris,1,,13249,BAO_0000218,,Compound was tested for in vivo bioavailability in dog,,A,,N,1,Intermediate,CHEMBL625103,,
10961,Cricetinae,1,,13249,BAO_0000218,,Compound was tested for in vivo bioavailability in hamsters,,A,,N,1,Intermediate,CHEMBL625104,,
10962,Simiiformes,1,,13249,BAO_0000218,,Compound was tested for in vivo bioavailability in monkey,,A,,U,0,Autocuration,CHEMBL625105,,
10963,Rattus norvegicus,1,,13249,BAO_0000218,,Compound was tested for in vivo bioavailability in rat,,A,,N,1,Intermediate,CHEMBL625106,,
10964,Mus musculus,1,,9552,BAO_0000218,,Oral bioavailability in mouse,,A,,U,0,Autocuration,CHEMBL625107,,
10965,Mus musculus,1,,9552,BAO_0000218,,Compound was tested for percent of oral bioavailability in mice; 56-74,,A,,N,1,Intermediate,CHEMBL625108,,
10966,Mus musculus,1,,14839,BAO_0000218,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,A,,U,0,Autocuration,CHEMBL625109,,
10967,Macaca fascicularis,1,,14839,BAO_0000218,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,A,,U,0,Autocuration,CHEMBL625110,,
10968,Macaca fascicularis,1,,14839,BAO_0000218,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,A,,U,0,Autocuration,CHEMBL625111,,
10969,Mus musculus,1,,14839,BAO_0000218,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,A,,N,1,Intermediate,CHEMBL625112,,
10970,Mus musculus,1,,14839,BAO_0000218,,Oral bioavailability in nude mice,,A,,N,1,Intermediate,CHEMBL875334,,
10971,Primates,1,,11219,BAO_0000218,,Bioavailability in monkey (i.d. dosing),,A,,U,0,Autocuration,CHEMBL628617,,
10972,Rattus norvegicus,1,,9552,BAO_0000218,,Bioavailability in rat,,A,,U,0,Autocuration,CHEMBL628618,,
10973,,1,,11732,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,A,,U,0,Autocuration,CHEMBL628619,,
10974,,1,,11732,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,A,,U,0,Autocuration,CHEMBL628620,,
10975,Macaca fascicularis,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,A,,N,1,Intermediate,CHEMBL628621,,
10976,Macaca fascicularis,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,A,,N,1,Intermediate,CHEMBL628622,,
10977,Macaca fascicularis,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,A,,N,1,Intermediate,CHEMBL628623,,
10978,Macaca fascicularis,1,1969.0,14839,BAO_0000218,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL628624,,
10979,Mus musculus,1,1969.0,14839,BAO_0000218,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL628625,,
10980,Macaca fascicularis,1,1969.0,14839,BAO_0000218,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL628626,,
10981,Mus musculus,1,1969.0,14839,BAO_0000218,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL627041,,
10982,Mus musculus,1,1969.0,14839,BAO_0000218,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL627042,,
10983,Mus musculus,1,1969.0,14839,BAO_0000218,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL627043,,
10984,,1,1969.0,13932,BAO_0000218,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,A,,U,0,Autocuration,CHEMBL627044,,
10985,Mus musculus,1,1969.0,11637,BAO_0000218,,Cmax in mouse plasma,,A,,N,1,Intermediate,CHEMBL627045,,
10986,,1,1969.0,11637,BAO_0000218,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,A,,U,0,Autocuration,CHEMBL627046,,
10987,Rattus norvegicus,1,1969.0,13960,BAO_0000218,,Maximal plasma concentration in rat,,A,,N,1,Intermediate,CHEMBL627047,,
10988,Rattus norvegicus,1,1969.0,15905,BAO_0000218,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,A,,N,1,Intermediate,CHEMBL627048,,
10989,Rattus norvegicus,1,,14062,BAO_0000218,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627049,,
10990,Rattus norvegicus,1,,14062,BAO_0000218,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627050,,
10991,Rattus norvegicus,1,,14062,BAO_0000218,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627051,,
10992,Rattus norvegicus,1,,14062,BAO_0000218,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627052,,
10993,Rattus norvegicus,1,,14062,BAO_0000218,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627053,,
10994,Rattus norvegicus,1,,14062,BAO_0000218,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627054,,
10995,Mus musculus,1,,15011,BAO_0000218,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,A,,N,1,Intermediate,CHEMBL627055,,
10996,Mus musculus,1,,15011,BAO_0000218,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,A,,N,1,Intermediate,CHEMBL627056,,
10997,Mus musculus,1,,15011,BAO_0000218,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,A,,N,1,Intermediate,CHEMBL627057,,
10998,Mus musculus,1,,15011,BAO_0000218,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,A,,N,1,Intermediate,CHEMBL627058,,
10999,Mus musculus,1,,15011,BAO_0000218,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,A,,N,1,Intermediate,CHEMBL626211,,
11000,,1,,10291,BAO_0000218,,Maximum Concentration of the compound.,,A,,U,0,Autocuration,CHEMBL626212,,
11001,Canis lupus familiaris,1,,14599,BAO_0000218,,Maximum Concentration was measured after iv administration into Beagle dog,,A,,N,1,Intermediate,CHEMBL626213,,
11002,Canis lupus familiaris,1,,14599,BAO_0000218,,Maximum Concentration was measured after iv administration into Beagle dog.,,A,,N,1,Intermediate,CHEMBL626214,,
11003,Canis lupus familiaris,1,,14599,BAO_0000218,,Maximum Concentration was measured after po administration into Beagle dog,,A,,N,1,Intermediate,CHEMBL626215,,
11004,Canis lupus familiaris,1,,14599,BAO_0000218,,Maximum Concentration was measured after po administration into Beagle dog.,,A,,N,1,Intermediate,CHEMBL626216,,
11005,,1,178.0,12767,BAO_0000218,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,A,,U,0,Autocuration,CHEMBL626217,,
11006,,1,178.0,12767,BAO_0000218,,Maximum blood level reached after an iv dose of 12.2 uM/kg,,A,,U,0,Autocuration,CHEMBL626218,,
11007,,1,178.0,12767,BAO_0000218,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,A,,U,0,Autocuration,CHEMBL626219,,
11008,,1,178.0,12767,BAO_0000218,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,A,,U,0,Autocuration,CHEMBL626220,,
11009,,1,178.0,12767,BAO_0000218,,Maximum blood level reached after an oral dose of 5.0 mg/kg,,A,,U,0,Autocuration,CHEMBL626221,,
11010,,1,178.0,12767,BAO_0000218,,Maximum blood level reached at dose of 10.6 uM/kg orally,,A,,U,0,Autocuration,CHEMBL626222,,
11011,Cavia porcellus,1,,14706,BAO_0000218,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,A,,N,1,Intermediate,CHEMBL626223,,
11012,Cavia porcellus,1,,14706,BAO_0000218,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,A,,N,1,Intermediate,CHEMBL626224,,
11013,Rattus norvegicus,1,955.0,14793,BAO_0000218,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL626225,,
11014,Rattus norvegicus,1,955.0,14793,BAO_0000218,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL626226,,
11015,Rattus norvegicus,1,955.0,14793,BAO_0000218,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,A,,N,1,Intermediate,CHEMBL626227,,
11016,Rattus norvegicus,1,955.0,14793,BAO_0000218,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL626228,,
11017,Rattus norvegicus,1,,14793,BAO_0000218,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL626229,,
11018,Rattus norvegicus,1,,14793,BAO_0000218,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL626921,,
11019,Rattus norvegicus,1,,14793,BAO_0000218,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,A,,N,1,Intermediate,CHEMBL876793,,
11020,Rattus norvegicus,1,,14793,BAO_0000218,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL625309,,
11021,Bacillus subtilis,1,,10524,BAO_0000218,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,A,,N,1,Intermediate,CHEMBL625310,,
11022,Simiiformes,1,,11871,BAO_0000218,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,A,,U,0,Autocuration,CHEMBL625311,,
11023,Rattus norvegicus,1,,11871,BAO_0000218,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,A,,N,1,Intermediate,CHEMBL625312,,
11024,,1,,3437,BAO_0000218,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,A,,U,0,Autocuration,CHEMBL625313,,
11025,Mus musculus,1,,12038,BAO_0000218,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL625314,,
11026,Rattus norvegicus,1,,12038,BAO_0000218,,Maximum concentration in male rats after iv administration of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL625315,,
11027,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,A,,N,1,Intermediate,CHEMBL625316,,
11028,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,A,,N,1,Intermediate,CHEMBL625317,,
11029,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,A,,N,1,Intermediate,CHEMBL625318,,
11030,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,A,,N,1,Intermediate,CHEMBL625319,,
11031,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,A,,N,1,Intermediate,CHEMBL625320,,
11032,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,A,,N,1,Intermediate,CHEMBL625321,,
11033,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,A,,N,1,Intermediate,CHEMBL625322,,
11034,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,A,,N,1,Intermediate,CHEMBL876801,,
11035,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,A,,N,1,Intermediate,CHEMBL625323,,
11036,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,A,,N,1,Intermediate,CHEMBL625324,,
11037,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,A,,N,1,Intermediate,CHEMBL625325,,
11038,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,A,,N,1,Intermediate,CHEMBL625326,,
11039,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,A,,N,1,Intermediate,CHEMBL625327,,
11040,Rattus norvegicus,1,2107.0,8418,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,A,,N,1,Intermediate,CHEMBL625328,,
11041,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,A,,N,1,Intermediate,CHEMBL625329,,
11042,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,A,,N,1,Intermediate,CHEMBL625330,,
11043,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,A,,N,1,Intermediate,CHEMBL627774,,
11044,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,A,,N,1,Intermediate,CHEMBL627775,,
11045,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,A,,N,1,Intermediate,CHEMBL627949,,
11046,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,A,,N,1,Intermediate,CHEMBL627950,,
11047,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,A,,N,1,Intermediate,CHEMBL627951,,
11048,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,A,,N,1,Intermediate,CHEMBL627952,,
11049,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,A,,N,1,Intermediate,CHEMBL627953,,
11050,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,A,,N,1,Intermediate,CHEMBL627954,,
11051,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,A,,N,1,Intermediate,CHEMBL627955,,
11052,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,A,,N,1,Intermediate,CHEMBL627956,,
11053,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,A,,N,1,Intermediate,CHEMBL876802,,
11054,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,A,,N,1,Intermediate,CHEMBL627957,,
11055,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,A,,N,1,Intermediate,CHEMBL627958,,
11056,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,A,,N,1,Intermediate,CHEMBL627959,,
11057,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,A,,N,1,Intermediate,CHEMBL627960,,
11058,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,A,,N,1,Intermediate,CHEMBL627961,,
11059,Rattus norvegicus,1,2048.0,8418,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,A,,N,1,Intermediate,CHEMBL627962,,
11060,Rattus norvegicus,1,,9796,BAO_0000218,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL627963,,
11061,Rattus norvegicus,1,,9796,BAO_0000218,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL624759,,
11062,Rattus norvegicus,1,,9796,BAO_0000218,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL624760,,
11063,Rattus norvegicus,1,,9796,BAO_0000218,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL624761,,
11064,Rattus norvegicus,1,,9796,BAO_0000218,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL877607,,
11065,Rattus norvegicus,1,2107.0,9796,BAO_0000218,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL624762,,
11066,Rattus norvegicus,1,2107.0,9796,BAO_0000218,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL624763,,
11067,Rattus norvegicus,1,2107.0,9796,BAO_0000218,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL624764,,
11068,Rattus norvegicus,1,2107.0,9796,BAO_0000218,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL624765,,
11069,Rattus norvegicus,1,2107.0,9796,BAO_0000218,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL624766,,
11070,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL624767,,
11071,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL624768,,
11072,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL624769,,
11073,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,A,,N,1,Intermediate,CHEMBL624770,,
11074,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,A,,N,1,Intermediate,CHEMBL624771,,
11075,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL624772,,
11076,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL624773,,
11077,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL624774,,
11078,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,A,,N,1,Intermediate,CHEMBL624775,,
11079,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,A,,N,1,Intermediate,CHEMBL624776,,
11080,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,A,,N,1,Intermediate,CHEMBL624777,,
11081,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL624778,,
11082,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL624779,,
11083,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,A,,N,1,Intermediate,CHEMBL624780,,
11084,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,A,,N,1,Intermediate,CHEMBL624781,,
11085,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL877608,,
11086,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,A,,N,1,Intermediate,CHEMBL624782,,
11087,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL624783,,
11088,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL624784,,
11089,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL624785,,
11090,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,A,,N,1,Intermediate,CHEMBL624786,,
11091,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,A,,N,1,Intermediate,CHEMBL624787,,
11092,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL628676,,
11093,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL621842,,
11094,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL621843,,
11095,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,A,,N,1,Intermediate,CHEMBL623873,,
11096,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,A,,N,1,Intermediate,CHEMBL623874,,
11097,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,A,,N,1,Intermediate,CHEMBL623875,,
11098,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL623876,,
11099,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL623877,,
11100,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL623878,,
11101,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL623879,,
11102,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL623880,,
11103,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL623881,,
11104,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL623957,,
11105,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL623958,,
11106,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL623959,,
11107,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL623960,,
11108,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL623961,,
11109,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,A,,N,1,Intermediate,CHEMBL623962,,
11110,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,A,,N,1,Intermediate,CHEMBL624676,,
11111,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL624677,,
11112,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL624678,,
11113,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL624679,,
11114,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,A,,N,1,Intermediate,CHEMBL624680,,
11115,,1,,11732,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,A,,U,0,Autocuration,CHEMBL624849,,
11116,,1,,11732,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,A,,U,0,Autocuration,CHEMBL624850,,
11117,,1,,11732,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,A,,U,0,Autocuration,CHEMBL874399,,
11118,,1,,11732,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,A,,U,0,Autocuration,CHEMBL624851,,
11119,,1,,11732,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,A,,U,0,Autocuration,CHEMBL624852,,
11120,Rattus norvegicus,1,,13359,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg),,A,,U,0,Autocuration,CHEMBL624853,,
11121,Rattus norvegicus,1,,16618,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley),,A,,U,0,Autocuration,CHEMBL624854,,
11122,Rattus norvegicus,1,,13960,BAO_0000218,,Oral bioavailability in rat,,A,,U,0,Autocuration,CHEMBL624855,,
11123,Rattus norvegicus,1,,13917,BAO_0000218,,Oral bioavailability in rats was determined in vivo,,A,,U,0,Autocuration,CHEMBL624856,,
11124,Canis lupus familiaris,1,,14266,BAO_0000218,,Oral bioavailability in dog,,A,,U,0,Autocuration,CHEMBL882957,,
11125,Simiiformes,1,,12359,BAO_0000218,,Oral bioavailability of compound in monkey,,A,,U,0,Autocuration,CHEMBL624857,,
11126,Rattus norvegicus,1,,12359,BAO_0000218,,Oral bioavailability of compound in rat,,A,,N,1,Intermediate,CHEMBL622202,,
11127,Rattus norvegicus,1,,12359,BAO_0000218,,Bioavailability in rat of PMEA prodrug,,A,,U,0,Autocuration,CHEMBL622203,,
11128,Rattus norvegicus,1,,12359,BAO_0000218,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,A,,N,1,Intermediate,CHEMBL625522,,
11129,Macaca mulatta,1,,10791,BAO_0000218,,Serum conc at 3 hours following 25 mg/kg dose,,A,,U,0,Autocuration,CHEMBL622868,,
11130,Macaca mulatta,1,1088.0,10791,BAO_0000218,,Urine conc 0-5 hours following 25 mg/kg dose,,A,,U,0,Autocuration,CHEMBL622869,,
11131,Macaca mulatta,1,1088.0,10791,BAO_0000218,,Urine conc 0-24 hours following 25 mg/kg dose,,A,,U,0,Autocuration,CHEMBL622870,,
11132,Chlorocebus aethiops,1,,138,BAO_0000218,,Oral bioavailability in African green monkeys; 20-25,,A,,U,0,Autocuration,CHEMBL622871,,
11133,Macaca fascicularis,1,,14521,BAO_0000218,,Oral bioavailability in cynomolgus monkey.,,A,,N,1,Intermediate,CHEMBL620560,,
11134,Canis lupus familiaris,1,,13953,BAO_0000218,,Oral bioavailability in dog,,A,,U,0,Autocuration,CHEMBL620561,,
11135,Canis lupus familiaris,1,,12836,BAO_0000218,,Oral bioavailability in dog at 10 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL620562,,
11136,Cricetinae,1,,12836,BAO_0000218,,Oral bioavailability in hamster at 10 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL620563,,
11137,Rattus norvegicus,1,,12836,BAO_0000218,,Oral bioavailability in rat at 10 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL620564,,
11138,Rattus norvegicus,1,,14521,BAO_0000218,,Oral bioavailability in rat,,A,,U,0,Autocuration,CHEMBL872265,,
11139,Rattus norvegicus,1,,13953,BAO_0000218,,Oral bioavailability in rat,,A,,U,0,Autocuration,CHEMBL620565,,
11140,Eutheria,1,,6799,BAO_0000218,,Oral bioavailability,,A,,U,0,Autocuration,CHEMBL620566,,
11141,,1,,11311,BAO_0000218,,Oral bioavailability was determined; range 49-102%,,A,,U,0,Autocuration,CHEMBL620567,,
11142,Canis lupus familiaris,1,,4013,BAO_0000218,,Oral bioavailability was determined in dogs,,A,,N,1,Intermediate,CHEMBL620568,,
11143,Rattus norvegicus,1,,4013,BAO_0000218,,Oral bioavailability in rat,,A,,U,0,Autocuration,CHEMBL620569,,
11144,Eutheria,1,,17591,BAO_0000218,,Oral bioavailability,,A,,U,0,Autocuration,CHEMBL620570,,
11145,,1,,17591,BAO_0000218,,Oral bioavailability was determined; Not orally available,,A,,U,0,Autocuration,CHEMBL620571,,
11146,Mus musculus,1,,15011,BAO_0000218,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,A,,N,1,Intermediate,CHEMBL620572,,
11147,Mus musculus,1,,15011,BAO_0000218,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,A,,U,0,Autocuration,CHEMBL620573,,
11148,Mus musculus,1,,15011,BAO_0000218,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,A,,U,0,Autocuration,CHEMBL620574,,
11149,Macaca mulatta,1,,9552,BAO_0000218,,Oral bioavailability in Rhesus monkey,,A,,U,0,Autocuration,CHEMBL620575,,
11150,Canis lupus familiaris,1,,9552,BAO_0000218,,Oral bioavailability in dog (female mongrel),,A,,U,0,Autocuration,CHEMBL620576,,
11151,,1,,3639,BAO_0000218,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,A,,U,0,Autocuration,CHEMBL875846,,
11152,Canis lupus familiaris,1,,13397,BAO_0000218,,Oral bioavailability in dog,,A,,U,0,Autocuration,CHEMBL620577,,
11153,,1,,3031,BAO_0000218,,Percentage Bioavailability was evaluated.,,A,,U,0,Autocuration,CHEMBL620578,,
11154,Rattus norvegicus,1,,12818,BAO_0000218,,Bioavailability in rat administered i.d.,,A,,U,0,Autocuration,CHEMBL620579,,
11155,Eutheria,1,,4847,BAO_0000218,,Bioavailability,,A,,U,0,Autocuration,CHEMBL621248,,
11156,Canis lupus familiaris,1,,12421,BAO_0000218,,Bioavailability in dog (male Beagle) i.v. administration,,A,,U,0,Autocuration,CHEMBL625390,,
11157,Rattus norvegicus,1,,11966,BAO_0000218,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,A,,U,0,Autocuration,CHEMBL625391,,
11158,Primates,1,,11218,BAO_0000218,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,A,,U,0,Autocuration,CHEMBL872266,,
11159,Rattus norvegicus,1,,13129,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (male),,A,,U,0,Autocuration,CHEMBL625392,,
11160,Rattus norvegicus,1,,12350,BAO_0000218,,The oral bioavailability was measured on rats after oral administration,,A,,N,1,Intermediate,CHEMBL625393,,
11161,Rattus norvegicus,1,,2231,BAO_0000218,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL625394,,
11162,Macaca mulatta,1,,2231,BAO_0000218,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL625395,,
11163,Rattus norvegicus,1,,12187,BAO_0000218,,Bioavailability in rat (dose 10 mg/kg i.d.),,A,,U,0,Autocuration,CHEMBL625396,,
11164,Canis lupus familiaris,1,,12421,BAO_0000218,,Bioavailability in dog (male Beagle) i.v. administration,,A,,U,0,Autocuration,CHEMBL625397,,
11165,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL625398,,
11166,Mus musculus,1,178.0,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL625399,,
11167,Mus musculus,1,2037.0,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL626074,,
11168,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL626075,,
11169,Rattus norvegicus,1,1969.0,2231,BAO_0000218,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL626076,,
11170,Macaca mulatta,1,1969.0,2231,BAO_0000218,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL626077,,
11171,Rattus norvegicus,1,178.0,12178,BAO_0000218,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,A,,N,1,Intermediate,CHEMBL626078,,
11172,,1,178.0,12178,BAO_0000218,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,A,,U,0,Autocuration,CHEMBL625846,,
11173,,1,178.0,12178,BAO_0000218,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,A,,U,0,Autocuration,CHEMBL625847,,
11174,Rattus norvegicus,1,,15633,BAO_0000218,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,A,,N,1,Expert,CHEMBL625848,,
11175,Rattus norvegicus,1,1969.0,14258,BAO_0000218,,Maximum concentration of compound in plasma administered orally to rats,,A,,N,1,Intermediate,CHEMBL625849,,
11176,Canis lupus familiaris,1,1969.0,14224,BAO_0000218,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,A,,N,1,Intermediate,CHEMBL626023,,
11177,Canis lupus familiaris,1,1969.0,14224,BAO_0000218,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,A,,N,1,Intermediate,CHEMBL626024,,
11178,Canis lupus familiaris,1,1969.0,14224,BAO_0000218,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,A,,N,1,Intermediate,CHEMBL626025,,
11179,,1,,5566,BAO_0000218,,Maximum concentration after 10 mg/kg by oral administration,,A,,U,0,Autocuration,CHEMBL626026,,
11180,,1,,16935,BAO_0000218,,Maximum concentration at a dose of 1.5 mg/kg,,A,,U,0,Autocuration,CHEMBL626027,,
11181,,1,,16935,BAO_0000218,,Maximum concentration at a dose of 2.0 mg/kg,,A,,U,0,Autocuration,CHEMBL626028,,
11182,Canis lupus familiaris,1,1969.0,14224,BAO_0000218,,Maximum concentration in dog plasma,,A,,N,1,Intermediate,CHEMBL626029,,
11183,,1,1969.0,12536,BAO_0000218,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,A,,U,0,Autocuration,CHEMBL626030,,
11184,,1,1969.0,12536,BAO_0000218,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,A,,U,0,Autocuration,CHEMBL626031,,
11185,,1,1969.0,12536,BAO_0000218,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,A,,U,0,Autocuration,CHEMBL626032,,
11186,,1,1969.0,12536,BAO_0000218,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,A,,U,0,Autocuration,CHEMBL626033,,
11187,,1,1969.0,12536,BAO_0000218,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,A,,U,0,Autocuration,CHEMBL626034,,
11188,Canis lupus familiaris,1,1969.0,9994,BAO_0000218,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,A,,N,1,Intermediate,CHEMBL626035,,
11189,,1,1969.0,1434,BAO_0000218,,Maximum concentration in plasma at Tmax,,A,,U,0,Autocuration,CHEMBL626036,,
11190,Canis lupus familiaris,1,1969.0,12836,BAO_0000218,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,A,,N,1,Expert,CHEMBL626037,,
11191,Cricetinae,1,1969.0,12836,BAO_0000218,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL626038,,
11192,Rattus norvegicus,1,1969.0,12836,BAO_0000218,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL626039,,
11193,Rattus norvegicus,1,1969.0,12545,BAO_0000218,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,A,,N,1,Intermediate,CHEMBL626040,,
11194,Oryctolagus cuniculus,1,1969.0,13856,BAO_0000218,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL626041,,
11195,,1,,3550,BAO_0000218,,Maximum concentration was calculated,,A,,U,0,Autocuration,CHEMBL626042,,
11196,,1,,2632,BAO_0000218,,Maximum concentration was calculated.,,A,,U,0,Autocuration,CHEMBL626043,,
11197,,1,,5566,BAO_0000218,,Maximum concentration at a peroral dose of 10 mg/kg,,A,,U,0,Autocuration,CHEMBL626044,,
11198,,1,,11883,BAO_0000218,,Maximum concentration of the drug at 10 uM/dg administered perorally,,A,,U,0,Autocuration,CHEMBL626045,,
11199,,1,,11883,BAO_0000218,,Maximum concentration of the drug at 2 uM/dg administered intravenously,,A,,U,0,Autocuration,CHEMBL626046,,
11200,Canis lupus familiaris,1,1969.0,14122,BAO_0000218,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,A,,N,1,Intermediate,CHEMBL626047,,
11201,Cricetinae,1,1969.0,14122,BAO_0000218,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,A,,N,1,Intermediate,CHEMBL626048,,
11202,Rattus norvegicus,1,1969.0,14122,BAO_0000218,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,A,,N,1,Intermediate,CHEMBL626049,,
11203,Rattus norvegicus,1,1969.0,12542,BAO_0000218,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL626050,,
11204,Canis lupus familiaris,1,1969.0,12542,BAO_0000218,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL874541,,
11205,Cricetinae,1,1969.0,12542,BAO_0000218,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL622826,,
11206,Cricetinae,1,1969.0,12542,BAO_0000218,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL622827,,
11207,Rattus norvegicus,1,1969.0,12542,BAO_0000218,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL622828,,
11208,Rattus norvegicus,1,1969.0,14080,BAO_0000218,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,A,,N,1,Intermediate,CHEMBL622829,,
11209,Rattus norvegicus,1,,11911,BAO_0000218,,Maximum concentration reached following intravenous administration in male rat,,A,,N,1,Intermediate,CHEMBL876806,,
11210,Canis lupus familiaris,1,,13204,BAO_0000218,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,A,,N,1,Intermediate,CHEMBL622830,,
11211,Rattus norvegicus,1,,13204,BAO_0000218,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,A,,N,1,Intermediate,CHEMBL622831,,
11212,Canis lupus familiaris,1,,14346,BAO_0000218,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,A,,N,1,Intermediate,CHEMBL626794,,
11213,Rattus norvegicus,1,,14346,BAO_0000218,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,A,,N,1,Intermediate,CHEMBL626795,,
11214,Rattus norvegicus,1,,14346,BAO_0000218,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,A,,N,1,Intermediate,CHEMBL626796,,
11215,Rattus norvegicus,1,,14346,BAO_0000218,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,A,,N,1,Intermediate,CHEMBL626797,,
11216,Rattus norvegicus,1,,14127,BAO_0000218,,Maximum drug concentration is determined after oral dosing in rats.,,A,,N,1,Intermediate,CHEMBL626798,,
11217,Canis lupus familiaris,1,,14339,BAO_0000218,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,A,,N,1,Intermediate,CHEMBL626799,,
11218,Canis lupus familiaris,1,,14339,BAO_0000218,,Maximum observed concentration in oral (5 mg/kg) fed dogs,,A,,N,1,Intermediate,CHEMBL626800,,
11219,,1,1969.0,13494,BAO_0000218,,Maximum plasma concentration,,A,,U,0,Autocuration,CHEMBL626801,,
11220,Rattus norvegicus,1,1969.0,14925,BAO_0000218,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,A,,N,1,Intermediate,CHEMBL876816,,
11221,Rattus norvegicus,1,1969.0,14474,BAO_0000218,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL626802,,
11222,Canis lupus familiaris,1,1969.0,14474,BAO_0000218,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,A,,N,1,Intermediate,CHEMBL626803,,
11223,,1,1969.0,13917,BAO_0000218,,Maximum plasma concentration following oral administration of 30 umol/kg,,A,,U,0,Autocuration,CHEMBL626804,,
11224,Rattus norvegicus,1,1969.0,9796,BAO_0000218,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,A,,N,1,Intermediate,CHEMBL626805,,
11225,Rattus norvegicus,1,1969.0,9796,BAO_0000218,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL626309,,
11226,Rattus norvegicus,1,1969.0,9796,BAO_0000218,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL626310,,
11227,Rattus norvegicus,1,1969.0,9796,BAO_0000218,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL626311,,
11228,Rattus norvegicus,1,1969.0,9796,BAO_0000218,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL626312,,
11229,Rattus norvegicus,1,995.0,9796,BAO_0000218,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL626313,,
11230,Rattus norvegicus,1,995.0,9796,BAO_0000218,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL626314,,
11231,Rattus norvegicus,1,995.0,9796,BAO_0000218,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL626315,,
11232,Rattus norvegicus,1,995.0,9796,BAO_0000218,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL626316,,
11233,Rattus norvegicus,1,995.0,9796,BAO_0000218,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,A,,N,1,Intermediate,CHEMBL626317,,
11234,Rattus norvegicus,1,,8363,BAO_0000218,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,A,,N,1,Intermediate,CHEMBL626318,,
11235,Rattus norvegicus,1,,8363,BAO_0000218,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,A,,N,1,Intermediate,CHEMBL626319,,
11236,Rattus norvegicus,1,,8363,BAO_0000218,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,A,,N,1,Intermediate,CHEMBL626320,,
11237,Rattus norvegicus,1,,8363,BAO_0000218,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,A,,N,1,Intermediate,CHEMBL875053,,
11238,Rattus norvegicus,1,,8363,BAO_0000218,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,A,,N,1,Intermediate,CHEMBL626321,,
11239,Rattus norvegicus,1,,8363,BAO_0000218,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,A,,N,1,Intermediate,CHEMBL626322,,
11240,Rattus norvegicus,1,,8363,BAO_0000218,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,A,,N,1,Intermediate,CHEMBL626323,,
11241,Rattus norvegicus,1,,8363,BAO_0000218,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,A,,N,1,Intermediate,CHEMBL626324,,
11242,Rattus norvegicus,1,,8363,BAO_0000218,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,A,,N,1,Intermediate,CHEMBL626325,,
11243,Rattus norvegicus,1,,8363,BAO_0000218,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,A,,N,1,Intermediate,CHEMBL626326,,
11244,Rattus norvegicus,1,,8363,BAO_0000218,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,A,,N,1,Intermediate,CHEMBL626327,,
11245,Rattus norvegicus,1,,8363,BAO_0000218,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,A,,N,1,Intermediate,CHEMBL626328,,
11246,Rattus norvegicus,1,178.0,8684,BAO_0000218,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL626329,,
11247,Rattus norvegicus,1,178.0,8684,BAO_0000218,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL626330,,
11248,Rattus norvegicus,1,178.0,8684,BAO_0000218,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL626331,,
11249,Rattus norvegicus,1,178.0,8684,BAO_0000218,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL626332,,
11250,Rattus norvegicus,1,178.0,8684,BAO_0000218,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL626333,,
11251,Rattus norvegicus,1,178.0,8684,BAO_0000218,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL626334,,
11252,Rattus norvegicus,1,178.0,8684,BAO_0000218,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL626335,,
11253,Rattus norvegicus,1,178.0,8684,BAO_0000218,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624798,,
11254,Rattus norvegicus,1,955.0,8684,BAO_0000218,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624799,,
11255,Rattus norvegicus,1,955.0,8684,BAO_0000218,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624800,,
11256,Rattus norvegicus,1,955.0,8684,BAO_0000218,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624801,,
11257,Rattus norvegicus,1,955.0,8684,BAO_0000218,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624802,,
11258,Rattus norvegicus,1,955.0,8684,BAO_0000218,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624803,,
11259,Rattus norvegicus,1,955.0,8684,BAO_0000218,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624804,,
11260,Rattus norvegicus,1,955.0,8684,BAO_0000218,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624805,,
11261,Rattus norvegicus,1,955.0,8684,BAO_0000218,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624806,,
11262,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624807,,
11263,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624808,,
11264,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624809,,
11265,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624810,,
11266,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL877618,,
11267,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624811,,
11268,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624812,,
11269,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624813,,
11270,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624814,,
11271,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624815,,
11272,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624816,,
11273,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624817,,
11274,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL624818,,
11275,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL624819,,
11276,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL624820,,
11277,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,A,,N,1,Intermediate,CHEMBL624821,,
11278,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,A,,N,1,Intermediate,CHEMBL624822,,
11279,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL624823,,
11280,Escherichia coli,1,,15599,BAO_0000218,,Observed diffusion coefficient in organic solvent for Escherichia coli,,A,,N,1,Intermediate,CHEMBL624824,,
11281,Rattus norvegicus,1,178.0,9614,BAO_0000218,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,A,,N,1,Intermediate,CHEMBL624825,,
11282,Rattus norvegicus,1,178.0,9614,BAO_0000218,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,A,,N,1,Intermediate,CHEMBL624826,,
11283,Rattus norvegicus,1,2081.0,9614,BAO_0000218,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,A,,N,1,Intermediate,CHEMBL876817,,
11284,Rattus norvegicus,1,2081.0,9614,BAO_0000218,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,A,,N,1,Intermediate,CHEMBL624827,,
11285,Rattus norvegicus,1,,9614,BAO_0000218,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,A,,N,1,Intermediate,CHEMBL624828,,
11286,Rattus norvegicus,1,,9614,BAO_0000218,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,A,,N,1,Intermediate,CHEMBL624829,,
11287,Rattus norvegicus,1,2107.0,9614,BAO_0000218,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,A,,N,1,Intermediate,CHEMBL624830,,
11288,Rattus norvegicus,1,2107.0,9614,BAO_0000218,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,A,,N,1,Intermediate,CHEMBL624831,,
11289,Rattus norvegicus,1,2081.0,9614,BAO_0000218,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,A,,N,1,Intermediate,CHEMBL624832,,
11290,Rattus norvegicus,1,2081.0,9614,BAO_0000218,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,A,,N,1,Intermediate,CHEMBL624833,,
11291,Rattus norvegicus,1,,9614,BAO_0000218,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,A,,N,1,Intermediate,CHEMBL624834,,
11292,Rattus norvegicus,1,,9614,BAO_0000218,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,A,,N,1,Intermediate,CHEMBL624835,,
11293,Rattus norvegicus,1,2106.0,9614,BAO_0000218,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,A,,N,1,Intermediate,CHEMBL624836,,
11294,Rattus norvegicus,1,2106.0,9614,BAO_0000218,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,A,,N,1,Intermediate,CHEMBL624837,,
11295,Rattus norvegicus,1,178.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,A,,N,1,Intermediate,CHEMBL624838,,
11296,Rattus norvegicus,1,178.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,A,,N,1,Intermediate,CHEMBL622188,,
11297,Rattus norvegicus,1,948.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,A,,N,1,Intermediate,CHEMBL622189,,
11298,Rattus norvegicus,1,948.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,A,,N,1,Intermediate,CHEMBL622190,,
11299,Rattus norvegicus,1,948.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,A,,N,1,Intermediate,CHEMBL625170,,
11300,Rattus norvegicus,1,2113.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,A,,N,1,Intermediate,CHEMBL625171,,
11301,Rattus norvegicus,1,2113.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,A,,N,1,Intermediate,CHEMBL625172,,
11302,Rattus norvegicus,1,2113.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,A,,N,1,Intermediate,CHEMBL625173,,
11303,Rattus norvegicus,1,2107.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,A,,N,1,Intermediate,CHEMBL625174,,
11304,Rattus norvegicus,1,2107.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,A,,N,1,Intermediate,CHEMBL625175,,
11305,Rattus norvegicus,1,2107.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,A,,N,1,Intermediate,CHEMBL625176,,
11306,Rattus norvegicus,1,2048.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,A,,N,1,Intermediate,CHEMBL625177,,
11307,Rattus norvegicus,1,2048.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,A,,N,1,Intermediate,CHEMBL625178,,
11308,Rattus norvegicus,1,2048.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,A,,N,1,Intermediate,CHEMBL625179,,
11309,Rattus norvegicus,1,2048.0,9071,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,A,,N,1,Intermediate,CHEMBL625180,,
11310,,1,,10677,BAO_0000218,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,A,,U,0,Autocuration,CHEMBL625181,,
11311,Mus musculus,1,1088.0,9750,BAO_0000218,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,A,,N,1,Intermediate,CHEMBL625182,,
11312,Rattus norvegicus,1,,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL625183,,
11313,Rattus norvegicus,1,,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL875848,,
11314,Rattus norvegicus,1,,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL622260,,
11315,Rattus norvegicus,1,,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL622261,,
11316,Rattus norvegicus,1,,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL622262,,
11317,Rattus norvegicus,1,2113.0,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL622263,,
11318,Rattus norvegicus,1,2113.0,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL622418,,
11319,Rattus norvegicus,1,2107.0,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL622419,,
11320,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL623388,,
11321,Mus musculus,1,2107.0,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL623389,,
11322,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL623390,,
11323,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL623391,,
11324,Mus musculus,1,178.0,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL623392,,
11325,Mus musculus,1,2037.0,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL623393,,
11326,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL623394,,
11327,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL618885,,
11328,Mus musculus,1,2107.0,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL618886,,
11329,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL618887,,
11330,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL619535,,
11331,Mus musculus,1,178.0,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL619536,,
11332,Mus musculus,1,2037.0,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL619537,,
11333,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL619705,,
11334,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL619706,,
11335,Mus musculus,1,2107.0,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL619707,,
11336,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL619708,,
11337,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL625219,,
11338,Mus musculus,1,178.0,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL625220,,
11339,Mus musculus,1,2037.0,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL625221,,
11340,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL625222,,
11341,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL625223,,
11342,Mus musculus,1,2107.0,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL625224,,
11343,Mus musculus,1,,13256,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,,N,1,Intermediate,CHEMBL625225,,
11344,Rattus norvegicus,1,178.0,8829,BAO_0000218,,Biodistribution in Rat blood after 24 hours of iv administration,,A,,N,1,Intermediate,CHEMBL625226,,
11345,Rattus norvegicus,1,178.0,8829,BAO_0000218,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,A,,N,1,Intermediate,CHEMBL625227,,
11346,Rattus norvegicus,1,178.0,8829,BAO_0000218,,Biodistribution in Rat blood after 30 minutes of iv administration,,A,,N,1,Intermediate,CHEMBL625228,,
11347,Rattus norvegicus,1,178.0,8829,BAO_0000218,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,A,,N,1,Intermediate,CHEMBL875354,,
11348,Rattus norvegicus,1,178.0,8829,BAO_0000218,,Biodistribution in Rat blood after 5 minutes of iv administration,,A,,N,1,Intermediate,CHEMBL625229,,
11349,Rattus norvegicus,1,178.0,8829,BAO_0000218,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,A,,N,1,Intermediate,CHEMBL625230,,
11350,Rattus norvegicus,1,948.0,8829,BAO_0000218,,Biodistribution in Rat heart after 24 hours of iv administration,,A,,N,1,Intermediate,CHEMBL625231,,
11351,Rattus norvegicus,1,948.0,8829,BAO_0000218,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,A,,N,1,Intermediate,CHEMBL625900,,
11352,Rattus norvegicus,1,948.0,8829,BAO_0000218,,Biodistribution in Rat heart after 30 minutes of iv administration,,A,,N,1,Intermediate,CHEMBL625901,,
11353,Rattus norvegicus,1,948.0,8829,BAO_0000218,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,A,,N,1,Intermediate,CHEMBL625902,,
11354,Rattus norvegicus,1,948.0,8829,BAO_0000218,,Biodistribution in Rat heart after 5 minutes of iv administration,,A,,N,1,Intermediate,CHEMBL625903,,
11355,Rattus norvegicus,1,948.0,8829,BAO_0000218,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,A,,N,1,Intermediate,CHEMBL625904,,
11356,Rattus norvegicus,1,2107.0,8829,BAO_0000218,,Biodistribution in Rat liver after 24 hours of iv administration,,A,,N,1,Intermediate,CHEMBL625905,,
11357,Rattus norvegicus,1,2107.0,8829,BAO_0000218,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,A,,N,1,Intermediate,CHEMBL627861,,
11358,Rattus norvegicus,1,2107.0,8829,BAO_0000218,,Biodistribution in Rat liver after 30 minutes of iv administration,,A,,N,1,Intermediate,CHEMBL627862,,
11359,Rattus norvegicus,1,2107.0,8829,BAO_0000218,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,A,,N,1,Intermediate,CHEMBL627863,,
11360,Rattus norvegicus,1,2107.0,8829,BAO_0000218,,Biodistribution in Rat liver after 30 minutes of iv administration,,A,,N,1,Intermediate,CHEMBL627769,,
11361,Canis lupus familiaris,1,1969.0,13249,BAO_0000218,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,A,,N,1,Intermediate,CHEMBL627770,,
11362,Macaca fascicularis,1,,13622,BAO_0000218,,Cmax in cynomolgus monkey (PO dose),,A,,N,1,Intermediate,CHEMBL627771,,
11363,Rattus norvegicus,1,,13622,BAO_0000218,,Cmax in rat (PO dose),,A,,N,1,Intermediate,CHEMBL627772,,
11364,Rattus norvegicus,1,,13622,BAO_0000218,,Cmax in rat (PO dose),,A,,N,1,Intermediate,CHEMBL627773,,
11365,Rattus norvegicus,1,1969.0,13494,BAO_0000218,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL621922,,
11366,Rattus norvegicus,1,1969.0,12170,BAO_0000218,,Cmax in rat plasma after oral dose (10 mg/kg),,A,,N,1,Intermediate,CHEMBL621923,,
11367,,1,1969.0,12170,BAO_0000218,,Cmax in plasma after oral dose (10 mg/kg),,A,,U,0,Autocuration,CHEMBL621924,,
11368,Canis lupus familiaris,1,1969.0,17025,BAO_0000218,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,A,,N,1,Intermediate,CHEMBL621925,,
11369,Simiiformes,1,1969.0,17025,BAO_0000218,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,A,,U,0,Autocuration,CHEMBL621926,,
11370,Oryctolagus cuniculus,1,1969.0,17025,BAO_0000218,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,A,,N,1,Intermediate,CHEMBL621927,,
11371,Rattus norvegicus,1,1969.0,17025,BAO_0000218,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,A,,N,1,Intermediate,CHEMBL621928,,
11372,Rattus norvegicus,1,1969.0,14187,BAO_0000218,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,A,,N,1,Intermediate,CHEMBL621929,,
11373,Mus musculus,1,1969.0,14816,BAO_0000218,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,A,,N,1,Intermediate,CHEMBL621930,,
11374,Rattus norvegicus,1,1969.0,17820,BAO_0000218,,Maximum plasma concentration after oral dosing in rat,,A,,N,1,Intermediate,CHEMBL621931,,
11375,,1,1969.0,14380,BAO_0000218,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL621932,,
11376,,1,1969.0,14380,BAO_0000218,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL621933,,
11377,Canis lupus familiaris,1,1969.0,14691,BAO_0000218,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,A,,N,1,Intermediate,CHEMBL621934,,
11378,Canis lupus familiaris,1,1969.0,14691,BAO_0000218,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,A,,N,1,Intermediate,CHEMBL621935,,
11379,Rattus norvegicus,1,1969.0,13375,BAO_0000218,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,A,,N,1,Intermediate,CHEMBL621936,,
11380,,1,1969.0,6236,BAO_0000218,,Maximum plasma concentration was determined,,A,,U,0,Autocuration,CHEMBL621937,,
11381,,1,1969.0,14380,BAO_0000218,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL621938,,
11382,,1,1969.0,14380,BAO_0000218,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL621939,,
11383,,1,1969.0,14380,BAO_0000218,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL621940,,
11384,,1,1969.0,14380,BAO_0000218,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL621941,,
11385,,1,1969.0,14380,BAO_0000218,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL621942,,
11386,,1,1969.0,14380,BAO_0000218,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL626178,,
11387,,1,1969.0,14380,BAO_0000218,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL626179,,
11388,,1,1969.0,14380,BAO_0000218,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL626180,,
11389,Rattus norvegicus,1,1969.0,13622,BAO_0000218,,Plasma Cmax in rat (PO dose),,A,,N,1,Intermediate,CHEMBL626181,,
11390,Rattus norvegicus,1,,15372,BAO_0000218,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL626182,,
11391,Rattus norvegicus,1,,15372,BAO_0000218,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL626183,,
11392,Rattus norvegicus,1,,15372,BAO_0000218,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL626184,,
11393,Rattus norvegicus,1,,15372,BAO_0000218,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL626185,,
11394,Canis lupus familiaris,1,1969.0,14925,BAO_0000218,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,A,,N,1,Intermediate,CHEMBL626186,,
11395,Canis lupus familiaris,1,1969.0,14925,BAO_0000218,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,A,,N,1,Intermediate,CHEMBL877589,,
11396,,1,,11883,BAO_0000218,,Maximum concentration of the drug at 1 uM/dg administered intravenously,,A,,U,0,Autocuration,CHEMBL626187,,
11397,,1,,11883,BAO_0000218,,Maximum concentration of the drug at 20 uM/dg administered perorally,,A,,U,0,Autocuration,CHEMBL626188,,
11398,,1,,13391,BAO_0000218,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,A,,U,0,Autocuration,CHEMBL626189,,
11399,,1,178.0,13391,BAO_0000218,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,A,,U,0,Autocuration,CHEMBL626855,,
11400,,1,178.0,13391,BAO_0000218,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,A,,U,0,Autocuration,CHEMBL623781,,
11401,,1,178.0,13391,BAO_0000218,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,A,,U,0,Autocuration,CHEMBL623782,,
11402,Rattus norvegicus,1,1969.0,16360,BAO_0000218,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL623783,,
11403,Canis lupus familiaris,1,1969.0,3673,BAO_0000218,,Cmax in dog plasma after 1mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL623784,,
11404,Canis lupus familiaris,1,1969.0,14431,BAO_0000218,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL623785,,
11405,Rattus norvegicus,1,1969.0,14431,BAO_0000218,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL623786,,
11406,Rattus norvegicus,1,,14964,BAO_0000218,,Oral maximum concentration in rat,,A,,N,1,Intermediate,CHEMBL623787,,
11407,Rattus norvegicus,1,,14964,BAO_0000218,,Oral maximum concentration in rat,,A,,N,1,Intermediate,CHEMBL623788,,
11408,Mus musculus,1,1969.0,14209,BAO_0000218,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,A,,N,1,Intermediate,CHEMBL623789,,
11409,Mus musculus,1,178.0,11355,BAO_0000218,,Peak concentration in blood after intravenous administration to mice,,A,,N,1,Intermediate,CHEMBL623790,,
11410,Mus musculus,1,178.0,11355,BAO_0000218,,Peak concentration in blood after peroral administration to mice,,A,,N,1,Intermediate,CHEMBL623791,,
11411,Rattus norvegicus,1,1969.0,11966,BAO_0000218,,Peak concentration in rat plasma was determined,,A,,N,1,Intermediate,CHEMBL623792,,
11412,Simiiformes,1,1969.0,8918,BAO_0000218,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,A,,U,0,Autocuration,CHEMBL623793,,
11413,Mus musculus,1,1969.0,8918,BAO_0000218,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,A,,N,1,Intermediate,CHEMBL623794,,
11414,Rattus norvegicus,1,1969.0,8918,BAO_0000218,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,A,,N,1,Intermediate,CHEMBL623795,,
11415,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623796,,
11416,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623797,,
11417,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623798,,
11418,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623799,,
11419,Rattus norvegicus,1,160.0,8684,BAO_0000218,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624490,,
11420,Rattus norvegicus,1,160.0,8684,BAO_0000218,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624491,,
11421,Rattus norvegicus,1,160.0,8684,BAO_0000218,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624492,,
11422,Rattus norvegicus,1,160.0,8684,BAO_0000218,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624493,,
11423,Rattus norvegicus,1,160.0,8684,BAO_0000218,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL877595,,
11424,Rattus norvegicus,1,160.0,8684,BAO_0000218,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624494,,
11425,Rattus norvegicus,1,160.0,8684,BAO_0000218,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624495,,
11426,Rattus norvegicus,1,160.0,8684,BAO_0000218,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624681,,
11427,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624682,,
11428,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624683,,
11429,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624684,,
11430,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624685,,
11431,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624686,,
11432,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624687,,
11433,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624688,,
11434,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL627161,,
11435,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL622127,,
11436,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL622128,,
11437,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL874384,,
11438,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624898,,
11439,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624899,,
11440,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624900,,
11441,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624901,,
11442,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624902,,
11443,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624903,,
11444,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624904,,
11445,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624905,,
11446,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624906,,
11447,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624907,,
11448,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624908,,
11449,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624909,,
11450,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624910,,
11451,Rattus norvegicus,1,2385.0,8684,BAO_0000218,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624911,,
11452,Rattus norvegicus,1,2385.0,8684,BAO_0000218,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL874388,,
11453,Rattus norvegicus,1,2385.0,8684,BAO_0000218,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL624912,,
11454,Rattus norvegicus,1,2385.0,8684,BAO_0000218,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL622930,,
11455,Rattus norvegicus,1,2385.0,8684,BAO_0000218,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623121,,
11456,Rattus norvegicus,1,2385.0,8684,BAO_0000218,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623122,,
11457,Rattus norvegicus,1,2385.0,8684,BAO_0000218,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623123,,
11458,Rattus norvegicus,1,2385.0,8684,BAO_0000218,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623124,,
11459,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623125,,
11460,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623126,,
11461,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623127,,
11462,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623128,,
11463,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623129,,
11464,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623130,,
11465,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623131,,
11466,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL623132,,
11467,Rattus norvegicus,1,2107.0,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL623133,,
11468,Rattus norvegicus,1,,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL623134,,
11469,Rattus norvegicus,1,,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL874389,,
11470,Rattus norvegicus,1,,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL623135,,
11471,Rattus norvegicus,1,,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL623136,,
11472,Rattus norvegicus,1,,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL623137,,
11473,Rattus norvegicus,1,,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL623138,,
11474,Rattus norvegicus,1,2113.0,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL623139,,
11475,Rattus norvegicus,1,2113.0,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL623140,,
11476,Rattus norvegicus,1,2107.0,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL623141,,
11477,Rattus norvegicus,1,2107.0,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL623142,,
11478,Rattus norvegicus,1,,8319,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL623143,,
11479,Mus musculus,1,1088.0,14571,BAO_0000218,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,A,,N,1,Intermediate,CHEMBL623144,,
11480,Rattus norvegicus,1,1088.0,14571,BAO_0000218,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,A,,N,1,Intermediate,CHEMBL623405,,
11481,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL624074,,
11482,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL624075,,
11483,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL624076,,
11484,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL624077,,
11485,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL624078,,
11486,Rattus norvegicus,1,2113.0,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL624079,,
11487,Rattus norvegicus,1,2113.0,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL624261,,
11488,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL624262,,
11489,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL624263,,
11490,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL624264,,
11491,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL624265,,
11492,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL624266,,
11493,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL624267,,
11494,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL624268,,
11495,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL875227,,
11496,Rattus norvegicus,1,2113.0,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL624269,,
11497,Rattus norvegicus,1,2113.0,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL624270,,
11498,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,A,,N,1,Intermediate,CHEMBL624271,,
11499,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL624272,,
11500,Rattus norvegicus,1,,8319,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,A,,N,1,Intermediate,CHEMBL624273,,
11501,Rattus norvegicus,1,1088.0,12064,BAO_0000218,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,A,,N,1,Intermediate,CHEMBL624274,,
11502,Rattus norvegicus,1,1088.0,12064,BAO_0000218,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,A,,N,1,Intermediate,CHEMBL624275,,
11503,Rattus norvegicus,1,1088.0,12064,BAO_0000218,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,A,,N,1,Intermediate,CHEMBL624276,,
11504,Rattus norvegicus,1,1088.0,12038,BAO_0000218,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,A,,N,1,Intermediate,CHEMBL624277,,
11505,,1,,14314,BAO_0000019,,% dose converted to 2-amino-5-chlorophenyl sulfate,,A,,U,0,Autocuration,CHEMBL624278,,
11506,,1,,14314,BAO_0000019,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,A,,U,0,Autocuration,CHEMBL624279,,
11507,Rattus norvegicus,1,1988.0,11488,BAO_0000218,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,A,,N,1,Intermediate,CHEMBL624280,,
11508,Rattus norvegicus,1,1988.0,11488,BAO_0000218,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,A,,N,1,Intermediate,CHEMBL624281,,
11509,Rattus norvegicus,1,1988.0,11488,BAO_0000218,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,A,,N,1,Intermediate,CHEMBL622933,,
11510,Rattus norvegicus,1,1988.0,11488,BAO_0000218,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,A,,N,1,Intermediate,CHEMBL622934,,
11511,Rattus norvegicus,1,2107.0,8829,BAO_0000218,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,A,,N,1,Intermediate,CHEMBL622935,,
11512,Rattus norvegicus,1,2107.0,8829,BAO_0000218,,Biodistribution in Rat liver after 5 minutes of iv administration,,A,,N,1,Intermediate,CHEMBL622936,,
11513,Rattus norvegicus,1,2107.0,8829,BAO_0000218,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,A,,N,1,Intermediate,CHEMBL875228,,
11514,Rattus norvegicus,1,2048.0,8829,BAO_0000218,,Biodistribution in Rat lung after 24 hours of iv administration,,A,,N,1,Intermediate,CHEMBL622937,,
11515,Rattus norvegicus,1,2048.0,8829,BAO_0000218,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,A,,N,1,Intermediate,CHEMBL622938,,
11516,Rattus norvegicus,1,2048.0,8829,BAO_0000218,,Biodistribution in Rat lung after 30 minutes of iv administration,,A,,N,1,Intermediate,CHEMBL619736,,
11517,Rattus norvegicus,1,2048.0,8829,BAO_0000218,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,A,,N,1,Intermediate,CHEMBL625117,,
11518,Rattus norvegicus,1,2048.0,8829,BAO_0000218,,Biodistribution in Rat lung after 5 minutes of iv administration,,A,,N,1,Intermediate,CHEMBL625118,,
11519,Rattus norvegicus,1,2048.0,8829,BAO_0000218,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,A,,N,1,Intermediate,CHEMBL625119,,
11520,Rattus norvegicus,1,2037.0,14972,BAO_0000218,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,A,,N,1,Intermediate,CHEMBL625120,,
11521,Rattus norvegicus,1,,14972,BAO_0000218,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,A,,N,1,Intermediate,CHEMBL625121,,
11522,Rattus norvegicus,1,10000006.0,14972,BAO_0000218,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,A,,N,1,Intermediate,CHEMBL625122,,
11523,Rattus norvegicus,1,178.0,14608,BAO_0000218,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL622204,,
11524,Rattus norvegicus,1,178.0,14608,BAO_0000218,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL877503,,
11525,Rattus norvegicus,1,178.0,14608,BAO_0000218,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL627127,,
11526,,1,10000000.0,14608,BAO_0000218,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,U,0,Autocuration,CHEMBL627128,,
11527,,1,10000000.0,14608,BAO_0000218,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,U,0,Autocuration,CHEMBL627129,,
11528,,1,10000000.0,14608,BAO_0000218,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,U,0,Autocuration,CHEMBL627130,,
11529,Rattus norvegicus,1,955.0,14608,BAO_0000218,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL627131,,
11530,Rattus norvegicus,1,955.0,14608,BAO_0000218,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL627132,,
11531,Rattus norvegicus,1,955.0,14608,BAO_0000218,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL627133,,
11532,Rattus norvegicus,1,2037.0,14608,BAO_0000218,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL627134,,
11533,Rattus norvegicus,1,2037.0,14608,BAO_0000218,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL627135,,
11534,Rattus norvegicus,1,2037.0,14608,BAO_0000218,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL627136,,
11535,Rattus norvegicus,1,,14608,BAO_0000218,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL628435,,
11536,Rattus norvegicus,1,,14608,BAO_0000218,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL628436,,
11537,Rattus norvegicus,1,,14608,BAO_0000218,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL628437,,
11538,Rattus norvegicus,1,948.0,14608,BAO_0000218,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL628438,,
11539,Rattus norvegicus,1,948.0,14608,BAO_0000218,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL628439,,
11540,Rattus norvegicus,1,948.0,14608,BAO_0000218,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL628440,,
11541,Rattus norvegicus,1,10000000.0,14608,BAO_0000218,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL628441,,
11542,Rattus norvegicus,1,10000000.0,14608,BAO_0000218,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL628442,,
11543,Rattus norvegicus,1,10000000.0,14608,BAO_0000218,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL628443,,
11544,Rattus norvegicus,1,2113.0,14608,BAO_0000218,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL628444,,
11545,Rattus norvegicus,1,2113.0,14608,BAO_0000218,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL628445,,
11546,Rattus norvegicus,1,2113.0,14608,BAO_0000218,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL877504,,
11547,Rattus norvegicus,1,2107.0,14608,BAO_0000218,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL628446,,
11548,Rattus norvegicus,1,2107.0,14608,BAO_0000218,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL626874,,
11549,Rattus norvegicus,1,2107.0,14608,BAO_0000218,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL626875,,
11550,Rattus norvegicus,1,2048.0,14608,BAO_0000218,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL626876,,
11551,Rattus norvegicus,1,2048.0,14608,BAO_0000218,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL626877,,
11552,Rattus norvegicus,1,2048.0,14608,BAO_0000218,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL626878,,
11553,Rattus norvegicus,1,2385.0,14608,BAO_0000218,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL626879,,
11554,Simiiformes,1,1969.0,8918,BAO_0000218,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,A,,U,0,Autocuration,CHEMBL626880,,
11555,Mus musculus,1,1969.0,8918,BAO_0000218,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,A,,N,1,Intermediate,CHEMBL626881,,
11556,Rattus norvegicus,1,1969.0,8918,BAO_0000218,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,A,,N,1,Intermediate,CHEMBL626882,,
11557,Canis lupus familiaris,1,1969.0,14470,BAO_0000218,,Peak plasma concentration was measured in dogs,,A,,N,1,Intermediate,CHEMBL626883,,
11558,Rattus norvegicus,1,,14393,BAO_0000218,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,A,,N,1,Intermediate,CHEMBL626884,,
11559,Rattus norvegicus,1,,14886,BAO_0000218,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,A,,N,1,Intermediate,CHEMBL626885,,
11560,Rattus norvegicus,1,,14886,BAO_0000218,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,A,,N,1,Intermediate,CHEMBL626886,,
11561,Rattus norvegicus,1,,14886,BAO_0000218,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,A,,N,1,Intermediate,CHEMBL626887,,
11562,Rattus norvegicus,1,,14393,BAO_0000218,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,A,,N,1,Intermediate,CHEMBL626888,,
11563,Canis lupus familiaris,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,A,,N,1,Intermediate,CHEMBL626889,,
11564,Simiiformes,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,A,,U,0,Autocuration,CHEMBL626761,,
11565,Canis lupus familiaris,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,A,,N,1,Intermediate,CHEMBL626762,,
11566,Canis lupus familiaris,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,A,,N,1,Intermediate,CHEMBL626763,,
11567,Rattus norvegicus,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,A,,N,1,Intermediate,CHEMBL626764,,
11568,Rattus norvegicus,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,A,,N,1,Intermediate,CHEMBL626765,,
11569,Canis lupus familiaris,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,A,,N,1,Intermediate,CHEMBL626766,,
11570,Rattus norvegicus,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,A,,N,1,Intermediate,CHEMBL626767,,
11571,Rattus norvegicus,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,A,,N,1,Intermediate,CHEMBL626768,,
11572,Canis lupus familiaris,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,A,,N,1,Intermediate,CHEMBL626769,,
11573,Canis lupus familiaris,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,A,,N,1,Intermediate,CHEMBL874463,,
11574,Simiiformes,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,A,,U,0,Autocuration,CHEMBL626770,,
11575,Simiiformes,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,A,,U,0,Autocuration,CHEMBL626771,,
11576,Rattus norvegicus,1,,13465,BAO_0000218,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,A,,N,1,Intermediate,CHEMBL626772,,
11577,Macaca fascicularis,1,,14731,BAO_0000218,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,A,,N,1,Intermediate,CHEMBL626773,,
11578,Mus musculus,1,,14731,BAO_0000218,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,A,,N,1,Intermediate,CHEMBL626774,,
11579,Canis lupus familiaris,1,,13376,BAO_0000218,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,A,,N,1,Intermediate,CHEMBL626775,,
11580,Canis lupus familiaris,1,,13376,BAO_0000218,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,A,,N,1,Intermediate,CHEMBL626776,,
11581,Rattus norvegicus,1,,14443,BAO_0000218,,Maximum concentration (Cmax) in rat when administered orally,,A,,N,1,Intermediate,CHEMBL626777,,
11582,Simiiformes,1,1969.0,13465,BAO_0000218,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,A,,U,0,Autocuration,CHEMBL626778,,
11583,Rattus norvegicus,1,,16359,BAO_0000218,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,A,,U,0,Autocuration,CHEMBL626779,,
11584,Rattus norvegicus,1,,16359,BAO_0000218,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,A,,U,0,Autocuration,CHEMBL626780,,
11585,,1,1969.0,15618,BAO_0000218,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,A,,U,0,Autocuration,CHEMBL626781,,
11586,Rattus norvegicus,1,,14554,BAO_0000218,,Pharmacokinetic profile Cmax was evaluated in rats,,A,,N,1,Intermediate,CHEMBL632164,,
11587,Canis lupus familiaris,1,,11537,BAO_0000218,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,A,,N,1,Intermediate,CHEMBL632165,,
11588,Mus musculus,1,,11537,BAO_0000218,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,A,,N,1,Intermediate,CHEMBL632166,,
11589,Canis lupus familiaris,1,,11537,BAO_0000218,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,A,,N,1,Intermediate,CHEMBL632167,,
11590,Mus musculus,1,,11537,BAO_0000218,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,A,,N,1,Intermediate,CHEMBL632168,,
11591,Rattus norvegicus,1,1969.0,2021,BAO_0000218,,Cmax in rat plasma,,A,,U,0,Autocuration,CHEMBL632169,,
11592,Canis lupus familiaris,1,1969.0,5932,BAO_0000218,,Cmax in dog plasma after 30mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL632170,,
11593,Rattus norvegicus,1,1969.0,5932,BAO_0000218,,Cmax in rat plasma after 30mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL632171,,
11594,Rattus norvegicus,1,1969.0,17320,BAO_0000218,,Plasma level in rats at 30 mg/kg,,A,,N,1,Intermediate,CHEMBL632172,,
11595,Mus musculus,1,1969.0,15831,BAO_0000218,,Tested for maximum plasma concentration in mice,,A,,N,1,Intermediate,CHEMBL632173,,
11596,Rattus norvegicus,1,,15078,BAO_0000218,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL632174,,
11597,Rattus norvegicus,1,,14941,BAO_0000218,,The Cmax values in female wistar rats.,,A,,N,1,Intermediate,CHEMBL632175,,
11598,Canis lupus familiaris,1,1969.0,15343,BAO_0000218,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,A,,N,1,Intermediate,CHEMBL632176,,
11599,Rattus norvegicus,1,1969.0,15343,BAO_0000218,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,A,,N,1,Intermediate,CHEMBL632177,,
11600,Rattus norvegicus,1,1969.0,14856,BAO_0000218,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,A,,N,1,Intermediate,CHEMBL632178,,
11601,Rattus norvegicus,1,,13129,BAO_0000218,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,A,,N,1,Intermediate,CHEMBL632179,,
11602,Rattus norvegicus,1,178.0,13098,BAO_0000218,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,A,,N,1,Intermediate,CHEMBL632180,,
11603,Rattus norvegicus,1,178.0,13098,BAO_0000218,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,A,,N,1,Intermediate,CHEMBL632181,,
11604,Rattus norvegicus,1,178.0,13098,BAO_0000218,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,A,,N,1,Intermediate,CHEMBL632182,,
11605,Mus musculus,1,178.0,15478,BAO_0000218,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,A,,U,0,Autocuration,CHEMBL632183,,
11606,Canis lupus familiaris,1,,15341,BAO_0000218,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,A,,N,1,Intermediate,CHEMBL632184,,
11607,Rattus norvegicus,1,,15341,BAO_0000218,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,A,,N,1,Intermediate,CHEMBL874470,,
11608,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL631302,,
11609,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL631303,,
11610,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL631304,,
11611,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL631305,,
11612,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL631306,,
11613,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL631307,,
11614,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL631308,,
11615,Rattus norvegicus,1,,8684,BAO_0000218,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL625557,,
11616,Rattus norvegicus,1,2106.0,8684,BAO_0000218,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL625558,,
11617,Rattus norvegicus,1,2106.0,8684,BAO_0000218,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL625559,,
11618,Rattus norvegicus,1,2106.0,8684,BAO_0000218,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL625560,,
11619,Rattus norvegicus,1,2106.0,8684,BAO_0000218,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL625561,,
11620,Rattus norvegicus,1,2106.0,8684,BAO_0000218,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL625562,,
11621,Rattus norvegicus,1,2106.0,8684,BAO_0000218,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL875320,,
11622,Rattus norvegicus,1,2106.0,8684,BAO_0000218,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL625563,,
11623,Rattus norvegicus,1,2106.0,8684,BAO_0000218,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL625564,,
11624,Rattus norvegicus,1,995.0,8684,BAO_0000218,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL625565,,
11625,Rattus norvegicus,1,995.0,8684,BAO_0000218,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL625566,,
11626,Rattus norvegicus,1,995.0,8684,BAO_0000218,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL625567,,
11627,Rattus norvegicus,1,995.0,8684,BAO_0000218,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL625568,,
11628,Rattus norvegicus,1,995.0,8684,BAO_0000218,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL628217,,
11629,Rattus norvegicus,1,995.0,8684,BAO_0000218,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL628218,,
11630,Rattus norvegicus,1,995.0,8684,BAO_0000218,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL628219,,
11631,Rattus norvegicus,1,995.0,8684,BAO_0000218,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,A,,N,1,Intermediate,CHEMBL628220,,
11632,,1,,8926,BAO_0000019,,Distribution in the blood after 120 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628221,,
11633,,1,,8926,BAO_0000019,,Distribution in the blood after 15 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628222,,
11634,,1,,8926,BAO_0000019,,Distribution in the blood after 30 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628223,,
11635,,1,,8926,BAO_0000019,,Distribution in the blood after 5 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628224,,
11636,,1,,8926,BAO_0000019,,Distribution in the blood after 60 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628225,,
11637,,1,,8926,BAO_0000019,,Distribution in the blood after 90 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628226,,
11638,,1,,8926,BAO_0000019,,Distribution in the bone after 120 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628227,,
11639,,1,,8926,BAO_0000019,,Distribution in the bone after 15 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL875481,,
11640,,1,,8926,BAO_0000019,,Distribution in the bone after 30 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628228,,
11641,,1,,8926,BAO_0000019,,Distribution in the bone after 5 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628229,,
11642,,1,,8926,BAO_0000019,,Distribution in the bone after 60 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628230,,
11643,,1,,8926,BAO_0000019,,Distribution in the bone after 90 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628231,,
11644,,1,,8926,BAO_0000019,,Distribution in the heart after 120 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628232,,
11645,,1,,8926,BAO_0000019,,Distribution in the heart after 15 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628233,,
11646,,1,,8926,BAO_0000019,,Distribution in the heart after 30 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628234,,
11647,,1,,8926,BAO_0000019,,Distribution in the heart after 5 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628235,,
11648,,1,,8926,BAO_0000019,,Distribution in the heart after 60 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628236,,
11649,,1,,8926,BAO_0000019,,Distribution in the heart after 90 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628237,,
11650,,1,,8926,BAO_0000019,,Distribution in the kidneys after 120 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628238,,
11651,,1,,8926,BAO_0000019,,Distribution in the kidneys after 15 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628239,,
11652,,1,,8926,BAO_0000019,,Distribution in the kidneys after 30 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628240,,
11653,,1,,8926,BAO_0000019,,Distribution in the kidneys after 5 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628241,,
11654,,1,,8926,BAO_0000019,,Distribution in the kidneys after 60 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628242,,
11655,,1,,8926,BAO_0000019,,Distribution in the kidneys after 90 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL875482,,
11656,,1,,8926,BAO_0000019,,Distribution in the liver after 120 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628243,,
11657,,1,,8926,BAO_0000019,,Distribution in the liver after 15 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628244,,
11658,,1,,8926,BAO_0000019,,Distribution in the liver after 30 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628245,,
11659,,1,,8926,BAO_0000019,,Distribution in the liver after 5 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628246,,
11660,,1,,8926,BAO_0000019,,Distribution in the liver after 60 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628247,,
11661,,1,,8926,BAO_0000019,,Distribution in the liver after 90 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628248,,
11662,,1,,8926,BAO_0000019,,Distribution in the lung after 120 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628249,,
11663,Mus musculus,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,A,,N,1,Intermediate,CHEMBL625452,,
11664,Mus musculus,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,A,,N,1,Intermediate,CHEMBL625453,,
11665,Mus musculus,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,A,,N,1,Intermediate,CHEMBL625454,,
11666,Mus musculus,1,,14839,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,A,,N,1,Intermediate,CHEMBL623844,,
11667,Rattus norvegicus,1,,12178,BAO_0000218,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,A,,N,1,Intermediate,CHEMBL623845,,
11668,Rattus norvegicus,1,,12178,BAO_0000218,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,A,,N,1,Intermediate,CHEMBL623846,,
11669,,1,,12178,BAO_0000218,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,A,,U,0,Autocuration,CHEMBL623847,,
11670,Macaca fascicularis,1,,12186,BAO_0000218,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,A,,N,1,Intermediate,CHEMBL623848,,
11671,Macaca fascicularis,1,,12186,BAO_0000218,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,A,,N,1,Intermediate,CHEMBL623849,,
11672,Macaca fascicularis,1,,12186,BAO_0000218,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,A,,N,1,Intermediate,CHEMBL623850,,
11673,Macaca fascicularis,1,,12186,BAO_0000218,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,A,,N,1,Intermediate,CHEMBL623851,,
11674,Simiiformes,1,,12187,BAO_0000218,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,A,,U,0,Autocuration,CHEMBL623852,,
11675,Mustela putorius furo,1,,12187,BAO_0000218,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,A,,N,1,Intermediate,CHEMBL624551,,
11676,Mustela putorius furo,1,,12187,BAO_0000218,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,A,,N,1,Intermediate,CHEMBL624552,,
11677,Simiiformes,1,,12187,BAO_0000218,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,A,,U,0,Autocuration,CHEMBL624553,,
11678,Simiiformes,1,,12187,BAO_0000218,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,A,,U,0,Autocuration,CHEMBL624554,,
11679,Rattus norvegicus,1,,12187,BAO_0000218,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL624555,,
11680,Rattus norvegicus,1,,12187,BAO_0000218,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,A,,N,1,Intermediate,CHEMBL624741,,
11681,Canis lupus familiaris,1,,14122,BAO_0000218,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,A,,N,1,Intermediate,CHEMBL624742,,
11682,Cricetinae,1,,14122,BAO_0000218,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,A,,N,1,Intermediate,CHEMBL624743,,
11683,Rattus norvegicus,1,,14122,BAO_0000218,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,A,,N,1,Intermediate,CHEMBL877606,,
11684,,1,,13391,BAO_0000218,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,A,,U,0,Autocuration,CHEMBL624744,,
11685,,1,178.0,13391,BAO_0000218,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,A,,U,0,Autocuration,CHEMBL624745,,
11686,,1,178.0,13391,BAO_0000218,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,A,,U,0,Autocuration,CHEMBL624746,,
11687,,1,178.0,13391,BAO_0000218,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,A,,U,0,Autocuration,CHEMBL624747,,
11688,,1,,16360,BAO_0000019,,Oral absorption expressed as Area under curve was determined,,A,,U,0,Autocuration,CHEMBL624748,,
11689,Canis lupus familiaris,1,,3673,BAO_0000218,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,A,,N,1,Intermediate,CHEMBL622504,,
11690,Canis lupus familiaris,1,,14122,BAO_0000218,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,A,,N,1,Intermediate,CHEMBL622505,,
11691,Cricetinae,1,,14122,BAO_0000218,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,A,,N,1,Intermediate,CHEMBL622506,,
11692,Cricetinae,1,,14122,BAO_0000218,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,A,,N,1,Intermediate,CHEMBL622507,,
11693,Rattus norvegicus,1,,14122,BAO_0000218,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,A,,N,1,Intermediate,CHEMBL622508,,
11694,,1,,13889,BAO_0000019,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,A,,U,0,Autocuration,CHEMBL622509,,
11695,Rattus norvegicus,1,,14393,BAO_0000218,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,A,,N,1,Intermediate,CHEMBL622510,,
11696,Rattus norvegicus,1,,17279,BAO_0000218,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,A,,N,1,Intermediate,CHEMBL622511,,
11697,Macaca fascicularis,1,,14548,BAO_0000218,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL622512,,
11698,Macaca fascicularis,1,,14548,BAO_0000218,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL622513,,
11699,Macaca fascicularis,1,,14548,BAO_0000218,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL622514,,
11700,Canis lupus familiaris,1,,14548,BAO_0000218,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL622515,,
11701,Canis lupus familiaris,1,,14548,BAO_0000218,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL622516,,
11702,Rattus norvegicus,1,,14548,BAO_0000218,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL622517,,
11703,Rattus norvegicus,1,,14548,BAO_0000218,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL622518,,
11704,Rattus norvegicus,1,,14548,BAO_0000218,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL622519,,
11705,Rattus norvegicus,1,2385.0,14608,BAO_0000218,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL622520,,
11706,Rattus norvegicus,1,2385.0,14608,BAO_0000218,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL622521,,
11707,Mus musculus,1,14.0,14608,BAO_0000218,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL625113,,
11708,Rattus norvegicus,1,14.0,14608,BAO_0000218,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL625114,,
11709,Rattus norvegicus,1,14.0,14608,BAO_0000218,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL874397,,
11710,Rattus norvegicus,1,2106.0,14608,BAO_0000218,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL625115,,
11711,Rattus norvegicus,1,2106.0,14608,BAO_0000218,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL625116,,
11712,Rattus norvegicus,1,2106.0,14608,BAO_0000218,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL623932,,
11713,Rattus norvegicus,1,2435.0,14608,BAO_0000218,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL623933,,
11714,Rattus norvegicus,1,2435.0,14608,BAO_0000218,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL623934,,
11715,Rattus norvegicus,1,2435.0,14608,BAO_0000218,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL623935,,
11716,Rattus norvegicus,1,2046.0,14608,BAO_0000218,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,,N,1,Intermediate,CHEMBL623936,,
11717,Rattus norvegicus,1,2046.0,14608,BAO_0000218,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,,N,1,Intermediate,CHEMBL623937,,
11718,Rattus norvegicus,1,2046.0,14608,BAO_0000218,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,,N,1,Intermediate,CHEMBL623938,,
11719,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,A,,N,1,Intermediate,CHEMBL623939,,
11720,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,A,,N,1,Intermediate,CHEMBL623940,,
11721,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,A,,N,1,Intermediate,CHEMBL623941,,
11722,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,,N,1,Intermediate,CHEMBL627216,,
11723,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,,N,1,Intermediate,CHEMBL623942,,
11724,Mus musculus,1,955.0,15383,BAO_0000218,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,A,,N,1,Intermediate,CHEMBL618793,,
11725,Mus musculus,1,955.0,15383,BAO_0000218,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,,N,1,Intermediate,CHEMBL618794,,
11726,Mus musculus,1,955.0,15383,BAO_0000218,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,,N,1,Intermediate,CHEMBL618795,,
11727,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,,N,1,Intermediate,CHEMBL618796,,
11728,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,,N,1,Intermediate,CHEMBL618797,,
11729,Mus musculus,1,2113.0,15383,BAO_0000218,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,A,,N,1,Intermediate,CHEMBL618798,,
11730,Mus musculus,1,2113.0,15383,BAO_0000218,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,A,,N,1,Intermediate,CHEMBL618799,,
11731,Mus musculus,1,2113.0,15383,BAO_0000218,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,A,,N,1,Intermediate,CHEMBL618800,,
11732,Mus musculus,1,2113.0,15383,BAO_0000218,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,A,,N,1,Intermediate,CHEMBL618801,,
11733,Mus musculus,1,2113.0,15383,BAO_0000218,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,,N,1,Intermediate,CHEMBL618802,,
11734,Mus musculus,1,2113.0,15383,BAO_0000218,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,,N,1,Intermediate,CHEMBL618803,,
11735,Mus musculus,1,2107.0,15383,BAO_0000218,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,A,,N,1,Intermediate,CHEMBL618804,,
11736,Mus musculus,1,2107.0,15383,BAO_0000218,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,A,,N,1,Intermediate,CHEMBL618805,,
11737,Mus musculus,1,2107.0,15383,BAO_0000218,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,A,,N,1,Intermediate,CHEMBL618806,,
11738,Mus musculus,1,2107.0,15383,BAO_0000218,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,A,,N,1,Intermediate,CHEMBL618807,,
11739,Mus musculus,1,2107.0,15383,BAO_0000218,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,,N,1,Intermediate,CHEMBL618808,,
11740,Mus musculus,1,2107.0,15383,BAO_0000218,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,,N,1,Intermediate,CHEMBL618809,,
11741,Mus musculus,1,2385.0,15383,BAO_0000218,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,A,,N,1,Intermediate,CHEMBL618810,,
11742,Mus musculus,1,2385.0,15383,BAO_0000218,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,A,,N,1,Intermediate,CHEMBL618811,,
11743,Mus musculus,1,2385.0,15383,BAO_0000218,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,A,,N,1,Intermediate,CHEMBL875844,,
11744,Mus musculus,1,2385.0,15383,BAO_0000218,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,,N,1,Intermediate,CHEMBL618812,,
11745,Mus musculus,1,2385.0,15383,BAO_0000218,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,,N,1,Intermediate,CHEMBL618813,,
11746,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,A,,N,1,Intermediate,CHEMBL618814,,
11747,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,,N,1,Intermediate,CHEMBL618815,,
11748,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,,N,1,Intermediate,CHEMBL618816,,
11749,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,,N,1,Intermediate,CHEMBL618817,,
11750,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,,N,1,Intermediate,CHEMBL620544,,
11751,Rattus norvegicus,1,,15341,BAO_0000218,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,A,,N,1,Intermediate,CHEMBL626230,,
11752,Rattus norvegicus,1,,15341,BAO_0000218,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,A,,N,1,Intermediate,CHEMBL626231,,
11753,Rattus norvegicus,1,,15341,BAO_0000218,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,A,,N,1,Intermediate,CHEMBL626232,,
11754,Canis lupus familiaris,1,1969.0,14906,BAO_0000218,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,A,,N,1,Intermediate,CHEMBL626233,,
11755,Rattus norvegicus,1,1969.0,14906,BAO_0000218,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,A,,N,1,Intermediate,CHEMBL626234,,
11756,Rattus norvegicus,1,1969.0,14906,BAO_0000218,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,A,,N,1,Intermediate,CHEMBL875341,,
11757,Homo sapiens,1,1969.0,14215,BAO_0000218,,The maximum plasma concentration (100 mg/kg) administered orally in human,,A,,N,1,Intermediate,CHEMBL626235,,
11758,Callithrix,1,1969.0,14215,BAO_0000218,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,A,,U,0,Autocuration,CHEMBL626236,,
11759,Simiiformes,1,1969.0,14215,BAO_0000218,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,A,,U,0,Autocuration,CHEMBL626237,,
11760,Canis lupus familiaris,1,1969.0,14215,BAO_0000218,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,A,,N,1,Intermediate,CHEMBL626238,,
11761,Homo sapiens,1,1969.0,14215,BAO_0000218,,The maximum plasma concentration (200 mg/kg) administered orally in human,,A,,N,1,Intermediate,CHEMBL622412,,
11762,Rattus norvegicus,1,1969.0,14215,BAO_0000218,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,A,,N,1,Intermediate,CHEMBL623114,,
11763,Callithrix,1,1969.0,14215,BAO_0000218,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,A,,U,0,Autocuration,CHEMBL623115,,
11764,Simiiformes,1,1969.0,14215,BAO_0000218,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,A,,U,0,Autocuration,CHEMBL623116,,
11765,Canis lupus familiaris,1,1969.0,14215,BAO_0000218,,The maximum plasma concentration (30 mg/kg) administered orally in dog,,A,,U,0,Autocuration,CHEMBL623117,,
11766,Homo sapiens,1,1969.0,14215,BAO_0000218,,The maximum plasma concentration (400 mg/kg) administered orally in human,,A,,N,1,Intermediate,CHEMBL623118,,
11767,Rattus norvegicus,1,1969.0,14215,BAO_0000218,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,A,,N,1,Intermediate,CHEMBL623119,,
11768,Rattus norvegicus,1,1969.0,14215,BAO_0000218,,The maximum plasma concentration (50 mg/kg) administered orally in rat,,A,,N,1,Intermediate,CHEMBL623120,,
11769,Homo sapiens,1,1969.0,14215,BAO_0000218,,The maximum plasma concentration (800 mg/kg) administered orally in human,,A,,N,1,Intermediate,CHEMBL623286,,
11770,Rattus norvegicus,1,1969.0,14067,BAO_0000218,,The maximum plasma concentration was measured on rats,,A,,N,1,Intermediate,CHEMBL623287,,
11771,Rattus norvegicus,1,1969.0,12350,BAO_0000218,,The maximum plasma concentration was measured on rats after oral administration,,A,,N,1,Intermediate,CHEMBL623288,,
11772,Rattus norvegicus,1,1969.0,14813,BAO_0000218,,Plasma drug Cmax in rat (PO dose),,A,,N,1,Intermediate,CHEMBL623289,,
11773,,1,,12536,BAO_0000218,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,A,,U,0,Autocuration,CHEMBL623290,,
11774,Canis lupus familiaris,1,1969.0,14169,BAO_0000218,,maximum Plasma concentration in Dog was determined after Peroral administration,,A,,N,1,Intermediate,CHEMBL623291,,
11775,Rattus norvegicus,1,1969.0,14169,BAO_0000218,,maximum Plasma concentration in Rats was determined after Peroral administration,,A,,N,1,Intermediate,CHEMBL623292,,
11776,Canis lupus familiaris,1,1969.0,15604,BAO_0000218,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,A,,N,1,Intermediate,CHEMBL623293,,
11777,Simiiformes,1,1969.0,15604,BAO_0000218,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,A,,U,0,Autocuration,CHEMBL623294,,
11778,Rattus norvegicus,1,1969.0,15604,BAO_0000218,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,A,,N,1,Intermediate,CHEMBL623295,,
11779,Mus musculus,1,,14387,BAO_0000218,,maximum concentration was measured when administered through oral route in mice,,A,,N,1,Intermediate,CHEMBL623296,,
11780,Mus musculus,1,,15115,BAO_0000218,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,A,,N,1,Intermediate,CHEMBL875349,,
11781,Simiiformes,1,,15115,BAO_0000019,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,A,,U,0,Autocuration,CHEMBL623297,,
11782,Simiiformes,1,,15115,BAO_0000019,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,A,,U,0,Autocuration,CHEMBL623298,,
11783,Simiiformes,1,,15115,BAO_0000019,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,A,,U,0,Autocuration,CHEMBL623299,,
11784,Rattus norvegicus,1,,16359,BAO_0000218,,Pharmacokinetic parameter was evaluated in rats,,A,,N,1,Intermediate,CHEMBL623300,,
11785,Mus musculus,1,,12829,BAO_0000218,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,A,,N,1,Intermediate,CHEMBL623301,,
11786,Mus musculus,1,,12829,BAO_0000218,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,A,,N,1,Intermediate,CHEMBL623302,,
11787,Mus musculus,1,,12829,BAO_0000218,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,A,,N,1,Intermediate,CHEMBL623303,,
11788,Mus musculus,1,,12829,BAO_0000218,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,A,,N,1,Intermediate,CHEMBL623304,,
11789,Mus musculus,1,,12829,BAO_0000218,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,A,,N,1,Intermediate,CHEMBL623305,,
11790,Rattus norvegicus,1,1969.0,15137,BAO_0000218,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,A,,N,1,Intermediate,CHEMBL623306,,
11791,Rattus norvegicus,1,1969.0,15137,BAO_0000218,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,A,,N,1,Intermediate,CHEMBL623307,,
11792,Rattus norvegicus,1,1969.0,15137,BAO_0000218,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,A,,N,1,Intermediate,CHEMBL623308,,
11793,Mus musculus,1,1969.0,15137,BAO_0000218,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,A,,N,1,Intermediate,CHEMBL623309,,
11794,Mus musculus,1,,13509,BAO_0000218,,Plasma Concentration after 120 min of oral administration to mice,,A,,N,1,Intermediate,CHEMBL623310,,
11795,Mus musculus,1,,13509,BAO_0000218,,Plasma Concentration after 30 min of oral administration to mice,,A,,N,1,Intermediate,CHEMBL623311,,
11796,Macaca fascicularis,1,,13509,BAO_0000218,,Plasma Concentration after 60 min of oral administration to mice,,A,,N,1,Intermediate,CHEMBL623312,,
11797,Mus musculus,1,,13509,BAO_0000218,,Plasma Concentration after 60 min of oral administration to mice; Not determined,,A,,N,1,Intermediate,CHEMBL875350,,
11798,Mus musculus,1,,13509,BAO_0000218,,Plasma Concentration after 90 min of oral administration to mice,,A,,N,1,Intermediate,CHEMBL628635,,
11799,Rattus norvegicus,1,,12064,BAO_0000218,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,A,,N,1,Intermediate,CHEMBL628636,,
11800,Rattus norvegicus,1,,12064,BAO_0000218,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,A,,N,1,Intermediate,CHEMBL628637,,
11801,Rattus norvegicus,1,,12064,BAO_0000218,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,A,,N,1,Intermediate,CHEMBL628058,,
11802,Rattus norvegicus,1,,10677,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,A,,N,1,Intermediate,CHEMBL628059,,
11803,Rattus norvegicus,1,,10677,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,A,,N,1,Intermediate,CHEMBL628060,,
11804,,1,,8926,BAO_0000019,,Distribution in the lung after 15 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628061,,
11805,,1,,8926,BAO_0000019,,Distribution in the lung after 30 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628062,,
11806,,1,,8926,BAO_0000019,,Distribution in the lung after 5 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628063,,
11807,,1,,8926,BAO_0000019,,Distribution in the lung after 60 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628064,,
11808,,1,,8926,BAO_0000019,,Distribution in the lung after 90 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628065,,
11809,,1,2385.0,8926,BAO_0000019,,Distribution in the muscle after 120 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628066,,
11810,,1,2385.0,8926,BAO_0000019,,Distribution in the muscle after 15 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628067,,
11811,Mus musculus,1,2385.0,8926,BAO_0000218,,Distribution in the muscle after 30 min of intravenous administration,,A,,N,1,Intermediate,CHEMBL874646,,
11812,,1,2385.0,8926,BAO_0000019,,Distribution in the muscle after 5 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628068,,
11813,,1,2385.0,8926,BAO_0000019,,Distribution in the muscle after 60 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628069,,
11814,,1,2385.0,8926,BAO_0000019,,Distribution in the muscle after 90 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628070,,
11815,,1,2106.0,8926,BAO_0000019,,Distribution in the spleen after 120 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628071,,
11816,,1,2106.0,8926,BAO_0000019,,Distribution in the spleen after 15 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628072,,
11817,,1,2106.0,8926,BAO_0000019,,Distribution in the spleen after 30 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628073,,
11818,,1,2106.0,8926,BAO_0000019,,Distribution in the spleen after 5 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628074,,
11819,,1,2106.0,8926,BAO_0000019,,Distribution in the spleen after 60 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628075,,
11820,,1,2106.0,8926,BAO_0000019,,Distribution in the spleen after 90 min of intravenous administration,,A,,U,0,Autocuration,CHEMBL628076,,
11821,Rattus norvegicus,1,1235.0,7570,BAO_0000218,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,A,,N,1,Intermediate,CHEMBL628077,,
11822,Rattus norvegicus,1,178.0,7570,BAO_0000218,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,A,,N,1,Intermediate,CHEMBL628078,,
11823,Rattus norvegicus,1,2107.0,7570,BAO_0000218,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,A,,N,1,Intermediate,CHEMBL628079,,
11824,Rattus norvegicus,1,992.0,7570,BAO_0000218,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,A,,N,1,Intermediate,CHEMBL628080,,
11825,Rattus norvegicus,1,2046.0,7570,BAO_0000218,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,A,,N,1,Intermediate,CHEMBL628081,,
11826,Rattus norvegicus,1,1235.0,7570,BAO_0000218,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,A,,N,1,Intermediate,CHEMBL628082,,
11827,Rattus norvegicus,1,178.0,7570,BAO_0000218,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,A,,N,1,Intermediate,CHEMBL874647,,
11828,Rattus norvegicus,1,2107.0,7570,BAO_0000218,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,A,,N,1,Intermediate,CHEMBL626406,,
11829,Rattus norvegicus,1,992.0,7570,BAO_0000218,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,A,,N,1,Intermediate,CHEMBL626407,,
11830,Rattus norvegicus,1,2046.0,7570,BAO_0000218,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,A,,N,1,Intermediate,CHEMBL626408,,
11831,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,A,,N,1,Intermediate,CHEMBL626409,,
11832,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,A,,N,1,Intermediate,CHEMBL626410,,
11833,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,A,,N,1,Intermediate,CHEMBL626411,,
11834,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,A,,N,1,Intermediate,CHEMBL626412,,
11835,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,A,,N,1,Intermediate,CHEMBL626413,,
11836,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,A,,N,1,Intermediate,CHEMBL626414,,
11837,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,A,,N,1,Intermediate,CHEMBL626415,,
11838,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,A,,N,1,Intermediate,CHEMBL626416,,
11839,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,A,,N,1,Intermediate,CHEMBL627062,,
11840,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,A,,N,1,Intermediate,CHEMBL627063,,
11841,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,A,,N,1,Intermediate,CHEMBL627064,,
11842,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,A,,N,1,Intermediate,CHEMBL627227,,
11843,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,A,,N,1,Intermediate,CHEMBL627228,,
11844,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,A,,N,1,Intermediate,CHEMBL627229,,
11845,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,A,,N,1,Intermediate,CHEMBL625792,,
11846,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,A,,N,1,Intermediate,CHEMBL625793,,
11847,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,A,,N,1,Intermediate,CHEMBL625794,,
11848,Rattus norvegicus,1,178.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,A,,N,1,Intermediate,CHEMBL625795,,
11849,Mus musculus,1,,13792,BAO_0000218,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,A,,N,1,Intermediate,CHEMBL625796,,
11850,Canis lupus familiaris,1,,13376,BAO_0000218,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,A,,N,1,Intermediate,CHEMBL625797,,
11851,Canis lupus familiaris,1,,13376,BAO_0000218,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,A,,N,1,Intermediate,CHEMBL625798,,
11852,,1,,14380,BAO_0000218,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL875613,,
11853,,1,,14380,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL625799,,
11854,,1,,14380,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL625800,,
11855,,1,,14380,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL625801,,
11856,,1,,14380,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL625802,,
11857,,1,,14380,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL625803,,
11858,,1,,14380,BAO_0000019,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,A,,U,0,Autocuration,CHEMBL625804,,
11859,,1,,14380,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,A,,U,0,Autocuration,CHEMBL622530,,
11860,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,A,,N,1,Intermediate,CHEMBL622531,,
11861,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,A,,N,1,Intermediate,CHEMBL622532,,
11862,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,A,,N,1,Intermediate,CHEMBL623176,,
11863,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,A,,N,1,Intermediate,CHEMBL623177,,
11864,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,A,,N,1,Intermediate,CHEMBL623178,,
11865,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,A,,N,1,Intermediate,CHEMBL623179,,
11866,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,A,,N,1,Intermediate,CHEMBL623180,,
11867,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,A,,N,1,Intermediate,CHEMBL623181,,
11868,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,A,,N,1,Intermediate,CHEMBL624131,,
11869,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,A,,N,1,Intermediate,CHEMBL624132,,
11870,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,A,,N,1,Intermediate,CHEMBL624133,,
11871,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,A,,N,1,Intermediate,CHEMBL624846,,
11872,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,A,,N,1,Intermediate,CHEMBL624847,,
11873,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,A,,N,1,Intermediate,CHEMBL624848,,
11874,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,A,,N,1,Intermediate,CHEMBL625012,,
11875,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,A,,N,1,Intermediate,CHEMBL625013,,
11876,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,A,,N,1,Intermediate,CHEMBL625014,,
11877,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,A,,N,1,Intermediate,CHEMBL625015,,
11878,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,A,,N,1,Intermediate,CHEMBL625016,,
11879,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,A,,N,1,Intermediate,CHEMBL625017,,
11880,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,A,,N,1,Intermediate,CHEMBL625018,,
11881,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,A,,N,1,Intermediate,CHEMBL625019,,
11882,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,A,,N,1,Intermediate,CHEMBL625020,,
11883,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,A,,N,1,Intermediate,CHEMBL625021,,
11884,Rattus norvegicus,1,,14393,BAO_0000218,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,A,,N,1,Intermediate,CHEMBL625022,,
11885,Mus musculus,1,,14731,BAO_0000218,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,A,,N,1,Intermediate,CHEMBL625023,,
11886,Macaca fascicularis,1,,14731,BAO_0000218,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,A,,N,1,Intermediate,CHEMBL625024,,
11887,Macaca fascicularis,1,,14731,BAO_0000218,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,A,,N,1,Intermediate,CHEMBL627626,,
11888,,1,955.0,13758,BAO_0000218,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,A,,U,0,Autocuration,CHEMBL627627,,
11889,,1,1977.0,13758,BAO_0000218,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,A,,U,0,Autocuration,CHEMBL627628,,
11890,,1,955.0,13758,BAO_0000218,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,A,,U,0,Autocuration,CHEMBL627629,,
11891,,1,1977.0,13758,BAO_0000218,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,A,,U,0,Autocuration,CHEMBL627630,,
11892,,1,,16359,BAO_0000019,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,A,,U,0,Autocuration,CHEMBL627631,,
11893,,1,,16359,BAO_0000218,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,A,,U,0,Autocuration,CHEMBL629515,,
11894,Mus musculus,1,2106.0,15383,BAO_0000218,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,A,,N,1,Intermediate,CHEMBL629516,,
11895,Mus musculus,1,2106.0,15383,BAO_0000218,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,,N,1,Intermediate,CHEMBL629517,,
11896,Mus musculus,1,2106.0,15383,BAO_0000218,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,,N,1,Intermediate,CHEMBL629518,,
11897,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,A,,N,1,Intermediate,CHEMBL877499,,
11898,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,A,,N,1,Intermediate,CHEMBL629519,,
11899,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,,N,1,Intermediate,CHEMBL629520,,
11900,Mus musculus,1,,15383,BAO_0000218,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,,N,1,Intermediate,CHEMBL629521,,
11901,Mus musculus,1,,14439,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,A,,N,1,Intermediate,CHEMBL629522,,
11902,Mus musculus,1,,14439,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,A,,N,1,Intermediate,CHEMBL629523,,
11903,Mus musculus,1,,14439,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,A,,N,1,Intermediate,CHEMBL629524,,
11904,Mus musculus,1,,14439,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,A,,N,1,Intermediate,CHEMBL629525,,
11905,Mus musculus,1,,14439,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,A,,N,1,Intermediate,CHEMBL629526,,
11906,Mus musculus,1,,14439,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,A,,N,1,Intermediate,CHEMBL629527,,
11907,Mus musculus,1,,14439,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,A,,N,1,Intermediate,CHEMBL629528,,
11908,Mus musculus,1,,14439,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,A,,N,1,Intermediate,CHEMBL629529,,
11909,Mus musculus,1,,14439,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,A,,N,1,Intermediate,CHEMBL629530,,
11910,Mus musculus,1,,14439,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,A,,N,1,Intermediate,CHEMBL629531,,
11911,Mus musculus,1,,14439,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,A,,N,1,Intermediate,CHEMBL628656,,
11912,Mus musculus,1,,14439,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,A,,N,1,Intermediate,CHEMBL628657,,
11913,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628658,,
11914,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628659,,
11915,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL877500,,
11916,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628660,,
11917,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628661,,
11918,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628662,,
11919,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628663,,
11920,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628664,,
11921,Rattus norvegicus,1,178.0,13751,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628665,,
11922,Rattus norvegicus,1,178.0,13751,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628666,,
11923,Rattus norvegicus,1,178.0,13751,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628667,,
11924,Rattus norvegicus,1,178.0,13751,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628668,,
11925,Rattus norvegicus,1,178.0,13751,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628669,,
11926,Rattus norvegicus,1,178.0,13751,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628670,,
11927,Rattus norvegicus,1,178.0,13751,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628671,,
11928,Rattus norvegicus,1,10000001.0,13751,BAO_0000218,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL628672,,
11929,Rattus norvegicus,1,10000001.0,13751,BAO_0000218,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL630300,,
11930,Rattus norvegicus,1,10000001.0,13751,BAO_0000218,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629787,,
11931,Rattus norvegicus,1,10000001.0,13751,BAO_0000218,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629788,,
11932,Rattus norvegicus,1,955.0,13751,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629789,,
11933,Rattus norvegicus,1,955.0,13751,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629790,,
11934,Rattus norvegicus,1,955.0,13751,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629791,,
11935,Rattus norvegicus,1,955.0,13751,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629792,,
11936,Rattus norvegicus,1,955.0,13751,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629793,,
11937,Rattus norvegicus,1,955.0,13751,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629794,,
11938,Rattus norvegicus,1,,10677,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,A,,N,1,Intermediate,CHEMBL874459,,
11939,Rattus norvegicus,1,,10677,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,A,,N,1,Intermediate,CHEMBL629795,,
11940,Rattus norvegicus,1,,10677,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,A,,N,1,Intermediate,CHEMBL629796,,
11941,Rattus norvegicus,1,,10677,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,A,,N,1,Intermediate,CHEMBL629797,,
11942,Rattus norvegicus,1,,10677,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,A,,N,1,Intermediate,CHEMBL629798,,
11943,Rattus norvegicus,1,2369.0,10911,BAO_0000218,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629799,,
11944,Rattus norvegicus,1,2369.0,10911,BAO_0000218,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629800,,
11945,Rattus norvegicus,1,2369.0,10911,BAO_0000218,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629801,,
11946,Rattus norvegicus,1,2369.0,10911,BAO_0000218,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,A,,N,1,Intermediate,CHEMBL629802,,
11947,Rattus norvegicus,1,2369.0,10911,BAO_0000218,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629803,,
11948,Rattus norvegicus,1,178.0,10911,BAO_0000218,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629804,,
11949,Rattus norvegicus,1,178.0,10911,BAO_0000218,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629805,,
11950,Rattus norvegicus,1,178.0,10911,BAO_0000218,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629806,,
11951,Rattus norvegicus,1,178.0,10911,BAO_0000218,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629807,,
11952,Rattus norvegicus,1,178.0,10911,BAO_0000218,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629808,,
11953,Rattus norvegicus,1,955.0,10911,BAO_0000218,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629809,,
11954,Rattus norvegicus,1,955.0,10911,BAO_0000218,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629810,,
11955,Rattus norvegicus,1,955.0,10911,BAO_0000218,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629811,,
11956,Rattus norvegicus,1,955.0,10911,BAO_0000218,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629812,,
11957,Rattus norvegicus,1,955.0,10911,BAO_0000218,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629813,,
11958,Rattus norvegicus,1,955.0,10911,BAO_0000218,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL874460,,
11959,Rattus norvegicus,1,,10911,BAO_0000218,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629814,,
11960,Rattus norvegicus,1,,10911,BAO_0000218,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629815,,
11961,Rattus norvegicus,1,,10911,BAO_0000218,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629816,,
11962,Rattus norvegicus,1,,10911,BAO_0000218,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL629817,,
11963,Rattus norvegicus,1,2113.0,10911,BAO_0000218,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL626643,,
11964,Rattus norvegicus,1,2113.0,10911,BAO_0000218,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL626644,,
11965,Rattus norvegicus,1,2113.0,10911,BAO_0000218,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL626806,,
11966,Rattus norvegicus,1,2113.0,10911,BAO_0000218,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL626807,,
11967,Rattus norvegicus,1,2107.0,10911,BAO_0000218,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627261,,
11968,Rattus norvegicus,1,2107.0,10911,BAO_0000218,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627262,,
11969,Rattus norvegicus,1,2107.0,10911,BAO_0000218,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627263,,
11970,Rattus norvegicus,1,2107.0,10911,BAO_0000218,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627264,,
11971,Rattus norvegicus,1,2048.0,10911,BAO_0000218,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627265,,
11972,Rattus norvegicus,1,2048.0,10911,BAO_0000218,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627266,,
11973,Rattus norvegicus,1,2048.0,10911,BAO_0000218,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627267,,
11974,Rattus norvegicus,1,2048.0,10911,BAO_0000218,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627268,,
11975,Rattus norvegicus,1,2385.0,10911,BAO_0000218,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627269,,
11976,Rattus norvegicus,1,2385.0,10911,BAO_0000218,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627270,,
11977,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,A,,N,1,Intermediate,CHEMBL627271,,
11978,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,A,,N,1,Intermediate,CHEMBL627946,,
11979,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,A,,N,1,Intermediate,CHEMBL875472,,
11980,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,A,,N,1,Intermediate,CHEMBL627947,,
11981,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,A,,N,1,Intermediate,CHEMBL627948,,
11982,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,A,,N,1,Intermediate,CHEMBL628113,,
11983,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,A,,N,1,Intermediate,CHEMBL628114,,
11984,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,A,,N,1,Intermediate,CHEMBL628115,,
11985,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,A,,N,1,Intermediate,CHEMBL628116,,
11986,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,A,,N,1,Intermediate,CHEMBL628117,,
11987,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,A,,N,1,Intermediate,CHEMBL628118,,
11988,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,A,,N,1,Intermediate,CHEMBL628119,,
11989,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,A,,N,1,Intermediate,CHEMBL628120,,
11990,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,A,,N,1,Intermediate,CHEMBL628121,,
11991,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,A,,N,1,Intermediate,CHEMBL628122,,
11992,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,A,,N,1,Intermediate,CHEMBL627297,,
11993,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,A,,N,1,Intermediate,CHEMBL627298,,
11994,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,A,,N,1,Intermediate,CHEMBL627299,,
11995,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,A,,N,1,Intermediate,CHEMBL627300,,
11996,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,A,,N,1,Intermediate,CHEMBL627301,,
11997,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,A,,N,1,Intermediate,CHEMBL627302,,
11998,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,A,,N,1,Intermediate,CHEMBL627303,,
11999,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,A,,N,1,Intermediate,CHEMBL627304,,
12000,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,A,,N,1,Intermediate,CHEMBL627305,,
12001,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,A,,N,1,Intermediate,CHEMBL627306,,
12002,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,A,,N,1,Intermediate,CHEMBL623982,,
12003,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,A,,N,1,Intermediate,CHEMBL623983,,
12004,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,A,,N,1,Intermediate,CHEMBL623984,,
12005,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,A,,N,1,Intermediate,CHEMBL623985,,
12006,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,A,,N,1,Intermediate,CHEMBL623986,,
12007,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,A,,N,1,Intermediate,CHEMBL623987,,
12008,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,A,,N,1,Intermediate,CHEMBL623988,,
12009,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,A,,N,1,Intermediate,CHEMBL623989,,
12010,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,A,,N,1,Intermediate,CHEMBL622215,,
12011,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,A,,N,1,Intermediate,CHEMBL622216,,
12012,Rattus norvegicus,1,,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,A,,N,1,Intermediate,CHEMBL877481,,
12013,,1,,16359,BAO_0000218,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,A,,U,0,Autocuration,CHEMBL622217,,
12014,Mus musculus,1,,13701,BAO_0000218,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,A,,N,1,Intermediate,CHEMBL622218,,
12015,Rattus norvegicus,1,,14554,BAO_0000218,,Pharmacokinetic profile AUC was evaluated in rats,,A,,N,1,Intermediate,CHEMBL622219,,
12016,,1,,6241,BAO_0000019,,Pharmacokinetic property (Area under curve),,A,,U,0,Autocuration,CHEMBL622220,,
12017,Canis lupus familiaris,1,,11537,BAO_0000218,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,A,,N,1,Intermediate,CHEMBL622221,,
12018,Mus musculus,1,,11537,BAO_0000218,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,A,,N,1,Intermediate,CHEMBL622222,,
12019,Canis lupus familiaris,1,,11537,BAO_0000218,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,A,,N,1,Intermediate,CHEMBL622223,,
12020,Mus musculus,1,,11537,BAO_0000218,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,A,,N,1,Intermediate,CHEMBL622224,,
12021,,1,,13118,BAO_0000019,,Plasma concentration (AUC) was determined,,A,,U,0,Autocuration,CHEMBL622225,,
12022,,1,,13118,BAO_0000019,,Plasma concentration (AUC) was determined; Not detectable,,A,,U,0,Autocuration,CHEMBL622226,,
12023,Cavia porcellus,1,,9562,BAO_0000218,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,A,,N,1,Intermediate,CHEMBL624154,,
12024,Rattus norvegicus,1,,10363,BAO_0000218,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,A,,N,1,Intermediate,CHEMBL624155,,
12025,Rattus norvegicus,1,,10363,BAO_0000218,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,A,,N,1,Intermediate,CHEMBL624156,,
12026,Rattus norvegicus,1,,10363,BAO_0000218,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,A,,N,1,Intermediate,CHEMBL624157,,
12027,Rattus norvegicus,1,,10363,BAO_0000218,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,A,,N,1,Intermediate,CHEMBL624158,,
12028,Rattus norvegicus,1,,12504,BAO_0000218,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,A,,N,1,Intermediate,CHEMBL624159,,
12029,Rattus norvegicus,1,,12504,BAO_0000218,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,A,,N,1,Intermediate,CHEMBL624160,,
12030,Rattus norvegicus,1,,12504,BAO_0000218,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,A,,N,1,Intermediate,CHEMBL624161,,
12031,Rattus norvegicus,1,,12504,BAO_0000218,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,A,,N,1,Intermediate,CHEMBL624162,,
12032,Canis lupus familiaris,1,,13317,BAO_0000218,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,A,,N,1,Intermediate,CHEMBL624163,,
12033,Rattus norvegicus,1,,15078,BAO_0000218,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL624164,,
12034,Rattus norvegicus,1,,14941,BAO_0000218,,The AUC(0-infinity) values in female wistar rats.,,A,,N,1,Intermediate,CHEMBL624165,,
12035,Rattus norvegicus,1,,15078,BAO_0000218,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL624166,,
12036,Rattus norvegicus,1,,15078,BAO_0000218,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,A,,N,1,Intermediate,CHEMBL624167,,
12037,Rattus norvegicus,1,,14941,BAO_0000218,,The AUC(0-t)values in female wistar rats.,,A,,N,1,Intermediate,CHEMBL624168,,
12038,Rattus norvegicus,1,,14067,BAO_0000218,,The Area under the concentration time curve of compound was measured on rats,,A,,N,1,Intermediate,CHEMBL624169,,
12039,Homo sapiens,1,,14215,BAO_0000218,,The area under curve (100 mg/kg) administered orally in humans,,A,,N,1,Intermediate,CHEMBL624170,,
12040,Callithrix,1,,14215,BAO_0000218,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,A,,U,0,Autocuration,CHEMBL624171,,
12041,Simiiformes,1,,14215,BAO_0000218,,The area under curve (12.5 mg/kg) administered intravenously in monkey,,A,,U,0,Autocuration,CHEMBL624172,,
12042,Canis lupus familiaris,1,,14215,BAO_0000218,,The area under curve (15 mg/kg) administered intravenously in dog,,A,,N,1,Intermediate,CHEMBL624173,,
12043,Homo sapiens,1,,14215,BAO_0000218,,The area under curve (200 mg/kg) administered orally in humans,,A,,N,1,Intermediate,CHEMBL877488,,
12044,Rattus norvegicus,1,,14215,BAO_0000218,,The area under curve (25 mg/kg) administered intravenously in rat,,A,,N,1,Intermediate,CHEMBL624174,,
12045,Callithrix,1,,14215,BAO_0000218,,The area under curve (25 mg/kg) administered orally in marmoset,,A,,U,0,Autocuration,CHEMBL624175,,
12046,Simiiformes,1,,14215,BAO_0000218,,The area under curve (25 mg/kg) administered orally in monkey,,A,,U,0,Autocuration,CHEMBL624176,,
12047,Canis lupus familiaris,1,,14215,BAO_0000218,,The area under curve (30 mg/kg) administered orally in dog,,A,,N,1,Intermediate,CHEMBL624177,,
12048,Homo sapiens,1,,14215,BAO_0000218,,The area under curve (400 mg/kg) administered orally in humans,,A,,N,1,Intermediate,CHEMBL624178,,
12049,Rattus norvegicus,1,,14215,BAO_0000218,,The area under curve (50 mg/kg) administered orally in fasted rat,,A,,N,1,Intermediate,CHEMBL624179,,
12050,Rattus norvegicus,1,,14215,BAO_0000218,,The area under curve (50 mg/kg) administered orally in rat,,A,,N,1,Intermediate,CHEMBL627689,,
12051,Homo sapiens,1,,14215,BAO_0000218,,The area under curve (800 mg/kg) administered orally in humans,,A,,N,1,Intermediate,CHEMBL627690,,
12052,,1,,11324,BAO_0000019,,The compound was evaluated for area under the curve,,A,,U,0,Autocuration,CHEMBL627691,,
12053,Callithrix,1,,11324,BAO_0000019,,The compound was evaluated for area under the curve in marmosets,,A,,U,0,Autocuration,CHEMBL627692,,
12054,Callithrix,1,,11324,BAO_0000019,,The compound was evaluated for area under the curve in marmosets,,A,,U,0,Autocuration,CHEMBL627693,,
12055,Rattus norvegicus,1,,13875,BAO_0000218,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,A,,N,1,Intermediate,CHEMBL627694,,
12056,Rattus norvegicus,1,,13875,BAO_0000218,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,A,,N,1,Intermediate,CHEMBL627695,,
12057,,1,,13875,BAO_0000218,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,A,,U,0,Autocuration,CHEMBL627696,,
12058,Rattus norvegicus,1,,13875,BAO_0000218,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,A,,N,1,Intermediate,CHEMBL627697,,
12059,Rattus norvegicus,1,,13875,BAO_0000218,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,A,,N,1,Intermediate,CHEMBL627698,,
12060,Rattus norvegicus,1,,13875,BAO_0000218,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,A,,N,1,Intermediate,CHEMBL627699,,
12061,Rattus norvegicus,1,,13807,BAO_0000218,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,A,,N,1,Intermediate,CHEMBL627700,,
12062,Rattus norvegicus,1,,14127,BAO_0000218,,Total drug exposure is determined after oral dosing in rats.,,A,,N,1,Intermediate,CHEMBL627701,,
12063,,1,,15116,BAO_0000218,,Total drug exposure (5 mg/kg) when administered intravenously,,A,,U,0,Autocuration,CHEMBL627702,,
12064,,1,,15116,BAO_0000218,,Total drug exposure (5 mg/kg) when administered orally,,A,,U,0,Autocuration,CHEMBL627703,,
12065,Simiiformes,1,,15604,BAO_0000218,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,A,,U,0,Autocuration,CHEMBL626873,,
12066,Rattus norvegicus,1,,15604,BAO_0000218,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,A,,N,1,Intermediate,CHEMBL629583,,
12067,Canis lupus familiaris,1,,15604,BAO_0000218,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,A,,N,1,Intermediate,CHEMBL629584,,
12068,Canis lupus familiaris,1,,15604,BAO_0000218,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,A,,N,1,Intermediate,CHEMBL629585,,
12069,Rattus norvegicus,1,955.0,13751,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629586,,
12070,Rattus norvegicus,1,955.0,13751,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629587,,
12071,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629588,,
12072,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629589,,
12073,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629590,,
12074,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629591,,
12075,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629592,,
12076,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629593,,
12077,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629594,,
12078,Rattus norvegicus,1,948.0,13751,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL629595,,
12079,Rattus norvegicus,1,948.0,13751,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL630290,,
12080,Rattus norvegicus,1,948.0,13751,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627137,,
12081,Rattus norvegicus,1,948.0,13751,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627138,,
12082,Rattus norvegicus,1,948.0,13751,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627139,,
12083,Rattus norvegicus,1,948.0,13751,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627140,,
12084,Rattus norvegicus,1,948.0,13751,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627141,,
12085,Rattus norvegicus,1,2113.0,13751,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627142,,
12086,Rattus norvegicus,1,2113.0,13751,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627143,,
12087,Rattus norvegicus,1,2113.0,13751,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL874449,,
12088,Rattus norvegicus,1,2113.0,13751,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627144,,
12089,Rattus norvegicus,1,2113.0,13751,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627145,,
12090,Rattus norvegicus,1,2113.0,13751,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627146,,
12091,Rattus norvegicus,1,2113.0,13751,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627147,,
12092,Rattus norvegicus,1,2107.0,13751,BAO_0000218,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627148,,
12093,Rattus norvegicus,1,2048.0,13751,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627149,,
12094,Rattus norvegicus,1,2048.0,13751,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL632160,,
12095,Rattus norvegicus,1,2048.0,13751,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL632161,,
12096,Rattus norvegicus,1,2048.0,13751,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL632162,,
12097,Rattus norvegicus,1,2048.0,13751,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL632163,,
12098,Rattus norvegicus,1,2048.0,13751,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL874469,,
12099,Rattus norvegicus,1,2048.0,13751,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627182,,
12100,Rattus norvegicus,1,2385.0,13751,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627183,,
12101,Rattus norvegicus,1,2385.0,13751,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627184,,
12102,Rattus norvegicus,1,2385.0,13751,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627185,,
12103,Rattus norvegicus,1,2385.0,13751,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627186,,
12104,Rattus norvegicus,1,2385.0,13751,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627187,,
12105,Rattus norvegicus,1,2385.0,13751,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627188,,
12106,Rattus norvegicus,1,2385.0,13751,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627189,,
12107,Rattus norvegicus,1,,13751,BAO_0000218,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627190,,
12108,Rattus norvegicus,1,2107.0,13751,BAO_0000218,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627191,,
12109,Rattus norvegicus,1,2107.0,13751,BAO_0000218,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627192,,
12110,Rattus norvegicus,1,2107.0,13751,BAO_0000218,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL627193,,
12111,Rattus norvegicus,1,2385.0,10911,BAO_0000218,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL874590,,
12112,Rattus norvegicus,1,2385.0,10911,BAO_0000218,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627194,,
12113,Rattus norvegicus,1,2385.0,10911,BAO_0000218,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627195,,
12114,Rattus norvegicus,1,992.0,10911,BAO_0000218,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627196,,
12115,Rattus norvegicus,1,992.0,10911,BAO_0000218,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627197,,
12116,Rattus norvegicus,1,992.0,10911,BAO_0000218,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627198,,
12117,Rattus norvegicus,1,992.0,10911,BAO_0000218,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,A,,N,1,Intermediate,CHEMBL627199,,
12118,Rattus norvegicus,1,992.0,10911,BAO_0000218,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627200,,
12119,Rattus norvegicus,1,1969.0,10911,BAO_0000218,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627201,,
12120,Rattus norvegicus,1,1969.0,10911,BAO_0000218,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627202,,
12121,Rattus norvegicus,1,1969.0,10911,BAO_0000218,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627203,,
12122,Rattus norvegicus,1,1969.0,10911,BAO_0000218,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627204,,
12123,Rattus norvegicus,1,2106.0,10911,BAO_0000218,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627205,,
12124,Rattus norvegicus,1,2106.0,10911,BAO_0000218,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627206,,
12125,Rattus norvegicus,1,2106.0,10911,BAO_0000218,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627207,,
12126,Rattus norvegicus,1,2106.0,10911,BAO_0000218,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627208,,
12127,Rattus norvegicus,1,2046.0,10911,BAO_0000218,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627209,,
12128,Rattus norvegicus,1,2046.0,10911,BAO_0000218,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627210,,
12129,Rattus norvegicus,1,2046.0,10911,BAO_0000218,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627211,,
12130,Rattus norvegicus,1,2046.0,10911,BAO_0000218,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627212,,
12131,Rattus norvegicus,1,995.0,10911,BAO_0000218,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL627213,,
12132,Rattus norvegicus,1,995.0,10911,BAO_0000218,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL626599,,
12133,Rattus norvegicus,1,995.0,10911,BAO_0000218,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL626600,,
12134,Rattus norvegicus,1,995.0,10911,BAO_0000218,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,,N,1,Intermediate,CHEMBL626601,,
12135,,1,,8081,BAO_0000019,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,A,,U,0,Autocuration,CHEMBL627484,,
12136,Macaca fascicularis,1,1969.0,17248,BAO_0000218,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,A,,N,1,Intermediate,CHEMBL627485,,
12137,Macaca fascicularis,1,1969.0,17248,BAO_0000218,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,A,,N,1,Intermediate,CHEMBL628147,,
12138,Macaca fascicularis,1,1969.0,17248,BAO_0000218,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,A,,N,1,Intermediate,CHEMBL628148,,
12139,Canis lupus familiaris,1,1969.0,17248,BAO_0000218,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,A,,N,1,Intermediate,CHEMBL628149,,
12140,Canis lupus familiaris,1,1969.0,17248,BAO_0000218,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,A,,N,1,Intermediate,CHEMBL628150,,
12141,Canis lupus familiaris,1,1969.0,17248,BAO_0000218,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,A,,N,1,Intermediate,CHEMBL628318,,
12142,Canis lupus familiaris,1,1969.0,17248,BAO_0000218,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,A,,N,1,Intermediate,CHEMBL628319,,
12143,Canis lupus familiaris,1,,15592,BAO_0000218,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,A,,N,1,Intermediate,CHEMBL875609,,
12144,,1,,7040,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,A,,U,0,Autocuration,CHEMBL628320,,
12145,,1,,7040,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,A,,U,0,Autocuration,CHEMBL628321,,
12146,,1,,7040,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,A,,U,0,Autocuration,CHEMBL628322,,
12147,,1,,7040,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,A,,U,0,Autocuration,CHEMBL628323,,
12148,,1,,7040,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,A,,U,0,Autocuration,CHEMBL628324,,
12149,,1,,7040,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,A,,U,0,Autocuration,CHEMBL628325,,
12150,,1,,7040,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,A,,U,0,Autocuration,CHEMBL628326,,
12151,Canis lupus familiaris,1,1236.0,9614,BAO_0000218,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,A,,N,1,Intermediate,CHEMBL628327,,
12152,Canis lupus familiaris,1,1236.0,9614,BAO_0000218,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,A,,N,1,Intermediate,CHEMBL628328,,
12153,Canis lupus familiaris,1,178.0,9614,BAO_0000218,,"Concentration of compound in blood of dog 1, after administering intravenously",,A,,N,1,Intermediate,CHEMBL628329,,
12154,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,A,,N,1,Intermediate,CHEMBL628330,,
12155,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,A,,N,1,Intermediate,CHEMBL628331,,
12156,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,A,,N,1,Intermediate,CHEMBL628332,,
12157,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,A,,N,1,Intermediate,CHEMBL628333,,
12158,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,A,,N,1,Intermediate,CHEMBL628334,,
12159,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,A,,N,1,Intermediate,CHEMBL628335,,
12160,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,A,,N,1,Intermediate,CHEMBL628336,,
12161,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,A,,N,1,Intermediate,CHEMBL628337,,
12162,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,A,,N,1,Intermediate,CHEMBL628338,,
12163,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,A,,N,1,Intermediate,CHEMBL875610,,
12164,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,A,,N,1,Intermediate,CHEMBL628339,,
12165,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,A,,N,1,Intermediate,CHEMBL628340,,
12166,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,A,,N,1,Intermediate,CHEMBL628341,,
12167,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,A,,N,1,Intermediate,CHEMBL622214,,
12168,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,A,,N,1,Intermediate,CHEMBL623167,,
12169,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,A,,N,1,Intermediate,CHEMBL623168,,
12170,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,A,,N,1,Intermediate,CHEMBL623169,,
12171,Rattus norvegicus,1,2107.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,A,,N,1,Intermediate,CHEMBL623170,,
12172,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,A,,N,1,Intermediate,CHEMBL627224,,
12173,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,A,,N,1,Intermediate,CHEMBL875634,,
12174,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,A,,N,1,Intermediate,CHEMBL627225,,
12175,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,A,,N,1,Intermediate,CHEMBL627226,,
12176,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,A,,N,1,Intermediate,CHEMBL626083,,
12177,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,A,,N,1,Intermediate,CHEMBL626084,,
12178,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,A,,N,1,Intermediate,CHEMBL626085,,
12179,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,A,,N,1,Intermediate,CHEMBL626086,,
12180,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,A,,N,1,Intermediate,CHEMBL626087,,
12181,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,A,,N,1,Intermediate,CHEMBL626088,,
12182,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,A,,N,1,Intermediate,CHEMBL626089,,
12183,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,A,,N,1,Intermediate,CHEMBL626090,,
12184,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,A,,N,1,Intermediate,CHEMBL626091,,
12185,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,A,,N,1,Intermediate,CHEMBL626092,,
12186,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,A,,N,1,Intermediate,CHEMBL626093,,
12187,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,A,,N,1,Intermediate,CHEMBL626094,,
12188,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,A,,N,1,Intermediate,CHEMBL626095,,
12189,Rattus norvegicus,1,2048.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,A,,N,1,Intermediate,CHEMBL626096,,
12190,Simiiformes,1,,15604,BAO_0000218,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,A,,U,0,Autocuration,CHEMBL626097,,
12191,Rattus norvegicus,1,,15604,BAO_0000218,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,A,,N,1,Intermediate,CHEMBL626098,,
12192,,1,1969.0,1806,BAO_0000218,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,A,,U,0,Autocuration,CHEMBL626099,,
12193,,1,1969.0,1806,BAO_0000218,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,A,,U,0,Autocuration,CHEMBL626100,,
12194,Canis lupus familiaris,1,1969.0,17237,BAO_0000218,,AUC 0-inf in dog,,A,,N,1,Intermediate,CHEMBL626101,,
12195,Cavia porcellus,1,1969.0,17237,BAO_0000218,,AUC 0-inf in guinea pig,,A,,N,1,Intermediate,CHEMBL626102,,
12196,Canis lupus familiaris,1,1969.0,17237,BAO_0000218,,AUC 0-t in dog,,A,,N,1,Intermediate,CHEMBL626103,,
12197,Cavia porcellus,1,1969.0,17237,BAO_0000218,,AUC 0-t in guinea pig,,A,,N,1,Intermediate,CHEMBL628391,,
12198,Rattus norvegicus,1,,15194,BAO_0000218,,The compound was tested for brain to plasma partition in rat,,A,,N,1,Intermediate,CHEMBL628392,,
12199,Rattus norvegicus,1,,15194,BAO_0000218,,The compound was tested for brain to plasma partition in rat.,,A,,N,1,Intermediate,CHEMBL628393,,
12200,,1,178.0,8787,BAO_0000019,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,A,,U,0,Autocuration,CHEMBL628394,,
12201,Canis lupus familiaris,1,,17025,BAO_0000218,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,A,,N,1,Intermediate,CHEMBL628395,,
12202,Simiiformes,1,,17025,BAO_0000218,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,A,,U,0,Autocuration,CHEMBL628396,,
12203,Oryctolagus cuniculus,1,,17025,BAO_0000218,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,A,,N,1,Intermediate,CHEMBL628397,,
12204,Rattus norvegicus,1,,17025,BAO_0000218,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,A,,N,1,Intermediate,CHEMBL628398,,
12205,Macaca mulatta,1,,4236,BAO_0000218,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,A,,N,1,Intermediate,CHEMBL628399,,
12206,Canis lupus familiaris,1,,15343,BAO_0000218,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,A,,N,1,Intermediate,CHEMBL628400,,
12207,Rattus norvegicus,1,,15343,BAO_0000218,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,A,,N,1,Intermediate,CHEMBL874907,,
12208,,1,,17720,BAO_0000019,,Area under curve of the compound was determined,,A,,U,0,Autocuration,CHEMBL628401,,
12209,Simiiformes,1,1969.0,17788,BAO_0000218,,AUC in monkeys at a dose of 1 mg/kg,,A,,U,0,Autocuration,CHEMBL628402,,
12210,Rattus norvegicus,1,1969.0,17788,BAO_0000218,,AUC in rats at a dose of 1 mg/kg,,A,,N,1,Intermediate,CHEMBL628403,,
12211,,1,,8778,BAO_0000019,,Compound was evaluated for the overall absorbance loss at pH of 2,,A,,U,0,Autocuration,CHEMBL628404,,
12212,,1,,8778,BAO_0000019,,Compound was evaluated for the overall absorbance loss at pH of 4,,A,,U,0,Autocuration,CHEMBL628405,,
12213,,1,,8778,BAO_0000019,,Compound was evaluated for the overall absorbance loss at pH of 7,,A,,U,0,Autocuration,CHEMBL628406,,
12214,Rattus norvegicus,1,,2249,BAO_0000218,,Compound was evaluated for its absorption in the rats,,A,,N,1,Intermediate,CHEMBL628407,,
12215,Rattus norvegicus,1,1088.0,8881,BAO_0000218,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,A,,N,1,Intermediate,CHEMBL628408,,
12216,Rattus norvegicus,1,1088.0,8881,BAO_0000218,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,A,,N,1,Intermediate,CHEMBL629171,,
12217,Rattus norvegicus,1,1088.0,8881,BAO_0000218,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,A,,N,1,Intermediate,CHEMBL629172,,
12218,Rattus norvegicus,1,1088.0,8881,BAO_0000218,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,A,,N,1,Intermediate,CHEMBL629173,,
12219,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum,,A,,N,1,Intermediate,CHEMBL629174,,
12220,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 10-17,,A,,N,1,Intermediate,CHEMBL629175,,
12221,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 10-18,,A,,N,1,Intermediate,CHEMBL629176,,
12222,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 10-19,,A,,N,1,Intermediate,CHEMBL629177,,
12223,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 12-15,,A,,N,1,Intermediate,CHEMBL629178,,
12224,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 13-19,,A,,N,1,Intermediate,CHEMBL631869,,
12225,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 14-17,,A,,N,1,Intermediate,CHEMBL631870,,
12226,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 15-18,,A,,N,1,Intermediate,CHEMBL631871,,
12227,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 2-5,,A,,N,1,Intermediate,CHEMBL631872,,
12228,,1,2116.0,15286,BAO_0000221,,In vitro percent permeability into rat ileum; Range is 23-42,,A,,U,0,Autocuration,CHEMBL875775,,
12229,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 28-36,,A,,N,1,Intermediate,CHEMBL631873,,
12230,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 29-35,,A,,N,1,Intermediate,CHEMBL631874,,
12231,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 46-66,,A,,N,1,Intermediate,CHEMBL631875,,
12232,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 50-68,,A,,N,1,Intermediate,CHEMBL631876,,
12233,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 78-81,,A,,N,1,Intermediate,CHEMBL631877,,
12234,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,A,,N,1,Intermediate,CHEMBL631878,,
12235,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; nd indicates not detected,,A,,N,1,Intermediate,CHEMBL631879,,
12236,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; nt indicates not detected,,A,,N,1,Intermediate,CHEMBL631880,,
12237,Rattus norvegicus,1,,15286,BAO_0000218,,In vitro percent permeability into rat ileum; nt indicates not tested,,A,,N,1,Intermediate,CHEMBL631881,,
12238,Rattus norvegicus,1,,13770,BAO_0000218,,Compound was tested for oral absorption in bile-duct cannulated rats,,A,,N,1,Intermediate,CHEMBL631882,,
12239,Rattus norvegicus,1,,13770,BAO_0000218,,Compound was tested for oral absorption in bile-duct cannulated rats.,,A,,N,1,Intermediate,CHEMBL630749,,
12240,Homo sapiens,1,,5202,BAO_0000218,,Oral absorption using Caco-2 cell monolayers.,,A,,N,1,Intermediate,CHEMBL630750,,
12241,Homo sapiens,1,,14920,BAO_0000218,,Percent of the drug absorbed after administration to humans was determined,,A,,N,1,Intermediate,CHEMBL630253,,
12242,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,A,,N,1,Intermediate,CHEMBL630254,,
12243,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,A,,N,1,Intermediate,CHEMBL630255,,
12244,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,A,,N,1,Intermediate,CHEMBL630256,,
12245,Rattus norvegicus,1,2107.0,13751,BAO_0000218,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL875781,,
12246,Rattus norvegicus,1,2107.0,13751,BAO_0000218,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL630257,,
12247,Rattus norvegicus,1,2107.0,13751,BAO_0000218,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,A,,N,1,Intermediate,CHEMBL630258,,
12248,Rattus norvegicus,1,,15807,BAO_0000218,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,A,,N,1,Intermediate,CHEMBL630259,,
12249,Rattus norvegicus,1,2435.0,15807,BAO_0000218,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,A,,N,1,Intermediate,CHEMBL630260,,
12250,Rattus norvegicus,1,2435.0,15807,BAO_0000218,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,A,,N,1,Intermediate,CHEMBL630261,,
12251,Rattus norvegicus,1,,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,A,,N,1,Intermediate,CHEMBL630262,,
12252,Rattus norvegicus,1,,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,A,,N,1,Intermediate,CHEMBL630263,,
12253,Rattus norvegicus,1,,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,A,,N,1,Intermediate,CHEMBL630264,,
12254,Rattus norvegicus,1,,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,A,,N,1,Intermediate,CHEMBL630265,,
12255,Rattus norvegicus,1,,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,A,,N,1,Intermediate,CHEMBL630266,,
12256,Rattus norvegicus,1,2113.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,A,,N,1,Intermediate,CHEMBL630267,,
12257,Rattus norvegicus,1,2113.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,A,,N,1,Intermediate,CHEMBL630268,,
12258,Rattus norvegicus,1,,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,A,,N,1,Intermediate,CHEMBL630269,,
12259,Rattus norvegicus,1,,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,A,,N,1,Intermediate,CHEMBL630270,,
12260,Rattus norvegicus,1,2048.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,A,,N,1,Intermediate,CHEMBL630141,,
12261,Rattus norvegicus,1,2048.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,A,,N,1,Intermediate,CHEMBL630142,,
12262,Rattus norvegicus,1,2385.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,A,,N,1,Intermediate,CHEMBL630143,,
12263,Rattus norvegicus,1,2385.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,A,,N,1,Intermediate,CHEMBL630144,,
12264,Rattus norvegicus,1,2367.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,A,,N,1,Intermediate,CHEMBL630145,,
12265,Rattus norvegicus,1,2367.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,A,,N,1,Intermediate,CHEMBL630146,,
12266,Rattus norvegicus,1,,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,A,,N,1,Intermediate,CHEMBL630147,,
12267,Rattus norvegicus,1,,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,A,,N,1,Intermediate,CHEMBL630148,,
12268,Rattus norvegicus,1,,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,A,,N,1,Intermediate,CHEMBL630149,,
12269,Rattus norvegicus,1,2106.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,A,,N,1,Intermediate,CHEMBL630150,,
12270,Rattus norvegicus,1,2106.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,A,,N,1,Intermediate,CHEMBL630151,,
12271,Rattus norvegicus,1,2046.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,A,,N,1,Intermediate,CHEMBL632031,,
12272,Rattus norvegicus,1,2046.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,A,,N,1,Intermediate,CHEMBL632032,,
12273,Rattus norvegicus,1,,14950,BAO_0000218,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,A,,N,1,Intermediate,CHEMBL632033,,
12274,Rattus norvegicus,1,,14950,BAO_0000218,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,A,,N,1,Intermediate,CHEMBL632034,,
12275,Rattus norvegicus,1,2385.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,A,,N,1,Intermediate,CHEMBL632035,,
12276,Rattus norvegicus,1,,14950,BAO_0000218,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,A,,N,1,Intermediate,CHEMBL632036,,
12277,Rattus norvegicus,1,2046.0,14950,BAO_0000218,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,A,,N,1,Intermediate,CHEMBL632037,,
12278,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,A,,N,1,Intermediate,CHEMBL632038,,
12279,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,A,,N,1,Intermediate,CHEMBL632039,,
12280,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,A,,N,1,Intermediate,CHEMBL632040,,
12281,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,A,,N,1,Intermediate,CHEMBL632041,,
12282,Canis lupus familiaris,1,178.0,9614,BAO_0000218,,"Concentration of compound in blood of dog 2, after administering intravenously",,A,,N,1,Intermediate,CHEMBL632042,,
12283,Canis lupus familiaris,1,,9614,BAO_0000218,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,A,,N,1,Intermediate,CHEMBL632043,,
12284,Canis lupus familiaris,1,,9614,BAO_0000218,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,A,,N,1,Intermediate,CHEMBL632044,,
12285,Canis lupus familiaris,1,2107.0,9614,BAO_0000218,,"Concentration of compound in liver of dog 1, after administering intravenously",,A,,N,1,Intermediate,CHEMBL632045,,
12286,Canis lupus familiaris,1,2107.0,9614,BAO_0000218,,"Concentration of compound in liver of dog 2, after administering intravenously",,A,,N,1,Intermediate,CHEMBL632046,,
12287,Canis lupus familiaris,1,2048.0,9614,BAO_0000218,,"Concentration of compound in lung of dog 1, after administering intravenously",,A,,N,1,Intermediate,CHEMBL632047,,
12288,Canis lupus familiaris,1,2048.0,9614,BAO_0000218,,"Concentration of compound in lung of dog 2, after administering intravenously",,A,,N,1,Intermediate,CHEMBL632048,,
12289,Canis lupus familiaris,1,2385.0,9614,BAO_0000218,,"Concentration of compound in muscle of dog 1, after administering intravenously",,A,,N,1,Intermediate,CHEMBL632049,,
12290,Canis lupus familiaris,1,2385.0,9614,BAO_0000218,,"Concentration of compound in muscle of dog 2, after administering intravenously",,A,,N,1,Intermediate,CHEMBL876418,,
12291,Canis lupus familiaris,1,2106.0,9614,BAO_0000218,,"Concentration of compound in spleen of dog 1,after administering intravenously",,A,,N,1,Intermediate,CHEMBL632050,,
12292,Canis lupus familiaris,1,2106.0,9614,BAO_0000218,,"Concentration of compound in spleen of dog 2, after administering intravenously",,A,,N,1,Intermediate,CHEMBL632051,,
12293,,1,,10353,BAO_0000218,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,F,,U,0,Autocuration,CHEMBL632052,,
12294,,1,,10353,BAO_0000218,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,F,,U,0,Autocuration,CHEMBL632053,,
12295,,1,,10353,BAO_0000218,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,A,,U,0,Autocuration,CHEMBL632054,,
12296,,1,,10353,BAO_0000218,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,F,,U,0,Autocuration,CHEMBL632055,,
12297,,1,,10353,BAO_0000218,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,F,,U,0,Autocuration,CHEMBL631181,,
12298,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,A,,U,0,Autocuration,CHEMBL631182,,
12299,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,A,,U,0,Autocuration,CHEMBL631183,,
12300,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,A,,U,0,Autocuration,CHEMBL631184,,
12301,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,A,,U,0,Autocuration,CHEMBL629774,,
12302,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,A,,U,0,Autocuration,CHEMBL629775,,
12303,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,A,,U,0,Autocuration,CHEMBL876549,,
12304,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,A,,U,0,Autocuration,CHEMBL628172,,
12305,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,A,,U,0,Autocuration,CHEMBL628173,,
12306,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,A,,U,0,Autocuration,CHEMBL628174,,
12307,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,A,,U,0,Autocuration,CHEMBL628175,,
12308,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,A,,U,0,Autocuration,CHEMBL628176,,
12309,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,A,,U,0,Autocuration,CHEMBL628177,,
12310,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,A,,U,0,Autocuration,CHEMBL628178,,
12311,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,A,,U,0,Autocuration,CHEMBL628179,,
12312,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,A,,U,0,Autocuration,CHEMBL628180,,
12313,,1,,9196,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,A,,U,0,Autocuration,CHEMBL628181,,
12314,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,A,,U,0,Autocuration,CHEMBL628182,,
12315,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,A,,U,0,Autocuration,CHEMBL628183,,
12316,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,A,,U,0,Autocuration,CHEMBL628184,,
12317,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,A,,U,0,Autocuration,CHEMBL628185,,
12318,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,A,,U,0,Autocuration,CHEMBL875617,,
12319,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,A,,U,0,Autocuration,CHEMBL628186,,
12320,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,A,,U,0,Autocuration,CHEMBL628187,,
12321,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,A,,U,0,Autocuration,CHEMBL628188,,
12322,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,A,,U,0,Autocuration,CHEMBL628189,,
12323,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,A,,U,0,Autocuration,CHEMBL628190,,
12324,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,A,,U,0,Autocuration,CHEMBL628191,,
12325,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,A,,U,0,Autocuration,CHEMBL626513,,
12326,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,A,,N,1,Intermediate,CHEMBL626514,,
12327,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,A,,N,1,Intermediate,CHEMBL626515,,
12328,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,A,,N,1,Intermediate,CHEMBL626516,,
12329,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,A,,N,1,Intermediate,CHEMBL626517,,
12330,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,A,,N,1,Intermediate,CHEMBL626518,,
12331,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,A,,N,1,Intermediate,CHEMBL626519,,
12332,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,A,,N,1,Intermediate,CHEMBL626520,,
12333,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,A,,N,1,Intermediate,CHEMBL626521,,
12334,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,A,,N,1,Intermediate,CHEMBL626522,,
12335,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,A,,N,1,Intermediate,CHEMBL626523,,
12336,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,A,,N,1,Intermediate,CHEMBL626524,,
12337,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,A,,N,1,Intermediate,CHEMBL626688,,
12338,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,A,,N,1,Intermediate,CHEMBL626689,,
12339,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,A,,N,1,Intermediate,CHEMBL626690,,
12340,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,A,,N,1,Intermediate,CHEMBL626691,,
12341,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,A,,N,1,Intermediate,CHEMBL627319,,
12342,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,A,,N,1,Intermediate,CHEMBL624052,,
12343,Rattus norvegicus,1,2046.0,8608,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,A,,N,1,Intermediate,CHEMBL624053,,
12344,Rattus norvegicus,1,,8085,BAO_0000218,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,A,,N,1,Intermediate,CHEMBL624054,,
12345,Rattus norvegicus,1,,8085,BAO_0000218,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,A,,N,1,Intermediate,CHEMBL624055,,
12346,Rattus norvegicus,1,,8085,BAO_0000218,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,A,,N,1,Intermediate,CHEMBL624056,,
12347,Rattus norvegicus,1,995.0,8085,BAO_0000218,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,A,,N,1,Intermediate,CHEMBL624057,,
12348,Rattus norvegicus,1,995.0,8085,BAO_0000218,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,A,,N,1,Intermediate,CHEMBL622281,,
12349,Rattus norvegicus,1,995.0,8085,BAO_0000218,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,A,,N,1,Intermediate,CHEMBL622282,,
12350,Rattus norvegicus,1,995.0,8085,BAO_0000218,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,A,,N,1,Intermediate,CHEMBL622283,,
12351,Rattus norvegicus,1,995.0,8085,BAO_0000218,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,A,,N,1,Intermediate,CHEMBL622284,,
12352,Rattus norvegicus,1,995.0,8085,BAO_0000218,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,A,,N,1,Intermediate,CHEMBL622285,,
12353,Rattus norvegicus,1,995.0,8085,BAO_0000218,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,A,,N,1,Intermediate,CHEMBL622286,,
12354,,1,,7657,BAO_0000100,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,P,,U,0,Autocuration,CHEMBL622287,,
12355,Mus musculus,1,,8935,BAO_0000218,,Partition coefficient (logD7.4),,A,,N,1,Intermediate,CHEMBL622288,,
12356,Mus musculus,1,,13792,BAO_0000218,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,A,,N,1,Intermediate,CHEMBL622289,,
12357,Mus musculus,1,955.0,13792,BAO_0000218,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,A,,N,1,Intermediate,CHEMBL622290,,
12358,Mus musculus,1,,13792,BAO_0000218,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,A,,N,1,Intermediate,CHEMBL622291,,
12359,Mus musculus,1,955.0,13792,BAO_0000218,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,A,,N,1,Intermediate,CHEMBL622292,,
12360,Mus musculus,1,,13792,BAO_0000218,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,A,,N,1,Intermediate,CHEMBL622293,,
12361,Mus musculus,1,955.0,13792,BAO_0000218,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,A,,N,1,Intermediate,CHEMBL622294,,
12362,Mus musculus,1,,13792,BAO_0000218,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,A,,N,1,Intermediate,CHEMBL622295,,
12363,Rattus norvegicus,1,955.0,13792,BAO_0000218,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,A,,N,1,Intermediate,CHEMBL622296,,
12364,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,A,,N,1,Intermediate,CHEMBL874409,,
12365,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,A,,N,1,Intermediate,CHEMBL622297,,
12366,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,A,,N,1,Intermediate,CHEMBL622298,,
12367,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,A,,N,1,Intermediate,CHEMBL622299,,
12368,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,A,,N,1,Intermediate,CHEMBL622300,,
12369,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,A,,N,1,Intermediate,CHEMBL622301,,
12370,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,A,,N,1,Intermediate,CHEMBL622302,,
12371,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,A,,N,1,Intermediate,CHEMBL622303,,
12372,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,A,,N,1,Intermediate,CHEMBL622304,,
12373,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,A,,N,1,Intermediate,CHEMBL622305,,
12374,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,A,,N,1,Intermediate,CHEMBL622306,,
12375,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,A,,N,1,Intermediate,CHEMBL626864,,
12376,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,A,,N,1,Intermediate,CHEMBL626865,,
12377,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,A,,N,1,Intermediate,CHEMBL626866,,
12378,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,A,,N,1,Intermediate,CHEMBL626867,,
12379,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,A,,N,1,Intermediate,CHEMBL626868,,
12380,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,A,,N,1,Intermediate,CHEMBL626869,,
12381,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,A,,N,1,Intermediate,CHEMBL626870,,
12382,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,A,,N,1,Intermediate,CHEMBL626871,,
12383,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,A,,N,1,Intermediate,CHEMBL626872,,
12384,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,A,,N,1,Intermediate,CHEMBL632185,,
12385,Rattus norvegicus,1,1969.0,14103,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,A,,N,1,Intermediate,CHEMBL632186,,
12386,,1,,12904,BAO_0000019,,Amount of acetic acid produced by the compound,,A,,U,0,Autocuration,CHEMBL629310,,
12387,,1,,12904,BAO_0000019,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,A,,U,0,Autocuration,CHEMBL629311,,
12388,Rattus norvegicus,1,,9663,BAO_0000218,,Log of (Cbrain/Cblood) in rats,,A,,N,1,Intermediate,CHEMBL629312,,
12389,,1,,7652,BAO_0000221,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629313,,
12390,,1,,7652,BAO_0000221,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629314,,
12391,,1,,7652,BAO_0000221,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629315,,
12392,,1,,7652,BAO_0000219,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,B,,U,0,Autocuration,CHEMBL629316,,
12393,,1,,7652,BAO_0000221,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629317,,
12394,,1,,7652,BAO_0000019,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629318,,
12395,,1,,7652,BAO_0000019,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL877497,,
12396,,1,,7652,BAO_0000019,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629319,,
12397,,1,,7652,BAO_0000019,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629320,,
12398,,1,,7652,BAO_0000019,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629496,,
12399,,1,,7652,BAO_0000019,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629497,,
12400,,1,,7652,BAO_0000019,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629498,,
12401,,1,,7652,BAO_0000019,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629499,,
12402,,1,,7652,BAO_0000019,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629500,,
12403,,1,,7652,BAO_0000019,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629501,,
12404,,1,,7652,BAO_0000019,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,A,,U,0,Autocuration,CHEMBL629502,,
12405,,1,,8267,BAO_0000218,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,F,,U,0,Autocuration,CHEMBL629503,,
12406,Canis lupus familiaris,1,,8267,BAO_0000218,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,A,,N,1,Intermediate,CHEMBL629504,,
12407,,1,,14479,BAO_0000019,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,A,,U,0,Autocuration,CHEMBL629505,,
12408,,1,,17515,BAO_0000019,,Compound was evaluated for total body clearance,,A,,U,0,Autocuration,CHEMBL629506,,
12409,,1,,17515,BAO_0000019,,Compound was evaluated for volume of distribution at steady state,,A,,U,0,Autocuration,CHEMBL629507,,
12410,,1,,8142,BAO_0000019,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,A,,U,0,Autocuration,CHEMBL877498,,
12411,,1,,14849,BAO_0000019,,Percentage of the diamine which is monoprotonated at pH 7.4,,A,,U,0,Autocuration,CHEMBL629508,,
12412,,1,,7653,BAO_0000019,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,A,,U,0,Autocuration,CHEMBL629509,,
12413,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,A,,N,1,Intermediate,CHEMBL629510,,
12414,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,A,,N,1,Intermediate,CHEMBL629511,,
12415,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,A,,N,1,Intermediate,CHEMBL629512,,
12416,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,A,,N,1,Intermediate,CHEMBL629513,,
12417,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,A,,N,1,Intermediate,CHEMBL629514,,
12418,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,A,,N,1,Intermediate,CHEMBL628447,,
12419,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,A,,N,1,Intermediate,CHEMBL628448,,
12420,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,A,,N,1,Intermediate,CHEMBL628449,,
12421,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,A,,N,1,Intermediate,CHEMBL631119,,
12422,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,A,,N,1,Intermediate,CHEMBL631120,,
12423,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,A,,N,1,Intermediate,CHEMBL631121,,
12424,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,A,,N,1,Intermediate,CHEMBL874458,,
12425,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,A,,N,1,Intermediate,CHEMBL631122,,
12426,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,A,,N,1,Intermediate,CHEMBL631123,,
12427,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,A,,N,1,Intermediate,CHEMBL631124,,
12428,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,A,,N,1,Intermediate,CHEMBL631125,,
12429,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,A,,N,1,Intermediate,CHEMBL631290,,
12430,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,A,,N,1,Intermediate,CHEMBL631291,,
12431,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,A,,N,1,Intermediate,CHEMBL631292,,
12432,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,A,,N,1,Intermediate,CHEMBL631293,,
12433,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,A,,N,1,Intermediate,CHEMBL631294,,
12434,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,A,,N,1,Intermediate,CHEMBL631295,,
12435,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,A,,N,1,Intermediate,CHEMBL631296,,
12436,Rattus norvegicus,1,178.0,8631,BAO_0000218,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,A,,N,1,Intermediate,CHEMBL631297,,
12437,,1,,10263,BAO_0000218,,Maximum biodistribution (Bmax) was determined.,,A,,U,0,Autocuration,CHEMBL631298,,
12438,Mus musculus,1,,12364,BAO_0000218,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,A,,N,1,Intermediate,CHEMBL631299,,
12439,Mus musculus,1,,12364,BAO_0000218,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,A,,N,1,Intermediate,CHEMBL631300,,
12440,Mus musculus,1,,12364,BAO_0000218,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,A,,N,1,Intermediate,CHEMBL631301,,
12441,Mus musculus,1,,12364,BAO_0000218,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,A,,N,1,Intermediate,CHEMBL630291,,
12442,,1,,14793,BAO_0000218,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,A,,U,0,Autocuration,CHEMBL630292,,
12443,,1,,14793,BAO_0000218,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,A,,U,0,Autocuration,CHEMBL630293,,
12444,,1,,14793,BAO_0000218,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,A,,U,0,Autocuration,CHEMBL630294,,
12445,,1,,14793,BAO_0000218,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,A,,U,0,Autocuration,CHEMBL630295,,
12446,,1,,14793,BAO_0000218,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,A,,U,0,Autocuration,CHEMBL630296,,
12447,,1,,14793,BAO_0000218,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,A,,U,0,Autocuration,CHEMBL626782,,
12448,,1,,14793,BAO_0000218,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,A,,U,0,Autocuration,CHEMBL626783,,
12449,,1,,14793,BAO_0000218,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,A,,U,0,Autocuration,CHEMBL626784,,
12450,,1,,14793,BAO_0000218,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,A,,U,0,Autocuration,CHEMBL626785,,
12451,,1,,14793,BAO_0000218,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,A,,U,0,Autocuration,CHEMBL626786,,
12452,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,A,,U,0,Autocuration,CHEMBL626787,,
12453,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,A,,U,0,Autocuration,CHEMBL626788,,
12454,,1,,9196,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,A,,U,0,Autocuration,CHEMBL625927,,
12455,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL625928,,
12456,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,A,,N,1,Intermediate,CHEMBL625929,,
12457,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,A,,N,1,Intermediate,CHEMBL625930,,
12458,Rattus norvegicus,1,178.0,8374,BAO_0000218,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,A,,N,1,Intermediate,CHEMBL625931,,
12459,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,A,,N,1,Intermediate,CHEMBL627230,,
12460,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627231,,
12461,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,A,,N,1,Intermediate,CHEMBL627232,,
12462,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,A,,N,1,Intermediate,CHEMBL627233,,
12463,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL875470,,
12464,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627234,,
12465,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627235,,
12466,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627236,,
12467,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627237,,
12468,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627238,,
12469,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627239,,
12470,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627240,,
12471,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627241,,
12472,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627242,,
12473,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,A,,N,1,Intermediate,CHEMBL627243,,
12474,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,A,,N,1,Intermediate,CHEMBL627244,,
12475,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627245,,
12476,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627246,,
12477,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627247,,
12478,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627248,,
12479,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627249,,
12480,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL625569,,
12481,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL625570,,
12482,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL625571,,
12483,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,A,,N,1,Intermediate,CHEMBL625572,,
12484,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,A,,N,1,Intermediate,CHEMBL625573,,
12485,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,A,,N,1,Intermediate,CHEMBL625574,,
12486,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,A,,N,1,Intermediate,CHEMBL626245,,
12487,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL626246,,
12488,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,A,,U,0,Autocuration,CHEMBL626247,,
12489,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,A,,U,0,Autocuration,CHEMBL626248,,
12490,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,A,,U,0,Autocuration,CHEMBL626249,,
12491,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,A,,U,0,Autocuration,CHEMBL626420,,
12492,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,A,,U,0,Autocuration,CHEMBL626421,,
12493,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,A,,U,0,Autocuration,CHEMBL626422,,
12494,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,A,,U,0,Autocuration,CHEMBL626423,,
12495,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,A,,U,0,Autocuration,CHEMBL626424,,
12496,Canis lupus familiaris,1,,12023,BAO_0000218,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,A,,N,1,Intermediate,CHEMBL626425,,
12497,Rattus norvegicus,1,,12023,BAO_0000218,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,A,,N,1,Intermediate,CHEMBL875476,,
12498,Macaca fascicularis,1,,12023,BAO_0000218,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,A,,N,1,Intermediate,CHEMBL626426,,
12499,,1,,10580,BAO_0000100,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,P,,U,0,Autocuration,CHEMBL626427,,
12500,,1,,10580,BAO_0000100,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,P,,U,0,Autocuration,CHEMBL626428,,
12501,,1,,16032,BAO_0000019,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,A,,U,0,Autocuration,CHEMBL626429,,
12502,,1,1088.0,16032,BAO_0000019,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,A,,U,0,Autocuration,CHEMBL625025,,
12503,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL625026,,
12504,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL625027,,
12505,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL874410,,
12506,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL625028,,
12507,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL625029,,
12508,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL625030,,
12509,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL625031,,
12510,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL625032,,
12511,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL625033,,
12512,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL625034,,
12513,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624872,,
12514,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624873,,
12515,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624874,,
12516,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624875,,
12517,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624876,,
12518,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624877,,
12519,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624878,,
12520,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624879,,
12521,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624880,,
12522,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624881,,
12523,Rattus norvegicus,1,948.0,8594,BAO_0000218,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,A,,N,1,Intermediate,CHEMBL624882,,
12524,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624883,,
12525,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624884,,
12526,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624885,,
12527,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624886,,
12528,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624887,,
12529,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624888,,
12530,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624889,,
12531,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624890,,
12532,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL621964,,
12533,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL621965,,
12534,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL621966,,
12535,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL621967,,
12536,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL622164,,
12537,,1,,7653,BAO_0000019,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,A,,U,0,Autocuration,CHEMBL623097,,
12538,,1,,7653,BAO_0000019,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,A,,U,0,Autocuration,CHEMBL623098,,
12539,,1,,7653,BAO_0000019,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,A,,U,0,Autocuration,CHEMBL623099,,
12540,,1,,7653,BAO_0000019,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,A,,U,0,Autocuration,CHEMBL623100,,
12541,Rattus norvegicus,1,,9104,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,A,,N,1,Intermediate,CHEMBL628673,,
12542,Rattus norvegicus,1,,9104,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,A,,N,1,Intermediate,CHEMBL628674,,
12543,Rattus norvegicus,1,,9104,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,A,,N,1,Intermediate,CHEMBL628675,,
12544,Rattus norvegicus,1,,9104,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,A,,N,1,Intermediate,CHEMBL627644,,
12545,Rattus norvegicus,1,,9104,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,A,,N,1,Intermediate,CHEMBL627645,,
12546,Rattus norvegicus,1,,9104,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,A,,N,1,Intermediate,CHEMBL627646,,
12547,Rattus norvegicus,1,,9104,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,A,,N,1,Intermediate,CHEMBL627647,,
12548,Rattus norvegicus,1,,9104,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,A,,N,1,Intermediate,CHEMBL627648,,
12549,Rattus norvegicus,1,,12902,BAO_0000218,,Free level in rat plasma,,A,,N,1,Intermediate,CHEMBL627649,,
12550,,1,,6614,BAO_0000019,,Level reaching in blood plasma of rat or human was determined,,A,,U,0,Autocuration,CHEMBL628313,,
12551,Rattus norvegicus,1,,9663,BAO_0000218,,Log (Cbrain/Cblood) in rats,,A,,N,1,Intermediate,CHEMBL628314,,
12552,,1,,17658,BAO_0000019,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,A,,U,0,Autocuration,CHEMBL628315,,
12553,,1,,17658,BAO_0000019,,Mean percentage of compound transport through membrane; expressed as membrane transport,,A,,U,0,Autocuration,CHEMBL628316,,
12554,,1,,14314,BAO_0000218,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,A,,U,0,Autocuration,CHEMBL628317,,
12555,,1,,7385,BAO_0000019,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,A,,U,0,Autocuration,CHEMBL628473,,
12556,,1,,7385,BAO_0000019,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,A,,U,0,Autocuration,CHEMBL628474,,
12557,,1,,7385,BAO_0000019,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,A,,U,0,Autocuration,CHEMBL628475,,
12558,,1,,1329,BAO_0000019,,Net water uptake by a carrier mediated transport (%cm) mechanism,,A,,U,0,Autocuration,CHEMBL628476,,
12559,Simiiformes,1,,12187,BAO_0000218,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,A,,U,0,Autocuration,CHEMBL628477,,
12560,Mustela putorius furo,1,,12187,BAO_0000218,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,A,,N,1,Intermediate,CHEMBL628478,,
12561,Mustela putorius furo,1,,12187,BAO_0000218,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,A,,N,1,Intermediate,CHEMBL628479,,
12562,Simiiformes,1,,12187,BAO_0000218,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,A,,U,0,Autocuration,CHEMBL628480,,
12563,Simiiformes,1,,12187,BAO_0000218,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,A,,U,0,Autocuration,CHEMBL628481,,
12564,Rattus norvegicus,1,,12187,BAO_0000218,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL628482,,
12565,Rattus norvegicus,1,,12187,BAO_0000218,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,A,,N,1,Intermediate,CHEMBL628483,,
12566,Rattus norvegicus,1,1969.0,9278,BAO_0000218,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,A,,N,1,Intermediate,CHEMBL628484,,
12567,Rattus norvegicus,1,1969.0,9278,BAO_0000218,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,A,,N,1,Intermediate,CHEMBL628485,,
12568,Macaca fascicularis,1,1969.0,9278,BAO_0000218,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,A,,N,1,Intermediate,CHEMBL628486,,
12569,Homo sapiens,1,1969.0,9278,BAO_0000218,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,A,,N,1,Intermediate,CHEMBL628487,,
12570,Rattus norvegicus,1,1969.0,9278,BAO_0000218,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,A,,N,1,Intermediate,CHEMBL628488,,
12571,Rattus norvegicus,1,1969.0,9278,BAO_0000218,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,A,,N,1,Intermediate,CHEMBL628489,,
12572,Rattus norvegicus,1,1969.0,9278,BAO_0000218,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,A,,N,1,Intermediate,CHEMBL628490,,
12573,Macaca fascicularis,1,,12186,BAO_0000218,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,A,,N,1,Intermediate,CHEMBL628491,,
12574,Macaca fascicularis,1,,12186,BAO_0000218,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,A,,N,1,Intermediate,CHEMBL877507,,
12575,,1,,12186,BAO_0000218,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,A,,U,0,Autocuration,CHEMBL628492,,
12576,Simiiformes,1,,12041,BAO_0000019,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,A,,U,0,Autocuration,CHEMBL628493,,
12577,Simiiformes,1,,12041,BAO_0000019,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,A,,U,0,Autocuration,CHEMBL628494,,
12578,Simiiformes,1,,12041,BAO_0000019,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,A,,U,0,Autocuration,CHEMBL628495,,
12579,Homo sapiens,1,,6737,BAO_0000218,,Permeability in Caco-2 assay at 10E-6,,A,,N,1,Intermediate,CHEMBL628496,,
12580,,1,955.0,13758,BAO_0000218,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,A,,U,0,Autocuration,CHEMBL628497,,
12581,,1,955.0,13758,BAO_0000218,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,A,,U,0,Autocuration,CHEMBL628498,,
12582,,1,,5676,BAO_0000019,,Plasma protein binding was determined,,A,,U,0,Autocuration,CHEMBL628499,,
12583,,1,,14793,BAO_0000218,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,A,,U,0,Autocuration,CHEMBL627656,,
12584,,1,,14793,BAO_0000218,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,A,,U,0,Autocuration,CHEMBL627657,,
12585,,1,,14793,BAO_0000218,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,A,,U,0,Autocuration,CHEMBL626808,,
12586,,1,,14793,BAO_0000218,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,A,,U,0,Autocuration,CHEMBL626809,,
12587,,1,,14793,BAO_0000218,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,A,,U,0,Autocuration,CHEMBL626810,,
12588,,1,,14793,BAO_0000218,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,A,,U,0,Autocuration,CHEMBL626811,,
12589,,1,,14793,BAO_0000218,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,A,,U,0,Autocuration,CHEMBL874465,,
12590,,1,,14793,BAO_0000218,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,A,,U,0,Autocuration,CHEMBL626812,,
12591,,1,,14793,BAO_0000218,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,A,,U,0,Autocuration,CHEMBL626813,,
12592,,1,,14793,BAO_0000218,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,A,,U,0,Autocuration,CHEMBL626814,,
12593,,1,,14000,BAO_0000019,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,A,,U,0,Autocuration,CHEMBL626815,,
12594,,1,,5948,BAO_0000019,,Partition coefficient (logP),,A,,U,0,Autocuration,CHEMBL628566,,
12595,,1,,13824,BAO_0000100,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,P,,U,0,Autocuration,CHEMBL628567,,
12596,,1,,10778,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL628568,,
12597,Canis lupus familiaris,1,,17237,BAO_0000218,,C max in dog,,A,,N,1,Intermediate,CHEMBL628569,,
12598,Cavia porcellus,1,,17237,BAO_0000218,,C max in guinea pig,,A,,N,1,Intermediate,CHEMBL628570,,
12599,,1,,2809,BAO_0000218,,C max value was evaluated,,A,,U,0,Autocuration,CHEMBL628571,,
12600,,1,,11954,BAO_0000218,,Cmax value after oral dose of 0.1 mg//kg,,A,,U,0,Autocuration,CHEMBL628572,,
12601,,1,,11954,BAO_0000218,,Cmax value after oral dose of 0.3 mg/kg,,A,,U,0,Autocuration,CHEMBL628573,,
12602,,1,,11954,BAO_0000218,,Cmax value after oral dose of 1 mg/kg,,A,,U,0,Autocuration,CHEMBL628574,,
12603,,1,,11954,BAO_0000218,,Cmax value after oral dose of 10 mg/kg,,A,,U,0,Autocuration,CHEMBL628575,,
12604,,1,,11954,BAO_0000218,,Cmax value after oral dose of 23.4 mg/kg,,A,,U,0,Autocuration,CHEMBL628576,,
12605,,1,,11954,BAO_0000218,,Cmax value after oral dose of 3 mg/kg,,A,,U,0,Autocuration,CHEMBL628577,,
12606,,1,,11954,BAO_0000218,,Cmax value after oral dose of 3.87 mg/kg,,A,,U,0,Autocuration,CHEMBL628578,,
12607,Canis lupus familiaris,1,,12768,BAO_0000218,,Cmax value in female Beagle dogs,,A,,N,1,Intermediate,CHEMBL874466,,
12608,Rattus norvegicus,1,,12768,BAO_0000218,,Cmax value in male rats,,A,,N,1,Intermediate,CHEMBL628579,,
12609,Rattus norvegicus,1,1969.0,12780,BAO_0000218,,Cmax value in rat plasma when administered 20 mg/kg perorally,,A,,N,1,Intermediate,CHEMBL628580,,
12610,Canis lupus familiaris,1,1969.0,15592,BAO_0000218,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,A,,N,1,Intermediate,CHEMBL628581,,
12611,Canis lupus familiaris,1,1969.0,15592,BAO_0000218,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,A,,N,1,Intermediate,CHEMBL628582,,
12612,Canis lupus familiaris,1,,17025,BAO_0000218,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,A,,N,1,Intermediate,CHEMBL628583,,
12613,Simiiformes,1,,17025,BAO_0000218,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,A,,U,0,Autocuration,CHEMBL625782,,
12614,Oryctolagus cuniculus,1,,17025,BAO_0000218,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,A,,N,1,Intermediate,CHEMBL625783,,
12615,Rattus norvegicus,1,,17025,BAO_0000218,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,A,,N,1,Intermediate,CHEMBL625784,,
12616,Macaca mulatta,1,1969.0,4236,BAO_0000218,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,A,,N,1,Intermediate,CHEMBL625785,,
12617,Rattus norvegicus,1,,15791,BAO_0000218,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL625786,,
12618,,1,,11149,BAO_0000019,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,A,,U,0,Autocuration,CHEMBL874467,,
12619,Canis lupus familiaris,1,,15592,BAO_0000218,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,A,,N,1,Intermediate,CHEMBL625787,,
12620,Human immunodeficiency virus,1,,15778,BAO_0000218,,cytotoxicity against HIV protease enzyme.,,A,,N,1,Intermediate,CHEMBL625964,,
12621,Mus musculus,1,,12745,BAO_0000218,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,A,,N,1,Intermediate,CHEMBL625965,,
12622,Mus musculus,1,,12745,BAO_0000218,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,A,,N,1,Intermediate,CHEMBL625966,,
12623,Canis lupus familiaris,1,1969.0,13941,BAO_0000218,,The plasma clearance in dog.,,A,,N,1,Intermediate,CHEMBL625967,,
12624,Rattus norvegicus,1,1969.0,13941,BAO_0000218,,The plasma clearance in rat.,,A,,N,1,Intermediate,CHEMBL625968,,
12625,Rattus norvegicus,1,1969.0,16449,BAO_0000218,,Clearance from plasma in male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL625969,,
12626,Macaca fascicularis,1,1969.0,16449,BAO_0000218,,Clearance from plasma in male cynomolgus monkeys,,A,,N,1,Intermediate,CHEMBL625970,,
12627,Canis lupus familiaris,1,1969.0,14224,BAO_0000218,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,A,,N,1,Intermediate,CHEMBL625971,,
12628,Canis lupus familiaris,1,1969.0,14224,BAO_0000218,,Clearance of compound in dog plasma,,A,,N,1,Intermediate,CHEMBL625972,,
12629,Homo sapiens,1,1969.0,14224,BAO_0000218,,Clearance of compound in human plasma,,A,,N,1,Intermediate,CHEMBL625973,,
12630,Canis lupus familiaris,1,,14317,BAO_0000218,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,A,,N,1,Intermediate,CHEMBL625974,,
12631,Canis lupus familiaris,1,,14317,BAO_0000218,,Clearance of compound when administered intravenously as an individual dose to a single dog.,,A,,N,1,Intermediate,CHEMBL625975,,
12632,Canis lupus familiaris,1,1969.0,14224,BAO_0000218,,"Clearance (10 mg/kg, intravenously) in dog plasma",,A,,N,1,Intermediate,CHEMBL625976,,
12633,Canis lupus familiaris,1,,17237,BAO_0000218,,Clearance value in dog,,A,,N,1,Intermediate,CHEMBL625977,,
12634,Cavia porcellus,1,,17237,BAO_0000218,,Clearance value in guinea pig,,A,,N,1,Intermediate,CHEMBL625978,,
12635,Rattus norvegicus,1,,14187,BAO_0000218,,Clearance values in rats after iv administration.,,A,,N,1,Intermediate,CHEMBL874468,,
12636,,1,1969.0,4806,BAO_0000218,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,A,,U,0,Autocuration,CHEMBL625421,,
12637,Oryctolagus cuniculus,1,,15025,BAO_0000218,,In vivo clearance (5 mg/kg) was determined in rabbits,,A,,N,1,Intermediate,CHEMBL625422,,
12638,Rattus norvegicus,1,,13197,BAO_0000218,,Plasma Clearance rate was determined for the compound in rats,,A,,N,1,Intermediate,CHEMBL625423,,
12639,Saimiri,1,,13197,BAO_0000218,,Plasma Clearance rate was determined for the compound in squirrel monkeys,,A,,U,0,Autocuration,CHEMBL625424,,
12640,Rattus norvegicus,1,,13960,BAO_0000218,,Plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL625425,,
12641,,1,,17820,BAO_0000218,,Plasma clearance of the compound,,A,,U,0,Autocuration,CHEMBL625426,,
12642,Cavia porcellus,1,,14706,BAO_0000218,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,A,,N,1,Intermediate,CHEMBL625427,,
12643,Cavia porcellus,1,,14706,BAO_0000218,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,A,,N,1,Intermediate,CHEMBL625428,,
12644,,1,,6504,BAO_0000218,,Plasma clearance was determined,,A,,U,0,Autocuration,CHEMBL625429,,
12645,Canis lupus familiaris,1,,14925,BAO_0000218,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,A,,N,1,Intermediate,CHEMBL625430,,
12646,Rattus norvegicus,1,,13197,BAO_0000218,,Plasma clearance rate was determined for the compound in rats,,A,,N,1,Intermediate,CHEMBL625431,,
12647,Saimiri,1,,13197,BAO_0000218,,Plasma clearance rate was determined for the compound in squirrel monkeys,,A,,U,0,Autocuration,CHEMBL627307,,
12648,,1,,3437,BAO_0000218,,Slow clearance (CL) was determined,,A,,U,0,Autocuration,CHEMBL627308,,
12649,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,A,,U,0,Autocuration,CHEMBL627309,,
12650,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,A,,U,0,Autocuration,CHEMBL627310,,
12651,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,A,,U,0,Autocuration,CHEMBL627311,,
12652,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,A,,U,0,Autocuration,CHEMBL627312,,
12653,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,A,,U,0,Autocuration,CHEMBL627313,,
12654,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,A,,U,0,Autocuration,CHEMBL627314,,
12655,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,A,,U,0,Autocuration,CHEMBL627315,,
12656,,1,,9196,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,A,,U,0,Autocuration,CHEMBL627316,,
12657,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,A,,U,0,Autocuration,CHEMBL627317,,
12658,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,A,,U,0,Autocuration,CHEMBL627318,,
12659,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,A,,U,0,Autocuration,CHEMBL627999,,
12660,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,A,,U,0,Autocuration,CHEMBL628000,,
12661,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,A,,U,0,Autocuration,CHEMBL628001,,
12662,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,A,,U,0,Autocuration,CHEMBL628002,,
12663,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,A,,U,0,Autocuration,CHEMBL625610,,
12664,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,A,,U,0,Autocuration,CHEMBL625611,,
12665,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,A,,U,0,Autocuration,CHEMBL625612,,
12666,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,A,,U,0,Autocuration,CHEMBL625613,,
12667,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,A,,U,0,Autocuration,CHEMBL875479,,
12668,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,A,,U,0,Autocuration,CHEMBL625614,,
12669,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,A,,U,0,Autocuration,CHEMBL625615,,
12670,,1,,9196,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,A,,U,0,Autocuration,CHEMBL626302,,
12671,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL626303,,
12672,Rattus norvegicus,1,178.0,8374,BAO_0000218,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,A,,N,1,Intermediate,CHEMBL627420,,
12673,Rattus norvegicus,1,,13477,BAO_0000218,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,A,,N,1,Intermediate,CHEMBL627421,,
12674,Rattus norvegicus,1,,13477,BAO_0000218,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,A,,N,1,Intermediate,CHEMBL625695,,
12675,Rattus norvegicus,1,,13477,BAO_0000218,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,A,,N,1,Intermediate,CHEMBL625696,,
12676,Mus musculus,1,955.0,10009,BAO_0000218,,Distribution of compound in mice brain was measured after 1 hr,,A,,N,1,Intermediate,CHEMBL875606,,
12677,Mus musculus,1,955.0,10009,BAO_0000218,,Distribution of compound in mice brain was measured after 24 hr r,,A,,N,1,Intermediate,CHEMBL625697,,
12678,Mus musculus,1,955.0,10009,BAO_0000218,,Distribution of compound in mice brain was measured after 2 hr,,A,,N,1,Intermediate,CHEMBL625698,,
12679,Mus musculus,1,955.0,10009,BAO_0000218,,Distribution of compound in mice brain was measured after 3 hr,,A,,N,1,Intermediate,CHEMBL625699,,
12680,Mus musculus,1,955.0,10009,BAO_0000218,,Distribution of compound in mice brain was measured after 6 hr,,A,,N,1,Intermediate,CHEMBL625700,,
12681,Mus musculus,1,,10009,BAO_0000218,,Distribution of compound in mice liver was measured after 1 hr,,A,,N,1,Intermediate,CHEMBL625701,,
12682,Mus musculus,1,,10009,BAO_0000218,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,A,,N,1,Intermediate,CHEMBL625702,,
12683,Mus musculus,1,,10009,BAO_0000218,,Distribution of compound in mice liver was measured after 2 hr,,A,,N,1,Intermediate,CHEMBL625703,,
12684,Mus musculus,1,,10009,BAO_0000218,,Distribution of compound in mice liver was measured after 3 hr,,A,,N,1,Intermediate,CHEMBL625704,,
12685,Mus musculus,1,,10009,BAO_0000218,,Distribution of compound in mice liver was measured after 6 hr,,A,,N,1,Intermediate,CHEMBL625705,,
12686,Canis lupus familiaris,1,1236.0,8170,BAO_0000218,,Distribution in dog adrenal medulla 30 min after administration.,,A,,N,1,Intermediate,CHEMBL625706,,
12687,Canis lupus familiaris,1,1236.0,8170,BAO_0000218,,Distribution in dog adrenal medulla 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL625707,,
12688,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog Ovary 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL625708,,
12689,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog Ovary 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL625709,,
12690,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog adipose 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624180,,
12691,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog adipose 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624181,,
12692,Canis lupus familiaris,1,1235.0,8170,BAO_0000218,,Distribution in female dog adrenal cortex 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624182,,
12693,Canis lupus familiaris,1,1235.0,8170,BAO_0000218,,Distribution in female dog adrenal cortex 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624183,,
12694,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624184,,
12695,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL877489,,
12696,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624185,,
12697,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624186,,
12698,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624187,,
12699,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624188,,
12700,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624189,,
12701,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624190,,
12702,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624191,,
12703,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624192,,
12704,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624193,,
12705,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624194,,
12706,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624891,,
12707,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL624892,,
12708,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL624893,,
12709,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL627632,,
12710,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL627633,,
12711,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL627634,,
12712,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL627635,,
12713,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL627636,,
12714,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL626816,,
12715,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626817,,
12716,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL626818,,
12717,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626819,,
12718,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL626820,,
12719,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626821,,
12720,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626822,,
12721,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626823,,
12722,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL626824,,
12723,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626825,,
12724,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL626826,,
12725,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626827,,
12726,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL626828,,
12727,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626829,,
12728,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626830,,
12729,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL627150,,
12730,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL627151,,
12731,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,A,,N,1,Intermediate,CHEMBL627152,,
12732,Rattus norvegicus,1,,8594,BAO_0000218,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL627153,,
12733,,1,,12904,BAO_0000019,,Rate of acetate production by the compound was determined,,A,,U,0,Autocuration,CHEMBL627154,,
12734,,1,,12904,BAO_0000019,,Rate of acetate production by the compound was determined; Not determined,,A,,U,0,Autocuration,CHEMBL627155,,
12735,,1,,3730,BAO_0000019,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,A,,U,0,Autocuration,CHEMBL627156,,
12736,,1,,3627,BAO_0000019,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,A,,U,0,Autocuration,CHEMBL627157,,
12737,Oryctolagus cuniculus,1,,13799,BAO_0000218,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,A,,N,1,Intermediate,CHEMBL627158,,
12738,Oryctolagus cuniculus,1,1969.0,13799,BAO_0000218,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,A,,N,1,Intermediate,CHEMBL627159,,
12739,Mus musculus,1,,13799,BAO_0000218,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,A,,N,1,Intermediate,CHEMBL627160,,
12740,Rattus norvegicus,1,,13799,BAO_0000218,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,A,,N,1,Intermediate,CHEMBL628540,,
12741,Rattus norvegicus,1,1969.0,13799,BAO_0000218,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,A,,N,1,Intermediate,CHEMBL628541,,
12742,Rattus norvegicus,1,1969.0,13799,BAO_0000218,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,A,,N,1,Intermediate,CHEMBL628542,,
12743,,1,,6629,BAO_0000100,,Solubility after at a pH 1.2,,P,,U,0,Autocuration,CHEMBL628543,,
12744,,1,,6629,BAO_0000100,,Solubility after at pH 1.2,,P,,U,0,Autocuration,CHEMBL628544,,
12745,,1,,6629,BAO_0000100,,Solubility after injection of water,,P,,U,0,Autocuration,CHEMBL628545,,
12746,,1,,14000,BAO_0000019,,Statistical significance of IC 50 values; Expressed as R value,,A,,U,0,Autocuration,CHEMBL628546,,
12747,,1,,8267,BAO_0000019,,Systemic availability with respect to methyldopa was determined,,A,,U,0,Autocuration,CHEMBL874455,,
12748,Rattus norvegicus,1,,13799,BAO_0000218,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,A,,N,1,Intermediate,CHEMBL628547,,
12749,Rattus norvegicus,1,1969.0,13799,BAO_0000218,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,A,,N,1,Intermediate,CHEMBL628548,,
12750,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,A,,N,1,Intermediate,CHEMBL628549,,
12751,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,A,,N,1,Intermediate,CHEMBL628550,,
12752,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,A,,N,1,Intermediate,CHEMBL628551,,
12753,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,A,,N,1,Intermediate,CHEMBL628552,,
12754,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,A,,N,1,Intermediate,CHEMBL628553,,
12755,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,A,,N,1,Intermediate,CHEMBL628554,,
12756,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,A,,N,1,Intermediate,CHEMBL628555,,
12757,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,A,,N,1,Intermediate,CHEMBL628556,,
12758,Oryctolagus cuniculus,1,2113.0,7132,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,A,,N,1,Intermediate,CHEMBL628557,,
12759,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,A,,N,1,Intermediate,CHEMBL628558,,
12760,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,A,,N,1,Intermediate,CHEMBL628559,,
12761,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,A,,N,1,Intermediate,CHEMBL628560,,
12762,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,A,,N,1,Intermediate,CHEMBL874456,,
12763,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,A,,N,1,Intermediate,CHEMBL628561,,
12764,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,A,,N,1,Intermediate,CHEMBL628562,,
12765,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,A,,N,1,Intermediate,CHEMBL628563,,
12766,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,A,,N,1,Intermediate,CHEMBL628564,,
12767,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,A,,N,1,Intermediate,CHEMBL628565,,
12768,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,A,,N,1,Intermediate,CHEMBL631248,,
12769,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,A,,N,1,Intermediate,CHEMBL631249,,
12770,Oryctolagus cuniculus,1,2113.0,7132,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,A,,N,1,Intermediate,CHEMBL627214,,
12771,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,A,,N,1,Intermediate,CHEMBL874591,,
12772,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,A,,N,1,Intermediate,CHEMBL627215,,
12773,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,A,,N,1,Intermediate,CHEMBL625471,,
12774,Oryctolagus cuniculus,1,,7132,BAO_0000218,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,A,,N,1,Intermediate,CHEMBL625472,,
12775,Oryctolagus cuniculus,1,,7132,BAO_0000218,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,A,,N,1,Intermediate,CHEMBL625473,,
12776,Canis lupus familiaris,1,,13317,BAO_0000218,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,A,,N,1,Intermediate,CHEMBL625474,,
12777,Canis lupus familiaris,1,,15341,BAO_0000218,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,A,,N,1,Intermediate,CHEMBL625475,,
12778,Rattus norvegicus,1,,15341,BAO_0000218,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,A,,N,1,Intermediate,CHEMBL625476,,
12779,Rattus norvegicus,1,,15341,BAO_0000218,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,A,,N,1,Intermediate,CHEMBL625477,,
12780,Rattus norvegicus,1,,15341,BAO_0000218,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,A,,N,1,Intermediate,CHEMBL625478,,
12781,Rattus norvegicus,1,,12801,BAO_0000218,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,A,,N,1,Intermediate,CHEMBL625479,,
12782,Rattus norvegicus,1,,12801,BAO_0000218,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,A,,N,1,Intermediate,CHEMBL625480,,
12783,Rattus norvegicus,1,1969.0,14856,BAO_0000218,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,A,,N,1,Intermediate,CHEMBL625481,,
12784,Rattus norvegicus,1,,14062,BAO_0000218,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL625482,,
12785,Rattus norvegicus,1,,14062,BAO_0000218,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL625483,,
12786,Rattus norvegicus,1,,14062,BAO_0000218,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL625484,,
12787,Rattus norvegicus,1,,14062,BAO_0000218,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL625485,,
12788,Canis lupus familiaris,1,1969.0,14346,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,A,,N,1,Intermediate,CHEMBL625486,,
12789,Rattus norvegicus,1,1969.0,14346,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,A,,N,1,Intermediate,CHEMBL625487,,
12790,Rattus norvegicus,1,1969.0,14346,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,A,,N,1,Intermediate,CHEMBL625488,,
12791,Rattus norvegicus,1,1969.0,14346,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,A,,N,1,Intermediate,CHEMBL625489,,
12792,Rattus norvegicus,1,1969.0,14346,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,A,,N,1,Intermediate,CHEMBL625490,,
12793,Canis lupus familiaris,1,1969.0,14346,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,A,,N,1,Intermediate,CHEMBL625491,,
12794,Rattus norvegicus,1,1969.0,14346,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,A,,N,1,Intermediate,CHEMBL625492,,
12795,Homo sapiens,1,1969.0,15711,BAO_0000218,,plasma clearance in human,,A,,N,1,Intermediate,CHEMBL625493,,
12796,Rattus norvegicus,1,,14886,BAO_0000218,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,A,,N,1,Intermediate,CHEMBL625494,,
12797,Rattus norvegicus,1,,14886,BAO_0000218,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,A,,N,1,Intermediate,CHEMBL625495,,
12798,Rattus norvegicus,1,,14886,BAO_0000218,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,A,,N,1,Intermediate,CHEMBL625496,,
12799,,1,,4115,BAO_0000100,,1-Octanol/water partition coefficient measured at 7.4,,P,,U,0,Autocuration,CHEMBL625497,,
12800,,1,,13733,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625498,,
12801,,1,,12102,BAO_0000019,,Partition coefficient (logP),,A,,U,0,Autocuration,CHEMBL625499,,
12802,,1,,12676,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625500,,
12803,,1,,13733,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625501,,
12804,,1,,13740,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625502,,
12805,,1,,12766,BAO_0000100,,Calculated partition coefficient (clogP) (relative to BAY K 8644),,P,,U,0,Autocuration,CHEMBL625503,,
12806,,1,,2764,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625504,,
12807,,1,,12355,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625505,,
12808,,1,,11314,BAO_0000100,,Calculated partition coefficient of the compound,,P,,U,0,Autocuration,CHEMBL625506,,
12809,,1,,12706,BAO_0000019,,Partition coefficient (logP),,A,,U,0,Autocuration,CHEMBL625507,,
12810,,1,,12645,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625508,,
12811,,1,,13668,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625509,,
12812,,1,,12819,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625510,,
12813,,1,,13668,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL883125,,
12814,,1,,13017,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625511,,
12815,,1,,2448,BAO_0000019,,Partition coefficient of the compound,,A,,U,0,Autocuration,CHEMBL874650,,
12816,,1,,11526,BAO_0000019,,Partition coefficient of the compound,,A,,U,0,Autocuration,CHEMBL625512,,
12817,,1,,12426,BAO_0000019,,Partition coefficient of compound was determined,,A,,U,0,Autocuration,CHEMBL625513,,
12818,,1,,2448,BAO_0000019,,Partition coefficient was determined,,A,,U,0,Autocuration,CHEMBL625514,,
12819,,1,,12001,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625515,,
12820,,1,,12426,BAO_0000100,,partition coefficient of compound was determined,,P,,U,0,Autocuration,CHEMBL625516,,
12821,Canis lupus familiaris,1,,13204,BAO_0000218,,The total body administered intravenously in dog,,A,,N,1,Intermediate,CHEMBL625517,,
12822,Rattus norvegicus,1,,13204,BAO_0000218,,The total body administered intravenously in rats,,A,,N,1,Intermediate,CHEMBL625518,,
12823,Mus musculus,1,,13889,BAO_0000218,,Time taken for the administration to female NIH mice weighing 25-30 g.,,A,,N,1,Intermediate,CHEMBL625519,,
12824,,1,,13889,BAO_0000019,,Time taken for the administration,,A,,U,0,Autocuration,CHEMBL625520,,
12825,Canis lupus familiaris,1,,17025,BAO_0000218,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,A,,N,1,Intermediate,CHEMBL874651,,
12826,Simiiformes,1,,17025,BAO_0000218,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,A,,U,0,Autocuration,CHEMBL625521,,
12827,Oryctolagus cuniculus,1,,17025,BAO_0000218,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,A,,N,1,Intermediate,CHEMBL623171,,
12828,Rattus norvegicus,1,,17025,BAO_0000218,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,A,,N,1,Intermediate,CHEMBL623853,,
12829,,1,,15067,BAO_0000019,,Plasma clearance for the compound was determined.,,A,,U,0,Autocuration,CHEMBL623854,,
12830,,1,,3091,BAO_0000100,,CLog P value of the compound,,P,,U,0,Autocuration,CHEMBL874405,,
12831,,1,,15592,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL623855,,
12832,,1,,14738,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL623856,,
12833,,1,,14738,BAO_0000100,,ClogP value of the compound; nd ='no data',,P,,U,0,Autocuration,CHEMBL623857,,
12834,,1,,14738,BAO_0000100,,ClogP value of the compound; nd ='not determined',,P,,U,0,Autocuration,CHEMBL623858,,
12835,,1,,6076,BAO_0000100,,CLog P was determined,,P,,U,0,Autocuration,CHEMBL623859,,
12836,,1,,17840,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL839829,,
12837,,1,,13589,BAO_0000019,,CLogP was calculated,,A,,U,0,Autocuration,CHEMBL623860,,
12838,,1,,17655,BAO_0000019,,CLogP value was determined,,A,,U,0,Autocuration,CHEMBL623861,,
12839,,1,,5867,BAO_0000019,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,A,,U,0,Autocuration,CHEMBL623862,,
12840,,1,,5867,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL874406,,
12841,,1,,10783,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL623863,,
12842,,1,,14849,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL624021,,
12843,Canis lupus familiaris,1,1236.0,8170,BAO_0000218,,Distribution in female dog adrenal medulla 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624022,,
12844,Canis lupus familiaris,1,1236.0,8170,BAO_0000218,,Distribution in female dog adrenal medulla 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624023,,
12845,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog bile 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624024,,
12846,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog bile 72 hr after administration.,,A,,N,1,Intermediate,CHEMBL624025,,
12847,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog blood 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624026,,
12848,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog blood 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624027,,
12849,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog heart 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624028,,
12850,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog heart 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624029,,
12851,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog kidney 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624030,,
12852,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog kidney 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624031,,
12853,Canis lupus familiaris,1,160.0,8170,BAO_0000218,,Distribution in female dog large intestine 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624032,,
12854,Canis lupus familiaris,1,160.0,8170,BAO_0000218,,Distribution in female dog large intestine 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL874407,,
12855,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog liver 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624033,,
12856,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog liver 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624034,,
12857,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog lung 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624035,,
12858,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog lung 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624036,,
12859,Canis lupus familiaris,1,2385.0,8170,BAO_0000218,,Distribution in female dog muscle 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624037,,
12860,Canis lupus familiaris,1,2385.0,8170,BAO_0000218,,Distribution in female dog muscle 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624038,,
12861,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog pancreas 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624039,,
12862,Canis lupus familiaris,1,,8170,BAO_0000218,,Distribution in female dog pancreas 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624040,,
12863,Canis lupus familiaris,1,160.0,8170,BAO_0000218,,Distribution in female dog small intestine 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624041,,
12864,Canis lupus familiaris,1,160.0,8170,BAO_0000218,,Distribution in female dog small intestine 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624042,,
12865,Canis lupus familiaris,1,2106.0,8170,BAO_0000218,,Distribution in female dog spleen 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624043,,
12866,Canis lupus familiaris,1,2106.0,8170,BAO_0000218,,Distribution in female dog spleen 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624044,,
12867,Canis lupus familiaris,1,945.0,8170,BAO_0000218,,Distribution in female dog stomach 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624045,,
12868,Canis lupus familiaris,1,945.0,8170,BAO_0000218,,Distribution in female dog stomach 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624046,,
12869,Canis lupus familiaris,1,2046.0,8170,BAO_0000218,,Distribution in female dog thyroid 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL624047,,
12870,Canis lupus familiaris,1,2046.0,8170,BAO_0000218,,Distribution in female dog thyroid 72 hours after administration.,,A,,N,1,Intermediate,CHEMBL624048,,
12871,Canis lupus familiaris,1,1088.0,8170,BAO_0000218,,Distribution in female dog urine 24 hours after administration.,,A,,N,1,Intermediate,CHEMBL874408,,
12872,Canis lupus familiaris,1,1088.0,8170,BAO_0000218,,Distribution in female dog urine 72 hr after administration.,,A,,N,1,Intermediate,CHEMBL624049,,
12873,,1,1969.0,14283,BAO_0000218,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,A,,U,0,Autocuration,CHEMBL624050,,
12874,,1,,5623,BAO_0000019,,Plasma concentration at 7 hr after intravenous dosing,,A,,U,0,Autocuration,CHEMBL624051,,
12875,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,A,,N,1,Intermediate,CHEMBL623278,,
12876,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,A,,N,1,Intermediate,CHEMBL623279,,
12877,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,A,,N,1,Intermediate,CHEMBL623280,,
12878,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,A,,N,1,Intermediate,CHEMBL623963,,
12879,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,A,,N,1,Intermediate,CHEMBL623964,,
12880,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,A,,N,1,Intermediate,CHEMBL623965,,
12881,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,A,,N,1,Intermediate,CHEMBL623966,,
12882,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,A,,N,1,Intermediate,CHEMBL874415,,
12883,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,A,,N,1,Intermediate,CHEMBL623967,,
12884,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,A,,N,1,Intermediate,CHEMBL623968,,
12885,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,A,,N,1,Intermediate,CHEMBL623969,,
12886,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,A,,N,1,Intermediate,CHEMBL628409,,
12887,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,A,,N,1,Intermediate,CHEMBL628410,,
12888,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,A,,N,1,Intermediate,CHEMBL628411,,
12889,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,A,,N,1,Intermediate,CHEMBL628412,,
12890,,1,,12553,BAO_0000019,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,A,,U,0,Autocuration,CHEMBL628413,,
12891,,1,1969.0,14548,BAO_0000019,,The concentration in plasmat; Not determined,,A,,U,0,Autocuration,CHEMBL628414,,
12892,Rattus norvegicus,1,,14393,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in blood,,A,,N,1,Intermediate,CHEMBL628415,,
12893,Rattus norvegicus,1,,14393,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,A,,N,1,Intermediate,CHEMBL628416,,
12894,Rattus norvegicus,1,,14393,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in heart,,A,,N,1,Intermediate,CHEMBL628417,,
12895,Rattus norvegicus,1,2107.0,14393,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in liver,,A,,N,1,Intermediate,CHEMBL874908,,
12896,Rattus norvegicus,1,,14393,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in plasma,,A,,N,1,Intermediate,CHEMBL628418,,
12897,Rattus norvegicus,1,2385.0,14393,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,A,,N,1,Intermediate,CHEMBL628419,,
12898,Rattus norvegicus,1,,14393,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,A,,N,1,Intermediate,CHEMBL628420,,
12899,,1,,1629,BAO_0000019,,Water solubility at 37 degree C.,,A,,U,0,Autocuration,CHEMBL628421,,
12900,,1,,8194,BAO_0000100,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,P,,U,0,Autocuration,CHEMBL626726,,
12901,,1,,8194,BAO_0000100,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,P,,U,0,Autocuration,CHEMBL626727,,
12902,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626728,,
12903,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626729,,
12904,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626730,,
12905,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626731,,
12906,Rattus norvegicus,1,178.0,8594,BAO_0000218,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626732,,
12907,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626733,,
12908,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626734,,
12909,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626735,,
12910,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL874909,,
12911,Rattus norvegicus,1,948.0,8594,BAO_0000218,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626736,,
12912,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL626737,,
12913,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL630999,,
12914,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL631000,,
12915,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL631001,,
12916,Rattus norvegicus,1,2113.0,8594,BAO_0000218,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL631002,,
12917,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL631003,,
12918,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL631004,,
12919,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL631005,,
12920,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL631006,,
12921,Rattus norvegicus,1,2107.0,8594,BAO_0000218,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL631007,,
12922,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL631008,,
12923,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL631009,,
12924,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL631010,,
12925,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL631011,,
12926,Rattus norvegicus,1,2048.0,8594,BAO_0000218,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL631012,,
12927,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL630271,,
12928,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL630272,,
12929,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL630273,,
12930,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL630274,,
12931,Rattus norvegicus,1,2046.0,8594,BAO_0000218,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL630275,,
12932,Rattus norvegicus,1,,8594,BAO_0000218,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL875782,,
12933,Rattus norvegicus,1,,8594,BAO_0000218,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL630276,,
12934,Rattus norvegicus,1,,8594,BAO_0000218,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL630277,,
12935,Rattus norvegicus,1,,8594,BAO_0000218,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL630278,,
12936,Rattus norvegicus,1,,8594,BAO_0000218,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,A,,N,1,Intermediate,CHEMBL630279,,
12937,,1,,8151,BAO_0000019,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,A,,U,0,Autocuration,CHEMBL630280,,
12938,,1,,8151,BAO_0000019,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,A,,U,0,Autocuration,CHEMBL630281,,
12939,Oryctolagus cuniculus,1,,7132,BAO_0000218,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,A,,N,1,Intermediate,CHEMBL630282,,
12940,Oryctolagus cuniculus,1,,7132,BAO_0000218,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,A,,N,1,Intermediate,CHEMBL630283,,
12941,,1,,5797,BAO_0000019,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,A,,U,0,Autocuration,CHEMBL630284,,
12942,,1,,7849,BAO_0000019,,Alkylating activity was determined,,A,,U,0,Autocuration,CHEMBL630285,,
12943,,1,,14220,BAO_0000251,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),Microsomes,A,,U,0,Autocuration,CHEMBL630286,,
12944,Oryctolagus cuniculus,1,,8650,BAO_0000218,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,A,,N,1,Intermediate,CHEMBL630069,,
12945,Oryctolagus cuniculus,1,,8650,BAO_0000218,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,A,,N,1,Intermediate,CHEMBL630070,,
12946,Oryctolagus cuniculus,1,,8650,BAO_0000218,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,A,,N,1,Intermediate,CHEMBL630071,,
12947,Oryctolagus cuniculus,1,,8650,BAO_0000218,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,A,,N,1,Intermediate,CHEMBL630072,,
12948,Oryctolagus cuniculus,1,,8650,BAO_0000218,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,A,,N,1,Intermediate,CHEMBL875110,,
12949,Rattus norvegicus,1,,7116,BAO_0000218,,Compound was tested for antidiuretic activity in rats,,A,,N,1,Intermediate,CHEMBL630073,,
12950,,1,,14131,BAO_0000019,,Compound was tested for inactivation kinetic values,,A,,U,0,Autocuration,CHEMBL630074,,
12951,,1,,7415,BAO_0000218,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,A,,U,0,Autocuration,CHEMBL630075,,
12952,,1,,13178,BAO_0000019,,Dissociation rate calculated from the first-order equation using the t1/2 value,,A,,U,0,Autocuration,CHEMBL630076,,
12953,,1,,8815,BAO_0000100,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,P,,U,0,Autocuration,CHEMBL630077,,
12954,,1,,1450,BAO_0000100,,Aqueous solubility was measured,,P,,U,0,Autocuration,CHEMBL630078,,
12955,,1,,1450,BAO_0000100,,Aqueous solubility was measured at a pH 4,,P,,U,0,Autocuration,CHEMBL630079,,
12956,,1,,1450,BAO_0000100,,Aqueous solubility (pH 7),,P,,U,0,Autocuration,CHEMBL630080,,
12957,,1,,1450,BAO_0000100,,Aqueous solubility was measured at a pH 9,,P,,U,0,Autocuration,CHEMBL630081,,
12958,,1,,12711,BAO_0000019,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,A,,U,0,Autocuration,CHEMBL630082,,
12959,,1,,12711,BAO_0000019,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,A,,U,0,Autocuration,CHEMBL630083,,
12960,,1,,12711,BAO_0000019,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,A,,U,0,Autocuration,CHEMBL630084,,
12961,,1,,15032,BAO_0000100,,Aqueous solubility of the compound,,P,,U,0,Autocuration,CHEMBL629198,,
12962,,1,,9964,BAO_0000100,,Aqueous solubility at 37 degree Celsius at pH 7.38,,P,,U,0,Autocuration,CHEMBL629199,,
12963,,1,,14962,BAO_0000100,,Aqueous solubility in pH 7.4 phosphate buffer,,P,,U,0,Autocuration,CHEMBL629200,,
12964,Canis lupus familiaris,1,,12487,BAO_0000218,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,A,,N,1,Intermediate,CHEMBL629201,,
12965,Canis lupus familiaris,1,,12487,BAO_0000218,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,A,,N,1,Intermediate,CHEMBL629202,,
12966,Homo sapiens,1,,10026,BAO_0000218,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,A,,N,1,Intermediate,CHEMBL875111,,
12967,Homo sapiens,1,,10026,BAO_0000218,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,A,,N,1,Intermediate,CHEMBL629203,,
12968,Homo sapiens,1,,10026,BAO_0000218,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,A,,N,1,Intermediate,CHEMBL629204,,
12969,Homo sapiens,1,,10026,BAO_0000218,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,A,,N,1,Intermediate,CHEMBL629205,,
12970,Homo sapiens,1,,10026,BAO_0000218,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,A,,N,1,Intermediate,CHEMBL629206,,
12971,,1,,10026,BAO_0000019,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,A,,U,0,Autocuration,CHEMBL631185,,
12972,Rattus norvegicus,1,,7415,BAO_0000218,,Compound was evaluated for the average bile flow rat in rats,,A,,N,1,Intermediate,CHEMBL631186,,
12973,Oryctolagus cuniculus,1,,17025,BAO_0000218,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,A,,N,1,Intermediate,CHEMBL631187,,
12974,Oryctolagus cuniculus,1,,17025,BAO_0000218,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,A,,N,1,Intermediate,CHEMBL631188,,
12975,,1,,10184,BAO_0000019,,Average half life period was determined,,A,,U,0,Autocuration,CHEMBL876419,,
12976,,1,,10184,BAO_0000019,,Average half life period was determined,,A,,U,0,Autocuration,CHEMBL631189,,
12977,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,A,,N,1,Intermediate,CHEMBL631190,,
12978,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,A,,N,1,Intermediate,CHEMBL631191,,
12979,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,A,,N,1,Intermediate,CHEMBL631192,,
12980,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,A,,N,1,Intermediate,CHEMBL632400,,
12981,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,A,,N,1,Intermediate,CHEMBL630564,,
12982,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,A,,N,1,Intermediate,CHEMBL630565,,
12983,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,A,,N,1,Intermediate,CHEMBL630566,,
12984,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,A,,N,1,Intermediate,CHEMBL631229,,
12985,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,A,,N,1,Intermediate,CHEMBL631230,,
12986,,1,,6030,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL876428,,
12987,,1,,6147,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL631231,,
12988,,1,,14556,BAO_0000100,,Calculated partition coefficient (clogP) (MacLogP),,P,,U,0,Autocuration,CHEMBL631232,,
12989,,1,,768,BAO_0000019,,Hydrophilicity was determined,,A,,U,0,Autocuration,CHEMBL631233,,
12990,,1,,14452,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL631234,,
12991,,1,,5237,BAO_0000019,,Increased absorption was determined,,A,,U,0,Autocuration,CHEMBL883126,,
12992,,1,,14378,BAO_0000100,,Lipophilicity value was evaluated,,P,,U,0,Autocuration,CHEMBL631235,,
12993,,1,,14418,BAO_0000100,,Log P value of the compound.,,P,,U,0,Autocuration,CHEMBL631236,,
12994,,1,,5249,BAO_0000019,,Partition coefficient of compound was determined,,A,,U,0,Autocuration,CHEMBL631237,,
12995,,1,,14621,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL631238,,
12996,,1,,12542,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL876429,,
12997,,1,,12542,BAO_0000019,,Partition coefficient was measured by medchem software; Not calculated,,A,,U,0,Autocuration,CHEMBL631414,,
12998,,1,,12542,BAO_0000100,,Partition coefficient was measured by octanol-water using standard shake-flask method,,P,,U,0,Autocuration,CHEMBL631415,,
12999,,1,,15462,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL631416,,
13000,,1,,14884,BAO_0000019,,Partition coefficient (logP),,A,,U,0,Autocuration,CHEMBL631417,,
13001,,1,,16526,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL631418,,
13002,,1,,13693,BAO_0000100,,The Octanol/Water partition coefficient CLogP,,P,,U,0,Autocuration,CHEMBL631419,,
13003,,1,,13693,BAO_0000019,,The pharmacokinetic parameter C Log p was reported,,A,,U,0,Autocuration,CHEMBL631420,,
13004,,1,,13779,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL631421,,
13005,,1,,14772,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL631422,,
13006,,1,,14393,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL631423,,
13007,Rattus norvegicus,1,1969.0,14793,BAO_0000218,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL876430,,
13008,Rattus norvegicus,1,1969.0,14793,BAO_0000218,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL631424,,
13009,Canis lupus familiaris,1,1969.0,13744,BAO_0000218,,Compound was administered intravenously in dog to evaluate plasma clearance values,,A,,N,1,Intermediate,CHEMBL631425,,
13010,Simiiformes,1,1969.0,13744,BAO_0000218,,Compound was administered intravenously in monkey to evaluate plasma clearance values,,A,,U,0,Autocuration,CHEMBL631426,,
13011,Mus musculus,1,1969.0,13744,BAO_0000218,,Compound was administered intravenously in mouse to evaluate plasma clearance values,,A,,N,1,Intermediate,CHEMBL631427,,
13012,Canis lupus familiaris,1,1969.0,13207,BAO_0000218,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,A,,N,1,Intermediate,CHEMBL631428,,
13013,Macaca mulatta,1,2107.0,5669,BAO_0000218,,Intrinsic clearance in Rhesus liver microsome,Microsomes,A,,N,1,Intermediate,CHEMBL631429,,
13014,Canis lupus familiaris,1,2107.0,5669,BAO_0000218,,Intrinsic clearance in dog liver microsome,Microsomes,A,,N,1,Intermediate,CHEMBL631430,,
13015,Rattus norvegicus,1,2107.0,5669,BAO_0000218,,Intrinsic clearance in rat liver microsome,Microsomes,A,,N,1,Intermediate,CHEMBL631431,,
13016,Macaca mulatta,1,1969.0,4853,BAO_0000218,,Low plasma clearance was calculated in rhesus monkey,,A,,N,1,Intermediate,CHEMBL631432,,
13017,Canis lupus familiaris,1,,16452,BAO_0000218,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,A,,N,1,Intermediate,CHEMBL631433,,
13018,,1,,11954,BAO_0000218,,Plasma clearance after intravenous dose of 0.3 mg/kg,,A,,U,0,Autocuration,CHEMBL631434,,
13019,,1,,11954,BAO_0000218,,Plasma clearance after intravenous dose of 1 mg/kg,,A,,U,0,Autocuration,CHEMBL631435,,
13020,,1,,11954,BAO_0000218,,Plasma clearance after intravenous dose of 3 mg/kg,,A,,U,0,Autocuration,CHEMBL631436,,
13021,,1,,11954,BAO_0000218,,Plasma clearance after intravenous dose of 3.87 mg/kg,,A,,U,0,Autocuration,CHEMBL631437,,
13022,Rattus norvegicus,1,,5669,BAO_0000218,,Plasma clearance after peroral administration at 10 mpk in Rat,,A,,N,1,Intermediate,CHEMBL631438,,
13023,Macaca mulatta,1,,5669,BAO_0000218,,Plasma clearance after peroral administration at 10 mpk in Rhesus,,A,,N,1,Intermediate,CHEMBL876431,,
13024,Canis lupus familiaris,1,,5669,BAO_0000218,,Plasma clearance after peroral administration at 10 mpk in dog,,A,,N,1,Intermediate,CHEMBL631439,,
13025,Rattus norvegicus,1,,13662,BAO_0000218,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,A,,N,1,Intermediate,CHEMBL631440,,
13026,,1,,8272,BAO_0000019,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,A,,U,0,Autocuration,CHEMBL631441,,
13027,,1,,13410,BAO_0000019,,Critical Micellar concentration was determined,,A,,U,0,Autocuration,CHEMBL631442,,
13028,,1,,13410,BAO_0000019,,Critical Micellar concentration of the compound. was determined,,A,,U,0,Autocuration,CHEMBL626525,,
13029,,1,,12628,BAO_0000019,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,A,,U,0,Autocuration,CHEMBL627168,,
13030,,1,,9675,BAO_0000019,,Critical micellar concentration was measured in water by the dye solubilization method,,A,,U,0,Autocuration,CHEMBL875618,,
13031,,1,,12628,BAO_0000019,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,B,,U,0,Autocuration,CHEMBL626612,,
13032,,1,,12766,BAO_0000019,,CMR value (relative to BAY K 8644),,A,,U,0,Autocuration,CHEMBL626613,,
13033,,1,,7849,BAO_0000019,,Carbamoylating activity was determined,,A,,U,0,Autocuration,CHEMBL626614,,
13034,Simiiformes,1,,12187,BAO_0000218,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,A,,U,0,Autocuration,CHEMBL626615,,
13035,,1,,2040,BAO_0000019,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,A,,U,0,Autocuration,CHEMBL626616,,
13036,,1,,2040,BAO_0000019,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,A,,U,0,Autocuration,CHEMBL626617,,
13037,Canis lupus familiaris,1,1969.0,14180,BAO_0000218,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,A,,N,1,Intermediate,CHEMBL626618,,
13038,Rattus norvegicus,1,1969.0,14180,BAO_0000218,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,A,,N,1,Intermediate,CHEMBL626619,,
13039,Canis lupus familiaris,1,,14474,BAO_0000218,,"Clearance rate at 0.46 mg/kg, iv, in dogs",,A,,N,1,Intermediate,CHEMBL626620,,
13040,Rattus norvegicus,1,,14474,BAO_0000218,,"Clearance rate at 5.5 mg/kg, iv, in rat",,A,,N,1,Intermediate,CHEMBL626621,,
13041,Macaca fascicularis,1,,14548,BAO_0000218,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL626622,,
13042,Macaca fascicularis,1,,14548,BAO_0000218,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL626623,,
13043,Canis lupus familiaris,1,,14548,BAO_0000218,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL626624,,
13044,Rattus norvegicus,1,,14548,BAO_0000218,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL626625,,
13045,Rattus norvegicus,1,2107.0,6125,BAO_0000218,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,A,,N,1,Intermediate,CHEMBL626626,,
13046,,1,,6874,BAO_0000218,,Tested for the total clearance of the compound,,A,,U,0,Autocuration,CHEMBL626627,,
13047,Canis lupus familiaris,1,,15343,BAO_0000218,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,A,,N,1,Intermediate,CHEMBL626628,,
13048,,1,,6236,BAO_0000218,,Total body clearance was determined,,A,,U,0,Autocuration,CHEMBL626629,,
13049,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,A,,N,1,Intermediate,CHEMBL626630,,
13050,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,A,,N,1,Intermediate,CHEMBL626631,,
13051,,1,,8194,BAO_0000100,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,P,,U,0,Autocuration,CHEMBL626632,,
13052,,1,,8194,BAO_0000100,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,P,,U,0,Autocuration,CHEMBL626633,,
13053,,1,,8194,BAO_0000100,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,P,,U,0,Autocuration,CHEMBL626634,,
13054,,1,,8194,BAO_0000100,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,P,,U,0,Autocuration,CHEMBL626635,,
13055,,1,,8194,BAO_0000100,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,P,,U,0,Autocuration,CHEMBL626636,,
13056,,1,,8194,BAO_0000100,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,P,,U,0,Autocuration,CHEMBL626637,,
13057,Pneumocystis carinii,1,,13273,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,A,,N,1,Intermediate,CHEMBL626638,,
13058,Pneumocystis carinii,1,,13273,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,A,,N,1,Intermediate,CHEMBL626639,,
13059,Pneumocystis carinii,1,,13273,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,A,,N,1,Intermediate,CHEMBL626640,,
13060,Pneumocystis carinii,1,,13273,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,A,,N,1,Intermediate,CHEMBL626641,,
13061,Pneumocystis carinii,1,,13273,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,A,,N,1,Intermediate,CHEMBL627272,,
13062,Pneumocystis carinii,1,,13273,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,A,,N,1,Intermediate,CHEMBL627273,,
13063,Pneumocystis carinii,1,,13273,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,A,,N,1,Intermediate,CHEMBL627441,,
13064,Pneumocystis carinii,1,,13273,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,A,,N,1,Intermediate,CHEMBL628355,,
13065,Pneumocystis carinii,1,,13273,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,A,,N,1,Intermediate,CHEMBL628356,,
13066,Pneumocystis carinii,1,,13273,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,A,,N,1,Intermediate,CHEMBL628357,,
13067,Pneumocystis carinii,1,,13273,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,A,,N,1,Intermediate,CHEMBL628358,,
13068,Pneumocystis carinii,1,,13273,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,A,,N,1,Intermediate,CHEMBL622307,,
13069,,1,,13118,BAO_0000019,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,A,,U,0,Autocuration,CHEMBL622527,,
13070,,1,,13118,BAO_0000019,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,A,,U,0,Autocuration,CHEMBL622528,,
13071,,1,,13118,BAO_0000019,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,A,,U,0,Autocuration,CHEMBL622529,,
13072,,1,,13118,BAO_0000019,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,A,,U,0,Autocuration,CHEMBL622992,,
13073,,1,,13118,BAO_0000019,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,A,,U,0,Autocuration,CHEMBL622993,,
13074,,1,,13118,BAO_0000019,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,A,,U,0,Autocuration,CHEMBL622994,,
13075,Rattus norvegicus,1,,10633,BAO_0000218,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,A,,N,1,Intermediate,CHEMBL622995,,
13076,Rattus norvegicus,1,,10633,BAO_0000218,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,A,,N,1,Intermediate,CHEMBL622996,,
13077,Rattus norvegicus,1,,10633,BAO_0000218,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,A,,N,1,Intermediate,CHEMBL622997,,
13078,Rattus norvegicus,1,,10633,BAO_0000218,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,A,,N,1,Intermediate,CHEMBL622998,,
13079,,1,,5767,BAO_0000218,,Cp max following ip administration at 1 mg/kg,,A,,U,0,Autocuration,CHEMBL622999,,
13080,,1,1969.0,3302,BAO_0000218,,Maximum concentration in plasma was reported at 0.5 hour,,A,,U,0,Autocuration,CHEMBL623000,,
13081,,1,1969.0,3302,BAO_0000218,,Maximum concentration in plasma was reported at 2 hour,,A,,U,0,Autocuration,CHEMBL623001,,
13082,Mus musculus,1,,12467,BAO_0000218,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,A,,N,1,Intermediate,CHEMBL623002,,
13083,,1,,11778,BAO_0000100,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,P,,U,0,Autocuration,CHEMBL623003,,
13084,,1,,4321,BAO_0000019,,Steady state concentration was evaluated,,A,,U,0,Autocuration,CHEMBL623004,,
13085,,1,,14884,BAO_0000019,,Partition coefficient (logP),,A,,U,0,Autocuration,CHEMBL623005,,
13086,,1,,15234,BAO_0000019,,Partition coefficient (logD7.4),,A,,U,0,Autocuration,CHEMBL623006,,
13087,Rattus norvegicus,1,2107.0,14198,BAO_0000218,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,A,,N,1,Intermediate,CHEMBL623007,,
13088,Rattus norvegicus,1,10000001.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,A,,N,1,Intermediate,CHEMBL623008,,
13089,Rattus norvegicus,1,2037.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,A,,N,1,Intermediate,CHEMBL876654,,
13090,Rattus norvegicus,1,,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,A,,N,1,Intermediate,CHEMBL623009,,
13091,Rattus norvegicus,1,,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,A,,N,1,Intermediate,CHEMBL623010,,
13092,Rattus norvegicus,1,948.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,A,,N,1,Intermediate,CHEMBL623011,,
13093,Rattus norvegicus,1,160.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,A,,N,1,Intermediate,CHEMBL623012,,
13094,,1,,8151,BAO_0000019,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,A,,U,0,Autocuration,CHEMBL623013,,
13095,,1,,8151,BAO_0000019,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,A,,U,0,Autocuration,CHEMBL623014,,
13096,,1,1088.0,8151,BAO_0000019,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,A,,U,0,Autocuration,CHEMBL623015,,
13097,,1,1088.0,8151,BAO_0000019,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,A,,U,0,Autocuration,CHEMBL623016,,
13098,,1,1088.0,8151,BAO_0000019,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,A,,U,0,Autocuration,CHEMBL624858,,
13099,Rattus norvegicus,1,,8151,BAO_0000218,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,A,,N,1,Intermediate,CHEMBL624859,,
13100,Rattus norvegicus,1,,8151,BAO_0000218,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,A,,N,1,Intermediate,CHEMBL624860,,
13101,Rattus norvegicus,1,,8151,BAO_0000218,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,A,,N,1,Intermediate,CHEMBL624861,,
13102,Rattus norvegicus,1,,8151,BAO_0000218,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,A,,N,1,Intermediate,CHEMBL624862,,
13103,Rattus norvegicus,1,,8151,BAO_0000218,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,A,,N,1,Intermediate,CHEMBL624863,,
13104,Rattus norvegicus,1,,8151,BAO_0000218,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,A,,N,1,Intermediate,CHEMBL876655,,
13105,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,A,,N,1,Intermediate,CHEMBL624864,,
13106,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,A,,N,1,Intermediate,CHEMBL624865,,
13107,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,A,,N,1,Intermediate,CHEMBL624866,,
13108,Canis lupus familiaris,1,,6996,BAO_0000218,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,F,,N,1,Expert,CHEMBL624867,,
13109,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,A,,N,1,Intermediate,CHEMBL624868,,
13110,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,A,,N,1,Intermediate,CHEMBL628450,,
13111,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,A,,N,1,Intermediate,CHEMBL628451,,
13112,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,A,,N,1,Intermediate,CHEMBL628452,,
13113,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,A,,N,1,Intermediate,CHEMBL628453,,
13114,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,A,,N,1,Intermediate,CHEMBL628454,,
13115,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,A,,N,1,Intermediate,CHEMBL628455,,
13116,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,A,,N,1,Intermediate,CHEMBL628456,,
13117,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,A,,N,1,Intermediate,CHEMBL628457,,
13118,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,A,,N,1,Intermediate,CHEMBL877505,,
13119,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,A,,N,1,Intermediate,CHEMBL628458,,
13120,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,A,,N,1,Intermediate,CHEMBL628459,,
13121,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,A,,N,1,Intermediate,CHEMBL628460,,
13122,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,A,,N,1,Intermediate,CHEMBL628461,,
13123,,1,,6996,BAO_0000218,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,B,,U,0,Autocuration,CHEMBL628462,,
13124,Canis lupus familiaris,1,,6996,BAO_0000218,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,A,,N,1,Intermediate,CHEMBL628463,,
13125,Rattus norvegicus,1,,6996,BAO_0000218,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,F,,N,1,Expert,CHEMBL625666,,
13126,,1,,6996,BAO_0000218,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,B,,U,0,Autocuration,CHEMBL625667,,
13127,Rattus norvegicus,1,,6996,BAO_0000218,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,A,,N,1,Expert,CHEMBL625668,,
13128,Rattus norvegicus,1,,6996,BAO_0000218,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,A,,N,1,Intermediate,CHEMBL625669,,
13129,,1,,7114,BAO_0000019,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,A,,U,0,Autocuration,CHEMBL625670,,
13130,Rattus norvegicus,1,,7114,BAO_0000218,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,A,,N,1,Intermediate,CHEMBL625671,,
13131,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,A,,N,1,Intermediate,CHEMBL625672,,
13132,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,A,,N,1,Intermediate,CHEMBL625673,,
13133,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,A,,N,1,Intermediate,CHEMBL625674,,
13134,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,A,,N,1,Intermediate,CHEMBL625675,,
13135,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,A,,N,1,Intermediate,CHEMBL627637,,
13136,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,A,,N,1,Intermediate,CHEMBL627638,,
13137,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,A,,N,1,Intermediate,CHEMBL627639,,
13138,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,A,,N,1,Intermediate,CHEMBL627640,,
13139,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,A,,N,1,Intermediate,CHEMBL627641,,
13140,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,A,,N,1,Intermediate,CHEMBL627642,,
13141,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,A,,N,1,Intermediate,CHEMBL877506,,
13142,Mus musculus,1,,8613,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,A,,N,1,Intermediate,CHEMBL627275,,
13143,Mustela putorius furo,1,,11219,BAO_0000218,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,A,,N,1,Intermediate,CHEMBL627643,,
13144,Mustela putorius furo,1,,11219,BAO_0000218,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,A,,N,1,Intermediate,CHEMBL631246,,
13145,Mustela putorius furo,1,,11219,BAO_0000218,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,A,,N,1,Intermediate,CHEMBL631247,,
13146,Mustela putorius furo,1,,11219,BAO_0000218,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,A,,N,1,Intermediate,CHEMBL629532,,
13147,Mustela putorius furo,1,,11219,BAO_0000218,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,A,,N,1,Intermediate,CHEMBL629533,,
13148,Mustela putorius furo,1,,11219,BAO_0000218,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,A,,N,1,Intermediate,CHEMBL629534,,
13149,Mustela putorius furo,1,,11219,BAO_0000218,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,A,,N,1,Intermediate,CHEMBL629535,,
13150,,1,,14837,BAO_0000019,,Pharmacokinetic parameter :drug bound to plasma was reported,,A,,U,0,Autocuration,CHEMBL625932,,
13151,,1,,14837,BAO_0000019,,compound was evaluated for drug bound in plasma,,A,,U,0,Autocuration,CHEMBL625933,,
13152,Rattus norvegicus,1,,15343,BAO_0000218,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,A,,N,1,Intermediate,CHEMBL625934,,
13153,Eutheria,1,,13761,BAO_0000218,,Bioavailability,,A,,U,0,Autocuration,CHEMBL625935,,
13154,Rattus norvegicus,1,,14810,BAO_0000218,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,A,,N,1,Intermediate,CHEMBL625936,,
13155,Rattus norvegicus,1,,14810,BAO_0000218,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,A,,N,1,Intermediate,CHEMBL625937,,
13156,Canis lupus familiaris,1,,13249,BAO_0000218,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,A,,N,1,Intermediate,CHEMBL625938,,
13157,Rattus norvegicus,1,1970.0,9267,BAO_0000218,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,A,,N,1,Intermediate,CHEMBL625939,,
13158,Rattus norvegicus,1,1970.0,9267,BAO_0000218,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,A,,N,1,Intermediate,CHEMBL625940,,
13159,Rattus norvegicus,1,1970.0,9267,BAO_0000218,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,A,,N,1,Intermediate,CHEMBL874464,,
13160,Rattus norvegicus,1,1970.0,9267,BAO_0000218,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,A,,N,1,Intermediate,CHEMBL625941,,
13161,Rattus norvegicus,1,1970.0,9267,BAO_0000218,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,A,,N,1,Intermediate,CHEMBL625942,,
13162,Rattus norvegicus,1,1970.0,9267,BAO_0000218,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,A,,N,1,Intermediate,CHEMBL625943,,
13163,Homo sapiens,1,1977.0,15549,BAO_0000218,,In vitro protein binding in human serum at 5 ug/ml,,A,,N,1,Intermediate,CHEMBL625944,,
13164,,1,,10929,BAO_0000019,,Serum protein binding ability was measured,,A,,U,0,Autocuration,CHEMBL625945,,
13165,,1,,15444,BAO_0000019,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,A,,U,0,Autocuration,CHEMBL625946,,
13166,Canis lupus familiaris,1,,12860,BAO_0000218,,Oral bioavailability in dog,,A,,U,0,Autocuration,CHEMBL625947,,
13167,Rattus norvegicus,1,,12170,BAO_0000218,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,A,,N,1,Intermediate,CHEMBL625948,,
13168,,1,,15173,BAO_0000218,,Absolute oral bioavailability at an iv dose of 14 mg/kg,,A,,U,0,Autocuration,CHEMBL625949,,
13169,,1,,15173,BAO_0000218,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,A,,U,0,Autocuration,CHEMBL625950,,
13170,Eutheria,1,,15173,BAO_0000218,,Oral bioavailability (dose 15 mg/kg i.v.),,A,,U,0,Autocuration,CHEMBL625951,,
13171,,1,,15173,BAO_0000218,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,A,,U,0,Autocuration,CHEMBL625952,,
13172,,1,,15173,BAO_0000218,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,A,,U,0,Autocuration,CHEMBL625953,,
13173,,1,,15173,BAO_0000218,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,A,,U,0,Autocuration,CHEMBL625954,,
13174,,1,,15173,BAO_0000218,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,A,,U,0,Autocuration,CHEMBL882959,,
13175,Canis lupus familiaris,1,,11767,BAO_0000218,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,A,,N,1,Intermediate,CHEMBL625955,,
13176,Mustela putorius furo,1,,11219,BAO_0000218,,Bioavailability in ferret,,A,,U,0,Autocuration,CHEMBL625956,,
13177,Macaca fascicularis,1,,12186,BAO_0000218,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,A,,N,1,Intermediate,CHEMBL625957,,
13178,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,A,,N,1,Intermediate,CHEMBL625958,,
13179,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,A,,N,1,Intermediate,CHEMBL625959,,
13180,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,A,,N,1,Intermediate,CHEMBL626642,,
13181,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,A,,N,1,Intermediate,CHEMBL631330,,
13182,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,A,,N,1,Intermediate,CHEMBL631331,,
13183,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,A,,N,1,Intermediate,CHEMBL631332,,
13184,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,A,,N,1,Intermediate,CHEMBL631333,,
13185,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,A,,N,1,Intermediate,CHEMBL632018,,
13186,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,A,,N,1,Intermediate,CHEMBL632019,,
13187,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,A,,N,1,Intermediate,CHEMBL632020,,
13188,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,A,,N,1,Intermediate,CHEMBL632021,,
13189,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,A,,N,1,Intermediate,CHEMBL632022,,
13190,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,A,,N,1,Intermediate,CHEMBL632023,,
13191,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,A,,N,1,Intermediate,CHEMBL632024,,
13192,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,A,,N,1,Intermediate,CHEMBL874472,,
13193,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,A,,N,1,Intermediate,CHEMBL632025,,
13194,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,A,,N,1,Intermediate,CHEMBL632026,,
13195,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,A,,N,1,Intermediate,CHEMBL632027,,
13196,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,A,,N,1,Intermediate,CHEMBL632028,,
13197,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,A,,N,1,Intermediate,CHEMBL626430,,
13198,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,A,,N,1,Intermediate,CHEMBL626431,,
13199,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,A,,N,1,Intermediate,CHEMBL626432,,
13200,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,A,,N,1,Intermediate,CHEMBL626433,,
13201,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,A,,N,1,Intermediate,CHEMBL626434,,
13202,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,A,,N,1,Intermediate,CHEMBL627280,,
13203,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,A,,N,1,Intermediate,CHEMBL627281,,
13204,Rattus norvegicus,1,,11510,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,A,,N,1,Intermediate,CHEMBL627282,,
13205,,1,,7199,BAO_0000019,,Total body clearance was measured at given dose,,A,,U,0,Autocuration,CHEMBL627283,,
13206,,1,,7199,BAO_0000218,,Total body clearance was measured at given dose.,,A,,U,0,Autocuration,CHEMBL627284,,
13207,Rattus norvegicus,1,,7095,BAO_0000218,,Metabolic clearance from the body in rat,,A,,N,1,Intermediate,CHEMBL627285,,
13208,,1,,7095,BAO_0000218,,Renal clearance from the body,,A,,U,0,Autocuration,CHEMBL627286,,
13209,Rattus norvegicus,1,,7095,BAO_0000218,,Renal clearance from the body in rat,,A,,N,1,Intermediate,CHEMBL875477,,
13210,Rattus norvegicus,1,,12528,BAO_0000218,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL627287,,
13211,Canis lupus familiaris,1,,12528,BAO_0000218,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,A,,N,1,Intermediate,CHEMBL627288,,
13212,Rattus norvegicus,1,,7095,BAO_0000218,,Total clearance from the body in rat,,A,,N,1,Intermediate,CHEMBL627289,,
13213,Rattus norvegicus,1,1969.0,14223,BAO_0000218,,Clearance into cortex from rat plasma or PBS,,A,,N,1,Intermediate,CHEMBL627290,,
13214,,1,,13569,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,A,,U,0,Autocuration,CHEMBL627291,,
13215,,1,,13569,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,A,,U,0,Autocuration,CHEMBL627292,,
13216,,1,,13569,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,A,,U,0,Autocuration,CHEMBL627293,,
13217,,1,,13569,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,A,,U,0,Autocuration,CHEMBL627294,,
13218,,1,,13569,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,A,,U,0,Autocuration,CHEMBL875478,,
13219,,1,,13979,BAO_0000218,,Clearance was determined,,A,,U,0,Autocuration,CHEMBL627295,,
13220,Mus musculus,1,,14315,BAO_0000218,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,A,,N,1,Intermediate,CHEMBL627296,,
13221,Oryctolagus cuniculus,1,,14315,BAO_0000218,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,A,,N,1,Intermediate,CHEMBL626119,,
13222,Rattus norvegicus,1,,14315,BAO_0000218,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,A,,N,1,Intermediate,CHEMBL626120,,
13223,Rattus norvegicus,1,,12174,BAO_0000218,,Clearance in rat after iv dose (100 ug/kg),,A,,N,1,Intermediate,CHEMBL626121,,
13224,Cavia porcellus,1,,12797,BAO_0000218,,Clearance in guinea pig,,A,,U,0,Autocuration,CHEMBL626122,,
13225,Rattus norvegicus,1,,12797,BAO_0000218,,Compound was evaluated for clearance in rat,,A,,N,1,Intermediate,CHEMBL626123,,
13226,Canis lupus familiaris,1,,12797,BAO_0000218,,Compound was evaluated for the clearance in dog,,A,,N,1,Intermediate,CHEMBL623456,,
13227,Rattus norvegicus,1,,12797,BAO_0000218,,Compound was evaluated for the clearance in rat,,A,,N,1,Intermediate,CHEMBL623457,,
13228,Rattus norvegicus,1,,11500,BAO_0000218,,Compound was tested in vivo for clearance after iv administration in the rat,,A,,N,1,Intermediate,CHEMBL623458,,
13229,,1,,15173,BAO_0000218,,IV clearance determined at an iv dose of 14 mg/kg,,A,,U,0,Autocuration,CHEMBL623459,,
13230,,1,,15173,BAO_0000218,,IV clearance determined at an iv dose of 15.2 mg/kg,,A,,U,0,Autocuration,CHEMBL875484,,
13231,,1,,15173,BAO_0000218,,IV clearance determined at an iv dose of 15 mg/kg,,A,,U,0,Autocuration,CHEMBL623460,,
13232,,1,,15173,BAO_0000218,,IV clearance determined at an peroral dose of 30 mg/kg.,,A,,U,0,Autocuration,CHEMBL623461,,
13233,,1,,15173,BAO_0000218,,IV clearance determined at an peroral dose of 30.2 mg/kg.,,A,,U,0,Autocuration,CHEMBL623462,,
13234,,1,,15173,BAO_0000218,,IV clearance determined at an peroral dose of 30.3 mg/kg.,,A,,U,0,Autocuration,CHEMBL627386,,
13235,Rattus norvegicus,1,2113.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,A,,N,1,Intermediate,CHEMBL627387,,
13236,Rattus norvegicus,1,2107.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,A,,N,1,Intermediate,CHEMBL627388,,
13237,Rattus norvegicus,1,2048.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,A,,N,1,Intermediate,CHEMBL627389,,
13238,Rattus norvegicus,1,2385.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,A,,N,1,Intermediate,CHEMBL627390,,
13239,Rattus norvegicus,1,1969.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,A,,N,1,Intermediate,CHEMBL627391,,
13240,Rattus norvegicus,1,,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,A,,N,1,Intermediate,CHEMBL627392,,
13241,Rattus norvegicus,1,2106.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,A,,N,1,Intermediate,CHEMBL627393,,
13242,Rattus norvegicus,1,3126.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,A,,N,1,Intermediate,CHEMBL627394,,
13243,Rattus norvegicus,1,10000001.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,A,,N,1,Intermediate,CHEMBL627395,,
13244,Rattus norvegicus,1,2037.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,A,,N,1,Intermediate,CHEMBL875485,,
13245,Rattus norvegicus,1,,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,A,,N,1,Intermediate,CHEMBL627396,,
13246,Rattus norvegicus,1,,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,A,,N,1,Intermediate,CHEMBL627397,,
13247,Rattus norvegicus,1,948.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,A,,N,1,Intermediate,CHEMBL627398,,
13248,Rattus norvegicus,1,10000001.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,A,,N,1,Intermediate,CHEMBL627399,,
13249,Rattus norvegicus,1,2113.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,A,,N,1,Intermediate,CHEMBL627400,,
13250,Rattus norvegicus,1,2107.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,A,,N,1,Intermediate,CHEMBL627401,,
13251,Rattus norvegicus,1,2048.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,A,,N,1,Intermediate,CHEMBL627402,,
13252,Rattus norvegicus,1,2385.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,A,,N,1,Intermediate,CHEMBL627403,,
13253,Rattus norvegicus,1,1969.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,A,,N,1,Intermediate,CHEMBL627404,,
13254,Rattus norvegicus,1,,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,A,,N,1,Intermediate,CHEMBL623101,,
13255,Rattus norvegicus,1,2106.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,A,,N,1,Intermediate,CHEMBL877480,,
13256,Rattus norvegicus,1,3126.0,14198,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,A,,N,1,Intermediate,CHEMBL623102,,
13257,Rattus norvegicus,1,10000001.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,A,,N,1,Intermediate,CHEMBL623103,,
13258,Rattus norvegicus,1,2037.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,A,,N,1,Intermediate,CHEMBL623104,,
13259,Rattus norvegicus,1,,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,A,,N,1,Intermediate,CHEMBL623105,,
13260,Rattus norvegicus,1,,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,A,,N,1,Intermediate,CHEMBL623106,,
13261,Rattus norvegicus,1,948.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,A,,N,1,Intermediate,CHEMBL623107,,
13262,Rattus norvegicus,1,160.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,A,,N,1,Intermediate,CHEMBL623108,,
13263,Rattus norvegicus,1,2113.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,A,,N,1,Intermediate,CHEMBL623109,,
13264,Rattus norvegicus,1,2107.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,A,,N,1,Intermediate,CHEMBL623110,,
13265,Rattus norvegicus,1,2048.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,A,,N,1,Intermediate,CHEMBL623111,,
13266,Rattus norvegicus,1,2385.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,A,,N,1,Intermediate,CHEMBL625060,,
13267,Rattus norvegicus,1,1969.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,A,,N,1,Intermediate,CHEMBL625061,,
13268,Rattus norvegicus,1,,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,A,,N,1,Intermediate,CHEMBL625062,,
13269,Rattus norvegicus,1,2106.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,A,,N,1,Intermediate,CHEMBL625063,,
13270,Rattus norvegicus,1,3126.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,A,,N,1,Intermediate,CHEMBL625064,,
13271,Rattus norvegicus,1,10000001.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,A,,N,1,Intermediate,CHEMBL625065,,
13272,Rattus norvegicus,1,2037.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,A,,N,1,Intermediate,CHEMBL625066,,
13273,Rattus norvegicus,1,,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,A,,N,1,Intermediate,CHEMBL625067,,
13274,Rattus norvegicus,1,,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,A,,N,1,Intermediate,CHEMBL625068,,
13275,Rattus norvegicus,1,948.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,A,,N,1,Intermediate,CHEMBL622159,,
13276,Rattus norvegicus,1,160.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,A,,N,1,Intermediate,CHEMBL622160,,
13277,Rattus norvegicus,1,2113.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,A,,N,1,Intermediate,CHEMBL622161,,
13278,Rattus norvegicus,1,2048.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,A,,N,1,Intermediate,CHEMBL622162,,
13279,Rattus norvegicus,1,2385.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,A,,N,1,Intermediate,CHEMBL622163,,
13280,Rattus norvegicus,1,1969.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,A,,N,1,Intermediate,CHEMBL622313,,
13281,Rattus norvegicus,1,,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,A,,N,1,Intermediate,CHEMBL622314,,
13282,Rattus norvegicus,1,2106.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,A,,N,1,Intermediate,CHEMBL622315,,
13283,Rattus norvegicus,1,3126.0,14198,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,A,,N,1,Intermediate,CHEMBL622316,,
13284,Escherichia coli,1,,15599,BAO_0000218,,Normal diffusion coefficient in water for Escherichia coli,,A,,N,1,Intermediate,CHEMBL877486,,
13285,,1,,8204,BAO_0000019,,Average max percent decrease in RVR (renal vascular resistance) was determined,,A,,U,0,Autocuration,CHEMBL622317,,
13286,,1,,8204,BAO_0000019,,Average max percent decrease in RVR (renal vascular resistance) was determined.,,A,,U,0,Autocuration,CHEMBL622318,,
13287,,1,,6154,BAO_0000019,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,A,,U,0,Autocuration,CHEMBL622319,,
13288,,1,,6154,BAO_0000019,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,A,,U,0,Autocuration,CHEMBL622320,,
13289,,1,,6154,BAO_0000019,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,A,,U,0,Autocuration,CHEMBL622321,,
13290,,1,,6154,BAO_0000019,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,A,,U,0,Autocuration,CHEMBL622322,,
13291,,1,,7114,BAO_0000019,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,A,,U,0,Autocuration,CHEMBL622323,,
13292,Rattus norvegicus,1,,7114,BAO_0000218,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,A,,N,1,Intermediate,CHEMBL622324,,
13293,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,A,,N,1,Intermediate,CHEMBL622325,,
13294,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,A,,N,1,Intermediate,CHEMBL622326,,
13295,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,A,,N,1,Intermediate,CHEMBL877487,,
13296,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,A,,N,1,Intermediate,CHEMBL622327,,
13297,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,A,,N,1,Intermediate,CHEMBL622328,,
13298,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,A,,N,1,Intermediate,CHEMBL622329,,
13299,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,A,,N,1,Intermediate,CHEMBL622330,,
13300,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,A,,N,1,Intermediate,CHEMBL622331,,
13301,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,A,,N,1,Intermediate,CHEMBL622332,,
13302,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,A,,N,1,Intermediate,CHEMBL622333,,
13303,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,A,,U,0,Autocuration,CHEMBL627658,,
13304,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,A,,U,0,Autocuration,CHEMBL630428,,
13305,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,A,,U,0,Autocuration,CHEMBL630429,,
13306,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,A,,U,0,Autocuration,CHEMBL630430,,
13307,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,A,,U,0,Autocuration,CHEMBL630431,,
13308,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,A,,N,1,Intermediate,CHEMBL630432,,
13309,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,A,,N,1,Intermediate,CHEMBL630433,,
13310,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,A,,N,1,Intermediate,CHEMBL630434,,
13311,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,A,,N,1,Intermediate,CHEMBL629372,,
13312,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,A,,N,1,Intermediate,CHEMBL629553,,
13313,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,A,,N,1,Intermediate,CHEMBL629554,,
13314,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,A,,N,1,Intermediate,CHEMBL874447,,
13315,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,A,,N,1,Intermediate,CHEMBL629555,,
13316,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,A,,N,1,Intermediate,CHEMBL629556,,
13317,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,A,,N,1,Intermediate,CHEMBL629557,,
13318,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,A,,N,1,Intermediate,CHEMBL629558,,
13319,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,A,,N,1,Intermediate,CHEMBL629559,,
13320,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,A,,N,1,Intermediate,CHEMBL629560,,
13321,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,A,,N,1,Intermediate,CHEMBL629561,,
13322,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,A,,N,1,Intermediate,CHEMBL629562,,
13323,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,A,,N,1,Intermediate,CHEMBL629563,,
13324,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,A,,N,1,Intermediate,CHEMBL629564,,
13325,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,A,,N,1,Intermediate,CHEMBL629565,,
13326,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,A,,N,1,Intermediate,CHEMBL629566,,
13327,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,A,,N,1,Intermediate,CHEMBL629567,,
13328,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,A,,N,1,Intermediate,CHEMBL629568,,
13329,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,A,,N,1,Intermediate,CHEMBL629569,,
13330,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,A,,N,1,Intermediate,CHEMBL629570,,
13331,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,A,,U,0,Autocuration,CHEMBL629571,,
13332,Rattus norvegicus,1,,12170,BAO_0000218,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,A,,U,0,Autocuration,CHEMBL629572,,
13333,Rattus norvegicus,1,,12170,BAO_0000218,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,A,,U,0,Autocuration,CHEMBL629573,,
13334,Eutheria,1,,4985,BAO_0000218,,Bioavailability (dose 20 mg/kg),,A,,U,0,Autocuration,CHEMBL629574,,
13335,Canis lupus familiaris,1,,15145,BAO_0000218,,Bioavailability in dog,,A,,U,0,Autocuration,CHEMBL629575,,
13336,Rattus norvegicus,1,,14080,BAO_0000218,,Bioavailability in rat (Sprague-Dawley) (male),,A,,U,0,Autocuration,CHEMBL874448,,
13337,Primates,1,,11219,BAO_0000218,,Bioavailability in monkey (dose 10 mg/kg i.d.),,A,,U,0,Autocuration,CHEMBL629576,,
13338,Rattus norvegicus,1,,15145,BAO_0000218,,Bioavailability in rat,,A,,U,0,Autocuration,CHEMBL629577,,
13339,Rattus norvegicus,1,,15145,BAO_0000218,,Bioavailability in rat,,A,,U,0,Autocuration,CHEMBL629578,,
13340,Canis lupus familiaris,1,,1202,BAO_0000218,,Bioavailability in dog (dose 3.0 mg/kg p.o.),,A,,U,0,Autocuration,CHEMBL629579,,
13341,Canis lupus familiaris,1,,1202,BAO_0000218,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,A,,U,0,Autocuration,CHEMBL882958,,
13342,Pan troglodytes,1,,1202,BAO_0000218,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,A,,N,1,Intermediate,CHEMBL629580,,
13343,Eutheria,1,,4026,BAO_0000218,,Bioavailability,,A,,U,0,Autocuration,CHEMBL629581,,
13344,Saimiri,1,,1492,BAO_0000218,,Bioavailability in squirrel monkey,,A,,U,0,Autocuration,CHEMBL629582,,
13345,Canis lupus familiaris,1,,12793,BAO_0000218,,Bioavailability was evaluated in dog,,A,,N,1,Intermediate,CHEMBL628522,,
13346,Cricetinae,1,,12793,BAO_0000218,,Bioavailability was evaluated in hamster,,A,,N,1,Intermediate,CHEMBL625432,,
13347,Rattus norvegicus,1,,12793,BAO_0000218,,Bioavailability in rat,,A,,U,0,Autocuration,CHEMBL625433,,
13348,Rattus norvegicus,1,1969.0,14793,BAO_0000218,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL625434,,
13349,Rattus norvegicus,1,1969.0,14793,BAO_0000218,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,A,,N,1,Intermediate,CHEMBL625435,,
13350,Rattus norvegicus,1,,14793,BAO_0000218,,Bioavailability in rat (dose 10 mg/kg p.o.),,A,,U,0,Autocuration,CHEMBL625436,,
13351,Macaca fascicularis,1,,14731,BAO_0000218,,Bioavailability was measured in cynomolgus monkeys.,,A,,N,1,Intermediate,CHEMBL874588,,
13352,Mus musculus,1,,14731,BAO_0000218,,Bioavailability was measured in nude mice.,,A,,N,1,Intermediate,CHEMBL625437,,
13353,Mustela putorius furo,1,,12187,BAO_0000218,,Bioavailability in ferret (dose 10 mg/kg i.d.),,A,,U,0,Autocuration,CHEMBL625438,,
13354,Simiiformes,1,,12187,BAO_0000218,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,A,,U,0,Autocuration,CHEMBL625439,,
13355,Simiiformes,1,,12187,BAO_0000218,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,A,,U,0,Autocuration,CHEMBL625440,,
13356,Simiiformes,1,,12187,BAO_0000218,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,A,,U,0,Autocuration,CHEMBL625441,,
13357,Rattus norvegicus,1,,12187,BAO_0000218,,Bioavailability in rat (dose 10 mg/kg i.d.),,A,,U,0,Autocuration,CHEMBL625442,,
13358,Rattus norvegicus,1,,12187,BAO_0000218,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,A,,N,1,Intermediate,CHEMBL625443,,
13359,,1,,17431,BAO_0000218,,Bioavailability was determined; extremely poor,,A,,U,0,Autocuration,CHEMBL625444,,
13360,Mus musculus,1,,13318,BAO_0000218,,% bioavailability in mice after oral administration of prodrug,,A,,N,1,Intermediate,CHEMBL625445,,
13361,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,A,,N,1,Intermediate,CHEMBL625446,,
13362,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,A,,N,1,Intermediate,CHEMBL882960,,
13363,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,A,,N,1,Intermediate,CHEMBL625447,,
13364,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,A,,N,1,Intermediate,CHEMBL625448,,
13365,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,A,,N,1,Intermediate,CHEMBL625449,,
13366,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,A,,N,1,Intermediate,CHEMBL874589,,
13367,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,A,,N,1,Intermediate,CHEMBL625450,,
13368,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,A,,N,1,Intermediate,CHEMBL625451,,
13369,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,A,,N,1,Intermediate,CHEMBL626584,,
13370,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,A,,N,1,Intermediate,CHEMBL626585,,
13371,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,A,,N,1,Intermediate,CHEMBL626586,,
13372,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,A,,N,1,Intermediate,CHEMBL626587,,
13373,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,A,,N,1,Intermediate,CHEMBL626588,,
13374,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,A,,N,1,Intermediate,CHEMBL626589,,
13375,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,A,,N,1,Intermediate,CHEMBL626590,,
13376,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,A,,N,1,Intermediate,CHEMBL626591,,
13377,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,A,,N,1,Intermediate,CHEMBL627181,,
13378,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,A,,N,1,Intermediate,CHEMBL628083,,
13379,,1,,15173,BAO_0000218,,IV clearance determined at an peroral dose of 15 mg/kg.,,A,,U,0,Autocuration,CHEMBL628084,,
13380,Hymenolepis nana,1,,7732,BAO_0000218,,Mouse oral clearance was measured against Hymenolepiasis nana.,,F,,N,1,Expert,CHEMBL628085,,
13381,Heligmosomoides polygyrus,1,,7732,BAO_0000218,,Mouse oral clearance was measured against Nematospiroides dubius,,F,,N,1,Expert,CHEMBL628086,,
13382,,1,,7732,BAO_0000218,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,F,,U,0,Autocuration,CHEMBL628087,,
13383,Mus musculus,1,,7732,BAO_0000218,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,A,,N,1,Intermediate,CHEMBL628088,,
13384,,1,,7732,BAO_0000218,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,B,,U,0,Autocuration,CHEMBL628089,,
13385,,1,,8328,BAO_0000218,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,A,,U,0,Autocuration,CHEMBL628090,,
13386,,1,,8328,BAO_0000218,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,A,,U,0,Autocuration,CHEMBL628091,,
13387,,1,,8328,BAO_0000218,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,A,,U,0,Autocuration,CHEMBL628092,,
13388,,1,,8328,BAO_0000218,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,A,,U,0,Autocuration,CHEMBL628093,,
13389,,1,,8328,BAO_0000218,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,A,,U,0,Autocuration,CHEMBL875607,,
13390,,1,,8328,BAO_0000218,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,A,,U,0,Autocuration,CHEMBL625710,,
13391,,1,,8328,BAO_0000218,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,A,,U,0,Autocuration,CHEMBL625711,,
13392,,1,,8328,BAO_0000218,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,A,,U,0,Autocuration,CHEMBL625712,,
13393,,1,,8328,BAO_0000218,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,A,,U,0,Autocuration,CHEMBL625713,,
13394,Canis lupus familiaris,1,,13376,BAO_0000218,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,A,,N,1,Intermediate,CHEMBL625714,,
13395,Macaca mulatta,1,,13477,BAO_0000218,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,A,,N,1,Intermediate,CHEMBL625715,,
13396,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,A,,N,1,Intermediate,CHEMBL625716,,
13397,Rattus norvegicus,1,,13477,BAO_0000218,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,A,,N,1,Intermediate,CHEMBL625717,,
13398,Rattus norvegicus,1,,13313,BAO_0000218,,Plasma clearance was determined for the compound in rats,,A,,N,1,Intermediate,CHEMBL625718,,
13399,Rattus norvegicus,1,,12504,BAO_0000218,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,A,,N,1,Intermediate,CHEMBL625719,,
13400,Rattus norvegicus,1,,12504,BAO_0000218,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,A,,N,1,Intermediate,CHEMBL625720,,
13401,Rattus norvegicus,1,,12504,BAO_0000218,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,A,,N,1,Intermediate,CHEMBL625721,,
13402,Rattus norvegicus,1,,12504,BAO_0000218,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,A,,N,1,Intermediate,CHEMBL625722,,
13403,Rattus norvegicus,1,,13129,BAO_0000218,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,A,,N,1,Intermediate,CHEMBL625723,,
13404,Heligmosomoides polygyrus,1,,7732,BAO_0000218,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,A,,N,1,Intermediate,CHEMBL625724,,
13405,Heligmosomoides polygyrus,1,,7732,BAO_0000218,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,A,,N,1,Intermediate,CHEMBL625725,,
13406,Heligmosomoides polygyrus,1,,7732,BAO_0000218,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,A,,N,1,Intermediate,CHEMBL625726,,
13407,Heligmosomoides polygyrus,1,,7732,BAO_0000218,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,A,,N,1,Intermediate,CHEMBL875608,,
13408,Heligmosomoides polygyrus,1,,7732,BAO_0000218,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,A,,N,1,Intermediate,CHEMBL625727,,
13409,Rattus norvegicus,1,1088.0,9278,BAO_0000218,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,A,,U,0,Autocuration,CHEMBL625728,,
13410,Rattus norvegicus,1,,9278,BAO_0000218,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,A,,U,0,Autocuration,CHEMBL625729,,
13411,Rattus norvegicus,1,,9278,BAO_0000218,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,A,,U,0,Autocuration,CHEMBL625730,,
13412,Rattus norvegicus,1,1088.0,9278,BAO_0000218,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,A,,U,0,Autocuration,CHEMBL625731,,
13413,Rattus norvegicus,1,1088.0,9278,BAO_0000218,,Urinary clearance was determined in rat at 25 mg/kg os dosage,,A,,U,0,Autocuration,CHEMBL626417,,
13414,Homo sapiens,1,1088.0,9278,BAO_0000218,,Urinary clearance was determined at 100 mg/kg oral dosage in human,,A,,N,1,Intermediate,CHEMBL626418,,
13415,Canis lupus familiaris,1,1088.0,9278,BAO_0000218,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,A,,N,1,Intermediate,CHEMBL626419,,
13416,Canis lupus familiaris,1,1969.0,5932,BAO_0000218,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL626592,,
13417,Rattus norvegicus,1,1969.0,5932,BAO_0000218,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,A,,N,1,Intermediate,CHEMBL626593,,
13418,Rattus norvegicus,1,,5182,BAO_0000218,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,A,,N,1,Intermediate,CHEMBL626594,,
13419,Canis lupus familiaris,1,,10499,BAO_0000218,,Clearance rate in dogs,,A,,N,1,Intermediate,CHEMBL625035,,
13420,,1,,6051,BAO_0000019,,Compound was measured for intrinsic clearance,,A,,U,0,Autocuration,CHEMBL625036,,
13421,,1,,17508,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625037,,
13422,,1,,6228,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625038,,
13423,,1,,6231,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625039,,
13424,,1,,17740,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625040,,
13425,,1,,6495,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625041,,
13426,,1,,2171,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625042,,
13427,,1,,3255,BAO_0000019,,Partition coefficient of the compound,,A,,U,0,Autocuration,CHEMBL874411,,
13428,,1,,6821,BAO_0000019,,Permeability,,A,,U,0,Autocuration,CHEMBL625043,,
13429,,1,,2685,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625044,,
13430,,1,,17584,BAO_0000019,,Partition coefficient (logD),,A,,U,0,Autocuration,CHEMBL625045,,
13431,,1,,13824,BAO_0000100,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,P,,U,0,Autocuration,CHEMBL625046,,
13432,,1,,13824,BAO_0000100,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,P,,U,0,Autocuration,CHEMBL625047,,
13433,,1,,16479,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625048,,
13434,,1,,11997,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625049,,
13435,,1,,2988,BAO_0000100,,Calculated logarithm of partition coefficient (P) was determined,,P,,U,0,Autocuration,CHEMBL625050,,
13436,,1,,931,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625051,,
13437,,1,,4381,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL874412,,
13438,,1,,4397,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625052,,
13439,,1,,5889,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL625053,,
13440,,1,,6154,BAO_0000019,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,A,,U,0,Autocuration,CHEMBL623250,,
13441,,1,,6154,BAO_0000019,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,A,,U,0,Autocuration,CHEMBL623251,,
13442,,1,,6154,BAO_0000019,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,A,,U,0,Autocuration,CHEMBL623252,,
13443,,1,,6154,BAO_0000019,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,A,,U,0,Autocuration,CHEMBL623253,,
13444,,1,,6154,BAO_0000019,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,A,,U,0,Autocuration,CHEMBL623254,,
13445,,1,,6154,BAO_0000019,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,A,,U,0,Autocuration,CHEMBL623255,,
13446,,1,,6887,BAO_0000019,,Percent degradation of compound at a pH of 1 over a 18 hr period,,A,,U,0,Autocuration,CHEMBL626831,,
13447,,1,,6887,BAO_0000019,,Percent degradation of compound at pH of 1 over an 18 hr period,,A,,U,0,Autocuration,CHEMBL877494,,
13448,,1,,14116,BAO_0000019,,Delta Logarithm of Partition Coefficient value was determined.,,A,,U,0,Autocuration,CHEMBL626832,,
13449,,1,,11137,BAO_0000019,,Delta logPoct-cyc,,A,,U,0,Autocuration,CHEMBL626833,,
13450,,1,,7230,BAO_0000100,,Lipophilicity estimated on reversed phase TLC,,P,,U,0,Autocuration,CHEMBL626834,,
13451,,1,,15741,BAO_0000019,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,A,,U,0,Autocuration,CHEMBL626835,,
13452,,1,,9663,BAO_0000019,,Delta logPoct-cyc,,A,,U,0,Autocuration,CHEMBL626836,,
13453,,1,,9663,BAO_0000100,,Change in logarithm of partition coefficient of the compound,,P,,U,0,Autocuration,CHEMBL626837,,
13454,,1,,13807,BAO_0000019,,Delta logD (pH 6.5),,A,,U,0,Autocuration,CHEMBL626838,,
13455,,1,,13807,BAO_0000100,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,P,,U,0,Autocuration,CHEMBL626839,,
13456,,1,,17425,BAO_0000019,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,A,,U,0,Autocuration,CHEMBL626840,,
13457,,1,,12143,BAO_0000019,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,A,,U,0,Autocuration,CHEMBL626841,,
13458,,1,,12608,BAO_0000219,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,A,,U,0,Autocuration,CHEMBL626842,,
13459,,1,,12608,BAO_0000219,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,A,,U,0,Autocuration,CHEMBL626843,,
13460,Rattus norvegicus,1,,8649,BAO_0000218,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,A,,N,1,Intermediate,CHEMBL626844,,
13461,Rattus norvegicus,1,,8649,BAO_0000218,,Amount of deuterium retained was reported after normal workup in rats,,A,,N,1,Intermediate,CHEMBL877495,,
13462,Rattus norvegicus,1,,8649,BAO_0000218,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,A,,N,1,Intermediate,CHEMBL626845,,
13463,Rattus norvegicus,1,,8649,BAO_0000218,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,A,,N,1,Intermediate,CHEMBL626846,,
13464,Rattus norvegicus,1,,8649,BAO_0000218,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,A,,N,1,Intermediate,CHEMBL626847,,
13465,Rattus norvegicus,1,,8649,BAO_0000218,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,A,,N,1,Intermediate,CHEMBL628677,,
13466,Rattus norvegicus,1,,8649,BAO_0000218,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,A,,N,1,Intermediate,CHEMBL628678,,
13467,,1,,9659,BAO_0000019,,Compound was subjected to electrochemical oxidation,,A,,U,0,Autocuration,CHEMBL628679,,
13468,,1,,9659,BAO_0000019,,Compound was subjected to photochemical oxidation,,A,,U,0,Autocuration,CHEMBL628680,,
13469,,1,,9659,BAO_0000019,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,A,,U,0,Autocuration,CHEMBL628681,,
13470,,1,,9659,BAO_0000019,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,A,,U,0,Autocuration,CHEMBL628682,,
13471,,1,,9659,BAO_0000019,,Oxidation of compound by methemoglobin in presence of hydroperoxide,,A,,U,0,Autocuration,CHEMBL628683,,
13472,Rattus norvegicus,1,,9607,BAO_0000218,,Percent diffusion through fuzzy rat skin after 48 h of incubation,,A,,N,1,Intermediate,CHEMBL628684,,
13473,,1,,7057,BAO_0000100,,Dissociation constant (pKa),,P,,U,0,Autocuration,CHEMBL877501,,
13474,,1,,7057,BAO_0000100,,Dissociation constant value of the compound; ND means not determined.,,P,,U,0,Autocuration,CHEMBL628685,,
13475,Rattus norvegicus,1,178.0,7911,BAO_0000218,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,A,,N,1,Intermediate,CHEMBL628686,,
13476,Rattus norvegicus,1,178.0,7911,BAO_0000218,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,A,,N,1,Intermediate,CHEMBL628687,,
13477,Rattus norvegicus,1,,7911,BAO_0000218,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,A,,N,1,Intermediate,CHEMBL628688,,
13478,Rattus norvegicus,1,,7911,BAO_0000218,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,A,,N,1,Intermediate,CHEMBL628689,,
13479,Rattus norvegicus,1,2107.0,7911,BAO_0000218,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,A,,N,1,Intermediate,CHEMBL628690,,
13480,Rattus norvegicus,1,2107.0,7911,BAO_0000218,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,A,,N,1,Intermediate,CHEMBL629363,,
13481,Rattus norvegicus,1,2106.0,7911,BAO_0000218,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,A,,N,1,Intermediate,CHEMBL629364,,
13482,Rattus norvegicus,1,2106.0,7911,BAO_0000218,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,A,,N,1,Intermediate,CHEMBL629365,,
13483,Rattus norvegicus,1,,7911,BAO_0000218,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,A,,N,1,Intermediate,CHEMBL629366,,
13484,Rattus norvegicus,1,1088.0,7911,BAO_0000218,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,A,,N,1,Intermediate,CHEMBL629367,,
13485,Rattus norvegicus,1,1988.0,7911,BAO_0000218,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,A,,N,1,Intermediate,CHEMBL629368,,
13486,Rattus norvegicus,1,1088.0,7911,BAO_0000218,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,A,,N,1,Intermediate,CHEMBL877502,,
13487,Mus musculus,1,2037.0,13792,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,A,,N,1,Intermediate,CHEMBL629369,,
13488,Mus musculus,1,955.0,13792,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,A,,N,1,Intermediate,CHEMBL629370,,
13489,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,A,,U,0,Autocuration,CHEMBL629371,,
13490,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,A,,U,0,Autocuration,CHEMBL626276,,
13491,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,A,,U,0,Autocuration,CHEMBL626277,,
13492,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,A,,U,0,Autocuration,CHEMBL631250,,
13493,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,A,,N,1,Intermediate,CHEMBL631251,,
13494,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,A,,N,1,Intermediate,CHEMBL631252,,
13495,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,A,,N,1,Intermediate,CHEMBL631253,,
13496,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,A,,N,1,Intermediate,CHEMBL631254,,
13497,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,A,,N,1,Intermediate,CHEMBL631255,,
13498,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,A,,N,1,Intermediate,CHEMBL631256,,
13499,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,A,,N,1,Intermediate,CHEMBL631257,,
13500,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,A,,N,1,Intermediate,CHEMBL628009,,
13501,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,A,,N,1,Intermediate,CHEMBL628010,,
13502,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,A,,N,1,Intermediate,CHEMBL628011,,
13503,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,A,,N,1,Intermediate,CHEMBL628012,,
13504,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,A,,N,1,Intermediate,CHEMBL628013,,
13505,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,A,,N,1,Intermediate,CHEMBL628014,,
13506,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,A,,N,1,Intermediate,CHEMBL628015,,
13507,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,A,,N,1,Intermediate,CHEMBL628016,,
13508,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,A,,N,1,Intermediate,CHEMBL874461,,
13509,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,A,,N,1,Intermediate,CHEMBL628017,,
13510,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,A,,N,1,Intermediate,CHEMBL628018,,
13511,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,A,,N,1,Intermediate,CHEMBL628019,,
13512,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,A,,N,1,Intermediate,CHEMBL628020,,
13513,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,A,,N,1,Intermediate,CHEMBL628021,,
13514,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,A,,N,1,Intermediate,CHEMBL628022,,
13515,Canis lupus familiaris,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,A,,N,1,Intermediate,CHEMBL628023,,
13516,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,A,,U,0,Autocuration,CHEMBL628024,,
13517,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,A,,U,0,Autocuration,CHEMBL628025,,
13518,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,A,,U,0,Autocuration,CHEMBL628026,,
13519,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,A,,U,0,Autocuration,CHEMBL628027,,
13520,Simiiformes,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,A,,U,0,Autocuration,CHEMBL628028,,
13521,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,A,,N,1,Intermediate,CHEMBL628029,,
13522,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,A,,N,1,Intermediate,CHEMBL628030,,
13523,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,A,,N,1,Intermediate,CHEMBL628031,,
13524,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,A,,N,1,Intermediate,CHEMBL628032,,
13525,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,A,,N,1,Intermediate,CHEMBL628033,,
13526,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,A,,N,1,Intermediate,CHEMBL628034,,
13527,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,A,,N,1,Intermediate,CHEMBL628035,,
13528,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,A,,N,1,Intermediate,CHEMBL628036,,
13529,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,A,,N,1,Intermediate,CHEMBL874462,,
13530,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,A,,N,1,Intermediate,CHEMBL628037,,
13531,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,A,,N,1,Intermediate,CHEMBL628123,,
13532,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,A,,N,1,Intermediate,CHEMBL628124,,
13533,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,A,,N,1,Intermediate,CHEMBL628125,,
13534,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,A,,N,1,Intermediate,CHEMBL628126,,
13535,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,A,,N,1,Intermediate,CHEMBL628127,,
13536,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,A,,N,1,Intermediate,CHEMBL628128,,
13537,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,A,,N,1,Intermediate,CHEMBL628129,,
13538,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,A,,N,1,Intermediate,CHEMBL628130,,
13539,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,A,,N,1,Intermediate,CHEMBL628131,,
13540,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,A,,N,1,Intermediate,CHEMBL628132,,
13541,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,A,,N,1,Intermediate,CHEMBL628133,,
13542,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,A,,N,1,Intermediate,CHEMBL628134,,
13543,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,A,,N,1,Intermediate,CHEMBL628135,,
13544,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,A,,N,1,Intermediate,CHEMBL628136,,
13545,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,A,,N,1,Intermediate,CHEMBL628137,,
13546,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,A,,N,1,Intermediate,CHEMBL628138,,
13547,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,A,,N,1,Intermediate,CHEMBL628139,,
13548,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,A,,N,1,Intermediate,CHEMBL628140,,
13549,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,A,,N,1,Intermediate,CHEMBL628141,,
13550,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,A,,N,1,Intermediate,CHEMBL628142,,
13551,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,A,,N,1,Intermediate,CHEMBL628143,,
13552,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,A,,N,1,Intermediate,CHEMBL628144,,
13553,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,A,,N,1,Intermediate,CHEMBL628145,,
13554,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,A,,N,1,Intermediate,CHEMBL628146,,
13555,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,A,,N,1,Intermediate,CHEMBL625355,,
13556,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,A,,N,1,Intermediate,CHEMBL625356,,
13557,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,A,,N,1,Intermediate,CHEMBL625357,,
13558,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,A,,N,1,Intermediate,CHEMBL625527,,
13559,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,A,,N,1,Intermediate,CHEMBL875473,,
13560,Canis lupus familiaris,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,A,,N,1,Intermediate,CHEMBL625528,,
13561,Rattus norvegicus,1,,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,A,,N,1,Intermediate,CHEMBL626304,,
13562,Canis lupus familiaris,1,1637.0,9025,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,A,,N,1,Intermediate,CHEMBL624138,,
13563,,1,,6448,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL624139,,
13564,,1,,17221,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL624140,,
13565,,1,,6545,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL624141,,
13566,,1,,577,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL624142,,
13567,,1,,6285,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL624143,,
13568,,1,,6500,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL624144,,
13569,,1,,6716,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL624145,,
13570,,1,,13658,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL624146,,
13571,,1,,6549,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL624147,,
13572,,1,,14685,BAO_0000100,,Calculated partition coefficient (clogP) (MacLogP),,P,,U,0,Autocuration,CHEMBL883123,,
13573,,1,,6893,BAO_0000019,,Partition coefficient (logP),,A,,U,0,Autocuration,CHEMBL624148,,
13574,,1,,3687,BAO_0000019,,Kinetic parameter was determined,,A,,U,0,Autocuration,CHEMBL874416,,
13575,,1,,4207,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL624149,,
13576,,1,,4626,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL624150,,
13577,,1,,1021,BAO_0000100,,Lipophilicity was determined,,P,,U,0,Autocuration,CHEMBL624151,,
13578,,1,,3777,BAO_0000100,,Lipophilicity was determined,,P,,U,0,Autocuration,CHEMBL624152,,
13579,,1,,17533,BAO_0000100,,Lipophilicity was determined,,P,,U,0,Autocuration,CHEMBL622139,,
13580,,1,,6524,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL622140,,
13581,,1,,17533,BAO_0000100,,Lipophilicity was determined,,P,,U,0,Autocuration,CHEMBL622141,,
13582,,1,,6480,BAO_0000100,,Lipophilicity in octanol-water,,P,,U,0,Autocuration,CHEMBL622142,,
13583,,1,,17606,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL622143,,
13584,,1,,6863,BAO_0000100,,Octanol-water partition coefficient was determined,,P,,U,0,Autocuration,CHEMBL622144,,
13585,,1,,1356,BAO_0000019,,Partition coefficient (logP),,A,,U,0,Autocuration,CHEMBL877473,,
13586,,1,,3326,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL622145,,
13587,,1,,1356,BAO_0000019,,Partition coefficient was determined; ND means not determined,,A,,U,0,Autocuration,CHEMBL622146,,
13588,,1,,12984,BAO_0000100,,Calculated partition coefficient (clogP),,P,,U,0,Autocuration,CHEMBL622147,,
13589,,1,,17363,BAO_0000019,,Partition coefficient of the compound,,A,,U,0,Autocuration,CHEMBL622148,,
13590,,1,,6827,BAO_0000019,,Permeability was determined,,A,,U,0,Autocuration,CHEMBL883124,,
13591,,1,,261,BAO_0000100,,The compound was evaluated for the partition coefficient,,P,,U,0,Autocuration,CHEMBL622149,,
13592,,1,,2685,BAO_0000019,,Partition coefficient (logP),,A,,U,0,Autocuration,CHEMBL622150,,
13593,,1,,414,BAO_0000100,,The lipophilicity was reported,,P,,U,0,Autocuration,CHEMBL622151,,
13594,,1,,15769,BAO_0000100,,logarithm of the octanol-water partition coefficient for the compound,,P,,U,0,Autocuration,CHEMBL622152,,
13595,,1,,17248,BAO_0000019,,Clogp value was determined,,A,,U,0,Autocuration,CHEMBL622153,,
13596,,1,,16935,BAO_0000218,,Clp at a dose of 1.5 mg/kg,,A,,U,0,Autocuration,CHEMBL877474,,
13597,,1,,16935,BAO_0000218,,Clp at a dose of 2.0 mg/kg,,A,,U,0,Autocuration,CHEMBL622154,,
13598,,1,1969.0,14832,BAO_0000218,,"Clp, plasma clearance at a dose of 10 mg/kg",,A,,U,0,Autocuration,CHEMBL622155,,
13599,,1,1969.0,14832,BAO_0000218,,"Clp, plasma clearance at a dose of 50 mg/kg",,A,,U,0,Autocuration,CHEMBL622156,,
13600,Rattus norvegicus,1,1969.0,2399,BAO_0000218,,Compound was tested for plasma clearance in rat,,A,,N,1,Intermediate,CHEMBL622157,,
13601,Rattus norvegicus,1,1969.0,2399,BAO_0000218,,Compound was tested for plasma clearance in rat; Not determined,,A,,N,1,Intermediate,CHEMBL622158,,
13602,Rattus norvegicus,1,,6227,BAO_0000218,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,A,,N,1,Intermediate,CHEMBL622807,,
13603,Macaca mulatta,1,,6227,BAO_0000218,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,A,,N,1,Intermediate,CHEMBL622808,,
13604,,1,,5623,BAO_0000218,,Plasma clearance by iv administration at a dose 0.003 ug/mL,,A,,U,0,Autocuration,CHEMBL622809,,
13605,,1,,4854,BAO_0000218,,Plasma clearance determined,,A,,U,0,Autocuration,CHEMBL622810,,
13606,Cricetinae,1,,4493,BAO_0000218,,Plasma clearance after iv administration at 3 mg/kg in hamster,,A,,N,1,Intermediate,CHEMBL876653,,
13607,Cricetinae,1,,4493,BAO_0000218,,Plasma clearance after iv administration at 4 mg/kg in hamster,,A,,N,1,Intermediate,CHEMBL622811,,
13608,Rattus norvegicus,1,,14956,BAO_0000218,,Rate of clearance in rat was determined,,A,,N,1,Intermediate,CHEMBL622986,,
13609,Rattus norvegicus,1,1969.0,15372,BAO_0000218,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL622987,,
13610,Rattus norvegicus,1,1969.0,15372,BAO_0000218,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL622988,,
13611,Rattus norvegicus,1,1969.0,15372,BAO_0000218,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL622989,,
13612,Rattus norvegicus,1,1969.0,15372,BAO_0000218,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,A,,N,1,Intermediate,CHEMBL622990,,
13613,Simiiformes,1,1969.0,15604,BAO_0000218,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,A,,U,0,Autocuration,CHEMBL622991,,
13614,Rattus norvegicus,1,1969.0,15604,BAO_0000218,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,A,,N,1,Intermediate,CHEMBL622227,,
13615,Canis lupus familiaris,1,1969.0,15604,BAO_0000218,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,A,,N,1,Intermediate,CHEMBL622228,,
13616,Rattus norvegicus,1,,14964,BAO_0000218,,Clpl value in rat,,A,,N,1,Intermediate,CHEMBL622229,,
13617,Cavia porcellus,1,,15240,BAO_0000218,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,A,,N,1,Intermediate,CHEMBL622230,,
13618,Rattus norvegicus,1,,16449,BAO_0000218,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,A,,N,1,Intermediate,CHEMBL622231,,
13619,Macaca fascicularis,1,,16449,BAO_0000218,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,A,,N,1,Intermediate,CHEMBL622232,,
13620,,1,,12902,BAO_0000218,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,A,,U,0,Autocuration,CHEMBL622233,,
13621,,1,,12902,BAO_0000218,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,A,,U,0,Autocuration,CHEMBL622234,,
13622,,1,,12902,BAO_0000218,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,A,,U,0,Autocuration,CHEMBL622235,,
13623,,1,,12902,BAO_0000218,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,A,,U,0,Autocuration,CHEMBL622236,,
13624,,1,,12902,BAO_0000218,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,A,,U,0,Autocuration,CHEMBL622237,,
13625,,1,,12902,BAO_0000218,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,A,,U,0,Autocuration,CHEMBL877482,,
13626,,1,,12902,BAO_0000218,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,A,,U,0,Autocuration,CHEMBL622238,,
13627,,1,,12902,BAO_0000218,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,A,,U,0,Autocuration,CHEMBL622239,,
13628,,1,178.0,11149,BAO_0000218,,Cmax was calculated as maximum concentration reached in the blood,,A,,U,0,Autocuration,CHEMBL622240,,
13629,,1,178.0,11149,BAO_0000218,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,A,,U,0,Autocuration,CHEMBL622241,,
13630,Rattus norvegicus,1,,5669,BAO_0000218,,Cmax was determine after peroral administration at 10 mpk in Rat,,A,,N,1,Intermediate,CHEMBL631013,,
13631,Macaca mulatta,1,,5669,BAO_0000218,,Cmax was determine after peroral administration at 10 mpk in Rhesus,,A,,N,1,Intermediate,CHEMBL631014,,
13632,Canis lupus familiaris,1,,5669,BAO_0000218,,Cmax was determine after peroral administration at 10 mpk in dog,,A,,N,1,Intermediate,CHEMBL631015,,
13633,Rattus norvegicus,1,,5669,BAO_0000218,,Cmax was determine after peroral administration at 160 mpk in Rat,,A,,N,1,Intermediate,CHEMBL631016,,
13634,Rattus norvegicus,1,,5669,BAO_0000218,,Cmax was determine after peroral administration at 20 mpk in Rat,,A,,N,1,Intermediate,CHEMBL631017,,
13635,Rattus norvegicus,1,,5669,BAO_0000218,,Cmax was determine after peroral administration at 50 mpk in Rat,,A,,N,1,Intermediate,CHEMBL631018,,
13636,,1,,4236,BAO_0000218,,Cmax was determined,,A,,U,0,Autocuration,CHEMBL631019,,
13637,Mus musculus,1,955.0,13792,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,A,,N,1,Intermediate,CHEMBL875761,,
13638,Mus musculus,1,955.0,13792,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,A,,N,1,Intermediate,CHEMBL631020,,
13639,Mus musculus,1,955.0,13792,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,A,,N,1,Intermediate,CHEMBL631669,,
13640,Mus musculus,1,955.0,13792,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,A,,N,1,Intermediate,CHEMBL631670,,
13641,Mus musculus,1,2435.0,13792,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,A,,N,1,Intermediate,CHEMBL631671,,
13642,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,A,,N,1,Intermediate,CHEMBL631672,,
13643,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,A,,N,1,Intermediate,CHEMBL631673,,
13644,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,A,,N,1,Intermediate,CHEMBL631856,,
13645,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,A,,N,1,Intermediate,CHEMBL631857,,
13646,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,A,,N,1,Intermediate,CHEMBL631858,,
13647,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,A,,N,1,Intermediate,CHEMBL631859,,
13648,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,A,,N,1,Intermediate,CHEMBL631860,,
13649,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,A,,N,1,Intermediate,CHEMBL631861,,
13650,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,A,,N,1,Intermediate,CHEMBL631862,,
13651,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,A,,N,1,Intermediate,CHEMBL631863,,
13652,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,A,,N,1,Intermediate,CHEMBL631864,,
13653,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,A,,N,1,Intermediate,CHEMBL631865,,
13654,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,A,,N,1,Intermediate,CHEMBL631866,,
13655,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,A,,N,1,Intermediate,CHEMBL629360,,
13656,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,A,,N,1,Intermediate,CHEMBL629361,,
13657,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,A,,N,1,Intermediate,CHEMBL629362,,
13658,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,A,,N,1,Intermediate,CHEMBL630740,,
13659,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,A,,N,1,Intermediate,CHEMBL630741,,
13660,Rattus norvegicus,1,178.0,8418,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,A,,N,1,Intermediate,CHEMBL630742,,
13661,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,A,,N,1,Intermediate,CHEMBL630743,,
13662,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,A,,N,1,Intermediate,CHEMBL630744,,
13663,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,A,,N,1,Intermediate,CHEMBL630745,,
13664,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,A,,N,1,Intermediate,CHEMBL630746,,
13665,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,A,,N,1,Intermediate,CHEMBL630747,,
13666,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,A,,N,1,Intermediate,CHEMBL630748,,
13667,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,A,,N,1,Intermediate,CHEMBL632056,,
13668,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,A,,N,1,Intermediate,CHEMBL632057,,
13669,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,A,,N,1,Intermediate,CHEMBL632058,,
13670,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,A,,N,1,Intermediate,CHEMBL632059,,
13671,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,A,,N,1,Intermediate,CHEMBL632060,,
13672,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,A,,N,1,Intermediate,CHEMBL632061,,
13673,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,A,,N,1,Intermediate,CHEMBL629207,,
13674,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,A,,N,1,Intermediate,CHEMBL629208,,
13675,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,A,,N,1,Intermediate,CHEMBL629209,,
13676,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,A,,N,1,Intermediate,CHEMBL629210,,
13677,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,A,,N,1,Intermediate,CHEMBL629211,,
13678,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,A,,N,1,Intermediate,CHEMBL629212,,
13679,Rattus norvegicus,1,,8418,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,A,,N,1,Intermediate,CHEMBL629213,,
13680,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,A,,N,1,Intermediate,CHEMBL629214,,
13681,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,A,,N,1,Intermediate,CHEMBL629215,,
13682,Rattus norvegicus,1,1088.0,8133,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,A,,N,1,Intermediate,CHEMBL635154,,
13683,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,A,,N,1,Intermediate,CHEMBL629216,,
13684,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL629217,,
13685,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL629218,,
13686,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,A,,N,1,Intermediate,CHEMBL629219,,
13687,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,A,,N,1,Intermediate,CHEMBL629220,,
13688,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,A,,N,1,Intermediate,CHEMBL629221,,
13689,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL631127,,
13690,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL631128,,
13691,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL631129,,
13692,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,A,,N,1,Intermediate,CHEMBL631130,,
13693,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,A,,N,1,Intermediate,CHEMBL631131,,
13694,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,A,,N,1,Intermediate,CHEMBL631132,,
13695,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL631133,,
13696,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL631134,,
13697,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL875120,,
13698,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,A,,N,1,Intermediate,CHEMBL631135,,
13699,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,A,,N,1,Intermediate,CHEMBL631136,,
13700,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,A,,N,1,Intermediate,CHEMBL631137,,
13701,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL631138,,
13702,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL631139,,
13703,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL631140,,
13704,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,A,,N,1,Intermediate,CHEMBL631141,,
13705,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,A,,N,1,Intermediate,CHEMBL631142,,
13706,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,A,,N,1,Intermediate,CHEMBL631143,,
13707,Rattus norvegicus,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,A,,N,1,Intermediate,CHEMBL631144,,
13708,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL631145,,
13709,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL631146,,
13710,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL631147,,
13711,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL631148,,
13712,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL631149,,
13713,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL631150,,
13714,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL631151,,
13715,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL631152,,
13716,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL631443,,
13717,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL631444,,
13718,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,A,,N,1,Intermediate,CHEMBL631445,,
13719,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,A,,N,1,Intermediate,CHEMBL631446,,
13720,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL631447,,
13721,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,A,,N,1,Intermediate,CHEMBL631448,,
13722,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,A,,N,1,Intermediate,CHEMBL631449,,
13723,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,A,,N,1,Intermediate,CHEMBL631450,,
13724,Canis lupus familiaris,1,,6996,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,A,,N,1,Intermediate,CHEMBL629724,,
13725,Mus musculus,1,14.0,9716,BAO_0000218,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL629725,,
13726,Mus musculus,1,14.0,9716,BAO_0000218,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL629726,,
13727,Mus musculus,1,2106.0,9716,BAO_0000218,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL629727,,
13728,Mus musculus,1,2106.0,9716,BAO_0000218,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL630404,,
13729,Mus musculus,1,2106.0,9716,BAO_0000218,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL630405,,
13730,Mus musculus,1,2106.0,9716,BAO_0000218,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL630406,,
13731,Mus musculus,1,945.0,9716,BAO_0000218,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL630407,,
13732,Mus musculus,1,945.0,9716,BAO_0000218,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL630573,,
13733,Mus musculus,1,945.0,9716,BAO_0000218,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL630574,,
13734,Mus musculus,1,945.0,9716,BAO_0000218,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL630575,,
13735,Mus musculus,1,,9716,BAO_0000218,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL630576,,
13736,Mus musculus,1,,9716,BAO_0000218,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL630577,,
13737,Mus musculus,1,,9716,BAO_0000218,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL630578,,
13738,Mus musculus,1,,9716,BAO_0000218,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,,N,1,Intermediate,CHEMBL630579,,
13739,Mus musculus,1,2113.0,12192,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,A,,N,1,Intermediate,CHEMBL630580,,
13740,Mus musculus,1,2113.0,12192,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,A,,N,1,Intermediate,CHEMBL630581,,
13741,Mus musculus,1,2113.0,12192,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,A,,N,1,Intermediate,CHEMBL630582,,
13742,Mus musculus,1,,12192,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,A,,N,1,Intermediate,CHEMBL630583,,
13743,Mus musculus,1,,12192,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,A,,N,1,Intermediate,CHEMBL630584,,
13744,Mus musculus,1,,12192,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,A,,N,1,Intermediate,CHEMBL630585,,
13745,Mus musculus,1,,12192,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,A,,N,1,Intermediate,CHEMBL630586,,
13746,Mus musculus,1,,12192,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,A,,N,1,Intermediate,CHEMBL630587,,
13747,Mus musculus,1,,12192,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,A,,N,1,Intermediate,CHEMBL630588,,
13748,Mus musculus,1,,12192,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,A,,N,1,Intermediate,CHEMBL630589,,
13749,Mus musculus,1,,12192,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,A,,N,1,Intermediate,CHEMBL630590,,
13750,,1,1988.0,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in feces at 24 h,,A,,U,0,Autocuration,CHEMBL630591,,
13751,,1,1988.0,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,A,,U,0,Autocuration,CHEMBL630592,,
13752,,1,,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,A,,U,0,Autocuration,CHEMBL630593,,
13753,,1,,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,A,,U,0,Autocuration,CHEMBL630594,,
13754,,1,1088.0,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,A,,U,0,Autocuration,CHEMBL630595,,
13755,,1,1088.0,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,A,,U,0,Autocuration,CHEMBL630596,,
13756,,1,1088.0,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in urine after 0-24 h,,A,,U,0,Autocuration,CHEMBL630597,,
13757,,1,1088.0,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,A,,U,0,Autocuration,CHEMBL630598,,
13758,,1,1088.0,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in urine after 0-4 h,,A,,U,0,Autocuration,CHEMBL630599,,
13759,,1,1088.0,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,A,,U,0,Autocuration,CHEMBL630600,,
13760,,1,1088.0,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in urine after 4-24 h,,A,,U,0,Autocuration,CHEMBL630601,,
13761,,1,1088.0,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,A,,U,0,Autocuration,CHEMBL630602,,
13762,,1,1088.0,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,A,,U,0,Autocuration,CHEMBL630603,,
13763,,1,1088.0,12192,BAO_0000019,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,A,,U,0,Autocuration,CHEMBL630604,,
13764,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL624869,,
13765,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL624870,,
13766,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL623189,,
13767,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL623190,,
13768,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL623191,,
13769,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL623192,,
13770,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL623193,,
13771,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL623194,,
13772,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL623195,,
13773,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL623196,,
13774,Rattus norvegicus,1,,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,A,,N,1,Intermediate,CHEMBL623197,,
13775,Rattus norvegicus,1,,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,A,,N,1,Intermediate,CHEMBL623198,,
13776,Rattus norvegicus,1,,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,A,,N,1,Intermediate,CHEMBL623199,,
13777,Rattus norvegicus,1,2385.0,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,A,,N,1,Intermediate,CHEMBL623200,,
13778,Rattus norvegicus,1,2385.0,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,A,,N,1,Intermediate,CHEMBL623201,,
13779,Rattus norvegicus,1,2385.0,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,A,,N,1,Intermediate,CHEMBL623202,,
13780,Rattus norvegicus,1,2385.0,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,A,,N,1,Intermediate,CHEMBL623203,,
13781,Rattus norvegicus,1,2385.0,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,A,,N,1,Intermediate,CHEMBL623204,,
13782,Rattus norvegicus,1,2385.0,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,A,,N,1,Intermediate,CHEMBL623205,,
13783,Rattus norvegicus,1,2385.0,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,A,,N,1,Intermediate,CHEMBL623206,,
13784,Rattus norvegicus,1,2385.0,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,A,,N,1,Intermediate,CHEMBL623207,,
13785,Rattus norvegicus,1,2385.0,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,A,,N,1,Intermediate,CHEMBL623208,,
13786,Rattus norvegicus,1,2385.0,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,A,,N,1,Intermediate,CHEMBL623209,,
13787,Rattus norvegicus,1,2385.0,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,A,,N,1,Intermediate,CHEMBL623210,,
13788,Rattus norvegicus,1,,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,A,,N,1,Intermediate,CHEMBL623211,,
13789,Rattus norvegicus,1,995.0,11836,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,A,,N,1,Intermediate,CHEMBL623212,,
13790,,1,,12640,BAO_0000019,,Tested in vitro for intrinsic activity relative to quinpirole,,A,,U,0,Autocuration,CHEMBL623213,,
13791,,1,,14218,BAO_0000019,,"Relative ion enhancement, determined in pulsed ultrafiltration",,A,,U,0,Autocuration,CHEMBL623214,,
13792,,1,,11296,BAO_0000019,,% ionization at the pH 7.4 at 37 degree Centigrade,,A,,U,0,Autocuration,CHEMBL623215,,
13793,,1,,10929,BAO_0000019,,Percentage ionization was measured,,A,,U,0,Autocuration,CHEMBL623216,,
13794,Bos taurus,1,,13841,BAO_0000218,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,A,,N,1,Intermediate,CHEMBL623217,,
13795,,1,,10431,BAO_0000019,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,A,,U,0,Autocuration,CHEMBL623218,,
13796,,1,,10431,BAO_0000019,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,A,,U,0,Autocuration,CHEMBL623913,,
13797,,1,,10431,BAO_0000019,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,A,,U,0,Autocuration,CHEMBL623914,,
13798,,1,,8826,BAO_0000100,,Compound was evaluated for the partition coefficient in octanol/water,,P,,U,0,Autocuration,CHEMBL623915,,
13799,,1,,8826,BAO_0000100,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,P,,U,0,Autocuration,CHEMBL624080,,
13800,,1,,9884,BAO_0000019,,Equilibrium constant measured by the pulse radiolysis at pH 7,,A,,U,0,Autocuration,CHEMBL624081,,
13801,Homo sapiens,1,,9827,BAO_0000218,,In vitro hydrolytic rate constant determined in human blood,,A,,N,1,Intermediate,CHEMBL624082,,
13802,Homo sapiens,1,,10009,BAO_0000218,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,A,,N,1,Intermediate,CHEMBL625054,,
13803,,1,,10009,BAO_0000019,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,A,,U,0,Autocuration,CHEMBL877485,,
13804,Mus musculus,1,,10009,BAO_0000218,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,A,,N,1,Intermediate,CHEMBL625055,,
13805,Mus musculus,1,,10009,BAO_0000218,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,A,,N,1,Intermediate,CHEMBL625056,,
13806,Homo sapiens,1,,10009,BAO_0000218,,In vitro oxidation of compound in presence of human plasma,,A,,N,1,Intermediate,CHEMBL625057,,
13807,,1,,10009,BAO_0000019,,In vitro oxidation of compound in presence of hydrogen peroxide,,A,,U,0,Autocuration,CHEMBL625058,,
13808,Mus musculus,1,,10009,BAO_0000218,,In vitro oxidation of compound in presence of mouse brain homogenate,,A,,N,1,Intermediate,CHEMBL625059,,
13809,Mus musculus,1,,10009,BAO_0000218,,In vitro oxidation of compound in presence of mouse liver homogenate,,A,,N,1,Intermediate,CHEMBL629536,,
13810,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,A,,N,1,Intermediate,CHEMBL629537,,
13811,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,A,,N,1,Intermediate,CHEMBL629538,,
13812,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,A,,N,1,Intermediate,CHEMBL629539,,
13813,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,A,,N,1,Intermediate,CHEMBL874445,,
13814,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,A,,N,1,Intermediate,CHEMBL629540,,
13815,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,A,,N,1,Intermediate,CHEMBL629541,,
13816,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,A,,N,1,Intermediate,CHEMBL629542,,
13817,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,A,,N,1,Intermediate,CHEMBL630243,,
13818,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,A,,N,1,Intermediate,CHEMBL630244,,
13819,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,A,,N,1,Intermediate,CHEMBL630245,,
13820,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,A,,N,1,Intermediate,CHEMBL630246,,
13821,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,A,,N,1,Intermediate,CHEMBL630247,,
13822,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,A,,N,1,Intermediate,CHEMBL630248,,
13823,Rattus norvegicus,1,178.0,13100,BAO_0000218,,Biodistribution in rat blood at 240 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630249,,
13824,Rattus norvegicus,1,178.0,13100,BAO_0000218,,Biodistribution in rat blood at 30 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630250,,
13825,Rattus norvegicus,1,178.0,13100,BAO_0000218,,Biodistribution in rat blood at 360 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630251,,
13826,Rattus norvegicus,1,178.0,13100,BAO_0000218,,Biodistribution in rat blood at 3 hr after dose administration.,,A,,N,1,Intermediate,CHEMBL630252,,
13827,Rattus norvegicus,1,178.0,13100,BAO_0000218,,Biodistribution in rat blood at 60 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630408,,
13828,Rattus norvegicus,1,2037.0,13100,BAO_0000218,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630409,,
13829,Rattus norvegicus,1,2037.0,13100,BAO_0000218,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL874446,,
13830,Rattus norvegicus,1,2037.0,13100,BAO_0000218,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630410,,
13831,Rattus norvegicus,1,2037.0,13100,BAO_0000218,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630411,,
13832,Rattus norvegicus,1,2037.0,13100,BAO_0000218,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630412,,
13833,Rattus norvegicus,1,2037.0,13100,BAO_0000218,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630413,,
13834,Rattus norvegicus,1,2037.0,13100,BAO_0000218,,Biodistribution in rat cerebellum at 3 hr after dose administration.,,A,,N,1,Intermediate,CHEMBL630414,,
13835,Rattus norvegicus,1,2037.0,13100,BAO_0000218,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630415,,
13836,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat cortex at 120 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630416,,
13837,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat cortex at 1440 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630417,,
13838,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat cortex at 15 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630418,,
13839,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat cortex at 240 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630419,,
13840,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat cortex at 30 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630420,,
13841,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat cortex at 360 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630421,,
13842,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat cortex at 3 hr after dose administration.,,A,,N,1,Intermediate,CHEMBL630422,,
13843,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat cortex at 60 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630423,,
13844,Rattus norvegicus,1,948.0,13100,BAO_0000218,,Biodistribution in rat heart at 120 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630424,,
13845,Rattus norvegicus,1,948.0,13100,BAO_0000218,,Biodistribution in rat heart at 15 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630425,,
13846,Rattus norvegicus,1,948.0,13100,BAO_0000218,,Biodistribution in rat heart at 240 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL629462,,
13847,Rattus norvegicus,1,948.0,13100,BAO_0000218,,Biodistribution in rat heart at 30 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630426,,
13848,Rattus norvegicus,1,948.0,13100,BAO_0000218,,Biodistribution in rat heart at 360 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630427,,
13849,Rattus norvegicus,1,948.0,13100,BAO_0000218,,Biodistribution in rat heart at 3 hr after dose administration.,,A,,N,1,Intermediate,CHEMBL625877,,
13850,Rattus norvegicus,1,948.0,13100,BAO_0000218,,Biodistribution in rat heart at 60 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625878,,
13851,Rattus norvegicus,1,10000000.0,13100,BAO_0000218,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625879,,
13852,Rattus norvegicus,1,10000000.0,13100,BAO_0000218,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625880,,
13853,Rattus norvegicus,1,10000000.0,13100,BAO_0000218,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625881,,
13854,Rattus norvegicus,1,10000000.0,13100,BAO_0000218,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625882,,
13855,Rattus norvegicus,1,10000000.0,13100,BAO_0000218,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625883,,
13856,Rattus norvegicus,1,2113.0,13100,BAO_0000218,,Biodistribution in rat kidney at 120 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625884,,
13857,Rattus norvegicus,1,2113.0,13100,BAO_0000218,,Biodistribution in rat kidney at 1440 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625885,,
13858,Rattus norvegicus,1,2113.0,13100,BAO_0000218,,Biodistribution in rat kidney at 15 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628649,,
13859,Rattus norvegicus,1,2113.0,13100,BAO_0000218,,Biodistribution in rat kidney at 240 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628650,,
13860,Rattus norvegicus,1,2113.0,13100,BAO_0000218,,Biodistribution in rat kidney at 30 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628651,,
13861,Rattus norvegicus,1,2113.0,13100,BAO_0000218,,Biodistribution in rat kidney at 360 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628652,,
13862,Rattus norvegicus,1,2113.0,13100,BAO_0000218,,Biodistribution in rat kidney at 60 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628653,,
13863,Rattus norvegicus,1,2107.0,13100,BAO_0000218,,Biodistribution in rat liver at 120 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628654,,
13864,Rattus norvegicus,1,2107.0,13100,BAO_0000218,,Biodistribution in rat liver at 1440 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628655,,
13865,Rattus norvegicus,1,2107.0,13100,BAO_0000218,,Biodistribution in rat liver at 15 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625238,,
13866,Rattus norvegicus,1,2107.0,13100,BAO_0000218,,Biodistribution in rat liver at 240 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625239,,
13867,Rattus norvegicus,1,2107.0,13100,BAO_0000218,,Biodistribution in rat liver at 30 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625240,,
13868,Rattus norvegicus,1,2107.0,13100,BAO_0000218,,Biodistribution in rat liver at 360 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625241,,
13869,Rattus norvegicus,1,2107.0,13100,BAO_0000218,,Biodistribution in rat liver at 60 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625242,,
13870,Rattus norvegicus,1,2048.0,13100,BAO_0000218,,Biodistribution in rat lung at 120 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL874587,,
13871,Rattus norvegicus,1,2048.0,13100,BAO_0000218,,Biodistribution in rat lung at 1440 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625405,,
13872,Rattus norvegicus,1,2048.0,13100,BAO_0000218,,Biodistribution in rat lung at 15 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625406,,
13873,Rattus norvegicus,1,2048.0,13100,BAO_0000218,,Biodistribution in rat lung at 240 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625407,,
13874,Rattus norvegicus,1,2048.0,13100,BAO_0000218,,Biodistribution in rat lung at 30 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625408,,
13875,Rattus norvegicus,1,2048.0,13100,BAO_0000218,,Biodistribution in rat lung at 360 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL625409,,
13876,Rattus norvegicus,1,1515.0,12361,BAO_0000218,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,A,,N,1,Intermediate,CHEMBL625410,,
13877,Rattus norvegicus,1,1515.0,12361,BAO_0000218,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,A,,N,1,Intermediate,CHEMBL625411,,
13878,Rattus norvegicus,1,1515.0,12361,BAO_0000218,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,A,,N,1,Intermediate,CHEMBL625412,,
13879,Rattus norvegicus,1,1515.0,12361,BAO_0000218,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,A,,N,1,Intermediate,CHEMBL625413,,
13880,Rattus norvegicus,1,1515.0,12361,BAO_0000218,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,A,,N,1,Intermediate,CHEMBL625414,,
13881,Rattus norvegicus,1,1515.0,12361,BAO_0000218,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,A,,N,1,Intermediate,CHEMBL625415,,
13882,Rattus norvegicus,1,1515.0,12361,BAO_0000218,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,A,,N,1,Intermediate,CHEMBL625416,,
13883,Rattus norvegicus,1,1088.0,12712,BAO_0000218,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,A,,N,1,Intermediate,CHEMBL625417,,
13884,Rattus norvegicus,1,1988.0,7415,BAO_0000218,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,A,,N,1,Intermediate,CHEMBL625418,,
13885,Rattus norvegicus,1,1088.0,7415,BAO_0000218,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,A,,N,1,Intermediate,CHEMBL625419,,
13886,Rattus norvegicus,1,,7415,BAO_0000218,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,A,,N,1,Intermediate,CHEMBL625420,,
13887,Rattus norvegicus,1,,7415,BAO_0000218,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,A,,N,1,Intermediate,CHEMBL626996,,
13888,Rattus norvegicus,1,1988.0,7415,BAO_0000218,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,A,,N,1,Intermediate,CHEMBL626997,,
13889,Rattus norvegicus,1,1088.0,7415,BAO_0000218,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,A,,N,1,Intermediate,CHEMBL626998,,
13890,Rattus norvegicus,1,,7415,BAO_0000218,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,A,,N,1,Intermediate,CHEMBL626999,,
13891,Mus musculus,1,,8050,BAO_0000218,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,A,,N,1,Intermediate,CHEMBL627000,,
13892,Mus musculus,1,,8050,BAO_0000218,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,A,,N,1,Intermediate,CHEMBL627001,,
13893,Mus musculus,1,,8050,BAO_0000218,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,A,,N,1,Intermediate,CHEMBL627002,,
13894,Mus musculus,1,,8050,BAO_0000218,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,A,,N,1,Intermediate,CHEMBL627003,,
13895,Mus musculus,1,1088.0,8050,BAO_0000218,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,A,,N,1,Intermediate,CHEMBL627004,,
13896,Mus musculus,1,1088.0,8050,BAO_0000218,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,A,,N,1,Intermediate,CHEMBL627005,,
13897,Mus musculus,1,1088.0,8050,BAO_0000218,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,A,,N,1,Intermediate,CHEMBL874594,,
13898,Mus musculus,1,1088.0,8050,BAO_0000218,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,A,,N,1,Intermediate,CHEMBL627006,,
13899,Mus musculus,1,1088.0,8050,BAO_0000218,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,A,,N,1,Intermediate,CHEMBL627007,,
13900,Mus musculus,1,1088.0,8050,BAO_0000218,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,A,,N,1,Intermediate,CHEMBL627884,,
13901,Mus musculus,1,1088.0,8050,BAO_0000218,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,A,,N,1,Intermediate,CHEMBL627885,,
13902,Mus musculus,1,1088.0,8050,BAO_0000218,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,A,,N,1,Intermediate,CHEMBL627886,,
13903,Mus musculus,1,1088.0,8050,BAO_0000218,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,A,,N,1,Intermediate,CHEMBL627887,,
13904,Mus musculus,1,1088.0,8050,BAO_0000218,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,A,,N,1,Intermediate,CHEMBL627888,,
13905,Mus musculus,1,1088.0,8050,BAO_0000218,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,A,,N,1,Intermediate,CHEMBL628057,,
13906,Mus musculus,1,1088.0,8050,BAO_0000218,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,A,,N,1,Intermediate,CHEMBL627405,,
13907,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627406,,
13908,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627407,,
13909,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627408,,
13910,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627409,,
13911,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL875486,,
13912,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627410,,
13913,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627411,,
13914,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627412,,
13915,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627413,,
13916,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627414,,
13917,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627415,,
13918,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627416,,
13919,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627417,,
13920,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627418,,
13921,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627419,,
13922,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627320,,
13923,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627321,,
13924,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL627322,,
13925,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL627323,,
13926,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL627491,,
13927,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL627492,,
13928,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL627493,,
13929,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL627494,,
13930,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL627495,,
13931,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL627496,,
13932,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL627497,,
13933,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL627498,,
13934,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL627499,,
13935,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL627500,,
13936,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL627501,,
13937,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL625616,,
13938,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL625617,,
13939,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL625618,,
13940,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL625619,,
13941,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL625620,,
13942,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL625621,,
13943,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL625622,,
13944,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL625788,,
13945,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL625789,,
13946,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL625790,,
13947,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL625791,,
13948,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL622334,,
13949,Rattus norvegicus,1,2046.0,12017,BAO_0000218,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL622335,,
13950,Rattus norvegicus,1,2046.0,12017,BAO_0000218,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL622336,,
13951,Rattus norvegicus,1,2046.0,12017,BAO_0000218,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL622337,,
13952,Rattus norvegicus,1,2046.0,12017,BAO_0000218,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL622338,,
13953,Rattus norvegicus,1,2046.0,12017,BAO_0000218,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL622339,,
13954,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL624153,,
13955,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL628430,,
13956,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL628431,,
13957,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL628432,,
13958,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL628433,,
13959,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,A,,N,1,Intermediate,CHEMBL628434,,
13960,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,A,,N,1,Intermediate,CHEMBL626789,,
13961,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,A,,N,1,Intermediate,CHEMBL626790,,
13962,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,A,,N,1,Intermediate,CHEMBL626791,,
13963,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,A,,N,1,Intermediate,CHEMBL626792,,
13964,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,A,,N,1,Intermediate,CHEMBL626793,,
13965,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,A,,N,1,Intermediate,CHEMBL627436,,
13966,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,A,,N,1,Intermediate,CHEMBL627437,,
13967,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,A,,N,1,Intermediate,CHEMBL627438,,
13968,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,A,,N,1,Intermediate,CHEMBL627439,,
13969,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,A,,N,1,Intermediate,CHEMBL627440,,
13970,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,A,,N,1,Intermediate,CHEMBL627602,,
13971,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,A,,N,1,Intermediate,CHEMBL627603,,
13972,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,A,,N,1,Intermediate,CHEMBL627604,,
13973,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,A,,N,1,Intermediate,CHEMBL627605,,
13974,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,A,,N,1,Intermediate,CHEMBL627606,,
13975,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,A,,N,1,Intermediate,CHEMBL627607,,
13976,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,A,,N,1,Intermediate,CHEMBL627608,,
13977,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,A,,N,1,Intermediate,CHEMBL627609,,
13978,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,A,,N,1,Intermediate,CHEMBL627610,,
13979,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,A,,N,1,Intermediate,CHEMBL627611,,
13980,Rattus norvegicus,1,,11510,BAO_0000218,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,A,,N,1,Intermediate,CHEMBL627612,,
13981,,1,,8362,BAO_0000100,,Octanol:water partition coefficient is evaluated,,P,,U,0,Autocuration,CHEMBL627613,,
13982,,1,,8257,BAO_0000100,,Partition coefficient in 1-octanol/water system,,P,,U,0,Autocuration,CHEMBL627614,,
13983,,1,,8257,BAO_0000100,,Partition coefficient in 1-octanol/water system measured using radio active compounds,,P,,U,0,Autocuration,CHEMBL627615,,
13984,,1,,9468,BAO_0000100,,Partition coefficient in octanol/water system was determined,,P,,U,0,Autocuration,CHEMBL627616,,
13985,,1,,9468,BAO_0000100,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,P,,U,0,Autocuration,CHEMBL627617,,
13986,,1,,10568,BAO_0000019,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,A,,U,0,Autocuration,CHEMBL627618,,
13987,,1,,10568,BAO_0000019,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,A,,U,0,Autocuration,CHEMBL627619,,
13988,,1,,15359,BAO_0000019,,Pseudo-first-order rate constant of the compound,,A,,U,0,Autocuration,CHEMBL627620,,
13989,,1,,15359,BAO_0000019,,Pseudo-first-order rate constant with 1-min time point,,A,,U,0,Autocuration,CHEMBL627621,,
13990,,1,,15359,BAO_0000019,,Pseudo-first-order rate constant without 1-min time point,,A,,U,0,Autocuration,CHEMBL627622,,
13991,,1,,10431,BAO_0000019,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,A,,U,0,Autocuration,CHEMBL627623,,
13992,,1,,10431,BAO_0000019,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,A,,U,0,Autocuration,CHEMBL627624,,
13993,,1,,10431,BAO_0000019,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,A,,U,0,Autocuration,CHEMBL627625,,
13994,,1,,15704,BAO_0000019,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,A,,U,0,Autocuration,CHEMBL628523,,
13995,,1,,15287,BAO_0000019,,The alkaline hydrolysis second order rate constant(K OH) of the compound,,A,,U,0,Autocuration,CHEMBL628524,,
13996,,1,,7516,BAO_0000019,,The efflux rate constant of the compound,,A,,U,0,Autocuration,CHEMBL628525,,
13997,,1,,12973,BAO_0000019,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,A,,U,0,Autocuration,CHEMBL625732,,
13998,,1,,12973,BAO_0000019,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,A,,U,0,Autocuration,CHEMBL625733,,
13999,,1,,12973,BAO_0000019,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,F,,U,0,Autocuration,CHEMBL625734,,
14000,,1,,12973,BAO_0000019,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,A,,U,0,Autocuration,CHEMBL625913,,
14001,,1,,8696,BAO_0000019,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,A,,U,0,Autocuration,CHEMBL625914,,
14002,,1,,15052,BAO_0000019,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,A,,U,0,Autocuration,CHEMBL625915,,
14003,,1,,15052,BAO_0000019,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,A,,U,0,Autocuration,CHEMBL625916,,
14004,,1,,10503,BAO_0000019,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,A,,U,0,Autocuration,CHEMBL625917,,
14005,,1,,8354,BAO_0000019,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL625918,,
14006,,1,,8354,BAO_0000019,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL625919,,
14007,,1,,8354,BAO_0000019,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL625920,,
14008,,1,,8354,BAO_0000019,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL874453,,
14009,,1,,8354,BAO_0000019,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL625921,,
14010,,1,,10503,BAO_0000019,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,A,,U,0,Autocuration,CHEMBL625922,,
14011,,1,,8354,BAO_0000019,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL625923,,
14012,,1,,8354,BAO_0000019,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL625924,,
14013,,1,,8354,BAO_0000019,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL625925,,
14014,,1,,8354,BAO_0000019,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL625926,,
14015,Rattus norvegicus,1,2048.0,13100,BAO_0000218,,Biodistribution in rat lung at 60 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL627704,,
14016,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL627705,,
14017,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL627706,,
14018,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL627707,,
14019,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL627708,,
14020,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628361,,
14021,Rattus norvegicus,1,,13100,BAO_0000218,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628362,,
14022,Rattus norvegicus,1,2435.0,13100,BAO_0000218,,Biodistribution in rat striatum at 120 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628363,,
14023,Rattus norvegicus,1,2435.0,13100,BAO_0000218,,Biodistribution in rat striatum at 1440 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628364,,
14024,Rattus norvegicus,1,2435.0,13100,BAO_0000218,,Biodistribution in rat striatum at 15 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628365,,
14025,Rattus norvegicus,1,2435.0,13100,BAO_0000218,,Biodistribution in rat striatum at 240 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL874454,,
14026,Rattus norvegicus,1,2435.0,13100,BAO_0000218,,Biodistribution in rat striatum at 30 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628531,,
14027,Rattus norvegicus,1,2435.0,13100,BAO_0000218,,Biodistribution in rat striatum at 360 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628532,,
14028,Rattus norvegicus,1,2435.0,13100,BAO_0000218,,Biodistribution in rat striatum at 3 hr after dose administration.,,A,,N,1,Intermediate,CHEMBL628533,,
14029,Rattus norvegicus,1,2435.0,13100,BAO_0000218,,Biodistribution in rat striatum at 60 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628534,,
14030,Rattus norvegicus,1,2046.0,13100,BAO_0000218,,Biodistribution in rat thyroid at 120 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628535,,
14031,Rattus norvegicus,1,2046.0,13100,BAO_0000218,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628536,,
14032,Rattus norvegicus,1,2046.0,13100,BAO_0000218,,Biodistribution in rat thyroid at 15 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628537,,
14033,Rattus norvegicus,1,2046.0,13100,BAO_0000218,,Biodistribution in rat thyroid at 240 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628538,,
14034,Rattus norvegicus,1,2046.0,13100,BAO_0000218,,Biodistribution in rat thyroid at 30 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628539,,
14035,Rattus norvegicus,1,2046.0,13100,BAO_0000218,,Biodistribution in rat thyroid at 360 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630297,,
14036,Rattus norvegicus,1,2046.0,13100,BAO_0000218,,Biodistribution in rat thyroid at 60 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630298,,
14037,Rattus norvegicus,1,955.0,13100,BAO_0000218,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL630299,,
14038,Rattus norvegicus,1,955.0,13100,BAO_0000218,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628094,,
14039,Rattus norvegicus,1,955.0,13100,BAO_0000218,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628095,,
14040,Rattus norvegicus,1,955.0,13100,BAO_0000218,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL874648,,
14041,Rattus norvegicus,1,955.0,13100,BAO_0000218,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628096,,
14042,Rattus norvegicus,1,955.0,13100,BAO_0000218,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628097,,
14043,Rattus norvegicus,1,955.0,13100,BAO_0000218,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,A,,N,1,Intermediate,CHEMBL628098,,
14044,,1,,13331,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,A,,U,0,Autocuration,CHEMBL628099,,
14045,,1,,13331,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,A,,U,0,Autocuration,CHEMBL628100,,
14046,,1,,13331,BAO_0000019,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,A,,U,0,Autocuration,CHEMBL628101,,
14047,,1,,13331,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,A,,U,0,Autocuration,CHEMBL628102,,
14048,,1,,13331,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,A,,U,0,Autocuration,CHEMBL628103,,
14049,,1,,13331,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,A,,U,0,Autocuration,CHEMBL628104,,
14050,,1,,13331,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,A,,U,0,Autocuration,CHEMBL628105,,
14051,,1,,13331,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,A,,U,0,Autocuration,CHEMBL628106,,
14052,Rattus norvegicus,1,1088.0,10086,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,A,,N,1,Intermediate,CHEMBL628107,,
14053,,1,1088.0,10086,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,F,,U,0,Autocuration,CHEMBL628108,,
14054,Rattus norvegicus,1,1088.0,10086,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,A,,N,1,Intermediate,CHEMBL628109,,
14055,,1,1088.0,10086,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,F,,U,0,Autocuration,CHEMBL625299,,
14056,Rattus norvegicus,1,1088.0,10086,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,A,,N,1,Intermediate,CHEMBL625300,,
14057,Rattus norvegicus,1,1088.0,10086,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,A,,N,1,Intermediate,CHEMBL625301,,
14058,Rattus norvegicus,1,1088.0,10086,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,A,,N,1,Intermediate,CHEMBL625302,,
14059,Rattus norvegicus,1,1088.0,10086,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,A,,N,1,Intermediate,CHEMBL874649,,
14060,Rattus norvegicus,1,,13248,BAO_0000218,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,A,,N,1,Intermediate,CHEMBL625303,,
14061,Rattus norvegicus,1,,13248,BAO_0000218,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,A,,N,1,Intermediate,CHEMBL625463,,
14062,Homo sapiens,1,2107.0,14527,BAO_0000218,,In vitro metabolism in human liver microsomes,,A,,N,1,Intermediate,CHEMBL625464,,
14063,Homo sapiens,1,,3008,BAO_0000218,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,A,,N,1,Intermediate,CHEMBL625465,,
14064,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625466,,
14065,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625467,,
14066,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625468,,
14067,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625469,,
14068,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625470,,
14069,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL632418,,
14070,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627250,,
14071,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627251,,
14072,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627252,,
14073,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627253,,
14074,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627254,,
14075,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL875471,,
14076,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627255,,
14077,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627256,,
14078,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627257,,
14079,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627258,,
14080,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627259,,
14081,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627260,,
14082,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623256,,
14083,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL874413,,
14084,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623257,,
14085,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623258,,
14086,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623259,,
14087,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623260,,
14088,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623261,,
14089,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623262,,
14090,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623263,,
14091,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623264,,
14092,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623265,,
14093,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623266,,
14094,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623267,,
14095,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623268,,
14096,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623269,,
14097,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623270,,
14098,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623271,,
14099,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623272,,
14100,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623273,,
14101,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623274,,
14102,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL874414,,
14103,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623275,,
14104,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL629150,,
14105,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623276,,
14106,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623277,,
14107,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623112,,
14108,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623113,,
14109,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623800,,
14110,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623801,,
14111,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,A,,N,1,Intermediate,CHEMBL623802,,
14112,Rattus norvegicus,1,995.0,12017,BAO_0000218,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL623803,,
14113,Rattus norvegicus,1,995.0,12017,BAO_0000218,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL623970,,
14114,Rattus norvegicus,1,995.0,12017,BAO_0000218,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL623971,,
14115,Rattus norvegicus,1,178.0,14045,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,A,,N,1,Intermediate,CHEMBL623972,,
14116,Rattus norvegicus,1,178.0,14045,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,A,,N,1,Intermediate,CHEMBL623973,,
14117,Rattus norvegicus,1,178.0,14045,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,A,,N,1,Intermediate,CHEMBL623974,,
14118,Rattus norvegicus,1,178.0,14045,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,A,,N,1,Intermediate,CHEMBL623975,,
14119,Rattus norvegicus,1,955.0,14045,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,A,,N,1,Intermediate,CHEMBL623976,,
14120,Rattus norvegicus,1,955.0,14045,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,A,,N,1,Intermediate,CHEMBL623977,,
14121,Rattus norvegicus,1,955.0,14045,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,A,,N,1,Intermediate,CHEMBL623978,,
14122,Rattus norvegicus,1,955.0,14045,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,A,,N,1,Intermediate,CHEMBL623979,,
14123,Rattus norvegicus,1,,14045,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,A,,N,1,Intermediate,CHEMBL623980,,
14124,Rattus norvegicus,1,,14045,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,A,,N,1,Intermediate,CHEMBL623981,,
14125,Rattus norvegicus,1,,14045,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,A,,N,1,Intermediate,CHEMBL626278,,
14126,Rattus norvegicus,1,,14045,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,A,,N,1,Intermediate,CHEMBL626279,,
14127,Mus musculus,1,,14045,BAO_0000218,,Biodistribution in mice bladder plus excreted urine was determined,,A,,N,1,Intermediate,CHEMBL626280,,
14128,Mus musculus,1,,14045,BAO_0000218,,"Percentage biodistribution in mouse blood, 10 minutes post injection",,A,,N,1,Intermediate,CHEMBL626281,,
14129,Mus musculus,1,,14045,BAO_0000218,,"Percentage biodistribution in mouse blood, 30 minutes post injection",,A,,N,1,Intermediate,CHEMBL626282,,
14130,Mus musculus,1,,14045,BAO_0000218,,"Percentage biodistribution in mouse blood, 5 minutes post injection",,A,,N,1,Intermediate,CHEMBL626283,,
14131,Mus musculus,1,,14045,BAO_0000218,,"Percentage biodistribution in mouse blood, 60 minutes post injection",,A,,N,1,Intermediate,CHEMBL626284,,
14132,Mus musculus,1,955.0,14045,BAO_0000218,,"Percentage biodistribution in mouse brain, 10 minutes post injection",,A,,N,1,Intermediate,CHEMBL626285,,
14133,Mus musculus,1,955.0,14045,BAO_0000218,,"Percentage biodistribution in mouse brain, 30 minutes post injection",,A,,N,1,Intermediate,CHEMBL626286,,
14134,Mus musculus,1,955.0,14045,BAO_0000218,,"Percentage biodistribution in mouse brain, 5 minutes post injection",,A,,N,1,Intermediate,CHEMBL626287,,
14135,Mus musculus,1,955.0,14045,BAO_0000218,,"Percentage biodistribution in mouse brain, 60 minutes post injection",,A,,N,1,Intermediate,CHEMBL626288,,
14136,Mus musculus,1,,14045,BAO_0000218,,"Percentage biodistribution in mouse heart, 10 minutes post injection",,A,,N,1,Intermediate,CHEMBL626289,,
14137,Mus musculus,1,,14045,BAO_0000218,,"Percentage biodistribution in mouse heart, 30 minutes post injection",,A,,N,1,Intermediate,CHEMBL626290,,
14138,Mus musculus,1,,14045,BAO_0000218,,"Percentage biodistribution in mouse heart, 5 minutes post injection",,A,,N,1,Intermediate,CHEMBL626291,,
14139,Mus musculus,1,,14045,BAO_0000218,,"Percentage biodistribution in mouse heart, 60 minutes post injection",,A,,N,1,Intermediate,CHEMBL839888,,
14140,Mus musculus,1,160.0,14045,BAO_0000218,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,A,,N,1,Intermediate,CHEMBL626292,,
14141,Mus musculus,1,160.0,14045,BAO_0000218,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,A,,N,1,Intermediate,CHEMBL626293,,
14142,Mus musculus,1,160.0,14045,BAO_0000218,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,A,,N,1,Intermediate,CHEMBL626294,,
14143,Mus musculus,1,160.0,14045,BAO_0000218,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,A,,N,1,Intermediate,CHEMBL626295,,
14144,Mus musculus,1,2107.0,14045,BAO_0000218,,"Percentage biodistribution in mouse liver, 10 minutes post injection",,A,,N,1,Intermediate,CHEMBL627659,,
14145,Mus musculus,1,2107.0,14045,BAO_0000218,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,A,,N,1,Intermediate,CHEMBL627660,,
14146,Mus musculus,1,2107.0,14045,BAO_0000218,,"Percentage biodistribution in mouse liver, 5 minutes post injection",,A,,N,1,Intermediate,CHEMBL627661,,
14147,Mus musculus,1,2107.0,14045,BAO_0000218,,Biodistribution in mice liver at 60 minutes of post injection,,A,,N,1,Intermediate,CHEMBL627662,,
14148,Mus musculus,1,2048.0,14045,BAO_0000218,,Biodistribution in mice lungs at 10 min of post injection,,A,,N,1,Intermediate,CHEMBL627663,,
14149,Mus musculus,1,,14045,BAO_0000218,,"Percentage biodistribution in mouse lung, 30 minutes post injection",,A,,N,1,Intermediate,CHEMBL627664,,
14150,Mus musculus,1,,14045,BAO_0000218,,"Percentage biodistribution in mousee lung, 5 minutes post injection",,A,,N,1,Intermediate,CHEMBL627665,,
14151,Mus musculus,1,2048.0,14045,BAO_0000218,,Biodistribution in mice lungs at 60 min of post injection,,A,,N,1,Intermediate,CHEMBL627666,,
14152,Mus musculus,1,2106.0,14045,BAO_0000218,,Percentage biodistribution in mouse spleen,,A,,N,1,Intermediate,CHEMBL627667,,
14153,Mus musculus,1,945.0,14045,BAO_0000218,,Percentage biodistribution in mouse stomach,,A,,N,1,Intermediate,CHEMBL627668,,
14154,Mus musculus,1,1088.0,11745,BAO_0000218,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,A,,N,1,Intermediate,CHEMBL627669,,
14155,,1,1255.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,A,,U,0,Autocuration,CHEMBL627670,,
14156,,1,178.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,A,,U,0,Autocuration,CHEMBL627671,,
14157,,1,1474.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,A,,U,0,Autocuration,CHEMBL627672,,
14158,,1,,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,A,,U,0,Autocuration,CHEMBL627673,,
14159,,1,2113.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,A,,U,0,Autocuration,CHEMBL627674,,
14160,,1,2107.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,A,,U,0,Autocuration,CHEMBL627675,,
14161,,1,2048.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,A,,U,0,Autocuration,CHEMBL627676,,
14162,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,A,,U,0,Autocuration,CHEMBL627677,,
14163,,1,,8354,BAO_0000019,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL627678,,
14164,Rattus norvegicus,1,1977.0,7095,BAO_0000218,,Affinity for protein binding expressed as association constant in fresh rat serum,,A,,N,1,Intermediate,CHEMBL627679,,
14165,,1,,12185,BAO_0000019,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,A,,U,0,Autocuration,CHEMBL627680,,
14166,,1,,12185,BAO_0000019,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,A,,U,0,Autocuration,CHEMBL627681,,
14167,,1,,12185,BAO_0000019,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,A,,U,0,Autocuration,CHEMBL627682,,
14168,,1,,12185,BAO_0000019,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,A,,U,0,Autocuration,CHEMBL627683,,
14169,,1,,12686,BAO_0000019,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,A,,U,0,Autocuration,CHEMBL627684,,
14170,,1,,12686,BAO_0000019,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,A,,U,0,Autocuration,CHEMBL874441,,
14171,,1,,12686,BAO_0000019,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,A,,U,0,Autocuration,CHEMBL627685,,
14172,,1,,12686,BAO_0000019,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,A,,U,0,Autocuration,CHEMBL627686,,
14173,,1,,8057,BAO_0000019,,Apparent rate constant Koff for inactivation of dTMP synthase.,,A,,U,0,Autocuration,CHEMBL627687,,
14174,,1,,15778,BAO_0000019,,The irreversible inhibitor activity by second order rate equation.,,A,,U,0,Autocuration,CHEMBL627688,,
14175,Rattus norvegicus,1,,12375,BAO_0000218,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL628038,,
14176,Rattus norvegicus,1,,12375,BAO_0000218,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,A,,N,1,Intermediate,CHEMBL628039,,
14177,Rattus norvegicus,1,,12375,BAO_0000218,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,A,,N,1,Intermediate,CHEMBL628040,,
14178,,1,,13588,BAO_0000019,,Dissociation rate calculated from the first-order equation using t1/2 value,,A,,U,0,Autocuration,CHEMBL628041,,
14179,,1,,15039,BAO_0000019,,The compound was tested for Binding constant against DNA,,A,,U,0,Autocuration,CHEMBL630226,,
14180,,1,,9500,BAO_0000019,,First order rate constant for cyclization of the compound,,A,,U,0,Autocuration,CHEMBL628042,,
14181,,1,,10014,BAO_0000019,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,A,,U,0,Autocuration,CHEMBL625232,,
14182,,1,,10014,BAO_0000019,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,A,,U,0,Autocuration,CHEMBL625233,,
14183,,1,,568,BAO_0000019,,Hydrolysis rate constant was determined,,A,,U,0,Autocuration,CHEMBL625979,,
14184,,1,,10026,BAO_0000019,,Observed first order rate constant,,A,,U,0,Autocuration,CHEMBL625980,,
14185,,1,,10281,BAO_0000019,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,A,,U,0,Autocuration,CHEMBL625981,,
14186,,1,,10281,BAO_0000019,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,A,,U,0,Autocuration,CHEMBL625982,,
14187,,1,,9680,BAO_0000019,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,A,,U,0,Autocuration,CHEMBL625983,,
14188,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL625984,,
14189,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL625985,,
14190,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL625986,,
14191,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL625987,,
14192,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL625988,,
14193,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL625989,,
14194,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL625990,,
14195,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL625991,,
14196,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL625992,,
14197,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL625993,,
14198,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL631973,,
14199,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL632143,,
14200,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL632144,,
14201,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL632145,,
14202,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL632146,,
14203,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL632147,,
14204,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL632148,,
14205,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL632149,,
14206,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL632150,,
14207,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL632151,,
14208,Homo sapiens,1,,3008,BAO_0000218,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,A,,N,1,Intermediate,CHEMBL632152,,
14209,Homo sapiens,1,,4509,BAO_0000218,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,A,,N,1,Intermediate,CHEMBL632153,,
14210,Homo sapiens,1,,4509,BAO_0000218,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,A,,N,1,Intermediate,CHEMBL632154,,
14211,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,A,,N,1,Intermediate,CHEMBL632155,,
14212,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,A,,N,1,Intermediate,CHEMBL632156,,
14213,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,A,,N,1,Intermediate,CHEMBL632157,,
14214,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,A,,N,1,Intermediate,CHEMBL632158,,
14215,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,A,,N,1,Intermediate,CHEMBL632159,,
14216,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,A,,N,1,Intermediate,CHEMBL626305,,
14217,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,A,,N,1,Intermediate,CHEMBL626306,,
14218,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,A,,N,1,Intermediate,CHEMBL626307,,
14219,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,A,,N,1,Intermediate,CHEMBL626308,,
14220,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,A,,N,1,Intermediate,CHEMBL626479,,
14221,Human herpesvirus 1,1,,8613,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,A,,N,1,Intermediate,CHEMBL626480,,
14222,,1,,6021,BAO_0000100,,Calculated partition coefficient (clogP) (MlogP),,P,,U,0,Autocuration,CHEMBL626481,,
14223,,1,,9348,BAO_0000019,,Equipotent potent ratio relative to carbachol (nicotinic activity),,A,,U,0,Autocuration,CHEMBL626482,,
14224,Canis lupus familiaris,1,,15592,BAO_0000218,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,A,,N,1,Intermediate,CHEMBL626483,,
14225,Canis lupus familiaris,1,,15592,BAO_0000218,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,A,,N,1,Intermediate,CHEMBL626484,,
14226,,1,,15592,BAO_0000100,,Solubility at pH 7.4 in micro g/mL;NA denotes available,,P,,U,0,Autocuration,CHEMBL626485,,
14227,,1,,15592,BAO_0000100,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,P,,U,0,Autocuration,CHEMBL626486,,
14228,,1,,15592,BAO_0000100,,Solubility at pH 7.4 in ug/mL;NA denotes not available,,P,,U,0,Autocuration,CHEMBL626487,,
14229,Canis lupus familiaris,1,1969.0,15592,BAO_0000218,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,A,,N,1,Intermediate,CHEMBL626488,,
14230,Rattus norvegicus,1,1977.0,7095,BAO_0000218,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,A,,N,1,Intermediate,CHEMBL626489,,
14231,,1,,16618,BAO_0000019,,Area under the MAP curve measured over 5 min; ND means Not determined,,A,,U,0,Autocuration,CHEMBL626490,,
14232,,1,,16835,BAO_0000100,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,P,,U,0,Autocuration,CHEMBL626491,,
14233,,1,,15284,BAO_0000100,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,P,,U,0,Autocuration,CHEMBL626492,,
14234,,1,,15750,BAO_0000019,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,A,,U,0,Autocuration,CHEMBL626493,,
14235,Rattus norvegicus,1,,16618,BAO_0000218,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,A,,N,1,Intermediate,CHEMBL626494,,
14236,,1,,16618,BAO_0000218,,Half life after oral tested,,A,,U,0,Autocuration,CHEMBL626495,,
14237,Rattus norvegicus,1,1969.0,15812,BAO_0000218,,Half life was determined in plasma of rat; NT indicates not tested,,A,,N,1,Intermediate,CHEMBL626496,,
14238,Rattus norvegicus,1,,16618,BAO_0000218,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,A,,N,1,Intermediate,CHEMBL626497,,
14239,,1,,16618,BAO_0000218,,Oral bioavailability after oral tested,,A,,U,0,Autocuration,CHEMBL626498,,
14240,Rattus norvegicus,1,,13098,BAO_0000218,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,A,,N,1,Intermediate,CHEMBL626499,,
14241,Rattus norvegicus,1,,13098,BAO_0000218,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,A,,N,1,Intermediate,CHEMBL626500,,
14242,Rattus norvegicus,1,1969.0,15812,BAO_0000218,,half life was determined in plasma of rat; NT indicates not tested,,A,,N,1,Intermediate,CHEMBL626501,,
14243,Rattus norvegicus,1,1969.0,15812,BAO_0000218,,half life was determined in plasma of rat; NT means not tested,,A,,N,1,Intermediate,CHEMBL626502,,
14244,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,A,,N,1,Intermediate,CHEMBL626503,,
14245,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,A,,N,1,Intermediate,CHEMBL626504,,
14246,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,A,,N,1,Intermediate,CHEMBL626505,,
14247,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,A,,N,1,Intermediate,CHEMBL626506,,
14248,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,A,,N,1,Intermediate,CHEMBL626507,,
14249,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,A,,N,1,Intermediate,CHEMBL626508,,
14250,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,A,,N,1,Intermediate,CHEMBL626509,,
14251,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,A,,N,1,Intermediate,CHEMBL875480,,
14252,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,A,,N,1,Intermediate,CHEMBL626510,,
14253,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,A,,N,1,Intermediate,CHEMBL626511,,
14254,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,A,,N,1,Intermediate,CHEMBL626512,,
14255,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,A,,N,1,Intermediate,CHEMBL628208,,
14256,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,A,,N,1,Intermediate,CHEMBL628209,,
14257,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,A,,N,1,Intermediate,CHEMBL628210,,
14258,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,A,,N,1,Intermediate,CHEMBL628211,,
14259,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,A,,N,1,Intermediate,CHEMBL628212,,
14260,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,A,,N,1,Intermediate,CHEMBL628213,,
14261,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628214,,
14262,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628215,,
14263,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628216,,
14264,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626595,,
14265,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626596,,
14266,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626597,,
14267,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626598,,
14268,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622242,,
14269,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622243,,
14270,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622244,,
14271,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622245,,
14272,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622246,,
14273,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622247,,
14274,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622248,,
14275,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL877483,,
14276,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622249,,
14277,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622250,,
14278,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622251,,
14279,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622252,,
14280,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622253,,
14281,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622254,,
14282,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622255,,
14283,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622256,,
14284,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622257,,
14285,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622258,,
14286,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622259,,
14287,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622927,,
14288,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622928,,
14289,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL622929,,
14290,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623182,,
14291,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623183,,
14292,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623184,,
14293,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623185,,
14294,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL877484,,
14295,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627274,,
14296,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623186,,
14297,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623187,,
14298,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL623188,,
14299,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628055,,
14300,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628056,,
14301,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628200,,
14302,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628201,,
14303,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628202,,
14304,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628203,,
14305,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628204,,
14306,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628205,,
14307,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628206,,
14308,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,A,,U,0,Autocuration,CHEMBL628207,,
14309,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,A,,U,0,Autocuration,CHEMBL627220,,
14310,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,A,,U,0,Autocuration,CHEMBL627221,,
14311,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,A,,U,0,Autocuration,CHEMBL627222,,
14312,,1,,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,A,,U,0,Autocuration,CHEMBL627223,,
14313,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,A,,U,0,Autocuration,CHEMBL632062,,
14314,,1,2106.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,A,,U,0,Autocuration,CHEMBL632063,,
14315,,1,1255.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,A,,U,0,Autocuration,CHEMBL632064,,
14316,,1,178.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,A,,U,0,Autocuration,CHEMBL632065,,
14317,,1,1474.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,A,,U,0,Autocuration,CHEMBL632066,,
14318,,1,,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,A,,U,0,Autocuration,CHEMBL632067,,
14319,,1,2113.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,A,,U,0,Autocuration,CHEMBL629188,,
14320,,1,2107.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,A,,U,0,Autocuration,CHEMBL629189,,
14321,,1,2048.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,A,,U,0,Autocuration,CHEMBL629190,,
14322,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,A,,U,0,Autocuration,CHEMBL629191,,
14323,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,A,,U,0,Autocuration,CHEMBL629192,,
14324,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,A,,U,0,Autocuration,CHEMBL629193,,
14325,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,A,,U,0,Autocuration,CHEMBL629194,,
14326,,1,,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,A,,U,0,Autocuration,CHEMBL629195,,
14327,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,A,,U,0,Autocuration,CHEMBL629373,,
14328,,1,2106.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,A,,U,0,Autocuration,CHEMBL629374,,
14329,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,A,,U,0,Autocuration,CHEMBL629375,,
14330,,1,1255.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,A,,U,0,Autocuration,CHEMBL629376,,
14331,,1,178.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,A,,U,0,Autocuration,CHEMBL629377,,
14332,,1,1474.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,A,,U,0,Autocuration,CHEMBL629378,,
14333,,1,,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,A,,U,0,Autocuration,CHEMBL629379,,
14334,,1,2113.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,A,,U,0,Autocuration,CHEMBL629151,,
14335,,1,2107.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,A,,U,0,Autocuration,CHEMBL629152,,
14336,,1,2048.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,A,,U,0,Autocuration,CHEMBL629153,,
14337,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,A,,U,0,Autocuration,CHEMBL629154,,
14338,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,A,,U,0,Autocuration,CHEMBL629155,,
14339,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,A,,U,0,Autocuration,CHEMBL629156,,
14340,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,A,,U,0,Autocuration,CHEMBL629157,,
14341,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,A,,U,0,Autocuration,CHEMBL629158,,
14342,,1,,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,A,,U,0,Autocuration,CHEMBL629159,,
14343,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,A,,U,0,Autocuration,CHEMBL629160,,
14344,,1,2106.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,A,,U,0,Autocuration,CHEMBL629161,,
14345,,1,1255.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,A,,U,0,Autocuration,CHEMBL629162,,
14346,,1,178.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,A,,U,0,Autocuration,CHEMBL629163,,
14347,,1,1474.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,A,,U,0,Autocuration,CHEMBL629164,,
14348,,1,,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,A,,U,0,Autocuration,CHEMBL629165,,
14349,,1,2107.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,A,,U,0,Autocuration,CHEMBL629166,,
14350,,1,2048.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,A,,U,0,Autocuration,CHEMBL629167,,
14351,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,A,,U,0,Autocuration,CHEMBL629168,,
14352,,1,,2193,BAO_0000019,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,A,,U,0,Autocuration,CHEMBL629169,,
14353,,1,,2193,BAO_0000019,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,A,,U,0,Autocuration,CHEMBL629170,,
14354,,1,,2193,BAO_0000019,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,A,,U,0,Autocuration,CHEMBL631153,,
14355,,1,,2193,BAO_0000019,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,A,,U,0,Autocuration,CHEMBL875121,,
14356,,1,,2193,BAO_0000019,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,A,,U,0,Autocuration,CHEMBL631154,,
14357,,1,,2193,BAO_0000019,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,A,,U,0,Autocuration,CHEMBL631155,,
14358,,1,,568,BAO_0000019,,Hydrolysis rate constant was determined,,A,,U,0,Autocuration,CHEMBL631156,,
14359,,1,,9680,BAO_0000019,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,A,,U,0,Autocuration,CHEMBL631157,,
14360,,1,,9680,BAO_0000019,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,A,,U,0,Autocuration,CHEMBL631158,,
14361,,1,,9680,BAO_0000019,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,A,,U,0,Autocuration,CHEMBL631159,,
14362,,1,,10026,BAO_0000019,,Observed second order rate constant,,A,,U,0,Autocuration,CHEMBL631160,,
14363,,1,,10281,BAO_0000019,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,A,,U,0,Autocuration,CHEMBL631161,,
14364,,1,,10014,BAO_0000019,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,A,,U,0,Autocuration,CHEMBL631162,,
14365,,1,,10014,BAO_0000019,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,A,,U,0,Autocuration,CHEMBL630313,,
14366,,1,,9680,BAO_0000019,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,A,,U,0,Autocuration,CHEMBL630314,,
14367,,1,,9680,BAO_0000019,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,A,,U,0,Autocuration,CHEMBL630315,,
14368,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL630316,,
14369,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL630986,,
14370,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL630987,,
14371,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL630988,,
14372,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL630989,,
14373,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL630990,,
14374,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL630991,,
14375,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL630992,,
14376,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL630993,,
14377,,1,,13028,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,,U,0,Autocuration,CHEMBL630994,,
14378,Rattus norvegicus,1,,10014,BAO_0000218,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,A,,N,1,Intermediate,CHEMBL630995,,
14379,,1,,9962,BAO_0000019,,Association constant for compound at 31 degree C was determined,,A,,U,0,Autocuration,CHEMBL629252,,
14380,,1,,12029,BAO_0000019,,Calculated antagonist equilibrium dissociation constant of the compound,,A,,U,0,Autocuration,CHEMBL629253,,
14381,,1,,12029,BAO_0000019,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,A,,U,0,Autocuration,CHEMBL629944,,
14382,Cavia porcellus,1,3126.0,10583,BAO_0000218,,Dissociation constants vs LTE4 on guinea pig trachea,,A,,N,1,Intermediate,CHEMBL629945,,
14383,,1,,568,BAO_0000019,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,A,,U,0,Autocuration,CHEMBL629946,,
14384,,1,,568,BAO_0000019,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,A,,U,0,Autocuration,CHEMBL629947,,
14385,,1,,568,BAO_0000019,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,A,,U,0,Autocuration,CHEMBL629948,,
14386,,1,,568,BAO_0000019,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,A,,U,0,Autocuration,CHEMBL856024,,
14387,,1,,7493,BAO_0000019,,Affinity constant KD value was derived from TMP,,A,,U,0,Autocuration,CHEMBL629949,,
14388,,1,,8371,BAO_0000019,,Apparent dissociation (binding) rate constant was evaluated,,A,,U,0,Autocuration,CHEMBL629950,,
14389,,1,,13114,BAO_0000100,,Dissociation constant (KD) of the compound,,P,,U,0,Autocuration,CHEMBL630127,,
14390,,1,,15515,BAO_0000100,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,P,,U,0,Autocuration,CHEMBL630128,,
14391,,1,,522,BAO_0000100,,Dissociation constant from ESR titration experiments,,P,,U,0,Autocuration,CHEMBL630129,,
14392,,1,,13888,BAO_0000019,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,,,U,0,Autocuration,CHEMBL630130,,
14393,,1,,2616,BAO_0000100,,Dissociation constant was evaluated.,,P,,U,0,Autocuration,CHEMBL875234,,
14394,,1,,3798,BAO_0000100,,Dissociation constant was reported,,P,,U,0,Autocuration,CHEMBL630131,,
14395,Rattus norvegicus,1,,8731,BAO_0000218,,Dissociation constant was determined in rat pituitary cells.,,A,,N,1,Intermediate,CHEMBL630132,,
14396,,1,,11892,BAO_0000019,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,A,,U,0,Autocuration,CHEMBL630133,,
14397,,1,,11892,BAO_0000019,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,A,,U,0,Autocuration,CHEMBL630134,,
14398,,1,,2582,BAO_0000019,,Equilibrium dissociation constant of the compound,,A,,U,0,Autocuration,CHEMBL630135,,
14399,,1,,11892,BAO_0000019,,Equilibrium dissociation constant was determined,,A,,U,0,Autocuration,CHEMBL630136,,
14400,,1,,13396,BAO_0000019,,Kinetic constant KD was evaluated,,A,,U,0,Autocuration,CHEMBL630137,,
14401,,1,,603,BAO_0000019,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,A,,U,0,Autocuration,CHEMBL630138,,
14402,,1,,15673,BAO_0000019,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,A,,U,0,Autocuration,CHEMBL630139,,
14403,,1,,10368,BAO_0000019,,Rate constant for hydrolysis in aqueous acetone.,,A,,U,0,Autocuration,CHEMBL630140,,
14404,,1,,14228,BAO_0000019,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,A,,U,0,Autocuration,CHEMBL875235,,
14405,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,A,,N,1,Intermediate,CHEMBL876439,,
14406,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,A,,N,1,Intermediate,CHEMBL630605,,
14407,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,A,,N,1,Intermediate,CHEMBL630606,,
14408,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,A,,N,1,Intermediate,CHEMBL630607,,
14409,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,A,,N,1,Intermediate,CHEMBL630608,,
14410,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,A,,N,1,Intermediate,CHEMBL630609,,
14411,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,A,,N,1,Intermediate,CHEMBL630610,,
14412,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,A,,N,1,Intermediate,CHEMBL630611,,
14413,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,A,,N,1,Intermediate,CHEMBL629552,,
14414,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,A,,N,1,Intermediate,CHEMBL629733,,
14415,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,A,,N,1,Intermediate,CHEMBL629734,,
14416,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,A,,N,1,Intermediate,CHEMBL629735,,
14417,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,A,,N,1,Intermediate,CHEMBL629736,,
14418,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,A,,N,1,Intermediate,CHEMBL629737,,
14419,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,A,,N,1,Intermediate,CHEMBL629738,,
14420,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,A,,N,1,Intermediate,CHEMBL629739,,
14421,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,A,,N,1,Intermediate,CHEMBL629740,,
14422,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,A,,N,1,Intermediate,CHEMBL629741,,
14423,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,A,,N,1,Intermediate,CHEMBL629742,,
14424,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,A,,N,1,Intermediate,CHEMBL629743,,
14425,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,A,,N,1,Intermediate,CHEMBL629744,,
14426,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,A,,N,1,Intermediate,CHEMBL629745,,
14427,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,A,,N,1,Intermediate,CHEMBL629746,,
14428,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,A,,N,1,Intermediate,CHEMBL629747,,
14429,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,A,,N,1,Intermediate,CHEMBL629748,,
14430,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,A,,N,1,Intermediate,CHEMBL629749,,
14431,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,A,,N,1,Intermediate,CHEMBL629750,,
14432,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,A,,N,1,Intermediate,CHEMBL629751,,
14433,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,A,,N,1,Intermediate,CHEMBL629752,,
14434,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,A,,N,1,Intermediate,CHEMBL629753,,
14435,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,A,,N,1,Intermediate,CHEMBL629754,,
14436,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,A,,N,1,Intermediate,CHEMBL629755,,
14437,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,A,,N,1,Intermediate,CHEMBL629756,,
14438,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,A,,N,1,Intermediate,CHEMBL629757,,
14439,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,A,,N,1,Intermediate,CHEMBL629758,,
14440,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,A,,N,1,Intermediate,CHEMBL629759,,
14441,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,A,,N,1,Intermediate,CHEMBL629760,,
14442,Rattus norvegicus,1,,11510,BAO_0000218,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,A,,N,1,Intermediate,CHEMBL876443,,
14443,Canis lupus familiaris,1,,8310,BAO_0000218,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,A,,N,1,Intermediate,CHEMBL629761,,
14444,Canis lupus familiaris,1,,8310,BAO_0000218,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,A,,N,1,Intermediate,CHEMBL629762,,
14445,Mus musculus,1,,8310,BAO_0000218,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,A,,N,1,Intermediate,CHEMBL629763,,
14446,Mus musculus,1,,8310,BAO_0000218,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,A,,N,1,Intermediate,CHEMBL629764,,
14447,Mus musculus,1,,8310,BAO_0000218,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,A,,N,1,Intermediate,CHEMBL629765,,
14448,Mus musculus,1,,8310,BAO_0000218,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,A,,N,1,Intermediate,CHEMBL629766,,
14449,Mus musculus,1,,8310,BAO_0000218,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,A,,N,1,Intermediate,CHEMBL629767,,
14450,Canis lupus familiaris,1,,8310,BAO_0000218,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,A,,N,1,Intermediate,CHEMBL629768,,
14451,Mus musculus,1,,8310,BAO_0000218,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,A,,N,1,Intermediate,CHEMBL629769,,
14452,Canis lupus familiaris,1,,8310,BAO_0000218,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,A,,N,1,Intermediate,CHEMBL629770,,
14453,Canis lupus familiaris,1,,8310,BAO_0000218,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,A,,N,1,Intermediate,CHEMBL629771,,
14454,Mus musculus,1,,8310,BAO_0000218,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,A,,N,1,Intermediate,CHEMBL629772,,
14455,Mus musculus,1,,8310,BAO_0000218,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,A,,N,1,Intermediate,CHEMBL629773,,
14456,Mus musculus,1,,8310,BAO_0000218,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,A,,N,1,Intermediate,CHEMBL625455,,
14457,Mus musculus,1,,8310,BAO_0000218,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,A,,N,1,Intermediate,CHEMBL625456,,
14458,Mus musculus,1,,8310,BAO_0000218,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,A,,N,1,Intermediate,CHEMBL625457,,
14459,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625458,,
14460,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625459,,
14461,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL875483,,
14462,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL634779,,
14463,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625460,,
14464,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626117,,
14465,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626118,,
14466,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628342,,
14467,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628343,,
14468,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628344,,
14469,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628345,,
14470,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628346,,
14471,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628347,,
14472,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628348,,
14473,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628349,,
14474,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL875611,,
14475,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628350,,
14476,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628351,,
14477,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628352,,
14478,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628353,,
14479,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628354,,
14480,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626667,,
14481,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626668,,
14482,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626669,,
14483,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626670,,
14484,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626671,,
14485,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626672,,
14486,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626673,,
14487,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626674,,
14488,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626675,,
14489,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626676,,
14490,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626677,,
14491,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626678,,
14492,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626679,,
14493,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL875612,,
14494,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626680,,
14495,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626681,,
14496,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626682,,
14497,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626683,,
14498,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626684,,
14499,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626685,,
14500,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626686,,
14501,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626687,,
14502,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL624978,,
14503,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL624979,,
14504,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL624980,,
14505,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL624981,,
14506,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL624982,,
14507,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,A,,U,0,Autocuration,CHEMBL627564,,
14508,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,A,,U,0,Autocuration,CHEMBL627565,,
14509,,1,,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,A,,U,0,Autocuration,CHEMBL627566,,
14510,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,A,,U,0,Autocuration,CHEMBL627567,,
14511,,1,2106.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,A,,U,0,Autocuration,CHEMBL627568,,
14512,,1,2113.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,A,,U,0,Autocuration,CHEMBL627569,,
14513,,1,1255.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,A,,U,0,Autocuration,CHEMBL627570,,
14514,,1,178.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,A,,U,0,Autocuration,CHEMBL627571,,
14515,,1,1474.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,A,,U,0,Autocuration,CHEMBL627572,,
14516,,1,,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,A,,U,0,Autocuration,CHEMBL627573,,
14517,,1,2113.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,A,,U,0,Autocuration,CHEMBL627574,,
14518,,1,2107.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,A,,U,0,Autocuration,CHEMBL627575,,
14519,,1,2048.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,A,,U,0,Autocuration,CHEMBL627576,,
14520,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,A,,U,0,Autocuration,CHEMBL627577,,
14521,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,A,,U,0,Autocuration,CHEMBL627578,,
14522,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,A,,U,0,Autocuration,CHEMBL627579,,
14523,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,A,,U,0,Autocuration,CHEMBL627580,,
14524,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,A,,U,0,Autocuration,CHEMBL627581,,
14525,,1,,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,A,,U,0,Autocuration,CHEMBL627582,,
14526,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,A,,U,0,Autocuration,CHEMBL627583,,
14527,,1,2106.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,A,,U,0,Autocuration,CHEMBL627584,,
14528,,1,2367.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,A,,U,0,Autocuration,CHEMBL627585,,
14529,,1,2385.0,13257,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,A,,U,0,Autocuration,CHEMBL627586,,
14530,Rattus norvegicus,1,,15413,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL627587,,
14531,Rattus norvegicus,1,,15413,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL627588,,
14532,Rattus norvegicus,1,,15413,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL628250,,
14533,Rattus norvegicus,1,,15413,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL628251,,
14534,Rattus norvegicus,1,10000000.0,15413,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL628252,,
14535,Rattus norvegicus,1,10000000.0,15413,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL628253,,
14536,Rattus norvegicus,1,1898.0,15413,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL628254,,
14537,Rattus norvegicus,1,1898.0,15413,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL877493,,
14538,Rattus norvegicus,1,,15413,BAO_0000218,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL628255,,
14539,Rattus norvegicus,1,,15413,BAO_0000218,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL628256,,
14540,Rattus norvegicus,1,10000000.0,15413,BAO_0000218,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL628257,,
14541,Rattus norvegicus,1,1898.0,15413,BAO_0000218,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL628258,,
14542,Rattus norvegicus,1,,15413,BAO_0000218,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL628259,,
14543,Rattus norvegicus,1,,15413,BAO_0000218,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL628429,,
14544,Rattus norvegicus,1,10000000.0,15413,BAO_0000218,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,A,,N,1,Intermediate,CHEMBL626862,,
14545,Rattus norvegicus,1,1898.0,15413,BAO_0000218,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,A,,N,1,Intermediate,CHEMBL626863,,
14546,Rattus norvegicus,1,2037.0,15413,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,A,,N,1,Intermediate,CHEMBL625886,,
14547,Rattus norvegicus,1,2037.0,15413,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,A,,N,1,Intermediate,CHEMBL625887,,
14548,Rattus norvegicus,1,,15413,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,A,,N,1,Intermediate,CHEMBL625888,,
14549,Rattus norvegicus,1,,15413,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,A,,N,1,Intermediate,CHEMBL625889,,
14550,Rattus norvegicus,1,10000000.0,15413,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,A,,N,1,Intermediate,CHEMBL625890,,
14551,Rattus norvegicus,1,10000000.0,15413,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,A,,N,1,Intermediate,CHEMBL625891,,
14552,Rattus norvegicus,1,1898.0,15413,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,A,,N,1,Intermediate,CHEMBL625892,,
14553,Rattus norvegicus,1,1898.0,15413,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,A,,N,1,Intermediate,CHEMBL625893,,
14554,Rattus norvegicus,1,2037.0,15413,BAO_0000218,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,A,,N,1,Intermediate,CHEMBL625894,,
14555,Rattus norvegicus,1,,15413,BAO_0000218,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,A,,N,1,Intermediate,CHEMBL625895,,
14556,,1,,12404,BAO_0000019,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,A,,U,0,Autocuration,CHEMBL625896,,
14557,,1,,568,BAO_0000019,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,A,,U,0,Autocuration,CHEMBL625897,,
14558,,1,,568,BAO_0000019,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,A,,U,0,Autocuration,CHEMBL625898,,
14559,,1,,568,BAO_0000019,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,A,,U,0,Autocuration,CHEMBL625899,,
14560,,1,,12404,BAO_0000019,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,A,,U,0,Autocuration,CHEMBL626124,,
14561,Escherichia coli,1,,7624,BAO_0000218,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,A,,N,1,Intermediate,CHEMBL628500,,
14562,Rattus norvegicus,1,,7624,BAO_0000218,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,A,,N,1,Intermediate,CHEMBL857856,,
14563,Rattus norvegicus,1,,7624,BAO_0000218,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,A,,N,1,Intermediate,CHEMBL628501,,
14564,,1,,4643,BAO_0000019,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,A,,U,0,Autocuration,CHEMBL628502,,
14565,,1,,11532,BAO_0000019,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,A,,U,0,Autocuration,CHEMBL628503,,
14566,,1,,11018,BAO_0000019,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,A,,U,0,Autocuration,CHEMBL628504,,
14567,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,A,,U,0,Autocuration,CHEMBL628505,,
14568,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,A,,U,0,Autocuration,CHEMBL874452,,
14569,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,A,,U,0,Autocuration,CHEMBL628506,,
14570,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,A,,U,0,Autocuration,CHEMBL628507,,
14571,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,A,,U,0,Autocuration,CHEMBL628508,,
14572,,1,,8949,BAO_0000019,,Michaelis constant (KM) was evaluated,,A,,U,0,Autocuration,CHEMBL628509,,
14573,,1,,12404,BAO_0000019,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,A,,U,0,Autocuration,CHEMBL628510,,
14574,,1,,7625,BAO_0000019,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,B,,U,0,Autocuration,CHEMBL628511,,
14575,,1,,7625,BAO_0000019,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,B,,U,0,Autocuration,CHEMBL628512,,
14576,,1,,7625,BAO_0000019,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,B,,U,0,Autocuration,CHEMBL628513,,
14577,,1,,7625,BAO_0000019,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,B,,U,0,Autocuration,CHEMBL628514,,
14578,,1,,12908,BAO_0000019,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,A,,U,0,Autocuration,CHEMBL628515,,
14579,,1,,10368,BAO_0000019,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,A,,U,0,Autocuration,CHEMBL628516,,
14580,,1,,13108,BAO_0000019,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,A,,U,0,Autocuration,CHEMBL628517,,
14581,,1,,13108,BAO_0000019,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,A,,U,0,Autocuration,CHEMBL628518,,
14582,,1,,15217,BAO_0000019,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,A,,U,0,Autocuration,CHEMBL628519,,
14583,,1,,15217,BAO_0000019,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,A,,U,0,Autocuration,CHEMBL628520,,
14584,,1,,10933,BAO_0000019,,Binding constant was determined,,A,,U,0,Autocuration,CHEMBL628521,,
14585,,1,,2363,BAO_0000019,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,A,,U,0,Autocuration,CHEMBL630443,,
14586,,1,,2363,BAO_0000019,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,A,,U,0,Autocuration,CHEMBL630444,,
14587,,1,,2276,BAO_0000019,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,A,,U,0,Autocuration,CHEMBL857732,,
14588,,1,,14915,BAO_0000100,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,P,,U,0,Autocuration,CHEMBL630445,,
14589,,1,,8847,BAO_0000019,,Catalytic rate constant of the compound,,A,,U,0,Autocuration,CHEMBL630446,,
14590,,1,,15357,BAO_0000019,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,B,,U,0,Autocuration,CHEMBL630447,,
14591,,1,,2869,BAO_0000019,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,A,,U,0,Autocuration,CHEMBL630448,,
14592,,1,,3484,BAO_0000019,,Catalytic rate constant against phospholipase A2 was determined,,A,,U,0,Autocuration,CHEMBL630449,,
14593,,1,,1373,BAO_0000019,,"Compound was evaluated for catalytic constant, Kcat",,A,,U,0,Autocuration,CHEMBL630450,,
14594,,1,,8142,BAO_0000019,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,A,,U,0,Autocuration,CHEMBL630451,,
14595,,1,,14131,BAO_0000019,,Kcat calculated from 0.693/T1/2,,A,,U,0,Autocuration,CHEMBL630452,,
14596,,1,,17269,BAO_0000019,,Kcat was determined,,A,,U,0,Autocuration,CHEMBL630453,,
14597,,1,,3485,BAO_0000019,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,A,,U,0,Autocuration,CHEMBL630454,,
14598,,1,,3485,BAO_0000019,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,A,,U,0,Autocuration,CHEMBL630455,,
14599,,1,,3485,BAO_0000019,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,A,,U,0,Autocuration,CHEMBL631487,,
14600,,1,,5962,BAO_0000019,,Kcat value was determined,,A,,U,0,Autocuration,CHEMBL631488,,
14601,,1,,3133,BAO_0000019,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,A,,U,0,Autocuration,CHEMBL876440,,
14602,,1,,3133,BAO_0000019,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,A,,U,0,Autocuration,CHEMBL631489,,
14603,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,A,,U,0,Autocuration,CHEMBL857742,,
14604,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,A,,U,0,Autocuration,CHEMBL631490,,
14605,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,A,,U,0,Autocuration,CHEMBL631491,,
14606,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,A,,U,0,Autocuration,CHEMBL631492,,
14607,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,A,,U,0,Autocuration,CHEMBL631493,,
14608,,1,,4892,BAO_0000019,,Kinetic parameter for rate of conversion to PABA was determined,,A,,U,0,Autocuration,CHEMBL631494,,
14609,,1,,3133,BAO_0000019,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,A,,U,0,Autocuration,CHEMBL631495,,
14610,Rattus norvegicus,1,1988.0,11488,BAO_0000218,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,A,,N,1,Intermediate,CHEMBL631496,,
14611,Rattus norvegicus,1,1088.0,11488,BAO_0000218,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,A,,N,1,Intermediate,CHEMBL631497,,
14612,Rattus norvegicus,1,1088.0,11488,BAO_0000218,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,A,,N,1,Intermediate,CHEMBL631498,,
14613,Rattus norvegicus,1,1088.0,11488,BAO_0000218,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,A,,N,1,Intermediate,CHEMBL629776,,
14614,Rattus norvegicus,1,1088.0,11488,BAO_0000218,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,A,,N,1,Intermediate,CHEMBL629777,,
14615,Rattus norvegicus,1,1088.0,11488,BAO_0000218,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,A,,N,1,Intermediate,CHEMBL629778,,
14616,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,A,,N,1,Intermediate,CHEMBL630456,,
14617,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,A,,N,1,Intermediate,CHEMBL630457,,
14618,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,A,,N,1,Intermediate,CHEMBL630458,,
14619,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,A,,N,1,Intermediate,CHEMBL630459,,
14620,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,A,,N,1,Intermediate,CHEMBL630460,,
14621,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,A,,N,1,Intermediate,CHEMBL876550,,
14622,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,A,,N,1,Intermediate,CHEMBL630461,,
14623,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,A,,N,1,Intermediate,CHEMBL630462,,
14624,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,A,,N,1,Intermediate,CHEMBL630463,,
14625,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,A,,N,1,Intermediate,CHEMBL630464,,
14626,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,A,,N,1,Intermediate,CHEMBL630465,,
14627,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,A,,N,1,Intermediate,CHEMBL630466,,
14628,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,A,,N,1,Intermediate,CHEMBL630467,,
14629,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,A,,N,1,Intermediate,CHEMBL630633,,
14630,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,A,,N,1,Intermediate,CHEMBL630634,,
14631,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,A,,N,1,Intermediate,CHEMBL630635,,
14632,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,A,,N,1,Intermediate,CHEMBL630636,,
14633,Rattus norvegicus,1,,11488,BAO_0000218,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,A,,N,1,Intermediate,CHEMBL630637,,
14634,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,A,,N,1,Intermediate,CHEMBL630638,,
14635,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,A,,N,1,Intermediate,CHEMBL630639,,
14636,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,A,,N,1,Intermediate,CHEMBL630640,,
14637,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,A,,N,1,Intermediate,CHEMBL876551,,
14638,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,A,,N,1,Intermediate,CHEMBL630641,,
14639,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,A,,N,1,Intermediate,CHEMBL630642,,
14640,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,A,,N,1,Intermediate,CHEMBL630643,,
14641,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,A,,N,1,Intermediate,CHEMBL630644,,
14642,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,A,,N,1,Intermediate,CHEMBL630645,,
14643,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,A,,N,1,Intermediate,CHEMBL625599,,
14644,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,A,,N,1,Intermediate,CHEMBL625600,,
14645,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,A,,N,1,Intermediate,CHEMBL625601,,
14646,Oryctolagus cuniculus,1,1988.0,7132,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,A,,N,1,Intermediate,CHEMBL625602,,
14647,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,A,,N,1,Intermediate,CHEMBL627470,,
14648,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,A,,N,1,Intermediate,CHEMBL627471,,
14649,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,A,,N,1,Intermediate,CHEMBL627472,,
14650,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,A,,N,1,Intermediate,CHEMBL627473,,
14651,Oryctolagus cuniculus,1,1088.0,7132,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,A,,N,1,Intermediate,CHEMBL627474,,
14652,Rattus norvegicus,1,178.0,13925,BAO_0000218,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL627475,,
14653,Rattus norvegicus,1,178.0,13925,BAO_0000218,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL627476,,
14654,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627477,,
14655,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627478,,
14656,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627479,,
14657,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627480,,
14658,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627481,,
14659,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627482,,
14660,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL627483,,
14661,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL875636,,
14662,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625764,,
14663,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625765,,
14664,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625766,,
14665,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625767,,
14666,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625768,,
14667,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625769,,
14668,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625770,,
14669,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625771,,
14670,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625772,,
14671,Canis lupus familiaris,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625773,,
14672,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625774,,
14673,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625775,,
14674,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625776,,
14675,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625777,,
14676,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625778,,
14677,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625779,,
14678,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625780,,
14679,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL625781,,
14680,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL875637,,
14681,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626473,,
14682,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626474,,
14683,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626475,,
14684,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626476,,
14685,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL634397,,
14686,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL626477,,
14687,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631069,,
14688,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631070,,
14689,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631071,,
14690,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631072,,
14691,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631073,,
14692,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631074,,
14693,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631075,,
14694,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631725,,
14695,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631726,,
14696,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631727,,
14697,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631728,,
14698,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631729,,
14699,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631730,,
14700,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631731,,
14701,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631910,,
14702,Rattus norvegicus,1,10000000.0,15413,BAO_0000218,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,A,,N,1,Intermediate,CHEMBL631911,,
14703,Rattus norvegicus,1,1898.0,15413,BAO_0000218,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,A,,N,1,Intermediate,CHEMBL631912,,
14704,Rattus norvegicus,1,1898.0,15413,BAO_0000218,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,A,,N,1,Intermediate,CHEMBL631913,,
14705,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631914,,
14706,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631915,,
14707,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL875778,,
14708,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631916,,
14709,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631917,,
14710,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631918,,
14711,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631919,,
14712,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL631920,,
14713,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631921,,
14714,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631922,,
14715,Rattus norvegicus,1,178.0,12017,BAO_0000218,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL631923,,
14716,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631924,,
14717,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630234,,
14718,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL630235,,
14719,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630236,,
14720,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630237,,
14721,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630238,,
14722,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630239,,
14723,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL630303,,
14724,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630304,,
14725,Rattus norvegicus,1,,12017,BAO_0000218,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630305,,
14726,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630306,,
14727,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630307,,
14728,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL630308,,
14729,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630309,,
14730,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL629309,,
14731,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL629993,,
14732,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL629994,,
14733,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL629995,,
14734,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631993,,
14735,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631994,,
14736,Rattus norvegicus,1,2113.0,12017,BAO_0000218,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631995,,
14737,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL631996,,
14738,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631997,,
14739,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631998,,
14740,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631999,,
14741,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL632000,,
14742,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL632001,,
14743,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL874424,,
14744,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL632002,,
14745,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL632003,,
14746,,1,,3133,BAO_0000019,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,A,,U,0,Autocuration,CHEMBL632004,,
14747,,1,,2742,BAO_0000019,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,A,,U,0,Autocuration,CHEMBL632005,,
14748,,1,,2742,BAO_0000019,,Compound was tested for amidase rate in the presence of N62C screen enzyme,,A,,U,0,Autocuration,CHEMBL632006,,
14749,,1,,2742,BAO_0000019,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,A,,U,0,Autocuration,CHEMBL632007,,
14750,,1,,2742,BAO_0000019,,Compound was tested for amidase rate in the presence of S166C screen enzyme,,A,,U,0,Autocuration,CHEMBL632008,,
14751,,1,,2742,BAO_0000019,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,A,,U,0,Autocuration,CHEMBL632009,,
14752,,1,,2742,BAO_0000019,,Compound was tested for esterase rate in the presence of N62C screen enzyme,,A,,U,0,Autocuration,CHEMBL632010,,
14753,,1,,2742,BAO_0000019,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,A,,U,0,Autocuration,CHEMBL857750,,
14754,,1,,2742,BAO_0000019,,Compound was tested for esterase rate in the presence of S166C screen enzyme,,A,,U,0,Autocuration,CHEMBL632011,,
14755,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,A,,U,0,Autocuration,CHEMBL632012,,
14756,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,A,,U,0,Autocuration,CHEMBL632013,,
14757,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,A,,U,0,Autocuration,CHEMBL632014,,
14758,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,A,,U,0,Autocuration,CHEMBL629622,,
14759,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,A,,U,0,Autocuration,CHEMBL629623,,
14760,,1,,2276,BAO_0000019,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,A,,U,0,Autocuration,CHEMBL629624,,
14761,,1,,17269,BAO_0000019,,Ratio of Kcat to that of Km was determined,,A,,U,0,Autocuration,CHEMBL629625,,
14762,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,A,,U,0,Autocuration,CHEMBL629626,,
14763,,1,,2276,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,A,,U,0,Autocuration,CHEMBL629627,,
14764,,1,,15917,BAO_0000019,,"Compound was evaluated for constant, Kd",,A,,U,0,Autocuration,CHEMBL629628,,
14765,,1,,10933,BAO_0000019,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,A,,U,0,Autocuration,CHEMBL629629,,
14766,,1,,10933,BAO_0000019,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,A,,U,0,Autocuration,CHEMBL629630,,
14767,,1,,14293,BAO_0000019,,Dissociation Constant of compound determined,,A,,U,0,Autocuration,CHEMBL856030,,
14768,,1,,6698,BAO_0000019,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,B,,U,0,Autocuration,CHEMBL629631,,
14769,,1,,6698,BAO_0000019,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,B,,U,0,Autocuration,CHEMBL629632,,
14770,,1,,4318,BAO_0000100,,Dissociation constant of compound with Fructose was determined,,P,,U,0,Autocuration,CHEMBL629633,,
14771,,1,,4318,BAO_0000100,,Dissociation constant of compound with Fructose was determined; Not determined,,P,,U,0,Autocuration,CHEMBL629634,,
14772,,1,,4318,BAO_0000100,,Dissociation constant of compound with Lactulose was determined,,P,,U,0,Autocuration,CHEMBL629635,,
14773,,1,,4318,BAO_0000100,,Dissociation constant of compound with Lactulose was determined; Not determined,,P,,U,0,Autocuration,CHEMBL629636,,
14774,,1,,14959,BAO_0000100,,Dissociation constant of the Compound,,P,,U,0,Autocuration,CHEMBL629637,,
14775,,1,,5913,BAO_0000100,,Dissociation constant by non-linear regression analysis,,P,,U,0,Autocuration,CHEMBL629638,,
14776,,1,,14218,BAO_0000100,,Dissociation constant was determined,,P,,U,0,Autocuration,CHEMBL629639,,
14777,,1,,10689,BAO_0000100,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,P,,U,0,Autocuration,CHEMBL629640,,
14778,,1,,13925,BAO_0000100,,Dissociation constant was determined,,P,,U,0,Autocuration,CHEMBL629641,,
14779,,1,,16359,BAO_0000100,,Dissociation constant was determined,,P,,U,0,Autocuration,CHEMBL631344,,
14780,Rattus norvegicus,1,2385.0,10944,BAO_0000218,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,A,,N,1,Intermediate,CHEMBL631345,,
14781,,1,,11080,BAO_0000019,,The dissociation constant determined by fluorescence displacement assay,,A,,U,0,Autocuration,CHEMBL631346,,
14782,,1,,17805,BAO_0000019,,kd value surface plasmon resonance (SPR) method,,A,,U,0,Autocuration,CHEMBL631524,,
14783,Rattus norvegicus,1,2385.0,10944,BAO_0000218,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,A,,N,1,Intermediate,CHEMBL631525,,
14784,,1,,16645,BAO_0000019,,First dissociation constant of the binding of compound to V30M TTR,,F,,U,0,Autocuration,CHEMBL631526,,
14785,,1,,16645,BAO_0000019,,Second dissociation constant of the binding of compound to V30M TTR,,F,,U,0,Autocuration,CHEMBL631527,,
14786,,1,,7793,BAO_0000019,,"Compound was evaluated for equilibrium constant, Ke",,A,,U,0,Autocuration,CHEMBL631528,,
14787,,1,1898.0,12199,BAO_0000019,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,A,,U,0,Autocuration,CHEMBL631529,,
14788,,1,1898.0,12199,BAO_0000019,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,A,,U,0,Autocuration,CHEMBL631530,,
14789,,1,,9680,BAO_0000019,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,A,,U,0,Autocuration,CHEMBL631531,,
14790,,1,,9680,BAO_0000019,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,A,,U,0,Autocuration,CHEMBL631532,,
14791,,1,,9680,BAO_0000019,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,A,,U,0,Autocuration,CHEMBL631533,,
14792,Mus musculus,1,,13758,BAO_0000218,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,A,,N,1,Intermediate,CHEMBL876552,,
14793,Mus musculus,1,,13758,BAO_0000218,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,A,,N,1,Intermediate,CHEMBL631534,,
14794,Mus musculus,1,,13758,BAO_0000218,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,A,,N,1,Intermediate,CHEMBL631535,,
14795,Mus musculus,1,,13758,BAO_0000218,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,A,,N,1,Intermediate,CHEMBL631536,,
14796,Mus musculus,1,,13758,BAO_0000218,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,A,,N,1,Intermediate,CHEMBL631537,,
14797,Mus musculus,1,,13758,BAO_0000218,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,A,,N,1,Intermediate,CHEMBL631538,,
14798,Mus musculus,1,,13758,BAO_0000218,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,A,,N,1,Intermediate,CHEMBL631539,,
14799,Mus musculus,1,,13758,BAO_0000218,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,A,,N,1,Intermediate,CHEMBL631540,,
14800,Rattus norvegicus,1,,14393,BAO_0000218,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,A,,N,1,Intermediate,CHEMBL625637,,
14801,Rattus norvegicus,1,,14393,BAO_0000218,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,A,,N,1,Intermediate,CHEMBL625638,,
14802,Rattus norvegicus,1,,15078,BAO_0000218,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,A,,N,1,Intermediate,CHEMBL625639,,
14803,Rattus norvegicus,1,955.0,13925,BAO_0000218,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625640,,
14804,Rattus norvegicus,1,955.0,13925,BAO_0000218,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625641,,
14805,Rattus norvegicus,1,948.0,13925,BAO_0000218,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625642,,
14806,Rattus norvegicus,1,948.0,13925,BAO_0000218,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625643,,
14807,Rattus norvegicus,1,2113.0,13925,BAO_0000218,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625644,,
14808,Rattus norvegicus,1,2113.0,13925,BAO_0000218,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625645,,
14809,Rattus norvegicus,1,2107.0,13925,BAO_0000218,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625646,,
14810,Rattus norvegicus,1,2107.0,13925,BAO_0000218,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625647,,
14811,Rattus norvegicus,1,2048.0,13925,BAO_0000218,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625648,,
14812,Rattus norvegicus,1,2048.0,13925,BAO_0000218,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625649,,
14813,Rattus norvegicus,1,2385.0,13925,BAO_0000218,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625650,,
14814,Rattus norvegicus,1,2385.0,13925,BAO_0000218,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625651,,
14815,Rattus norvegicus,1,14.0,13925,BAO_0000218,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625652,,
14816,Rattus norvegicus,1,14.0,13925,BAO_0000218,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625653,,
14817,Rattus norvegicus,1,2106.0,13925,BAO_0000218,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625654,,
14818,Rattus norvegicus,1,2106.0,13925,BAO_0000218,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,A,,N,1,Intermediate,CHEMBL625655,,
14819,Rattus norvegicus,1,178.0,9712,BAO_0000218,,Biodistribution of Compound in rat blood after 15 minutes of administration,,A,,N,1,Intermediate,CHEMBL625656,,
14820,Rattus norvegicus,1,178.0,9712,BAO_0000218,,Biodistribution of Compound in rat blood after 2 minutes of administration,,A,,N,1,Intermediate,CHEMBL625657,,
14821,Rattus norvegicus,1,955.0,9712,BAO_0000218,,Biodistribution of Compound in rat brain after 15 minutes of administration,,A,,N,1,Intermediate,CHEMBL625658,,
14822,Rattus norvegicus,1,955.0,9712,BAO_0000218,,Biodistribution of Compound in rat brain after 2 minutes of administration,,A,,N,1,Intermediate,CHEMBL625659,,
14823,Rattus norvegicus,1,948.0,9712,BAO_0000218,,Biodistribution of Compound in rat heart after 15 minutes of administration,,A,,N,1,Intermediate,CHEMBL625660,,
14824,Rattus norvegicus,1,948.0,9712,BAO_0000218,,Biodistribution of Compound in rat heart after 2 minutes of administration,,A,,N,1,Intermediate,CHEMBL625661,,
14825,Rattus norvegicus,1,2107.0,9712,BAO_0000218,,Biodistribution of Compound in rat liver after 15 minutes of administration,,A,,N,1,Intermediate,CHEMBL625662,,
14826,Rattus norvegicus,1,2107.0,9712,BAO_0000218,,Biodistribution of Compound in rat liver after 2 minutes of administration,,A,,N,1,Intermediate,CHEMBL625663,,
14827,Rattus norvegicus,1,2048.0,9712,BAO_0000218,,Biodistribution of Compound in rat lung after 15 minutes of administration,,A,,N,1,Intermediate,CHEMBL875621,,
14828,Rattus norvegicus,1,2048.0,9712,BAO_0000218,,Biodistribution of Compound in rat lung after 2 minutes of administration,,A,,N,1,Intermediate,CHEMBL628382,,
14829,Rattus norvegicus,1,2385.0,9712,BAO_0000218,,Biodistribution of Compound in rat muscle after 15 minutes of administration,,A,,N,1,Intermediate,CHEMBL628383,,
14830,Rattus norvegicus,1,2385.0,9712,BAO_0000218,,Biodistribution of Compound in rat muscle after 2 minutes of administration,,A,,N,1,Intermediate,CHEMBL628384,,
14831,Rattus norvegicus,1,,13925,BAO_0000218,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,A,,N,1,Intermediate,CHEMBL628385,,
14832,Rattus norvegicus,1,,13925,BAO_0000218,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,A,,N,1,Intermediate,CHEMBL875753,,
14833,Rattus norvegicus,1,,13925,BAO_0000218,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,A,,N,1,Intermediate,CHEMBL628386,,
14834,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat blood 2 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL628387,,
14835,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat blood 2 hr after intravenous injection,,A,,N,1,Intermediate,CHEMBL628388,,
14836,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat blood 30 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL628389,,
14837,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat blood 30 min after intravenous injection,,A,,N,1,Intermediate,CHEMBL632756,,
14838,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat brain 2 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL628390,,
14839,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat brain 2 hr after intravenous injection,,A,,N,1,Intermediate,CHEMBL631811,,
14840,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat brain 30 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL631812,,
14841,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat heart 2 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL631813,,
14842,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat heart 2 hr after intravenous injection,,A,,N,1,Intermediate,CHEMBL631814,,
14843,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat heart 30 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL631815,,
14844,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat kidney 2 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL631816,,
14845,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat kidney 2 hr after intravenous injection,,A,,N,1,Intermediate,CHEMBL875758,,
14846,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat kidney 30 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL631817,,
14847,Rattus norvegicus,1,2107.0,6941,BAO_0000218,,Organ distribution in rat liver 2 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL631818,,
14848,Rattus norvegicus,1,2107.0,6941,BAO_0000218,,Organ distribution in rat liver 2 hr after intravenous injection,,A,,N,1,Intermediate,CHEMBL631819,,
14849,Rattus norvegicus,1,2107.0,6941,BAO_0000218,,Organ distribution in rat liver 30 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL631820,,
14850,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat lung 2 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL631821,,
14851,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat lung 2 hr after intravenous injection,,A,,N,1,Intermediate,CHEMBL631822,,
14852,Rattus norvegicus,1,,6941,BAO_0000218,,Organ distribution in rat lung 30 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL631823,,
14853,Rattus norvegicus,1,2385.0,6941,BAO_0000218,,Organ distribution in rat muscle 2 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL631824,,
14854,Rattus norvegicus,1,2385.0,6941,BAO_0000218,,Organ distribution in rat muscle 2 hr after intravenous injection,,A,,N,1,Intermediate,CHEMBL631825,,
14855,Rattus norvegicus,1,2385.0,6941,BAO_0000218,,Organ distribution in rat muscle 30 minutes after intravenous injection,,A,,N,1,Intermediate,CHEMBL631826,,
14856,Mus musculus,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,A,,N,1,Intermediate,CHEMBL631827,,
14857,Mus musculus,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,A,,N,1,Intermediate,CHEMBL631828,,
14858,Mus musculus,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,A,,N,1,Intermediate,CHEMBL631829,,
14859,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL875759,,
14860,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631830,,
14861,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631831,,
14862,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631832,,
14863,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631833,,
14864,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631834,,
14865,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631835,,
14866,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631836,,
14867,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631837,,
14868,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631838,,
14869,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631839,,
14870,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631840,,
14871,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631841,,
14872,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631842,,
14873,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631843,,
14874,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631844,,
14875,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631845,,
14876,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631846,,
14877,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL875760,,
14878,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL632199,,
14879,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631847,,
14880,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL631848,,
14881,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628707,,
14882,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628708,,
14883,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628709,,
14884,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628710,,
14885,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628711,,
14886,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628712,,
14887,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628713,,
14888,Rattus norvegicus,1,1088.0,12582,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,A,,N,1,Intermediate,CHEMBL628714,,
14889,Rattus norvegicus,1,,7415,BAO_0000218,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,A,,N,1,Intermediate,CHEMBL628715,,
14890,,1,,7313,BAO_0000019,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,A,,U,0,Autocuration,CHEMBL629179,,
14891,,1,,7313,BAO_0000019,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,A,,U,0,Autocuration,CHEMBL629180,,
14892,,1,,7313,BAO_0000019,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,A,,U,0,Autocuration,CHEMBL875108,,
14893,,1,1235.0,7570,BAO_0000019,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629181,,
14894,,1,1235.0,7570,BAO_0000019,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629182,,
14895,,1,,7570,BAO_0000019,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629183,,
14896,,1,,7570,BAO_0000019,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629184,,
14897,,1,1235.0,7570,BAO_0000019,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629185,,
14898,,1,1235.0,7570,BAO_0000019,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629186,,
14899,,1,,7570,BAO_0000019,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629187,,
14900,,1,,7570,BAO_0000019,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629887,,
14901,,1,,7570,BAO_0000019,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629888,,
14902,,1,,7570,BAO_0000019,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629889,,
14903,,1,1235.0,7570,BAO_0000019,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629890,,
14904,,1,,7570,BAO_0000019,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629891,,
14905,,1,,7570,BAO_0000019,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629892,,
14906,,1,1235.0,7570,BAO_0000019,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629893,,
14907,,1,,7570,BAO_0000019,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629894,,
14908,,1,,7570,BAO_0000019,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,A,,U,0,Autocuration,CHEMBL629895,,
14909,Canis lupus familiaris,1,,14122,BAO_0000218,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,A,,U,0,Autocuration,CHEMBL875109,,
14910,Macaca fascicularis,1,,16449,BAO_0000218,,Absolute bioavailability in male cynomolgus monkeys,,A,,U,0,Autocuration,CHEMBL629896,,
14911,Rattus norvegicus,1,,16449,BAO_0000218,,Absolute bioavailability in maleSprague-Dawley rats,,A,,U,0,Autocuration,CHEMBL629897,,
14912,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL629898,,
14913,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630057,,
14914,Rattus norvegicus,1,2107.0,12017,BAO_0000218,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630058,,
14915,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630059,,
14916,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630060,,
14917,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL630061,,
14918,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630062,,
14919,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630063,,
14920,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630064,,
14921,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630065,,
14922,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL630066,,
14923,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630067,,
14924,Rattus norvegicus,1,2048.0,12017,BAO_0000218,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630068,,
14925,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631113,,
14926,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631114,,
14927,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL631115,,
14928,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL631116,,
14929,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630528,,
14930,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630529,,
14931,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630530,,
14932,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL630531,,
14933,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630532,,
14934,Rattus norvegicus,1,2385.0,12017,BAO_0000218,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630533,,
14935,Mus musculus,1,178.0,15045,BAO_0000218,,Biodistribution in normal mice blood after 120 hr,,A,,N,1,Intermediate,CHEMBL630534,,
14936,Mus musculus,1,178.0,15045,BAO_0000218,,Biodistribution in normal mice blood after 24 hr,,A,,N,1,Intermediate,CHEMBL630535,,
14937,Mus musculus,1,178.0,15045,BAO_0000218,,Biodistribution in normal mice blood after 4 hr,,A,,N,1,Intermediate,CHEMBL630536,,
14938,Mus musculus,1,10000001.0,15045,BAO_0000218,,Biodistribution in normal mice bone after 120 hr,,A,,N,1,Intermediate,CHEMBL630537,,
14939,Mus musculus,1,10000001.0,15045,BAO_0000218,,Biodistribution in normal mice bone after 24 hr,,A,,N,1,Intermediate,CHEMBL630538,,
14940,Mus musculus,1,10000001.0,15045,BAO_0000218,,Biodistribution in normal mice bone after 4 hr,,A,,N,1,Intermediate,CHEMBL630539,,
14941,Mus musculus,1,948.0,15045,BAO_0000218,,Biodistribution in normal mice heart after 120 hr,,A,,N,1,Intermediate,CHEMBL630540,,
14942,Mus musculus,1,948.0,15045,BAO_0000218,,Biodistribution in normal mice heart after 24 hr,,A,,N,1,Intermediate,CHEMBL630541,,
14943,Mus musculus,1,948.0,15045,BAO_0000218,,Biodistribution in normal mice heart after 4 hr,,A,,N,1,Intermediate,CHEMBL630542,,
14944,Mus musculus,1,2113.0,15045,BAO_0000218,,Biodistribution in normal mice kidney after 120 hr,,A,,N,1,Intermediate,CHEMBL630543,,
14945,Mus musculus,1,2113.0,15045,BAO_0000218,,Biodistribution in normal mice kidney after 24 hr,,A,,N,1,Intermediate,CHEMBL630544,,
14946,Mus musculus,1,2113.0,15045,BAO_0000218,,Biodistribution in normal mice kidney after 4 hr,,A,,N,1,Intermediate,CHEMBL630545,,
14947,Mus musculus,1,2107.0,15045,BAO_0000218,,Biodistribution in normal mice liver after 120 hr,,A,,N,1,Intermediate,CHEMBL630546,,
14948,Mus musculus,1,2107.0,15045,BAO_0000218,,Biodistribution in normal mice liver after 24 hr,,A,,N,1,Intermediate,CHEMBL630547,,
14949,Mus musculus,1,2107.0,15045,BAO_0000218,,Biodistribution in normal mice liver after 4 hr,,A,,N,1,Intermediate,CHEMBL630548,,
14950,Mus musculus,1,2106.0,15045,BAO_0000218,,Biodistribution in normal mice spleen after 120 hr,,A,,N,1,Intermediate,CHEMBL630549,,
14951,Mus musculus,1,2106.0,15045,BAO_0000218,,Biodistribution in normal mice spleen after 24 hr,,A,,N,1,Intermediate,CHEMBL630550,,
14952,Mus musculus,1,2106.0,15045,BAO_0000218,,Biodistribution in normal mice spleen after 4 hr,,A,,N,1,Intermediate,CHEMBL876426,,
14953,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630551,,
14954,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630552,,
14955,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL630553,,
14956,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630554,,
14957,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630555,,
14958,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630556,,
14959,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630557,,
14960,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,,N,1,Intermediate,CHEMBL630558,,
14961,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630559,,
14962,Rattus norvegicus,1,2106.0,12017,BAO_0000218,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL630560,,
14963,Rattus norvegicus,1,2046.0,12017,BAO_0000218,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,,N,1,Intermediate,CHEMBL876427,,
14964,Rattus norvegicus,1,,14941,BAO_0000218,,The Kel values in female wistar rats.,,A,,N,1,Intermediate,CHEMBL630561,,
14965,,1,,4646,BAO_0000019,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,A,,U,0,Autocuration,CHEMBL630562,,
14966,,1,,8847,BAO_0000019,,Hydrolysis rate constant of the compound,,A,,U,0,Autocuration,CHEMBL630563,,
14967,,1,,11778,BAO_0000100,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,P,,U,0,Autocuration,CHEMBL629673,,
14968,,1,,2363,BAO_0000019,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,A,,U,0,Autocuration,CHEMBL629674,,
14969,,1,,2363,BAO_0000019,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,A,,U,0,Autocuration,CHEMBL629675,,
14970,,1,,2363,BAO_0000019,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,A,,U,0,Autocuration,CHEMBL629676,,
14971,,1,,2363,BAO_0000019,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,A,,U,0,Autocuration,CHEMBL629677,,
14972,,1,,8371,BAO_0000019,,Apparent inactivation rate constant was evaluated,,A,,U,0,Autocuration,CHEMBL629678,,
14973,,1,,14883,BAO_0000019,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,A,,U,0,Autocuration,CHEMBL629679,,
14974,,1,,14883,BAO_0000019,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,A,,U,0,Autocuration,CHEMBL629680,,
14975,,1,,4643,BAO_0000019,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,A,,U,0,Autocuration,CHEMBL629681,,
14976,,1,,3519,BAO_0000019,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,A,,U,0,Autocuration,CHEMBL629682,,
14977,,1,,10600,BAO_0000019,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,A,,U,0,Autocuration,CHEMBL629683,,
14978,,1,,8501,BAO_0000019,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,F,,U,0,Autocuration,CHEMBL629684,,
14979,,1,,8505,BAO_0000100,,Dissociation constant was determined,,P,,U,0,Autocuration,CHEMBL629685,,
14980,,1,,9778,BAO_0000100,,Dissociation constant was determined,,P,,U,0,Autocuration,CHEMBL629686,,
14981,,1,,9778,BAO_0000100,,Dissociation constant at pH 7.4,,P,,U,0,Autocuration,CHEMBL872932,,
14982,,1,,9778,BAO_0000100,,Dissociation constant in presence of 1 mM dithiothreitol,,P,,U,0,Autocuration,CHEMBL629687,,
14983,,1,,13007,BAO_0000019,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,A,,U,0,Autocuration,CHEMBL872931,,
14984,,1,,13007,BAO_0000019,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,A,,U,0,Autocuration,CHEMBL628151,,
14985,,1,,13007,BAO_0000019,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,A,,U,0,Autocuration,CHEMBL628152,,
14986,,1,,13007,BAO_0000019,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,A,,U,0,Autocuration,CHEMBL628153,,
14987,,1,,11482,BAO_0000019,,Kinetic constant for aromatization of androstenedione,,A,,U,0,Autocuration,CHEMBL628154,,
14988,,1,,11482,BAO_0000019,,Kinetic constant for aromatization of testosterone,,A,,U,0,Autocuration,CHEMBL628155,,
14989,,1,,2303,BAO_0000019,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,A,,U,0,Autocuration,CHEMBL628156,,
14990,,1,,11964,BAO_0000019,,Local inhibition constant was determined,,A,,U,0,Autocuration,CHEMBL628157,,
14991,Saccharomyces cerevisiae,1,,3140,BAO_0000218,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,A,,N,1,Intermediate,CHEMBL857533,,
14992,,1,,10650,BAO_0000100,,Dissociation constant value of the compound,,P,,U,0,Autocuration,CHEMBL628158,,
14993,,1,964.0,4667,BAO_0000019,,In vitro permeability through cornea without epithelium,,A,,U,0,Autocuration,CHEMBL628159,,
14994,,1,964.0,4667,BAO_0000019,,In vitro permeability through intact cornea,,A,,U,0,Autocuration,CHEMBL875616,,
14995,Oryctolagus cuniculus,1,964.0,9199,BAO_0000218,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,A,,N,1,Intermediate,CHEMBL628160,,
14996,,1,,11966,BAO_0000019,,Rate of enzyme inactivation for the compound was determined,,A,,U,0,Autocuration,CHEMBL628161,,
14997,,1,964.0,4667,BAO_0000019,,In vitro permeability through cornea without epithelium,,A,,U,0,Autocuration,CHEMBL628162,,
14998,,1,964.0,4667,BAO_0000019,,In vitro permeability through intact cornea,,A,,U,0,Autocuration,CHEMBL628163,,
14999,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL628164,,
15000,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL628165,,
15001,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL628166,,
15002,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL628167,,
15003,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL628168,,
15004,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL628169,,
15005,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL628170,,
15006,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL628171,,
15007,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL627434,,
15008,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL627435,,
15009,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL628110,,
15010,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL628111,,
15011,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL628112,,
15012,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL628260,,
15013,,1,,8354,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,,U,0,Autocuration,CHEMBL628261,,
15014,Mus musculus,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,A,,N,1,Intermediate,CHEMBL628262,,
15015,Homo sapiens,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,A,,N,1,Intermediate,CHEMBL628263,,
15016,Mus musculus,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,A,,N,1,Intermediate,CHEMBL628264,,
15017,Mus musculus,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,A,,N,1,Intermediate,CHEMBL628265,,
15018,Mus musculus,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,A,,N,1,Intermediate,CHEMBL628266,,
15019,Mus musculus,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,A,,N,1,Intermediate,CHEMBL628267,,
15020,Mus musculus,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,A,,N,1,Intermediate,CHEMBL628268,,
15021,Mus musculus,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,A,,N,1,Intermediate,CHEMBL628269,,
15022,Mus musculus,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,A,,N,1,Intermediate,CHEMBL628270,,
15023,Mus musculus,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,A,,N,1,Intermediate,CHEMBL628271,,
15024,Mus musculus,1,,14439,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,A,,N,1,Intermediate,CHEMBL628272,,
1,,1,,11087,BAO_0000019,,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 30 uM,,B,,H,8,Autocuration,CHEMBL615117,,
2,,1,,684,BAO_0000219,,Compound was evaluated for its ability to mobilize calcium in 1321NI cells,,F,,U,0,Autocuration,CHEMBL615118,,
3,,1,,15453,BAO_0000019,,,,B,,U,0,Autocuration,CHEMBL615119,,
4,Bos taurus,1,,17841,BAO_0000249,,Binding affinity against A2 adenosine receptor in bovine striatal membranes using [3H]CGS-21680,,B,,H,4,Autocuration,CHEMBL615120,,
5,Homo sapiens,1,,17430,BAO_0000219,,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),,F,,N,1,Intermediate,CHEMBL615121,163.0,
6,Homo sapiens,1,,17430,BAO_0000219,,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),,F,,N,1,Intermediate,CHEMBL615122,163.0,
7,Mus musculus,1,,13799,BAO_0000219,,Cytotoxic Activity was evaluated against 143B (TK-) tumor cells,,F,,N,1,Intermediate,CHEMBL615123,163.0,
8,Homo sapiens,1,,17774,BAO_0000219,,In vitro cell cytotoxicity was determined against 143B cell line,,F,,N,1,Expert,CHEMBL615124,163.0,
9,Homo sapiens,1,,3801,BAO_0000219,,Inhibitory activity against tumor osteosarcoma cell line 143B after 72 hr continuous exposure to compound,,F,,N,1,Intermediate,CHEMBL615125,163.0,
10,Homo sapiens,1,,17430,BAO_0000219,,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,,F,,N,1,Intermediate,CHEMBL615126,163.0,
11,Homo sapiens,1,,17430,BAO_0000219,,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,,F,,N,1,Intermediate,CHEMBL615127,163.0,
12,Homo sapiens,1,,17774,BAO_0000219,,In vitro cell cytotoxicity was determined against 143B-LTK cell line,,F,,N,1,Expert,CHEMBL615128,163.0,
13,Staphylococcus aureus,1,,11324,BAO_0000218,,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,F,,N,1,Intermediate,CHEMBL857900,,
14,Staphylococcus aureus,1,,11324,BAO_0000218,,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,F,,N,1,Intermediate,CHEMBL615129,,
15,Staphylococcus aureus,1,,11324,BAO_0000218,,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,F,,N,1,Intermediate,CHEMBL615130,,
16,Staphylococcus aureus,1,,11324,BAO_0000218,,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,F,,N,1,Intermediate,CHEMBL615131,,
17,Rattus norvegicus,1,,11347,BAO_0000357,,Inhibition of cytochrome P450 progesterone 15-alpha hydroxylase,,A,,D,9,Expert,CHEMBL884521,,
18,,1,,16474,BAO_0000357,,Concentration that cause 50% activation of human reticulocyte 15-lipoxygenase (15-HLO),,B,,H,8,Autocuration,CHEMBL615132,,
19,,1,,10091,BAO_0000019,,Inhibition of partially purified 15-lipoxygenase from human leukocytes,,B,,H,8,Autocuration,CHEMBL615133,,
20,,1,,16474,BAO_0000357,,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),,B,,H,8,Autocuration,CHEMBL615134,,
21,,1,,16474,BAO_0000357,,Compound was evaluated for the percent increase in activation concentration of human reticulocyte 15-lipoxygenase (15-HLO),,B,,H,8,Autocuration,CHEMBL615135,,
22,,1,,16474,BAO_0000357,,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),,B,,H,8,Autocuration,CHEMBL615136,,
23,,1,,16474,BAO_0000357,,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,,B,,H,8,Autocuration,CHEMBL615137,,
24,,1,,16474,BAO_0000357,,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,,B,,H,8,Autocuration,CHEMBL615138,,
25,,1,,14352,BAO_0000219,,"Inhibitory concentration against 15-lipoxygenase, by inhibiting 15-HETE production by human umbilical vein endothelial cells (HUVEC) stimulated by calcium ionophore A 23187 at concentration of 10e-5 M.",,B,,U,0,Autocuration,CHEMBL836324,,
26,Oryctolagus cuniculus,1,,5646,BAO_0000357,,In vitro inhibitory activity of compound on rabbit reticulocyte 15-lipoxygenase,,B,,H,8,Autocuration,CHEMBL615139,,
27,Oryctolagus cuniculus,1,,5646,BAO_0000357,,Inhibition of rabbit reticulocyte 15-lipoxygenase by compound (30 uM),,B,,H,8,Autocuration,CHEMBL615140,,
28,,1,,10997,BAO_0000219,,Inhibitory activity against 15-lipoxygenase in rat polymorphonuclear leukocytes,,B,,H,8,Autocuration,CHEMBL615141,,
29,soya bean,1,,6309,BAO_0000357,,Inhibitory activity against 15-lipoxygenase was determined obtained from soya bean,,B,,H,8,Autocuration,CHEMBL615142,,
30,Glycine max,1,,167,BAO_0000357,,Inhibitory activity against soybean 15-lipoxygenase was evaluated,,B,,H,8,Autocuration,CHEMBL615143,,
31,Glycine max,1,,167,BAO_0000357,,Inhibitory activity against soybean 15-lipoxygenase was evaluated at 100 uM,,B,,H,8,Autocuration,CHEMBL615144,,
32,Glycine max,1,,11087,BAO_0000357,,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 10 uM,,B,,H,8,Autocuration,CHEMBL872867,,
33,Glycine max,1,,11087,BAO_0000357,,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 100 uM,,B,,H,8,Autocuration,CHEMBL615145,,
34,Glycine max,1,,13622,BAO_0000357,,Compound was tested in vitro for inhibition of 15-lipoxygenase soybean,,B,,H,8,Autocuration,CHEMBL615146,,
35,Glycine max,1,,13622,BAO_0000357,,Compound at 100 uM was tested in vitro for inhibition of 15-lipoxygenase soybean,,B,,H,8,Autocuration,CHEMBL615147,,
36,Rattus norvegicus,1,,11347,BAO_0000019,,Inhibition of cytochrome P450 progesterone 16-alpha hydroxylase,,A,,U,0,Autocuration,CHEMBL615148,,
37,Escherichia coli,1,,5926,BAO_0000019,,Binding affinity against bacterial 16S rRNA using mass spectrometry based assay,,B,,U,0,Autocuration,CHEMBL615149,,
38,,1,,4567,BAO_0000019,,Dissociation constant with dimeric 16S rRNA RNA construct B,,B,,U,0,Autocuration,CHEMBL615150,,
39,,1,,3782,BAO_0000225,,Dissociation constant towards 16S rRNA construct A,,B,,M,3,Intermediate,CHEMBL615151,,
40,,1,,3782,BAO_0000225,,Dissociation constant towards 16S rRNA construct B,,B,,M,3,Intermediate,CHEMBL615152,,
41,Escherichia coli,1,,4466,BAO_0000225,,Binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli,,B,,M,3,Expert,CHEMBL615153,,
42,Escherichia coli,1,,6592,BAO_0000225,,Binding affinity for the 16S ribosomal RNA A-site of Escherichia coli,,B,,M,3,Expert,CHEMBL615154,,
43,,1,,898,BAO_0000019,,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,B,,H,8,Autocuration,CHEMBL615155,,
44,,1,,898,BAO_0000019,,Inhibitory constant against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,B,,H,8,Autocuration,CHEMBL615156,,
45,Homo sapiens,1,,13163,BAO_0000019,,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,,B,,H,8,Autocuration,CHEMBL615157,,
46,Homo sapiens,1,,13163,BAO_0000019,,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,,B,,H,8,Autocuration,CHEMBL615158,,
47,Rattus norvegicus,1,,10691,BAO_0000019,,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",,B,,D,9,Expert,CHEMBL615159,,
48,Rattus norvegicus,1,,10691,BAO_0000019,,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",,B,,D,9,Expert,CHEMBL615172,,
49,Rattus norvegicus,1,,10691,BAO_0000019,,"Percent inhibition of 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",,B,,D,9,Expert,CHEMBL615173,,
50,Rattus norvegicus,1,,10691,BAO_0000019,,"Percent inhibition of Steroid 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",,B,,D,9,Expert,CHEMBL615174,,
51,,1,,898,BAO_0000019,,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,B,,H,8,Autocuration,CHEMBL884518,,
52,,1,,912,BAO_0000357,,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1),,B,,H,8,Autocuration,CHEMBL615175,,
53,,1,,912,BAO_0000357,,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 1 uM concentration,,B,,H,8,Autocuration,CHEMBL615176,,
54,,1,,912,BAO_0000357,,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 10 uM concentration,,B,,H,8,Autocuration,CHEMBL615177,,
55,Rattus norvegicus,1,,15103,BAO_0000249,,Selectivity ratio of binding affinity towards mu to delta receptors of rat brain membranes,Membranes,B,,D,5,Autocuration,CHEMBL615178,,
56,Homo sapiens,1,,5116,BAO_0000219,,Cytotoxicity against ovarian cancer cell line (1A-9) of humans was determined,,F,,N,1,Intermediate,CHEMBL615179,506.0,
57,Rattus norvegicus,1,,14578,BAO_0000219,,Functional antagonism by electrical assays in Xenopus oocytes expressing 1A/2A NMDA receptor subtype,,F,,D,7,Autocuration,CHEMBL615180,,
58,Rattus norvegicus,1,,14578,BAO_0000219,,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2B NMDA receptor,,F,,D,7,Autocuration,CHEMBL615181,,
59,Rattus norvegicus,1,,14578,BAO_0000219,,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2C NMDA receptor,,F,,D,7,Autocuration,CHEMBL615182,,
60,Homo sapiens,1,,4787,BAO_0000219,,In vitro effective concentration required to reduce the number of human ovarian cancer (1A9) after 3-day incubation,,F,,N,1,Expert,CHEMBL615183,506.0,
61,Homo sapiens,1,,4787,BAO_0000219,,In vitro effective concentration required to reduce the number of human ovarian cancer cells (1A9) after 3-day incubation,,F,,N,1,Intermediate,CHEMBL615184,506.0,
62,Homo sapiens,1,,3547,BAO_0000219,,Cytotoxic activity against human ovarian cancer (1A9) cell line,,F,,N,1,Intermediate,CHEMBL615185,506.0,
63,Homo sapiens,1,,3547,BAO_0000219,,Cytotoxic activity against human ovarian cancer (1A9) cell line; ND=Not determined,,F,,N,1,Intermediate,CHEMBL615186,506.0,
64,Homo sapiens,1,,6726,BAO_0000219,,Effective dose of compound against replication of 1A9 cell line was evaluated,,F,,N,1,Intermediate,CHEMBL615187,506.0,
65,Homo sapiens,1,,3455,BAO_0000219,,In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line,,F,,N,1,Expert,CHEMBL885343,506.0,
66,Homo sapiens,1,,5726,BAO_0000219,,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line),,F,,N,1,Intermediate,CHEMBL615188,506.0,
67,Homo sapiens,1,,5726,BAO_0000219,,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line); NA is not active,,F,,N,1,Intermediate,CHEMBL615189,506.0,
68,Homo sapiens,1,,5726,BAO_0000219,,In vitro percent inhibition evaluated against human ovarian cancer (1A9 cell line) at >20 ug/mL,,F,,N,1,Intermediate,CHEMBL615190,506.0,
69,Homo sapiens,1,,3395,BAO_0000219,,Inhibitory activity against Taxol resistant 1A9 cell lines,,F,,N,1,Intermediate,CHEMBL615191,506.0,
70,Homo sapiens,1,,3415,BAO_0000219,,Cytotoxicity against human ovarian cancer (1A9) cell lines.,,F,,N,1,Expert,CHEMBL615192,506.0,
71,Homo sapiens,1,,3415,BAO_0000219,,Percentage inhibition of human ovarian cancer (1A9) cell lines.,,F,,N,1,Expert,CHEMBL827083,506.0,
72,Homo sapiens,1,,17099,BAO_0000219,,Effective dose required for inhibitory activity against 1A9 human tumor cell line.,,F,,N,1,Expert,CHEMBL615193,506.0,
73,Homo sapiens,1,,17099,BAO_0000219,,Percent inhibition against 1A9 human tumor cell line at 0.10 ug/mL,,F,,N,1,Intermediate,CHEMBL615194,506.0,
74,Homo sapiens,1,,17099,BAO_0000219,,Percent inhibition against 1A9 human tumor cell line at <0.00008 ug/mL,,F,,N,1,Intermediate,CHEMBL615195,506.0,
75,Homo sapiens,1,,17099,BAO_0000219,,Percent inhibition against 1A9 human tumor cell line at >10 ug/mL,,F,,N,1,Intermediate,CHEMBL615196,506.0,
76,Homo sapiens,1,,17721,BAO_0000219,,Inhibitory concentration against Jurkat cells,,F,,N,1,Intermediate,CHEMBL615197,503.0,
77,,1,,1229,BAO_0000019,,In vitro anticancer activity against 2 NCI SCLC cell lines; inactive,,F,,U,0,Intermediate,CHEMBL615198,,
78,Rattus norvegicus,1,,11347,BAO_0000357,,Inhibition of cytochrome P450 progesterone 2-alpha-hydroxylase,,A,,D,9,Expert,CHEMBL615199,,
79,,1,,17117,BAO_0000357,,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",,B,,H,8,Expert,CHEMBL615200,,
80,,1,,17117,BAO_0000357,,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",,B,,H,8,Expert,CHEMBL615201,,
81,,1,,17117,BAO_0000357,,"In vitro inhibition of human 2,3-oxidosqualene cyclase at 100 nM.",,B,,H,8,Expert,CHEMBL615202,,
82,Candida albicans,1,,11375,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Candida albicans microsomes",Microsomes,B,,H,8,Autocuration,CHEMBL615203,,
83,Candida albicans,1,,11375,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Candida albicans microsomes",Microsomes,B,,H,8,Autocuration,CHEMBL615204,,
84,Saccharomyces cerevisiae,1,,11375,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Saccharomyces cerevisiae microsomes",Microsomes,B,,H,8,Autocuration,CHEMBL615205,,
85,Saccharomyces cerevisiae,1,,11375,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Saccharomyces cerevisiae microsomes",Microsomes,B,,H,8,Autocuration,CHEMBL615206,,
86,Sus scrofa,1,2107.0,11375,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in pig liver microsomes",Microsomes,B,,H,8,Autocuration,CHEMBL615207,,
87,Rattus norvegicus,1,,791,BAO_0000019,,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase",,B,,H,8,Autocuration,CHEMBL827084,,
88,Rattus norvegicus,1,,791,BAO_0000019,,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase (OSC)",,B,,H,8,Autocuration,CHEMBL615208,,
89,Rattus norvegicus,1,,791,BAO_0000019,,"Evaluated for its activity to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase, activity expressed as Ki",,B,,H,8,Autocuration,CHEMBL615209,,
90,Rattus norvegicus,1,2107.0,11375,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in rat liver microsomes",Microsomes,B,,D,9,Autocuration,CHEMBL615210,,
91,Rattus norvegicus,1,2107.0,11375,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",Microsomes,B,,D,9,Autocuration,CHEMBL615211,,
92,Rattus norvegicus,1,2107.0,153,BAO_0000251,,"Compound was evaluated for inhibitory activity against 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",Microsomes,B,,D,9,Autocuration,CHEMBL615212,,
93,,1,,8269,BAO_0000357,,Molar concentration needed to give 50% prevention of 2-5A (Adenosine dependent endoribonuclease),,B,,H,8,Expert,CHEMBL615213,,
94,,1,,8269,BAO_0000357,,Molar concentration required to displace 50% of the radiolabeled probe from 2-5A (Adenosine dependent endoribonuclease) in endonuclease-nitrocellulose complex,,B,,H,8,Expert,CHEMBL615273,,
95,Homo sapiens,1,,17653,BAO_0000219,,In vitro cytotoxic concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,,F,,N,1,Expert,CHEMBL615274,726.0,
96,Homo sapiens,1,,14277,BAO_0000219,,50% Effective concentration of compound required for inhibiting intracellular viral replicative intermediate DNA in HBV-transfected 2.2.15 cell line.,,F,,N,1,Intermediate,CHEMBL615275,726.0,
97,Homo sapiens,1,,1717,BAO_0000219,,Antiviral activity against Hepatitis B virus in 2.2.15 cell line,,F,,N,1,Intermediate,CHEMBL615276,726.0,
98,Homo sapiens,1,,14091,BAO_0000219,,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells,,F,,N,1,Intermediate,CHEMBL615277,726.0,
99,Homo sapiens,1,,14091,BAO_0000219,,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells; Not determined,,F,,N,1,Intermediate,CHEMBL615326,726.0,
100,Hepatitis B virus,1,,17653,BAO_0000218,,In vitro effective concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,,F,,N,1,Expert,CHEMBL883130,,
101,Homo sapiens,1,,13105,BAO_0000219,,Ability to inhibit the episomal HBV-DNA in 2.2.15 cells.,,F,,N,1,Intermediate,CHEMBL884519,726.0,
102,Homo sapiens,1,,1717,BAO_0000219,,Concentration required to inhibit 50% of 2.2.15 cell line,,F,,N,1,Intermediate,CHEMBL615327,726.0,
103,Homo sapiens,1,,13105,BAO_0000219,,Anti viral activity against 2.2.15 cells (concentration required to reduce the log phase cell growth by 50%).,,A,,N,1,Intermediate,CHEMBL615328,726.0,
104,Homo sapiens,1,,13600,BAO_0000218,,Cytotoxic activity of compound against uninfected 2.2.15 cells.,,F,,N,1,Intermediate,CHEMBL615329,,
105,Homo sapiens,1,,13467,BAO_0000218,,Anti hepatitis-B virus activity was evaluated in 2.2.15 cells.,,F,,N,1,Intermediate,CHEMBL615330,,
106,Hepatitis B virus,1,,17477,BAO_0000218,,"Inhibition of the replication of HBV in 2.2.15 cells, by DNA hybridization assay",,F,,N,1,Expert,CHEMBL615331,,
107,Homo sapiens,1,,1593,BAO_0000218,,In vitro anti-HBV activity in 2.2.15 cells,,F,,N,1,Intermediate,CHEMBL615332,,
108,Homo sapiens,1,,1593,BAO_0000218,,In vitro anti-HBV activity in 2.2.15 cells; Not determined,,F,,N,1,Intermediate,CHEMBL615333,,
109,Homo sapiens,1,,15089,BAO_0000218,,The compound was tested in vitro for the anti-HBV activity against 2.2.15 cells,,F,,N,1,Intermediate,CHEMBL615334,,
110,Homo sapiens,1,,15089,BAO_0000218,,The compound was tested in vitro for the anti-HBV activity in 2.2.15 cells,,F,,N,1,Intermediate,CHEMBL615335,,
111,Homo sapiens,1,,1593,BAO_0000218,,Cytotoxicity in 2.2.15 cells,,F,,N,1,Intermediate,CHEMBL615336,,
112,Homo sapiens,1,,1593,BAO_0000218,,Cytotoxicity in 2.2.15 cells; Not determined,,F,,N,1,Intermediate,CHEMBL615337,,
113,Homo sapiens,1,,13600,BAO_0000218,,Inhibitory activity of compound against hepatitis B virus (HBV) in growing cultures of 2.2.15 cells,,F,,N,1,Intermediate,CHEMBL615338,,
114,Homo sapiens,1,,13467,BAO_0000218,,The growth inhibition activity for the compound was evaluated in 2.2.15 cells.,,F,,N,1,Intermediate,CHEMBL615339,,
115,Homo sapiens,1,,13467,BAO_0000218,,Selectivity index was determined from the ratio of IC50 to the EC50 values evaluated in 2.2.15 cells.,,F,,N,1,Intermediate,CHEMBL615340,,
116,Homo sapiens,1,,14764,BAO_0000219,,Antiviral activity against HBV was determined in 2.215 cell line,,F,,N,1,Intermediate,CHEMBL615341,726.0,
117,Homo sapiens,1,,6531,BAO_0000251,,Inhibition of 20-HETE synthesis in human renal microsomes,Microsomes,B,,U,0,Autocuration,CHEMBL615342,,
118,,1,,17322,BAO_0000019,,Inhibitory activity against 20-HETE production from arachidonic acid using human renal microsome 20-HETE synthase.,,B,,U,0,Autocuration,CHEMBL615343,,
119,Homo sapiens,1,,17072,BAO_0000219,,Inhibitory concentration against 2008 (ovarian) cells,,F,,N,1,Intermediate,CHEMBL615344,388.0,
120,Homo sapiens,1,,16936,BAO_0000219,,50% Growth inhibitory concentration( GI 50 ) by using 2008 human ovarian carcinoma cell lines.,,F,,N,1,Intermediate,CHEMBL615345,388.0,
121,Homo sapiens,1,,16936,BAO_0000219,,Compound was tested for 50% growth inhibitory concentration by using human ovarian carcinoma cell lines (2008),,F,,N,1,Intermediate,CHEMBL615346,388.0,
122,Homo sapiens,1,,17146,BAO_0000219,,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells,,F,,N,1,Intermediate,CHEMBL615347,388.0,
123,Homo sapiens,1,,17146,BAO_0000219,,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells; not detected,,F,,N,1,Intermediate,CHEMBL615348,388.0,
124,Homo sapiens,1,,10797,BAO_0000219,,In vitro inhibition of 2008/R ovarian cancer cell line,,F,,N,1,Intermediate,CHEMBL827085,561.0,
125,Homo sapiens,1,,10797,BAO_0000219,,In vitro inhibition of 2008/R ovarian cancer cell line; NA= Not achievable,,F,,N,1,Intermediate,CHEMBL615349,561.0,
126,Homo sapiens,1,,10797,BAO_0000219,,In vitro inhibition of 2008/S ovarian cancer cell line,,F,,N,1,Intermediate,CHEMBL615350,389.0,
127,Homo sapiens,1,,10797,BAO_0000219,,In vitro inhibition of 2008/S ovarian cancer cell line; NA= Not achievable,,F,,N,1,Intermediate,CHEMBL615351,389.0,
128,Homo sapiens,1,,4823,BAO_0000220,,Tested in vitro for inhibition of chymotrypsin like activity of purified human 20S proteasome,,B,,S,2,Expert,CHEMBL615352,,
129,Homo sapiens,1,,12912,BAO_0000220,,Compound was evaluated for inhibitory activity against 20S proteasome from human liver and brain,,B,,S,2,Intermediate,CHEMBL615353,,
130,,1,,2957,BAO_0000220,,Inhibition of chymotrypsin-like activity of 20S proteasome,,B,,S,2,Expert,CHEMBL615354,,
131,,1,,2957,BAO_0000220,,Inhibition of chymotrypsin-like activity of 20S proteasome; value ranges from 10-20 uM,,B,,S,2,Expert,CHEMBL615355,,
132,,1,,3260,BAO_0000220,,Inhibitory activity against 20S proteosome,,B,,S,2,Intermediate,CHEMBL615356,,
133,Homo sapiens,1,,3451,BAO_0000019,,Compound was tested for inhibitory activity against tryptase,,B,,U,0,Autocuration,CHEMBL615357,,
134,Homo sapiens,1,,13885,BAO_0000219,,Concentration required to inhibit 50% of extracellular circular replication of HBV DNA using 2215 cell line,,F,,N,1,Intermediate,CHEMBL615358,726.0,
135,Homo sapiens,1,,13885,BAO_0000219,,Concentration required to inhibit 50% of intracellular circular replication of HBV DNA using 2215 cell line,,F,,N,1,Intermediate,CHEMBL827086,726.0,
136,,1,,3676,BAO_0000019,,Compound was tested for the inhibition of Alpha-glucosidase,,B,,U,0,Autocuration,CHEMBL615359,,
137,,1,,6043,BAO_0000357,,Inhibitory concentration against human neutrophil elastase (HNE),,B,,H,8,Autocuration,CHEMBL615360,,
138,Rattus norvegicus,1,948.0,11140,BAO_0000218,,Change in heart rate was expressed in percent at at a dose 0.002 mg/kg iv in anesthetized rat,,F,,U,0,Autocuration,CHEMBL615361,,
139,,1,,10543,BAO_0000019,,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,,F,,H,8,Autocuration,CHEMBL615362,,
140,,1,,10543,BAO_0000019,,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,,F,,H,8,Expert,CHEMBL615363,,
141,,1,,10543,BAO_0000357,,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,,B,,H,8,Autocuration,CHEMBL615364,,
142,,1,,10543,BAO_0000019,,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,,F,,H,8,Expert,CHEMBL615365,,
143,Mus musculus,1,,11365,BAO_0000219,,In Vitro evaluation for the growth inhibition of Subline (P388/AMSA) Leukemia cell lines,,F,,N,1,Intermediate,CHEMBL615366,524.0,
144,Mus musculus,1,,11365,BAO_0000219,,In Vitro evaluation for the growth inhibition of Subline (P388/CP) Leukemia cell lines,,F,,N,1,Intermediate,CHEMBL615367,524.0,
145,Homo sapiens,1,,11803,BAO_0000219,,Compound was evaluated for the inhibition of cell replication human peripheral blood lymphocytes (PBL's).,,F,,N,1,Intermediate,CHEMBL615368,554.0,
146,Ovis aries,1,,11803,BAO_0000019,,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells,,F,,U,0,Autocuration,CHEMBL615369,,
147,Ovis aries,1,,11803,BAO_0000019,,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells.,,F,,U,0,Autocuration,CHEMBL615370,,
148,,1,,12278,BAO_0000357,,Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RT (Y181C),,B,,H,8,Autocuration,CHEMBL615673,,
149,Homo sapiens,1,,8249,BAO_0000019,,Compound was evaluated for its inhibitory effect on thymidine [3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-5,,F,,U,0,Autocuration,CHEMBL615674,,
150,Homo sapiens,1,,8249,BAO_0000019,,Compound was evaluated for its inhibitory effect on thymidine [3H]-dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-6,,F,,U,0,Autocuration,CHEMBL615675,,
151,Homo sapiens,1,,8249,BAO_0000219,,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in at conc. 10e-7,,F,,U,0,Autocuration,CHEMBL615676,635.0,
152,Homo sapiens,1,,8249,BAO_0000219,,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM cells in culture at conc. 10e-4,,F,,U,0,Autocuration,CHEMBL615677,635.0,
153,Homo sapiens,1,,8249,BAO_0000219,,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-5,,F,,U,0,Autocuration,CHEMBL615678,635.0,
154,Homo sapiens,1,,8249,BAO_0000219,,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-6,,F,,U,0,Autocuration,CHEMBL615679,635.0,
155,Homo sapiens,1,,8249,BAO_0000019,,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM/MTX cells in at conc. 10e-7.,,F,,U,0,Autocuration,CHEMBL615680,,
156,Homo sapiens,1,,8249,BAO_0000019,,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-4,,F,,U,0,Autocuration,CHEMBL615681,,
157,,1,,16992,BAO_0000249,,In vitro binding affinity towards (alpha-4)2(beta-2)3 neuronal nicotinic acetylcholine receptor in P2 membrane fractions of rat forebrain,,B,,H,6,Autocuration,CHEMBL857972,,
158,Streptococcus pyogenes,1,,10543,BAO_0000218,,Minimum inhibitory concentration of compound against Streptococcus pyogenus septicemia in the mouse,,F,,N,1,Intermediate,CHEMBL857899,,
159,Human herpesvirus 3,1,,17833,BAO_0000218,,Antiviral activity against 07/1 strain of thymidine kinase negative (TK-) Varicella-Zoster Virus (VZV),,F,,N,1,Intermediate,CHEMBL615371,,
160,vericilla zoster virus,1,,17290,BAO_0000218,,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,,F,,N,1,Expert,CHEMBL615372,468.0,
161,vericilla zoster virus,1,,17290,BAO_0000218,,Antiviral activity against 07/1 strain of VZV; ND: No data,,F,,N,1,Intermediate,CHEMBL615373,,
162,vericilla zoster virus,1,,17290,BAO_0000218,,Antiviral activity against 07/1 strain of VZV; ND=No data,,F,,N,1,Intermediate,CHEMBL615374,,
163,escherichia cloac,1,,10932,BAO_0000218,,"Antibacterial activity was determined against gram negative organism, Enterobacter cloacae (MA2646)",,F,,N,1,Intermediate,CHEMBL615375,,
164,,1,,9707,BAO_0000019,,Ratio of Ki at A2 to Ki at A1 receptors,,B,,U,0,Autocuration,CHEMBL615376,,
165,Candida albicans,1,,2346,BAO_0000249,,"In vitro inhibition of 1,3-beta-glucan synthase in Candida albicans membrane assay.",,B,,H,8,Expert,CHEMBL615377,,
166,Candida glabrata CBS 138,1,,2205,BAO_0000357,,"Inhibition of 1,3-beta-glucan synthase",,B,,H,8,Expert,CHEMBL615378,,
167,Homo sapiens,1,,11900,BAO_0000219,,Inhibition of growth of 1-87 human tumor cell line,,F,,N,1,Intermediate,CHEMBL615379,832.0,
168,Rattus norvegicus,1,,14864,BAO_0000219,,Inhibition of 1-lipoxygenase (LOX)in RBL cells,,B,,D,9,Expert,CHEMBL615380,,
169,Glycine max,1,,16474,BAO_0000357,,Inhibitory activity against soybean 1-lipoxygenase (SLO),,B,,D,9,Autocuration,CHEMBL615381,,
170,Glycine max,1,,16474,BAO_0000357,,Inhibitory activity against soybean 1-lipoxygenase (SLO); no effect,,B,,D,9,Autocuration,CHEMBL615382,,
171,Glycine max,1,,16474,BAO_0000357,,% inhibition against soybean 1-lipoxygenase (SLO),,B,,D,9,Autocuration,CHEMBL615383,,
172,Glycine max,1,,16474,BAO_0000357,,percent inhibition against soybean 1-lipoxygenase (SLO);NI is no inhibition,,B,,D,9,Autocuration,CHEMBL615384,,
173,Glycine max,1,,3094,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 10:90,,B,,D,9,Autocuration,CHEMBL615385,,
174,Glycine max,1,,3094,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 1:99,,B,,D,9,Autocuration,CHEMBL615386,,
175,Glycine max,1,,3094,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 25:75,,B,,D,9,Autocuration,CHEMBL615387,,
176,Glycine max,1,,3094,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 35:65,,B,,D,9,Autocuration,CHEMBL615388,,
177,Glycine max,1,,3094,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 50:50,,B,,D,9,Autocuration,CHEMBL615214,,
178,Glycine max,1,,3094,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 76:24,,B,,D,9,Autocuration,CHEMBL827087,,
179,Glycine max,1,,3094,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 87:13,,B,,D,9,Autocuration,CHEMBL615215,,
180,Glycine max,1,,3094,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 89:11,,B,,D,9,Autocuration,CHEMBL615216,,
181,Glycine max,1,,3094,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 95:5,,B,,D,9,Autocuration,CHEMBL615217,,
182,Glycine max,1,,3094,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 97:3,,B,,D,9,Autocuration,CHEMBL615218,,
183,Glycine max,1,,3094,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 99:1,,B,,D,9,Autocuration,CHEMBL615219,,
184,Mus musculus,1,,10413,BAO_0000019,,Evaluated for inhibitory activity on 10-formyltetrahydrofolate synthetase(L cell) at folate substrate concentration of 100 uM,,B,,U,0,Autocuration,CHEMBL615220,,
185,Mus musculus,1,,16929,BAO_0000219,,Cells were harvested and were assayed for luciferase and -galactosidase activities (Transcriptional activity),,F,,N,1,Intermediate,CHEMBL615221,294.0,
186,,1,,1229,BAO_0000019,,In vitro anticancer activity against 11 NCI NSCLC cell lines; inactive,,F,,U,0,Intermediate,CHEMBL615222,,
187,,1,,16587,BAO_0000357,,In vitro inhibitory activity against human 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),,B,,H,8,Autocuration,CHEMBL615223,,
188,,1,,16587,BAO_0000357,,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),,B,,H,8,Autocuration,CHEMBL615224,,
189,,1,,16587,BAO_0000357,,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA).,,B,,H,8,Autocuration,CHEMBL615225,,
190,,1,,16587,BAO_0000357,,Ability to convert [3H]cortisol to the tritium labeled cortisone in the presence of human 11 beta hydroxysteroid dehydrogenase type 2,,B,,H,8,Autocuration,CHEMBL615226,,
191,,1,,16587,BAO_0000357,,Inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 2 at a concentration of 0.2 mM; NI means no inhibition,,B,,H,8,Autocuration,CHEMBL615227,,
192,Bos taurus,1,,8058,BAO_0000019,,Evaluated for inhibition of bovine adrenal cortical mitochondrial 11 beta-hydroxylase,,F,,D,9,Expert,CHEMBL615228,,
193,Rattus norvegicus,1,,9065,BAO_0000357,,Effect on adrenal 11-beta-hydroxylase activity at 10e-4 M; No significant effect,,B,,D,9,Expert,CHEMBL615229,,
194,Rattus norvegicus,1,2369.0,8865,BAO_0000357,,Inhibition of 11 beta-hydroxylase from rat adrenal gland,,B,,D,9,Expert,CHEMBL615230,,
195,Rattus norvegicus,1,,9066,BAO_0000357,,Inhibition of rat adrenal 11-beta-hydroxylase,,B,,D,9,Expert,CHEMBL615231,,
196,Rattus norvegicus,1,,8394,BAO_0000357,,Inhibition of rat adrenal 11-beta-hydroxylase,,B,,D,9,Expert,CHEMBL884520,,
197,Rattus norvegicus,1,,8394,BAO_0000357,,Inhibition of rat adrenal 11-beta-hydroxylase at 10e-5 M,,B,,D,9,Expert,CHEMBL615232,,
198,,1,,6431,BAO_0000019,,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 1 of wistar rat liver cytosol at 10 uM was determined using [3H]cortisone,,B,,H,8,Autocuration,CHEMBL615233,,
199,,1,,6431,BAO_0000357,,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,,B,,H,8,Autocuration,CHEMBL827088,,
200,,1,,6431,BAO_0000357,,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,,B,,H,8,Autocuration,CHEMBL615234,,
201,,1,,9295,BAO_0000019,,Compound was tested for the percent of inhibition against 12-LO at 10 uM,,F,,H,8,Autocuration,CHEMBL615235,,
202,,1,,10193,BAO_0000019,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,B,,H,8,Autocuration,CHEMBL615236,,
203,,1,,13622,BAO_0000019,,Compound was tested in vitro for inhibition of 12-LO human platelet,,B,,H,8,Autocuration,CHEMBL615237,,
204,,1,,12079,BAO_0000019,,Inhibitory concentration against human platelet 12-lipoxygenase,,F,,H,8,Autocuration,CHEMBL615238,,
205,,1,,13622,BAO_0000019,,Compound at 100 uM was tested in vitro for inhibition of 12-LO human platelet,,B,,H,8,Autocuration,CHEMBL615239,,
206,Homo sapiens,1,,12079,BAO_0000019,,Inhibitory concentration against human platelet 12-lipoxygenase,,F,,D,9,Autocuration,CHEMBL615240,,
207,,1,,13500,BAO_0000019,,Tested for inhibition of 12-LO (12-lipoxygenase) as an inhibitor of 12(S)-HETE biosynthesis in mouse epidermal homogenates,,B,,H,8,Expert,CHEMBL615241,,
208,,1,,13723,BAO_0000357,,Inhibitory activity against conversion of [1-14C]arachidonic acid to 12-HPETE and its reduction product 12-HETE by porcine leukocyte type 12-lipoxygenase,,B,,H,8,Expert,CHEMBL615242,,
209,,1,,16474,BAO_0000019,,Inhibitory activity against human platelet 12-lipoxygenase (12-HLO),,B,,H,8,Autocuration,CHEMBL615243,,
210,,1,,1630,BAO_0000019,,Inhibitory activity against human platelet 12-lipoxygenase,,B,,H,8,Autocuration,CHEMBL615244,,
211,,1,,167,BAO_0000019,,Inhibitory activity against human platelet 12-lipoxygenase was evaluated,,B,,H,8,Autocuration,CHEMBL615245,,
212,,1,,16474,BAO_0000019,,% inhibition against human platelet 12-lipoxygenase (12-HLO),,B,,H,8,Autocuration,CHEMBL615246,,
213,,1,,167,BAO_0000019,,Inhibitory activity against human platelet 12-lipoxygenase was evaluated at 100 uM,,B,,H,8,Autocuration,CHEMBL615247,,
214,,1,,16474,BAO_0000019,,percent inhibition against human platelet 12-lipoxygenase (12-HLO); NI is no inhibition,,B,,H,8,Autocuration,CHEMBL615248,,
215,,1,,10091,BAO_0000357,,Inhibitory activity towards porcine 12-lipoxygenase,,B,,H,8,Autocuration,CHEMBL615249,,
216,,1,,11966,BAO_0000357,,Tested for inhibition against porcine 12-LO,,B,,H,8,Autocuration,CHEMBL615250,,
217,,1,,951,BAO_0000019,,Inhibition of 12-lipoxygenase was evaluated in rat platelets stimulated by thrombin up to a concentration of 10 uM; NE means No effect,,B,,H,8,Autocuration,CHEMBL615251,,
218,,1,,10997,BAO_0000019,,Inhibitory activity against 12-lipoxygenase in rat platelet rich plasma,,B,,H,8,Autocuration,CHEMBL615252,,
219,,1,,10193,BAO_0000019,,In vitro inhibition of rat platelet 12-lipoxygenase,,B,,H,8,Expert,CHEMBL828340,,
220,,1,,10193,BAO_0000019,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,B,,H,8,Autocuration,CHEMBL615253,,
221,,1,,10193,BAO_0000019,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 100 uM,,B,,H,8,Autocuration,CHEMBL615254,,
222,,1,,10193,BAO_0000019,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 30 uM,,B,,H,8,Autocuration,CHEMBL615255,,
223,,1,,10193,BAO_0000019,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,B,,H,8,Autocuration,CHEMBL615256,,
224,,1,,10193,BAO_0000019,,In vitro inhibitory activity against rat platelet 12-lipoxygenase,,B,,H,8,Autocuration,CHEMBL615257,,
225,,1,,11087,BAO_0000019,,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 100 uM,,B,,H,8,Autocuration,CHEMBL615258,,
226,Homo sapiens,1,,15569,BAO_0000219,,Cytotoxic activity in a panel of Human ovarian tumor 41M cell line after 96h of drug exposure,,F,,N,1,Intermediate,CHEMBL615259,621.0,
227,Homo sapiens,1,,12989,BAO_0000219,,In vitro antitumor activity against 41M cell line.,,F,,N,1,Expert,CHEMBL615260,621.0,
228,Homo sapiens,1,,16745,BAO_0000219,,cytotoxicity against 41M cells incubated for 24 hr in MTT assay.,,F,,N,1,Intermediate,CHEMBL615261,621.0,
229,Homo sapiens,1,,15569,BAO_0000219,,Cytotoxic activity in a panel of Human ovarian tumor 41M/CDDP cell line after 96h of drug exposure,,F,,N,1,Intermediate,CHEMBL615262,621.0,
230,Homo sapiens,1,,12989,BAO_0000219,,In vitro antitumor activity against 41McisR cell line.,,F,,N,1,Expert,CHEMBL615263,621.0,
231,Homo sapiens,1,,12989,BAO_0000219,,Resistant factor was determined between IC50 of cisplatin-resistant human tumor cell lines to that of 41McisR cell line,,F,,N,1,Expert,CHEMBL838393,621.0,
232,Homo sapiens,1,,16745,BAO_0000219,,cytotoxicity against 41McisR cells incubated for 24 hr in MTT assay,,F,,N,1,Intermediate,CHEMBL615264,621.0,
233,Homo sapiens,1,,6210,BAO_0000357,,Inhibition of 5'-inosine monophosphate dehydrogenase type I (IMPDH I),,B,,D,9,Expert,CHEMBL615265,,
234,Homo sapiens,1,,6210,BAO_0000357,,Inhibition of 5'-inosine monophosphate dehydrogenase type II (IMPDH II),,B,,D,9,Expert,CHEMBL615266,,
235,,1,,6226,BAO_0000357,,Inhibitory activity against inosine 5'-inosine monophosphate dehydrogenase type II (IMPDH II),,B,,H,8,Expert,CHEMBL615267,,
236,,1,,17855,BAO_0000357,,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase,,B,,H,8,Expert,CHEMBL615268,,
237,,1,,17855,BAO_0000357,,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase; nd = Not determined,,B,,H,8,Expert,CHEMBL615269,,
238,,1,,17855,BAO_0000357,,Initial dissociation constant towards human 5'-methylthioadenosine phosphorylase,,B,,H,8,Expert,CHEMBL615270,,
239,,1,,10413,BAO_0000357,,"Evaluated for inhibitory activity on 5,10-Methenyl Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",,B,,H,8,Autocuration,CHEMBL615271,,
240,Escherichia coli,1,,10413,BAO_0000357,,"Inhibitory activity against 5,10-methylenetetrahydrofolate dehydrogenase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",,B,,H,8,Autocuration,CHEMBL615272,,
241,Escherichia coli,1,,10413,BAO_0000357,,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",,B,,H,8,Autocuration,CHEMBL615103,,
242,Escherichia coli,1,,10413,BAO_0000357,,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM;NT=Not tested",,B,,H,8,Autocuration,CHEMBL615104,,
243,,1,,10413,BAO_0000357,,"Evaluated for inhibitory activity on 5,10-Methylene Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",,B,,H,8,Autocuration,CHEMBL615105,,
244,,1,,10413,BAO_0000357,,"Evaluated for inhibitory activity on 5,10-methylenetetrahydrofolate dehydrogenase(L cell) at folate substrate concentration of 100 uM",,B,,H,8,Autocuration,CHEMBL872866,,
245,Sus scrofa,1,,7587,BAO_0000357,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,B,,H,8,Autocuration,CHEMBL615106,,
246,Sus scrofa,1,,7587,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (A,porcine liver) enzyme.",,B,,H,8,Autocuration,CHEMBL615107,,
247,Sus scrofa,1,,7587,BAO_0000357,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-4 M inhibitory concentration",,B,,H,8,Autocuration,CHEMBL615108,,
248,Sus scrofa,1,,7587,BAO_0000357,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-5 M inhibitory concentration",,B,,H,8,Autocuration,CHEMBL615109,,
249,Sus scrofa,1,,7587,BAO_0000357,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,B,,H,8,Autocuration,CHEMBL615110,,
250,Sus scrofa,1,,7587,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",,B,,H,8,Autocuration,CHEMBL840105,,
251,Sus scrofa,1,,7587,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-5 M inhibitory concentration",,B,,H,8,Autocuration,CHEMBL615111,,
252,Sus scrofa,1,,7587,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-6 M inhibitory concentration",,B,,H,8,Autocuration,CHEMBL615112,,
253,Sus scrofa,1,,7587,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-7 M inhibitory concentration",,B,,H,8,Autocuration,CHEMBL615113,,
254,Sus scrofa,1,,7587,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme.",,B,,H,8,Autocuration,CHEMBL615114,,
255,Sus scrofa,1,,7587,BAO_0000357,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,B,,H,8,Autocuration,CHEMBL615115,,
256,Sus scrofa,1,,7587,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",,B,,H,8,Autocuration,CHEMBL615116,,
257,,1,,7323,BAO_0000357,,"Compound was tested for in vitro inhibition of 5,10-Methylene Tetrahydrofolate Cyclohydrolase, competitive against (+)-L-5,10-methenyltetrahydrofolate",,B,,H,8,Autocuration,CHEMBL615698,,
258,Sus scrofa,1,,7587,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme at 10E-4 M inhibitory concentration",,B,,U,0,Autocuration,CHEMBL615699,,
259,Sus scrofa,1,,7587,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme.",,B,,U,0,Autocuration,CHEMBL615700,,
260,Saccharomyces cerevisiae,1,,13750,BAO_0000357,,Inhibition of 5-Desaturase involved in ergosterol biosynthesis,,B,,H,8,Expert,CHEMBL615701,,
261,Rattus norvegicus,1,,7662,BAO_0000019,,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,,B,,U,0,Autocuration,CHEMBL615702,,
262,Rattus norvegicus,1,,7662,BAO_0000019,,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,,B,,U,0,Autocuration,CHEMBL615703,,
263,Rattus norvegicus,1,,7662,BAO_0000019,,"Irreversible inhibition of Walker 256 FUDR phosphorylase; expressed as Vo/Vi, velocity without inhibitor to that of velocity with inhibitor",,B,,U,0,Autocuration,CHEMBL615704,,
264,,1,,12211,BAO_0000019,,"Tested for 5-HT 3 receptor antagonist potency by ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",,F,,H,6,Autocuration,CHEMBL615705,,
265,,1,,12211,BAO_0000019,,"Compound was tested for its 5-HT 3 receptor antagonist potency by their ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",,F,,H,6,Autocuration,CHEMBL615706,,
266,Cavia porcellus,1,2116.0,12211,BAO_0000221,,Relative ability to increase cholinergically mediated contractions in isolated ileum of guinea pig,,F,,D,9,Intermediate,CHEMBL615707,,
267,,1,,12211,BAO_0000019,,Stimulatory activity of intragastric pressure was tested in the rat,,F,,H,8,Expert,CHEMBL615708,,
268,,1,,15453,BAO_0000357,,% Decrease of 5-HT carrier-receptor -bound radioactivity using paroxetine as a radioligand.,,B,,H,8,Autocuration,CHEMBL615709,,
269,Rattus norvegicus,1,,11884,BAO_0000218,,Dose to reduce neuronal firing against 5-HT cells in rats (iv),,F,,U,0,Autocuration,CHEMBL615710,,
270,,1,,7185,BAO_0000019,,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,,F,,H,8,Autocuration,CHEMBL615711,,
271,Homo sapiens,1,,6876,BAO_0000357,,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine,,B,,D,9,Expert,CHEMBL615712,,
272,Homo sapiens,1,,6876,BAO_0000357,,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine; No data,,B,,D,9,Expert,CHEMBL836325,,
273,,1,,11863,BAO_0000019,,Inhibition of high affinity 5-HT uptake at concentration of 1 uM,,F,,H,8,Autocuration,CHEMBL615713,,
274,,1,,11863,BAO_0000357,,Inhibition constant of high-affinity 5-HT uptake,,B,,H,8,Autocuration,CHEMBL615714,,
275,,1,,11863,BAO_0000019,,Michaelis-Menten constant was reported for high affinity transport of 5-HT,,F,,H,8,Autocuration,CHEMBL615715,,
276,,1,,11863,BAO_0000019,,Maximum rate was determined for high affinity transport of 5-HT,,F,,H,8,Autocuration,CHEMBL615716,,
277,,1,,4639,BAO_0000019,,Compound was tested for agonistic activity against 5-HT uptake,,F,,H,4,Autocuration,CHEMBL615717,,
278,,1,,15796,BAO_0000019,,Inhibition affinity against 5-HT-1B receptor in rat frontal cortex using radio binding assay,,B,,H,8,Expert,CHEMBL881818,,
279,Bos taurus,1,,15796,BAO_0000357,,Inhibition affinity against 5-HT-1D receptor in bovine caudate nucleus using radio binding assay,,B,,H,8,Expert,CHEMBL884540,,
280,Rattus norvegicus,1,,12801,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,,B,,D,5,Autocuration,CHEMBL615718,,
281,,1,,12801,BAO_0000224,,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1 using [3H]5-HT as radioligand,,B,,H,4,Autocuration,CHEMBL615719,,
282,,1,,12120,BAO_0000249,,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M,Membranes,B,,H,4,Autocuration,CHEMBL615720,,
283,,1,,12120,BAO_0000249,,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M.,Membranes,B,,H,4,Autocuration,CHEMBL615721,,
284,,1,,11963,BAO_0000019,,Displacement of binding of [3H]-5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,B,,H,4,Autocuration,CHEMBL615722,,
285,,1,,11701,BAO_0000019,,Dose required to reduce neuronal firing of 5-HT1A cells by 50%,,F,,H,8,Autocuration,CHEMBL615723,,
286,,1,10000000.0,9995,BAO_0000221,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615724,,
287,,1,10000000.0,9995,BAO_0000221,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615725,,
288,,1,10000000.0,9995,BAO_0000221,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615726,,
289,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-HT1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (.26-3.52),,F,,H,8,Autocuration,CHEMBL615727,,
290,Cavia porcellus,1,,11574,BAO_0000019,,Effect on forskolin stimulated adenylate cyclase activity at 5-HT1D receptor of guinea pig substantia nigra.,,F,,D,9,Intermediate,CHEMBL615728,,
291,,1,,15779,BAO_0000219,,Binding affinity towards 5-HT1F (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL857971,449.0,
292,,1,,15363,BAO_0000357,,Compound was tested for the displacement of [125I]DOI from clone human 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL615729,,
293,Rattus norvegicus,1,,15363,BAO_0000019,,Efficacy against 5-hydroxytryptamine 2A receptor,,F,,D,9,Expert,CHEMBL615730,,
294,,1,,15329,BAO_0000019,,Intrinsic activity towards 5-HT2A receptor of rat tail artery,,F,,H,8,Expert,CHEMBL615731,,
295,,1,,15329,BAO_0000019,,Relative potency towards 5-HT2A receptor of rat tail artery,,F,,H,8,Expert,CHEMBL615732,,
296,,1,,15329,BAO_0000019,,Blocking 5-HT2A receptor-mediated contractions of rat tail artery,,F,,H,8,Expert,CHEMBL615733,,
297,,1,,15329,BAO_0000019,,Partial agonism at 5-HT2A receptor was evaluated in presence of ketanserin (3-10 nM) in isolated rat tail artery,,F,,H,8,Expert,CHEMBL615734,,
298,,1,,15329,BAO_0000019,,Compound was tested for the intrinsic activity against 5-HT2A receptors of rat tail artery.,,F,,H,8,Autocuration,CHEMBL615735,,
299,,1,,15329,BAO_0000019,,Effectiveness in blocking 5-HT2A receptor-mediated contractions of rat tail artery,,F,,H,8,Expert,CHEMBL615736,,
300,Cavia porcellus,1,2116.0,273,BAO_0000221,,Evaluated for the agonistic activity against 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,,F,,D,9,Intermediate,CHEMBL615737,,
301,Cavia porcellus,1,2116.0,273,BAO_0000221,,Agonistic activity against Serotonin 5-HT4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI),,F,,D,9,Intermediate,CHEMBL615738,,
302,Cavia porcellus,1,2116.0,273,BAO_0000221,,Evaluated for the agonistic activity against Serotonin 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,,F,,D,9,Intermediate,CHEMBL615739,,
303,,1,,12092,BAO_0000357,,The binding affinity was measured on 5-hydroxytryptamine 4 receptor using [3H]- GR-113808 as radioligand.,,B,,H,8,Autocuration,CHEMBL615278,,
304,Rattus norvegicus,1,,1317,BAO_0000019,,Antagonist activity against 5-HT4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,,F,,D,9,Expert,CHEMBL615279,,
305,,1,,12409,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 4 receptor,,B,,H,8,Expert,CHEMBL615280,,
306,Gallus gallus,1,,11126,BAO_0000019,,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of chick intestine,,B,,U,0,Autocuration,CHEMBL615281,,
307,Homo sapiens,1,,11126,BAO_0000019,,Inhibitory effect (10e-6 M) on the 25-OH-D3-1-hydroxylase activity,,F,,U,0,Autocuration,CHEMBL615282,,
308,Homo sapiens,1,,11126,BAO_0000019,,25-OH-D3-1-hydroxylase activity (10e-6 M) was measured as %control,,F,,U,0,Autocuration,CHEMBL615283,,
309,Homo sapiens,1,,11126,BAO_0000219,,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of human HL-60 cells,,B,,N,1,Autocuration,CHEMBL615284,649.0,
310,Homo sapiens,1,,11126,BAO_0000019,,Inhibitory effect (10e-6 M) on the 25-hydroxyvitamin D3-1-hydroxylase activity,,B,,U,0,Autocuration,CHEMBL615285,,
311,Homo sapiens,1,,11126,BAO_0000019,,25-hydroxyvitamin D3-1-hydroxylase activity (10e-6 M) was measured as %control,,B,,U,0,Autocuration,CHEMBL615286,,
312,Homo sapiens,1,,17807,BAO_0000219,,Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-1-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes,,B,,D,7,Autocuration,CHEMBL615287,,
313,,1,,16575,BAO_0000220,,Chymotryptic inhibitory activity against 26S proteasome,,F,,S,2,Intermediate,CHEMBL615288,,
314,,1,,15407,BAO_0000220,,Inhibitory activity against 26S proteasome degradation of IkB,,B,,S,2,Intermediate,CHEMBL615289,,
315,Homo sapiens,1,,10797,BAO_0000219,,In vitro inhibition of 2780/DOX ovarian cancer cell line,,F,,N,1,Intermediate,CHEMBL615290,478.0,
316,Homo sapiens,1,,10797,BAO_0000219,,In vitro inhibition of 2780/S ovarian cancer cell line,,F,,N,1,Intermediate,CHEMBL884522,478.0,
317,Homo sapiens,1,,3469,BAO_0000019,,Relative activity on the cellular accumulation of vincristine in multidrug-resistant (MDR) human ovarian cancer 2780AD cells,,F,,U,0,Autocuration,CHEMBL615291,,
318,,1,,16037,BAO_0000225,,Association constant for binding to AATT 28-mer AATT hairpin,,B,,M,3,Intermediate,CHEMBL615292,,
319,,1,,16037,BAO_0000225,,Kinetically Defined Association Constant for 28-mer AATT hairpin.,,B,,M,3,Intermediate,CHEMBL615293,,
320,,1,,16037,BAO_0000225,,Reaction Rate Parameter for 28-mer AATT hairpin,,B,,M,3,Intermediate,CHEMBL615294,,
321,,1,,16037,BAO_0000225,,Reaction Rate Parameter for 28-mer AATT hairpin,,B,,M,3,Intermediate,CHEMBL615295,,
322,Homo sapiens,1,,16524,BAO_0000019,,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 1),,F,,U,0,Autocuration,CHEMBL825021,,
323,Homo sapiens,1,,16524,BAO_0000019,,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 2),,F,,U,0,Autocuration,CHEMBL615296,,
324,Homo sapiens,1,,16524,BAO_0000019,,Inhibitory concentration by single cycle replication assay using envelope deficient HIV-1,,F,,U,0,Autocuration,CHEMBL615297,,
325,Cricetulus griseus,1,,16758,BAO_0000019,,Cytotoxicity against cell line 2SC/20 determined by MTT test,,F,,U,0,Autocuration,CHEMBL615298,,
326,Cricetulus griseus,1,,16758,BAO_0000019,,Cytotoxicity against cell line 2SC/20 of hamster determined by MTT test,,F,,U,0,Autocuration,CHEMBL615299,,
327,Cricetulus griseus,1,,16758,BAO_0000019,,Inhibitory concentration against the growth of 2SC/20 cell line after 72 hr of drug exposure by MTT test,,F,,U,0,Autocuration,CHEMBL615300,,
328,,1,,14360,BAO_0000357,,Binding affinity on 3 beta-hydroxysteroid dehydrogenase,,B,,H,8,Autocuration,CHEMBL615301,,
329,Homo sapiens,1,,14360,BAO_0000357,,Binding affinity for 3-beta-hydroxysteroid dehydrogenase,,B,,D,9,Expert,CHEMBL615302,,
330,Rattus norvegicus,1,,9964,BAO_0000019,,Selectivity ratio of ID50 in liver and heart,,B,,U,0,Autocuration,CHEMBL615303,,
331,,1,,9964,BAO_0000019,,"Selectivity, ratio of relative ID50 in liver and heart",,B,,H,8,Autocuration,CHEMBL615304,,
332,,1,,9964,BAO_0000019,,Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to T3,,B,,H,8,Autocuration,CHEMBL615305,,
333,,1,,9964,BAO_0000218,,"Binding affinity to the receptor was determined in nuclei of heart In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,B,,H,8,Autocuration,CHEMBL615306,,
334,,1,,9964,BAO_0000218,,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,B,,H,8,Autocuration,CHEMBL615307,,
335,,1,,9964,BAO_0000218,,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,B,,H,8,Autocuration,CHEMBL615308,,
336,,1,,9964,BAO_0000218,,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,F,,H,8,Autocuration,CHEMBL615309,,
337,,1,,9964,BAO_0000019,,"Binding affinity to the thyroid hormone receptor was determined in vitro in isolated nuclei of rat liver relative to 3,5,3' triiodothyronine",,B,,U,0,Autocuration,CHEMBL615310,,
338,,1,,9964,BAO_0000019,,Binding affinity to the receptor was determined in vitro in isolated nuclei of rat liver relative to T3,,B,,H,8,Autocuration,CHEMBL615311,,
339,Homo sapiens,1,,9964,BAO_0000019,,"Binding affinity to thyroid hormone receptor beta, relative to 3,5,3' triiodothyronine receptor, in isolated nuclei of heart",,B,,U,0,Autocuration,CHEMBL615312,,
340,,1,,9964,BAO_0000019,,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,,B,,H,8,Autocuration,CHEMBL615313,,
341,,1,,9964,BAO_0000019,,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,,F,,H,8,Autocuration,CHEMBL615314,,
342,,1,,9964,BAO_0000019,,"Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to 3,5,3' triiodothyronine receptor",,B,,H,8,Autocuration,CHEMBL615315,,
343,Rattus norvegicus,1,,9964,BAO_0000218,,"In vivo binding affinity for 3,5,3'' triiodothyronine receptor of heart nuclei 1 hr after intravenous administration",,B,,U,0,Autocuration,CHEMBL615316,,
344,,1,,9964,BAO_0000218,,Binding affinity to the receptor was determined in nuclei of heart in vivo 1 hour after intravenous administration relative to T3,,B,,H,8,Autocuration,CHEMBL615317,,
345,,1,,9964,BAO_0000218,,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,B,,H,8,Autocuration,CHEMBL615318,,
346,Rattus norvegicus,1,,9964,BAO_0000218,,"In vivo binding affinity for 3,5,3' triiodothyronine receptor of liver nuclei 1 hour after intravenous administration",,B,,U,0,Autocuration,CHEMBL615319,,
347,,1,,9964,BAO_0000019,,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",,B,,H,8,Autocuration,CHEMBL615320,,
348,,1,,9964,BAO_0000019,,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",,F,,H,8,Autocuration,CHEMBL615321,,
349,Rattus norvegicus,1,,3796,BAO_0000019,,"Inhibition of [125I]L-T3 binding to rat hepatic 3,5,3''-triiodo-L-thyronine receptor",,B,,U,0,Autocuration,CHEMBL615322,,
350,Escherichia coli,1,,4251,BAO_0000357,,Inhibition constant for binding to Co2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,,B,,H,8,Autocuration,CHEMBL615323,,
351,Escherichia coli,1,,4251,BAO_0000357,,Inhibition constant for binding to Zn2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,,B,,H,8,Autocuration,CHEMBL615407,,
352,Escherichia coli,1,,4251,BAO_0000357,,Kinetics expressed as Michaelis-Menten constant against Co2+ form of 3-dehydroquinate synthase purified from Escherichia coli,,B,,H,8,Autocuration,CHEMBL857267,,
353,Escherichia coli,1,,4251,BAO_0000357,,Kinetics expressed as Michaelis-Menten constant against Zn2+ form of 3-dehydroquinate synthase purified from Escherichia coli,,B,,H,8,Autocuration,CHEMBL615408,,
354,,1,,166,BAO_0000357,,Type of inhibition of 3-dehydroquinate synthase was determined; R - Slowly reversible,,B,,H,8,Autocuration,CHEMBL615409,,
355,,1,,17861,BAO_0000357,,Compound was evaluated for its inhibitory constant against 3-dehydroquinate synthase,,B,,H,8,Autocuration,CHEMBL615410,,
356,,1,,166,BAO_0000357,,Inhibition constant against 3-dehydroquinate synthase,,B,,H,8,Autocuration,CHEMBL615411,,
357,,1,,166,BAO_0000357,,Association rate constant against 3-dehydroquinate synthase,,B,,H,8,Autocuration,CHEMBL615412,,
358,,1,,166,BAO_0000357,,Rate constant against 3-dehydroquinate synthase,,B,,H,8,Autocuration,CHEMBL615413,,
359,,1,,3548,BAO_0000019,,Inhibitory activity against fuc-TVII,,B,,U,0,Autocuration,CHEMBL615414,,
360,Rattus norvegicus,1,2107.0,9877,BAO_0000251,,Ability of compound (2.5 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,B,,D,9,Autocuration,CHEMBL615415,,
361,Rattus norvegicus,1,2107.0,9877,BAO_0000251,,Ability of compound (2500 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,B,,D,9,Autocuration,CHEMBL615416,,
362,Rattus norvegicus,1,2107.0,9877,BAO_0000251,,Ability of compound (250 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,B,,D,9,Autocuration,CHEMBL615417,,
363,Rattus norvegicus,1,2107.0,9877,BAO_0000251,,Ability of compound (25 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,B,,D,9,Autocuration,CHEMBL615418,,
364,Rattus norvegicus,1,2107.0,9877,BAO_0000251,,Ability of compound at 0 uM to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,B,,D,9,Autocuration,CHEMBL615419,,
365,Rattus norvegicus,1,2107.0,9877,BAO_0000251,,Ability of compound to inhibit the activity of 3-hydroxy-3-methylglutarylcoenzyme A(HMGR) reductase in rat liver microsomes,Microsomes,B,,D,9,Autocuration,CHEMBL615420,,
366,Rattus norvegicus,1,2107.0,9877,BAO_0000251,,Percentage inhibition of 3-hydroxy-3-methyl glutaryl coenzyme A reductase in rat liver microsomes at 250 uM,Microsomes,B,,D,9,Autocuration,CHEMBL615421,,
367,Rattus norvegicus,1,2107.0,9877,BAO_0000251,,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 0 uM,Microsomes,B,,D,9,Autocuration,CHEMBL615422,,
368,Rattus norvegicus,1,2107.0,9877,BAO_0000251,,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2.5 uM,Microsomes,B,,D,9,Autocuration,CHEMBL615423,,
369,Rattus norvegicus,1,2107.0,9877,BAO_0000251,,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2500 uM,Microsomes,B,,D,9,Autocuration,CHEMBL872868,,
370,Rattus norvegicus,1,2107.0,9877,BAO_0000251,,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 25 uM,Microsomes,B,,D,9,Autocuration,CHEMBL615424,,
371,,1,,3003,BAO_0000224,,Inhibitory activity against 3-phosphoglycerate kinase.,,B,,H,4,Autocuration,CHEMBL825022,,
372,,1,,3003,BAO_0000224,,Binding affinity was evaluated towards 3-phosphoglycerate kinase at 37 degrees Celsius in 0.1 m NaCl pH 7.1,,B,,H,4,Autocuration,CHEMBL615425,,
373,,1,,3003,BAO_0000224,,"Michaelis-Menten constant with 1,3-bisphosphoglyceric acid (1,3-BPG) against 3-phosphoglycerate kinase",,B,,H,4,Autocuration,CHEMBL615426,,
374,Homo sapiens,1,,17185,BAO_0000357,,Inhibition of human 3-phosphoinositide-dependent protein kinase 1 at 10 uM,,B,,D,9,Expert,CHEMBL615427,,
375,Homo sapiens,1,,6072,BAO_0000219,,Cytotoxicity on 3677 melanoma cells,,F,,N,1,Intermediate,CHEMBL615428,844.0,
376,Homo sapiens,1,,6072,BAO_0000219,,Cytotoxicity on 3677 melanoma cells in combination with L-49-sFv-bL,,F,,N,1,Intermediate,CHEMBL615429,844.0,
377,Mus musculus,1,,5018,BAO_0000219,,Antitumor activity against Mouse colon 38 at 500 ug/disk in disk diffusion assay,,F,,N,1,Intermediate,CHEMBL615430,700.0,
378,Homo sapiens,1,,2852,BAO_0000019,,Compound was evaluated for inhibition of tumor cell growth using sulforhodamine-B assay in 38 human cell lines,,F,,U,0,Intermediate,CHEMBL615431,,
379,,1,,8663,BAO_0000218,,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; NT= Not tested,,F,,U,0,Autocuration,CHEMBL615432,798.0,
380,,1,,8663,BAO_0000218,,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; reproducible significant activity.,,F,,U,0,Autocuration,CHEMBL615433,798.0,
381,Human rhinovirus 14,1,,3245,BAO_0000019,,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease,,F,,D,9,Expert,CHEMBL615434,,
382,Human rhinovirus sp.,1,,3245,BAO_0000218,,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease; NI means No inhibition to 50 uM,,F,,N,1,Intermediate,CHEMBL615435,,
383,human rhinovirus type 14,1,,3877,BAO_0000218,,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as KI,,F,,N,1,Intermediate,CHEMBL615436,,
384,human rhinovirus type 14,1,,3877,BAO_0000218,,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as kinact,,F,,N,1,Intermediate,CHEMBL615437,,
385,Human rhinovirus 14,1,,5861,BAO_0000019,,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,F,,D,9,Expert,CHEMBL615438,,
386,Human rhinovirus 14,1,,5861,BAO_0000019,,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,F,,D,9,Expert,CHEMBL615439,,
387,Human rhinovirus 14,1,,5861,BAO_0000019,,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,F,,D,9,Expert,CHEMBL615440,,
388,Human rhinovirus 14,1,,5861,BAO_0000019,,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay; inactive,,F,,D,9,Expert,CHEMBL615441,,
389,Enterovirus,1,,13748,BAO_0000218,,Compound was tested for the inhibitory activity of compound towards human rhinovirus 3C protease,,F,,N,1,Intermediate,CHEMBL615641,,
390,Enterovirus,1,,13748,BAO_0000218,,Compound was tested for the inhibitory activity of compound towards human rhinovirus-16 3C protease,,F,,N,1,Intermediate,CHEMBL872065,,
391,Enterovirus,1,,13748,BAO_0000218,,Compound was tested for the inhibitory activity of compound towards human rhinovirus-2 3C protease,,F,,N,1,Intermediate,CHEMBL825023,,
392,Enterovirus,1,,13748,BAO_0000218,,Compound was tested for the inhibitory activity of compound towards human rhinovirus-89 3C protease,,F,,N,1,Intermediate,CHEMBL615642,,
393,Human rhinovirus B,1,,13748,BAO_0000357,,Inhibition of human rhinovirus 3C protease,,B,,H,8,Expert,CHEMBL615643,,
394,Homo sapiens,1,,17699,BAO_0000019,,Compound was tested for inhibition of a proteinase 3CL pro of human coronavirus; Inhibited,,B,,U,0,Autocuration,CHEMBL615644,,
395,Mus musculus,1,,7145,BAO_0000218,,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 100 mg/kg (Dose range 200-12.5),,F,,N,1,Intermediate,CHEMBL615645,833.0,
396,Mus musculus,1,,7145,BAO_0000218,,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 128 mg/kg (Dose range 256-16),,F,,N,1,Intermediate,CHEMBL615646,833.0,
397,Mus musculus,1,,7145,BAO_0000218,,Compound tested for toxicity against 3EM 37 Mouse Ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (10/10),,F,,N,1,Intermediate,CHEMBL615647,833.0,
398,Mus musculus,1,,7145,BAO_0000218,,Compound tested for toxicity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (6/6),,F,,N,1,Intermediate,CHEMBL615648,833.0,
399,Mus musculus,1,,7145,BAO_0000218,,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as animal weight difference of the treated and the control (T-C) at OD of 100 mg/kg,,F,,N,1,Intermediate,CHEMBL615649,833.0,
400,Mus musculus,1,,7145,BAO_0000218,,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as percentage of cured animals at OD of 100 mg/kg,,F,,N,1,Intermediate,CHEMBL615650,833.0,
401,Mus musculus,1,,5325,BAO_0000218,,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing 15 mg/kg b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,,F,,N,1,Intermediate,CHEMBL615651,847.0,
402,Mus musculus,1,,5325,BAO_0000218,,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,,F,,N,1,Intermediate,CHEMBL615652,847.0,
403,Mus musculus,1,,5325,BAO_0000218,,In vivo anti-tumor and anti-metastatic activity following p.o. administration b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor; Not tested.,,F,,N,1,Expert,CHEMBL615653,847.0,
404,Mus musculus,1,,16169,BAO_0000219,,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 1 uM dose,,F,,N,1,Intermediate,CHEMBL615654,847.0,
405,Mus musculus,1,,16169,BAO_0000219,,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 10 uM dose,,F,,N,1,Intermediate,CHEMBL615655,847.0,
406,Mus musculus,1,,16169,BAO_0000219,,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 250 uM dose,,F,,N,1,Intermediate,CHEMBL825024,847.0,
407,Mus musculus,1,,16169,BAO_0000219,,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 50 uM dose,,F,,N,1,Intermediate,CHEMBL615656,847.0,
408,Mus musculus,1,,16169,BAO_0000219,,accumulation of compound in 3LL cells was measured with DFMO by ICP-AES at 50 uM dose,,F,,N,1,Intermediate,CHEMBL615657,847.0,
409,Mus musculus,1,,16169,BAO_0000219,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 1 uM dose,,F,,N,1,Intermediate,CHEMBL615658,847.0,
410,Mus musculus,1,,16169,BAO_0000219,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 10 uM dose,,F,,N,1,Intermediate,CHEMBL615659,847.0,
411,Mus musculus,1,,16169,BAO_0000219,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 250 uM dose,,F,,N,1,Intermediate,CHEMBL615660,847.0,
412,Mus musculus,1,,16169,BAO_0000219,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,,F,,N,1,Intermediate,CHEMBL615661,847.0,
413,Mus musculus,1,,16169,BAO_0000219,,accumulation of compound in 3LL cells was measured without DFMO by ICP-AES at 50 uM dose,,F,,N,1,Intermediate,CHEMBL615662,847.0,
414,Mus musculus,1,,16169,BAO_0000219,,Effect on the growth of 3LL cells by DFMO pretreatment at 48 hr incubation,,F,,N,1,Intermediate,CHEMBL615663,847.0,
415,Mus musculus,1,,16169,BAO_0000219,,Effect on the growth of 3LL cells was evaluated using an MTT assay at 48 hour incubation,,F,,N,1,Intermediate,CHEMBL615664,847.0,
416,Mus musculus,1,,16169,BAO_0000219,,Effect on the growth of 3LL cells was evaluated using an MTT assay at 72 hour incubation,,F,,N,1,Intermediate,CHEMBL615665,847.0,
417,Mus musculus,1,,16169,BAO_0000219,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,,F,,N,1,Intermediate,CHEMBL615666,847.0,
418,Mus musculus,1,,16169,BAO_0000219,,putrescine levels in 3LL cells after the treatment of 1 uM of Compound,,F,,N,1,Intermediate,CHEMBL615667,847.0,
419,Mus musculus,1,,16169,BAO_0000219,,putrescine levels in 3LL cells after the treatment of 10 uM of Compound,,F,,N,1,Intermediate,CHEMBL615668,847.0,
420,Mus musculus,1,,16169,BAO_0000219,,putrescine levels in 3LL cells after the treatment of 250 uM of Compound,,F,,N,1,Intermediate,CHEMBL615669,847.0,
421,Mus musculus,1,,16169,BAO_0000219,,putrescine levels in 3LL cells after the treatment of 50 uM of Compound,,F,,N,1,Intermediate,CHEMBL615670,847.0,
422,Mus musculus,1,,16169,BAO_0000219,,spermidine levels in 3LL cells after the treatment of 1 uM of Compound,,F,,N,1,Intermediate,CHEMBL836739,847.0,
423,Mus musculus,1,,16169,BAO_0000219,,spermidine levels in 3LL cells after the treatment of 10 uM of Compound,,F,,N,1,Intermediate,CHEMBL615671,847.0,
424,Mus musculus,1,,16169,BAO_0000219,,spermidine levels in 3LL cells after the treatment of 250 uM of Compound,,F,,N,1,Intermediate,CHEMBL615672,847.0,
425,Mus musculus,1,,16169,BAO_0000219,,spermidine levels in 3LL cells after the treatment of 50 uM of Compound,,F,,N,1,Intermediate,CHEMBL615791,847.0,
426,Mus musculus,1,,16169,BAO_0000219,,spermine levels in 3LL cells after the treatment of 1 uM of Compound,,F,,N,1,Intermediate,CHEMBL615792,847.0,
427,Mus musculus,1,,16169,BAO_0000219,,spermine levels in 3LL cells after the treatment of 10 uM of Compound,,F,,N,1,Intermediate,CHEMBL615793,847.0,
428,Mus musculus,1,,16169,BAO_0000219,,spermine levels in 3LL cells after the treatment of 250 uM of Compound,,F,,N,1,Intermediate,CHEMBL615794,847.0,
429,Mus musculus,1,,16169,BAO_0000219,,spermine levels in 3LL cells after the treatment of 50 uM of Compound,,F,,N,1,Intermediate,CHEMBL615795,847.0,
430,Homo sapiens,1,,15547,BAO_0000219,,Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50%,,F,,N,1,Intermediate,CHEMBL615590,971.0,
431,,1,,8663,BAO_0000218,,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible minimal activity,,F,,U,0,Autocuration,CHEMBL615591,,
432,,1,,8663,BAO_0000218,,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible significant activity.,,F,,U,0,Autocuration,CHEMBL615592,,
433,,1,,8663,BAO_0000218,,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; NT= Not tested,,F,,U,0,Autocuration,CHEMBL615593,,
434,,1,,8663,BAO_0000218,,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; reproducible significant activity.,,F,,U,0,Autocuration,CHEMBL615594,,
435,Mus musculus,1,,4504,BAO_0000219,,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,,F,,N,1,Intermediate,CHEMBL615595,723.0,
436,Mus musculus,1,,4504,BAO_0000219,,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,,F,,N,1,Intermediate,CHEMBL615596,723.0,
437,,1,,12695,BAO_0000219,,Inhibition of 6 nM bombesin induced [3H]thymidine incorporation measured in swiss 3T3 cells using a mitogenicity assay,,F,,H,8,Expert,CHEMBL615597,723.0,
438,Mus musculus,1,,12695,BAO_0000219,,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; na=Not active,,F,,N,1,Intermediate,CHEMBL615598,723.0,
439,Mus musculus,1,,12695,BAO_0000219,,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; nt=Not tested,,F,,N,1,Intermediate,CHEMBL615599,723.0,
440,Mus musculus,1,,17642,BAO_0000219,,Effective dose against murine 3T3 fibroblasts cells,,F,,N,1,Expert,CHEMBL615600,723.0,
441,Mus musculus,1,,17642,BAO_0000219,,Dose required against murine 3T3 fibroblasts cells; 1-10 uM,,F,,N,1,Expert,CHEMBL615601,723.0,
442,Mus musculus,1,,12340,BAO_0000219,,Cytotoxic effect on 3T3 cells,,F,,N,1,Expert,CHEMBL615602,723.0,
443,Mus musculus,1,,12340,BAO_0000219,,Cytotoxic effect on 3T3 cells,,F,,N,1,Expert,CHEMBL615603,723.0,
444,Mus musculus,1,,12716,BAO_0000219,,Compound was tested for the concentration necessary to inhibit swiss 3T3 Mouse Fibroblast cell growth rate by 50%.,,F,,N,1,Intermediate,CHEMBL615604,723.0,
445,Mus musculus,1,,6277,BAO_0000219,,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,,F,,N,1,Intermediate,CHEMBL615605,723.0,
446,Mus musculus,1,,6277,BAO_0000219,,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration; nd=No data,,F,,N,1,Intermediate,CHEMBL615606,723.0,
447,Mus musculus,1,,6277,BAO_0000219,,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration,,F,,N,1,Expert,CHEMBL884526,723.0,
448,Mus musculus,1,,6277,BAO_0000219,,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.d.=no data,,F,,N,1,Expert,CHEMBL615607,723.0,
449,Mus musculus,1,,6277,BAO_0000219,,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.t.=not tested,,F,,N,1,Intermediate,CHEMBL615608,723.0,
450,Mus musculus,1,,6277,BAO_0000219,,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration,,F,,N,1,Expert,CHEMBL615609,723.0,
451,Mus musculus,1,,6277,BAO_0000219,,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.d.=no data,,F,,N,1,Expert,CHEMBL615682,723.0,
452,Mus musculus,1,,6277,BAO_0000219,,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.t.=not tested,,F,,N,1,Intermediate,CHEMBL615683,723.0,
453,Mus musculus,1,,17780,BAO_0000218,,In vivo inhibition of H-ras-transformed 3T3 fibroblasts in nude mouse tumor models,,F,,N,1,Expert,CHEMBL615684,723.0,
454,Mus musculus,1,,12751,BAO_0000219,,Inhibition of PDGF-dependent autophosphorylation of PDGF-R in mouse BALB/c3T3 cells,,F,,D,7,Autocuration,CHEMBL615685,,
455,Mus musculus,1,,12380,BAO_0000219,,Inhibition of Swiss 3T3 Mouse fibroblast proliferation,,F,,N,1,Expert,CHEMBL615686,723.0,
456,Mus musculus,1,,14892,BAO_0000219,,Inhibitory activity against 3T3 cell line,,F,,N,1,Intermediate,CHEMBL615687,723.0,
457,Mus musculus,1,,12695,BAO_0000219,,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured,,F,,N,1,Intermediate,CHEMBL884523,723.0,
458,,1,,12695,BAO_0000019,,Ability of peptide to inhibit binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane.,,F,,H,8,Expert,CHEMBL615688,,
459,Mus musculus,1,,12695,BAO_0000219,,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured; nt=Not tested,,F,,N,1,Intermediate,CHEMBL615689,723.0,
460,Mus musculus,1,,12695,BAO_0000219,,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells was measured,,F,,N,1,Intermediate,CHEMBL615690,723.0,
461,,1,,12695,BAO_0000019,,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells,,F,,H,8,Expert,CHEMBL615691,,
462,,1,,12695,BAO_0000019,,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells; nt=Not tested,,F,,H,8,Expert,CHEMBL615692,,
463,Mus musculus,1,,6277,BAO_0000219,,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,,F,,N,1,Intermediate,CHEMBL615693,723.0,
464,Mus musculus,1,,6277,BAO_0000219,,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line was determined using NR coloration; n.d.=no data,,F,,N,1,Expert,CHEMBL615324,723.0,
465,Homo sapiens,1,,4959,BAO_0000219,,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells,,F,,D,9,Expert,CHEMBL615325,723.0,
466,Homo sapiens,1,,4959,BAO_0000219,,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells (Not tested),,F,,D,9,Expert,CHEMBL615490,723.0,
467,Homo sapiens,1,,4959,BAO_0000219,,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,,F,,D,9,Expert,CHEMBL615491,723.0,
468,Homo sapiens,1,,4959,BAO_0000219,,Inhibition of ligand-induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells (Not tested),,F,,D,9,Expert,CHEMBL615492,723.0,
469,Mus musculus,1,,12082,BAO_0000219,,Inhibitory concentration of compound rwas calculated on 3T3 cells by [3H]Thd incorporation,,F,,N,1,Intermediate,CHEMBL615493,723.0,
470,Mus musculus,1,,12082,BAO_0000219,,Inhibitory concentration of compound was calculated on 3T3 cells by [14C]Leu incorporation,,F,,N,1,Intermediate,CHEMBL615494,723.0,
471,Mus musculus,1,,12082,BAO_0000219,,Inhibitory concentration of compound was calculated on 3T3 cells by using clonal assay,,F,,N,1,Intermediate,CHEMBL615495,723.0,
472,Mus musculus,1,,12082,BAO_0000219,,Inhibitory concentration was calculated on 3T3 cells by using growth assay,,F,,N,1,Intermediate,CHEMBL615496,723.0,
473,Mus musculus,1,,2643,BAO_0000219,,In vitro cytotoxicity was evaluated in mouse embryo BALB/c 3T3 cells,,F,,N,1,Intermediate,CHEMBL615497,723.0,
474,Mus musculus,1,,11926,BAO_0000219,,Inhibition of Swiss 3T3 mouse fibroblast proliferation,,F,,N,1,Expert,CHEMBL615498,723.0,
475,Mus musculus,1,,15204,BAO_0000219,,The compound was tested for cytotoxicity against 3T3 fibroblast murine cell line.,,A,,N,1,Intermediate,CHEMBL615499,723.0,
476,Mus musculus,1,,15992,BAO_0000219,,Effective concentration required to inhibit the growth of murine 3T3 fibroblasts,,F,,N,1,Expert,CHEMBL835522,723.0,
477,Mus musculus,1,,16279,BAO_0000219,,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014); Not tested,,F,,N,1,Intermediate,CHEMBL615500,723.0,
478,Mus musculus,1,,16279,BAO_0000219,,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,F,,N,1,Intermediate,CHEMBL615501,723.0,
479,Mus musculus,1,,16279,BAO_0000219,,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,F,,N,1,Intermediate,CHEMBL615502,723.0,
480,Mus musculus,1,,16279,BAO_0000219,,cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,F,,N,1,Intermediate,CHEMBL615503,723.0,
481,Mus musculus,1,,16279,BAO_0000219,,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,F,,N,1,Intermediate,CHEMBL615504,723.0,
482,Mus musculus,1,,16279,BAO_0000219,,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,F,,N,1,Intermediate,CHEMBL615505,723.0,
483,Mus musculus,1,,12831,BAO_0000219,,Inhibition of swiss 3T3 mouse fibroblast proliferation,,F,,N,1,Expert,CHEMBL615506,723.0,
484,Mus musculus,1,,13497,BAO_0000219,,Compound was tested for sublethal concentrations in 3T3 mouse fibroblast lysis.,,F,,N,1,Intermediate,CHEMBL615507,723.0,
485,,1,,13715,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,,F,,N,1,Intermediate,CHEMBL615508,620.0,
486,Mus musculus,1,,13618,BAO_0000219,,Concentration required to stimulate glucose uptake in 3T3-L1 adipocytes after 48 hr incubation,,F,,N,1,Intermediate,CHEMBL615509,620.0,
487,Mus musculus,1,,11902,BAO_0000219,,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 0.3 uM,,F,,N,1,Intermediate,CHEMBL615510,620.0,
488,Mus musculus,1,,11902,BAO_0000219,,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 3 uM,,F,,N,1,Intermediate,CHEMBL615511,620.0,
489,Mus musculus,1,,11902,BAO_0000219,,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 30 uM,,F,,N,1,Intermediate,CHEMBL615512,620.0,
490,Mus musculus,1,,14840,BAO_0000218,,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 24 hr",,F,,N,1,Intermediate,CHEMBL615513,620.0,
491,Mus musculus,1,,14840,BAO_0000218,,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 3 hr",,F,,N,1,Intermediate,CHEMBL615514,620.0,
492,,1,,13715,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes,,F,,N,1,Intermediate,CHEMBL615515,620.0,
493,,1,,13715,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,,F,,N,1,Intermediate,CHEMBL615516,620.0,
494,,1,,13715,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,F,,N,1,Intermediate,CHEMBL615517,620.0,
495,,1,,13715,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,,F,,N,1,Intermediate,CHEMBL615518,620.0,
496,,1,,13715,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,F,,N,1,Intermediate,CHEMBL615519,620.0,
497,,1,,13715,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.3 uM dose.,,F,,N,1,Intermediate,CHEMBL615520,620.0,
498,,1,,13715,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.5 uM dose.,,F,,N,1,Intermediate,CHEMBL615521,620.0,
499,,1,,13715,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,,F,,N,1,Intermediate,CHEMBL615522,620.0,
500,,1,,13715,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,,F,,N,1,Intermediate,CHEMBL615523,620.0,
501,,1,,13715,BAO_0000218,,In vitro measurements 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,,F,,N,1,Expert,CHEMBL615524,620.0,
502,,1,,13715,BAO_0000218,,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,,F,,N,1,Expert,CHEMBL615525,620.0,
503,,1,,13715,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,,F,,N,1,Intermediate,CHEMBL615526,620.0,
504,,1,,13715,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,,F,,N,1,Intermediate,CHEMBL615527,620.0,
505,,1,,13715,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 300 uM dose.,,F,,N,1,Intermediate,CHEMBL615528,620.0,
506,,1,,13715,BAO_0000218,,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,,F,,N,1,Expert,CHEMBL615529,620.0,
507,,1,,13715,BAO_0000218,,In vitro by measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,,F,,N,1,Expert,CHEMBL615530,620.0,
508,,1,,13715,BAO_0000218,,In vitro measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,,F,,N,1,Expert,CHEMBL615531,620.0,
509,,1,,13715,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,,F,,N,1,Intermediate,CHEMBL615532,620.0,
510,,1,,13715,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,F,,N,1,Intermediate,CHEMBL615533,620.0,
511,,1,,13715,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,,F,,N,1,Intermediate,CHEMBL615534,620.0,
512,,1,,13715,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,,F,,N,1,Intermediate,CHEMBL615535,620.0,
513,,1,,13715,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,,F,,N,1,Intermediate,CHEMBL615536,620.0,
514,,1,,13715,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,,F,,N,1,Intermediate,CHEMBL615537,620.0,
515,,1,,13715,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,,F,,N,1,Intermediate,CHEMBL615538,620.0,
516,,1,,13715,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,,F,,N,1,Intermediate,CHEMBL836166,620.0,
517,,1,,6411,BAO_0000219,,Inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells,,F,,H,8,Expert,CHEMBL615539,620.0,
518,Mus musculus,1,,6411,BAO_0000219,,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; ND = No data,,F,,N,1,Intermediate,CHEMBL615540,620.0,
519,,1,,6411,BAO_0000219,,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; Na = Not active,,F,,H,8,Expert,CHEMBL615541,620.0,
520,Mus musculus,1,,3966,BAO_0000219,,Insulin-sensitizing activity; triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 1 uM expressed as percent activity of pioglitazone,,F,,N,1,Expert,CHEMBL615542,620.0,
521,Mus musculus,1,,3966,BAO_0000219,,Compound was tested for insulin-sensitizing activity by measuring triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 10 uM expressed as percent activity of pioglitazone,,F,,N,1,Intermediate,CHEMBL615543,620.0,
522,Mus musculus,1,,15556,BAO_0000219,,Stimulation of adipogenesis in 3T3-L1 cells is expressed as concentration equivalent to the [ 1-14C] uptake counts after treatment with 0.2 ug/mL troglitazone,,F,,N,1,Expert,CHEMBL615544,620.0,
523,Mus musculus,1,,5845,BAO_0000219,,Effective concentration for enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,,F,,N,1,Expert,CHEMBL615545,620.0,
524,Mus musculus,1,,14422,BAO_0000219,,Effective concentration for 50% enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,,F,,N,1,Expert,CHEMBL615546,620.0,
525,Mus musculus,1,,5845,BAO_0000219,,Percentage of rosiglitazone response for insulin-sensitizing activity at 1 uM concentration in 3T3-L1 cells,,F,,N,1,Expert,CHEMBL615547,620.0,
526,Mus musculus,1,,14508,BAO_0000219,,In vitro glucose transport activity in 3T3-LI adipocytes at 10 uM concentration.,,F,,N,1,Expert,CHEMBL615548,620.0,
527,Mus musculus,1,,14508,BAO_0000219,,In vitro glucose transport activity in 3T3-LI adipocytes at 3 uM concentration.,,F,,N,1,Expert,CHEMBL615549,620.0,
528,Mus musculus,1,,14508,BAO_0000219,,In vitro glucose transport activity in 3T3-LI adipocytes at 30 uM concentration.,,F,,N,1,Expert,CHEMBL615550,620.0,
529,Rattus norvegicus,1,,6349,BAO_0000219,,Inhibitory activity against rat fibroblast (3Y1) cell line,,F,,N,1,Intermediate,CHEMBL615551,1118.0,
530,Rattus norvegicus,1,,15899,BAO_0000219,,Mean concentration causing inhibition of cell growth in 3Y1 cells.,,F,,N,1,Expert,CHEMBL615552,1118.0,
531,Rattus norvegicus,1,,15899,BAO_0000219,,Cytotoxicity in 3Y1 cells.,,F,,N,1,Expert,CHEMBL615553,1118.0,
532,Rattus norvegicus,1,,15899,BAO_0000219,,Cytostatic effect in 3Y1 cells.,,F,,N,1,Expert,CHEMBL615554,1118.0,
533,Rattus norvegicus,1,,15899,BAO_0000219,,"Mean averaged concentration for total growth inhibition, which signifies cytostatic effect",,F,,N,1,Intermediate,CHEMBL615555,1118.0,
534,Rattus norvegicus,1,,17038,BAO_0000219,,Concentration to inhibit growth of normal rat fibroblast cells (3Y1-B cells) after 72 h exposure,,F,,N,1,Expert,CHEMBL615556,1118.0,
535,,1,,12421,BAO_0000019,,In vitro inhibitory activity against human adrenal 3-beta hydroxy-delta 5-teroid isomerase,,B,,U,0,Autocuration,CHEMBL615557,,
536,,1,,12947,BAO_0000019,,Inhibition of recombinant human adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,,B,,U,0,Autocuration,CHEMBL615558,,
537,,1,,12947,BAO_0000019,,Inhibition of recombinant rat adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,,B,,U,0,Autocuration,CHEMBL872066,,
538,Sus scrofa,1,,4896,BAO_0000019,,In vitro inhibition against of 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) from pig liver by the enol borate method,,B,,D,9,Expert,CHEMBL615559,,
539,,1,,6148,BAO_0000019,,In vitro inhibitory concentration required against 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) taken from pig liver,,B,,H,8,Autocuration,CHEMBL615560,,
540,,1,,16432,BAO_0000019,,Inhibition of pig liver 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) enzyme,,B,,H,8,Autocuration,CHEMBL615561,,
541,,1,,4978,BAO_0000019,,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver,,B,,H,8,Expert,CHEMBL857062,,
542,,1,,4978,BAO_0000019,,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver; (observed value),,B,,H,8,Expert,CHEMBL615562,,
543,,1,,3723,BAO_0000019,,In vitro inhibitory activity against HPPD(4-hydroxyphenylpyruvate Dioxygenase) from pig liver using enol borate assay method,,B,,H,8,Autocuration,CHEMBL615563,,
544,,1,,3518,BAO_0000357,,Compound was evaluated for complete competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD),,B,,H,8,Autocuration,CHEMBL615564,,
545,,1,,4164,BAO_0000019,,In vitro inhibition of 4-hydroxyphenylpyruvate dioxygenase obtained from purified pig liver by enol-borate method,,B,,H,8,Autocuration,CHEMBL615565,,
546,,1,,3518,BAO_0000019,,Inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated,,B,,H,8,Autocuration,CHEMBL615566,,
547,Sus scrofa,1,,4164,BAO_0000019,,Inhibition of 4-hydroxyphenylpyruvate dioxygenase of purified pig liver by enol-borate method,,B,,D,9,Expert,CHEMBL615567,,
548,,1,,3518,BAO_0000019,,The inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated.,,B,,H,8,Autocuration,CHEMBL615568,,
549,,1,,3518,BAO_0000357,,Compound was evaluated for competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD) (complete inhibition was observed at a concentration of 0.5-1.0 mM),,B,,H,8,Autocuration,CHEMBL615569,,
550,,1,,4978,BAO_0000019,,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver,,B,,H,8,Autocuration,CHEMBL615570,,
551,,1,,4978,BAO_0000019,,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver; (observed value),,B,,H,8,Autocuration,CHEMBL615571,,
552,,1,,6455,BAO_0000224,,Binding affinity against melatonin (MT1) receptor (pC1),,B,,H,4,Autocuration,CHEMBL615572,,
553,,1,,2222,BAO_0000019,,Compound was tested for inhibitory activity against 5-hydroxytryptamine 1 receptor,,B,,U,0,Autocuration,CHEMBL615573,,
554,,1,,13020,BAO_0000019,,Inhibition of [3H]- 5-HT binding to 5-hydroxytryptamine 1 receptor at 10e-5 M,,B,,U,0,Autocuration,CHEMBL615574,,
555,,1,,13021,BAO_0000019,,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1 receptor of central nervous system,,B,,U,0,Autocuration,CHEMBL615575,,
556,,1,,14532,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand at 10e-5 M concentration,,B,,H,8,Autocuration,CHEMBL615576,,
557,,1,,14118,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL615577,,
558,,1,10000000.0,11884,BAO_0000221,,Binding affinity at 5-hydroxytryptamine 1A receptor in bovine hippocampal preparation using [3H]8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL615578,,
559,,1,,13969,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor was measured using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL615579,,
560,,1,,13392,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL615580,,
561,,1,,14430,BAO_0000019,,Affinity towards 5-hydroxytryptamine 1A receptor in membranes from bovine hippocampus using [3H]OH-DPAT,,B,,H,8,Expert,CHEMBL615581,,
562,,1,10000000.0,12248,BAO_0000221,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615582,,
563,,1,10000000.0,12249,BAO_0000221,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615583,,
564,,1,10000000.0,9995,BAO_0000221,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615584,,
565,,1,10000000.0,9995,BAO_0000221,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL833691,,
566,,1,10000000.0,9995,BAO_0000221,,In vitro inhibition of azido-[125I]-IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615585,,
567,,1,10000000.0,9995,BAO_0000221,,In vitro inhibition of [125I]IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615586,,
568,,1,10000000.0,9995,BAO_0000221,,In vitro inhibition of [125I]IPAPP (2.5 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL884524,,
569,,1,10000000.0,12249,BAO_0000221,,Inhibitory concentration against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615587,,
570,,1,10000000.0,11799,BAO_0000221,,"Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",,B,,H,8,Autocuration,CHEMBL615588,,
571,Rattus norvegicus,1,,14331,BAO_0000249,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampal membranes,Membranes,B,,D,9,Expert,CHEMBL615589,,
572,Bos taurus,1,10000000.0,11884,BAO_0000221,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of bovine hippocampus.,,B,,H,8,Expert,CHEMBL615442,,
573,,1,10000000.0,14331,BAO_0000221,,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (0.5 nM) ligand in hippocampus + frontal bovine was determined,,B,,H,8,Autocuration,CHEMBL615443,,
574,,1,10000000.0,11701,BAO_0000221,,Compound was evaluated for its ability to displace [3H]DPAT from 5-HT1A receptor in homogenates of bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615444,,
575,,1,10000000.0,11701,BAO_0000221,,Ability to displace [3H]-DPAT from 5-hydroxytryptamine 1A receptor in homogenates of bovine hippocampus.,,B,,H,8,Expert,CHEMBL615445,,
576,,1,10000000.0,12248,BAO_0000221,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615446,,
577,,1,,12248,BAO_0000219,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in CHO cells,,B,,H,8,Autocuration,CHEMBL615447,449.0,
578,,1,10000000.0,12248,BAO_0000221,,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,B,,H,8,Expert,CHEMBL615448,,
579,,1,10000000.0,12249,BAO_0000221,,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,B,,H,8,Expert,CHEMBL615449,,
580,,1,,12248,BAO_0000219,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,B,,H,8,Autocuration,CHEMBL615450,449.0,
581,,1,10000000.0,11799,BAO_0000221,,"Binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",,B,,H,8,Expert,CHEMBL615451,,
582,,1,,634,BAO_0000357,,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,,B,,H,8,Autocuration,CHEMBL615452,,
583,,1,10000000.0,9995,BAO_0000221,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615453,,
584,,1,10000000.0,9995,BAO_0000221,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615454,,
585,,1,10000000.0,9995,BAO_0000221,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615455,,
586,,1,10000000.0,9995,BAO_0000221,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615456,,
587,,1,10000000.0,9995,BAO_0000221,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL615457,,
588,,1,10000000.0,12210,BAO_0000218,,In vivo binding affinity towards [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus.,,B,,H,8,Expert,CHEMBL615458,,
589,,1,10000000.0,13311,BAO_0000221,,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,,B,,H,8,Expert,CHEMBL615459,,
590,Homo sapiens,1,,2331,BAO_0000219,,"Tested in vitro for the inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor, expressed in cloned CHO cells.",,B,,D,9,Expert,CHEMBL615460,449.0,
591,Cavia porcellus,1,,1375,BAO_0000019,,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig,,F,,H,8,Autocuration,CHEMBL615461,,
592,Cavia porcellus,1,,1375,BAO_0000019,,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig; NT means not tested,,F,,H,8,Autocuration,CHEMBL615462,,
593,Cavia porcellus,1,10000000.0,11574,BAO_0000221,,Effect on forskolin stimulated adenylate cyclase activity at 5-hydroxytryptamine 1A receptor of guinea pig hippocampus.,,F,,H,8,Autocuration,CHEMBL615463,,
594,Cavia porcellus,1,2116.0,12867,BAO_0000221,,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,,B,,H,8,Autocuration,CHEMBL615464,,
595,Cavia porcellus,1,2116.0,12867,BAO_0000221,,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,,B,,H,8,Autocuration,CHEMBL615465,,
596,Cavia porcellus,1,2116.0,12867,BAO_0000221,,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,,B,,H,8,Autocuration,CHEMBL615466,,
597,Cavia porcellus,1,2116.0,12867,BAO_0000221,,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,,B,,H,8,Autocuration,CHEMBL615467,,
598,Cavia porcellus,1,2116.0,12867,BAO_0000221,,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,,B,,H,8,Autocuration,CHEMBL615468,,
599,Cavia porcellus,1,2116.0,12867,BAO_0000221,,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor; Inactive at dose level of 1.0 uM,,B,,H,8,Autocuration,CHEMBL615469,,
600,Cavia porcellus,1,,11574,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615470,,
601,Cavia porcellus,1,,13114,BAO_0000357,,Compound is evaluated for in vitro receptor binding affinity against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615471,,
602,Cavia porcellus,1,,13181,BAO_0000357,,Binding affinity was determined against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615472,,
603,Cavia porcellus,1,10000000.0,10639,BAO_0000221,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,,B,,H,8,Autocuration,CHEMBL883242,,
604,Cavia porcellus,1,10000000.0,10639,BAO_0000221,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,,F,,H,8,Autocuration,CHEMBL615473,,
605,Cricetulus griseus,1,,11883,BAO_0000218,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),,B,,H,8,Autocuration,CHEMBL615474,449.0,
606,,1,,17785,BAO_0000357,,Fraction involved in salt bridge interactions with Asp3:11 part of the 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615475,,
607,,1,,1558,BAO_0000219,,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-HT 1A receptor in HeLa cells; value ranges from 85-370,,F,,H,8,Autocuration,CHEMBL615476,308.0,
608,,1,,1558,BAO_0000219,,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1A receptor in HeLa cells; value ranges from 95-320,,F,,H,8,Autocuration,CHEMBL615477,308.0,
609,,1,,15740,BAO_0000019,,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,,F,,H,8,Autocuration,CHEMBL615478,,
610,,1,,17624,BAO_0000219,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,,F,,H,8,Autocuration,CHEMBL615160,449.0,
611,,1,,17624,BAO_0000219,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,,F,,H,8,Expert,CHEMBL615161,449.0,
612,,1,,17624,BAO_0000219,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=Not determined,,F,,H,8,Autocuration,CHEMBL615162,449.0,
613,,1,,17624,BAO_0000219,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=not determined,,F,,H,8,Autocuration,CHEMBL615163,449.0,
614,,1,,17624,BAO_0000219,,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,B,,H,8,Expert,CHEMBL615164,449.0,
615,,1,,17624,BAO_0000219,,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,B,,H,8,Expert,CHEMBL615165,449.0,
616,,1,,17624,BAO_0000219,,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells; nd=not determined,,B,,H,8,Autocuration,CHEMBL615166,449.0,
617,,1,,14256,BAO_0000219,,In vitro potency at human 5-hydroxytryptamine 1A receptor in inhibiting forskolin-stimulated accumulation of intracellular cAMP,,F,,H,8,Autocuration,CHEMBL615167,,
618,Homo sapiens,1,,3445,BAO_0000219,,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,,B,,D,9,Expert,CHEMBL615168,308.0,
619,Homo sapiens,1,,3445,BAO_0000219,,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells; Inverse,,B,,D,9,Expert,CHEMBL615169,308.0,
620,Homo sapiens,1,,17200,BAO_0000219,,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL615170,449.0,
621,Homo sapiens,1,,17200,BAO_0000219,,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor; Not determined,,B,,D,9,Expert,CHEMBL615171,449.0,
622,,1,,15180,BAO_0000019,,Eudisimic ratio(ER) is the antilog of the defference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,,F,,H,8,Autocuration,CHEMBL615694,,
623,,1,,15180,BAO_0000019,,Eudisimic ratio(ER) is the antilog of the difference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,,F,,H,8,Autocuration,CHEMBL615695,,
624,,1,,16026,BAO_0000019,,"Percent of maximum effect on binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,F,,H,8,Autocuration,CHEMBL615696,,
625,,1,,2759,BAO_0000219,,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,F,,H,8,Autocuration,CHEMBL615697,449.0,
626,Homo sapiens,1,,2759,BAO_0000219,,Agonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),,F,,D,9,Expert,CHEMBL859410,449.0,
627,,1,,2759,BAO_0000219,,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),,F,,H,8,Autocuration,CHEMBL615841,449.0,
628,Homo sapiens,1,,2759,BAO_0000219,,Agonistic efficacy in adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),,F,,D,9,Expert,CHEMBL615842,449.0,
629,,1,,2759,BAO_0000219,,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,F,,H,8,Autocuration,CHEMBL835003,449.0,
630,,1,,2759,BAO_0000219,,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 1),,F,,H,8,Autocuration,CHEMBL615843,449.0,
631,Homo sapiens,1,,2759,BAO_0000219,,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),,F,,D,9,Expert,CHEMBL615979,449.0,
632,,1,,2759,BAO_0000219,,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),,F,,H,8,Autocuration,CHEMBL615980,449.0,
633,Homo sapiens,1,,2759,BAO_0000219,,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),,F,,D,9,Expert,CHEMBL615981,449.0,
634,Homo sapiens,1,,3445,BAO_0000019,,Percent efficacy against cloned human 5-hydroxytryptamine 1A receptor normalized to the maximal 5-HT response,,F,,D,9,Expert,CHEMBL615982,,
635,Homo sapiens,1,,5272,BAO_0000019,,"Agonist activity at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",,F,,D,9,Expert,CHEMBL615983,,
636,Homo sapiens,1,,5272,BAO_0000019,,"Agonist activity at the 5-hydroxytryptamine 1A receptor in vitro using a [35S]GTP-gamma-S, No data",,F,,D,9,Expert,CHEMBL615984,,
637,Homo sapiens,1,,5272,BAO_0000019,,"Agonist activity at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S,",,F,,D,9,Expert,CHEMBL615985,,
638,,1,,17624,BAO_0000219,,Agonistic effect against 5-HT1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,F,,H,8,Autocuration,CHEMBL615986,449.0,
639,,1,,17624,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,F,,H,8,Autocuration,CHEMBL615987,449.0,
640,,1,,17624,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,,F,,H,8,Autocuration,CHEMBL615988,449.0,
641,,1,,17624,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,F,,H,8,Expert,CHEMBL615989,449.0,
642,,1,,17624,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,,F,,H,8,Autocuration,CHEMBL615990,449.0,
643,,1,,17624,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=not determined,,F,,H,8,Autocuration,CHEMBL615991,449.0,
644,,1,,17624,BAO_0000219,,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,,F,,H,8,Autocuration,CHEMBL615992,449.0,
645,,1,,17624,BAO_0000219,,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=Not determined,,F,,H,8,Autocuration,CHEMBL615993,449.0,
646,,1,,17624,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,,F,,H,8,Expert,CHEMBL615994,449.0,
647,,1,,17624,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=not determined,,F,,H,8,Autocuration,CHEMBL615995,449.0,
648,,1,,17624,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,,F,,H,8,Autocuration,CHEMBL615996,449.0,
649,,1,,17624,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT; nd=Not determined,,F,,H,8,Autocuration,CHEMBL615997,449.0,
650,,1,,6563,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,F,,H,8,Autocuration,CHEMBL615998,,
651,,1,,6563,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,F,,H,8,Autocuration,CHEMBL615999,,
652,,1,,6563,BAO_0000019,,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,,F,,H,8,Autocuration,CHEMBL616000,,
653,,1,,17296,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,F,,H,8,Autocuration,CHEMBL616001,722.0,
654,Homo sapiens,1,,6876,BAO_0000019,,"Evaluated for stimulation at 1 uM concentration expressed as percent of the maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine",,F,,D,9,Expert,CHEMBL616002,,
655,,1,,6876,BAO_0000019,,"Stimulation of percent maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine at 1 uM; nd = not determined",,F,,H,8,Expert,CHEMBL616003,,
656,Homo sapiens,1,,5272,BAO_0000019,,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor,,F,,D,9,Expert,CHEMBL616004,,
657,Homo sapiens,1,,5272,BAO_0000019,,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor; No data,,F,,D,9,Expert,CHEMBL616005,,
658,,1,,5548,BAO_0000019,,"Maximal response as a result of 5-HT1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,F,,H,8,Autocuration,CHEMBL616006,,
659,,1,,5548,BAO_0000019,,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding",,F,,H,8,Expert,CHEMBL616007,,
660,,1,,5548,BAO_0000019,,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,F,,H,8,Autocuration,CHEMBL616008,,
661,,1,,5548,BAO_0000019,,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,F,,H,8,Autocuration,CHEMBL616009,,
662,,1,,5929,BAO_0000019,,"Maximal stimulation of expressed human 5-hydroxytryptamine 1A receptor assayed by [35S]GTP-gamma-S, binding",,F,,H,8,Expert,CHEMBL616010,,
663,Homo sapiens,1,,5929,BAO_0000019,,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND means not determined",,F,,D,9,Expert,CHEMBL616011,,
664,Homo sapiens,1,,5929,BAO_0000019,,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND=Not determined",,F,,D,9,Expert,CHEMBL615740,,
665,,1,,16245,BAO_0000019,,"Maximal stimulation was expressed as percentage of the maximal 5-HT response in the [35S]GTP-gamma-S, binding assay on 5-hydroxytryptamine 1A receptor",,F,,H,8,Autocuration,CHEMBL615741,,
666,,1,,5640,BAO_0000019,,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",,F,,H,8,Expert,CHEMBL615742,,
667,,1,,5640,BAO_0000019,,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Emin (%): not determined",,F,,H,8,Autocuration,CHEMBL615743,,
668,,1,,14509,BAO_0000219,,Antagonist activity was measured against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay,,F,,H,8,Autocuration,CHEMBL615744,449.0,
669,,1,,14509,BAO_0000219,,Antagonist activity against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay.,,F,,H,8,Expert,CHEMBL615745,449.0,
670,,1,,15331,BAO_0000357,,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,B,,H,8,Autocuration,CHEMBL615746,,
671,,1,,15331,BAO_0000357,,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,B,,H,8,Autocuration,CHEMBL615747,,
672,,1,,6563,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,F,,H,8,Autocuration,CHEMBL615748,,
673,,1,,6563,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay; NA indicates not available",,F,,H,8,Autocuration,CHEMBL615749,,
674,,1,,6563,BAO_0000019,,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,,F,,H,8,Autocuration,CHEMBL615750,,
675,Homo sapiens,1,,6563,BAO_0000019,,Forskolin stimulated cAMP assessment of agonist activity for 5-hydroxytryptamine 1A receptor,,F,,D,9,Expert,CHEMBL616259,,
676,,1,,6563,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,F,,H,8,Autocuration,CHEMBL616260,,
677,Homo sapiens,1,,5272,BAO_0000019,,Antagonism of 5-hydroxytryptamine 1A receptor determined in vitro,,F,,D,9,Expert,CHEMBL616261,,
678,Homo sapiens,1,,5272,BAO_0000019,,"Antagonism of 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",,F,,D,9,Expert,CHEMBL616262,,
679,Homo sapiens,1,,5272,BAO_0000019,,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",,F,,D,9,Expert,CHEMBL616263,,
680,Homo sapiens,1,,5272,BAO_0000019,,Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro; No data,,F,,D,9,Expert,CHEMBL616264,,
681,Homo sapiens,1,,5272,BAO_0000019,,Antagonism at the 5-hydroxytryptamine 1A receptor in vitro,,F,,D,9,Expert,CHEMBL616265,,
682,Homo sapiens,1,,5272,BAO_0000019,,"Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",,F,,D,9,Expert,CHEMBL616266,,
683,Homo sapiens,1,,5272,BAO_0000019,,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",,F,,D,9,Expert,CHEMBL616267,,
684,Homo sapiens,1,,5272,BAO_0000019,,Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro; No data,,F,,D,9,Expert,CHEMBL616268,,
685,Homo sapiens,1,,16146,BAO_0000357,,Inhibition of human 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616269,,
686,,1,,17624,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,B,,H,8,Autocuration,CHEMBL884528,449.0,
687,,1,,13706,BAO_0000219,,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor alpha expressed in HEK 293 cells,,B,,D,9,Expert,CHEMBL616270,722.0,
688,,1,,15250,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1A receptor stably expressed in CHO cells,,B,,H,8,Autocuration,CHEMBL616271,449.0,
689,,1,,17624,BAO_0000219,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,,F,,H,8,Autocuration,CHEMBL616272,449.0,
690,,1,,6861,BAO_0000357,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in human CYP3A4 assay,,B,,H,8,Expert,CHEMBL616273,,
691,Homo sapiens,1,,17200,BAO_0000357,,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616274,,
692,,1,,17624,BAO_0000219,,Inhibition concentration against 5-HT 1A receptor using cAMP as radioligand in CHO cells,,B,,H,8,Autocuration,CHEMBL616275,449.0,
693,,1,,17624,BAO_0000219,,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,B,,H,8,Autocuration,CHEMBL616276,449.0,
694,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,,F,,U,0,Autocuration,CHEMBL616277,,
695,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration; Inactive,,F,,U,0,Autocuration,CHEMBL616278,,
696,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration,,F,,U,0,Autocuration,CHEMBL616279,,
697,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,,F,,U,0,Autocuration,CHEMBL616280,,
698,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Partial response at the highest dose tested,,F,,U,0,Autocuration,CHEMBL616281,,
699,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,,F,,U,0,Autocuration,CHEMBL616282,,
700,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration,,F,,U,0,Autocuration,CHEMBL616283,,
701,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration; Inactive,,F,,U,0,Autocuration,CHEMBL616284,,
702,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration,,F,,U,0,Autocuration,CHEMBL616285,,
703,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; Inactive,,F,,U,0,Autocuration,CHEMBL616286,,
704,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; partial response at the highest dose tested,,F,,U,0,Autocuration,CHEMBL616287,,
705,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration,,F,,U,0,Autocuration,CHEMBL616288,,
706,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Inactive,,F,,U,0,Autocuration,CHEMBL616289,,
707,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Partial response at the highest dose tested,,F,,U,0,Autocuration,CHEMBL615610,,
708,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration,,F,,U,0,Autocuration,CHEMBL615611,,
709,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Inactive,,F,,U,0,Autocuration,CHEMBL615612,,
710,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Partial response at the highest dose tested,,F,,U,0,Autocuration,CHEMBL615613,,
711,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; partial response at the highest dose tested,,F,,U,0,Autocuration,CHEMBL615614,,
712,Rattus norvegicus,1,,12058,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,,F,,U,0,Autocuration,CHEMBL615615,,
713,,1,,11440,BAO_0000019,,Affinity in displacing [125I](R)-DOI from rat cortical homogenate 5-HT2 receptor.,,B,,H,4,Autocuration,CHEMBL615616,,
714,,1,1898.0,6238,BAO_0000249,,Binding affinity towards 5-HT 7 receptor in rat hypothalamus membranes using [3H]5-CT as radioligand,,B,,H,8,Autocuration,CHEMBL615617,,
715,,1,,10046,BAO_0000019,,Inhibitory activity against 5-HT1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data,,B,,H,8,Autocuration,CHEMBL615618,,
716,,1,,10046,BAO_0000019,,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data.,,B,,H,8,Autocuration,CHEMBL615619,,
717,,1,,10046,BAO_0000019,,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,,B,,H,8,Expert,CHEMBL615620,,
718,,1,,167,BAO_0000357,,"Inhibitory activity against human whole blood, LTB4 5-lipoxygenase was evaluated",,B,,H,8,Autocuration,CHEMBL615621,,
719,,1,,167,BAO_0000357,,"Inhibitory activity against intact human PMNL, LTB4 5-lipoxygenase was evaluated",,B,,H,8,Autocuration,CHEMBL615622,,
720,,1,,11520,BAO_0000019,,Compound was evaluated for the inhibition of 5-LO (lipoxygenase),,F,,H,8,Autocuration,CHEMBL615623,,
721,,1,,11520,BAO_0000019,,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,F,,H,8,Autocuration,CHEMBL615624,,
722,,1,,11520,BAO_0000019,,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,F,,H,8,Autocuration,CHEMBL615625,,
723,,1,,11520,BAO_0000019,,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,F,,H,8,Autocuration,CHEMBL767045,,
724,Cavia porcellus,1,,135,BAO_0000019,,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN,,F,,H,8,Autocuration,CHEMBL615626,,
725,Cavia porcellus,1,,135,BAO_0000019,,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN; not active at the highest concentration (3 ug/mL) tested; No activity,,F,,H,8,Autocuration,CHEMBL615627,,
726,Cavia porcellus,1,,11311,BAO_0000019,,The compound was tested for inhibitory activity against 5-Lipoxygenase in guinea pig polymorphonuclear leukocytes,,B,,H,8,Autocuration,CHEMBL615628,,
727,Cavia porcellus,1,,10193,BAO_0000357,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant at 10 uM,,B,,H,8,Autocuration,CHEMBL615629,,
728,Homo sapiens,1,,12281,BAO_0000357,,Inhibitory concentration against 5-lipoxygenase from human whole blood,,B,,D,9,Expert,CHEMBL615630,,
729,,1,,11311,BAO_0000219,,The compound was tested for inhibitory activity against 5-Lipoxygenase in human polymorphonuclear leukocytes[PMNS],,B,,H,8,Autocuration,CHEMBL615631,,
730,,1,,12576,BAO_0000218,,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,,F,,H,8,Autocuration,CHEMBL615632,,
731,,1,,12281,BAO_0000357,,Inhibitory concentration against 5-lipoxygenase from mouse macrophage,,B,,H,8,Autocuration,CHEMBL615633,,
732,,1,,12576,BAO_0000218,,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,,F,,H,8,Autocuration,CHEMBL615634,,
733,Sus scrofa,1,,11089,BAO_0000019,,Inhibition of arachidonate 5-lipoxygenase purified from porcine leukocytes.,,B,,H,8,Expert,CHEMBL615635,,
734,,1,,11006,BAO_0000357,,In vitro inhibition of rat 5-Lipoxygenase,,B,,H,8,Expert,CHEMBL615636,,
735,Rattus norvegicus,1,,11481,BAO_0000357,,Inhibitory activity against 5-Lipoxygenase,,B,,D,9,Expert,CHEMBL615637,,
736,,1,,10864,BAO_0000219,,Inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells,,B,,H,8,Expert,CHEMBL615638,702.0,
737,,1,,3595,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),,B,,H,8,Autocuration,CHEMBL615639,702.0,
738,,1,,11311,BAO_0000219,,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat RBL-1,,B,,H,8,Autocuration,CHEMBL615640,702.0,
739,,1,,11311,BAO_0000019,,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat blood,,B,,H,8,Autocuration,CHEMBL615796,,
740,,1,,11311,BAO_0000219,,The compound was tested for inhibitory activity against 5-Lipoxygenase receptor in rat polymorphonuclear leukocytes[PMNS],,B,,H,8,Autocuration,CHEMBL615845,,
741,,1,,11006,BAO_0000357,,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,,B,,H,8,Autocuration,CHEMBL615846,,
742,,1,,3595,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1)at 10 uM,,B,,H,8,Autocuration,CHEMBL615847,702.0,
743,,1,,11311,BAO_0000357,,The compound was tested for inhibition of isolated 5-Lipoxygenase,,B,,H,8,Autocuration,CHEMBL615848,,
744,Rattus norvegicus,1,,11481,BAO_0000019,,Ratio of IC50 against 5-LO and COX,,B,,U,0,Autocuration,CHEMBL615849,,
745,,1,,11006,BAO_0000357,,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,,B,,H,8,Autocuration,CHEMBL615850,,
746,,1,,11006,BAO_0000357,,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM; range is 20-35%,,B,,H,8,Autocuration,CHEMBL615851,,
747,,1,,11311,BAO_0000219,,The compound was tested for inhibition against 5-Lipoxygenase in rat polymorphonuclear leukocytes at 10 uM concentration,,B,,H,8,Autocuration,CHEMBL615852,,
748,,1,,11006,BAO_0000019,,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) ex vivo,,F,,H,8,Autocuration,CHEMBL615853,,
749,,1,2367.0,4288,BAO_0000357,,Compound was tested for the inhibition of type 2 5-alpha-reductase of human prostates,,B,,H,8,Autocuration,CHEMBL884527,,
750,Columba livia,1,,7587,BAO_0000019,,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-4 M inhibitory concentration,,B,,U,0,Autocuration,CHEMBL872871,,
751,Columba livia,1,,7587,BAO_0000019,,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-5 M inhibitory concentration,,B,,U,0,Autocuration,CHEMBL615854,,
752,Columba livia,1,,7587,BAO_0000019,,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme.,,B,,U,0,Autocuration,CHEMBL767046,,
753,,1,,11249,BAO_0000357,,Compound was evaluated for the inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide transformylase obtained from human at 100 uM,,B,,H,8,Autocuration,CHEMBL615855,,
754,Rattus norvegicus,1,,8003,BAO_0000019,,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT); NT = Not Tested,,F,,D,9,Expert,CHEMBL615856,,
755,Rattus norvegicus,1,,8003,BAO_0000019,,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),,F,,D,9,Expert,CHEMBL615857,,
756,Rattus norvegicus,1,,8003,BAO_0000019,,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),,F,,D,9,Expert,CHEMBL615858,,
757,,1,10000000.0,12416,BAO_0000221,,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,,B,,H,8,Expert,CHEMBL615859,,
758,,1,,16293,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1 receptor,,B,,H,8,Autocuration,CHEMBL615860,,
759,Oryctolagus cuniculus,1,,13047,BAO_0000019,,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,B,,U,0,Autocuration,CHEMBL615861,,
760,Oryctolagus cuniculus,1,,13047,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,B,,U,0,Autocuration,CHEMBL615862,,
761,Oryctolagus cuniculus,1,,13047,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1D receptor using rabbit saphenous vein assay.,,B,,U,0,Autocuration,CHEMBL615863,,
762,Oryctolagus cuniculus,1,,13047,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,,B,,U,0,Autocuration,CHEMBL615864,,
763,,1,10000000.0,10085,BAO_0000221,,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,B,,H,4,Autocuration,CHEMBL615865,,
764,,1,10000000.0,10085,BAO_0000221,,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,B,,H,4,Autocuration,CHEMBL615866,,
765,,1,10000000.0,10085,BAO_0000221,,Ability to bind at serotonin 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,B,,H,4,Autocuration,CHEMBL615867,,
766,,1,,9841,BAO_0000249,,Ability to inhibit binding of titreated serotonin to the 5-hydroxytryptamine 1 receptor in rat brain frontal cortex membranes,Membranes,B,,H,4,Autocuration,CHEMBL615868,,
767,Rattus norvegicus,1,,8822,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1 receptor in brain cortical membranes of rat,,B,,D,5,Autocuration,CHEMBL615869,,
768,Rattus norvegicus,1,,9806,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1 receptor in rat frontal cortex homogenates using [3H]5-HT as a radioligand,,B,,D,5,Autocuration,CHEMBL615870,,
769,Rattus norvegicus,1,,9806,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as a radioligand from rat frontal cortex homogenates,,B,,D,5,Autocuration,CHEMBL615871,,
770,,1,,8868,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 1 receptor was measured using radioligand ([3H]5-HT) binding assay,,B,,H,4,Autocuration,CHEMBL615872,,
771,,1,10000000.0,9036,BAO_0000221,,Binding affinity towards hippocampus 5-hydroxytryptamine 1 receptor was measured using radioligand [3H]5-HT,,B,,H,4,Autocuration,CHEMBL833492,,
772,,1,10000000.0,11374,BAO_0000221,,Compound was evaluated for the inhibition of [3H]5-HT (concentration of 12 nM) specific binding to rat hippocampus,,B,,H,4,Autocuration,CHEMBL615873,,
773,,1,,10881,BAO_0000224,,Inhibitory activity against 5-hydroxytryptamine 1 receptor by 3H ligand binding experiments.,,B,,H,4,Autocuration,CHEMBL615479,,
774,,1,,8822,BAO_0000019,,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat,,B,,H,4,Autocuration,CHEMBL615480,,
775,Rattus norvegicus,1,,9806,BAO_0000249,,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat cortical membrane homogenates using radioligand ([3H]5-HT) binding assay.,,B,,D,5,Autocuration,CHEMBL615481,,
776,,1,,15463,BAO_0000019,,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,B,,H,4,Autocuration,CHEMBL872869,,
777,,1,,15463,BAO_0000019,,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,B,,H,4,Autocuration,CHEMBL615482,,
778,,1,955.0,14542,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,B,,H,4,Autocuration,CHEMBL615483,,
779,,1,955.0,14542,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,B,,H,4,Autocuration,CHEMBL615484,,
780,,1,,8569,BAO_0000019,,Percent inhibition of 5-hydroxytryptamine 1 receptor from rat cortex membrane using [3H]- serotonin as radioligand at 33 uM,,B,,H,4,Autocuration,CHEMBL615485,,
781,Rattus norvegicus,1,,10062,BAO_0000224,,Inhibition of [3H]5-HT radioligand binding against 5-hydroxytryptamine 1 receptor,,B,,D,5,Autocuration,CHEMBL615486,,
782,,1,,4771,BAO_0000224,,Ancillary Binding affinity towards rat 5-hydroxytryptamine 1 receptor,,B,,H,4,Autocuration,CHEMBL615487,,
783,,1,,10062,BAO_0000224,,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,B,,H,4,Autocuration,CHEMBL615488,,
784,,1,,10062,BAO_0000224,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,B,,H,4,Autocuration,CHEMBL615489,,
785,,1,,10062,BAO_0000224,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,B,,H,4,Autocuration,CHEMBL615389,,
786,,1,,15463,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,,B,,H,4,Autocuration,CHEMBL615390,,
787,,1,,15463,BAO_0000019,,Binding affinity towards central 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,,B,,H,4,Autocuration,CHEMBL615391,,
788,,1,,9098,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined,,B,,H,4,Autocuration,CHEMBL615392,,
789,Rattus norvegicus,1,,3070,BAO_0000019,,Affinity for 5-hydroxytryptamine 1 receptor,,B,,U,0,Autocuration,CHEMBL615393,,
790,,1,955.0,14542,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex,,B,,H,4,Autocuration,CHEMBL615394,,
791,,1,955.0,14542,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,B,,H,4,Autocuration,CHEMBL615395,,
792,,1,,6398,BAO_0000224,,Compound was evaluated for 5-hydroxytryptamine 1 receptor binding,,B,,H,4,Autocuration,CHEMBL615396,,
793,,1,955.0,1344,BAO_0000221,,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 1 receptor in rat brain using [3H]HT radioligand assay,,B,,H,4,Autocuration,CHEMBL615397,,
794,,1,,11963,BAO_0000019,,Displacement of binding of [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,B,,H,4,Autocuration,CHEMBL615398,,
795,Rattus norvegicus,1,,8908,BAO_0000019,,Displacement of [3H]spiperone from 5-hydroxytryptamine 1 receptor of rat cortex,,B,,U,0,Autocuration,CHEMBL615399,,
796,,1,,9098,BAO_0000019,,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,,B,,H,4,Autocuration,CHEMBL615400,,
797,Rattus norvegicus,1,,8841,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1 receptor of rat prefrontal cortex,,B,,D,5,Autocuration,CHEMBL615401,,
798,Rattus norvegicus,1,,8814,BAO_0000019,,Displacement of [3H]5-HT from 5-hydroxytryptamine 1 receptor of rat cortical membrane homogenates,,B,,U,0,Autocuration,CHEMBL615402,,
799,,1,,11752,BAO_0000019,,The ability to inhibit [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cortex,,B,,H,4,Autocuration,CHEMBL615403,,
800,,1,955.0,11642,BAO_0000221,,The binding affinity was measured on serotonin 5-hydroxytryptamine 1 receptor in rat brain tissue,,B,,H,4,Autocuration,CHEMBL615404,,
801,,1,,11642,BAO_0000019,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1 receptor by displacing [3H]5-HT radioligand in rat cerebral cortex,,B,,H,4,Autocuration,CHEMBL615781,,
802,,1,955.0,9231,BAO_0000220,,Tested for 5-hydroxytryptamine 1 receptor binding ability by displacement of [3H]5-HT from rat brain synaptosomes,,B,,H,4,Autocuration,CHEMBL615782,,
803,,1,955.0,11351,BAO_0000221,,Inhibition constant (1 uM) was measured on 5-hydroxytryptamine 1 receptor/uptake using [3H]- serotonin as radioligand in rat brain cortex.,,B,,H,4,Autocuration,CHEMBL615783,,
804,,1,,4639,BAO_0000019,,Compound was tested for binding affinity against 5-HT1 receptor,,B,,U,0,Autocuration,CHEMBL873481,,
805,,1,,1205,BAO_0000019,,Inhibitory concentration against 5-hydroxytryptamine 1 receptor,,B,,U,0,Autocuration,CHEMBL615784,,
806,,1,,10025,BAO_0000357,,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,,B,,H,8,Expert,CHEMBL615785,,
807,,1,,13241,BAO_0000249,,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",,F,,H,8,Autocuration,CHEMBL615786,,
808,,1,,16245,BAO_0000218,,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,,F,,H,8,Autocuration,CHEMBL615787,,
809,,1,,16245,BAO_0000218,,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,,F,,H,8,Autocuration,CHEMBL615788,,
810,,1,,12438,BAO_0000019,,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor,,F,,H,8,Autocuration,CHEMBL767044,,
811,,1,,16245,BAO_0000218,,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,,F,,H,8,Autocuration,CHEMBL615789,,
812,,1,,16245,BAO_0000218,,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,,F,,H,8,Autocuration,CHEMBL615790,,
813,,1,,15740,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats,,F,,H,8,Autocuration,CHEMBL615813,,
814,,1,,15535,BAO_0000219,,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 10 uM concentration,,F,,H,8,Autocuration,CHEMBL615814,,
815,,1,,15535,BAO_0000219,,Percent inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation in GH4ZD10 cells expressing 5-HT1A receptor at 50 uM relative to 5-HT,,F,,H,8,Expert,CHEMBL615815,,
816,,1,,15535,BAO_0000219,,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 50 uM concentration; No effect,,F,,H,8,Autocuration,CHEMBL615816,,
817,,1,,9888,BAO_0000249,,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes expressed as Hill values,,B,,H,8,Expert,CHEMBL615817,,
818,,1,10000000.0,10085,BAO_0000221,,Ability to bind at 5-hydroxytryptamine 1A receptor of rat hippocampus by displacing [3H]8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL615818,,
819,,1,10000000.0,10085,BAO_0000221,,Ability to bind at serotonin 5-hydroxytryptamine 1A receptors of rat hippocampus by displacing [3H]8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL615819,,
820,,1,,17331,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 1A receptor (5-HT1A) by displacement of [3H]8-OH-DPAT from rat hippocampus membranes,Membranes,B,,H,8,Expert,CHEMBL615820,,
821,Rattus norvegicus,1,10000000.0,10845,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]8-OH-DPAT,,B,,D,9,Expert,CHEMBL615821,,
822,Rattus norvegicus,1,10000000.0,10845,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,,B,,D,9,Expert,CHEMBL615822,,
823,,1,10000000.0,10845,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor using in rat hippocampal tissue using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL615823,,
824,Rattus norvegicus,1,10000000.0,10845,BAO_0000221,,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor; IA-Inactive,,B,,D,9,Expert,CHEMBL615824,,
825,Rattus norvegicus,1,10000000.0,10845,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,,B,,D,9,Expert,CHEMBL615825,,
826,,1,,13730,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 1A receptor was evaluated using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL615826,,
827,,1,,13508,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL615827,,
828,,1,10000000.0,13508,BAO_0000249,,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus membrane using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL615828,,
829,,1,10000000.0,12073,BAO_0000221,,Binding affinity by measuring displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,B,,H,8,Expert,CHEMBL615829,,
830,,1,10000000.0,4671,BAO_0000221,,Binding affinity to 5-hydroxytryptamine 1A receptor of rat hippocampus with [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL615830,,
831,,1,10000000.0,13631,BAO_0000221,,Binding affinity towards serotonin 5-HT1A receptor was determined in rat hippocampus using [3H]8-OH-DPAT as ligand,,B,,H,8,Expert,CHEMBL615831,,
832,,1,,12438,BAO_0000357,,Binding affinity was measured against serotonin 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615832,,
833,,1,,10483,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH- DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL615833,,
834,,1,10000000.0,10483,BAO_0000221,,Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]-8-OH- DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL615834,,
835,,1,,12352,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 1A (5-HT1A) receptor in rat hippocampus membranes,,B,,H,8,Intermediate,CHEMBL615835,,
836,,1,10000000.0,14732,BAO_0000249,,Binding affinity was measured at the serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampal membrane.,,B,,H,8,Autocuration,CHEMBL615836,,
837,Rattus norvegicus,1,,11049,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand.,,B,,D,9,Expert,CHEMBL615837,,
838,Rattus norvegicus,1,,11049,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand; ND-Not determined,,B,,D,9,Expert,CHEMBL615838,,
839,,1,,13657,BAO_0000249,,"Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding (NSB)",,B,,H,8,Expert,CHEMBL615839,,
840,,1,,11473,BAO_0000019,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL884525,,
841,,1,,2014,BAO_0000249,,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonin 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,,B,,H,8,Autocuration,CHEMBL615840,,
842,,1,10000000.0,3086,BAO_0000221,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,B,,H,8,Expert,CHEMBL615405,,
843,,1,,15854,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,B,,H,8,Expert,CHEMBL615406,,
844,,1,10000000.0,10922,BAO_0000221,,Affinity for 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,,B,,H,8,Expert,CHEMBL615900,,
845,,1,10000000.0,13346,BAO_0000221,,Inhibition of [3H]8-OH-DPAT binding at serotonin 5-hydroxytryptamine 1A receptor from rat hippocampus tissue.,,B,,H,8,Expert,CHEMBL615901,,
846,,1,,15311,BAO_0000357,,In vitro inhibition of [3H]8-OH-DPAT binding to rat 5-HT 1a receptors.,,B,,H,8,Expert,CHEMBL615902,,
847,,1,10000000.0,10922,BAO_0000221,,Compound was measured for affinity at 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,,B,,H,8,Autocuration,CHEMBL615903,,
848,,1,,10025,BAO_0000357,,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor<br>at 1 uM,,B,,H,8,Autocuration,CHEMBL615904,,
849,,1,,10025,BAO_0000357,,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,,B,,H,8,Expert,CHEMBL615905,,
850,,1,,9742,BAO_0000019,,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,,B,,H,8,Autocuration,CHEMBL615906,,
851,,1,,9742,BAO_0000019,,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,,F,,H,8,Autocuration,CHEMBL615907,,
852,,1,,12304,BAO_0000019,,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,B,,H,8,Expert,CHEMBL615908,,
853,,1,10000000.0,15789,BAO_0000221,,In vitro affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT in rat hippocampus,,B,,H,8,Autocuration,CHEMBL615909,,
854,,1,,9912,BAO_0000019,,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]-8-OH-DPAT as the radioligand",,B,,H,8,Autocuration,CHEMBL615910,,
855,,1,,9912,BAO_0000019,,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand.",,B,,H,8,Autocuration,CHEMBL615911,,
856,,1,,9912,BAO_0000019,,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand",,B,,H,8,Autocuration,CHEMBL615912,,
857,,1,,16693,BAO_0000019,,In vitro binding affinity for serotonin 5-hydroxytryptamine 1A receptor fof rat cerebral cortex using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL615913,,
858,,1,,13276,BAO_0000357,,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,B,,H,8,Expert,CHEMBL615914,,
859,,1,10000000.0,12678,BAO_0000221,,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,,B,,H,8,Autocuration,CHEMBL615915,,
860,,1,,11825,BAO_0000357,,In vitro binding affinity towards the 5-hydroxytryptamine 1A receptor was evaluated,,B,,H,8,Autocuration,CHEMBL615916,,
861,,1,,12443,BAO_0000357,,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 1A receptor by displacement of [3H]- tetralin,,B,,H,8,Expert,CHEMBL615917,,
862,,1,,13830,BAO_0000357,,In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL615918,,
863,,1,10000000.0,14286,BAO_0000249,,In vitro inhibitory concentration against radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane.,,B,,H,8,Expert,CHEMBL615919,,
864,Rattus norvegicus,1,10000000.0,14356,BAO_0000221,,In vitro radioligand binding assay on 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,B,,D,9,Expert,CHEMBL615920,,
865,,1,,15306,BAO_0000357,,Inhibition concentration against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615921,,
866,,1,,15306,BAO_0000357,,Inhibitory concentration against 5-hydroxytryptamine 1A receptor (Inactive at >1000 nM concentration),,B,,H,8,Expert,CHEMBL615922,,
867,Rattus norvegicus,1,,16616,BAO_0000249,,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",,F,,D,9,Expert,CHEMBL881290,,
868,,1,10000000.0,3651,BAO_0000221,,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Residual radioligand binding higher than 50%",,B,,H,8,Autocuration,CHEMBL615923,,
869,,1,10000000.0,14331,BAO_0000221,,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,,F,,H,8,Autocuration,CHEMBL615924,,
870,,1,10000000.0,14331,BAO_0000221,,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,,F,,H,8,Autocuration,CHEMBL615925,,
871,Rattus norvegicus,1,,14178,BAO_0000357,,Inhibition of radiolabeled [3H]-8-OH-DPAT ligand binding to 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL615926,,
872,Rattus norvegicus,1,,10639,BAO_0000019,,Displacement of [3H]8-OH-DPAT from rat cortex 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL615927,,
873,,1,10000000.0,12306,BAO_0000221,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,B,,H,8,Autocuration,CHEMBL615928,,
874,Rattus norvegicus,1,,1348,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1A receptor subtype,,B,,D,9,Expert,CHEMBL615929,,
875,,1,10000000.0,13605,BAO_0000221,,Inhibitory activity against [3H]DPAT binding to 5-HT1A receptor in rat hippocampus,,B,,H,8,Autocuration,CHEMBL615930,,
876,,1,,17624,BAO_0000219,,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,B,,H,8,Autocuration,CHEMBL615931,449.0,
877,,1,,17624,BAO_0000219,,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,,F,,H,8,Autocuration,CHEMBL615932,449.0,
878,,1,,17624,BAO_0000219,,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,,F,,H,8,Autocuration,CHEMBL615933,449.0,
879,,1,,15267,BAO_0000357,,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615934,,
880,,1,,16532,BAO_0000357,,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT; Not tested,,B,,H,8,Autocuration,CHEMBL615935,,
881,,1,,6563,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,F,,H,8,Autocuration,CHEMBL615936,,
882,,1,,4751,BAO_0000219,,Ability to displace [3H]-8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor at a concentration of 1 uM,,B,,H,8,Autocuration,CHEMBL615937,449.0,
883,,1,,15463,BAO_0000357,,Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615938,,
884,,1,,3805,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 1A receptor at a concentration of 100 (nM),,B,,H,8,Autocuration,CHEMBL615797,,
885,,1,,5640,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL615798,,
886,,1,,6563,BAO_0000357,,Inhibition of [3H]8-OH-DPAT binding to human 5-hydroxytryptamine 1A receptor at 1000 nM compound concentration,,B,,H,8,Autocuration,CHEMBL872870,,
887,,1,,5548,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand at 100 nM concentration,,B,,H,8,Autocuration,CHEMBL615799,,
888,,1,,6347,BAO_0000357,,Percent binding affinity against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615800,,
889,,1,,17296,BAO_0000219,,Intrinsic activity for human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,F,,H,8,Autocuration,CHEMBL615801,722.0,
890,,1,,13047,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the absence of endothelium,,B,,H,8,Autocuration,CHEMBL615802,,
891,,1,,15740,BAO_0000357,,Dissociation constant against human 5-hydroxytryptamine 1A receptor receptor,,B,,H,8,Autocuration,CHEMBL615803,,
892,,1,,5640,BAO_0000019,,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",,F,,H,8,Expert,CHEMBL835002,,
893,,1,,5640,BAO_0000019,,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Ki (nM): not determined",,F,,H,8,Autocuration,CHEMBL615804,,
894,,1,,17211,BAO_0000219,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL615805,308.0,
895,,1,,4751,BAO_0000219,,Ability to displace [3H]8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615806,449.0,
896,Homo sapiens,1,,6491,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 1A serotonin receptor,,B,,D,9,Expert,CHEMBL615807,,
897,,1,,4707,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT-as radioligand,,B,,H,8,Autocuration,CHEMBL615808,,
898,Homo sapiens,1,,13910,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL615809,,
899,,1,,16190,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1A receptor in HeLa cells was determined using [3H]5-HT,,B,,H,8,Autocuration,CHEMBL615810,308.0,
900,,1,,16633,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL615811,,
901,,1,,11898,BAO_0000219,,Binding affinity against [3H]- -8-OH-DPAT -labeled 5-hydroxytryptamine 1A sites in cloned CHO cells,,B,,H,8,Autocuration,CHEMBL615812,449.0,
902,,1,,11898,BAO_0000219,,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,B,,H,8,Autocuration,CHEMBL615751,449.0,
903,,1,,14331,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615752,,
904,,1,,17624,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand,,B,,H,8,Expert,CHEMBL615753,449.0,
905,,1,,17624,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand; nd=not determined,,B,,H,8,Autocuration,CHEMBL615754,449.0,
906,,1,,3307,BAO_0000357,,Binding affinity of compound to human 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615755,,
907,Homo sapiens,1,,6563,BAO_0000219,,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,,B,,D,9,Expert,CHEMBL615756,449.0,
908,,1,,14165,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1A receptor in HeLa transfected cell type using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL615757,,
909,,1,,5732,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,,B,,H,8,Autocuration,CHEMBL615758,,
910,,1,,13366,BAO_0000357,,In vitro affinity at human cloned 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,,B,,H,8,Expert,CHEMBL615759,,
911,,1,,17626,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615760,,
912,,1,,6588,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 1A receptor by the displacement of [3H]5-HT radioligand from the cloned receptor expressed in HeLa cells,,B,,H,8,Expert,CHEMBL615761,308.0,
913,,1,,16209,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]-5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL872104,,
914,,1,,15463,BAO_0000357,,Binding affinity towards recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL615762,,
915,,1,,15463,BAO_0000357,,Binding affinity towards recombinant human Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL615763,,
916,,1,,14770,BAO_0000357,,Binding affinity for recombinant human 5-hydroxytryptamine 1A receptor using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL615764,,
917,,1,,16245,BAO_0000219,,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines (He La),,B,,H,8,Autocuration,CHEMBL615765,1167.0,
918,,1,,16245,BAO_0000019,,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines(He La),,B,,H,8,Autocuration,CHEMBL615766,,
919,,1,,5548,BAO_0000357,,Binding affinity towards 5-HT1A receptor using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL615767,,
920,,1,,5548,BAO_0000357,,Binding affinity was determined towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL615768,,
921,,1,,5548,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL615769,,
922,,1,,6876,BAO_0000357,,Binding affinity was evaluated at 5-hydroxytryptamine 1A receptor labeled with [3H]-8-OH-DPAT,,B,,H,8,Expert,CHEMBL615770,,
923,,1,,2598,BAO_0000357,,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL615771,,
924,,1,,17785,BAO_0000357,,Binding affinity to human 5-hydroxytryptamine 1A receptor was measured using [3H]-8-hydroxy-2-(di-n-propylamine) tetraline [3H]8-OH-DPAT) as radioligand,,B,,H,8,Expert,CHEMBL615772,,
925,,1,,6013,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL615773,,
926,,1,,5929,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL615774,,
927,,1,,16633,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL615775,,
928,,1,,1558,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,,B,,H,8,Autocuration,CHEMBL615776,,
929,,1,,16026,BAO_0000357,,Binding affinity towards human cloned 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL615777,,
930,,1,,12469,BAO_0000219,,Binding affinity was measured on 5-hydroxytryptamine 1A receptor in AK cells transfected with human 5-HT1A gene labeled with [3H]-8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL615778,,
931,Homo sapiens,1,,15874,BAO_0000357,,Binding affinity was measured on cloned Human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,B,,D,9,Expert,CHEMBL615779,,
932,,1,,15874,BAO_0000357,,Binding affinity was measured on cloned human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL615780,,
933,,1,,3935,BAO_0000357,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616298,,
934,,1,,15818,BAO_0000357,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616299,,
935,,1,,13706,BAO_0000219,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells.,,B,,H,8,Autocuration,CHEMBL616300,485.0,
936,,1,,13729,BAO_0000219,,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1A receptor in CHO-K1 cells,,F,,H,8,Expert,CHEMBL616301,485.0,
937,,1,,15413,BAO_0000019,,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616302,,
938,,1,,15413,BAO_0000019,,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 1),,B,,H,8,Autocuration,CHEMBL616117,,
939,,1,,15413,BAO_0000019,,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 2),,B,,H,8,Autocuration,CHEMBL616118,,
940,,1,,15413,BAO_0000019,,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor by Panlabs assay,,B,,H,8,Autocuration,CHEMBL616119,,
941,Homo sapiens,1,,3445,BAO_0000219,,Displacement of specific [3H]- 5-HT binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,,B,,D,9,Expert,CHEMBL616120,308.0,
942,,1,,15740,BAO_0000357,,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616121,,
943,,1,,15740,BAO_0000357,,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor receptor,,B,,H,8,Autocuration,CHEMBL616122,,
944,,1,,17626,BAO_0000357,,In vitro binding affinity tested on human 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616123,,
945,Homo sapiens,1,,4234,BAO_0000357,,In vitro binding affinity to human 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616124,,
946,,1,,5640,BAO_0000357,,In vitro binding affinity at 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,,B,,H,8,Expert,CHEMBL616125,,
947,Rattus norvegicus,1,,5272,BAO_0000357,,In vitro binding affinity towards Human 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT,,B,,H,8,Expert,CHEMBL616126,,
948,,1,,4622,BAO_0000219,,In vitro binding affinity towards cloned human 5-hydroxytryptamine 1A receptor expressed in Chinese hamster ovary (CHO) cells using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616127,449.0,
949,,1,,17085,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL616128,,
950,,1,,3025,BAO_0000357,,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,,B,,H,8,Autocuration,CHEMBL616129,,
951,,1,,15315,BAO_0000357,,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL616130,,
952,,1,,15267,BAO_0000357,,Inhibition of [3H]- OH-DPAT binding against 5-hydroxytryptamine 1A receptor from human recombinant,,B,,H,8,Autocuration,CHEMBL616131,,
953,,1,,17158,BAO_0000219,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor serotonergic receptor in human HeLa cells,,B,,H,8,Autocuration,CHEMBL616132,308.0,
954,Homo sapiens,1,,14214,BAO_0000219,,Receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor in HeLa cells,,B,,D,9,Expert,CHEMBL616133,308.0,
955,,1,,17133,BAO_0000357,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616134,,
956,,1,,16532,BAO_0000357,,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT,,B,,H,8,Autocuration,CHEMBL616135,,
957,Homo sapiens,1,,2391,BAO_0000357,,Affinity for 5-hydroxytryptamine 1A receptor subtype,,B,,D,9,Expert,CHEMBL616136,,
958,,1,,14447,BAO_0000019,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes,,B,,H,8,Autocuration,CHEMBL616137,,
959,,1,,14447,BAO_0000019,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes.,,B,,H,8,Autocuration,CHEMBL872105,,
960,,1,,15086,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor receptor,,B,,H,8,Autocuration,CHEMBL616138,,
961,Homo sapiens,1,,13051,BAO_0000357,,Binding affinity for cloned human 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616139,,
962,,1,,16026,BAO_0000019,,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor; Not active",,F,,H,8,Autocuration,CHEMBL616140,,
963,,1,,17085,BAO_0000019,,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor; ND means not determined,,B,,H,8,Expert,CHEMBL616141,,
964,,1,,17133,BAO_0000357,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616142,,
965,,1,,17133,BAO_0000357,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; ND means Not determined,,B,,H,8,Autocuration,CHEMBL616143,,
966,,1,,17211,BAO_0000219,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,,B,,H,8,Autocuration,CHEMBL616144,308.0,
967,,1,,17211,BAO_0000219,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT=not tested,,B,,H,8,Autocuration,CHEMBL616145,308.0,
968,,1,,17211,BAO_0000219,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,,B,,H,8,Autocuration,CHEMBL616012,308.0,
969,,1,,17211,BAO_0000219,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,,B,,H,8,Autocuration,CHEMBL616013,308.0,
970,,1,,16394,BAO_0000019,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,F,,H,8,Autocuration,CHEMBL616014,,
971,,1,,16394,BAO_0000019,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,F,,H,8,Autocuration,CHEMBL616015,,
972,,1,,16394,BAO_0000019,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,F,,H,8,Autocuration,CHEMBL616016,,
973,,1,,16394,BAO_0000218,,Antagonist induction of hypothermia by 8-OH-DPAT in 5-hydroxytryptamine 1A receptor after subcutaneous administration; NT is not tested,,F,,H,8,Autocuration,CHEMBL616017,,
974,,1,,16394,BAO_0000019,,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]-8-OH-DPAT binding in Chinese hamster ovary cell line; NT is not tested,,B,,H,8,Autocuration,CHEMBL616018,,
975,,1,,15740,BAO_0000019,,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor receptor; Not tested,,F,,H,8,Autocuration,CHEMBL616019,,
976,,1,,15740,BAO_0000019,,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor; Not tested,,F,,H,8,Autocuration,CHEMBL616020,,
977,,1,,15740,BAO_0000357,,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL858018,,
978,,1,,17296,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,F,,H,8,Autocuration,CHEMBL616021,722.0,
979,,1,,5640,BAO_0000019,,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at 1 uM.",,F,,H,8,Expert,CHEMBL616022,,
980,,1,,5640,BAO_0000019,,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means Not determined",,F,,H,8,Autocuration,CHEMBL616023,,
981,,1,,5640,BAO_0000019,,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means not determined",,F,,H,8,Autocuration,CHEMBL616024,,
982,,1,,5640,BAO_0000019,,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; Not determined",,F,,H,8,Autocuration,CHEMBL616025,,
983,,1,,2759,BAO_0000219,,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,F,,H,8,Autocuration,CHEMBL616026,449.0,
984,,1,,16394,BAO_0000019,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT",,F,,H,8,Autocuration,CHEMBL616027,,
985,Homo sapiens,1,,16394,BAO_0000019,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared to 5-HT",,F,,D,9,Expert,CHEMBL616028,,
986,Homo sapiens,1,,3445,BAO_0000019,,Percent efficacy against human 5-hydroxytryptamine 1A receptor relative to maximal 5-HT response,,F,,D,9,Expert,CHEMBL616029,,
987,,1,,4316,BAO_0000219,,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by incubating human 5-hydroxytryptamine 1A receptor transfected CHO cells with [3H]8-OH-DPAT,,B,,H,8,Expert,CHEMBL616030,449.0,
988,,1,,4316,BAO_0000019,,In vitro inhibition of [3H]8-OH-DPAT binding to human cloned 5-hydroxytryptamine 1A receptor on CHO cell membranes.,,B,,H,8,Expert,CHEMBL616031,,
989,Homo sapiens,1,,15180,BAO_0000019,,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,,F,,D,9,Expert,CHEMBL616032,,
990,Homo sapiens,1,,15180,BAO_0000019,,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,,F,,D,9,Expert,CHEMBL616033,,
991,,1,,15042,BAO_0000019,,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,F,,H,8,Autocuration,CHEMBL616034,,
992,,1,,15042,BAO_0000019,,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,F,,H,8,Autocuration,CHEMBL616035,,
993,,1,,15042,BAO_0000019,,Maximum binding affinity was evaluated as ([35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,,F,,H,8,Autocuration,CHEMBL616036,,
994,,1,,15042,BAO_0000019,,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,F,,H,8,Autocuration,CHEMBL616037,,
995,,1,,15042,BAO_0000019,,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,F,,H,8,Autocuration,CHEMBL616038,,
996,,1,,15042,BAO_0000019,,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,F,,H,8,Autocuration,CHEMBL616039,,
997,,1,,15042,BAO_0000019,,Agonist efficacy was evaluated as [35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,,F,,H,8,Autocuration,CHEMBL616040,,
998,Homo sapiens,1,,15180,BAO_0000219,,Concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,,F,,D,9,Expert,CHEMBL616041,308.0,
999,Homo sapiens,1,,15180,BAO_0000219,,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,,F,,D,9,Expert,CHEMBL616042,308.0,
1000,Homo sapiens,1,,15180,BAO_0000219,,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,,F,,D,9,Expert,CHEMBL616043,308.0,
1001,,1,,16245,BAO_0000019,,"Potency (pD2) for the stimulation of [35S]GTP-gamma-S, binding on 5-hydroxytryptamine 1A receptor",,F,,H,8,Autocuration,CHEMBL616044,,
1002,,1,,16026,BAO_0000019,,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,F,,H,8,Autocuration,CHEMBL616045,,
1003,,1,,17296,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,F,,H,8,Autocuration,CHEMBL616046,722.0,
1004,,1,,2759,BAO_0000219,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),,F,,H,8,Autocuration,CHEMBL616047,449.0,
1005,,1,,2759,BAO_0000219,,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells,,F,,H,8,Autocuration,CHEMBL616048,449.0,
1006,Homo sapiens,1,,2759,BAO_0000219,,Potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 1),,F,,D,9,Expert,CHEMBL616049,449.0,
1007,,1,,2759,BAO_0000219,,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),,F,,H,8,Autocuration,CHEMBL616050,449.0,
1008,,1,,15419,BAO_0000219,,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor,,F,,H,8,Expert,CHEMBL616051,,
1009,,1,,15419,BAO_0000219,,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor; Not tested,,F,,H,8,Autocuration,CHEMBL616212,,
1010,,1,,16026,BAO_0000019,,"ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,F,,H,8,Autocuration,CHEMBL616213,,
1011,,1,,1414,BAO_0000219,,Ability to bind to 5-hydroxytryptamine 1A receptor from cloned human expressed in Ha7 cells,,B,,H,8,Expert,CHEMBL616214,,
1012,,1,,1414,BAO_0000219,,Ability to bind to 5-hydroxytryptamine 1A receptor subtype from cloned human expressed in Ha7 cells,,B,,H,8,Expert,CHEMBL616215,,
1013,,1,,12861,BAO_0000357,,Binding activity radioligand.,,B,,H,8,Autocuration,CHEMBL616216,,
1014,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,B,,H,8,Autocuration,CHEMBL616217,,
1015,,1,,5104,BAO_0000357,,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616218,,
1016,,1,,5105,BAO_0000357,,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616219,,
1017,,1,,16312,BAO_0000357,,binding affinity towards human recombinant 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616220,,
1018,Homo sapiens,1,,15180,BAO_0000357,,Displacement of [3H]8-hydroxy-2-(di-n-propylamino)tetralin from human 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL833493,,
1019,,1,,5033,BAO_0000357,,Ability to displace the radioligand [3H]-8-OH-DPAT from human 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616221,,
1020,Homo sapiens,1,,16909,BAO_0000219,,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,,B,,D,9,Expert,CHEMBL616222,449.0,
1021,,1,,2590,BAO_0000019,,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor,,F,,H,8,Autocuration,CHEMBL616223,,
1022,,1,,2590,BAO_0000019,,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor; Not determined,,F,,H,8,Autocuration,CHEMBL616224,,
1023,,1,,16394,BAO_0000019,,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding in Chinese hamster ovary cell line,,B,,H,8,Expert,CHEMBL616225,,
1024,Homo sapiens,1,,4540,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]-8-OH- DPAT as radioligand,,B,,D,9,Expert,CHEMBL616226,722.0,
1025,,1,,17296,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells,,B,,H,8,Autocuration,CHEMBL616227,722.0,
1026,,1,,17296,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616228,722.0,
1027,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,,B,,H,8,Autocuration,CHEMBL616229,722.0,
1028,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand; ND means no data,,B,,H,8,Autocuration,CHEMBL616230,722.0,
1029,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;ND means no data.,,B,,H,8,Autocuration,CHEMBL616231,722.0,
1030,,1,,6166,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616232,,
1031,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,,B,,H,8,Autocuration,CHEMBL616233,722.0,
1032,,1,,4199,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT as the radioligand,,B,,H,8,Autocuration,CHEMBL857973,722.0,
1033,,1,,15316,BAO_0000219,,Compound was evaluated for its ability to displace [3H]8-OH-DPAT binding from human 5-hydroxytryptamine 1A receptor in mammalian cells,,B,,H,8,Autocuration,CHEMBL616234,,
1034,,1,,14875,BAO_0000357,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616235,,
1035,,1,,14727,BAO_0000219,,Binding affinity at human cloned 5-hydroxytryptamine 1A receptor expressed in HeLa cells by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,,B,,H,8,Expert,CHEMBL616236,308.0,
1036,,1,,14727,BAO_0000019,,Binding affinity at native 5-hydroxytryptamine 1A receptor in rat by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,,B,,H,8,Expert,CHEMBL616237,,
1037,,1,,15146,BAO_0000219,,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor in human cloned receptors in HEK 293 cells using [3H]8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL616238,722.0,
1038,,1,,5213,BAO_0000219,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1A receptor in HEK 293 using [3H]5-CT as a radioligand,,B,,H,8,Autocuration,CHEMBL616239,722.0,
1039,,1,,16429,BAO_0000219,,In vitro binding affinity at human recombinant 5-hydroxytryptamine 1A receptor in mammalian cells using 3[H]8-OH-DPAT as the radioligand,,B,,H,8,Autocuration,CHEMBL616240,,
1040,Homo sapiens,1,,15042,BAO_0000219,,The binding affinity was evaluated on cloned human 5-hydroxytryptamine 1A receptor expressed in HeLa cells by using DPAT as radioligand.,,B,,D,9,Expert,CHEMBL616241,308.0,
1041,,1,,14818,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT.,,B,,H,8,Autocuration,CHEMBL616242,722.0,
1042,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1A receptor in HEK293 cells, using [3H]8-OH-DPAT as radioligand",,B,,H,8,Autocuration,CHEMBL616243,722.0,
1043,,1,,17200,BAO_0000357,,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616244,,
1044,Homo sapiens,1,,13051,BAO_0000357,,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor,,B,,D,9,Autocuration,CHEMBL616245,,
1045,,1,,5486,BAO_0000357,,Binding affinity towards 5-HT1B receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,,B,,H,8,Autocuration,CHEMBL616246,,
1046,,1,,5254,BAO_0000357,,Binding affinity against 5-HT1D receptor,,B,,H,8,Autocuration,CHEMBL616247,,
1047,,1,,5254,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616248,,
1048,,1,,15331,BAO_0000357,,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,B,,H,8,Autocuration,CHEMBL616249,,
1049,Homo sapiens,1,,13506,BAO_0000357,,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,,B,,H,8,Autocuration,CHEMBL616250,,
1050,,1,,15267,BAO_0000357,,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616251,,
1051,,1,,16616,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 15 min after administration of the compound,,F,,H,8,Autocuration,CHEMBL616252,,
1052,,1,,16616,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 30 min after administration of the compound,,F,,H,8,Autocuration,CHEMBL616253,,
1053,,1,,16616,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 60 min after administration of the compound,,F,,H,8,Autocuration,CHEMBL616254,,
1054,Mus musculus,1,,16616,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 15 min,,F,,D,9,Expert,CHEMBL616255,,
1055,Mus musculus,1,,16616,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 30 min,,F,,D,9,Expert,CHEMBL832872,,
1056,Mus musculus,1,,16616,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 60 min,,F,,D,9,Expert,CHEMBL616256,,
1057,Mus musculus,1,,16616,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 15 min,,F,,D,9,Expert,CHEMBL616257,,
1058,Mus musculus,1,,16616,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 30 min,,F,,D,9,Expert,CHEMBL616258,,
1059,Mus musculus,1,,16616,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 60 min,,F,,D,9,Expert,CHEMBL616384,,
1060,,1,10000000.0,10297,BAO_0000221,,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,,B,,H,8,Autocuration,CHEMBL616385,,
1061,,1,,13704,BAO_0000357,,Inhibitory activity against serotonin 5-hydroxytryptamine 1A receptor from mice.,,B,,H,8,Expert,CHEMBL616386,,
1062,Mus musculus,1,10000000.0,10297,BAO_0000221,,Inhibitory activity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,,B,,D,9,Expert,CHEMBL616387,,
1063,,1,10000000.0,10297,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,,B,,H,8,Autocuration,CHEMBL616388,,
1064,Mus musculus,1,10000000.0,10297,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,,B,,D,9,Expert,CHEMBL616389,,
1065,,1,10000000.0,10297,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,,B,,H,8,Autocuration,CHEMBL616390,,
1066,,1,,217,BAO_0000357,,Compound was tested for binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as a radioligand,,B,,H,8,Autocuration,CHEMBL616391,,
1067,Mus musculus,1,10000000.0,10297,BAO_0000221,,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,,B,,D,9,Expert,CHEMBL616392,,
1068,Sus scrofa,1,,4921,BAO_0000357,,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616393,,
1069,Sus scrofa,1,,4921,BAO_0000357,,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor; ND denotes not determined,,B,,H,8,Autocuration,CHEMBL616394,,
1070,Sus scrofa,1,,4996,BAO_0000019,,Binding affinity of compound measured for 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT-labeled porcine brain homogenates,,B,,H,8,Autocuration,CHEMBL616395,,
1071,Sus scrofa,1,,12918,BAO_0000357,,Compound was evaluated for the binding affinity at 5- HT1A receptor,,B,,H,8,Autocuration,CHEMBL616396,,
1072,Sus scrofa,1,,5333,BAO_0000019,,Compound was tested in vitro for its ability to compete with [3H]8-OH-DPAT at 5-hydroxytryptamine 1A receptor in porcine brain homogenate,,B,,H,8,Autocuration,CHEMBL872907,,
1073,Sus scrofa,1,,4437,BAO_0000019,,In vitro for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in porcine brain homogenate,,B,,H,8,Autocuration,CHEMBL616397,,
1074,Sus scrofa,1,,1742,BAO_0000019,,Compound was tested for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in pig cortex,,B,,H,8,Autocuration,CHEMBL616398,,
1075,Sus scrofa,1,,16688,BAO_0000357,,Displacement of [3H]- 8-OH-DPAT from porcine 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL616399,,
1076,Sus scrofa,1,,12861,BAO_0000357,,Binding activity radioligand.,,B,,H,8,Autocuration,CHEMBL857065,,
1077,Sus scrofa,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,,B,,H,8,Expert,CHEMBL616400,,
1078,Sus scrofa,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL616401,,
1079,,1,,12490,BAO_0000019,,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor from pig cortex,,B,,H,8,Expert,CHEMBL616402,,
1080,Sus scrofa,1,,11828,BAO_0000019,,Displacement of [3H]8-OH-DPAT from pig cortex 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL616403,,
1081,Sus scrofa,1,10000000.0,11866,BAO_0000221,,Binding affinity for 5-hydroxytryptamine 1A receptor in piglet hippocampus using [3H]8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL616404,,
1082,Sus scrofa,1,,12827,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1A receptor in pig frontal cortex membranes using [8H]-OH-DPAT,,B,,H,8,Autocuration,CHEMBL616405,,
1083,Sus scrofa,1,,12918,BAO_0000019,,Binding affinity was evaluated by 5-hydroxytryptamine 1A receptor agonism in the pig cortex by displacing 8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL616406,,
1084,Sus scrofa,1,,12919,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 1A receptor in pig cortex using [3H]8-OH-DPAT,,F,,H,8,Expert,CHEMBL616407,,
1085,Oryctolagus cuniculus,1,,13047,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the presence of endothelium,,B,,H,8,Autocuration,CHEMBL616408,,
1086,Rattus norvegicus,1,,15796,BAO_0000249,,Inhibition activity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using radio binding assays,,B,,D,9,Expert,CHEMBL616409,,
1087,Rattus norvegicus,1,10000000.0,3651,BAO_0000221,,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Less active",,B,,D,9,Expert,CHEMBL616410,,
1088,,1,,188,BAO_0000357,,Tested for the effect on binding at 5-hydroxytryptamine 1A receptor; No activity,,B,,H,8,Autocuration,CHEMBL616411,,
1089,Rattus norvegicus,1,,16616,BAO_0000249,,"Antagonist activity to stimulate binding of [35S]GTP-gamma-S, to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",Membranes,F,,D,9,Expert,CHEMBL616412,,
1090,Rattus norvegicus,1,10000000.0,16616,BAO_0000249,,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",Membranes,F,,D,9,Expert,CHEMBL616413,,
1091,,1,10000000.0,12306,BAO_0000221,,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,B,,H,8,Autocuration,CHEMBL616414,,
1092,Rattus norvegicus,1,10000000.0,17167,BAO_0000221,,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding,,B,,D,9,Expert,CHEMBL616415,,
1093,,1,,14776,BAO_0000019,,Binding affinity measured at the 5-hydroxytryptamine 1A receptor by the inhibition of [3H]8-OH-DPAT binding to rat cortex using unlabeled buspirone for nonspecific binding.,,B,,H,8,Autocuration,CHEMBL616416,,
1094,,1,,12158,BAO_0000357,,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand.,,B,,H,8,Expert,CHEMBL616417,,
1095,,1,,13481,BAO_0000357,,Binding affinity of [3H]- -8-OH-DPAT labelled towards Rat Hippocampal 5-hydroxytryptamine 1A receptor using radioligand binding assay,,B,,H,8,Autocuration,CHEMBL616418,,
1096,,1,,13427,BAO_0000219,,Binding affinity of [3H]-8-OH-DPAT towards 5-hydroxytryptamine 1A receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,B,,H,8,Autocuration,CHEMBL616419,,
1097,,1,,10210,BAO_0000357,,Binding affinity of compound against 5-hydroxytryptamine 1A receptor binding site using radioligand [3H]8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL616420,,
1098,,1,,10205,BAO_0000249,,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,Membranes,B,,H,8,Autocuration,CHEMBL616421,,
1099,,1,,10205,BAO_0000249,,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,Membranes,B,,H,8,Autocuration,CHEMBL616422,,
1100,,1,,10205,BAO_0000249,,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor in rat striatal membranes by [3H]OH-DPAT displacement.,Membranes,B,,H,8,Expert,CHEMBL616423,,
1101,Rattus norvegicus,1,,12280,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor with [3H]5-HT,,B,,D,9,Expert,CHEMBL616424,,
1102,,1,,17386,BAO_0000357,,Binding affinity to the rat 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL616425,,
1103,,1,,13654,BAO_0000357,,Binding affinity was tested on 5-hydroxytryptamine 1A receptor using radioligand [3H]5-HT binding assay.,,B,,H,8,Expert,CHEMBL616426,,
1104,,1,10000000.0,14423,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as the radioligand.,,B,,H,8,Autocuration,CHEMBL616427,,
1105,,1,10000000.0,15412,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus tissue.,,B,,H,8,Autocuration,CHEMBL616428,,
1106,,1,10000000.0,12073,BAO_0000221,,Binding affinity by measuring displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,B,,H,8,Autocuration,CHEMBL616290,,
1107,Rattus norvegicus,1,,4101,BAO_0000357,,Displacement of [3H]8-OH-DPAT from rat striata 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616052,,
1108,,1,,10062,BAO_0000357,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616053,,
1109,,1,,6238,BAO_0000249,,Binding affinity towards 5-HT 1A receptor in rat cerebral cortex membranes using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616054,,
1110,,1,,16273,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616055,,
1111,,1,,11139,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in competitive binding assay,,B,,H,8,Autocuration,CHEMBL616056,,
1112,,1,,16796,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,,B,,H,8,Expert,CHEMBL616057,,
1113,Rattus norvegicus,1,955.0,9548,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,B,,D,9,Expert,CHEMBL616058,,
1114,,1,955.0,10381,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,B,,H,8,Autocuration,CHEMBL616059,,
1115,,1,,13408,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hypocampus membrane using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616060,,
1116,Rattus norvegicus,1,10000000.0,13825,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor in the rat brain (hippocampus) using [3H]8-OH-DPAT,,B,,D,9,Expert,CHEMBL616061,,
1117,,1,10000000.0,11147,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]-8-hydroxy-2-(di-n-propylamine) tetralin (8-OH-DPAT) as a radioligand,,B,,H,8,Expert,CHEMBL616062,,
1118,,1,,10552,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1A receptor sites in cortical membranes using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616063,,
1119,,1,2435.0,10552,BAO_0000249,,"Binding affinity towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",,B,,H,8,Autocuration,CHEMBL616064,,
1120,Rattus norvegicus,1,,17136,BAO_0000249,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cortex membranes,Membranes,B,,D,9,Expert,CHEMBL616065,,
1121,Rattus norvegicus,1,,5778,BAO_0000249,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cerebral cortex membranes,Membranes,B,,D,9,Expert,CHEMBL616066,,
1122,,1,10000000.0,13481,BAO_0000221,,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616067,,
1123,,1,10000000.0,13481,BAO_0000221,,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; Not tested,,B,,H,8,Autocuration,CHEMBL616068,,
1124,,1,10000000.0,13630,BAO_0000221,,Binding affinity against rat hippocampal 5-hydroxytryptamine 1A (5-HT1A) receptor determined using [3H]8-OH-DPAT as radioligand,,B,,H,8,Intermediate,CHEMBL616069,,
1125,,1,,16245,BAO_0000249,,Binding was determined on 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,,B,,H,8,Expert,CHEMBL616070,,
1126,,1,10000000.0,14509,BAO_0000221,,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616071,,
1127,,1,10000000.0,14509,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.,,B,,H,8,Expert,CHEMBL616072,,
1128,,1,10000000.0,14509,BAO_0000221,,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.; ND = Not determined,,B,,H,8,Autocuration,CHEMBL616073,,
1129,,1,10000000.0,14509,BAO_0000221,,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand; ND = Not determined,,B,,H,8,Autocuration,CHEMBL616074,,
1130,,1,,14256,BAO_0000019,,Binding affinity was evaluated by determining in vitro displacement of [3H]8-OH-DPAT from the central 5-hydroxytryptamine 1A receptor recognition site in rat frontal cortex homogenate.,,B,,H,8,Expert,CHEMBL616075,,
1131,,1,,11139,BAO_0000357,,Binding affinity was evaluated by using [3H]8-OH-DPAT radioligand by using competitive binding assay on 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616076,,
1132,Rattus norvegicus,1,,11047,BAO_0000019,,Binding affinity for 5-HT1A measured by displacing [3H]8-OH-DPAT from rat cortical membranes; Not determined,,B,,D,9,Expert,CHEMBL616077,,
1133,Rattus norvegicus,1,,11047,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes,,B,,D,9,Expert,CHEMBL616078,,
1134,Rattus norvegicus,1,,11047,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes;ND-Not determined,,B,,D,9,Expert,CHEMBL616079,,
1135,Rattus norvegicus,1,,2395,BAO_0000219,,Binding affinity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,,B,,D,9,Expert,CHEMBL616080,485.0,
1136,,1,,9699,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616081,,
1137,Rattus norvegicus,1,10000000.0,12028,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [125I]trans-8-OH-PIPAT in membrane homogenates of hippocampal tissue of rat brain,,B,,D,9,Expert,CHEMBL616082,,
1138,,1,10000000.0,12028,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in membrane homogenates of hippocampal tissue of rat brain,,B,,H,8,Autocuration,CHEMBL616083,,
1139,,1,,5815,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,B,,H,8,Autocuration,CHEMBL616084,,
1140,,1,,16616,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates,,B,,H,8,Expert,CHEMBL616085,,
1141,,1,,5815,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL616086,,
1142,,1,10000000.0,2761,BAO_0000221,,"Binding affinity towards 5-hydroxytryptamine 1A receptor using 0.1 nM [3H]-8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tet-ralin), from rat hippocampal homogenate",,B,,H,8,Autocuration,CHEMBL616087,,
1143,,1,,13133,BAO_0000357,,Binding affinity was determined against 5-hydroxytryptamine 1A receptor using [3H]WB-4101,,B,,H,8,Expert,CHEMBL616088,,
1144,,1,,10444,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 1A receptor was determined in male Sprague-Dawley rat brain.,,B,,H,8,Autocuration,CHEMBL616089,,
1145,Rattus norvegicus,1,,13278,BAO_0000357,,Binding affinity was measured against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT by lysergic acid amides,,B,,D,9,Expert,CHEMBL616090,,
1146,,1,,15874,BAO_0000357,,Binding affinity was measured on cloned rat 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL616091,,
1147,,1,2435.0,10552,BAO_0000249,,"Binding affinity of the compound towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",Membranes,B,,H,8,Autocuration,CHEMBL616092,,
1148,,1,,11130,BAO_0000357,,Binding constant against 5-hydroxytryptamine 1A receptor (in vitro),,B,,H,8,Autocuration,CHEMBL616093,,
1149,,1,,11130,BAO_0000218,,Binding constant against 5-hydroxytryptamine 1A receptor (in vivo),,B,,H,8,Autocuration,CHEMBL616094,,
1150,,1,955.0,14542,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex,,B,,H,8,Autocuration,CHEMBL616095,,
1151,Rattus norvegicus,1,,13670,BAO_0000357,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616096,,
1152,,1,,9888,BAO_0000249,,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes,,B,,H,8,Expert,CHEMBL616097,,
1153,Rattus norvegicus,1,,3678,BAO_0000249,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus membranes,Membranes,B,,D,9,Expert,CHEMBL616098,,
1154,,1,10000000.0,11332,BAO_0000221,,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616099,,
1155,,1,10000000.0,11332,BAO_0000221,,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 1A receptor receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616100,,
1156,,1,,1185,BAO_0000357,,Ability to displace [3H]-8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL616101,,
1157,,1,,2014,BAO_0000249,,Binding affinity at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes by [3H]8-OH-DPAT displacement.,,B,,H,8,Expert,CHEMBL616102,,
1158,,1,,1185,BAO_0000357,,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616103,,
1159,,1,,14429,BAO_0000019,,Compound was evaluated for its binding affinity against 5-hydroxytryptamine 1A receptor from rat cerebral cortex,,B,,H,8,Expert,CHEMBL616104,,
1160,,1,,16288,BAO_0000019,,"Binding affinity to 5-hydroxytryptamine 1A receptor (5-HT 1A receptor, serotonin receptor) from rat cortex using [3H]8-OH-DPAT as radioligand",,B,,H,8,Expert,CHEMBL616105,,
1161,Rattus norvegicus,1,,5432,BAO_0000019,,Displacement of [3H]prazosin from rat cortex membrane 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616106,,
1162,,1,,14429,BAO_0000019,,Compound was evaluated for its binding affinity with 5-hydroxytryptamine 1A receptor using membranes prepared from rat cerebral cortex,,B,,H,8,Autocuration,CHEMBL616107,,
1163,,1,,13672,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand.,,B,,H,8,Expert,CHEMBL616108,,
1164,,1,10000000.0,11296,BAO_0000221,,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,B,,H,8,Expert,CHEMBL616109,,
1165,,1,,11296,BAO_0000357,,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site.,,B,,H,8,Autocuration,CHEMBL616110,,
1166,,1,,14749,BAO_0000219,,Binding affinity against rat 5-hydroxytryptamine 1A receptor in CHO cells.,,B,,H,8,Expert,CHEMBL616111,449.0,
1167,,1,,15086,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat brain using [3H]-8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL616112,,
1168,,1,10000000.0,13462,BAO_0000221,,Compound was tested for the Binding affinity against rat hippocampal 5-hydroxytryptamine 1A receptor by Radio ligand [3H]8-OH-DPAT binding assay.,,B,,H,8,Autocuration,CHEMBL616113,,
1169,,1,,15363,BAO_0000019,,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616114,,
1170,,1,,15363,BAO_0000019,,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616115,,
1171,,1,,10796,BAO_0000357,,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616116,,
1172,,1,955.0,12816,BAO_0000221,,Binding affinity for 5-hydroxytryptamine 1A receptor in rat brain tissue using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL615844,,
1173,,1,10000000.0,13542,BAO_0000221,,In vitro displacement of [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL615939,,
1174,,1,,13308,BAO_0000019,,In vitro ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor sites of rat brain cortex.,,B,,H,8,Expert,CHEMBL615940,,
1175,,1,10000000.0,13541,BAO_0000221,,In vitro affinity at 5-hydroxytryptamine 1A receptor of rat hippocampus by [3H]8-OH-DPAT displacement.,,B,,H,8,Expert,CHEMBL615941,,
1176,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-HT1A receptor of rat hippocampus and the value ranges from 9 - 12,,B,,H,8,Autocuration,CHEMBL615942,,
1177,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,,B,,H,8,Autocuration,CHEMBL615943,,
1178,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 12 to 17,,B,,H,8,Autocuration,CHEMBL615944,,
1179,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 391-841,,B,,H,8,Autocuration,CHEMBL615945,,
1180,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 17.,,B,,H,8,Autocuration,CHEMBL615946,,
1181,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 20.,,B,,H,8,Autocuration,CHEMBL615947,,
1182,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 245 to 736,,B,,H,8,Autocuration,CHEMBL615948,,
1183,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 25 - 84,,B,,H,8,Autocuration,CHEMBL615949,,
1184,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 48 to 59,,B,,H,8,Autocuration,CHEMBL615950,,
1185,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 3 -5,,B,,H,8,Autocuration,CHEMBL615951,,
1186,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 15 - 31,,B,,H,8,Autocuration,CHEMBL615952,,
1187,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 27 - 42,,B,,H,8,Autocuration,CHEMBL615953,,
1188,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 6 - 13,,B,,H,8,Autocuration,CHEMBL615954,,
1189,Rattus norvegicus,1,10000000.0,10058,BAO_0000221,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,,B,,D,9,Expert,CHEMBL615955,,
1190,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.; ND is No Data.,,B,,H,8,Autocuration,CHEMBL615956,,
1191,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus. and the value ranges from 16 - 27,,B,,H,8,Autocuration,CHEMBL615957,,
1192,,1,,12879,BAO_0000019,,Displacement of [3H]2-(di-N-propylamino)-8-hydroxytetralin from central 5-hydroxytryptamine 1A receptor recognition sites in rat frontal cortex homogenates.,,B,,H,8,Expert,CHEMBL615958,,
1193,,1,,11964,BAO_0000019,,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate,,B,,H,8,Expert,CHEMBL615959,,
1194,,1,,11964,BAO_0000019,,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 1),,B,,H,8,Autocuration,CHEMBL615960,,
1195,,1,,11964,BAO_0000019,,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 2),,B,,H,8,Autocuration,CHEMBL615961,,
1196,,1,955.0,9548,BAO_0000221,,Evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,B,,H,8,Expert,CHEMBL615962,,
1197,,1,,9098,BAO_0000019,,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand.,,B,,H,8,Expert,CHEMBL615963,,
1198,,1,,9098,BAO_0000019,,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand; ND is no data.,,B,,H,8,Autocuration,CHEMBL615964,,
1199,,1,,9098,BAO_0000019,,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand;ND means no data,,B,,H,8,Autocuration,CHEMBL615965,,
1200,,1,,13248,BAO_0000219,,In vitro displacement of radioactively labeled ligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor site in CHO cells,,B,,H,8,Expert,CHEMBL615966,449.0,
1201,,1,,3147,BAO_0000249,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat cortical membranes,,B,,H,8,Expert,CHEMBL615967,,
1202,,1,,13949,BAO_0000019,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor of rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,,B,,H,8,Expert,CHEMBL615968,,
1203,,1,,11883,BAO_0000218,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),,B,,H,8,Autocuration,CHEMBL615969,449.0,
1204,,1,,11883,BAO_0000218,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (agonist) as radioligand (sc),,B,,H,8,Autocuration,CHEMBL615970,,
1205,Rattus norvegicus,1,,11883,BAO_0000357,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT,,B,,D,9,Expert,CHEMBL615971,,
1206,,1,,15535,BAO_0000249,,In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,Membranes,B,,H,8,Expert,CHEMBL615972,,
1207,,1,,15535,BAO_0000249,,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes + cortex,,B,,H,8,Autocuration,CHEMBL615973,,
1208,,1,,15535,BAO_0000249,,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes+cortex,,B,,H,8,Autocuration,CHEMBL615974,,
1209,Homo sapiens,1,,16372,BAO_0000219,,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,,B,,D,9,Expert,CHEMBL615975,449.0,
1210,,1,,14608,BAO_0000249,,In vitro binding affinity for 5-hydroxytryptamine 1A receptor in rat hippocampal membranes by [125I]-labeled agonist displacement.,,B,,H,8,Expert,CHEMBL615976,,
1211,Rattus norvegicus,1,10000000.0,4795,BAO_0000221,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus,,B,,D,9,Expert,CHEMBL872106,,
1212,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL615977,,
1213,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=100-230,,B,,H,8,Autocuration,CHEMBL615978,,
1214,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=12-14,,B,,H,8,Autocuration,CHEMBL616166,,
1215,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=16-20,,B,,H,8,Autocuration,CHEMBL616167,,
1216,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=160-430,,B,,H,8,Autocuration,CHEMBL616168,,
1217,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=174-224,,B,,H,8,Autocuration,CHEMBL616169,,
1218,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=184-503,,B,,H,8,Autocuration,CHEMBL616170,,
1219,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=19-23,,B,,H,8,Autocuration,CHEMBL616171,,
1220,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=2.2-3.2,,B,,H,8,Autocuration,CHEMBL616172,,
1221,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=2.7-3.6,,B,,H,8,Autocuration,CHEMBL616173,,
1222,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=20-23,,B,,H,8,Autocuration,CHEMBL616174,,
1223,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=21-28,,B,,H,8,Autocuration,CHEMBL616175,,
1224,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=240-760,,B,,H,8,Autocuration,CHEMBL616176,,
1225,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=39-87,,B,,H,8,Autocuration,CHEMBL616177,,
1226,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=4.6-5.2,,B,,H,8,Autocuration,CHEMBL616178,,
1227,,1,,9742,BAO_0000019,,Inhibitory activity tested in vitro at 5-hydroxytryptamine 1A receptor binding site in rat,,B,,H,8,Autocuration,CHEMBL616179,,
1228,,1,,12073,BAO_0000357,,Inhibitory concentration against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616180,,
1229,,1,,4101,BAO_0000357,,Inhibitory concentration against binding of 5-hydroxytryptamine 1A receptor from striata of male Wistar rats by displacement of [3H]8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL616181,,
1230,,1,,15360,BAO_0000019,,Inhibitory concentration against radioligand [3H]hydroxy-2-(di-n-propylamino)-tetralin binding to 5-hydroxytryptamine 1A receptor in rat,,B,,H,8,Autocuration,CHEMBL616182,,
1231,,1,10000000.0,11576,BAO_0000221,,Inhibitory concentration against radioligand [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616183,,
1232,,1,,5834,BAO_0000019,,Inhibition of the 5-hydroxytryptamine 1A receptor in rat dorsal raphe,,B,,H,8,Expert,CHEMBL615874,,
1233,Rattus norvegicus,1,,2395,BAO_0000219,,Inhibitory concentration against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,,B,,D,9,Expert,CHEMBL615875,485.0,
1234,,1,,1375,BAO_0000019,,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand,,B,,H,8,Autocuration,CHEMBL615876,,
1235,,1,,1375,BAO_0000019,,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand; NT means not tested,,B,,H,8,Autocuration,CHEMBL615877,,
1236,,1,,3967,BAO_0000357,,The compound was evaluated for the ability to displace [3H]- 8-OH -DPAT from 5-hydroxytryptamine 1A receptor ( striata of male wistar rats),,B,,H,8,Autocuration,CHEMBL615878,,
1237,,1,,12884,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor binding site using [3H]8-OH-DPAT. ,,B,,H,8,Expert,CHEMBL615879,,
1238,,1,,2343,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor using receptor binding assay,,B,,H,8,Expert,CHEMBL615880,,
1239,,1,,11511,BAO_0000019,,"The compound was tested in vitro for inhibitory activity against 5-HT1A receptor in rats, using [3H]8-OH-DPAT as radioligand",,B,,H,8,Autocuration,CHEMBL615881,,
1240,Rattus norvegicus,1,,11511,BAO_0000019,,"Inhibitory activity against 5-hydroxytryptamine 1A receptor in rats, using [3H]8-OH-DPAT as radioligand",,B,,D,9,Expert,CHEMBL615882,,
1241,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat,,F,,H,8,Autocuration,CHEMBL615883,,
1242,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.10-6.20),,F,,H,8,Autocuration,CHEMBL615884,,
1243,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.60),,F,,H,8,Autocuration,CHEMBL615885,,
1244,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.80),,F,,H,8,Autocuration,CHEMBL615886,,
1245,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.37-4.27),,F,,H,8,Autocuration,CHEMBL615887,,
1246,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-2.70),,F,,H,8,Autocuration,CHEMBL615888,,
1247,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-4),,F,,H,8,Autocuration,CHEMBL615889,,
1248,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.45-4.51),,F,,H,8,Autocuration,CHEMBL615890,,
1249,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.50-5.30),,F,,H,8,Autocuration,CHEMBL615891,,
1250,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.60-1.60),,F,,H,8,Autocuration,CHEMBL615892,,
1251,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.72-2.87),,F,,H,8,Autocuration,CHEMBL615893,,
1252,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.80-5.80),,F,,H,8,Autocuration,CHEMBL615894,,
1253,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (1.50-16.5),,F,,H,8,Autocuration,CHEMBL615895,,
1254,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (2.20-30.5),,F,,H,8,Autocuration,CHEMBL615896,,
1255,,1,,16394,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges is not computable,,F,,H,8,Autocuration,CHEMBL615897,,
1256,Rattus norvegicus,1,,16616,BAO_0000249,,"Percent increase of R(+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",Membranes,F,,D,9,Expert,CHEMBL615898,,
1257,,1,,16796,BAO_0000019,,% inhibition towards 5-HT1A receptor from rat hippocampal membranes,,B,,H,8,Autocuration,CHEMBL615899,,
1258,,1,,16796,BAO_0000019,,% inhibition towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,,B,,H,8,Autocuration,CHEMBL616291,,
1259,,1,,15629,BAO_0000357,,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor.,,B,,H,8,Autocuration,CHEMBL616292,,
1260,,1,,13241,BAO_0000249,,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",,F,,H,8,Autocuration,CHEMBL616293,,
1261,,1,10000000.0,12073,BAO_0000221,,Measurement of binding affinity by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,B,,H,8,Expert,CHEMBL616294,,
1262,,1,10000000.0,14286,BAO_0000249,,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane,,B,,H,8,Autocuration,CHEMBL616295,,
1263,,1,955.0,14542,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex at 10 uM,,B,,H,8,Autocuration,CHEMBL616296,,
1264,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,,F,,H,8,Autocuration,CHEMBL616297,,
1265,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0+ 1 uM 5-HT.,,F,,H,8,Autocuration,CHEMBL616605,,
1266,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.01 uM+ 1 uM 5-HT.,,F,,H,8,Autocuration,CHEMBL616606,,
1267,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,,F,,H,8,Autocuration,CHEMBL616607,,
1268,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,,F,,H,8,Expert,CHEMBL616608,,
1269,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM+ 1 uM 5-HT.,,F,,H,8,Autocuration,CHEMBL616609,,
1270,Rattus norvegicus,1,,13630,BAO_0000019,,Effect against 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at 0.1 uM dose,,F,,D,9,Expert,CHEMBL616610,,
1271,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,,F,,H,8,Autocuration,CHEMBL616611,,
1272,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 1 uM 5-HT.,,F,,H,8,Expert,CHEMBL616612,,
1273,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 0.1 uM 5-HT.,,F,,H,8,Autocuration,CHEMBL616613,,
1274,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM,,F,,H,8,Expert,CHEMBL616614,,
1275,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM+ 10 uM 5-HT.,,F,,H,8,Autocuration,CHEMBL616615,,
1276,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,,F,,H,8,Expert,CHEMBL616616,,
1277,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 0.1 uM 5-HT.,,F,,H,8,Autocuration,CHEMBL616617,,
1278,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,,F,,H,8,Autocuration,CHEMBL616618,,
1279,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 1 uM 5-HT.,,F,,H,8,Autocuration,CHEMBL616619,,
1280,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 3 uM 5-HT.,,F,,H,8,Expert,CHEMBL616620,,
1281,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,,F,,H,8,Expert,CHEMBL616621,,
1282,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 30 uM,,F,,H,8,Autocuration,CHEMBL616622,,
1283,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM,,F,,H,8,Expert,CHEMBL616146,,
1284,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM+ 50 uM 5-HT.,,F,,H,8,Autocuration,CHEMBL832873,,
1285,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM,,F,,H,8,Autocuration,CHEMBL616147,,
1286,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,,F,,H,8,Autocuration,CHEMBL872872,,
1287,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,,F,,H,8,Autocuration,CHEMBL616148,,
1288,,1,10000000.0,9783,BAO_0000221,,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue,,B,,H,8,Autocuration,CHEMBL616149,,
1289,,1,10000000.0,9783,BAO_0000221,,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue at 1 uM,,B,,H,8,Expert,CHEMBL616150,,
1290,Rattus norvegicus,1,,14331,BAO_0000249,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membranes at 10e-7 M,Membranes,B,,D,9,Expert,CHEMBL616151,,
1291,,1,10000000.0,15260,BAO_0000221,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue at 1 uM,,B,,H,8,Expert,CHEMBL872873,,
1292,,1,10000000.0,15260,BAO_0000221,,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 0.1 uM concentration,,B,,H,8,Autocuration,CHEMBL616670,,
1293,,1,10000000.0,15260,BAO_0000221,,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 1 uM concentration,,B,,H,8,Autocuration,CHEMBL616671,,
1294,Rattus norvegicus,1,,16616,BAO_0000249,,"Percent inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",,F,,D,9,Expert,CHEMBL884861,,
1295,,1,,15629,BAO_0000357,,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor,,B,,H,8,Autocuration,CHEMBL616672,,
1296,,1,,15086,BAO_0000019,,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,,B,,H,8,Autocuration,CHEMBL616673,,
1297,,1,,5717,BAO_0000019,,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,,F,,H,8,Expert,CHEMBL616674,,
1298,,1,,12652,BAO_0000357,,Binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL616675,,
1299,,1,10000000.0,14608,BAO_0000221,,In vitro binding affinity for 5-hydroxytryptamine 1A receptor was determined by measuring specific inhibition of [125I]-binding to rat hippocampal membrane preparations,,B,,H,8,Autocuration,CHEMBL616676,,
1300,,1,10000000.0,12306,BAO_0000221,,Inhibition of binding of [125I]-8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,B,,H,8,Autocuration,CHEMBL616677,,
1301,,1,10000000.0,12306,BAO_0000221,,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,B,,H,8,Autocuration,CHEMBL616678,,
1302,Rattus norvegicus,1,,15247,BAO_0000357,,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616679,,
1303,,1,10000000.0,17529,BAO_0000221,,Ability to bind to central serotonin 5-hydroxytryptamine 1A receptor in vitro in hippocampus of the rat brain using [3H]8-OH-DPAT radioligand,,B,,H,8,Expert,CHEMBL616680,,
1304,,1,10000000.0,14826,BAO_0000221,,Ability to displace [3H]- -OH-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,,B,,H,8,Autocuration,CHEMBL616681,,
1305,,1,10000000.0,14826,BAO_0000221,,Ability to displace [3H]- -(OH)-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,,B,,H,8,Autocuration,CHEMBL616682,,
1306,,1,10000000.0,13241,BAO_0000221,,Ability to displace [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616683,,
1307,,1,10000000.0,14093,BAO_0000221,,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616684,,
1308,,1,10000000.0,14093,BAO_0000221,,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor; Not tested,,B,,H,8,Autocuration,CHEMBL616685,,
1309,,1,955.0,14442,BAO_0000221,,Affinity at [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in rat brain homogenate was determined,,B,,H,8,Autocuration,CHEMBL616686,,
1310,,1,,9919,BAO_0000357,,Affinity for 5-hydroxytryptamine 1A receptor site,,B,,H,8,Autocuration,CHEMBL616687,,
1311,,1,,9919,BAO_0000357,,Affinity for 5-hydroxytryptamine 1A receptor site,,B,,H,8,Autocuration,CHEMBL616688,,
1312,,1,10000000.0,11440,BAO_0000221,,Affinity in displacing [3H]8-OH-DPAT from rat hippocampal 5-HT1A receptor.,,B,,H,8,Autocuration,CHEMBL616689,,
1313,,1,,11257,BAO_0000357,,Affinity on 5-hydroxytryptamine 1A receptor labeled by [3H]8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL616690,,
1314,,1,,10330,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL616691,,
1315,Rattus norvegicus,1,10000000.0,17331,BAO_0000221,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus mambranes,,B,,D,9,Expert,CHEMBL616692,,
1316,,1,,16567,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane,,B,,H,8,Expert,CHEMBL616693,,
1317,Rattus norvegicus,1,,12058,BAO_0000019,,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",,B,,D,9,Expert,CHEMBL616694,,
1318,,1,10000000.0,9699,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal tissue,,B,,H,8,Autocuration,CHEMBL616695,,
1319,,1,,9547,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat was determined using [3H]8-OH-DPAT in binding assay,,B,,H,8,Autocuration,CHEMBL616696,,
1320,,1,,10330,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]DOB as radioligand,,B,,H,8,Autocuration,CHEMBL616697,,
1321,,1,,14331,BAO_0000357,,Binding affinity against rat 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616698,,
1322,Rattus norvegicus,1,,14060,BAO_0000019,,Binding affinity against rat brain 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616949,,
1323,,1,10000000.0,14744,BAO_0000221,,Binding affinity against the 5-hydroxytryptamine 1A receptor labelled with [3H]8-OH-DPAT in rat hippocampal homogenates,,B,,H,8,Autocuration,CHEMBL616950,,
1324,,1,,13506,BAO_0000357,,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,,B,,H,8,Autocuration,CHEMBL832875,,
1325,,1,955.0,10862,BAO_0000221,,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,B,,H,8,Expert,CHEMBL616951,,
1326,,1,955.0,10862,BAO_0000221,,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,B,,H,8,Expert,CHEMBL616952,,
1327,,1,,10062,BAO_0000357,,Binding affinity at rat 5-hydroxytryptamine 1A receptor by [3H]WB-4101 displacement.,,B,,H,8,Expert,CHEMBL616953,,
1328,,1,,12073,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor by use of [3H]8-OH-DPAT in male rat,,B,,H,8,Autocuration,CHEMBL616954,,
1329,,1,,14875,BAO_0000357,,GTPgammaS radioligand binding assay,,B,,H,8,Autocuration,CHEMBL616955,,
1330,,1,,2391,BAO_0000357,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,,B,,H,8,Autocuration,CHEMBL616956,,
1331,,1,,2391,BAO_0000019,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Partial agonist,,F,,H,8,Autocuration,CHEMBL616957,,
1332,,1,,2391,BAO_0000019,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Slient antagonist,,F,,H,8,Autocuration,CHEMBL616958,,
1333,,1,,2391,BAO_0000357,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL616959,,
1334,,1,,2391,BAO_0000357,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,,B,,H,8,Autocuration,CHEMBL616960,,
1335,,1,,2391,BAO_0000019,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; silent antagonist,,F,,H,8,Autocuration,CHEMBL616961,,
1336,,1,,17211,BAO_0000219,,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor,,B,,H,8,Expert,CHEMBL616962,308.0,
1337,,1,,17211,BAO_0000219,,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor receptor,,B,,H,8,Autocuration,CHEMBL616963,308.0,
1338,Homo sapiens,1,,6491,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 1B serotonin receptor,,B,,D,9,Expert,CHEMBL616524,,
1339,,1,,16190,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616525,449.0,
1340,,1,,14165,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]5-CT as radioligand,,B,,H,8,Autocuration,CHEMBL872908,,
1341,,1,,14165,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]GR-125743 as radioligand,,B,,H,8,Autocuration,CHEMBL616526,,
1342,Homo sapiens,1,,4234,BAO_0000357,,Binding affinity to cloned human 5-hydroxytryptamine 1B receptor,,B,,D,9,Expert,CHEMBL616527,,
1343,,1,,6328,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 1B receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,,B,,H,8,Expert,CHEMBL616528,,
1344,,1,,14770,BAO_0000357,,Binding affinity for recombinant human 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL616529,,
1345,,1,,2598,BAO_0000357,,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1B receptor using [3H]5-CT as radioligand,,B,,H,8,Autocuration,CHEMBL616530,,
1346,,1,,6897,BAO_0000357,,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,,B,,H,8,Expert,CHEMBL616531,,
1347,,1,,6897,BAO_0000357,,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL616532,,
1348,,1,,6013,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL616533,,
1349,,1,,5843,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,,B,,H,8,Expert,CHEMBL616534,,
1350,,1,,14454,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT trifluoroacetate as radioligand,,B,,H,8,Expert,CHEMBL616535,,
1351,,1,,16209,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT radioligand,,B,,H,8,Autocuration,CHEMBL616536,,
1352,,1,,3935,BAO_0000357,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL616537,,
1353,,1,,13729,BAO_0000219,,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1B receptor in CHO-K1 cells,,F,,H,8,Expert,CHEMBL616538,485.0,
1354,,1,,14251,BAO_0000019,,Agonist activity to the human recombinant 5-hydroxytryptamine 1B receptor,,F,,H,8,Expert,CHEMBL616539,,
1355,,1,,17085,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor,,B,,H,8,Expert,CHEMBL616540,,
1356,,1,,3025,BAO_0000357,,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,,B,,H,8,Autocuration,CHEMBL616429,,
1357,,1,,15315,BAO_0000357,,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor,,B,,H,8,Expert,CHEMBL616430,,
1358,Homo sapiens,1,,14214,BAO_0000219,,Receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor in Cos-7 cells,,B,,D,9,Expert,CHEMBL616431,,
1359,Homo sapiens,1,,3804,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,,B,,D,9,Expert,CHEMBL616432,,
1360,Homo sapiens,1,,2391,BAO_0000357,,Affinity for 5-hydroxytryptamine 1B receptor subtype,,B,,D,9,Expert,CHEMBL616433,,
1361,Homo sapiens,1,,4175,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 1B receptor,,B,,D,9,Expert,CHEMBL616434,,
1362,,1,,17296,BAO_0000219,,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand; Not determined,,B,,H,8,Autocuration,CHEMBL616435,449.0,
1363,,1,,17085,BAO_0000019,,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor; ND means not determined,,B,,H,8,Expert,CHEMBL616436,,
1364,,1,,17211,BAO_0000219,,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,,B,,H,8,Autocuration,CHEMBL616437,308.0,
1365,,1,,17211,BAO_0000219,,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT=not tested,,B,,H,8,Autocuration,CHEMBL616438,308.0,
1366,,1,,17211,BAO_0000219,,Ability to displace [3H]-5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,,B,,H,8,Autocuration,CHEMBL616439,308.0,
1367,Homo sapiens,1,,15926,BAO_0000357,,Binding activity against human 5-hydroxytryptamine 1B receptor; NT means not tested,,B,,D,9,Expert,CHEMBL616440,,
1368,,1,,16312,BAO_0000219,,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor; not tested,,B,,H,8,Autocuration,CHEMBL616441,485.0,
1369,,1,,5843,BAO_0000357,,Selectivity ratio against cloned human 5-HT1B receptor to that of h5-HT1D receptor,,B,,H,8,Expert,CHEMBL616442,,
1370,,1,,5843,BAO_0000357,,Selectivity ratio against cloned human 5-hydroxytryptamine 1B receptor to that of human 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616443,,
1371,,1,,16312,BAO_0000219,,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor,,B,,H,8,Expert,CHEMBL616444,485.0,
1372,Homo sapiens,1,,15926,BAO_0000357,,Binding activity against human 5-hydroxytryptamine 1B receptor,,B,,D,9,Expert,CHEMBL616445,,
1373,Homo sapiens,1,,15926,BAO_0000357,,Binding activity against human 5-hydroxytryptamine 1B receptor,,B,,D,9,Expert,CHEMBL616446,,
1374,Homo sapiens,1,,4540,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,,B,,D,9,Expert,CHEMBL616447,449.0,
1375,,1,,6166,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor was determined,,B,,H,8,Autocuration,CHEMBL616448,,
1376,,1,,17296,BAO_0000219,,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand,,B,,H,8,Autocuration,CHEMBL616449,449.0,
1377,,1,,17296,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells,,B,,H,8,Autocuration,CHEMBL616450,449.0,
1378,,1,,17296,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells using [3H]5-CT as radioligand,,B,,H,8,Autocuration,CHEMBL857974,449.0,
1379,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1B (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616451,449.0,
1380,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616452,449.0,
1381,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand;ND means no data.,,B,,H,8,Autocuration,CHEMBL616453,449.0,
1382,,1,,4199,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as the radioligand,,B,,H,8,Autocuration,CHEMBL616454,449.0,
1383,Homo sapiens,1,,14875,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 1B receptor,,B,,D,9,Expert,CHEMBL616455,,
1384,,1,,15146,BAO_0000219,,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,,B,,H,8,Autocuration,CHEMBL616456,449.0,
1385,,1,,5213,BAO_0000357,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1B receptor in CHO using [3H]5-HT as a radioligand,,B,,H,8,Autocuration,CHEMBL616457,,
1386,,1,,14818,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,,B,,H,8,Autocuration,CHEMBL616458,449.0,
1387,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1B receptor in CHO cells, using [3H]5-HT as radioligand",,B,,H,8,Autocuration,CHEMBL616459,449.0,
1388,,1,,14454,BAO_0000019,,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 1 uM,,F,,H,8,Expert,CHEMBL616460,,
1389,,1,,14454,BAO_0000019,,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 10 uM,,F,,H,8,Expert,CHEMBL616461,,
1390,,1,,14875,BAO_0000219,,"Effect of compound on [35S]GTP-gamma-S, radioligand binding CHO cells expressing human 5-hydroxytryptamine 1B receptor",,F,,H,8,Autocuration,CHEMBL616462,449.0,
1391,,1,,14875,BAO_0000219,,"Effect of compound on [35S]GTP-gamma-S, radioligand binding in CHO cells expressing human 5-hydroxytryptamine 1B receptor",,F,,H,8,Autocuration,CHEMBL616463,449.0,
1392,,1,,15250,BAO_0000019,,"Compound was tested for maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-HT.",,F,,H,8,Autocuration,CHEMBL616464,,
1393,,1,,15250,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells.,,B,,H,8,Autocuration,CHEMBL616465,449.0,
1394,,1,,15086,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL832874,,
1395,Oryctolagus cuniculus,1,,3025,BAO_0000019,,5-hydroxytryptamine 1B receptor agonist potency determined in rabbit saphenous vein contraction model,,F,,H,8,Autocuration,CHEMBL616184,,
1396,Oryctolagus cuniculus,1,,14998,BAO_0000019,,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein (RbSV).,,B,,H,8,Autocuration,CHEMBL616185,,
1397,Oryctolagus cuniculus,1,,14998,BAO_0000019,,"Binding affinity against vascular 5-hydroxytryptamine 1B receptor, measured using ring preparations of rabbit saphenous vein (RbSV)",,B,,H,8,Intermediate,CHEMBL616186,,
1398,Oryctolagus cuniculus,1,,14998,BAO_0000019,,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein(RbSV).,,B,,H,8,Autocuration,CHEMBL616187,,
1399,,1,,13969,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1B receptor was measured using [3H]5-HT as radioligand,,B,,H,8,Expert,CHEMBL616188,,
1400,,1,,13392,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1B receptor,,B,,D,9,Intermediate,CHEMBL873475,,
1401,Rattus norvegicus,1,2435.0,3651,BAO_0000019,,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Less active,,B,,D,9,Expert,CHEMBL616189,,
1402,,1,,10025,BAO_0000357,,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,,B,,H,8,Expert,CHEMBL616190,,
1403,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=48-77,,B,,H,8,Autocuration,CHEMBL616191,,
1404,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=63-95,,B,,H,8,Autocuration,CHEMBL616192,,
1405,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=710-980,,B,,H,8,Autocuration,CHEMBL616193,,
1406,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=78-140,,B,,H,8,Autocuration,CHEMBL616194,,
1407,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=85-130,,B,,H,8,Autocuration,CHEMBL616195,,
1408,,1,,13863,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=89-280,,B,,H,8,Autocuration,CHEMBL616196,,
1409,,1,10000000.0,4622,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampus membrane.,,B,,H,8,Autocuration,CHEMBL616197,,
1410,,1,,14911,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 1A (5-HT1A) receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand,,B,,H,8,Intermediate,CHEMBL616198,,
1411,,1,10000000.0,12678,BAO_0000221,,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,,B,,H,8,Autocuration,CHEMBL616199,,
1412,,1,10000000.0,12678,BAO_0000221,,In vitro binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampal homogenate by [125I](R)-(+)-trans-8-OH-PIPAT displacement.,,B,,H,8,Expert,CHEMBL616200,,
1413,,1,10000000.0,14235,BAO_0000221,,In vitro binding affinity to rat hippocampal 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL616201,,
1414,,1,10000000.0,14949,BAO_0000221,,In vitro binding affinity towards 5-hydroxytryptamine 1A r receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,,B,,H,8,Expert,CHEMBL616202,,
1415,,1,10000000.0,14949,BAO_0000221,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,,B,,H,8,Expert,CHEMBL616203,,
1416,,1,10000000.0,14949,BAO_0000221,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; ND=not determined,,B,,H,8,Expert,CHEMBL616204,,
1417,,1,10000000.0,14949,BAO_0000221,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; Not determined,,B,,H,8,Expert,CHEMBL616205,,
1418,,1,10000000.0,14949,BAO_0000221,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; not determined,,B,,H,8,Expert,CHEMBL616206,,
1419,,1,,16118,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,,B,,H,8,Expert,CHEMBL616207,,
1420,,1,,3268,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes,,B,,H,8,Autocuration,CHEMBL616208,,
1421,,1,,3268,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes; Inactive,,B,,H,8,Autocuration,CHEMBL616209,,
1422,,1,,16117,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using radioligand [3H]-8-OH-DPAT,,B,,H,8,Expert,CHEMBL616210,,
1423,,1,10000000.0,9783,BAO_0000221,,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue.,,B,,H,8,Expert,CHEMBL616211,,
1424,,1,10000000.0,9783,BAO_0000221,,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue; NT=Not tested,,B,,H,8,Autocuration,CHEMBL616504,,
1425,Rattus norvegicus,1,10000000.0,14356,BAO_0000221,,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616505,,
1426,,1,,15740,BAO_0000019,,Inhibition constant of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,,F,,H,8,Autocuration,CHEMBL616506,,
1427,,1,10000000.0,12306,BAO_0000221,,Inhibition of binding of [125I]8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,B,,H,8,Autocuration,CHEMBL872107,,
1428,Rattus norvegicus,1,10000000.0,13348,BAO_0000221,,Displacement of [3H]5-HT from rat hippocampal 5-hydroxytryptamine 1A receptor with 10e-6 M ketanserin,,B,,D,9,Expert,CHEMBL616507,,
1429,,1,,10394,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 1A receptor in rat cortical membranes using [3H]8-OH-DPAT as a radioligand,,B,,H,8,Autocuration,CHEMBL616303,,
1430,,1,10000000.0,15260,BAO_0000221,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue,,B,,H,8,Autocuration,CHEMBL616304,,
1431,,1,10000000.0,10046,BAO_0000221,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,,B,,H,8,Expert,CHEMBL616305,,
1432,,1,10000000.0,15260,BAO_0000221,,Antagonist activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor,,F,,H,8,Intermediate,CHEMBL616306,,
1433,,1,,12851,BAO_0000357,,Inhibitory affinity constant against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616307,,
1434,Rattus norvegicus,1,10000000.0,2148,BAO_0000221,,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat brain hippocampus,,B,,D,9,Expert,CHEMBL881829,,
1435,,1,,13134,BAO_0000357,,Affinity against the 5-hydroxytryptamine receptor 1A using [3H]WB-4101.,,B,,H,8,Expert,CHEMBL616308,,
1436,,1,,12462,BAO_0000019,,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain,,B,,H,8,Autocuration,CHEMBL616309,,
1437,,1,,12462,BAO_0000019,,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain tissue,,B,,H,8,Expert,CHEMBL616310,,
1438,,1,,12462,BAO_0000219,,Tested for affinity against 5-hydroxytryptamine 1A receptors using [3H]8-OH-DPAT in homogenized rat cloned CHO cells,,B,,H,8,Autocuration,CHEMBL616311,449.0,
1439,,1,,11933,BAO_0000357,,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL616312,,
1440,,1,,11933,BAO_0000357,,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand; ND is Not Determined,,B,,H,8,Autocuration,CHEMBL616313,,
1441,Rattus norvegicus,1,10000000.0,403,BAO_0000221,,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616314,,
1442,,1,10000000.0,15538,BAO_0000221,,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus,,B,,H,8,Autocuration,CHEMBL616315,,
1443,,1,10000000.0,15538,BAO_0000221,,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; NA means Not Active,,B,,H,8,Autocuration,CHEMBL616567,,
1444,,1,10000000.0,15538,BAO_0000221,,Tested for binding affinity by measuring displacement of [3H]-8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; ND means Not Determined,,B,,H,8,Autocuration,CHEMBL616568,,
1445,,1,,12464,BAO_0000019,,Binding affinity to displace [3H]2-(di-N-propylamino)-8-hydroxy-tetralin from 5-hydroxytryptamine 1A (5-HT1A) receptor in rat frontal cortex homogenates,,B,,H,8,Intermediate,CHEMBL616569,,
1446,,1,,1455,BAO_0000357,,Binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand assay.,,B,,H,8,Expert,CHEMBL616570,,
1447,,1,,12652,BAO_0000357,,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,,B,,H,8,Autocuration,CHEMBL616571,,
1448,,1,10000000.0,12639,BAO_0000221,,Tested for the inhibitory activity against 5-hydroxytryptamine 1A receptor in rat hippocampal,,B,,H,8,Autocuration,CHEMBL616572,,
1449,,1,,13949,BAO_0000249,,Tested in vitro for binding affinity by measuring its ability to inhibit [3H]8-OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes.,,B,,H,8,Expert,CHEMBL616573,,
1450,Rattus norvegicus,1,,12463,BAO_0000357,,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT,,B,,D,9,Expert,CHEMBL616574,,
1451,,1,10000000.0,14829,BAO_0000221,,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation,,B,,H,8,Expert,CHEMBL616575,,
1452,,1,10000000.0,14829,BAO_0000221,,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation; ND=not determined,,B,,H,8,Autocuration,CHEMBL872108,,
1453,,1,,12092,BAO_0000357,,The binding affinity was measured on 5-hydroxytryptamine 1A receptor using [3H]- 8-OH-DPAT as radioligand.,,B,,H,8,Autocuration,CHEMBL616576,,
1454,,1,,403,BAO_0000249,,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 1 mM of MnCl2,,B,,H,8,Autocuration,CHEMBL616577,,
1455,,1,,403,BAO_0000249,,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 3*10e-5 M GTP gamma S,,B,,H,8,Autocuration,CHEMBL616578,,
1456,,1,,3967,BAO_0000357,,Binding affinity at 5-hydroxytryptamine 1A receptor from striata of wistar rats by [3H]- 8-OH -DPAT displacement.,,B,,H,8,Expert,CHEMBL616579,,
1457,Rattus norvegicus,1,,12771,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat brain synaptosomal preparations,,B,,D,9,Expert,CHEMBL616580,,
1458,,1,,15086,BAO_0000019,,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,,B,,H,8,Autocuration,CHEMBL616581,,
1459,,1,10000000.0,14909,BAO_0000221,,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,,B,,H,8,Autocuration,CHEMBL616582,,
1460,,1,10000000.0,14949,BAO_0000221,,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,,B,,H,8,Expert,CHEMBL616583,,
1461,Rattus norvegicus,1,10000000.0,2309,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]8-OH-DPAT,,B,,D,9,Expert,CHEMBL616584,,
1462,,1,,4170,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL616585,,
1463,Rattus norvegicus,1,10000000.0,11642,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 from rat hippocampus,,B,,D,9,Expert,CHEMBL616586,,
1464,,1,10000000.0,11642,BAO_0000221,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 radioligand in rat hippocampus,,B,,H,8,Autocuration,CHEMBL616587,,
1465,,1,10000000.0,12953,BAO_0000221,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]-8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616588,,
1466,,1,10000000.0,12953,BAO_0000221,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand.,,B,,H,8,Autocuration,CHEMBL616589,,
1467,,1,10000000.0,12953,BAO_0000221,,Binding affinity for 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL616590,,
1468,,1,,12903,BAO_0000219,,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1A receptor expressed in CHO cells, by using [3H]8-OH-DPAT as radioligand.",,B,,H,8,Expert,CHEMBL616591,449.0,
1469,,1,,12536,BAO_0000357,,Displacement of the radioligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL616592,,
1470,,1,,10058,BAO_0000357,,The inhibition activity of 5-HT1A at 1 uM,,B,,H,8,Autocuration,CHEMBL616593,,
1471,,1,,12902,BAO_0000219,,"Binding affinity against 5-hydroxytryptamine 1A receptor from CHO-K1 cells, using [3H]8-OH-DPAT as the radioligand.",,B,,H,8,Expert,CHEMBL616594,485.0,
1472,,1,,14057,BAO_0000249,,Binding affinities against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membrane,,B,,H,8,Expert,CHEMBL616595,,
1473,,1,,11296,BAO_0000357,,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-HT 1A receptor site.,,B,,H,8,Autocuration,CHEMBL616596,,
1474,,1,10000000.0,11296,BAO_0000221,,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,B,,H,8,Autocuration,CHEMBL616597,,
1475,,1,10000000.0,11296,BAO_0000221,,Ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,B,,H,8,Expert,CHEMBL616598,,
1476,Rattus norvegicus,1,,16616,BAO_0000249,,Antagonist activity to stimulate binding of [35S]-GTP-gamma S binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes,Membranes,F,,D,9,Expert,CHEMBL616599,,
1477,Rattus norvegicus,1,10000000.0,16616,BAO_0000249,,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",Membranes,F,,D,9,Expert,CHEMBL616600,,
1478,,1,,16567,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not -determined.,,B,,H,8,Autocuration,CHEMBL616601,,
1479,,1,,16567,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not defined.,,B,,H,8,Autocuration,CHEMBL616602,,
1480,,1,,16567,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not determined.,,B,,H,8,Autocuration,CHEMBL616603,,
1481,,1,,16567,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND means not determined.,,B,,H,8,Autocuration,CHEMBL616604,,
1482,,1,,17136,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; No data,,B,,H,8,Autocuration,CHEMBL616316,,
1483,,1,,17136,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; Not determined,,B,,H,8,Autocuration,CHEMBL616317,,
1484,Rattus norvegicus,1,,16616,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates; ND means No data,,B,,D,9,Expert,CHEMBL616318,,
1485,,1,10000000.0,17331,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes,,B,,H,8,Autocuration,CHEMBL616319,,
1486,,1,10000000.0,17331,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes; Not tested,,B,,H,8,Autocuration,CHEMBL616320,,
1487,Rattus norvegicus,1,10000000.0,17167,BAO_0000221,,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding; Not tested,,B,,D,9,Expert,CHEMBL616321,,
1488,,1,,15740,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,,F,,H,8,Autocuration,CHEMBL616322,,
1489,,1,,15740,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; not tested,,F,,H,8,Autocuration,CHEMBL616323,,
1490,,1,,4671,BAO_0000357,,Ratio of binding affinity to 5-HT 1A and D2 receptor,,B,,H,8,Autocuration,CHEMBL616324,,
1491,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,,B,,H,8,Autocuration,CHEMBL616325,,
1492,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,,B,,H,8,Autocuration,CHEMBL616326,,
1493,,1,10000000.0,10058,BAO_0000221,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.,,B,,H,8,Autocuration,CHEMBL616327,,
1494,,1,,12073,BAO_0000357,,Percentage inhibition against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616328,,
1495,,1,,2759,BAO_0000249,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),,B,,H,8,Autocuration,CHEMBL858110,,
1496,,1,,2759,BAO_0000249,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),,F,,H,8,Autocuration,CHEMBL616329,,
1497,,1,,2759,BAO_0000249,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),,B,,H,8,Autocuration,CHEMBL616330,,
1498,,1,,2759,BAO_0000249,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),,F,,H,8,Autocuration,CHEMBL616331,,
1499,,1,,2759,BAO_0000249,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,,F,,H,8,Autocuration,CHEMBL616332,,
1500,,1,955.0,9737,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,B,,H,8,Autocuration,CHEMBL857063,,
1501,,1,,9737,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [3H]8-OH-DPAT as a radioligand,,B,,H,8,Autocuration,CHEMBL616333,,
1502,,1,,5717,BAO_0000019,,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT as radioligand.,,F,,H,8,Expert,CHEMBL616334,,
1503,,1,10000000.0,12253,BAO_0000221,,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,B,,H,8,Autocuration,CHEMBL616335,,
1504,,1,,14025,BAO_0000019,,Affinity pKi for 5-hydroxytryptamine 1A receptor was measured in rat cortex homogenates.,,B,,H,8,Autocuration,CHEMBL616336,,
1505,,1,,10425,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cerebral cortical membrane using [3H]-8-OH-DPAT as radioligand.,,B,,H,8,Expert,CHEMBL616337,,
1506,,1,,14998,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cortex homogenates.,,B,,H,8,Autocuration,CHEMBL616338,,
1507,,1,10000000.0,13694,BAO_0000221,,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]- 8-hydri\oxy-2-(di-n-propylamino)tetraline) binding assay,,B,,H,8,Autocuration,CHEMBL616339,,
1508,,1,10000000.0,13694,BAO_0000221,,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]8-hydroxy-2-(di-n-propylamino)-tetraline) binding assay,,B,,H,8,Autocuration,CHEMBL616340,,
1509,,1,,4342,BAO_0000357,,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined,,B,,H,8,Autocuration,CHEMBL616341,,
1510,Rattus norvegicus,1,,12936,BAO_0000357,,Binding affinity against rat 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616342,,
1511,Rattus norvegicus,1,,13144,BAO_0000019,,Inhibition of [3H]2-(di-N-propylamino)-8-hydroxytetralin binding to 5-HT1A receptor of rat frontal cortex homogenates,,B,,D,9,Expert,CHEMBL616343,,
1512,,1,,13343,BAO_0000019,,Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement,,B,,H,8,Expert,CHEMBL616344,,
1513,,1,,12132,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,B,,H,8,Expert,CHEMBL616345,,
1514,,1,,15419,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]8-OH-DPAT as a radioligand,,B,,H,8,Expert,CHEMBL616346,,
1515,,1,10000000.0,1479,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,B,,H,8,Autocuration,CHEMBL616347,,
1516,,1,,14287,BAO_0000019,,In vitro by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor on rat cortical membrane,,B,,H,8,Expert,CHEMBL616348,,
1517,,1,,13116,BAO_0000357,,Binding affinity at 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL616349,,
1518,Rattus norvegicus,1,,2759,BAO_0000249,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat frontal cortex membranes,Membranes,B,,D,9,Expert,CHEMBL616152,,
1519,,1,,2759,BAO_0000249,,Compound was tested for inhibition constant against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,,B,,H,8,Autocuration,CHEMBL616153,,
1520,,1,,14748,BAO_0000019,,"Binding affinity for rat cortex 5-hydroxytryptamine 1A receptor, by displacement of 0.2 nM [3H]8-OH-DPAT radioligand",,B,,H,8,Expert,CHEMBL616154,,
1521,,1,,12304,BAO_0000019,,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,B,,H,8,Autocuration,CHEMBL616155,,
1522,Rattus norvegicus,1,10000000.0,12409,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT,,B,,D,9,Expert,CHEMBL616156,,
1523,Rattus norvegicus,1,10000000.0,12409,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus with [3H]8-OH-DPAT,,B,,D,9,Expert,CHEMBL616157,,
1524,,1,10000000.0,13267,BAO_0000221,,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]-SB 207710 as radioligand,,B,,H,8,Autocuration,CHEMBL616158,,
1525,,1,,15194,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,B,,H,8,Autocuration,CHEMBL616159,,
1526,,1,,14256,BAO_0000357,,pKi value against rat 5-hydroxytryptamine 1A receptor.,,B,,H,8,Expert,CHEMBL616160,,
1527,,1,,16567,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is define as non-determined.,,B,,H,8,Autocuration,CHEMBL616161,,
1528,,1,,15740,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,,F,,H,8,Autocuration,CHEMBL616162,,
1529,Rattus norvegicus,1,,13278,BAO_0000357,,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,,B,,D,9,Expert,CHEMBL616163,,
1530,,1,,1970,BAO_0000249,,Inhibition of specific [3H]OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,Membranes,B,,H,8,Expert,CHEMBL616164,,
1531,,1,955.0,10034,BAO_0000221,,Concentration of compound required to inhibit cortical 5-hydroxytryptamine 1A receptor binding sites in rat brain was evaluated,,B,,H,8,Autocuration,CHEMBL616165,,
1532,Rattus norvegicus,1,,13348,BAO_0000019,,Inhibitory activity against 5-hydroxytryptamine 1A receptor isolated from rat hippocampus membranes membrane using [3H]5-HT as radioligand in the presence of 10e-6 M ketanserin as 5-HT2 blocker,,B,,H,8,Autocuration,CHEMBL616355,,
1533,,1,,13630,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,,F,,H,8,Autocuration,CHEMBL616356,,
1534,,1,955.0,10862,BAO_0000221,,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,B,,H,8,Autocuration,CHEMBL616357,,
1535,,1,,12058,BAO_0000019,,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",,B,,H,8,Autocuration,CHEMBL616358,,
1536,,1,,4639,BAO_0000357,,Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616359,,
1537,,1,,15453,BAO_0000357,,Percent decrease in 5-hydroxytryptamine 1A receptor binding using 8-OH-DPAT,,B,,H,8,Expert,CHEMBL616360,,
1538,,1,,4820,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL616361,,
1539,,1,,1089,BAO_0000357,,Tested for binding affinity for 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616362,,
1540,,1,,386,BAO_0000249,,The compound was evaluated for its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in cellular brain membranes,Brain membranes,B,,H,8,Autocuration,CHEMBL616363,,
1541,,1,,6011,BAO_0000357,,Inhibition of binding towards 5-hydroxytryptamine 1A receptor at 100 nM concentration,,B,,H,8,Autocuration,CHEMBL616364,,
1542,,1,,5014,BAO_0000357,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616365,,
1543,,1,,4402,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor determined using [3H]8-OH-DPAT as radioligand,,B,,H,8,Expert,CHEMBL616366,,
1544,,1,,17066,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor,,B,,H,8,Expert,CHEMBL872906,,
1545,,1,,17515,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1A receptor; inactive at 10 uM,,B,,H,8,Autocuration,CHEMBL616367,,
1546,,1,,2474,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616368,,
1547,,1,,4775,BAO_0000357,,Binding affinity to 5-hydroxytryptamine 1A receptor was determined,,B,,H,8,Autocuration,CHEMBL616369,,
1548,Homo sapiens,1,,14294,BAO_0000357,,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H]-(+)-8-OH-DPAT.,,B,,D,9,Expert,CHEMBL616370,,
1549,Homo sapiens,1,,14294,BAO_0000357,,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H](+)-8-OH-DPAT; inactive,,B,,D,9,Expert,CHEMBL616371,,
1550,,1,,12249,BAO_0000219,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,B,,H,8,Autocuration,CHEMBL616372,449.0,
1551,,1,,11376,BAO_0000219,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor expressed in CHO cell membranes,,B,,H,8,Expert,CHEMBL616373,,
1552,,1,,2474,BAO_0000218,,Compound was measured in vivo for its binding affinity at 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616374,,
1553,,1,10000000.0,13311,BAO_0000221,,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,,B,,H,8,Autocuration,CHEMBL616375,,
1554,,1,,4373,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1A receptor was determined,,B,,H,8,Autocuration,CHEMBL616376,,
1555,,1,,1633,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT.,,B,,H,8,Expert,CHEMBL857064,,
1556,,1,,11866,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,,B,,H,8,Autocuration,CHEMBL616377,,
1557,,1,,4373,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,,B,,H,8,Autocuration,CHEMBL616378,,
1558,,1,,4687,BAO_0000357,,Evaluated for the binding affinity to 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616379,,
1559,,1,,16946,BAO_0000357,,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616380,,
1560,,1,,13291,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT radioligand,,B,,H,8,Autocuration,CHEMBL616381,,
1561,,1,,14159,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616382,,
1562,,1,,10812,BAO_0000357,,Compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor by using [3H]DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616383,,
1563,Mus musculus,1,,3032,BAO_0000219,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor in CHO cells,,B,,D,9,Expert,CHEMBL616350,449.0,
1564,,1,,16655,BAO_0000357,,Inhibition of 5-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616351,,
1565,,1,,14532,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand at 10e-5 M concentration,,B,,H,8,Autocuration,CHEMBL616352,,
1566,,1,,13944,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616353,,
1567,,1,,13033,BAO_0000357,,Binding affinity against serotonergic 5-HT1a receptor,,B,,H,8,Autocuration,CHEMBL616354,,
1568,,1,,10321,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616508,,
1569,Mus musculus,1,,2968,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616559,,
1570,,1,,13964,BAO_0000357,,Binding affinity at 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616560,,
1571,,1,,15527,BAO_0000357,,"Binding affinity towards 5-hydroxytryptamine 1A receptor receptor, using [3H]5-HT as radioligand.",,B,,H,8,Autocuration,CHEMBL616561,,
1572,,1,,12248,BAO_0000219,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,B,,H,8,Autocuration,CHEMBL616562,449.0,
1573,,1,,12249,BAO_0000219,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,B,,H,8,Autocuration,CHEMBL616563,449.0,
1574,,1,,15120,BAO_0000357,,Compound was tested for binding affinity using [3H]8-OH-DPAT against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616564,,
1575,,1,,13313,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by using [3H]-8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616565,,
1576,,1,,2613,BAO_0000218,,In vivo binding affinity was evaluated against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616566,,
1577,,1,,16700,BAO_0000357,,The binding affinity towards 5-hydroxytryptamine 1A receptor; No affinity,,B,,H,8,Autocuration,CHEMBL616989,,
1578,,1,,2201,BAO_0000357,,Ability to displace [125I]iodosulpiride from 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL857975,,
1579,Mus musculus,1,,1274,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,,B,,D,9,Expert,CHEMBL616990,,
1580,,1,,1317,BAO_0000357,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor using radioligand binding assay,,B,,H,8,Autocuration,CHEMBL616991,,
1581,,1,,12146,BAO_0000357,,Tested against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616992,,
1582,,1,,14059,BAO_0000357,,The compound's binding affinity against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL616993,,
1583,Oryctolagus cuniculus,1,,14025,BAO_0000019,,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein,,B,,H,8,Expert,CHEMBL616994,,
1584,Oryctolagus cuniculus,1,,14025,BAO_0000019,,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein(RbSV); NS=non surmountable,,B,,H,8,Autocuration,CHEMBL616995,,
1585,Gorilla gorilla,1,,14447,BAO_0000219,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1B receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,,B,,D,9,Intermediate,CHEMBL616996,722.0,
1586,Cavia porcellus,1,,3025,BAO_0000218,,5-HT1B agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,,F,,H,8,Autocuration,CHEMBL616997,,
1587,Cavia porcellus,1,,3025,BAO_0000218,,5-hydroxytryptamine 1B receptor agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,,F,,H,8,Autocuration,CHEMBL616998,,
1588,Cavia porcellus,1,,15329,BAO_0000019,,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery,,F,,H,8,Autocuration,CHEMBL616999,,
1589,Cavia porcellus,1,,15329,BAO_0000019,,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery; n.d. indicates Not determined,,F,,H,8,Autocuration,CHEMBL617000,,
1590,Cavia porcellus,1,,15847,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig,,F,,H,8,Autocuration,CHEMBL617001,,
1591,Cavia porcellus,1,,15847,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig; ND means not done,,F,,H,8,Autocuration,CHEMBL858111,,
1592,,1,,14165,BAO_0000019,,Intrinsic activity for Antagonism of 5-hydroxytryptamine 1B receptor-mediated stimulation of [35S]GTP gamma S binding,,F,,H,8,Autocuration,CHEMBL617002,,
1593,,1,,14214,BAO_0000019,,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine (5-CT),,F,,H,8,Autocuration,CHEMBL617003,,
1594,,1,,14214,BAO_0000019,,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine(5-CT),,F,,H,8,Autocuration,CHEMBL617004,,
1595,Homo sapiens,1,,14214,BAO_0000019,,Agonist activity at 5-hydroxytryptamine 1B receptor by measuring the inhibition of forskolin-stimulated cAMP formation,,F,,D,9,Expert,CHEMBL617005,,
1596,Homo sapiens,1,,13729,BAO_0000219,,Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells,,F,,D,9,Expert,CHEMBL616623,485.0,
1597,,1,,3025,BAO_0000219,,Effective concentration determined by measuring inhibition of forskolin-stimulated c-AMP formation at 5-hydroxytryptamine 1B receptor stably transfected in CHO cell lines,,F,,H,8,Autocuration,CHEMBL616624,449.0,
1598,,1,,2391,BAO_0000357,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL883243,,
1599,,1,,2391,BAO_0000019,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; full agonist,,F,,H,8,Autocuration,CHEMBL616625,,
1600,,1,,14956,BAO_0000219,,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1B receptor",,F,,H,8,Expert,CHEMBL616626,449.0,
1601,,1,,2598,BAO_0000219,,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line,,F,,H,8,Autocuration,CHEMBL616627,449.0,
1602,,1,,2598,BAO_0000219,,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Antagonist,,F,,H,8,Autocuration,CHEMBL616628,449.0,
1603,,1,,2598,BAO_0000219,,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist,,F,,H,8,Autocuration,CHEMBL616629,449.0,
1604,,1,,2598,BAO_0000219,,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Partial Agonist,,F,,H,8,Autocuration,CHEMBL616630,449.0,
1605,,1,,14956,BAO_0000019,,"Efficacy was evaluated relative to human 5-HT1B receptor using [35S]GTP-gamma-S, as radioligand",,F,,H,8,Expert,CHEMBL616631,,
1606,,1,,14956,BAO_0000019,,"Efficacy of compound was evaluated relative to human 5-hydroxytryptamine 1B receptor using [35S]GTP-gamma-S, as radioligand",,F,,H,8,Autocuration,CHEMBL616632,,
1607,Homo sapiens,1,,14214,BAO_0000357,,Percentage Maximal inhibition obtained with 1 uM 5-HT against 5-hydroxytryptamine 1B receptor,,B,,D,9,Expert,CHEMBL616633,,
1608,,1,,3463,BAO_0000219,,Ability to displace [3H]5-HT from recombinant human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells determined in vitro,,B,,H,8,Expert,CHEMBL616634,449.0,
1609,,1,,15331,BAO_0000357,,Affinity of compound towards 5-hydroxytryptamine 1B receptor was evaluated using radioligand binding technique,,B,,H,8,Autocuration,CHEMBL616635,,
1610,Homo sapiens,1,,16146,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1B receptor,,B,,D,9,Expert,CHEMBL885358,,
1611,Homo sapiens,1,,14159,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1B receptor expressed in CHO cells,,B,,D,9,Expert,CHEMBL616636,449.0,
1612,,1,,14158,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells by [3H]5-HT binding displacement.,,B,,H,8,Expert,CHEMBL616637,449.0,
1613,,1,,14159,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL616638,,
1614,,1,,15250,BAO_0000219,,Displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,,B,,H,8,Expert,CHEMBL616639,449.0,
1615,,1,,15250,BAO_0000219,,Binding affinity at cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells by [3H]5-HT displacement.,,B,,H,8,Expert,CHEMBL616640,449.0,
1616,,1,,15331,BAO_0000219,,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,,B,,H,8,Expert,CHEMBL616641,449.0,
1617,,1,,15332,BAO_0000219,,Displacement of [3H]5-HT binding from cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells.,,B,,H,8,Expert,CHEMBL616642,449.0,
1618,,1,,14956,BAO_0000219,,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1B receptor expressed in CHO cells,,B,,H,8,Expert,CHEMBL616643,449.0,
1619,,1,,3805,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 1B receptor at a concentration of 100 (nM),,B,,H,8,Autocuration,CHEMBL616644,,
1620,,1,,14875,BAO_0000357,,Intrinsic activity for each compound is calculated as a percentage of the 5-hydroxytryptamine 1B receptor response,,B,,H,8,Autocuration,CHEMBL616645,,
1621,Oryctolagus cuniculus,1,,14454,BAO_0000019,,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),,F,,H,8,Autocuration,CHEMBL616646,,
1622,Oryctolagus cuniculus,1,,14454,BAO_0000019,,Tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),,F,,H,8,Expert,CHEMBL616647,,
1623,,1,,16288,BAO_0000357,,Affinity at 5-hydroxytryptamine 1D receptor (For sumatriptan = Ki (nM)-12+/-1.9),,B,,H,8,Autocuration,CHEMBL616509,,
1624,,1,,16288,BAO_0000357,,Affinity at 5-hydroxytryptamine 1D receptor from calf caudate using [3H]5-HT as radioligand (For sumatriptan = Ki(nM)-12+/-1.9),,B,,H,8,Autocuration,CHEMBL616510,,
1625,,1,,16312,BAO_0000357,,Binding affinity against calf caudate 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616511,,
1626,Bos taurus,1,,1348,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1D receptor subtype,,B,,H,8,Expert,CHEMBL616512,,
1627,Bos taurus,1,,5834,BAO_0000357,,Inhibitory concentration required against 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT,,B,,H,8,Autocuration,CHEMBL616513,,
1628,Bos taurus,1,2435.0,13366,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,,B,,H,8,Autocuration,CHEMBL616514,,
1629,Bos taurus,1,,1414,BAO_0000357,,Ability to bind to 5-hydroxytryptamine 1D receptor of calf substantia nigra,,B,,H,8,Expert,CHEMBL616515,,
1630,Bos taurus,1,,14998,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1D receptor in calf caudate homogenates.,,B,,H,8,Autocuration,CHEMBL616516,,
1631,Bos taurus,1,,11473,BAO_0000357,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,,B,,H,8,Autocuration,CHEMBL616517,,
1632,Bos taurus,1,,11473,BAO_0000357,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,,B,,H,8,Autocuration,CHEMBL616518,,
1633,Bos taurus,1,,10639,BAO_0000357,,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,,B,,H,8,Autocuration,CHEMBL616519,,
1634,Bos taurus,1,,10639,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,,B,,H,8,Autocuration,CHEMBL616520,,
1635,Bos taurus,1,,1375,BAO_0000357,,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand,,B,,H,8,Autocuration,CHEMBL616521,,
1636,Bos taurus,1,,1375,BAO_0000357,,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand; NT means not tested,,B,,H,8,Autocuration,CHEMBL616522,,
1637,Bos taurus,1,,16532,BAO_0000357,,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,,B,,H,8,Autocuration,CHEMBL884531,,
1638,Bos taurus,1,,11147,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616523,,
1639,Bos taurus,1,2435.0,13366,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,,B,,H,8,Autocuration,CHEMBL616731,,
1640,Bos taurus,1,,10444,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 1D receptor in bovine caudate homogenate,,B,,H,8,Autocuration,CHEMBL616732,,
1641,Bos taurus,1,,16532,BAO_0000357,,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT,,B,,H,8,Autocuration,CHEMBL616733,,
1642,Bos taurus,1,,16532,BAO_0000357,,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,,B,,H,8,Autocuration,CHEMBL616734,,
1643,Bos taurus,1,,12827,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP,,B,,H,8,Autocuration,CHEMBL616735,,
1644,Bos taurus,1,,12827,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP; Not determined,,B,,H,8,Autocuration,CHEMBL616736,,
1645,Bos taurus,1,,12919,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,F,,H,8,Expert,CHEMBL616737,,
1646,Bos taurus,1,,14025,BAO_0000019,,Affinity pKi for 5-hydroxytryptamine 1D receptor was measured in calf caudate homogenate,,B,,H,8,Autocuration,CHEMBL616738,,
1647,Bos taurus,1,,12919,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,F,,H,8,Expert,CHEMBL616739,,
1648,Bos taurus,1,,12919,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,F,,H,8,Expert,CHEMBL616740,,
1649,Bos taurus,1,,12919,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,F,,H,8,Expert,CHEMBL616741,,
1650,Gorilla gorilla,1,,14447,BAO_0000219,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1D receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,,B,,H,8,Autocuration,CHEMBL616742,722.0,
1651,Cavia porcellus,1,,1375,BAO_0000019,,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra,,B,,D,9,Intermediate,CHEMBL616743,,
1652,Cavia porcellus,1,,1375,BAO_0000019,,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra; NT means not tested,,B,,D,9,Intermediate,CHEMBL616744,,
1653,Cavia porcellus,1,,12409,BAO_0000019,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptor by the agonist GR-46611,,F,,D,9,Intermediate,CHEMBL616745,,
1654,Cavia porcellus,1,,12409,BAO_0000019,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,F,,D,9,Intermediate,CHEMBL616746,,
1655,Cavia porcellus,1,,12409,BAO_0000019,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611; range is 2-9,,F,,D,9,Intermediate,CHEMBL616747,,
1656,Cavia porcellus,1,,12409,BAO_0000019,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-0.4,,F,,D,9,Intermediate,CHEMBL616748,,
1657,Cavia porcellus,1,,12409,BAO_0000019,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-1.2,,F,,D,9,Intermediate,CHEMBL616648,,
1658,Cavia porcellus,1,,11574,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor,,B,,D,9,Intermediate,CHEMBL616649,,
1659,Cavia porcellus,1,,1558,BAO_0000357,,Binding affinity towards guinea pig 5-hydroxytryptamine 1D receptor was determined,,B,,D,9,Intermediate,CHEMBL616650,,
1660,Cavia porcellus,1,,12409,BAO_0000218,,Compound at 3 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,F,,D,9,Intermediate,CHEMBL616651,,
1661,Cavia porcellus,1,,12409,BAO_0000218,,Compound at 45 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,F,,D,9,Intermediate,CHEMBL616652,,
1662,Cavia porcellus,1,,12409,BAO_0000218,,Compound at 50 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,F,,D,9,Intermediate,CHEMBL616653,,
1663,Cavia porcellus,1,,12409,BAO_0000218,,Compound at oral dose of 45 mg/kg was tested for percent inhibition against 5-hydroxytryptamine 1D receptor causes hypothermia in guinea pig,,F,,D,9,Intermediate,CHEMBL616654,,
1664,Cavia porcellus,1,,12253,BAO_0000019,,Binding affinity of 5-hydroxytryptamine 1D receptor using [3H]-8-HT in guinea pig cortex,,B,,D,9,Intermediate,CHEMBL616655,,
1665,Cavia porcellus,1,,12936,BAO_0000357,,Binding affinity against guinea pig 5-hydroxytryptamine 1D receptor,,B,,D,9,Intermediate,CHEMBL616656,,
1666,Cavia porcellus,1,,13181,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 4 receptor using [125I]SB 207710 as radioligand from piglet hippocampal membranes,,B,,H,8,Autocuration,CHEMBL616657,,
1667,Cavia porcellus,1,2435.0,12409,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor in guinea-pig striatum in presence of BMY-7378 and mesulergine,,B,,D,9,Intermediate,CHEMBL616658,,
1668,Cavia porcellus,1,,10639,BAO_0000357,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of guinea pig substantia nigra,,B,,D,9,Intermediate,CHEMBL616659,,
1669,,1,,5254,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616660,,
1670,,1,,13051,BAO_0000357,,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta,,B,,H,8,Autocuration,CHEMBL616661,,
1671,,1,,3463,BAO_0000019,,Maximum stimulation of [35S]GTP gamma-S binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor,,F,,H,8,Expert,CHEMBL616662,,
1672,,1,,15315,BAO_0000019,,Ability to inhibit forskolin-stimulated adenylate cyclase in a cell line expressing human 5-hydroxytryptamine 1D receptor,,F,,H,8,Autocuration,CHEMBL616663,,
1673,,1,,6011,BAO_0000019,,Ability to inhibit forskolin-stimulated adenylate cyclase activity in Chinese hamster ovary (CHO) stable cell lines expressing human 5-hydroxytryptamine 1D receptor,,F,,H,8,Autocuration,CHEMBL616664,,
1674,Homo sapiens,1,,14159,BAO_0000219,,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing 5-hydroxytryptamine 1D receptor",,F,,D,9,Expert,CHEMBL881820,449.0,
1675,,1,,14159,BAO_0000219,,"Compound was evaluated for the stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor.",,F,,H,8,Autocuration,CHEMBL616665,449.0,
1676,,1,,15250,BAO_0000219,,Agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,,B,,H,8,Expert,CHEMBL616666,449.0,
1677,,1,,15250,BAO_0000219,,Compound was tested for measuring agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616667,449.0,
1678,,1,,15331,BAO_0000219,,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",,F,,H,8,Expert,CHEMBL616668,449.0,
1679,Homo sapiens,1,,15332,BAO_0000219,,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",,F,,D,9,Expert,CHEMBL616669,449.0,
1680,,1,,15332,BAO_0000219,,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the human 5-hydroxytryptamine 1D receptor.",,F,,H,8,Expert,CHEMBL617040,449.0,
1681,,1,,3294,BAO_0000219,,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor",,F,,H,8,Autocuration,CHEMBL617041,449.0,
1682,,1,,14158,BAO_0000219,,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor.",,F,,H,8,Expert,CHEMBL617042,449.0,
1683,,1,,14956,BAO_0000219,,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor",,F,,H,8,Expert,CHEMBL617043,449.0,
1684,,1,,12469,BAO_0000019,,Compound was evaluated for its agonistic activity on 5-hydroxytryptamine 1D receptor,,F,,H,8,Autocuration,CHEMBL617044,,
1685,,1,,3463,BAO_0000219,,Measurement of agonist-induced [35S]-GTP gamma-S binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,,F,,H,8,Expert,CHEMBL617045,449.0,
1686,Homo sapiens,1,,15250,BAO_0000219,,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",,F,,D,9,Expert,CHEMBL617046,449.0,
1687,Homo sapiens,1,,15250,BAO_0000219,,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",,F,,D,9,Expert,CHEMBL617047,449.0,
1688,,1,,14956,BAO_0000019,,"Efficacy was evaluated relative to human 5-hydroxytryptamine 1D receptor using [35S]GTP-gamma-S, as radioligand",,F,,H,8,Expert,CHEMBL617048,,
1689,,1,,14159,BAO_0000019,,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor.",,F,,H,8,Autocuration,CHEMBL616897,,
1690,Homo sapiens,1,,14159,BAO_0000019,,"Maximum stimulation of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1D receptor relative to 5-HT",,F,,D,9,Expert,CHEMBL616898,,
1691,Homo sapiens,1,,14499,BAO_0000219,,Percent efficacy relative to 5-HT treatment of CHO cells expressing 5-HT 1d receptor,,F,,D,9,Expert,CHEMBL858201,449.0,
1692,,1,,15315,BAO_0000019,,Intrinsic activity for 5-hydroxytryptamine 1D receptor,,F,,H,8,Autocuration,CHEMBL616899,,
1693,,1,,3294,BAO_0000219,,Ability to displace [3H]- -5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in chinese hamster cells (CHO cells),,B,,H,8,Autocuration,CHEMBL616900,,
1694,,1,,3463,BAO_0000219,,Ability to displace [3H]-5-HT from recombinant human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells determined in vitro,,B,,H,8,Expert,CHEMBL616901,449.0,
1695,,1,,15331,BAO_0000357,,Affinity of compound towards 5-hydroxytryptamine 1D receptor was evaluated using radioligand binding technique,,B,,H,8,Autocuration,CHEMBL616902,,
1696,Homo sapiens,1,,14159,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,,B,,D,9,Expert,CHEMBL616903,449.0,
1697,,1,,14158,BAO_0000219,,Binding affinity by displacement to human cloned 5-hydroxytryptamine 1D receptor in CHO cells by [3H]5-HT displacement.,,B,,H,8,Expert,CHEMBL616904,449.0,
1698,,1,,14159,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616905,,
1699,,1,,15250,BAO_0000219,,Binding affinity at human cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells by [3H]5-HT displacement.,,B,,H,8,Expert,CHEMBL616906,449.0,
1700,,1,,15250,BAO_0000219,,Displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,,B,,H,8,Expert,CHEMBL616907,449.0,
1701,,1,,15331,BAO_0000219,,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,,B,,H,8,Expert,CHEMBL616908,449.0,
1702,Homo sapiens,1,,15332,BAO_0000219,,Displacement of [3H]5-HT binding from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,,B,,D,9,Expert,CHEMBL616909,449.0,
1703,Homo sapiens,1,,14499,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,,B,,D,9,Expert,CHEMBL616910,449.0,
1704,,1,,15332,BAO_0000219,,Displacement of [3H]5-HT binding to the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,,B,,H,8,Expert,CHEMBL616911,449.0,
1705,,1,,14956,BAO_0000219,,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor expressed in CHO cells,,B,,H,8,Expert,CHEMBL616912,449.0,
1706,,1,,3805,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 1D receptor at a concentration of 100 (nM),,B,,H,8,Autocuration,CHEMBL616913,,
1707,Homo sapiens,1,,6011,BAO_0000219,,Inhibition of [3H]5-HT binding to human 5-hydroxytryptamine 1D receptor expressed in CHO cells at 1 uM,,B,,D,9,Expert,CHEMBL616914,449.0,
1708,,1,,16190,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616915,449.0,
1709,,1,,14165,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1D receptor in Cos-7 transfected cell type using [3H]5-CT as radioligand,,B,,H,8,Autocuration,CHEMBL616916,,
1710,Homo sapiens,1,,4234,BAO_0000357,,Binding affinity to cloned human 5-hydroxytryptamine 1D receptor,,B,,D,9,Expert,CHEMBL616917,,
1711,,1,,15527,BAO_0000357,,"Binding affinity towards 5-HT1D receptor, using [3H]5-HT as radioligand.",,B,,H,8,Autocuration,CHEMBL616918,,
1712,,1,,6328,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 1D receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,,B,,H,8,Expert,CHEMBL616919,,
1713,,1,,16209,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1D receptor was determined using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616920,,
1714,,1,,14770,BAO_0000357,,Binding affinity for recombinant human 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL872914,,
1715,,1,,2598,BAO_0000357,,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1D receptor using [3H]-5-CT as radioligand,,B,,H,8,Autocuration,CHEMBL616921,,
1716,,1,,6897,BAO_0000357,,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1D receptor,,B,,H,8,Expert,CHEMBL616922,,
1717,,1,,6013,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616923,,
1718,,1,,5843,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,,B,,H,8,Expert,CHEMBL616924,,
1719,,1,,14454,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand,,B,,H,8,Expert,CHEMBL875909,,
1720,,1,,14454,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; Not determined,,B,,H,8,Autocuration,CHEMBL616925,,
1721,,1,,14454,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; not determined,,B,,H,8,Autocuration,CHEMBL616926,,
1722,,1,,15818,BAO_0000357,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616927,,
1723,,1,,13729,BAO_0000219,,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1D receptor in CHO-K1 cells,,F,,H,8,Expert,CHEMBL616928,485.0,
1724,Homo sapiens,1,,6011,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in Chinese hamster ovary cells (CHO cells),,B,,D,9,Expert,CHEMBL616929,,
1725,Homo sapiens,1,,4234,BAO_0000357,,In vitro binding affinity to human 5-hydroxytryptamine 1D receptor,,B,,D,9,Expert,CHEMBL616930,,
1726,,1,,17085,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,,B,,H,8,Expert,CHEMBL616931,,
1727,,1,,3025,BAO_0000357,,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,,B,,H,8,Autocuration,CHEMBL616932,,
1728,,1,,15315,BAO_0000357,,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor,,B,,H,8,Expert,CHEMBL616933,,
1729,Homo sapiens,1,,14214,BAO_0000219,,Receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor in Cos-7 cells,,B,,D,9,Expert,CHEMBL616934,,
1730,Homo sapiens,1,,3804,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 1D receptor,,B,,D,9,Expert,CHEMBL616935,,
1731,,1,,16700,BAO_0000357,,The binding affinity towards the 5-hydroxytryptamine 1D receptor; No affinity,,B,,H,8,Autocuration,CHEMBL616936,,
1732,Homo sapiens,1,,2391,BAO_0000357,,Affinity for 5-hydroxytryptamine 1D receptor subtype,,B,,D,9,Expert,CHEMBL616937,,
1733,Homo sapiens,1,,4175,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 1D receptor,,B,,D,9,Expert,CHEMBL616938,,
1734,,1,,17085,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616939,,
1735,,1,,17085,BAO_0000019,,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor; ND means not determined,,B,,H,8,Expert,CHEMBL616940,,
1736,Homo sapiens,1,,15926,BAO_0000357,,Binding activity against human 5-hydroxytryptamine 1D receptor; NT means not tested,,B,,D,9,Expert,CHEMBL616941,,
1737,,1,,16312,BAO_0000219,,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; Not tested,,B,,H,8,Autocuration,CHEMBL616942,485.0,
1738,,1,,16312,BAO_0000219,,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; not tested,,B,,H,8,Autocuration,CHEMBL616943,485.0,
1739,,1,,14956,BAO_0000219,,Selectivity towards 5-HT1D and to that of 5-HT1B in CHO cells,,B,,H,4,Autocuration,CHEMBL616944,449.0,
1740,,1,,3294,BAO_0000019,,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by the 5-HT",,F,,H,8,Autocuration,CHEMBL616945,,
1741,,1,,12861,BAO_0000357,,Binding activity radioligand.,,B,,H,8,Autocuration,CHEMBL616946,,
1742,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,B,,H,8,Autocuration,CHEMBL616947,,
1743,,1,,16312,BAO_0000219,,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor,,B,,H,8,Expert,CHEMBL616948,485.0,
1744,,1,,5104,BAO_0000357,,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616851,,
1745,,1,,5105,BAO_0000357,,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616852,,
1746,,1,,14499,BAO_0000357,,Measured as -log Ka on 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616853,,
1747,Homo sapiens,1,,15926,BAO_0000357,,Binding activity against human 5-hydroxytryptamine 1D receptor,,B,,D,9,Expert,CHEMBL616854,,
1748,Homo sapiens,1,,4540,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,,B,,D,9,Expert,CHEMBL616855,449.0,
1749,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]-5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL616856,449.0,
1750,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL616857,449.0,
1751,,1,,6166,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616858,,
1752,,1,,15779,BAO_0000219,,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL616859,449.0,
1753,,1,,15779,BAO_0000219,,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]-5-HT as radioligand.;ND means no data.,,B,,H,8,Autocuration,CHEMBL616860,449.0,
1754,,1,,17451,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,,B,,H,8,Autocuration,CHEMBL616861,722.0,
1755,,1,,17451,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,,B,,H,8,Autocuration,CHEMBL616541,722.0,
1756,,1,,17451,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand; Not determined,,B,,H,8,Autocuration,CHEMBL616542,722.0,
1757,,1,,4199,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as the radioligand,,B,,H,8,Autocuration,CHEMBL616543,449.0,
1758,Homo sapiens,1,,14875,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 1D receptor,,B,,D,9,Expert,CHEMBL616544,,
1759,,1,,15146,BAO_0000219,,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT,,B,,H,8,Autocuration,CHEMBL616545,449.0,
1760,,1,,5213,BAO_0000357,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1D receptor in CHO using [3H]5-HT as a radioligand,,B,,H,8,Autocuration,CHEMBL616546,,
1761,,1,,14818,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT.,,B,,H,8,Autocuration,CHEMBL616547,449.0,
1762,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells, using [3H]5-HT as radioligand",,B,,H,8,Autocuration,CHEMBL616548,449.0,
1763,,1,,14454,BAO_0000019,,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 1 uM,,F,,H,8,Expert,CHEMBL616549,,
1764,,1,,14454,BAO_0000019,,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 10 uM,,F,,H,8,Expert,CHEMBL616550,,
1765,,1,,5254,BAO_0000357,,Binding affinity against 5-HT2C receptor,,B,,H,8,Autocuration,CHEMBL857066,,
1766,,1,,5254,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616551,,
1767,,1,,10639,BAO_0000357,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,,B,,H,8,Autocuration,CHEMBL616552,,
1768,,1,,10639,BAO_0000019,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,,F,,H,8,Autocuration,CHEMBL832876,,
1769,,1,,12352,BAO_0000019,,"Binding affinity for 5-hydroxytryptamine 1B receptor in rat cortex, striatum and globus pallidus",,B,,H,8,Expert,CHEMBL616553,,
1770,,1,,9098,BAO_0000357,,Binding affinity towards 5-HT1B was determined,,B,,H,8,Autocuration,CHEMBL616554,,
1771,,1,,14430,BAO_0000019,,Affinity towards 5-hydroxytryptamine 1B receptor in membranes from rat frontal cortex using [3H]5-HT,,B,,H,8,Expert,CHEMBL616555,,
1772,,1,,13657,BAO_0000019,,"Binding affinity to 5-HT1B receptors using rat cortex+striatum + globus pallidus,[3H]-5-OH-tryptamine, and serotonin for NSB",,B,,H,8,Expert,CHEMBL616556,,
1773,,1,,13657,BAO_0000019,,"Compound was evaluated for binding affinity on 5-HT1B receptors using rat cortex+striatum+ globus pallidus,[ 3H]-5-OH-tryptamine, and serotonin for NSB.",,B,,H,8,Autocuration,CHEMBL616557,,
1774,,1,,15854,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,B,,H,8,Expert,CHEMBL616558,,
1775,Rattus norvegicus,1,,10639,BAO_0000019,,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT,,B,,D,9,Expert,CHEMBL616749,,
1776,,1,,10025,BAO_0000357,,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,,B,,H,8,Autocuration,CHEMBL616750,,
1777,,1,,10025,BAO_0000357,,"Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol, binds to 5-hydroxytryptamine 1B receptor at 1 uM",,B,,H,8,Autocuration,CHEMBL616751,,
1778,,1,,14286,BAO_0000249,,In vitro inhibitory concentration against radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,,B,,H,8,Autocuration,CHEMBL616752,,
1779,,1,2435.0,3651,BAO_0000019,,Inhibition of [3H]-5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Residual radioligand binding higher than 50%,,B,,H,8,Autocuration,CHEMBL616753,,
1780,Rattus norvegicus,1,,14178,BAO_0000357,,Inhibition of radiolabeled [3H]-5-HT ligand binding to 5-hydroxytryptamine 1B receptor,,B,,D,9,Expert,CHEMBL616754,,
1781,,1,,10639,BAO_0000019,,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT as the radioligand.,,B,,H,8,Autocuration,CHEMBL616755,,
1782,,1,2435.0,13605,BAO_0000019,,Inhibitory activity against [3H]5-HT binding to 5-HT1B receptor in rat striatum,,B,,H,8,Autocuration,CHEMBL616756,,
1783,,1,2435.0,5834,BAO_0000019,,Inhibitory concentration required against 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT,,B,,H,8,Autocuration,CHEMBL616757,,
1784,,1,2435.0,10922,BAO_0000357,,compound was measured for affinity against 5-hydroxytryptamine 1B receptor labelled with [3H]5-HT radioligand in striatum tissue,,B,,H,8,Autocuration,CHEMBL616758,,
1785,,1,,14286,BAO_0000249,,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,,B,,H,8,Autocuration,CHEMBL616759,,
1786,,1,,11825,BAO_0000357,,In vitro binding affinity towards the 5-hydroxytryptamine 1B receptor at 10 e-6 M,,B,,H,8,Autocuration,CHEMBL616760,,
1787,,1,2435.0,14826,BAO_0000019,,Ability to displace [3H]5-HT bound to 5-hydroxytryptamine 1B receptor in rat striatum,,B,,H,8,Autocuration,CHEMBL616761,,
1788,,1,2435.0,9699,BAO_0000019,,Binding affinity against 5-HT1B serotonin receptor in rat striatum,,B,,H,8,Autocuration,CHEMBL616762,,
1789,,1,,14423,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1B receptor in membranes of Rat cerebral cortex,,B,,H,8,Autocuration,CHEMBL616763,,
1790,,1,,10062,BAO_0000357,,Binding affinity at rat 5-hydroxytryptamine 1B receptor by [3H]5-HT displacement.,,B,,H,8,Expert,CHEMBL872909,,
1791,,1,,10062,BAO_0000357,,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL616764,,
1792,Rattus norvegicus,1,,12280,BAO_0000357,,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor,,B,,D,9,Expert,CHEMBL616765,,
1793,,1,2435.0,15412,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum,,B,,H,8,Autocuration,CHEMBL616766,,
1794,,1,2435.0,15412,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum.,,B,,H,8,Autocuration,CHEMBL616767,,
1795,,1,,10062,BAO_0000357,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL616768,,
1796,,1,,11147,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616769,,
1797,,1,,9547,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat was determined using 50 uL of [125I]ICYP in binding assay,,B,,H,8,Autocuration,CHEMBL616770,,
1798,,1,,10444,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 1B receptor was determined in male Sprague-Dawley rat brain.,,B,,H,8,Autocuration,CHEMBL616771,,
1799,,1,2435.0,12469,BAO_0000019,,Binding affinity was measured on 5-hydroxytryptamine 1B receptor in rat striatum labeled with [3H]5-HT,,B,,H,8,Autocuration,CHEMBL616772,,
1800,,1,,9098,BAO_0000019,,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,,B,,H,8,Expert,CHEMBL616773,,
1801,,1,,9098,BAO_0000019,,Compound was evaluated for the binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand; ND is no data.,,B,,H,8,Autocuration,CHEMBL616774,,
1802,,1,,9699,BAO_0000357,,Evaluated for binding affinity towards 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL616775,,
1803,,1,,10394,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 1B receptor in rat cortical membranes using [3H]5-HT as a radioligand,,B,,H,8,Autocuration,CHEMBL616776,,
1804,,1,,12092,BAO_0000357,,The binding affinity was measured on 5-hydroxytryptamine 1B receptor using [3H]- serotonin as radioligand.,,B,,H,8,Autocuration,CHEMBL616777,,
1805,,1,,16700,BAO_0000357,,The binding affinity towards the receptor rat 5-hydroxytryptamine 1B receptor; No affinity,,B,,H,8,Autocuration,CHEMBL616778,,
1806,Rattus norvegicus,1,,403,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 1B receptor in rat striatal membranes using [3H]5-HT as radioligand,,B,,D,9,Expert,CHEMBL616779,,
1807,Rattus norvegicus,1,,12771,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1B receptor,,B,,D,9,Expert,CHEMBL616780,,
1808,,1,,11642,BAO_0000019,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1B receptor by displacing [3H]serotonin radioligand in rat cerebral cortex,,B,,H,8,Autocuration,CHEMBL616781,,
1809,,1,,12953,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616782,,
1810,,1,,12953,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL616783,,
1811,,1,2435.0,12953,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT as radioligand,,B,,H,8,Expert,CHEMBL616784,,
1812,,1,,12953,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand; Nonactive at 10 uM,,B,,H,8,Autocuration,CHEMBL616785,,
1813,,1,955.0,9737,BAO_0000249,,Binding affinity against 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,B,,H,8,Autocuration,CHEMBL857067,,
1814,,1,,9737,BAO_0000019,,Binding affinity against 5-HT1B receptor in rat frontal cortex using [3H]-5-HT in presence of 0.1 uM [3H]-8-OH-DPAT as a radioligand,,B,,H,8,Autocuration,CHEMBL616786,,
1815,,1,955.0,9737,BAO_0000249,,Binding affinity towards 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,B,,H,8,Autocuration,CHEMBL616787,,
1816,,1,,12827,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor of porcine choroid plexus using [3H]mesulergine,,B,,H,8,Autocuration,CHEMBL616788,,
1817,,1,,5033,BAO_0000357,,Ability to displace the radioligand [125I](-)-iodocyanopindolol from rat striatal 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL616789,,
1818,Rattus norvegicus,1,,9786,BAO_0000019,,Displacement of [3H]5-HT from 5-HT1B receptor of rat frontal cortex homogenate,,B,,D,9,Expert,CHEMBL616790,,
1819,,1,,13116,BAO_0000357,,Binding affinity at 5-hydroxytryptamine 1B receptor,,B,,H,8,Expert,CHEMBL616791,,
1820,,1,,16429,BAO_0000019,,In vitro binding affinity at 5-hydroxytryptamine 1B receptor in rat striatal muscles using [125I](-)-iodocyanopindolol as the radioligand,,B,,H,8,Autocuration,CHEMBL616792,,
1821,Rattus norvegicus,1,,12409,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine 1B receptor in rat striatal membrane with [125I]- iodocyanopindolol,,B,,D,9,Expert,CHEMBL616793,,
1822,,1,,15194,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616794,,
1823,,1,,15194,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL616795,,
1824,,1,,5486,BAO_0000019,,Binding affinity towards 5-HT2 receptor by the displacement of [3H]-ketanserin] in rat cerebral cortex,,B,,H,4,Autocuration,CHEMBL616796,,
1825,,1,,4639,BAO_0000357,,Compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL616797,,
1826,,1,,386,BAO_0000249,,The compound was evaluated for its ability to displace [3H]5-HT from 5-hydroxytryptamine 1B receptor in cellular brain membranes,Brain membranes,B,,H,8,Autocuration,CHEMBL616798,,
1827,,1,,2474,BAO_0000357,,Compound was measured for its binding affinity at 5-hydroxytryptamine 1B receptor at a concentration of 100 nM using [125I]CYP as radioligand,,B,,H,8,Autocuration,CHEMBL616799,,
1828,,1,,6011,BAO_0000357,,Inhibition of binding towards 5-hydroxytryptamine 1B receptor at 100 nM concentration,,B,,H,8,Autocuration,CHEMBL616800,,
1829,,1,,5014,BAO_0000357,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL616801,,
1830,,1,,17515,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1B receptor; inactive at 10 uM,,B,,H,8,Autocuration,CHEMBL616802,,
1831,,1,,4373,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1B receptor was determined,,B,,H,8,Autocuration,CHEMBL616803,,
1832,,1,,1633,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]5-HT.,,B,,H,8,Expert,CHEMBL857068,,
1833,,1,,1633,BAO_0000357,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]ketanserin.,,B,,H,8,Autocuration,CHEMBL616804,,
1834,,1,,4373,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1B receptor was determined,,B,,H,8,Autocuration,CHEMBL616805,,
1835,,1,,4687,BAO_0000357,,Evaluated for the binding affinity to 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL616806,,
1836,,1,,11574,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1B receptor,,B,,H,8,Autocuration,CHEMBL616807,,
1837,,1,,10321,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1B receptor was determined by using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616808,,
1838,,1,,15527,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL616809,,
1839,,1,,17200,BAO_0000357,,Inhibitory constant against 5-hydroxytryptamine 1B receptor using with [125I]- cyanopindolol radioligand,,B,,H,8,Autocuration,CHEMBL616810,,
1840,,1,,14423,BAO_0000224,,Binding affinity against 5-hydroxytryptamine 1B receptor - 5-hydroxytryptamine 1D receptor using [3H]5-HT as the radioligand.,,B,,H,4,Autocuration,CHEMBL616811,,
1841,Bos taurus,1,,5834,BAO_0000357,,Inhibitory concentration required against 5-hydroxytryptamine 1C receptor in bovine choroid plexus using [3H]mesulergine,,B,,H,8,Autocuration,CHEMBL616812,,
1842,Sus scrofa,1,,11473,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL616813,,
1843,Sus scrofa,1,,11473,BAO_0000357,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1C receptor in pig choroid plexus using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL616814,,
1844,Sus scrofa,1,,10639,BAO_0000357,,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,,B,,H,8,Autocuration,CHEMBL616815,,
1845,Sus scrofa,1,,10639,BAO_0000357,,inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,,B,,H,8,Autocuration,CHEMBL616816,,
1846,Sus scrofa,1,,14331,BAO_0000357,,Binding affinity of compound towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine (1.2 nM) ligand in choroid Plexus pig was determined,,B,,H,8,Autocuration,CHEMBL616817,,
1847,Sus scrofa,1,,10796,BAO_0000357,,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1C receptor,,B,,H,8,Autocuration,CHEMBL616818,,
1848,Sus scrofa,1,,9098,BAO_0000357,,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand.,,B,,H,8,Expert,CHEMBL616819,,
1849,Sus scrofa,1,,14331,BAO_0000357,,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 1C receptor of pig choroid Plexus,,B,,H,8,Expert,CHEMBL616820,,
1850,Sus scrofa,1,,11828,BAO_0000019,,Displacement of [3H]mesulergine from pig cortex 5-hydroxytryptamine 1C receptor,,B,,H,8,Expert,CHEMBL616821,,
1851,Sus scrofa,1,,11866,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1C receptor in piglet choroid plexus using [3H]5-HT,,B,,H,8,Autocuration,CHEMBL616822,,
1852,Oryctolagus cuniculus,1,,13047,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,,B,,H,8,Autocuration,CHEMBL616823,,
1853,Rattus norvegicus,1,,188,BAO_0000357,,Tested for the effect on binding at 5-hydroxytryptamine 1C receptor; No activity,,B,,D,9,Autocuration,CHEMBL616824,,
1854,Rattus norvegicus,1,,11825,BAO_0000357,,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,,B,,D,9,Autocuration,CHEMBL616825,,
1855,Rattus norvegicus,1,,11825,BAO_0000357,,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,,B,,D,9,Autocuration,CHEMBL616826,,
1856,Rattus norvegicus,1,,11624,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1C receptor in rat using [3H]mesulergine as radioligand,,B,,D,9,Expert,CHEMBL616827,,
1857,Rattus norvegicus,1,,11139,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1C receptor using [125 I]-SCH23982 as radioligand in competitive binding assay,,B,,D,9,Autocuration,CHEMBL616828,,
1858,Rattus norvegicus,1,,11147,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,,B,,D,9,Autocuration,CHEMBL616829,,
1859,Rattus norvegicus,1,,10444,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 1C receptor was determined in male Sprague-Dawley rat brain.,,B,,D,9,Autocuration,CHEMBL616830,,
1860,Rattus norvegicus,1,,11624,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1C receptor,,B,,D,9,Expert,CHEMBL616831,,
1861,Rattus norvegicus,1,,11662,BAO_0000019,,"Compound was tested for binding affinity towards 5-HT1C (5-HT1C) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,B,,D,9,Autocuration,CHEMBL616832,,
1862,Rattus norvegicus,1,,11662,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,B,,D,9,Autocuration,CHEMBL616833,,
1863,Rattus norvegicus,1,,11662,BAO_0000019,,"Binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,B,,D,9,Expert,CHEMBL616834,,
1864,Rattus norvegicus,1,,11662,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,B,,D,9,Autocuration,CHEMBL829595,,
1865,Rattus norvegicus,1,,9098,BAO_0000357,,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 1C receptor binding site by using [3H]- MES as a radioligand.,,B,,D,9,Autocuration,CHEMBL616835,,
1866,Rattus norvegicus,1,,10394,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 1C receptor in rat cortical membranes using [3H]mesulergine as a radioligand,,B,,D,9,Autocuration,CHEMBL872910,,
1867,,1,,11933,BAO_0000357,,Tested for binding affinity against 5-hydroxytryptamine 1C receptor from rat frontal cortical regions using [3H]mesulergine as radioligand,,B,,H,8,Expert,CHEMBL616836,,
1868,Rattus norvegicus,1,,12092,BAO_0000357,,The binding affinity was measured on 5-hydroxytryptamine 1C receptor using [3H]- serotonin as radioligand.,,B,,D,9,Autocuration,CHEMBL616837,,
1869,Rattus norvegicus,1,,12253,BAO_0000019,,Binding affinity of 5-hydroxytryptamine 1C receptor using [3H]- ketanserin in rat frontal cortex,,B,,D,9,Autocuration,CHEMBL616466,,
1870,Rattus norvegicus,1,,12253,BAO_0000219,,Binding affinity towards rat 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand expressed in 293 cells,,B,,D,9,Autocuration,CHEMBL616467,722.0,
1871,,1,,1558,BAO_0000357,,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,,B,,H,8,Autocuration,CHEMBL616468,,
1872,,1,,2474,BAO_0000357,,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL616469,,
1873,,1,,2474,BAO_0000357,,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL616470,,
1874,,1,,11574,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1C receptor,,B,,H,8,Autocuration,CHEMBL616471,,
1875,,1,,1558,BAO_0000357,,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,,B,,H,8,Autocuration,CHEMBL616472,,
1876,,1,,13944,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1C receptor,,B,,H,8,Autocuration,CHEMBL616473,,
1877,,1,,13033,BAO_0000357,,Binding affinity against serotonergic 5-HT1c receptor,,B,,H,8,Autocuration,CHEMBL616474,,
1878,,1,,10321,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1C receptor was determined by using [3H]- mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL616475,,
1879,,1,,11866,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1C receptor was determined,,B,,H,8,Autocuration,CHEMBL616476,,
1880,Oryctolagus cuniculus,1,,14454,BAO_0000019,,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),,B,,H,8,Autocuration,CHEMBL616477,,
1881,,1,,11574,BAO_0000224,,Binding affinity against 5-hydroxytryptamine 2 receptor using [125I]DOI as radioligand.,,B,,H,4,Autocuration,CHEMBL616478,,
1882,,1,,11574,BAO_0000224,,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ket as radioligand.,,B,,H,4,Autocuration,CHEMBL616479,,
1883,,1,,13631,BAO_0000019,,Binding affinity towards serotonin 5-HT2 receptor was determined in rat cortex using [3H]spiperone as ligand,,B,,H,4,Autocuration,CHEMBL616480,,
1884,Rattus norvegicus,1,,9630,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor as antagonism of serotonin-induced contractions in rat jugular vein,,B,,D,5,Autocuration,CHEMBL616481,,
1885,Rattus norvegicus,1,,8822,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain cortical membranes,,B,,D,5,Autocuration,CHEMBL616482,,
1886,Rattus norvegicus,1,955.0,9064,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain using [3H]spiroperidol,,B,,D,5,Autocuration,CHEMBL884713,,
1887,,1,,8868,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor measured using radioligand ([3H]spiperone) binding assay,,B,,H,4,Autocuration,CHEMBL616483,,
1888,,1,,9064,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- spiroperidol,,B,,H,4,Autocuration,CHEMBL616484,,
1889,,1,,9806,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenates by [3H]-spiperone displacement.,,B,,H,4,Autocuration,CHEMBL616485,,
1890,,1,,9098,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,B,,H,4,Autocuration,CHEMBL616486,,
1891,,1,,8868,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor was measured using radioligand ([3H]spiperone) binding assay,,B,,H,4,Autocuration,CHEMBL616487,,
1892,,1,,12765,BAO_0000224,,Binding affinity at serotonin 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,,B,,H,4,Autocuration,CHEMBL616488,,
1893,,1,,11049,BAO_0000019,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,B,,H,4,Autocuration,CHEMBL616489,,
1894,,1,,11049,BAO_0000019,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,B,,H,4,Autocuration,CHEMBL616490,,
1895,,1,,11049,BAO_0000019,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]-Ketanserin as radioligand; not determined,,B,,H,4,Autocuration,CHEMBL616491,,
1896,,1,,11049,BAO_0000019,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand; ND-Not determined,,B,,H,4,Autocuration,CHEMBL616492,,
1897,,1,,11049,BAO_0000019,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,B,,H,4,Autocuration,CHEMBL616493,,
1898,,1,,11473,BAO_0000019,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [125I]DOI as radioligand,,B,,H,4,Autocuration,CHEMBL616494,,
1899,,1,,11473,BAO_0000019,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [3H]ketanserin as radioligand,,B,,H,4,Autocuration,CHEMBL616495,,
1900,,1,,3086,BAO_0000019,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat pre frontal cortex,,B,,H,4,Autocuration,CHEMBL616496,,
1901,,1,,11049,BAO_0000019,,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,B,,H,4,Autocuration,CHEMBL616497,,
1902,,1,,11049,BAO_0000019,,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,B,,H,4,Autocuration,CHEMBL616498,,
1903,,1,,10639,BAO_0000019,,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 2 receptor of rat anterior cortex using [3H]ketanserin as the radioligand,,B,,H,4,Autocuration,CHEMBL616499,,
1904,,1,,10922,BAO_0000019,,Compound was measured for affinity at 5-hydroxytryptamine 2 receptor in rat cortical by [3H]spiroperidol displacement.,,B,,H,4,Autocuration,CHEMBL616500,,
1905,Rattus norvegicus,1,955.0,9064,BAO_0000221,,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,,B,,D,5,Autocuration,CHEMBL616501,,
1906,,1,955.0,10748,BAO_0000221,,Compound was tested for its inhibitory effect on the binding profile in 5-hydroxytryptamine 2 receptor using [3H]spiroperidol in rat brain.,,B,,H,4,Autocuration,CHEMBL616502,,
1907,,1,,11614,BAO_0000249,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor from rat cortical membranes.,Membranes,B,,H,4,Autocuration,CHEMBL884529,,
1908,,1,,11615,BAO_0000249,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,Membranes,B,,H,4,Autocuration,CHEMBL616503,,
1909,,1,,11615,BAO_0000224,,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL616964,,
1910,,1,,11614,BAO_0000249,,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor from rat cortical membranes.,Membranes,B,,H,4,Autocuration,CHEMBL616965,,
1911,,1,,11702,BAO_0000224,,Inhibition of [3H]ketanserin binding to rat 5-hydroxytryptamine 2 receptors.,,B,,H,4,Autocuration,CHEMBL616966,,
1912,,1,,11702,BAO_0000224,,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor; NT=Not tested,,B,,H,4,Autocuration,CHEMBL616967,,
1913,Rattus norvegicus,1,,11702,BAO_0000224,,Inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor,,B,,D,5,Autocuration,CHEMBL616968,,
1914,,1,,11702,BAO_0000224,,Compound was tested for the inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor; NT=Not tested,,B,,H,4,Autocuration,CHEMBL616969,,
1915,,1,,13346,BAO_0000019,,Inhibition of [3H]ketanserin binding at 5-hydroxytryptamine 2 receptor from rat frontal cortex.,,B,,H,4,Autocuration,CHEMBL884530,,
1916,,1,,10025,BAO_0000224,,Concentration necessary to achieve half maximal inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL616970,,
1917,,1,,10025,BAO_0000224,,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,,B,,H,4,Autocuration,CHEMBL616971,,
1918,,1,,10025,BAO_0000224,,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",,B,,H,4,Autocuration,CHEMBL616972,,
1919,,1,,9036,BAO_0000224,,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]-spiperone,,B,,H,4,Autocuration,CHEMBL616973,,
1920,,1,,9036,BAO_0000224,,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]spiperone; IA=Inactive,,B,,H,4,Autocuration,CHEMBL616974,,
1921,,1,,9161,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.,,B,,H,4,Autocuration,CHEMBL616975,,
1922,,1,,12304,BAO_0000019,,Inhibition of binding of radioligand [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cerebral cortex,,B,,H,4,Autocuration,CHEMBL616976,,
1923,,1,,13276,BAO_0000224,,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand.,,B,,H,4,Autocuration,CHEMBL616977,,
1924,,1,,11825,BAO_0000224,,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,,B,,H,4,Autocuration,CHEMBL616978,,
1925,,1,,12443,BAO_0000224,,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 2 receptor by displacement of [3H]- ketanserin,,B,,H,4,Autocuration,CHEMBL616979,,
1926,,1,,13830,BAO_0000224,,In vitro inhibitory activity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL616980,,
1927,,1,,9592,BAO_0000249,,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes,Membranes,B,,H,4,Autocuration,CHEMBL616981,,
1928,,1,,9592,BAO_0000249,,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes; Not tested,Membranes,B,,H,4,Autocuration,CHEMBL616982,,
1929,,1,,10881,BAO_0000224,,Inhibitory activity against 5-hydroxytryptamine 2 receptor by 3H ligand binding experiments.,,B,,H,4,Autocuration,CHEMBL616983,,
1930,,1,,13605,BAO_0000019,,Inhibitory activity against [3H]spiroperidol binding to 5-HT2 receptor in rat cortex,,B,,H,4,Autocuration,CHEMBL616984,,
1931,Rattus norvegicus,1,,11624,BAO_0000224,,Inhibitory activity against 5-hydroxytryptamine 2 receptor,,B,,D,5,Autocuration,CHEMBL616985,,
1932,,1,,4101,BAO_0000224,,Inhibitory concentration against 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,,B,,H,4,Autocuration,CHEMBL616986,,
1933,,1,,4101,BAO_0000224,,Inhibitory concentration against binding of 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,,B,,H,4,Autocuration,CHEMBL616987,,
1934,,1,,15360,BAO_0000019,,Inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat,,B,,H,4,Autocuration,CHEMBL616988,,
1935,,1,,11576,BAO_0000019,,Inhibitory concentration against radioligand [3H]spiperone binding to 5-hydroxytryptamine 2 receptor in rat cortex,,B,,H,4,Autocuration,CHEMBL617243,,
1936,,1,,5834,BAO_0000019,,Inhibitory concentration required against 5-hydroxytryptamine 2 receptor in rat cortex using [3H]spiperone,,B,,H,4,Autocuration,CHEMBL617244,,
1937,Rattus norvegicus,1,,2395,BAO_0000219,,Inhibitory concentration against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,,B,,D,5,Autocuration,CHEMBL617245,485.0,
1938,,1,,11965,BAO_0000249,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,Membranes,B,,H,4,Autocuration,CHEMBL617246,,
1939,,1,,3967,BAO_0000224,,The compound was evaluated for the ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor ( striata of male wistar rats),,B,,H,4,Autocuration,CHEMBL617546,,
1940,,1,,11130,BAO_0000249,,The concentration required to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat brain membranes (in vitro),Brain membranes,B,,H,4,Autocuration,CHEMBL617547,,
1941,,1,,13427,BAO_0000219,,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,B,,H,4,Autocuration,CHEMBL617548,,
1942,,1,,9443,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617549,,
1943,,1,,9443,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,,B,,H,4,Autocuration,CHEMBL617550,,
1944,,1,,11825,BAO_0000224,,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,,B,,H,4,Autocuration,CHEMBL617551,,
1945,,1,,12120,BAO_0000249,,Percent inhibition of binding of 1.0 nM [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e -5 M,Membranes,B,,H,4,Autocuration,CHEMBL617552,,
1946,,1,,12120,BAO_0000249,,Percent inhibition of binding of 1.0 nM [3H]-ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e-5 M.,Membranes,B,,H,4,Autocuration,CHEMBL617553,,
1947,,1,1515.0,11963,BAO_0000019,,Tested for antagonistic activity against 5-hydroxytryptamine 2 receptor from rat thoracic aorta,,F,,H,4,Autocuration,CHEMBL617554,,
1948,,1,,9069,BAO_0000019,,Binding affinity for membrane-bound 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617555,,
1949,,1,,8868,BAO_0000224,,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,,B,,H,4,Autocuration,CHEMBL617556,,
1950,,1,,17200,BAO_0000357,,Inhibitory constant against human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,,B,,H,8,Autocuration,CHEMBL617557,,
1951,,1,,17200,BAO_0000357,,Inhibitory constant against human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,,B,,H,8,Autocuration,CHEMBL617558,,
1952,,1,,13969,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor was measured using [3H]5-HT as radioligand,,B,,H,8,Expert,CHEMBL617559,,
1953,,1,,13392,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1D receptor,,B,,D,9,Expert,CHEMBL617560,,
1954,,1,,1742,BAO_0000249,,Compound was tested for its ability to displace [125I]GTI binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,B,,H,8,Autocuration,CHEMBL617561,,
1955,,1,,1742,BAO_0000249,,Compound was tested for its ability to displace [3H]-5-HT binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,B,,H,8,Autocuration,CHEMBL617562,,
1956,,1,2435.0,14331,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor using [3H]5-HT in pig striatum + frontalCortex,,B,,H,8,Autocuration,CHEMBL617563,,
1957,,1,,12861,BAO_0000019,,Relative agonist efficacy against 1 uM 5-hydroxytryptamine 1D receptor,,F,,H,8,Autocuration,CHEMBL617564,,
1958,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 1D receptor from pig caudate membrane using [3H]5-HT as radioligand,,B,,H,8,Expert,CHEMBL617565,,
1959,,1,,12861,BAO_0000357,,Binding activity radioligand.,,B,,H,8,Autocuration,CHEMBL856076,,
1960,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,B,,H,8,Autocuration,CHEMBL617566,,
1961,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,B,,H,8,Expert,CHEMBL875911,,
1962,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,,B,,H,8,Autocuration,CHEMBL617567,,
1963,,1,,675,BAO_0000249,,Compound was tested for the displacement of [3H]-5-HT to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,B,,H,8,Autocuration,CHEMBL617568,,
1964,,1,,12490,BAO_0000019,,Displacement of [3H]5-HT binding to 5-hydroxytryptamine 1D receptor from pig caudate membrane,,B,,H,8,Expert,CHEMBL617569,,
1965,,1,,11828,BAO_0000249,,Displacement of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1D receptor in pig caudate membrane,,B,,H,8,Expert,CHEMBL617570,,
1966,,1,,11866,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1D receptor in piglet caudate using [3H]5-HT,,B,,H,8,Autocuration,CHEMBL617571,,
1967,Sus scrofa,1,,773,BAO_0000357,,In Vitro Binding affinity againist 5-hydroxytryptamine 1D receptor by displacing [125I]GTI from pig caudate,,B,,H,8,Autocuration,CHEMBL617572,,
1968,Oryctolagus cuniculus,1,,13047,BAO_0000357,,The compound was tested for intrinsic activity against 5-HT1D receptor,,B,,H,8,Expert,CHEMBL617573,,
1969,Oryctolagus cuniculus,1,,13047,BAO_0000019,,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,B,,H,8,Autocuration,CHEMBL617574,,
1970,Oryctolagus cuniculus,1,,13047,BAO_0000357,,The compound was tested for binding affinity against 5-HT1D receptor,,B,,H,8,Expert,CHEMBL617575,,
1971,,1,,188,BAO_0000357,,Tested for the effect on binding at 5-hydroxytryptamine 1D receptor; No activity,,B,,H,8,Autocuration,CHEMBL617576,,
1972,,1,,10639,BAO_0000019,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of rat substantia nigra,,F,,H,8,Autocuration,CHEMBL617577,,
1973,,1,,12438,BAO_0000019,,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor,,F,,H,8,Autocuration,CHEMBL617578,,
1974,,1,,12438,BAO_0000357,,Binding affinity was measured against serotonin 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL617579,,
1975,,1,,15854,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1D receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,B,,H,8,Expert,CHEMBL617580,,
1976,,1,,10394,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 1D receptor in rat cortical membranes using [3H]5-HT as a radioligand,,B,,H,8,Autocuration,CHEMBL617581,,
1977,,1,,12092,BAO_0000357,,The binding affinity was measured on 5-hydroxytryptamine 1D receptor using [3H]- serotonin as radioligand.,,B,,H,8,Autocuration,CHEMBL617582,,
1978,,1,,3389,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 1D receptor in the rat forebrain by [3H]- SB-204269 displacement.,,B,,H,8,Expert,CHEMBL617583,,
1979,,1,,6011,BAO_0000357,,Inhibition of binding towards 5-hydroxytryptamine 1D receptor at 100 nM concentration,,B,,H,8,Autocuration,CHEMBL617584,,
1980,,1,,4639,BAO_0000357,,Compound was tested for binding affinity against 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL617585,,
1981,,1,,2474,BAO_0000357,,Compound was measured for its binding affinity at 5-hydroxytryptamine 1D receptor at a concentration of 10 uM using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL875912,,
1982,,1,,5014,BAO_0000357,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL617586,,
1983,,1,,17515,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1D receptor; inactive at 10 uM,,B,,H,8,Autocuration,CHEMBL617587,,
1984,,1,,11866,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1D receptor was determined,,B,,H,8,Autocuration,CHEMBL617588,,
1985,,1,,4687,BAO_0000357,,Evaluated for the binding affinity against 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL857980,,
1986,,1,,12146,BAO_0000357,,Tested against 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL617589,,
1987,,1,,10321,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1D receptor was determined by using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL617590,,
1988,,1,,13267,BAO_0000219,,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL617591,722.0,
1989,Homo sapiens,1,,1274,BAO_0000357,,Binding affinity against 5-Hydroxytryptamine 1D receptor,,B,,D,9,Expert,CHEMBL617592,,
1990,,1,,15250,BAO_0000357,,,,B,,H,8,Autocuration,CHEMBL617593,,
1991,,1,,13706,BAO_0000219,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,,B,,H,8,Autocuration,CHEMBL617594,485.0,
1992,,1,,13706,BAO_0000219,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,,B,,H,8,Autocuration,CHEMBL617595,485.0,
1993,,1,,13706,BAO_0000219,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line.,,B,,H,8,Autocuration,CHEMBL617596,722.0,
1994,,1,,13706,BAO_0000219,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,,B,,H,8,Autocuration,CHEMBL617597,722.0,
1995,,1,,13047,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,,B,,H,8,Autocuration,CHEMBL617598,,
1996,,1,,13366,BAO_0000357,,Binding affinity of compound against 5-HT1Dalpha Binding affinity of compound against 5-HT1D alpha receptors in human,,B,,H,8,Autocuration,CHEMBL872916,,
1997,,1,,13366,BAO_0000357,,In vitro affinity human cloned 5-hydroxytryptamine 1D receptor alpha by [3H]5-HT displacement.,,B,,H,8,Expert,CHEMBL617599,,
1998,,1,,1558,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor alpha was determined,,B,,H,8,Autocuration,CHEMBL617091,,
1999,,1,,12902,BAO_0000219,,"Binding affinity against 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells, using [3H]-5-HT as the radioligand.",,B,,H,8,Expert,CHEMBL617092,485.0,
2000,,1,,13706,BAO_0000219,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,,B,,H,8,Autocuration,CHEMBL617093,485.0,
2001,,1,,13706,BAO_0000019,,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor alpha measured as the reduction of forskolin-stimulated cAMP.,,F,,H,8,Autocuration,CHEMBL617094,,
2002,,1,,13706,BAO_0000019,,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,F,,H,8,Autocuration,CHEMBL617095,,
2003,,1,,14251,BAO_0000019,,Compound was tested for its agonist activity against human 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,F,,H,8,Autocuration,CHEMBL617096,,
2004,,1,,14251,BAO_0000019,,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,F,,H,8,Autocuration,CHEMBL617097,,
2005,,1,,14251,BAO_0000019,,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,F,,H,8,Autocuration,CHEMBL617098,,
2006,,1,,13313,BAO_0000357,,In vitro binding affinity towards 5-HT1D alpha receptor by using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL617301,,
2007,,1,,13313,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL617302,,
2008,,1,,13366,BAO_0000357,,Selectivity towards 5-hydroxytryptamine 1D receptor beta to that of 5-hydroxytryptamine 1D receptor alpha,,B,,H,8,Autocuration,CHEMBL617303,,
2009,,1,,13051,BAO_0000357,,Binding affinity to recombinant human 5-hydroxytryptamine 1D receptor alpha,,B,,H,8,Expert,CHEMBL617304,,
2010,,1,,12903,BAO_0000219,,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor alpha expressed in CHO cells, by using [3H]5-HT as radioligand",,B,,H,8,Expert,CHEMBL617305,449.0,
2011,Homo sapiens,1,,12469,BAO_0000219,,Binding affinity was measured on 5-hydroxytryptamine 1D receptor alpha in COS cells transfected with human 5-HT1D alpha gene labeled with [3H]5-HT,,B,,D,9,Autocuration,CHEMBL617306,,
2012,,1,,5619,BAO_0000357,,Binding affinity (in vitro) against 5-hydroxytryptamine 1D receptor alpha using radio-ligand binding assay,,B,,H,8,Autocuration,CHEMBL617307,,
2013,Oryctolagus cuniculus,1,,13047,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,,B,,H,8,Autocuration,CHEMBL617308,,
2014,,1,,16633,BAO_0000357,,Binding affinities against 5-hydroxytryptamine 1D receptor alpha,,B,,H,8,Autocuration,CHEMBL617309,,
2015,,1,,16633,BAO_0000357,,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,,B,,H,8,Autocuration,CHEMBL617310,,
2016,,1,,16633,BAO_0000357,,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,,B,,H,8,Autocuration,CHEMBL617311,,
2017,,1,,16633,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1D receptor alpha using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL617312,,
2018,,1,,3269,BAO_0000357,,Affinity against 5-hydroxytryptamine 1D receptor alpha,,B,,H,8,Autocuration,CHEMBL617313,,
2019,,1,,12409,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor alpha,,B,,H,8,Expert,CHEMBL617314,,
2020,,1,,13706,BAO_0000019,,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,F,,H,8,Autocuration,CHEMBL617315,,
2021,,1,,13706,BAO_0000219,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line.,,B,,H,8,Autocuration,CHEMBL617316,722.0,
2022,,1,,13706,BAO_0000219,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,,B,,H,8,Autocuration,CHEMBL617317,722.0,
2023,,1,,12903,BAO_0000219,,"The compound was tested in vitro for binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",,B,,H,8,Autocuration,CHEMBL617318,449.0,
2024,,1,,13047,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,,B,,H,8,Autocuration,CHEMBL617319,,
2025,,1,,13366,BAO_0000357,,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,B,,D,9,Expert,CHEMBL617320,,
2026,,1,,13366,BAO_0000357,,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,B,,D,9,Expert,CHEMBL617321,,
2027,,1,,13366,BAO_0000357,,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,B,,D,9,Expert,CHEMBL617322,,
2028,,1,,13366,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616862,,
2029,,1,,13366,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor was determined using [3H]8-OH-DPAT as radioligand,,B,,H,8,Autocuration,CHEMBL616863,,
2030,,1,,12469,BAO_0000219,,Binding affinity was measured on 5-hydroxytryptamine 1D receptor beta in CHO cells transfected with human 5-HT1D beta gene labeled with [3H]5-HT,,B,,H,8,Autocuration,CHEMBL616864,449.0,
2031,,1,,13706,BAO_0000219,,Compound was tested for binding affinity against cloned human 5-HT1D beta receptor expressed in CHO-K1 cells.,,B,,H,8,Autocuration,CHEMBL616865,485.0,
2032,,1,,13706,BAO_0000219,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells.,,B,,H,8,Autocuration,CHEMBL616866,485.0,
2033,,1,,13706,BAO_0000019,,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,F,,H,8,Autocuration,CHEMBL616867,,
2034,,1,,12902,BAO_0000219,,"Binding affinity against 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells, using [3H]5-HT as the radioligand.",,B,,H,8,Expert,CHEMBL616868,485.0,
2035,,1,,13051,BAO_0000357,,Binding affinity for cloned human 5-hydroxytryptamine 1D receptor beta,,B,,H,8,Expert,CHEMBL616869,,
2036,,1,,12903,BAO_0000219,,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",,B,,H,8,Expert,CHEMBL616870,449.0,
2037,,1,,1558,BAO_0000219,,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.24-0.55,,F,,H,8,Autocuration,CHEMBL616871,485.0,
2038,,1,,1558,BAO_0000219,,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.6-2.0,,F,,H,8,Autocuration,CHEMBL616872,485.0,
2039,,1,,1558,BAO_0000219,,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 2.8-6.5,,F,,H,8,Autocuration,CHEMBL616873,485.0,
2040,,1,,1558,BAO_0000219,,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 30-70,,F,,H,8,Autocuration,CHEMBL616838,485.0,
2041,,1,,1558,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined,,B,,H,8,Autocuration,CHEMBL616839,,
2042,Oryctolagus cuniculus,1,,13047,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 3 receptor using rabbit saphenous vein assay.,,B,,H,8,Autocuration,CHEMBL616840,,
2043,,1,,13313,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]-5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616841,,
2044,,1,,13313,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor beta by using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616842,,
2045,,1,,12409,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor beta,,B,,H,8,Expert,CHEMBL857976,,
2046,,1,,15250,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1E receptor stably expressed in CHO cells,,B,,H,8,Autocuration,CHEMBL616843,449.0,
2047,Homo sapiens,1,,1348,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype,,B,,D,9,Expert,CHEMBL616844,,
2048,,1,,1348,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype; NA denotes data not available,,B,,H,8,Autocuration,CHEMBL616845,,
2049,Homo sapiens,1,,4234,BAO_0000357,,Binding affinity to cloned human 5-hydroxytryptamine 1E receptor,,B,,D,9,Expert,CHEMBL616846,,
2050,,1,,16209,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1E receptor was determined using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616847,,
2051,,1,,10444,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 1E receptor in human cortical homogenate,,B,,H,8,Autocuration,CHEMBL616848,,
2052,,1,,3935,BAO_0000357,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1E receptor,,B,,H,8,Autocuration,CHEMBL616849,,
2053,,1,,15818,BAO_0000357,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1E receptor,,B,,H,8,Autocuration,CHEMBL872911,,
2054,,1,,17085,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1E receptor,,B,,H,8,Autocuration,CHEMBL616850,,
2055,Homo sapiens,1,,12936,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1E receptor expressed in CHO cells,,B,,D,9,Expert,CHEMBL616699,449.0,
2056,,1,,6166,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1E receptor was determined,,B,,H,8,Autocuration,CHEMBL616700,,
2057,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1E receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL616701,449.0,
2058,,1,,15779,BAO_0000219,,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL616702,449.0,
2059,,1,,15779,BAO_0000219,,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand;ND means no data.,,B,,H,8,Autocuration,CHEMBL616703,449.0,
2060,,1,,13181,BAO_0000357,,Binding affinity was determined against 5-hydroxytryptamine 1D receptor,,B,,H,8,Autocuration,CHEMBL616704,,
2061,,1,,4199,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as the radioligand,,B,,H,8,Autocuration,CHEMBL616705,449.0,
2062,,1,,14875,BAO_0000357,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1E receptor,,B,,H,8,Autocuration,CHEMBL616706,,
2063,,1,,15146,BAO_0000219,,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]-5-HT,,B,,H,8,Autocuration,CHEMBL616707,449.0,
2064,,1,,5213,BAO_0000357,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1E receptor in CHO using [3H]5-HT as a radioligand,,B,,H,8,Autocuration,CHEMBL616708,,
2065,,1,,12146,BAO_0000357,,Tested for binding affinity towards cloned human 5-hydroxytryptamine 1E receptor using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616709,,
2066,,1,,13267,BAO_0000219,,The binding affinity (pKi) measured against 5-hydroxytryptamine 1E receptor (cloned human receptors in CHO cells) using [3H]5-HT1E as radioligand,,B,,H,8,Autocuration,CHEMBL616710,449.0,
2067,,1,,14818,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT.,,B,,H,8,Autocuration,CHEMBL616711,449.0,
2068,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells, using [3H]5-HT as radioligand",,B,,H,8,Autocuration,CHEMBL616712,449.0,
2069,,1,,4373,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1E receptor was determined,,B,,H,8,Autocuration,CHEMBL616713,,
2070,,1,,4373,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1E receptor was determined,,B,,H,8,Autocuration,CHEMBL616714,,
2071,,1,,14159,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1E receptor,,B,,H,8,Autocuration,CHEMBL616715,,
2072,,1,,16633,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1E receptor,,B,,H,8,Autocuration,CHEMBL616716,,
2073,,1,,17085,BAO_0000019,,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-HT1F receptor",,F,,H,8,Autocuration,CHEMBL616717,,
2074,,1,,17085,BAO_0000019,,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-hydroxytryptamine 1F receptor",,F,,H,8,Expert,CHEMBL616718,,
2075,,1,,16209,BAO_0000019,,In vitro effective concentration for inhibition of skolin-stimulated adenylate cyclase in cell line expressing human 5-hydroxytryptamine 1F receptor,,F,,H,8,Autocuration,CHEMBL875905,,
2076,,1,,16209,BAO_0000019,,In vitro agonist potency against human 5-hydroxytryptamine 1F receptor,,F,,H,8,Autocuration,CHEMBL616719,,
2077,,1,,17085,BAO_0000019,,"Maximum stimulation of of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine 1F receptor",,F,,H,8,Expert,CHEMBL616720,,
2078,,1,,14159,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1F receptor,,B,,H,8,Autocuration,CHEMBL616721,,
2079,,1,,15250,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1F receptor stably expressed in CHO cells,,B,,H,8,Autocuration,CHEMBL616722,449.0,
2080,,1,,3805,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 1F receptor at a concentration of 100 (nM),,B,,H,8,Autocuration,CHEMBL616723,,
2081,,1,,16190,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT radioligand,,B,,H,8,Autocuration,CHEMBL616724,449.0,
2082,,1,,16190,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT radioligand,,B,,H,8,Autocuration,CHEMBL616725,,
2083,,1,,16209,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1F receptor,,B,,H,8,Autocuration,CHEMBL616726,,
2084,,1,,16209,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1F receptor was determined,,B,,H,8,Autocuration,CHEMBL616727,,
2085,,1,,16209,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1F receptor using [3H]-5-HT radioligand,,B,,H,8,Autocuration,CHEMBL616728,,
2086,,1,,6866,BAO_0000357,,In vitro binding affinity for human 5-hydroxytryptamine 1F receptor,,B,,H,8,Autocuration,CHEMBL616729,,
2087,,1,,17085,BAO_0000019,,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1F receptor,,B,,H,8,Expert,CHEMBL616730,,
2088,,1,,16312,BAO_0000357,,Binding affinity towards human recombinant 5-hydroxytryptamine 1F receptor,,B,,H,8,Autocuration,CHEMBL617125,,
2089,,1,,6166,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1F receptor was determined,,B,,H,8,Autocuration,CHEMBL857977,,
2090,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1F receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL617126,449.0,
2091,,1,,4199,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1F receptor in CHO cells using [3H]-5-HT as the radioligand,,B,,H,8,Autocuration,CHEMBL617127,449.0,
2092,,1,,14875,BAO_0000357,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1F receptor,,B,,H,8,Autocuration,CHEMBL617128,,
2093,,1,,15146,BAO_0000219,,Compound was tested for its binding affinity against 5-hydroxytryptamine 1F receptor in human cloned receptors in CHO cells using [3H]5-HT,,B,,H,8,Autocuration,CHEMBL617129,449.0,
2094,,1,,5213,BAO_0000357,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT as a radioligand,,B,,H,8,Autocuration,CHEMBL617130,,
2095,,1,,14818,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT.,,B,,H,8,Autocuration,CHEMBL617131,449.0,
2096,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",,B,,H,8,Autocuration,CHEMBL617132,449.0,
2097,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",,B,,H,8,Autocuration,CHEMBL617133,449.0,
2098,,1,,4373,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1F receptor was determined,,B,,H,8,Autocuration,CHEMBL617134,,
2099,,1,,4373,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1F receptor was determined,,B,,H,8,Autocuration,CHEMBL617135,,
2100,,1,,5014,BAO_0000357,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1F receptor,,B,,H,8,Autocuration,CHEMBL617136,,
2101,,1,,11662,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]-ketanserin as radioligand",,B,,H,4,Autocuration,CHEMBL617137,,
2102,,1,,11662,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",,B,,H,4,Autocuration,CHEMBL617138,,
2103,,1,,11662,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,B,,H,4,Autocuration,CHEMBL617139,,
2104,,1,,14093,BAO_0000019,,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617140,,
2105,,1,,11200,BAO_0000218,,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-HT2 receptor 1 hr after oral administration",,F,,H,4,Autocuration,CHEMBL617141,,
2106,,1,,11200,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,F,,H,4,Autocuration,CHEMBL858112,,
2107,,1,,12352,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor in calf frontal cortex,,B,,H,8,Intermediate,CHEMBL617142,,
2108,Bos taurus,1,,13657,BAO_0000019,,"Binding affinity to 5-hydroxytryptamine 2 receptor using calf frontal cortex, [3H]- ketanserin, and spiperone for NSB",,B,,U,0,Autocuration,CHEMBL617143,,
2109,Bos taurus,1,,14331,BAO_0000019,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex at 10e-7 M,,B,,U,0,Autocuration,CHEMBL617144,,
2110,Bos taurus,1,,14331,BAO_0000019,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex,,B,,U,0,Autocuration,CHEMBL617145,,
2111,,1,,14331,BAO_0000019,,Binding affinity of compound towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin (0.8 nM) ligand in frontal cortex bovine was determined,,B,,U,0,Autocuration,CHEMBL617146,,
2112,Cavia porcellus,1,,12685,BAO_0000019,,Binding affinity for serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin in guinea pig frontal cortex,,B,,H,4,Autocuration,CHEMBL617147,,
2113,Cavia porcellus,1,,14389,BAO_0000019,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of guinea pig frontal cortex membranes,,B,,H,4,Autocuration,CHEMBL617148,,
2114,Cavia porcellus,1,,14386,BAO_0000019,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin from guinea pig frontal cortex,,B,,H,4,Autocuration,CHEMBL617149,,
2115,,1,,5732,BAO_0000224,,Binding affinity towards cloned human 5-hydroxytryptamine 2 receptor was determined,,B,,H,4,Autocuration,CHEMBL617150,,
2116,,1,,16293,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,B,,H,4,Autocuration,CHEMBL617151,,
2117,,1,,2078,BAO_0000224,,In vitro binding affinity of compound against neuronal 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617201,,
2118,,1,,5486,BAO_0000357,,Binding affinity towards 5-HT7 receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,,B,,H,8,Autocuration,CHEMBL617202,,
2119,,1,,11820,BAO_0000218,,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,,B,,H,4,Autocuration,CHEMBL617203,,
2120,,1,,10297,BAO_0000019,,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,,B,,H,4,Autocuration,CHEMBL617204,,
2121,,1,,13704,BAO_0000224,,Inhibitory activity against serotonin 5-hydroxytryptamine 2 receptor from mice.,,B,,H,4,Autocuration,CHEMBL617205,,
2122,Mus musculus,1,,10297,BAO_0000019,,Inhibitory activity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in mouse cerebral cortex,,B,,D,5,Autocuration,CHEMBL617206,,
2123,,1,,11820,BAO_0000218,,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,,B,,H,4,Autocuration,CHEMBL617207,,
2124,Mus musculus,1,,10297,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]-ketanserin in mouse cerebral cortex,,B,,D,5,Autocuration,CHEMBL617208,,
2125,,1,,11555,BAO_0000224,,The compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617209,,
2126,,1,,11555,BAO_0000224,,In vitro binding affinity for serotonin 5-hydroxytryptamine (5-HT) 2 receptors,,B,,H,4,Autocuration,CHEMBL617210,,
2127,,1,,11555,BAO_0000224,,The compound was tested in vitro for its binding affinity towards serotonin 5-hydroxytryptamine 2 receptor; nd = no data,,B,,H,4,Autocuration,CHEMBL617211,,
2128,Mus musculus,1,,10297,BAO_0000019,,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,,B,,D,5,Autocuration,CHEMBL617212,,
2129,Sus scrofa,1,,16688,BAO_0000224,,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin,,B,,H,4,Autocuration,CHEMBL617213,,
2130,Sus scrofa,1,,16688,BAO_0000224,,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin with 10 uM prazosin,,B,,H,4,Autocuration,CHEMBL617214,,
2131,,1,,5333,BAO_0000221,,Compound was tested in vitro for its ability to compete with [3H]-ketanserin at 5-hydroxytryptamine 2 receptor in porcine brain homogenate,,B,,U,0,Autocuration,CHEMBL617215,,
2132,,1,,4437,BAO_0000221,,In vitro for its ability to displace [3H]- ketanserin from 5-hydroxytryptamine 2 receptor in porcine brain homogenate,,B,,U,0,Autocuration,CHEMBL617216,,
2133,Sus scrofa,1,,5033,BAO_0000357,,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2 receptor,,B,,H,8,Autocuration,CHEMBL617217,,
2134,,1,,15267,BAO_0000019,,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617218,,
2135,,1,,15267,BAO_0000019,,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL872913,,
2136,,1,,11820,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor from rat cortical synaptosomal membrane using radioligand [3H]ketanserin.,,B,,H,4,Autocuration,CHEMBL617219,,
2137,,1,,9069,BAO_0000224,,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL873482,,
2138,Rattus norvegicus,1,,9162,BAO_0000019,,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; ND means no data,,B,,D,5,Autocuration,CHEMBL617220,,
2139,,1,,9162,BAO_0000019,,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein.,,B,,H,4,Autocuration,CHEMBL617221,,
2140,,1,,9162,BAO_0000019,,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; no appreciable 5-HT2 receptor affinity,,B,,H,4,Autocuration,CHEMBL617222,,
2141,,1,,10428,BAO_0000019,,Antagonistic activity against (5-hydroxytryptamine 2 receptor) serotonin-induced contractions in the rat jugular vein,,F,,H,4,Autocuration,CHEMBL875906,,
2142,,1,,9628,BAO_0000019,,Binding affinity to the 5-hydroxytryptamine 2 receptor assayed by antagonism of serotonin-induced contractions in the rat jugular vein,,B,,H,4,Autocuration,CHEMBL617223,,
2143,,1,,12704,BAO_0000224,,Binding affinity against serotonin 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617224,,
2144,Rattus norvegicus,1,,15453,BAO_0000224,,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,,B,,D,5,Autocuration,CHEMBL617225,,
2145,,1,,188,BAO_0000224,,Tested for the effect on binding at 5-hydroxytryptamine 2 receptor; No activity,,B,,H,4,Autocuration,CHEMBL617226,,
2146,,1,,10349,BAO_0000224,,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.4 nM dose of [3H]- spiperone as a radioligand.,,B,,H,4,Autocuration,CHEMBL617227,,
2147,,1,,10349,BAO_0000224,,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.6 nM dose of [3H]- spiperone as a radioligand.,,B,,H,4,Autocuration,CHEMBL617228,,
2148,,1,,8868,BAO_0000224,,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,,B,,H,4,Autocuration,CHEMBL617229,,
2149,,1,,10025,BAO_0000224,,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,,B,,H,4,Autocuration,CHEMBL617230,,
2150,,1,,10025,BAO_0000224,,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",,B,,H,4,Autocuration,CHEMBL617231,,
2151,,1,,11702,BAO_0000224,,Compound was tested for the inhibition of quipazine binding at 5-HT2 receptor,,B,,H,4,Autocuration,CHEMBL617232,,
2152,,1,,11702,BAO_0000224,,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617233,,
2153,,1,,11702,BAO_0000224,,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor; NT=Not tested,,B,,H,4,Autocuration,CHEMBL617234,,
2154,,1,,11702,BAO_0000019,,Compound was tested for the inhibition of quipazine induced head twitches in rats,,F,,H,4,Autocuration,CHEMBL617235,,
2155,,1,,11702,BAO_0000019,,Compound was tested for the inhibition of quipazine induced head twitches in rats; NT=Not tested,,F,,H,4,Autocuration,CHEMBL617236,,
2156,,1,10000000.0,10085,BAO_0000221,,Ability to bind at 5-hydroxytryptamine 2 receptor of rat hippocampus by displacing [3H]spiperone,,B,,H,4,Autocuration,CHEMBL617237,,
2157,,1,10000000.0,10085,BAO_0000221,,Ability to bind at serotonin 5-hydroxytryptamine 2 receptors of rat hippocampus by displacing [3H]spiperone,,B,,H,4,Autocuration,CHEMBL617238,,
2158,Rattus norvegicus,1,955.0,9630,BAO_0000221,,Displacement of [3H]spiroperidol from 5-hydroxytryptamine 2 receptor in rat brain,,B,,D,5,Autocuration,CHEMBL617239,,
2159,,1,,11070,BAO_0000019,,Ability to inhibit binding of [3H]KET to 5-hydroxytryptamine 2 receptor in rat cortex,,B,,H,4,Autocuration,CHEMBL617240,,
2160,,1,,9841,BAO_0000249,,Ability to inhibit binding of titreated spiperone to 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,Membranes,B,,H,4,Autocuration,CHEMBL617241,,
2161,,1,,9841,BAO_0000249,,Ability to inhibit binding of titreated spiperone to the 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,Membranes,B,,H,4,Autocuration,CHEMBL875907,,
2162,,1,,13291,BAO_0000019,,Affinity for 5-hydroxytryptamine 2 receptor binding sites by its ability to displace [3H]spiperone from rat frontal cortex.,,B,,H,4,Autocuration,CHEMBL617242,,
2163,,1,,10590,BAO_0000019,,Antagonistic activity against 5-hydroxytryptamine 2 receptor on rat frontal cortex membrane.,,F,,H,4,Autocuration,CHEMBL617152,,
2164,Rattus norvegicus,1,955.0,9064,BAO_0000221,,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,,B,,D,5,Autocuration,CHEMBL617153,,
2165,Rattus norvegicus,1,,12268,BAO_0000249,,Binding affinity at 5-hydroxytryptamine 2 receptor by the inhibition of binding to [3H]ketanserin in rat cortical membranes,Membranes,B,,D,5,Autocuration,CHEMBL617154,,
2166,,1,955.0,13508,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 2 receptor in rat brain using [3H]ketanserin as radioligand,,B,,H,4,Autocuration,CHEMBL617155,,
2167,,1,,11279,BAO_0000019,,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,,F,,H,4,Autocuration,CHEMBL617156,,
2168,,1,,11200,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-HT2 receptor in rat thoracic aortic strips,,F,,H,4,Autocuration,CHEMBL617157,,
2169,,1,,11200,BAO_0000019,,In vitro antagonistic activity tested against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,F,,H,4,Autocuration,CHEMBL617158,,
2170,,1,,11200,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,,F,,H,4,Autocuration,CHEMBL617159,,
2171,,1,,11200,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,,F,,H,4,Autocuration,CHEMBL617160,,
2172,,1,,11200,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,F,,H,4,Autocuration,CHEMBL858113,,
2173,,1,955.0,9231,BAO_0000220,,Tested for 5-hydroxytryptamine 2 receptor binding ability by displacement of [3H]spiperone from rat brain frontal cortex synaptosomes,,B,,H,4,Autocuration,CHEMBL617247,,
2174,,1,,9737,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,,B,,H,4,Autocuration,CHEMBL617248,,
2175,,1,955.0,9737,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,B,,H,4,Autocuration,CHEMBL617249,,
2176,,1,,9737,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex,,B,,H,4,Autocuration,CHEMBL617250,,
2177,,1,,9737,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,,B,,H,4,Autocuration,CHEMBL617251,,
2178,Rattus norvegicus,1,,11828,BAO_0000019,,isplacement of [3H]DOB from rat cortex homogenate 5-hydroxytryptamine 2 receptor,,B,,D,5,Autocuration,CHEMBL617252,,
2179,,1,,12253,BAO_0000019,,Binding affinity of 5-hydroxytryptamine 2 receptor using [3H]- ketanserin in rat frontal cortex,,B,,H,4,Autocuration,CHEMBL617006,,
2180,,1,,12253,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat frontal cortex,,B,,H,4,Autocuration,CHEMBL617007,,
2181,,1,,11279,BAO_0000019,,"5-hydroxytryptamine 2 receptor antagonistic activity at concentrations of<br>3,10 and 30 uM on the rat tail artery.",,F,,H,4,Autocuration,CHEMBL617008,,
2182,,1,,11866,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- ketanserin,,B,,H,4,Autocuration,CHEMBL617009,,
2183,Rattus norvegicus,1,,14424,BAO_0000224,,Binding affinity against 5-hydroxytryptamine 2 receptor in serotonin-induced contraction of the rat aorta,,B,,D,5,Autocuration,CHEMBL617010,,
2184,Rattus norvegicus,1,,15180,BAO_0000019,,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,,B,,D,5,Autocuration,CHEMBL857978,,
2185,Rattus norvegicus,1,,15180,BAO_0000019,,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,,B,,D,5,Autocuration,CHEMBL617011,,
2186,Rattus norvegicus,1,,9786,BAO_0000019,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat frontal cortex homogenate,,B,,D,5,Autocuration,CHEMBL617012,,
2187,,1,,12132,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand.,,B,,H,4,Autocuration,CHEMBL617013,,
2188,,1,,5486,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in rat cerebral cortex membrane,,B,,H,4,Autocuration,CHEMBL617014,,
2189,,1,,15316,BAO_0000019,,Compound was evaluated for its ability to displace [3H]ketanserin binding from cloned rat cerebral cortex membranes 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617015,,
2190,,1,,16429,BAO_0000019,,In vitro binding affinity to 5-hydroxytryptamine 2 receptor of rat cerebral cortex membranes using [3H]ketanserin as the radioligand,,B,,H,4,Autocuration,CHEMBL617016,,
2191,,1,,14617,BAO_0000224,,pKi value for 5-hydroxytryptamine 2 receptor binding site,,B,,H,4,Autocuration,CHEMBL617017,,
2192,,1,955.0,11351,BAO_0000221,,Inhibitory constant (1 uM) was measured on 5-hydroxytryptamine 2 receptor/uptake using [3H]- ketanserin as radioligand in rat brain cortex.,,B,,H,4,Autocuration,CHEMBL617018,,
2193,,1,,11279,BAO_0000019,,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,,F,,H,4,Autocuration,CHEMBL617019,,
2194,,1,,9523,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,B,,H,4,Autocuration,CHEMBL617020,,
2195,,1,,9523,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,B,,H,4,Autocuration,CHEMBL617021,,
2196,,1,,9523,BAO_0000019,,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,B,,H,4,Autocuration,CHEMBL617022,,
2197,,1,,9523,BAO_0000019,,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,B,,H,4,Autocuration,CHEMBL617023,,
2198,,1,,9523,BAO_0000019,,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,B,,H,4,Autocuration,CHEMBL617024,,
2199,,1,,9523,BAO_0000019,,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,B,,H,4,Autocuration,CHEMBL617025,,
2200,,1,,9523,BAO_0000224,,Hill coefficient of compound was determined,,B,,H,4,Autocuration,CHEMBL617026,,
2201,,1,,4771,BAO_0000019,,Ancillary Binding affinity towards rat 5-hydroxytryptamine 2 receptor,,B,,U,0,Autocuration,CHEMBL617027,,
2202,Rattus norvegicus,1,,5033,BAO_0000019,,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-ketanserin) from 5-hydroxytryptamine 2 receptor of rat cerebral cortex membrane,,B,,D,5,Autocuration,CHEMBL617028,,
2203,,1,,10845,BAO_0000019,,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand,,B,,H,8,Expert,CHEMBL617029,,
2204,,1,,10845,BAO_0000019,,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand; IA-Inactive,,B,,H,8,Expert,CHEMBL875908,,
2205,,1,,16288,BAO_0000357,,Affinity at 5-hydroxytryptamine 2 receptor (For ketanserin = Ki(nM)= 0.7+/-0.09),,B,,H,8,Autocuration,CHEMBL617030,,
2206,,1,,16288,BAO_0000019,,Affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex using [3H]ketanserin as radioligand (For ketanserin = Ki(nM)=0.7+/-0.09),,B,,H,8,Autocuration,CHEMBL617031,,
2207,,1,,16190,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 2 receptor of rat cortical membrane using [3H]DOB radioligand,,B,,H,8,Autocuration,CHEMBL617032,,
2208,Rattus norvegicus,1,,12463,BAO_0000224,,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 2 receptor using radioligand [3H]ketanserin,,B,,D,5,Autocuration,CHEMBL617033,,
2209,,1,,9699,BAO_0000224,,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand",,B,,H,4,Autocuration,CHEMBL617034,,
2210,,1,,9699,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand,,B,,H,4,Autocuration,CHEMBL617035,,
2211,,1,,11662,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,B,,H,4,Autocuration,CHEMBL617036,,
2212,,1,,1205,BAO_0000224,,Inhibitory concentration against 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617037,,
2213,,1,,11376,BAO_0000219,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2 receptor from mammalian clones expressed in CHO cell membranes using [3H]-ketanserin as radioligand,,B,,U,0,Autocuration,CHEMBL617038,,
2214,,1,,11376,BAO_0000219,,"Binding affinity towards 5-hydroxytryptamine 2 receptor expressed in CHO cell membranes using [3H]ketanserin (60 Ci/mmol, 1 nM)",,B,,H,4,Autocuration,CHEMBL617039,,
2215,,1,,4639,BAO_0000224,,Compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617161,,
2216,,1,,2222,BAO_0000224,,Compound was tested for inhibitory activity against 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617162,,
2217,,1,,1558,BAO_0000224,,Compound was tested for its affinity towards 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617163,,
2218,,1,,1089,BAO_0000224,,Tested for binding affinity for 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617164,,
2219,,1,,386,BAO_0000249,,The compound was evaluated for its ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor in cellular brain membranes,Brain membranes,B,,H,4,Autocuration,CHEMBL617165,,
2220,,1,,2474,BAO_0000224,,Compound was measured for its binding affinity at 5-hydroxytryptamine 2 receptor at a concentration of 10 uM using [3H]ketanserin as radioligand,,B,,H,4,Autocuration,CHEMBL617166,,
2221,,1,,17066,BAO_0000224,,Binding affinity towards 5-HT2 receptor,,B,,H,4,Autocuration,CHEMBL617167,,
2222,,1,,959,BAO_0000224,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL872912,,
2223,,1,,6398,BAO_0000224,,Compound was evaluated for 5-hydroxytryptamine 2 receptor binding,,B,,H,4,Autocuration,CHEMBL617168,,
2224,,1,,11889,BAO_0000224,,In vitro binding affinity against rat 5-hydroxytryptamine 2 receptor.,,B,,H,4,Autocuration,CHEMBL617169,,
2225,,1,,4221,BAO_0000224,,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617170,,
2226,,1,,11026,BAO_0000224,,The compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor using ketanserin as radioligand,,B,,H,4,Autocuration,CHEMBL617171,,
2227,,1,,11866,BAO_0000224,,Binding affinity for 5-hydroxytryptamine 2 receptor was determined,,B,,H,4,Autocuration,CHEMBL617172,,
2228,,1,,4221,BAO_0000224,,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617173,,
2229,,1,,13950,BAO_0000019,,In Vitro binding affinity for 5-hydroxytryptamine 2 receptor,,B,,U,0,Autocuration,CHEMBL617174,,
2230,,1,,1263,BAO_0000224,,5-hydroxytryptamine 2 receptor binding affinity,,B,,H,4,Autocuration,CHEMBL617175,,
2231,,1,,13291,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2 receptor was determined using [ [3H]spiperone radioligand,,B,,H,8,Autocuration,CHEMBL617176,,
2232,,1,,10812,BAO_0000357,,Compound was tested for the binding affinity against 5-hydroxytryptamine 2 receptor by using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL617177,,
2233,,1,,13020,BAO_0000224,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,,B,,H,4,Autocuration,CHEMBL617178,,
2234,,1,,13021,BAO_0000224,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of central nervous system,,B,,H,4,Autocuration,CHEMBL617179,,
2235,,1,,13020,BAO_0000224,,Ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,,B,,H,4,Autocuration,CHEMBL617180,,
2236,,1,,14532,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand at 10e-5 M concentration,,B,,H,8,Autocuration,CHEMBL617181,,
2237,,1,,13944,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2 receptor,,B,,H,8,Autocuration,CHEMBL617182,,
2238,,1,,14331,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2 receptor,,B,,H,8,Autocuration,CHEMBL617183,,
2239,,1,,14118,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL617184,,
2240,,1,,13033,BAO_0000357,,Binding affinity against serotonergic 5-HT2 receptor,,B,,H,8,Autocuration,CHEMBL617185,,
2241,,1,,10321,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2 receptor was determined by using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL617186,,
2242,,1,,12918,BAO_0000357,,Compound was evaluated for the binding affinity at 5- HT2 receptor,,B,,H,8,Autocuration,CHEMBL617187,,
2243,,1,,15120,BAO_0000357,,Compound was tested for binding affinity using [3H]ketanserin against 5-hydroxytryptamine 2 receptor,,B,,H,8,Autocuration,CHEMBL617188,,
2244,,1,,2613,BAO_0000218,,In vivo binding affinity was evaluated against 5-hydroxytryptamine 2 receptor,,B,,H,8,Autocuration,CHEMBL617189,,
2245,Homo sapiens,1,,13378,BAO_0000224,,Inhibitory activity against cloned human 5-HT2 receptor,,B,,D,5,Autocuration,CHEMBL617190,,
2246,Homo sapiens,1,,2331,BAO_0000219,,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells",,B,,D,5,Autocuration,CHEMBL617191,449.0,
2247,Homo sapiens,1,,2331,BAO_0000219,,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells.",,B,,D,5,Autocuration,CHEMBL617192,449.0,
2248,Homo sapiens,1,,2331,BAO_0000219,,"Tested in vitro for the inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; Inactive",,B,,D,5,Autocuration,CHEMBL617193,449.0,
2249,Homo sapiens,1,,2331,BAO_0000219,,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; not tested",,B,,D,5,Autocuration,CHEMBL617194,449.0,
2250,,1,,4170,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617195,,
2251,,1,,15453,BAO_0000224,,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,,B,,H,4,Autocuration,CHEMBL881830,,
2252,,1,,1479,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2 receptor,,B,,H,8,Autocuration,CHEMBL617196,,
2253,,1,,11139,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2- receptor using [3H]ketanserin as radioligand in competitive binding assay,,B,,H,4,Autocuration,CHEMBL617197,,
2254,,1,,13969,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2A receptor was measured using [3H]ketanserin as radioligand,,B,,H,8,Expert,CHEMBL617198,,
2255,,1,,13392,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor,,B,,H,8,Expert,CHEMBL873476,,
2256,,1,,14430,BAO_0000019,,Affinity towards 5-hydroxytryptamine 2A receptor in membranes from bovine frontal cortex using [3H]ketanserin,,B,,H,8,Expert,CHEMBL617199,,
2257,Cavia porcellus,1,,13181,BAO_0000357,,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617200,,
2258,,1,,17200,BAO_0000357,,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,B,,H,8,Autocuration,CHEMBL617484,,
2259,,1,,17200,BAO_0000357,,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,B,,H,8,Autocuration,CHEMBL617485,,
2260,,1,,17200,BAO_0000357,,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,B,,H,8,Autocuration,CHEMBL617486,,
2261,,1,,13463,BAO_0000357,,Binding affinity analysed on 5-HT 2A human clone using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL858022,,
2262,,1,,6347,BAO_0000219,,Effective concentration against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,,B,,H,8,Autocuration,CHEMBL617049,449.0,
2263,Homo sapiens,1,,6857,BAO_0000219,,Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader,,F,,D,9,Expert,CHEMBL617050,449.0,
2264,,1,,4176,BAO_0000219,,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,,F,,H,8,Autocuration,CHEMBL617051,,
2265,,1,,4176,BAO_0000219,,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line; no data,,F,,H,8,Autocuration,CHEMBL617052,,
2266,,1,,4176,BAO_0000219,,Functional antagonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,,F,,H,8,Autocuration,CHEMBL617053,,
2267,,1,,6347,BAO_0000219,,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand, expressed as Emax",,B,,H,8,Autocuration,CHEMBL617054,449.0,
2268,,1,,6347,BAO_0000219,,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells, expressed as Emax",,B,,H,8,Autocuration,CHEMBL617055,449.0,
2269,,1,,15331,BAO_0000357,,Affinity of compound towards human 5-hydroxytryptamine 2A receptor was evaluated using radioligand binding technique,,B,,H,8,Autocuration,CHEMBL882924,,
2270,Homo sapiens,1,,16146,BAO_0000357,,Inhibition of human 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL617056,,
2271,,1,,15250,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,B,,H,8,Autocuration,CHEMBL617057,449.0,
2272,,1,,13631,BAO_0000219,,Inhibitory concentration against human 5-HT2A receptor in BEK cells,,B,,H,8,Expert,CHEMBL617058,,
2273,,1,,3805,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 2A receptor at a concentration of 100 (nM),,B,,H,8,Autocuration,CHEMBL617059,,
2274,,1,,4011,BAO_0000219,,Ability to displace [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor was determined,,B,,H,8,Autocuration,CHEMBL617060,449.0,
2275,,1,,4012,BAO_0000219,,Displacement of [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor.,,B,,H,8,Expert,CHEMBL617061,449.0,
2276,,1,,6366,BAO_0000219,,Ability to displace [125I]R91150 from human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells,,B,,H,8,Expert,CHEMBL617062,307.0,
2277,,1,,15949,BAO_0000219,,Ability to displace [3H]ketanserin binding to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,B,,H,8,Expert,CHEMBL617063,449.0,
2278,,1,,14093,BAO_0000019,,Agonist activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand,,F,,H,8,Autocuration,CHEMBL617064,,
2279,,1,,13481,BAO_0000019,,Agonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,F,,H,8,Autocuration,CHEMBL617065,,
2280,,1,,6347,BAO_0000219,,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,,B,,H,8,Autocuration,CHEMBL617066,449.0,
2281,,1,,6347,BAO_0000219,,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand; Nd means not done,,B,,H,8,Autocuration,CHEMBL617067,449.0,
2282,,1,,14093,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]-Ketanserin radioligand,,F,,H,8,Autocuration,CHEMBL617068,,
2283,,1,,14093,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand; Not tested,,F,,H,8,Autocuration,CHEMBL617069,,
2284,,1,,13481,BAO_0000019,,Antagonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,F,,H,8,Autocuration,CHEMBL617070,,
2285,,1,,14442,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [125 I]DOI as radioligand,,B,,H,8,Autocuration,CHEMBL617071,,
2286,,1,,14442,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL872915,,
2287,,1,,14755,BAO_0000357,,Binding activity against cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand.,,B,,H,8,Autocuration,CHEMBL617072,,
2288,,1,,16441,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2A receptor in humans,,B,,H,8,Autocuration,CHEMBL617073,,
2289,,1,,14744,BAO_0000357,,Binding affinity against the cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand,,B,,H,8,Autocuration,CHEMBL617074,,
2290,,1,,16659,BAO_0000219,,Binding affinity for displacement of [3H]ketanserin to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,B,,H,8,Expert,CHEMBL617075,449.0,
2291,,1,,3307,BAO_0000357,,Binding affinity of compound to human 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617076,,
2292,Homo sapiens,1,,6857,BAO_0000019,,Affinity for human 5-hydroxytryptamine 2A receptor expressed in mammalian cell line,,B,,D,9,Expert,CHEMBL617077,,
2293,,1,,5635,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand.,,B,,H,8,Expert,CHEMBL617078,,
2294,Homo sapiens,1,,4234,BAO_0000357,,Binding affinity to cloned human 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL617079,,
2295,,1,,15527,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL617080,,
2296,,1,,6588,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 2A receptor by the displacement of [3H]ketanserin radioligand from the cloned receptor expressed in CHO cells,,B,,H,8,Expert,CHEMBL617081,449.0,
2297,,1,,13631,BAO_0000219,,Binding affinity towards human 5-HT2A receptor in BEK cells,,B,,H,8,Expert,CHEMBL617082,,
2298,,1,,17723,BAO_0000357,,Binding affinity towards human serotonin 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617083,,
2299,,1,,14770,BAO_0000357,,Binding affinity for recombinant human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL617084,,
2300,Homo sapiens,1,,16293,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL617085,,
2301,,1,,16209,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,B,,H,8,Autocuration,CHEMBL617086,,
2302,,1,,12469,BAO_0000219,,Binding affinity was measured on 5-hydroxytryptamine 2A receptor in GF6 cells transfected with human 5-HT2A gene labeled with [3H]ketanserin,,B,,H,8,Autocuration,CHEMBL617087,,
2303,,1,,15363,BAO_0000357,,Compound was tested for the displacement of [125I]-DOI from clone human 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617088,,
2304,,1,,15363,BAO_0000357,,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617089,,
2305,,1,,16441,BAO_0000019,,"Tested on genetically transfected COS7 cell membranes selectively expressing human 5-hydroxytryptamine 2A receptor, using [3H]ketanserin as radioligand",,B,,H,8,Expert,CHEMBL617090,,
2306,,1,,8,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in human using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL617513,,
2307,,1,,4176,BAO_0000219,,In vitro binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells was determined using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL617514,722.0,
2308,,1,,17085,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617515,,
2309,,1,,17200,BAO_0000357,,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,B,,H,8,Autocuration,CHEMBL617516,,
2310,Homo sapiens,1,,17200,BAO_0000357,,Inhibitory constant determined against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,B,,D,9,Expert,CHEMBL617517,,
2311,Homo sapiens,1,,4013,BAO_0000219,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in CHO cells,,B,,D,9,Expert,CHEMBL617518,449.0,
2312,,1,,5088,BAO_0000357,,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617519,,
2313,Homo sapiens,1,,5088,BAO_0000357,,Displacement of [3H]DOB from human 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL617520,,
2314,,1,,5088,BAO_0000357,,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]DOB as labeled ligand; binding data not obtained,,B,,H,8,Autocuration,CHEMBL617521,,
2315,Homo sapiens,1,,5088,BAO_0000357,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL617522,,
2316,,1,,5088,BAO_0000357,,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL617523,,
2317,,1,,5088,BAO_0000357,,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,B,,H,8,Autocuration,CHEMBL617524,,
2318,,1,,9786,BAO_0000019,,Ability to displace 0.75 nM [3H]ketanserin in 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenate,,B,,H,4,Autocuration,CHEMBL617525,,
2319,Rattus norvegicus,1,,9205,BAO_0000019,,Ability to inhibit [3H]spiperone binding to 5-hydroxytryptamine 2 receptor determined in rat,,B,,D,5,Autocuration,CHEMBL617526,,
2320,,1,,11257,BAO_0000224,,Affinity on 5-hydroxytryptamine 2 receptor labeled by [125I]DOI,,B,,H,4,Autocuration,CHEMBL617527,,
2321,,1,,9362,BAO_0000019,,Affinity towards [3H]- DOB -labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,,B,,H,4,Autocuration,CHEMBL617528,,
2322,,1,,9362,BAO_0000019,,Affinity towards [3H]- ketanserin-labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,,B,,H,4,Autocuration,CHEMBL617529,,
2323,,1,,10590,BAO_0000224,,Inhibition of 5-hydroxytryptamine 2 induced vasoconstriction of rat caudal artery.,,B,,H,4,Autocuration,CHEMBL617530,,
2324,,1,,10468,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,,B,,H,4,Autocuration,CHEMBL617531,,
2325,,1,,13050,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortex using [125]-(R)-DOI as radioligand,,B,,H,4,Autocuration,CHEMBL617532,,
2326,,1,,11624,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor in rat using [3H]ketanserin as radioligand,,B,,H,4,Autocuration,CHEMBL617533,,
2327,,1,,10468,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,,B,,H,4,Autocuration,CHEMBL617534,,
2328,,1,,10330,BAO_0000224,,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,,B,,H,4,Autocuration,CHEMBL617535,,
2329,,1,,10062,BAO_0000224,,Binding affinity at rat 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,,B,,H,4,Autocuration,CHEMBL617536,,
2330,,1,,11642,BAO_0000224,,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617537,,
2331,,1,,10062,BAO_0000224,,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617538,,
2332,,1,,13427,BAO_0000219,,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,B,,H,4,Autocuration,CHEMBL617539,,
2333,Rattus norvegicus,1,,12280,BAO_0000224,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,B,,D,5,Autocuration,CHEMBL617540,,
2334,Rattus norvegicus,1,,4101,BAO_0000224,,Binding affinity for 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]ketanserin,,B,,D,5,Autocuration,CHEMBL617541,,
2335,,1,,10062,BAO_0000224,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617542,,
2336,,1,,11147,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]DOB as,,B,,H,4,Autocuration,CHEMBL617543,,
2337,Rattus norvegicus,1,,2395,BAO_0000219,,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,,B,,D,5,Autocuration,CHEMBL617544,485.0,
2338,Rattus norvegicus,1,,2395,BAO_0000219,,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,,B,,D,5,Autocuration,CHEMBL617545,485.0,
2339,Rattus norvegicus,1,,9098,BAO_0000019,,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand,,B,,D,5,Autocuration,CHEMBL617413,,
2340,,1,,9098,BAO_0000019,,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand.,,B,,H,4,Autocuration,CHEMBL617414,,
2341,Rattus norvegicus,1,,9098,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 2 receptor of rat cortical membranes using [3H]- DOB; ND means no data.,,B,,D,5,Autocuration,CHEMBL617415,,
2342,,1,,9443,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617416,,
2343,,1,,9443,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,,B,,H,4,Autocuration,CHEMBL617417,,
2344,,1,,9699,BAO_0000019,,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand in rat frontal cortex",,B,,H,4,Autocuration,CHEMBL617418,,
2345,,1,,9699,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand in rat frontal cortex,,B,,H,4,Autocuration,CHEMBL617419,,
2346,,1,,9098,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,B,,H,4,Autocuration,CHEMBL617420,,
2347,Rattus norvegicus,1,,3070,BAO_0000224,,Affinity for 5-hydroxytryptamine 2 receptor,,B,,D,5,Autocuration,CHEMBL617421,,
2348,,1,,9547,BAO_0000224,,Binding affinity towards serotonin 5-hydroxytryptamine 2 receptor of rat determined using 0.5 nM of [3H]ketanserin in binding assay,,B,,H,4,Autocuration,CHEMBL617422,,
2349,,1,,10444,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 2 receptor from male Sprague-Dawley rat brain.,,B,,H,4,Autocuration,CHEMBL617423,,
2350,,1,,14617,BAO_0000019,,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor from rat tissue homogenate,,B,,H,4,Autocuration,CHEMBL617424,,
2351,,1,,14617,BAO_0000019,,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor rat tissue homogenate,,B,,H,4,Autocuration,CHEMBL617425,,
2352,,1,,11130,BAO_0000224,,Binding constant against 5-hydroxytryptamine 2 receptor (in vitro),,B,,H,4,Autocuration,CHEMBL617426,,
2353,,1,,11130,BAO_0000218,,Binding constant against 5-hydroxytryptamine 2 receptor (in vivo),,B,,H,4,Autocuration,CHEMBL617427,,
2354,,1,955.0,14542,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat brain,,B,,H,4,Autocuration,CHEMBL617428,,
2355,,1,,2797,BAO_0000224,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2 receptor from rat,,B,,H,4,Autocuration,CHEMBL617429,,
2356,,1,,11332,BAO_0000019,,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,,B,,H,4,Autocuration,CHEMBL617430,,
2357,,1,,11332,BAO_0000019,,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,,B,,H,4,Autocuration,CHEMBL617431,,
2358,,1,1870.0,10752,BAO_0000019,,Compound was evaluated for its ability to displace 0.25 nM [125I](R)-DOI from binding sites in rat frontal cortex.,,B,,H,4,Autocuration,CHEMBL617432,,
2359,,1,,1185,BAO_0000224,,Ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617433,,
2360,,1,,1185,BAO_0000224,,Compound was evaluated for its ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617434,,
2361,Rattus norvegicus,1,,11624,BAO_0000224,,Binding affinity against 5-Hydroxy tryptamine 2 (5-hydroxytryptamine 2)receptor,,B,,D,5,Autocuration,CHEMBL617435,,
2362,,1,,1344,BAO_0000019,,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 2 receptor in rat cortex using [3H]ketanserin radioligand assay,,B,,H,4,Autocuration,CHEMBL617436,,
2363,Rattus norvegicus,1,2435.0,15453,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor in rat striatum using [3H]-RP62203,,B,,D,5,Autocuration,CHEMBL617437,,
2364,,1,,11662,BAO_0000019,,"Binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",,B,,H,4,Autocuration,CHEMBL617438,,
2365,,1,,11662,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,B,,H,4,Autocuration,CHEMBL617439,,
2366,,1,,10796,BAO_0000224,,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617440,,
2367,,1,,9069,BAO_0000224,,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617441,,
2368,Rattus norvegicus,1,,8814,BAO_0000019,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortical membrane homogenates,,B,,D,5,Autocuration,CHEMBL872918,,
2369,Rattus norvegicus,1,,8908,BAO_0000019,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortex,,B,,D,5,Autocuration,CHEMBL617442,,
2370,,1,,9098,BAO_0000019,,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,,B,,H,4,Autocuration,CHEMBL617443,,
2371,,1,,9098,BAO_0000019,,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 (5-HT2) receptor using [3H]KET as a radioligand,,B,,H,4,Autocuration,CHEMBL617444,,
2372,,1,,9098,BAO_0000019,,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,,B,,H,4,Autocuration,CHEMBL617445,,
2373,,1,,9098,BAO_0000019,,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.,,B,,H,4,Autocuration,CHEMBL617446,,
2374,,1,,9098,BAO_0000249,,Binding affinity to 5-hydroxytryptamine 2 receptor in rat frontal cortical membranes by [3H]- KET displacement.,,B,,H,4,Autocuration,CHEMBL617447,,
2375,,1,,9098,BAO_0000019,,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.;ND is not determined,,B,,H,4,Autocuration,CHEMBL617448,,
2376,,1,,9098,BAO_0000019,,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand;ND means no data,,B,,H,4,Autocuration,CHEMBL617449,,
2377,,1,,9161,BAO_0000019,,In vitro binding affinity at 5-hydroxytryptamine 2 receptor in rat cortical tissue by [3H]spiperone displacement; No data.,,B,,H,4,Autocuration,CHEMBL617450,,
2378,,1,,9161,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 165 to 263,,B,,H,4,Autocuration,CHEMBL617451,,
2379,,1,,9161,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 2.4 to 5.3,,B,,H,4,Autocuration,CHEMBL617452,,
2380,,1,,9161,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue.,,B,,H,4,Autocuration,CHEMBL617453,,
2381,,1,,9161,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 140 to 980,,B,,H,4,Autocuration,CHEMBL617660,,
2382,,1,,9161,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 76 to 299,,B,,H,4,Autocuration,CHEMBL617661,,
2383,,1,,9161,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue; value may range from 12 to 66,,B,,H,4,Autocuration,CHEMBL617662,,
2384,,1,,9161,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 136 to 220,,B,,H,4,Autocuration,CHEMBL872919,,
2385,,1,,9161,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 197 to 341,,B,,H,4,Autocuration,CHEMBL617663,,
2386,,1,,9161,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 23 to 187,,B,,H,4,Autocuration,CHEMBL617664,,
2387,,1,,9161,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 29 to 132,,B,,H,4,Autocuration,CHEMBL617665,,
2388,,1,,9161,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 6 to 75,,B,,H,4,Autocuration,CHEMBL617666,,
2389,,1,,12094,BAO_0000019,,In vitro binding affinity on 5-hydroxytryptamine 2 receptor is inhibition of binding of [125I]- I-LSD to P11 cells,,B,,H,4,Autocuration,CHEMBL617667,,
2390,,1,,12018,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat striatal membranes by [3H]ketanserin displacement.,,B,,H,4,Autocuration,CHEMBL617668,,
2391,,1,,10394,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 2 receptor in rat cortical membranes using [3H]ketanserin as a radioligand,,B,,H,4,Autocuration,CHEMBL617669,,
2392,,1,,15260,BAO_0000224,,Inhibitory activity against rat cortical 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617670,,
2393,Rattus norvegicus,1,,11624,BAO_0000224,,Inhibitory constant against 5-hydroxytryptamine 2 receptor,,B,,D,5,Autocuration,CHEMBL617671,,
2394,,1,,13654,BAO_0000224,,Percentage specific displacement of radioligand [3H]-ketanserin from 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617672,,
2395,,1,,9541,BAO_0000019,,Potency to displace [3H]- Spiperone from 5-hydroxytryptamine 2 receptor in rat striatum,,B,,H,4,Autocuration,CHEMBL617673,,
2396,,1,,11933,BAO_0000224,,Tested for binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortical regions using [3H]ketanserin as radioligand,,B,,H,4,Autocuration,CHEMBL617674,,
2397,,1,,15538,BAO_0000019,,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex,,B,,H,4,Autocuration,CHEMBL617675,,
2398,,1,,15538,BAO_0000019,,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; NA means Not Active,,B,,H,4,Autocuration,CHEMBL617676,,
2399,,1,,15538,BAO_0000019,,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; not determined,,B,,H,4,Autocuration,CHEMBL617677,,
2400,,1,,8841,BAO_0000019,,Displacement of [3H]ketanserin from rat prefrontal cortex 5-hydroxytryptamine 2 receptor,,B,,D,5,Autocuration,CHEMBL617678,,
2401,,1,,1455,BAO_0000224,,Binding affinity to 5-hydroxytryptamine 2 receptor using [3H]ketanserin radioligand assay.,,B,,H,4,Autocuration,CHEMBL617679,,
2402,,1,,1455,BAO_0000224,,Tested for its binding affinity to Tested for its binding affinity to 5-hydroxytryptamine 2 receptor using [3H]-ketanserin radioligand assay using [3H]-ketanserin radioligand assay,,B,,H,4,Autocuration,CHEMBL617680,,
2403,,1,,11752,BAO_0000019,,The ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat whole brain,,B,,H,4,Autocuration,CHEMBL617681,,
2404,,1,955.0,11642,BAO_0000221,,The binding affinity was measured on 5-hydroxytryptamine 2 receptor in rat brain tissue,,B,,H,4,Autocuration,CHEMBL617682,,
2405,,1,,12092,BAO_0000224,,The binding affinity was measured on 5-hydroxytryptamine 2 receptor using [3H]- spiperone as radioligand.,,B,,H,4,Autocuration,CHEMBL617683,,
2406,,1,,3967,BAO_0000224,,Binding affinity at 5-hydroxytryptamine 2 receptor from striata wistar rats by [3H]ketanserin displacement.,,B,,H,4,Autocuration,CHEMBL617684,,
2407,Rattus norvegicus,1,,12771,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor,,B,,D,5,Autocuration,CHEMBL617685,,
2408,,1,,11642,BAO_0000019,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [3H]ketanserin radioligand in rat cerebral cortex,,B,,H,4,Autocuration,CHEMBL617686,,
2409,,1,,11628,BAO_0000224,,The compound was tested in vitro for binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [125]I-LSD radioligand,,B,,H,4,Autocuration,CHEMBL617687,,
2410,,1,,13654,BAO_0000224,,Percentage specific displacement of radioligand [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,B,,H,4,Autocuration,CHEMBL617688,,
2411,,1,,11200,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,F,,H,4,Autocuration,CHEMBL617689,,
2412,,1,,11200,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,F,,H,4,Autocuration,CHEMBL617690,,
2413,,1,,11200,BAO_0000218,,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",,F,,H,4,Autocuration,CHEMBL617691,,
2414,,1,,11200,BAO_0000218,,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",,F,,H,4,Autocuration,CHEMBL617692,,
2415,,1,,11200,BAO_0000218,,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",,F,,H,4,Autocuration,CHEMBL617693,,
2416,,1,,11200,BAO_0000218,,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",,F,,H,4,Autocuration,CHEMBL617694,,
2417,,1,955.0,15436,BAO_0000221,,Affinity for 5-hydroxytryptamine 2A receptor in rat brain cortex by ability to displace [3H]ketanserin,,B,,H,8,Expert,CHEMBL857985,,
2418,Rattus norvegicus,1,,15436,BAO_0000019,,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,,B,,D,9,Expert,CHEMBL617695,,
2419,,1,,14025,BAO_0000019,,Affinity pKi for 5-hydroxytryptamine 2A receptor was measured in rat cortex homogenates,,B,,H,8,Autocuration,CHEMBL617696,,
2420,,1,,4342,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor was determined,,B,,H,8,Autocuration,CHEMBL617697,,
2421,Rattus norvegicus,1,,13735,BAO_0000019,,Displacement of [3H]ketanserin from 5-HT2A receptor of rat frontal cortex,,B,,D,9,Expert,CHEMBL617257,,
2422,Rattus norvegicus,1,,5816,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,,B,,D,9,Expert,CHEMBL617258,,
2423,,1,,14287,BAO_0000019,,Binding affinity was evaluated in vitro by displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor on rat cortical membrane,,B,,H,8,Expert,CHEMBL617259,,
2424,,1,,15738,BAO_0000357,,In vitro affinity against serotonin ( 5-hydroxytryptamine 2A receptor ) receptor,,B,,H,8,Autocuration,CHEMBL617260,,
2425,Rattus norvegicus,1,,15738,BAO_0000357,,In vitro affinity against serotonin 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL617261,,
2426,,1,,15026,BAO_0000019,,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]-ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL617262,,
2427,,1,,16647,BAO_0000019,,Half-maximal inhibition of [3H]- Ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,,B,,H,8,Expert,CHEMBL617263,,
2428,,1,,16647,BAO_0000019,,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat tissue homogenate,,B,,H,8,Autocuration,CHEMBL617264,,
2429,Rattus norvegicus,1,,13345,BAO_0000019,,Displacement of [3H]-ketanserin from rat brain 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL617265,,
2430,,1,,1543,BAO_0000249,,Inhibition constant for in vitro inhibition of [3H]ketanserin binding to rat frontal cortex membranes 5-hydroxytryptamine 2A receptor,Membranes,B,,H,8,Autocuration,CHEMBL617266,,
2431,,1,,12444,BAO_0000019,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor rat frontal cortex membrane,,B,,H,8,Autocuration,CHEMBL617267,,
2432,,1,,16404,BAO_0000019,,Inhibitory constant on 5-hydroxytryptamine 2A receptor of Rat frontal cortex,,B,,H,8,Expert,CHEMBL617268,,
2433,,1,,16404,BAO_0000219,,Inhibitory constant on human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,,B,,H,8,Autocuration,CHEMBL617269,449.0,
2434,,1,,15577,BAO_0000357,,Kinetic inhibition constant evaluated by measuring serotonergic activity,,B,,H,8,Expert,CHEMBL617323,,
2435,,1,,15577,BAO_0000357,,Serotonergic activity of the compound.,,B,,H,8,Autocuration,CHEMBL617324,,
2436,,1,,2495,BAO_0000249,,Tested in vitro for its ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat frontal cortex membranes,,B,,H,8,Autocuration,CHEMBL617325,,
2437,Rattus norvegicus,1,,15042,BAO_0000019,,The binding affinity was evaluated on 5-hydroxytryptamine 2A receptor expressed in rat cortex by using [3H]ketanserin as radioligand.,,B,,D,9,Expert,CHEMBL617326,,
2438,,1,,15026,BAO_0000249,,In vitro ability to displace [3H]ketanserin binding from 5-hydroxytryptamine 2A receptor in rat striatal membrane.,,B,,H,8,Expert,CHEMBL617327,,
2439,Rattus norvegicus,1,,12919,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,F,,D,9,Expert,CHEMBL617328,,
2440,Rattus norvegicus,1,,12919,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,F,,D,9,Expert,CHEMBL617329,,
2441,Rattus norvegicus,1,,12919,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,F,,D,9,Expert,CHEMBL617330,,
2442,,1,,15194,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL617331,,
2443,,1,,15194,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand.,,B,,H,8,Autocuration,CHEMBL617332,,
2444,,1,,4820,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor,,B,,H,8,Expert,CHEMBL617333,,
2445,,1,,6736,BAO_0000357,,Binding affinity against serotonin 5-hydroxytryptamine 2A receptor was determined using human [125I]-eotaxin,,B,,H,8,Autocuration,CHEMBL617334,,
2446,,1,,5163,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.000001 mol/L,,B,,H,8,Autocuration,CHEMBL617335,,
2447,,1,,5163,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.00001 mol/L,,B,,H,8,Autocuration,CHEMBL617336,,
2448,,1,,6011,BAO_0000357,,Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration,,B,,H,8,Autocuration,CHEMBL617337,,
2449,Homo sapiens,1,,14294,BAO_0000357,,Percent inhibition against 5-hydroxytryptamine 2A receptor using [3H]ketanserin at 1 uM,,B,,D,9,Expert,CHEMBL617338,,
2450,,1,,5014,BAO_0000357,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617339,,
2451,,1,,17066,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor,,B,,H,8,Expert,CHEMBL617340,,
2452,,1,,17515,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor; inactive at 10 uM,,B,,H,8,Autocuration,CHEMBL617341,,
2453,,1,,6736,BAO_0000357,,Inhibition of [125I]-eotaxin binding to serotonin 5-hydroxytryptamine 2A receptor,,B,,H,8,Expert,CHEMBL617342,,
2454,,1,,5163,BAO_0000357,,Affinity for 5-hydroxytryptamine 2A receptor,,B,,H,8,Expert,CHEMBL617343,,
2455,,1,,16911,BAO_0000219,,Binding affinity was performed using [3H]ketanserin as the radioligand and stably transfected NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor (GF-62 cells).,,B,,H,8,Expert,CHEMBL617344,723.0,
2456,,1,,6841,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,,B,,H,8,Expert,CHEMBL617345,,
2457,,1,,6119,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand.,,B,,H,8,Expert,CHEMBL617346,,
2458,,1,,3962,BAO_0000357,,Compound was evaluated for its binding against 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617347,,
2459,,1,,4373,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2A receptor was determined,,B,,H,8,Autocuration,CHEMBL617348,,
2460,,1,,4373,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1)for 5-hydroxytryptamine 2A receptor was determined,,B,,H,8,Autocuration,CHEMBL617349,,
2461,,1,,3962,BAO_0000019,,Compound was evaluated for its inverse agonist activity against 5-hydroxytryptamine 2A receptor,,F,,H,8,Autocuration,CHEMBL617350,,
2462,,1,,1633,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin,,B,,H,8,Expert,CHEMBL872339,,
2463,,1,,4373,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2A receptor was determined,,B,,H,8,Autocuration,CHEMBL617351,,
2464,,1,,6576,BAO_0000357,,Binding affinity towards serotonin 5-hydroxytryptamine 2A receptor,,B,,H,8,Expert,CHEMBL617352,,
2465,,1,,4687,BAO_0000357,,Evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617353,,
2466,,1,,16946,BAO_0000357,,Ability to displace [3H]-ketanserin from 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617354,,
2467,,1,,14159,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617355,,
2468,Mus musculus,1,,3032,BAO_0000219,,In vitro binding affinity against 5-hydroxytryptamine 2A receptor in CHO cells,,B,,H,8,Expert,CHEMBL617356,449.0,
2469,,1,,16655,BAO_0000357,,Inhibition of ketanserin binding to 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617357,,
2470,,1,,13964,BAO_0000357,,Binding affinity at 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617358,,
2471,,1,,16989,BAO_0000357,,Binding affinity towards Serotonin 5-hydroxytryptamine 2A receptor,,B,,H,8,Expert,CHEMBL617359,,
2472,,1,,16117,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor was determined,,B,,H,8,Autocuration,CHEMBL617360,,
2473,,1,,16700,BAO_0000357,,The binding affinity towards 5-hydroxytryptamine 2A receptor; No affinity,,B,,H,8,Autocuration,CHEMBL875913,,
2474,,1,,3269,BAO_0000357,,Affinity against 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617361,,
2475,Homo sapiens,1,,1274,BAO_0000357,,Binding affinity against 5-Hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL617362,,
2476,,1,,1317,BAO_0000357,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using radioligand binding assay,,B,,H,8,Autocuration,CHEMBL617363,,
2477,,1,,12146,BAO_0000357,,Tested against 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617364,,
2478,,1,,12652,BAO_0000224,,Binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,,B,,H,4,Autocuration,CHEMBL617365,,
2479,,1,,12652,BAO_0000224,,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H] ketanserin,,B,,H,4,Autocuration,CHEMBL617366,,
2480,,1,,12652,BAO_0000224,,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor agonist [125I]- - (+/-)DOI,,B,,H,4,Autocuration,CHEMBL617367,,
2481,,1,,12652,BAO_0000224,,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,,B,,H,4,Autocuration,CHEMBL617368,,
2482,,1,,16647,BAO_0000357,,Selectivity ratio towards 5-hydroxytryptamine 2A receptor to Dopamine receptor D2 (5-HT2A/D2 ),,B,,H,8,Autocuration,CHEMBL617369,,
2483,Homo sapiens,1,,15851,BAO_0000219,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND means no data,,B,,D,9,Expert,CHEMBL617370,722.0,
2484,Homo sapiens,1,,6857,BAO_0000219,,Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader,,F,,D,9,Expert,CHEMBL617371,449.0,
2485,,1,,3805,BAO_0000357,,In vitro binding affinity against human 5-HT2B receptor at a concentration of 100 (nM),,B,,H,8,Autocuration,CHEMBL617372,,
2486,Homo sapiens,1,,6491,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 2B serotonin receptor,,B,,D,9,Expert,CHEMBL617373,,
2487,,1,,14093,BAO_0000019,,Agonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT radioligand,,F,,H,8,Autocuration,CHEMBL617374,,
2488,,1,,13481,BAO_0000019,,Agonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]-5-HT as radioligand,,F,,H,8,Autocuration,CHEMBL617375,,
2489,,1,,14093,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand,,F,,H,8,Autocuration,CHEMBL617376,,
2490,,1,,14093,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand; Not tested,,F,,H,8,Autocuration,CHEMBL617377,,
2491,,1,,14093,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine radioligand,,F,,H,8,Autocuration,CHEMBL617378,,
2492,,1,,13481,BAO_0000019,,Antagonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,,F,,H,8,Autocuration,CHEMBL617379,,
2493,,1,,14442,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine as radioligand,,B,,H,8,Autocuration,CHEMBL617380,,
2494,,1,,14442,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT 2B as radioligand,,B,,H,8,Autocuration,CHEMBL617381,,
2495,,1,,14442,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,,B,,H,8,Autocuration,CHEMBL617382,,
2496,,1,,12369,BAO_0000357,,The compound evaluated for its affinity against 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617383,,
2497,,1,,12369,BAO_0000357,,Affinity against 5-hydroxytryptamine 2A receptor (D) labeled with [125I]DOI.,,B,,H,8,Expert,CHEMBL617384,,
2498,,1,,12369,BAO_0000357,,Affinity against 5-hydroxytryptamine 2A receptor (K) labeled with [3H]ketanserin.,,B,,H,8,Expert,CHEMBL617385,,
2499,,1,,14447,BAO_0000019,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes,,B,,H,8,Autocuration,CHEMBL617386,,
2500,,1,,14447,BAO_0000019,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes.,,B,,H,8,Autocuration,CHEMBL617387,,
2501,,1,,17451,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,B,,H,8,Autocuration,CHEMBL617388,723.0,
2502,,1,,6857,BAO_0000219,,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,F,,H,8,Autocuration,CHEMBL617389,449.0,
2503,Homo sapiens,1,,6857,BAO_0000219,,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,F,,D,9,Expert,CHEMBL617390,449.0,
2504,,1,,5635,BAO_0000224,,Selectivity ratio of binding affinity of 5-hydroxytryptamine 2A receptor to that of 5-hydroxytryptamine 2C receptor.,,B,,H,4,Autocuration,CHEMBL617391,,
2505,,1,,12861,BAO_0000357,,Binding activity radioligand.,,B,,H,8,Autocuration,CHEMBL617392,,
2506,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,B,,H,8,Autocuration,CHEMBL617393,,
2507,,1,,5105,BAO_0000219,,Binding affinity for human cloned 5-HT2A receptor expressed in L929 cells using [125I]R91150 as radioligand,,B,,H,8,Autocuration,CHEMBL617394,307.0,
2508,,1,,5104,BAO_0000219,,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand,,B,,H,8,Expert,CHEMBL617395,307.0,
2509,,1,,5105,BAO_0000219,,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells by [125I]R91150 displacement.,,B,,H,8,Expert,CHEMBL617396,307.0,
2510,,1,,5105,BAO_0000219,,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand; Not tested,,B,,H,8,Autocuration,CHEMBL617397,307.0,
2511,,1,,5254,BAO_0000357,,Binding affinity against 5-HT2A receptor,,B,,H,8,Autocuration,CHEMBL617398,,
2512,,1,,5254,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617399,,
2513,,1,,13267,BAO_0000219,,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL617400,722.0,
2514,,1,,13267,BAO_0000219,,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL617401,722.0,
2515,Homo sapiens,1,,14157,BAO_0000219,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells,,B,,D,9,Expert,CHEMBL617402,722.0,
2516,Homo sapiens,1,,12936,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,,B,,D,9,Expert,CHEMBL617403,722.0,
2517,,1,,14068,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 2A receptor using displacement of [3H]5-HT,,B,,H,8,Expert,CHEMBL617404,,
2518,Homo sapiens,1,,12936,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,,B,,D,9,Expert,CHEMBL857981,722.0,
2519,Homo sapiens,1,,12936,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,,B,,D,9,Expert,CHEMBL617405,722.0,
2520,Homo sapiens,1,,4540,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]- ketanserin as radioligand,,B,,D,9,Expert,CHEMBL617253,722.0,
2521,,1,,6166,BAO_0000357,,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor.,,B,,H,8,Expert,CHEMBL617254,,
2522,,1,,17296,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL617255,722.0,
2523,,1,,17296,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL617256,722.0,
2524,,1,,17296,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL616874,722.0,
2525,Homo sapiens,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 2A receptor (human cloned receptor) in HEK 293 cells using [3H]ketanserin as radioligand.,,B,,D,9,Expert,CHEMBL616875,722.0,
2526,,1,,14391,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells using [3H]ketanserin as radioligand,,B,,H,8,Expert,CHEMBL616876,722.0,
2527,,1,,15851,BAO_0000219,,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2A in HEK293 cells, using [3H]ketanserin as radioligand.",,B,,H,8,Expert,CHEMBL616877,722.0,
2528,Homo sapiens,1,,15851,BAO_0000219,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells; compound is insoluble,,B,,D,9,Expert,CHEMBL616878,722.0,
2529,,1,,3832,BAO_0000219,,Binding affinity towards human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by displacement of [3H]ketanserin,,B,,H,8,Expert,CHEMBL616879,722.0,
2530,,1,,3833,BAO_0000219,,In vitro binding affinity at human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by [3H]ketanserin displacement.,,B,,H,8,Expert,CHEMBL616880,722.0,
2531,Homo sapiens,1,,12936,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,,B,,D,9,Expert,CHEMBL616881,722.0,
2532,,1,,17451,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL616882,723.0,
2533,,1,,17451,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,B,,H,8,Autocuration,CHEMBL616883,723.0,
2534,,1,,17451,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,B,,H,8,Autocuration,CHEMBL616884,723.0,
2535,,1,,4199,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]ketanserin as the radioligand,,B,,H,8,Autocuration,CHEMBL616885,722.0,
2536,,1,,1883,BAO_0000219,,Compound was evaluated for displacement of [3H]ketanserin from human cloned 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells,,B,,H,8,Autocuration,CHEMBL616886,485.0,
2537,,1,,1883,BAO_0000219,,Displacement of [3H]-ketanserin from human cloned 5-hydroxytryptamine 2A receptor expressed in CHO-K1 cells.,,B,,H,8,Expert,CHEMBL616887,485.0,
2538,Homo sapiens,1,,14875,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL616888,,
2539,,1,,15146,BAO_0000219,,Compound was tested for its binding affinity against 5-hydroxytryptamine 2A receptor in human cloned receptors in HEK 293 cells using [3H]ketanserin,,B,,H,8,Autocuration,CHEMBL616889,722.0,
2540,,1,,5213,BAO_0000219,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2A receptor in HEK 293 using [3H]ketanserin as a radioligand,,B,,H,8,Autocuration,CHEMBL616890,722.0,
2541,Homo sapiens,1,,16404,BAO_0000219,,Inhibitory constant for human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,,B,,D,9,Expert,CHEMBL616891,449.0,
2542,,1,,14818,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2A receptor in HEK293 cells using [3H]-ketanserin.,,B,,H,8,Autocuration,CHEMBL616892,722.0,
2543,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2A receptor in HEK293 cells, using [3H]ketanserin as radioligand",,B,,H,8,Autocuration,CHEMBL616893,722.0,
2544,,1,,12652,BAO_0000219,,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2A receptor in 3T3 cells,,F,,H,8,Autocuration,CHEMBL616894,723.0,
2545,,1,,4682,BAO_0000219,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells,,B,,H,8,Expert,CHEMBL616895,723.0,
2546,,1,,12652,BAO_0000019,,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2A receptor,,F,,H,8,Autocuration,CHEMBL616896,,
2547,,1,,4921,BAO_0000357,,Ability to displace [3H]-Ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617099,,
2548,,1,,4921,BAO_0000357,,Ability to displace [3H]ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor; ND denotes not determined,,B,,H,8,Autocuration,CHEMBL617100,,
2549,Oryctolagus cuniculus,1,,16312,BAO_0000357,,Binding affinity against rabbit aorta 5-HT2A receptor,,B,,H,8,Autocuration,CHEMBL884532,,
2550,Oryctolagus cuniculus,1,,14998,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2A receptor of rabbit aorta ring preparations,,B,,H,8,Expert,CHEMBL617101,,
2551,Oryctolagus cuniculus,1,,14025,BAO_0000357,,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 2A receptor in the rabbit saphenous aorta,,B,,H,8,Expert,CHEMBL617102,,
2552,Oryctolagus cuniculus,1,,13047,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,,B,,H,8,Autocuration,CHEMBL617103,,
2553,Oryctolagus cuniculus,1,,13047,BAO_0000357,,The compound was tested for binding affinity against 5-HT2A receptor,,B,,H,8,Expert,CHEMBL617104,,
2554,,1,,1883,BAO_0000219,,Compound was evaluated for displacement of [3H]ketanserin from cloned rat 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells.,,B,,H,8,Autocuration,CHEMBL857979,485.0,
2555,,1,,13463,BAO_0000019,,Binding affinity analysed towards 5-HT 2A in rat jugular vein,,B,,H,8,Autocuration,CHEMBL857502,,
2556,,1,,13463,BAO_0000019,,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,,B,,H,8,Autocuration,CHEMBL617105,,
2557,,1,945.0,13463,BAO_0000019,,Binding affinity analysed on 5-HT 2A in rat stomach fundus.,,B,,H,8,Autocuration,CHEMBL858021,,
2558,Rattus norvegicus,1,945.0,13463,BAO_0000019,,Binding affinity for 5-HT 2A in rat stomach fundus,,B,,D,9,Expert,CHEMBL875910,,
2559,,1,,13463,BAO_0000019,,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,,B,,H,8,Autocuration,CHEMBL617106,,
2560,,1,,16326,BAO_0000219,,Ability to stimulate phosphoinositide hydrolysis in NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor,,B,,H,8,Expert,CHEMBL617107,723.0,
2561,,1,,14093,BAO_0000019,,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2A receptor,,F,,H,8,Autocuration,CHEMBL617108,,
2562,,1,,14093,BAO_0000019,,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast expressing 5-hydroxytryptamine 2A receptor,,F,,H,8,Autocuration,CHEMBL617109,,
2563,,1,,15740,BAO_0000357,,Evaluated for the effective concentration at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617110,,
2564,,1,,16633,BAO_0000357,,Functional potency at the rat 5-hydroxytryptamine 2A receptor as effective concentration EC50 for stimulating Phosphoinositide accumulation,,B,,H,8,Autocuration,CHEMBL617111,,
2565,Rattus norvegicus,1,,17200,BAO_0000019,,In vitro relative agonist activity against 5-hydroxytryptamine 2A using PI assay in rat vascular smooth muscle cells,,F,,D,9,Expert,CHEMBL617112,,
2566,,1,,17133,BAO_0000357,,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617113,,
2567,,1,,17133,BAO_0000357,,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617114,,
2568,,1,,17133,BAO_0000357,,Tested for its ability to activate phospholipase c by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617115,,
2569,,1,,17200,BAO_0000219,,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,F,,H,8,Autocuration,CHEMBL617116,,
2570,,1,,15363,BAO_0000019,,Efficacy at 5-hydroxytryptamine 2A receptor,,F,,H,8,Autocuration,CHEMBL617117,,
2571,,1,,17200,BAO_0000357,,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),,B,,H,8,Autocuration,CHEMBL617118,,
2572,Rattus norvegicus,1,,17200,BAO_0000357,,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),,B,,D,9,Expert,CHEMBL617119,,
2573,Rattus norvegicus,1,,17200,BAO_0000357,,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor determined by using PI assay (Emax),,B,,D,9,Expert,CHEMBL617120,,
2574,Rattus norvegicus,1,,17200,BAO_0000219,,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,F,,D,9,Expert,CHEMBL617121,,
2575,,1,,17200,BAO_0000219,,The receptor (5-hydroxytryptamine 2A) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,F,,H,8,Autocuration,CHEMBL617122,,
2576,,1,,17211,BAO_0000019,,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617123,,
2577,,1,,17331,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes,,B,,H,8,Expert,CHEMBL617124,,
2578,,1,,13565,BAO_0000249,,Binding affinity to serotonin 5-hydroxytryptamine 2A receptors using a radioligand [3H]ketanserin binding assay in rat cortical membranes,,B,,H,8,Expert,CHEMBL617600,,
2579,,1,,13730,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was evaluated using [3H]- ketanserin as radioligand,,B,,H,8,Expert,CHEMBL617601,,
2580,,1,,12416,BAO_0000019,,In vitro affinity towards 5-hydroxytryptamine 2A receptor using [3H]spiroperidol as radioligand in cortex,,B,,H,8,Expert,CHEMBL882923,,
2581,,1,,15295,BAO_0000357,,Compound was tested for it's binding affinity towards 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617602,,
2582,,1,,1742,BAO_0000019,,Compound was tested for its ability to displace [3H]DOB from 5-hydroxytryptamine 2A receptor in rat cortex homogenates,,B,,H,8,Autocuration,CHEMBL617603,,
2583,,1,,15295,BAO_0000357,,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617604,,
2584,,1,,14970,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]ketanserin as radioligand,,B,,H,8,Expert,CHEMBL617605,,
2585,,1,,16693,BAO_0000019,,In vitro binding affinity for serotonin 5-hydroxytryptamine 2A receptor of rat cerebral cortex using [3H]ketanserin as radioligand,,B,,H,8,Expert,CHEMBL617606,,
2586,Rattus norvegicus,1,,14776,BAO_0000019,,Inhibition of [3H]ketanserin binding to rat frontal cortex membrane 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL617607,,
2587,,1,,14286,BAO_0000249,,In vitro inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cortical membrane,,B,,H,8,Autocuration,CHEMBL617455,,
2588,Rattus norvegicus,1,,17200,BAO_0000019,,In vitro inhibition of [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,,B,,D,9,Expert,CHEMBL617456,,
2589,,1,,15306,BAO_0000357,,Inhibitory concentration against 5-hydroxytryptamine 2A receptor (Inactive at >1000 nM concentration),,B,,H,8,Expert,CHEMBL617457,,
2590,Rattus norvegicus,1,,14178,BAO_0000357,,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL617458,,
2591,Rattus norvegicus,1,,14229,BAO_0000019,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor from rat brain,,B,,D,9,Expert,CHEMBL617459,,
2592,,1,,12884,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor binding site using [3H]ketanserin. ,,B,,H,8,Expert,CHEMBL617460,,
2593,,1,,13149,BAO_0000357,,"Binding affinity for 5-hydroxytryptamine 2A receptor, activity is expressed as IC50 values.",,B,,H,8,Expert,CHEMBL617461,,
2594,Rattus norvegicus,1,,15295,BAO_0000019,,Displacement of [3H]ketanserin from rat cortical membrane 5-hydroxytryptamine 2A receptor at 10e-7 M,,B,,D,9,Expert,CHEMBL617462,,
2595,,1,,15740,BAO_0000357,,Intrinsic activity was determined at 5-hydroxytryptamine 2A receptor which is percentage response given compared with the response produced by 10 uM serotonin.,,B,,H,8,Autocuration,CHEMBL617463,,
2596,,1,,15185,BAO_0000019,,"Compound was tested for binding affinity at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate using [125I]-2,5-Dimethoxy -4-iodoamphetamine (DOI).",,B,,H,8,Autocuration,CHEMBL617464,,
2597,,1,,15185,BAO_0000019,,"Compound was tested for binding affinity using [3H]MDL-100,907 at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate.",,B,,H,8,Autocuration,CHEMBL617465,,
2598,,1,,17529,BAO_0000019,,Ability to bind to central serotonin 5-hydroxytryptamine 2A receptor in vitro in cortex of the rat brain using [3H]ketanserin radioligand,,B,,H,8,Expert,CHEMBL617466,,
2599,,1,,14826,BAO_0000019,,Ability to displace [3H]- ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,,B,,H,8,Autocuration,CHEMBL617467,,
2600,,1,,17211,BAO_0000019,,Displacement of [3H]ketanserin (0.5 nM) from rat cerebral cortex 5-hydroxytryptamine 2A receptors,,B,,H,8,Expert,CHEMBL617468,,
2601,,1,,14826,BAO_0000019,,Ability to displace [3H]ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,,B,,H,8,Autocuration,CHEMBL617469,,
2602,,1,,14093,BAO_0000019,,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617470,,
2603,,1,,14093,BAO_0000019,,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor; Not tested,,B,,H,8,Autocuration,CHEMBL617471,,
2604,,1,,13246,BAO_0000219,,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor in NIH3T3 cell line membranes,,B,,H,8,Expert,CHEMBL617472,723.0,
2605,,1,,13246,BAO_0000357,,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor.,,B,,H,8,Expert,CHEMBL617473,,
2606,Rattus norvegicus,1,,15436,BAO_0000019,,Affinity 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,,B,,D,9,Expert,CHEMBL617474,,
2607,Rattus norvegicus,1,,15436,BAO_0000019,,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,,B,,D,9,Expert,CHEMBL617475,,
2608,,1,955.0,14442,BAO_0000221,,Affinity at [3H]ketanserin-labeled 5-hydroxytryptamine 2A receptor in rat brain homogenate was determined,,B,,H,8,Autocuration,CHEMBL617476,,
2609,,1,,12457,BAO_0000357,,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2A receptor,,B,,H,8,Expert,CHEMBL617477,,
2610,,1,,12457,BAO_0000219,,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2A receptor,,B,,H,8,Expert,CHEMBL617478,723.0,
2611,,1,,14755,BAO_0000221,,"Antagonistic activity measured for 5-hydroxytryptamine 2A receptor using [3H]-MDL- 100,907 as radioligand in rat cortical homogenates.",,F,,H,8,Autocuration,CHEMBL617479,,
2612,,1,,4707,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was determined using [125I]- DOI as radioligand,,B,,H,8,Autocuration,CHEMBL617480,,
2613,,1,,13297,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2A receptor,,B,,H,8,Expert,CHEMBL617481,,
2614,,1,,17331,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat prefrontal cerebral cortex mambranes,,B,,H,8,Expert,CHEMBL617482,,
2615,,1,,4664,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor from rat forebrain using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL617483,,
2616,,1,,16633,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,B,,H,8,Autocuration,CHEMBL621528,,
2617,Rattus norvegicus,1,,4664,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells using [3H]ketanserin,,B,,D,9,Expert,CHEMBL621529,723.0,
2618,,1,,16133,BAO_0000357,,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,B,,H,8,Expert,CHEMBL621530,,
2619,,1,,16133,BAO_0000357,,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,B,,H,8,Expert,CHEMBL621531,,
2620,Rattus norvegicus,1,,14060,BAO_0000019,,Binding affinity against rat brain 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL621532,,
2621,,1,,16326,BAO_0000357,,Binding affinity at cloned rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,B,,H,8,Expert,CHEMBL621533,,
2622,,1,,16659,BAO_0000219,,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,B,,H,8,Expert,CHEMBL621534,449.0,
2623,,1,,14776,BAO_0000019,,Binding affinity measured at the 5-hydroxytryptamine 2A receptor by the inhibition of [3H]ketanserin binding to rat cortex using unlabeled mianserin for nonspecific binding.,,B,,H,8,Autocuration,CHEMBL621535,,
2624,,1,,13481,BAO_0000357,,Binding affinity of [3H]- ketanserin labelled towards Rat cortical 5-hydroxytryptamine 2A receptor using radioligand binding assay,,B,,H,8,Autocuration,CHEMBL621536,,
2625,,1,,17386,BAO_0000357,,Binding affinity of compound was tested for 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL621537,,
2626,Rattus norvegicus,1,,6611,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL621538,,
2627,,1,,14423,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as the radioligand.,,B,,H,8,Autocuration,CHEMBL621539,,
2628,,1,,15412,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex,,B,,H,8,Autocuration,CHEMBL621540,,
2629,,1,,15412,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex.,,B,,H,8,Autocuration,CHEMBL621541,,
2630,,1,,6238,BAO_0000019,,Binding affinity towards 5-HT 2A receptor in rat cerebral frontal cortex membranes using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL621542,,
2631,,1,,6648,BAO_0000357,,Binding affinity at 5-hydroxytryptamine 2A receptor of rat.,,B,,H,8,Expert,CHEMBL621543,,
2632,,1,,5667,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor sites by using [3H]ketanserin as radioligand,,B,,H,8,Expert,CHEMBL621544,,
2633,Rattus norvegicus,1,,6611,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2A serotonin receptor,,B,,D,9,Expert,CHEMBL621545,,
2634,,1,,13481,BAO_0000357,,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL621546,,
2635,,1,,13481,BAO_0000357,,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand; Not tested,,B,,H,8,Autocuration,CHEMBL621547,,
2636,,1,,15558,BAO_0000219,,Displacement of [3H]ketanserin from NIH3T3 cells stably expressing rat 5-hydroxytryptamine 2A receptor,,B,,H,8,Expert,CHEMBL618692,723.0,
2637,,1,,6013,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL618693,,
2638,,1,,16633,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,B,,H,8,Autocuration,CHEMBL872922,,
2639,,1,,6013,BAO_0000357,,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor from fundus tissue was determined using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL618694,,
2640,Rattus norvegicus,1,,6013,BAO_0000357,,Binding affinity for rat 5-hydroxytryptamine 2A receptor using [3H]DOB,,B,,D,9,Expert,CHEMBL618695,,
2641,,1,,6013,BAO_0000357,,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor was determined using [3H]DOB as radioligand; ND=No data,,B,,H,8,Autocuration,CHEMBL618696,,
2642,,1,,6013,BAO_0000357,,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor by [3H]ketanserin displacement.,,B,,H,8,Expert,CHEMBL618697,,
2643,,1,,6013,BAO_0000357,,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]DOB as radioligand,,B,,H,8,Autocuration,CHEMBL618892,,
2644,,1,,6013,BAO_0000357,,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL618893,,
2645,,1,,16293,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL618894,,
2646,,1,,17175,BAO_0000219,,Binding affinity towards rat 5-hydroxytryptamine 2A receptor expressed in NIH3T3 cells using [3H]ketanserin as radioligand,,B,,H,8,Expert,CHEMBL618895,723.0,
2647,Rattus norvegicus,1,,13278,BAO_0000357,,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,,B,,D,9,Expert,CHEMBL618896,,
2648,,1,5383.0,3682,BAO_0000019,,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2A receptor in homogenate of caudate putamen tissue from rat brain,,B,,H,8,Autocuration,CHEMBL618897,,
2649,,1,,2014,BAO_0000357,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand,,B,,H,8,Autocuration,CHEMBL618898,,
2650,,1,,2014,BAO_0000357,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand; Not determined,,B,,H,8,Autocuration,CHEMBL618899,,
2651,,1,,4932,BAO_0000357,,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2A receptor in cloned rat cell culture,,B,,H,8,Autocuration,CHEMBL618900,,
2652,,1,,4932,BAO_0000019,,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2A receptor in cloned rat prefrontal cortex homogenate,,B,,H,8,Autocuration,CHEMBL618901,,
2653,,1,,3935,BAO_0000357,,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL618902,,
2654,Rattus norvegicus,1,10000000.0,5432,BAO_0000221,,Displacement of [3H]8-OH-DPAT from rat hippocampus membrane 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL618903,,
2655,,1,,15818,BAO_0000357,,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL618904,,
2656,,1,,13672,BAO_0000357,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand.,,B,,H,8,Autocuration,CHEMBL618905,,
2657,,1,,13672,BAO_0000357,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]-ketanserin radioligand.,,B,,H,8,Autocuration,CHEMBL618906,,
2658,,1,,14749,BAO_0000219,,Binding affinity against rat 5-hydroxytryptamine 2A receptor in NIH3T3 cells.,,B,,H,8,Expert,CHEMBL618907,723.0,
2659,,1,,13462,BAO_0000019,,Compound was tested for the Binding affinity against rat frontal cortex 5-hydroxytryptamine 2A receptor by Radio ligand [3H]ketanserin binding assay.,,B,,H,8,Autocuration,CHEMBL618908,,
2660,,1,,15740,BAO_0000357,,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617909,,
2661,,1,,16647,BAO_0000019,,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,,B,,H,8,Expert,CHEMBL617910,,
2662,,1,955.0,13345,BAO_0000221,,In vitro ability to displace [3H]ketanserin from 5-hydroxytryptamine 2A receptor in rat brain.,,B,,H,8,Autocuration,CHEMBL617911,,
2663,,1,,16740,BAO_0000249,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,B,,H,8,Autocuration,CHEMBL872923,,
2664,,1,,16740,BAO_0000249,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,B,,H,8,Autocuration,CHEMBL617912,,
2665,Rattus norvegicus,1,,15535,BAO_0000019,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat cortex,,B,,D,9,Expert,CHEMBL617913,,
2666,,1,,16740,BAO_0000249,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,B,,H,8,Expert,CHEMBL617914,,
2667,,1,,16740,BAO_0000249,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,B,,H,8,Autocuration,CHEMBL617915,,
2668,,1,,16740,BAO_0000249,,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane,,B,,H,8,Autocuration,CHEMBL617916,,
2669,Rattus norvegicus,1,,4795,BAO_0000019,,Displacement of [3H]- Ketanserin from rat cortex 5-hydroxytryptamine 2A receptor,,B,,D,9,Expert,CHEMBL617917,,
2670,,1,,8,BAO_0000019,,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand,,B,,H,8,Expert,CHEMBL617918,,
2671,,1,,8,BAO_0000019,,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand; Not active at 10-5 M,,B,,H,8,Autocuration,CHEMBL617919,,
2672,Rattus norvegicus,1,,17200,BAO_0000019,,In vitro inhibitory constant against [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,,B,,D,9,Expert,CHEMBL617920,,
2673,Rattus norvegicus,1,,2148,BAO_0000019,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor of rat brain cortex,,B,,D,9,Expert,CHEMBL617921,,
2674,Rattus norvegicus,1,,13345,BAO_0000224,,"Relative binding affinity for D2 receptor and 5-hydroxytryptamine 2A receptor, ratio of Ki",,B,,D,5,Expert,CHEMBL617922,,
2675,,1,,5088,BAO_0000357,,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,B,,H,8,Autocuration,CHEMBL617923,,
2676,,1,,5088,BAO_0000357,,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,B,,H,8,Autocuration,CHEMBL617924,,
2677,,1,,17133,BAO_0000357,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2A receptor using [125 I]-DOI as radioligand,,B,,H,8,Autocuration,CHEMBL617925,,
2678,Rattus norvegicus,1,,17133,BAO_0000357,,In vitro binding to 5-hydroxytryptamine 2A receptor using [125 I]-DOI,,B,,D,9,Expert,CHEMBL617926,,
2679,,1,,16532,BAO_0000357,,The binding affinity at 5-hydroxytryptamine 2A receptor was determined using [3H]ketanserin,,B,,H,8,Autocuration,CHEMBL617927,,
2680,,1,,15086,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 2A receptor,,B,,H,8,Autocuration,CHEMBL617928,,
2681,Rattus norvegicus,1,,2309,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,B,,D,9,Expert,CHEMBL617929,,
2682,,1,,12953,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 2A receptor from rat cortex assayed using [3H]ketanserin as radioligand.,,B,,H,8,Expert,CHEMBL617930,,
2683,,1,,12953,BAO_0000019,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as radioligand.; Nonactive at 10 uM,,B,,H,8,Autocuration,CHEMBL617931,,
2684,,1,,12953,BAO_0000019,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]-ketanserin as radioligand; Nonactive at 10 uM,,B,,H,8,Autocuration,CHEMBL617932,,
2685,,1,,16659,BAO_0000219,,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells; ND is No Data,,B,,H,8,Autocuration,CHEMBL617933,449.0,
2686,,1,,16740,BAO_0000019,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,,B,,H,8,Autocuration,CHEMBL617934,,
2687,,1,,16740,BAO_0000019,,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,,B,,H,8,Autocuration,CHEMBL617935,,
2688,,1,,17133,BAO_0000357,,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor; Not determined,,B,,H,8,Autocuration,CHEMBL617936,,
2689,,1,,17211,BAO_0000019,,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor; NT=not tested,,B,,H,8,Autocuration,CHEMBL617937,,
2690,,1,,17331,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes; Not tested,,B,,H,8,Autocuration,CHEMBL617938,,
2691,,1,,16633,BAO_0000218,,Compound was evaluated for effective dose measured in nmol/kg following a dose of 0.04 mg/kg and 0.093 uM/kg (95%CI); range 32-63,,B,,H,8,Autocuration,CHEMBL617939,,
2692,,1,,16633,BAO_0000218,,Compound was evaluated for the percentage of rats disrupted following a dose of 0.04 mg/kg and 0.097 uM/kg,,B,,H,8,Autocuration,CHEMBL617940,,
2693,,1,,16633,BAO_0000218,,Compound was evaluated for the percentage of rats disrupted following a dose of 0.08 mg/kg and 0.194 uM/kg,,B,,H,8,Autocuration,CHEMBL617941,,
2694,,1,,15026,BAO_0000357,,Ratio of pKi of 5-HT2A to that of 5-HT2C receptor,,B,,H,8,Expert,CHEMBL617942,,
2695,,1,,15026,BAO_0000357,,Ratio of pKi of 5-HT2A to that of D2 receptor,,B,,H,8,Expert,CHEMBL617943,,
2696,,1,,16404,BAO_0000224,,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,,B,,H,4,Expert,CHEMBL617944,,
2697,,1,,16404,BAO_0000224,,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,,B,,H,4,Expert,CHEMBL617945,,
2698,,1,,16404,BAO_0000224,,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor,,B,,H,4,Expert,CHEMBL617946,,
2699,,1,,16404,BAO_0000357,,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor; ND is no data,,B,,H,8,Autocuration,CHEMBL617947,,
2700,,1,,16326,BAO_0000357,,Percent maximal 5-HT stimulation at cloned rat 5-hydroxytryptamine 2A receptor (phosphoinositide hydrolysis study) at a conc of 100 uM,,B,,H,8,Expert,CHEMBL617948,,
2701,,1,,15847,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat,,F,,H,8,Autocuration,CHEMBL858116,,
2702,,1,,15847,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat; ND means not done,,F,,H,8,Autocuration,CHEMBL617949,,
2703,,1,,15329,BAO_0000019,,Effectiveness of compound in blocking 5-hydroxytryptamine 2A receptor-mediated contractions of rat tail artery,,F,,H,8,Autocuration,CHEMBL617950,,
2704,,1,1515.0,16404,BAO_0000019,,Negative log concentration of antagonist on 5-hydroxytryptamine 2A receptor in rat thoracic aorta,,F,,H,8,Expert,CHEMBL617951,,
2705,,1,1515.0,16404,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta,,F,,H,8,Expert,CHEMBL617952,,
2706,,1,1515.0,16404,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta; ND is not determined.,,F,,H,8,Autocuration,CHEMBL617953,,
2707,,1,,12861,BAO_0000357,,Binding activity radioligand.,,B,,H,8,Autocuration,CHEMBL617954,,
2708,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,B,,H,8,Expert,CHEMBL617955,,
2709,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,,B,,H,8,Autocuration,CHEMBL857071,,
2710,,1,,12490,BAO_0000019,,Displacement of [3H]DOB binding to 5-hydroxytryptamine 2A receptor from rat cortex homogenate,,B,,H,8,Expert,CHEMBL617270,,
2711,,1,,12827,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930,,B,,H,8,Autocuration,CHEMBL617271,339.0,
2712,,1,,12827,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930; Not determined,,B,,H,8,Autocuration,CHEMBL617272,339.0,
2713,,1,,12918,BAO_0000019,,Binding affinity was evaluated by 5-hydroxytryptamine 2A receptor agonism in the rat cortex by displacing ketanserin,,B,,H,8,Autocuration,CHEMBL617273,,
2714,Rattus norvegicus,1,,12919,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]-ketanserin,,F,,D,9,Expert,CHEMBL617274,,
2715,,1,,17723,BAO_0000357,,Binding affinity towards human serotonin 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617275,,
2716,,1,,6013,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617276,,
2717,,1,,16293,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617277,,
2718,,1,,3857,BAO_0000019,,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,,B,,H,8,Expert,CHEMBL617278,,
2719,,1,,3857,BAO_0000019,,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor; Not determined,,B,,H,8,Expert,CHEMBL617279,,
2720,,1,,3857,BAO_0000019,,Binding affinity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,,B,,H,8,Expert,CHEMBL617280,,
2721,,1,,15363,BAO_0000357,,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617281,,
2722,,1,,15363,BAO_0000357,,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617282,,
2723,,1,,16441,BAO_0000019,,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]mesulergine,,B,,H,8,Expert,CHEMBL617283,,
2724,,1,,16441,BAO_0000019,,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]-mesulergine; ND is No Data.,,B,,H,8,Expert,CHEMBL617284,,
2725,,1,,4176,BAO_0000219,,In vitro binding affinity towards human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells was determined using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL617285,722.0,
2726,,1,,17085,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617286,,
2727,Homo sapiens,1,,17200,BAO_0000357,,Inhibitory constant against cloned human 5-hydroxytryptamine 2C receptor using with [125I]- DOI radioligand,,B,,D,9,Expert,CHEMBL617287,,
2728,,1,,5088,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 2C receptor.,,B,,H,8,Expert,CHEMBL617288,,
2729,,1,,5088,BAO_0000357,,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]DOB as radioligand,,B,,H,8,Autocuration,CHEMBL617289,,
2730,,1,,5088,BAO_0000357,,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL872917,,
2731,,1,,5088,BAO_0000357,,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL617290,,
2732,,1,,16659,BAO_0000219,,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,,B,,H,8,Autocuration,CHEMBL617291,449.0,
2733,,1,,16659,BAO_0000219,,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells; ND is no data,,B,,H,8,Autocuration,CHEMBL617292,449.0,
2734,,1,,17451,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,B,,H,8,Autocuration,CHEMBL617293,723.0,
2735,Homo sapiens,1,,6857,BAO_0000219,,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,F,,D,9,Expert,CHEMBL617294,449.0,
2736,,1,,3857,BAO_0000019,,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,,B,,H,8,Expert,CHEMBL617295,,
2737,,1,,12861,BAO_0000357,,Binding activity radioligand.,,B,,H,8,Autocuration,CHEMBL617296,,
2738,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,B,,H,8,Autocuration,CHEMBL617297,,
2739,,1,,5104,BAO_0000219,,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand,,B,,H,8,Expert,CHEMBL617298,449.0,
2740,,1,,5105,BAO_0000219,,Binding affinity at human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells by [3H]mesulergine displacement.,,B,,H,8,Expert,CHEMBL617299,449.0,
2741,,1,,5105,BAO_0000219,,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand; NT means not tested,,B,,H,8,Autocuration,CHEMBL617300,449.0,
2742,,1,,5254,BAO_0000357,,Binding affinity against 5-HT2C receptor,,B,,H,8,Autocuration,CHEMBL617454,,
2743,,1,,13267,BAO_0000219,,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL617505,722.0,
2744,Homo sapiens,1,,14157,BAO_0000219,,Displacement of [3H]mesulergine from 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells,,B,,D,9,Expert,CHEMBL617506,722.0,
2745,Homo sapiens,1,,12936,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,,B,,D,9,Expert,CHEMBL617507,722.0,
2746,,1,,14068,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 2C receptor using displacement of [3H]DOB,,B,,H,8,Expert,CHEMBL617508,,
2747,Homo sapiens,1,,12936,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,,B,,D,9,Expert,CHEMBL857982,722.0,
2748,Homo sapiens,1,,4540,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand,,B,,D,9,Expert,CHEMBL617509,722.0,
2749,Homo sapiens,1,,4540,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand; Nd means not determined,,B,,D,9,Expert,CHEMBL617510,722.0,
2750,,1,,6166,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor was determined,,B,,H,8,Autocuration,CHEMBL617511,,
2751,,1,,17296,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptors in HEK 293 cells using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL617512,722.0,
2752,,1,,17296,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL617749,722.0,
2753,,1,,15779,BAO_0000219,,Binding affinity towards 5-HT2C (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,B,,H,8,Autocuration,CHEMBL617750,722.0,
2754,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 2C receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,B,,H,8,Autocuration,CHEMBL617751,722.0,
2755,,1,,14391,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells using [3H]mesulergine as radioligand,,B,,H,8,Expert,CHEMBL617752,722.0,
2756,,1,,15779,BAO_0000219,,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand",,B,,H,8,Autocuration,CHEMBL617753,722.0,
2757,,1,,15851,BAO_0000219,,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2C in HEK293 cells, using [3H]mesulergine as radioligand.",,B,,H,8,Expert,CHEMBL617754,722.0,
2758,Homo sapiens,1,,15851,BAO_0000219,,Displacement of [3H]mesulergine from human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells; compound insoluble,,B,,D,9,Expert,CHEMBL617755,722.0,
2759,,1,,15779,BAO_0000219,,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand; no data",,B,,H,8,Autocuration,CHEMBL617756,722.0,
2760,,1,,3832,BAO_0000219,,Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by displacement of [3H]mesulergine,,B,,H,8,Expert,CHEMBL617757,722.0,
2761,,1,,3833,BAO_0000219,,In vitro binding affinity at human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by [3H]mesulergine displacement.,,B,,H,8,Expert,CHEMBL617758,722.0,
2762,,1,,17451,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL617759,723.0,
2763,,1,,4199,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine as the radioligand,,B,,H,8,Autocuration,CHEMBL617760,722.0,
2764,,1,,1883,BAO_0000219,,Displacement of [3H]mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO-K1 cells,,B,,H,8,Expert,CHEMBL617761,485.0,
2765,Homo sapiens,1,,4321,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2C receptor,,B,,D,9,Expert,CHEMBL617762,,
2766,,1,,14875,BAO_0000357,,Compound was tested for binding affinity against human 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617763,,
2767,,1,,15146,BAO_0000219,,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine,,B,,H,8,Autocuration,CHEMBL857983,722.0,
2768,,1,,5213,BAO_0000219,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2C receptor in HEK 293 using [3H]mesulergine as a radioligand,,B,,H,8,Autocuration,CHEMBL617764,722.0,
2769,,1,,16404,BAO_0000219,,Inhibitory constant on human 5-hydroxytryptamine 2C receptor transfected in to HeLa cells,,B,,H,8,Autocuration,CHEMBL617765,308.0,
2770,,1,,13267,BAO_0000019,,Selectivity as the ratio of Ki value towards 5-hydroxytryptamine 2C receptor to that of pA2 value towards 5-hydroxytryptamine 2B receptor,,F,,H,8,Autocuration,CHEMBL617766,,
2771,,1,10000000.0,13267,BAO_0000221,,The binding affinity (pKi) measured against 5-hydroxytryptamine 3 receptor of rat hippocampus and entorhinal cortex using [3H]granisetron as radioligand,,F,,H,8,Autocuration,CHEMBL617767,,
2772,,1,,14818,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2C receptor in HEK293 cells using [3H]mesulergine.,,B,,H,8,Autocuration,CHEMBL617768,722.0,
2773,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]5-mesulergine as radioligand",,B,,H,8,Autocuration,CHEMBL617769,722.0,
2774,,1,,13463,BAO_0000357,,Binding affinity analysed on 5-HT 2C in human clone using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL858023,,
2775,,1,945.0,13463,BAO_0000019,,Binding affinity analysed on 5-HT 2C in rat stomach fundus,,B,,H,8,Autocuration,CHEMBL617770,,
2776,,1,945.0,13463,BAO_0000019,,Binding affinity analysed towards 5-HT 2C in rat stomach fundus,,B,,H,8,Autocuration,CHEMBL617771,,
2777,,1,,12652,BAO_0000219,,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2C receptor in A9 cells,,F,,H,8,Autocuration,CHEMBL617772,625.0,
2778,,1,,4682,BAO_0000219,,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,,B,,H,8,Autocuration,CHEMBL617773,723.0,
2779,,1,,4682,BAO_0000219,,Binding affinity to 5-hydroxytryptamine 2C receptor measured using radioligand [3H]Mesulergine in stably transfected NIH3T3 cells,,B,,H,8,Autocuration,CHEMBL617850,723.0,
2780,,1,,4682,BAO_0000219,,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,,B,,H,8,Autocuration,CHEMBL617851,723.0,
2781,,1,,12652,BAO_0000019,,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2C receptor,,F,,H,8,Autocuration,CHEMBL617852,,
2782,Mus musculus,1,945.0,13463,BAO_0000019,,Binding affinity analysed on 5-HT 2C in rat stomach fundus.,,B,,H,8,Autocuration,CHEMBL858024,,
2783,Rattus norvegicus,1,945.0,13463,BAO_0000019,,Binding affinity towards 5-HT 2C receptor in rat stomach fundus,,B,,D,9,Expert,CHEMBL617853,,
2784,,1,,13969,BAO_0000357,,Binding affinity against 5-Hydroxytryptamine 2C Receptor was measured using [3H]N-methyl-mesulergine as radioligand,,B,,H,8,Expert,CHEMBL617854,,
2785,Sus scrofa,1,,13392,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2C receptor,,B,,H,8,Expert,CHEMBL873477,,
2786,,1,,13392,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor,,B,,H,8,Expert,CHEMBL617855,,
2787,,1,,14430,BAO_0000019,,Affinity towards 5-hydroxytryptamine 2C receptor in membranes from pig choroid plexus using [3H]N-methyl-mesulergine,,B,,H,8,Expert,CHEMBL617856,,
2788,,1,,1742,BAO_0000019,,Compound was tested for its ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor in pig cortex,,B,,H,8,Autocuration,CHEMBL617857,,
2789,,1,,14286,BAO_0000249,,In vitro inhibitory concentration against radioligand [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in pig cortical membrane,,B,,H,8,Autocuration,CHEMBL617858,,
2790,,1,,5619,BAO_0000357,,Binding affinity towards pig 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617859,,
2791,,1,,15086,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617860,,
2792,,1,,12861,BAO_0000357,,Binding activity radioligand.,,B,,H,8,Autocuration,CHEMBL617861,,
2793,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,B,,H,8,Expert,CHEMBL617862,,
2794,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,,B,,H,8,Autocuration,CHEMBL617863,,
2795,,1,,12827,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT,,B,,H,8,Autocuration,CHEMBL617864,,
2796,,1,,12827,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT; Not determined,,B,,H,8,Autocuration,CHEMBL617649,,
2797,Sus scrofa,1,,12919,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,,F,,H,8,Expert,CHEMBL617650,,
2798,Sus scrofa,1,,12919,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,,F,,H,8,Expert,CHEMBL617651,,
2799,Sus scrofa,1,,16429,BAO_0000357,,In vitro binding affinity at 5-hydroxytryptamine 2C receptor in pig choroid plexus using 3[H]mesulergine as the radioligand,,B,,H,8,Autocuration,CHEMBL617652,,
2800,Sus scrofa,1,,773,BAO_0000019,,In Vitro Binding affinity againist 5-hydroxytryptamine 2C receptor by displacing [3H]mesulergine from pig cortex,,B,,H,8,Autocuration,CHEMBL857072,,
2801,Sus scrofa,1,,5033,BAO_0000357,,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617653,,
2802,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,B,,H,8,Autocuration,CHEMBL617654,,
2803,,1,,14093,BAO_0000019,,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2C receptor,,F,,H,8,Autocuration,CHEMBL617655,,
2804,,1,,14970,BAO_0000357,,Binding affinity towards 5-HT2C receptor from rat using [3H]mesulergine as radioligand,,B,,H,8,Expert,CHEMBL617656,,
2805,,1,,14970,BAO_0000357,,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL617657,,
2806,,1,,14970,BAO_0000357,,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand; Not tested,,B,,H,8,Autocuration,CHEMBL617658,,
2807,Rattus norvegicus,1,,14178,BAO_0000357,,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2C receptor,,B,,D,9,Expert,CHEMBL617659,,
2808,Rattus norvegicus,1,,14178,BAO_0000357,,Inhibition of radiolabeled [3H]mesulergine ligand binding to 5-hydroxytryptamine 2C receptor,,B,,D,9,Expert,CHEMBL617838,,
2809,Rattus norvegicus,1,,14229,BAO_0000249,,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in rat brain membranes,Brain membranes,B,,D,9,Expert,CHEMBL617839,,
2810,,1,,16532,BAO_0000357,,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine; Not tested,,B,,H,8,Autocuration,CHEMBL617840,,
2811,,1,,14826,BAO_0000019,,Ability to displace [3H]mesulergine bound to 5-hydroxytryptamine 2C receptor in rat cortex,,B,,H,8,Autocuration,CHEMBL617841,,
2812,,1,,17211,BAO_0000019,,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-HT2C receptor,,B,,H,8,Autocuration,CHEMBL875915,,
2813,,1,,17211,BAO_0000219,,Displacement of [3H]mesulergine (0.5 nM) from rat 5-hydroxytryptamine 2C receptor expressed in SR-3T3 cells,,B,,H,8,Expert,CHEMBL617842,,
2814,,1,,13246,BAO_0000219,,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor in NIH3T3 cell line membranes,,B,,H,8,Expert,CHEMBL617843,723.0,
2815,,1,,13246,BAO_0000357,,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor.,,B,,H,8,Expert,CHEMBL617844,,
2816,,1,,12457,BAO_0000357,,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2C receptor,,B,,H,8,Expert,CHEMBL617845,,
2817,,1,,12457,BAO_0000219,,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2C receptor,,B,,H,8,Expert,CHEMBL617846,723.0,
2818,,1,,4707,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 2C receptor was determined using [125I]- DOI as radioligand,,B,,H,8,Autocuration,CHEMBL617847,,
2819,,1,,13297,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2C receptor,,B,,H,8,Expert,CHEMBL617848,,
2820,,1,,16633,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,B,,H,8,Autocuration,CHEMBL617849,,
2821,,1,,16133,BAO_0000357,,Binding affinity against rat 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,B,,H,8,Expert,CHEMBL621507,,
2822,,1,,16326,BAO_0000357,,Binding affinity at cloned rat 5-hydroxytryptamine 2C receptor using [3H]DOI as radioligand,,B,,H,8,Expert,CHEMBL621508,,
2823,,1,,14423,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2C receptor from rat cortex using [3H]mesulergine as the radioligand.,,B,,H,8,Autocuration,CHEMBL621509,,
2824,,1,,15412,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex,,B,,H,8,Autocuration,CHEMBL621510,,
2825,,1,,15412,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex.,,B,,H,8,Autocuration,CHEMBL621511,,
2826,,1,,15558,BAO_0000219,,Displacement of [3H]mesulergine from A9 cells stably expressing rat 5-hydroxytryptamine 2C receptor,,B,,H,8,Expert,CHEMBL621512,625.0,
2827,,1,,16633,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,B,,H,8,Autocuration,CHEMBL621513,,
2828,,1,,6013,BAO_0000357,,Binding affinity towards cloned rat 5-hydroxytryptamine 2C receptor from fundus tissue by [3H]mesulergine displacement.,,B,,H,8,Expert,CHEMBL621514,,
2829,,1,,17175,BAO_0000219,,Binding affinity towards rat 5-hydroxytryptamine 2C receptor expressed in A-9 cells using [3H]mesulergine as radioligand,,B,,H,8,Expert,CHEMBL621515,,
2830,,1,,12469,BAO_0000219,,Binding affinity was measured on 5-hydroxytryptamine 2C receptor in J1 cells transfected with rat 5-HT2C gene labeled with [3H]mesulergine,,B,,H,8,Autocuration,CHEMBL621516,,
2831,,1,5383.0,3682,BAO_0000019,,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2C receptor in homogenate of caudate putamen tissue from rat brain,,B,,H,8,Autocuration,CHEMBL621517,,
2832,,1,,4932,BAO_0000357,,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2C receptor in cloned rat cell culture,,B,,H,8,Autocuration,CHEMBL621518,,
2833,,1,,4932,BAO_0000019,,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2C receptor in cloned rat prefrontal cortex homogenate; ND denotes no data,,B,,H,8,Autocuration,CHEMBL621519,,
2834,,1,,3935,BAO_0000357,,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL621520,,
2835,,1,,15818,BAO_0000357,,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL621521,,
2836,,1,,15818,BAO_0000357,,Compound was evaluated for its binding affinity towards rat r5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL621522,,
2837,,1,,14749,BAO_0000219,,Binding affinity against rat 5-hydroxytryptamine 2C receptor in A-9 cells.,,B,,H,8,Expert,CHEMBL621523,,
2838,,1,,15740,BAO_0000357,,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL621524,,
2839,Rattus norvegicus,1,,17133,BAO_0000357,,In vitro binding to 5-hydroxytryptamine 2C receptor using [125 I]-DOI,,B,,D,9,Expert,CHEMBL621525,,
2840,,1,,16532,BAO_0000357,,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine,,B,,H,8,Autocuration,CHEMBL872921,,
2841,,1,,12369,BAO_0000357,,The compound evaluated for its affinity against 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL621526,,
2842,,1,,12369,BAO_0000219,,Affinity against 5-hydroxytryptamine 2C receptor in J1 cells transfected with the rat 5-HT2C gene labeled with [3H]mesulergine.,,B,,H,8,Expert,CHEMBL621527,,
2843,Rattus norvegicus,1,,2309,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2C receptor in rat choroid plexus using [3H]N-methyl-mesulergine,,B,,D,9,Expert,CHEMBL617865,,
2844,,1,,12953,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617866,,
2845,,1,,12953,BAO_0000019,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor from rat cortex using [3H]-citalopram as radioligand; Nonactive at 10 uM,,B,,H,8,Autocuration,CHEMBL617867,,
2846,,1,,12953,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand; Nonactive at 10 uM,,B,,H,8,Autocuration,CHEMBL617487,,
2847,,1,,12953,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2C receptor,,B,,H,8,Expert,CHEMBL617488,,
2848,,1,,17133,BAO_0000357,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2C receptor using [125 I]-DOI as radioligand; Not determined,,B,,H,8,Autocuration,CHEMBL617489,,
2849,,1,,17211,BAO_0000019,,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT denotes not tested,,B,,H,8,Autocuration,CHEMBL617490,,
2850,,1,,17211,BAO_0000019,,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT=not tested,,B,,H,8,Autocuration,CHEMBL617491,,
2851,,1,,14025,BAO_0000019,,Affinity pKi for 5-hydroxytryptamine 2C receptor was measured in rat cortex homogenates.,,B,,H,8,Autocuration,CHEMBL617492,,
2852,,1,,14998,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2C receptor in rat cortex homogenates.,,B,,H,8,Autocuration,CHEMBL617493,,
2853,,1,,4342,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2C receptor was determined,,B,,H,8,Autocuration,CHEMBL617494,,
2854,Rattus norvegicus,1,,13735,BAO_0000019,,Displacement of [3H]mesulergine from rat 5-HT2C receptor expressed in HEK293,,B,,D,9,Expert,CHEMBL617495,,
2855,,1,,13181,BAO_0000357,,Binding affinity was determined against cloned human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL617496,,
2856,,1,,1883,BAO_0000219,,Compound was evaluated for displacement of [3H]mesulergine from cloned rat 5-hydroxytryptamine 2C receptor in transfected CHO-K1 cells.,,B,,H,8,Autocuration,CHEMBL617497,485.0,
2857,,1,,15194,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL617498,,
2858,,1,,15194,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand.,,B,,H,8,Autocuration,CHEMBL617499,,
2859,,1,,14579,BAO_0000019,,Compound tested for relative response using 0.1 uM 5-HT as agonist against 5-hydroxytryptamine 2C receptor,,F,,H,8,Autocuration,CHEMBL617500,,
2860,,1,,4639,BAO_0000357,,Compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617501,,
2861,,1,,4820,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor,,B,,H,8,Expert,CHEMBL617502,,
2862,,1,,14442,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand; Not Tested,,B,,H,8,Autocuration,CHEMBL617503,,
2863,,1,,14755,BAO_0000357,,Binding activity against cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand.,,B,,H,8,Autocuration,CHEMBL617504,,
2864,,1,,14744,BAO_0000357,,Binding affinity against the cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand,,B,,H,8,Autocuration,CHEMBL617406,,
2865,Homo sapiens,1,,6857,BAO_0000019,,Affinity for human 5-hydroxytryptamine 2B receptor expressed in mammalian cell line,,B,,D,9,Expert,CHEMBL617407,,
2866,,1,,16209,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 2B receptor using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL617408,,
2867,,1,,15363,BAO_0000357,,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,,B,,H,8,Autocuration,CHEMBL617409,,
2868,,1,,15363,BAO_0000357,,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,,B,,H,8,Autocuration,CHEMBL617410,,
2869,,1,,15363,BAO_0000357,,Compound was tested for the displacement of [3H]5-HT from cloned human 5-hydroxytryptamine 2B receptor,,B,,H,8,Autocuration,CHEMBL617411,,
2870,,1,,17085,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2B receptor,,B,,H,8,Autocuration,CHEMBL617412,,
2871,Homo sapiens,1,,17200,BAO_0000357,,Inhibitory constant against cloned human 5-hydroxytryptamine 2B receptor using with [125I]- DOI radioligand,,B,,D,9,Expert,CHEMBL617774,,
2872,Homo sapiens,1,,15851,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,,B,,D,9,Expert,CHEMBL617775,722.0,
2873,Homo sapiens,1,,15851,BAO_0000219,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,,B,,D,9,Expert,CHEMBL617776,722.0,
2874,Homo sapiens,1,,6857,BAO_0000219,,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,F,,D,9,Expert,CHEMBL617777,449.0,
2875,Homo sapiens,1,,6857,BAO_0000219,,Rleative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,F,,D,9,Expert,CHEMBL617778,449.0,
2876,,1,,15779,BAO_0000219,,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",,B,,H,8,Autocuration,CHEMBL617779,722.0,
2877,,1,,15851,BAO_0000219,,Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells using [3H]5-HT as radioligand.,,B,,H,8,Expert,CHEMBL617780,722.0,
2878,,1,,15779,BAO_0000219,,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand; no data",,B,,H,8,Autocuration,CHEMBL617781,722.0,
2879,Homo sapiens,1,,14157,BAO_0000219,,Displacement of [3H]5-HT from 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells,,B,,D,9,Expert,CHEMBL617782,722.0,
2880,Homo sapiens,1,,4540,BAO_0000219,,Binding affinity to human cloned 5-HT2B receptor in HEK 293 cells using [3H]- -5-HT as radioligand,,B,,D,9,Expert,CHEMBL617783,722.0,
2881,,1,,6166,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor was determined,,B,,H,8,Autocuration,CHEMBL617784,,
2882,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 2B receptor (human cloned receptor) in HEK 293 cells using [3H]5-HT as radioligand.,,B,,H,8,Autocuration,CHEMBL617785,722.0,
2883,,1,,14391,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells using [3H]5-HT as radioligand,,B,,H,8,Expert,CHEMBL857984,722.0,
2884,,1,,3832,BAO_0000219,,Binding affinity towards human cloned 5-HT2B receptor of HEK293 cells by displacement of [3H]5-HT,,B,,H,8,Expert,CHEMBL617786,722.0,
2885,,1,,3833,BAO_0000219,,In vitro binding affinity at human cloned 5-hydroxytryptamine 2B receptor of HEK293 cells by [3H]5-HT displacement.,,B,,H,8,Expert,CHEMBL617787,722.0,
2886,Homo sapiens,1,,15851,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells,,B,,D,9,Expert,CHEMBL617788,722.0,
2887,Homo sapiens,1,,15851,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; compound is insoluble,,B,,D,9,Expert,CHEMBL617789,722.0,
2888,,1,,4199,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-HT2B receptor in HEK 293 cells using [3H]5-HT as the radioligand,,B,,H,8,Autocuration,CHEMBL617790,722.0,
2889,,1,,1883,BAO_0000219,,Displacement of [3H]-5-5HT from human cloned 5-hydroxytryptamine 2B receptor expressed in CHO-K1 cells,,B,,H,8,Expert,CHEMBL617791,485.0,
2890,,1,,4321,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2B receptor,,B,,H,8,Expert,CHEMBL617608,,
2891,,1,,15146,BAO_0000219,,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 2B receptor in HEK 293 cells using [3H]5-HT,,B,,H,8,Autocuration,CHEMBL617609,722.0,
2892,,1,,5213,BAO_0000219,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2B receptor in HEK 293 using [3H]ketanserin as a radioligand,,B,,H,8,Autocuration,CHEMBL617610,722.0,
2893,,1,,14818,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2B receptors in HEK293 cells using [3H]5-HT.,,B,,H,8,Autocuration,CHEMBL617611,722.0,
2894,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",,B,,H,8,Autocuration,CHEMBL617612,722.0,
2895,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",,B,,H,8,Autocuration,CHEMBL617613,722.0,
2896,Oryctolagus cuniculus,1,,14025,BAO_0000019,,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 2B receptor in the endothelium intact rabbit jugular vein.,,B,,H,8,Autocuration,CHEMBL617614,,
2897,,1,945.0,13463,BAO_0000019,,Binding affinity analysed for 5-HT 2B receptor in rat stomach fundus,,B,,H,8,Expert,CHEMBL617615,,
2898,,1,945.0,7259,BAO_0000357,,Affinity against 5-hydroxytryptamine 2B receptor in the isolated rat stomach fundus,,B,,H,8,Expert,CHEMBL858114,,
2899,,1,945.0,7259,BAO_0000357,,Affinity against serotonergic receptor in the isolated rat stomach fundus,,B,,H,8,Autocuration,CHEMBL617616,,
2900,Rattus norvegicus,1,945.0,7185,BAO_0000019,,Antagonistic activity against 5-hydroxytryptamine 2B receptor obtained from rat stomach fundus preparation,,F,,D,9,Expert,CHEMBL617617,,
2901,Rattus norvegicus,1,,7185,BAO_0000019,,Antagonistic against 5-hydroxytryptamine 2B receptor,,F,,D,9,Expert,CHEMBL875914,,
2902,,1,945.0,13267,BAO_0000019,,Antagonistic affinity measured as pA2 value on 5-hydroxytryptamine 2B receptor of the rat stomach fundus,,F,,H,8,Autocuration,CHEMBL617618,,
2903,Rattus norvegicus,1,945.0,13735,BAO_0000357,,Inhibition of 5-HT binding to 5-HT2B receptor of Rat stomach fundus,,B,,D,9,Expert,CHEMBL617619,,
2904,,1,,15738,BAO_0000019,,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor,,F,,H,8,Autocuration,CHEMBL617620,,
2905,,1,,15738,BAO_0000019,,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor; No data,,F,,H,8,Autocuration,CHEMBL617621,,
2906,,1,,15738,BAO_0000019,,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B) receptor,,F,,H,8,Autocuration,CHEMBL617622,,
2907,Rattus norvegicus,1,945.0,12936,BAO_0000357,,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,B,,D,9,Expert,CHEMBL617623,,
2908,Rattus norvegicus,1,945.0,12936,BAO_0000357,,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,B,,D,9,Expert,CHEMBL617624,,
2909,Rattus norvegicus,1,945.0,12936,BAO_0000357,,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,B,,D,9,Expert,CHEMBL617625,,
2910,Rattus norvegicus,1,945.0,12936,BAO_0000357,,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,B,,D,9,Expert,CHEMBL617626,,
2911,,1,945.0,16404,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,F,,H,8,Autocuration,CHEMBL617627,,
2912,,1,945.0,16404,BAO_0000019,,Negative log concentration of antagonist was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,F,,H,8,Expert,CHEMBL617628,,
2913,,1,945.0,16404,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is No Data.,,F,,H,8,Autocuration,CHEMBL617629,,
2914,,1,945.0,16404,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is not determined.,,F,,H,8,Autocuration,CHEMBL858115,,
2915,Rattus norvegicus,1,945.0,16404,BAO_0000019,,Antagonistic activity on 5-hydroxytryptamine 2B receptor of Rat stomach fundus;ND is not determined,,F,,D,9,Expert,CHEMBL617630,,
2916,,1,1515.0,16404,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat thoracic aorta; ND is not determined,,F,,H,8,Autocuration,CHEMBL617631,,
2917,,1,,7483,BAO_0000357,,The binding affinity of compound to 5-HT receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,,B,,H,8,Autocuration,CHEMBL617632,,
2918,,1,,7483,BAO_0000357,,The binding affinity to 5-hydroxytryptamine 2B receptor of rat fundus,,B,,H,8,Expert,CHEMBL617633,,
2919,,1,,7483,BAO_0000357,,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,,B,,H,8,Autocuration,CHEMBL617634,,
2920,,1,,7483,BAO_0000357,,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus; Unable to determine valid PA2 value due to slope of Schild plot,,B,,H,8,Autocuration,CHEMBL617635,,
2922,Rattus norvegicus,1,945.0,16404,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,F,,D,9,Autocuration,CHEMBL617637,,
2923,,1,,6347,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,,B,,H,8,Autocuration,CHEMBL617638,,
2924,,1,,4373,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2B receptor was determined,,B,,H,8,Autocuration,CHEMBL617639,,
2925,,1,,4373,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2B receptor was determined,,B,,H,8,Autocuration,CHEMBL617640,,
2926,,1,,4687,BAO_0000357,,Evaluated for the binding affinity to 5-HT 2B receptor,,B,,H,8,Autocuration,CHEMBL617641,,
2927,,1,,16946,BAO_0000357,,Ability to displace [3H]5-HT from 5-hydroxytryptamine 2B receptor,,B,,H,8,Autocuration,CHEMBL617642,,
2928,,1,,16633,BAO_0000357,,Binding affinities against 5-hydroxytryptamine 2B receptor,,B,,H,8,Autocuration,CHEMBL617643,,
2929,,1,,16633,BAO_0000357,,Binding affinities towards 5-hydroxytryptamine 2B receptor,,B,,H,8,Autocuration,CHEMBL617644,,
2930,,1,,16633,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2B receptor using [125I]DOI as radioligand,,B,,H,8,Autocuration,CHEMBL617645,,
2931,,1,,15026,BAO_0000357,,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,,B,,H,8,Expert,CHEMBL617646,,
2932,Bos taurus,1,,15738,BAO_0000357,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,,B,,H,8,Autocuration,CHEMBL617647,,
2933,Bos taurus,1,,15738,BAO_0000357,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10E-6 M,,B,,H,8,Autocuration,CHEMBL617648,,
2934,Bos taurus,1,,15738,BAO_0000357,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10e-6 M,,B,,H,8,Autocuration,CHEMBL617875,,
2935,Bos taurus,1,,15738,BAO_0000357,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at concentration of 10e-6 M,,B,,H,8,Autocuration,CHEMBL617876,,
2936,Bos taurus,1,,16404,BAO_0000357,,Inhibitory constant was determined on 5-hydroxytryptamine 2C receptor of Bovine choroid plexus,,B,,H,8,Expert,CHEMBL617877,,
2937,Bos taurus,1,,15026,BAO_0000357,,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,,B,,H,8,Expert,CHEMBL617878,,
2938,Bos taurus,1,,15738,BAO_0000357,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,,B,,H,8,Autocuration,CHEMBL617879,,
2939,Cavia porcellus,1,,16312,BAO_0000019,,Binding affinity against guinea pig cortex 5-HT2C receptor in the presence of [3H]mesulergine,,B,,H,8,Autocuration,CHEMBL617880,,
2940,Cavia porcellus,1,2435.0,5486,BAO_0000357,,Binding affinity towards 5-HT4 receptor by the displacement of [3H]GR-113808 in guinea-pig striatum,,B,,D,9,Intermediate,CHEMBL617881,,
2941,,1,,5254,BAO_0000357,,Binding affinity against 5-HT1A receptor,,B,,H,8,Autocuration,CHEMBL857073,,
2942,,1,,3857,BAO_0000219,,Agonistic activity for 5-HT2c (5-HT2C) by measuring [3H]inositol monophosphate fromation in CHO cells in which the human 5-HT2C receptor subtype was stably expressed,,F,,H,8,Expert,CHEMBL617882,449.0,
2943,Homo sapiens,1,,6857,BAO_0000219,,Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader,,F,,D,9,Expert,CHEMBL617883,449.0,
2944,,1,,4176,BAO_0000219,,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2c receptor cell line,,F,,H,8,Autocuration,CHEMBL617884,,
2945,,1,,6347,BAO_0000219,,Agonistic binding efficacy against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand,,B,,H,8,Autocuration,CHEMBL617885,449.0,
2946,,1,,6347,BAO_0000219,,"Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand, expressed as Emax",,B,,H,8,Autocuration,CHEMBL617886,449.0,
2947,Homo sapiens,1,,16146,BAO_0000357,,Inhibition of human 5-hydroxytryptamine 2C receptor,,B,,D,9,Expert,CHEMBL617887,,
2948,,1,,3805,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 2C receptor at a concentration of 100 (nM),,B,,H,8,Autocuration,CHEMBL617888,,
2949,,1,,3857,BAO_0000019,,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,,B,,H,8,Autocuration,CHEMBL617889,,
2950,,1,,5635,BAO_0000357,,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617890,,
2951,,1,,5635,BAO_0000357,,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,,B,,H,8,Autocuration,CHEMBL617891,,
2952,,1,,5635,BAO_0000357,,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,,B,,H,8,Autocuration,CHEMBL617892,,
2953,,1,,4012,BAO_0000219,,Displacement of [H]-mesulergine from CHO cells expressing human 5-hydroxytryptamine 2C receptor.,,B,,H,8,Expert,CHEMBL617893,449.0,
2954,,1,,6366,BAO_0000219,,Ability to displace [3H]- mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells,,B,,H,8,Expert,CHEMBL617894,449.0,
2955,,1,,15949,BAO_0000219,,Ability to displace [3H]mesulergine binding to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,,B,,H,8,Expert,CHEMBL617895,449.0,
2956,,1,,17211,BAO_0000219,,Ability to displace [3H]mesulergine (0.5 nM) from CHO cells of human 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL617896,449.0,
2957,Homo sapiens,1,,6491,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 2C serotonin receptor,,B,,D,9,Expert,CHEMBL617897,,
2958,,1,,14093,BAO_0000019,,Agonist activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand,,F,,H,8,Autocuration,CHEMBL617898,,
2959,,1,,13481,BAO_0000019,,Agonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,F,,H,8,Autocuration,CHEMBL617899,,
2960,Rattus norvegicus,1,,6347,BAO_0000219,,Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI ,,B,,H,8,Expert,CHEMBL617900,449.0,
2961,,1,,14093,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand,,F,,H,8,Autocuration,CHEMBL617901,,
2962,,1,,14093,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand; Not tested,,F,,H,8,Autocuration,CHEMBL617902,,
2963,,1,,13481,BAO_0000019,,Antagonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,F,,H,8,Autocuration,CHEMBL617903,,
2964,,1,,14442,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [125 I]DOI as radioligand,,B,,H,8,Autocuration,CHEMBL617904,,
2965,,1,,14442,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL617905,,
2966,,1,,14442,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand;not tested,,B,,H,8,Autocuration,CHEMBL617906,,
2967,,1,,14755,BAO_0000357,,Binding activity against cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand.,,B,,H,8,Autocuration,CHEMBL617907,,
2968,,1,,14744,BAO_0000357,,Binding affinity against the cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand,,B,,H,8,Autocuration,CHEMBL617908,,
2969,,1,,16659,BAO_0000219,,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,,B,,H,8,Expert,CHEMBL620617,449.0,
2970,Homo sapiens,1,,6857,BAO_0000019,,Affinity for human 5-hydroxytryptamine 2C receptor expressed in mammalian cell line,,B,,D,9,Expert,CHEMBL620618,,
2971,,1,,5635,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand.,,B,,H,8,Expert,CHEMBL620619,,
2972,Homo sapiens,1,,4234,BAO_0000357,,Binding affinity to cloned human 5-hydroxytryptamine 2C receptor,,B,,D,9,Expert,CHEMBL620620,,
2973,,1,,16209,BAO_0000357,,Binding affinity towards human 5-HT2C receptor was determined using [125I]- DOI as radioligand,,B,,H,8,Autocuration,CHEMBL620621,,
2974,Rattus norvegicus,1,,5778,BAO_0000249,,Binding affinity for 5-HT3 receptor by displacement of [3H]-LY 278584 in rat cerebral cortex membranes,Membranes,B,,D,7,Autocuration,CHEMBL872920,,
2975,,1,,5094,BAO_0000223,,Binding affinity towards rat 5-hydroxytryptamine 3 receptor was evaluated,,B,,H,6,Autocuration,CHEMBL620622,,
2976,Rattus norvegicus,1,,809,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 in rat posterior cortex,,B,,D,7,Autocuration,CHEMBL620623,,
2977,,1,,1578,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex,,B,,H,6,Autocuration,CHEMBL620624,,
2978,,1,,809,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex; Not tested,,B,,H,6,Autocuration,CHEMBL620625,,
2979,,1,,12469,BAO_0000219,,Binding affinity was measured on 5-hydroxytryptamine 3 receptor in NG-108 cells labeled with [3H]GR-65630,,B,,H,6,Autocuration,CHEMBL620626,,
2980,,1,,14290,BAO_0000019,,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex,,B,,H,6,Autocuration,CHEMBL621307,,
2981,,1,,14290,BAO_0000019,,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex.,,B,,H,6,Autocuration,CHEMBL621308,,
2982,,1,,10609,BAO_0000223,,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-5-HT,,B,,H,6,Autocuration,CHEMBL621309,,
2983,,1,,10609,BAO_0000223,,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]GR-65630,,B,,H,6,Autocuration,CHEMBL621310,,
2984,,1,,10609,BAO_0000223,,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-ketanserin,,B,,H,6,Autocuration,CHEMBL621311,,
2985,,1,,15253,BAO_0000249,,"Compound was evaluated for its in vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",,B,,H,6,Autocuration,CHEMBL621502,,
2986,,1,,15253,BAO_0000249,,"In vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",,B,,H,6,Autocuration,CHEMBL621503,,
2987,,1,,11683,BAO_0000249,,Displacement of the 5-hydroxytryptamine 3 receptor ligand [3H]GR-65630 from rat brain cortical membranes.,Membranes,B,,H,6,Autocuration,CHEMBL621504,,
2988,,1,,12092,BAO_0000223,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor,,B,,H,6,Autocuration,CHEMBL621505,,
2989,,1,,1946,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,,B,,H,6,Autocuration,CHEMBL621506,,
2990,,1,,11623,BAO_0000223,,Ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15.,,B,,H,6,Autocuration,CHEMBL619781,,
2991,,1,,11623,BAO_0000223,,Compound was evaluated for its ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15. ,,B,,H,6,Autocuration,CHEMBL619782,,
2992,,1,,14788,BAO_0000019,,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex,,B,,H,6,Autocuration,CHEMBL619783,,
2993,Rattus norvegicus,1,,5432,BAO_0000019,,Displacement of [3H]ketanserin from rat cortex 5-HT3 receptor,,B,,D,7,Autocuration,CHEMBL619784,,
2994,,1,,14826,BAO_0000249,,Ability to displace [3H]granisetron specifically bound to 5-hydroxytryptamine 3 receptor in rat cortical membrane,,B,,H,6,Autocuration,CHEMBL619785,,
2995,,1,,2222,BAO_0000223,,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,,B,,H,6,Autocuration,CHEMBL619786,,
2996,,1,,11963,BAO_0000019,,Displacement of binding of [3H]-BRL 43694 to 5-hydroxytryptamine 3 receptor in rat cerebral cortex,,B,,H,6,Autocuration,CHEMBL619787,,
2997,,1,,14145,BAO_0000019,,In vitro affinity for 5-hydroxytryptamine 3 (5-HT3) receptor by displacement of [3H]BRL-43694 from rat entorhinal cortex,,B,,H,6,Autocuration,CHEMBL872925,,
2998,,1,,17819,BAO_0000019,,In vitro binding affinity at serotonin 5-hydroxytryptamine 3 receptor in rat cortex by [3H]granisetron displacement.,,B,,H,6,Autocuration,CHEMBL619788,,
2999,,1,,10394,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]- 1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,,B,,H,6,Autocuration,CHEMBL619789,,
3000,,1,,10394,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]-1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,,B,,H,6,Autocuration,CHEMBL619790,,
3001,,1,,15034,BAO_0000019,,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,,B,,H,6,Autocuration,CHEMBL619791,,
3002,,1,,691,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,,B,,H,6,Autocuration,CHEMBL619792,,
3003,,1,,12092,BAO_0000249,,Displacement of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortical membranes,Membranes,B,,H,6,Autocuration,CHEMBL619793,,
3004,Rattus norvegicus,1,,11752,BAO_0000223,,Inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor,,B,,D,7,Autocuration,CHEMBL619794,,
3005,,1,955.0,11752,BAO_0000221,,The ability to inhibit [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortices,,B,,H,6,Autocuration,CHEMBL619795,,
3006,,1,,301,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 3 receptor in rat posterior cortex by [3H]-BRL 43694 displacement.,,B,,H,6,Autocuration,CHEMBL619796,,
3007,,1,,16532,BAO_0000223,,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584,,B,,H,6,Autocuration,CHEMBL620448,,
3008,,1,,16532,BAO_0000223,,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,,B,,H,6,Autocuration,CHEMBL620449,,
3009,,1,,12092,BAO_0000223,,The binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand.,,B,,H,6,Autocuration,CHEMBL620450,,
3010,,1,,11684,BAO_0000223,,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630,,B,,H,6,Autocuration,CHEMBL620451,,
3011,,1,,11684,BAO_0000223,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630.,,B,,H,6,Autocuration,CHEMBL620631,,
3012,,1,,12953,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand,,B,,H,6,Autocuration,CHEMBL620632,,
3013,,1,,12953,BAO_0000019,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand; NA means Not active,,B,,H,6,Autocuration,CHEMBL620633,,
3014,,1,,12953,BAO_0000223,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 3 receptor; Nonactive at 10 uM,,B,,H,6,Autocuration,CHEMBL620634,,
3015,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,,B,,H,6,Autocuration,CHEMBL620635,,
3016,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 0.5 hours in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620636,,
3017,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 1 hour in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620637,,
3018,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 3 hours in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620638,,
3019,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 6 hours in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620639,,
3020,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 0.5 hours in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620640,,
3021,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 1 hour in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620641,,
3022,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 16 hours in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620642,,
3023,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 3 hours in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620643,,
3024,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 6 hours in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620644,,
3025,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 0.5 hours in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620645,,
3026,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 1 hour in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620646,,
3027,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 3 hours in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620647,,
3028,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 6 hours in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620648,,
3029,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 0.5 hours in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620649,,
3030,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 3 hours in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620650,,
3031,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 1 hour in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620651,,
3032,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 3 hours in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL872875,,
3033,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 1 hour in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL620652,,
3034,,1,,10609,BAO_0000019,,5-hydroxytryptamine 3 receptor antagonist activity was confirmed by its ability to antagonize 5-HT evoked tachycardia of rabbit isolated heart,,F,,H,6,Autocuration,CHEMBL620653,,
3035,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2A receptor from rat cortex homogenates using [3H]DOB as radioligand.,,B,,H,6,Autocuration,CHEMBL857076,,
3036,Rattus norvegicus,1,,12861,BAO_0000019,,Inhibition of [3H]-Q-ICS 205-930 binding to rat cortex homogenate 5-hydroxytryptamine 3 receptor,,B,,D,7,Autocuration,CHEMBL620654,,
3037,,1,,12861,BAO_0000223,,Binding activity radioligand.,,B,,H,6,Autocuration,CHEMBL620655,,
3038,,1,,10728,BAO_0000249,,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor in rat brain membranes,Brain membranes,B,,H,6,Autocuration,CHEMBL620656,,
3039,,1,,10728,BAO_0000249,,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes.,Brain membranes,B,,H,6,Autocuration,CHEMBL620657,,
3040,,1,,5163,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.000001 mol/L,,B,,H,8,Autocuration,CHEMBL620658,,
3041,,1,,5163,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.00001 mol/L,,B,,H,8,Autocuration,CHEMBL620659,,
3042,,1,,6011,BAO_0000357,,Inhibition of binding towards 5-hydroxytryptamine 2C receptor at 100 nM concentration,,B,,H,8,Autocuration,CHEMBL620660,,
3043,,1,,5014,BAO_0000357,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL620661,,
3044,,1,,5635,BAO_0000357,,Binding affinity of compound towards 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL620662,,
3045,,1,,5163,BAO_0000357,,Affinity for 5-hydroxytryptamine 2C receptor,,B,,H,8,Expert,CHEMBL620663,,
3046,,1,,6841,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,B,,H,8,Autocuration,CHEMBL620664,,
3047,,1,,6119,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand.,,B,,H,8,Expert,CHEMBL620665,,
3048,,1,,4373,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2C receptor was determined,,B,,H,8,Autocuration,CHEMBL620666,,
3049,,1,,1633,BAO_0000357,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]-Ketanserin,,B,,H,8,Autocuration,CHEMBL620667,,
3050,,1,,1633,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]N-methyl-mesulergine,,B,,H,8,Expert,CHEMBL620668,,
3051,,1,,4373,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2C receptor was determined,,B,,H,8,Autocuration,CHEMBL620669,,
3052,,1,,6576,BAO_0000357,,Binding affinity towards serotonin 5-hydroxytryptamine 2C receptor,,B,,H,8,Expert,CHEMBL620670,,
3053,,1,,4687,BAO_0000357,,Evaluated for the binding affinity to 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL620671,,
3054,,1,,12146,BAO_0000357,,Tested agains t5-hydroxytryptamine 2C receptor in experiment 1,,B,,H,8,Autocuration,CHEMBL620672,,
3055,,1,,12146,BAO_0000357,,Tested against 5-hydroxytryptamine 2C receptor in experiment 2,,B,,H,8,Autocuration,CHEMBL620673,,
3056,,1,,16946,BAO_0000357,,Ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL620674,,
3057,,1,,14159,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL620675,,
3058,,1,,16700,BAO_0000357,,The binding affinity towards 5-hydroxytryptamine 2C receptor; No affinity,,B,,H,8,Autocuration,CHEMBL620676,,
3059,,1,,3269,BAO_0000357,,Affinity against 5-hydroxytryptamine 2C receptor,,B,,H,8,Autocuration,CHEMBL621382,,
3060,Homo sapiens,1,,1274,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2C receptor,,B,,D,9,Expert,CHEMBL621383,,
3061,,1,,1317,BAO_0000357,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2C receptor using radioligand binding assay,,B,,H,8,Autocuration,CHEMBL621384,,
3062,Bos taurus,1,,5834,BAO_0000357,,Inhibitory concentration required against 5-HT3 receptor in bovine area postrema using [3H]GR-65630,,B,,H,8,Autocuration,CHEMBL621385,,
3063,Bos taurus,1,,11147,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand,,B,,H,8,Autocuration,CHEMBL617989,,
3064,Cavia porcellus,1,,14145,BAO_0000019,,Antagonistic potency against serotonin 5-hydroxytryptamine 3 receptor in GPI assay,,F,,H,4,Expert,CHEMBL617990,,
3065,Cavia porcellus,1,2116.0,10561,BAO_0000221,,Binding affinity to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,,B,,H,4,Autocuration,CHEMBL875085,,
3066,Cavia porcellus,1,,15847,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig,,F,,H,4,Autocuration,CHEMBL617991,,
3067,Cavia porcellus,1,,15847,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig; ND means not done,,F,,H,4,Autocuration,CHEMBL617992,,
3068,Cavia porcellus,1,2116.0,10561,BAO_0000221,,Potency to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,,B,,H,4,Autocuration,CHEMBL617993,,
3069,Cavia porcellus,1,2116.0,11454,BAO_0000221,,In vitro binding affinity was measured for 5-hydroxytryptamine 3 receptor in the guinea pig ileum.,,B,,H,4,Autocuration,CHEMBL617994,,
3070,Cavia porcellus,1,,4639,BAO_0000019,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea colon at a concentration 0.01 uM,,F,,H,4,Autocuration,CHEMBL617995,,
3071,Cavia porcellus,1,,4639,BAO_0000019,,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.1 uM,,F,,H,4,Autocuration,CHEMBL617996,,
3072,Cavia porcellus,1,,4639,BAO_0000019,,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM,,F,,H,4,Autocuration,CHEMBL617997,,
3073,Cavia porcellus,1,,4639,BAO_0000019,,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM in the presence of 30 uM MDL 72222,,F,,H,4,Autocuration,CHEMBL617998,,
3074,Cavia porcellus,1,,4639,BAO_0000019,,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 0.01 uM,,F,,H,4,Autocuration,CHEMBL617999,,
3075,Cavia porcellus,1,,4639,BAO_0000019,,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 1 uM,,F,,H,4,Autocuration,CHEMBL618000,,
3076,Cavia porcellus,1,2116.0,15253,BAO_0000221,,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum",,F,,H,4,Autocuration,CHEMBL617815,,
3077,Cavia porcellus,1,2116.0,15253,BAO_0000221,,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum.",,F,,H,4,Autocuration,CHEMBL617816,,
3078,Cavia porcellus,1,2116.0,11963,BAO_0000221,,Tested for the antagonistic activity against 5-hydroxytryptamine 3 receptor from guinea pig ileum,,F,,H,4,Autocuration,CHEMBL617817,,
3079,Cavia porcellus,1,2116.0,1946,BAO_0000221,,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum,,B,,H,4,Autocuration,CHEMBL617818,,
3080,Cavia porcellus,1,2116.0,1946,BAO_0000221,,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum; Not tested,,B,,H,4,Autocuration,CHEMBL617819,,
3081,Cavia porcellus,1,,12045,BAO_0000223,,Binding affinity towards [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in HG108-15,,B,,H,4,Autocuration,CHEMBL617820,,
3082,Cavia porcellus,1,2116.0,1559,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,,B,,H,4,Autocuration,CHEMBL617821,,
3083,Cavia porcellus,1,2116.0,273,BAO_0000221,,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),,F,,H,4,Autocuration,CHEMBL617822,,
3084,Cavia porcellus,1,2116.0,273,BAO_0000221,,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor of isolated guinea pig ileum (GPI),,F,,H,4,Autocuration,CHEMBL617823,,
3085,Cavia porcellus,1,2116.0,188,BAO_0000221,,Tested for antagonistic activity on 5-hydroxytryptamine 3 receptor mediated effects of 5-HT in guinea pig isolated ileum,,F,,H,4,Autocuration,CHEMBL617824,,
3086,Cavia porcellus,1,2116.0,12919,BAO_0000221,,Agonistic activity against 5-hydroxytryptamine 3 receptor in guinea pig ileum assay,,F,,H,4,Autocuration,CHEMBL617825,,
3087,Cavia porcellus,1,2116.0,12918,BAO_0000221,,5-hydroxytryptamine 3 receptor agonism in the guinea pig ileum by functional 5-HT3 receptor assay,,F,,H,4,Autocuration,CHEMBL617826,,
3088,Cavia porcellus,1,2116.0,1559,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,,B,,H,4,Autocuration,CHEMBL617827,,
3089,Cavia porcellus,1,2116.0,273,BAO_0000221,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),,F,,H,4,Autocuration,CHEMBL617828,,
3090,Cavia porcellus,1,2116.0,1559,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,,B,,H,4,Autocuration,CHEMBL617829,,
3091,Cavia porcellus,1,2116.0,1559,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum; Not determined,,B,,H,4,Autocuration,CHEMBL617830,,
3092,Cavia porcellus,1,2116.0,1559,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 3 receptor of guinea pig ileum; not determined,,B,,H,4,Autocuration,CHEMBL617831,,
3093,Cavia porcellus,1,2116.0,14424,BAO_0000221,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor in guinea pig ileum.,,B,,H,4,Autocuration,CHEMBL617832,,
3094,Cavia porcellus,1,,13181,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,,B,,U,0,Autocuration,CHEMBL617833,,
3095,,1,,5486,BAO_0000357,,Binding affinity towards 5-HT1A receptor by the displacement of [3H]-8-OH-DPAT] in human recombinant receptors in mammalian cell,,B,,H,8,Autocuration,CHEMBL617834,,
3096,Homo sapiens,1,,6491,BAO_0000223,,Affinity towards human 5-hydroxytryptamine 3 serotonin receptor,,B,,D,5,Expert,CHEMBL617835,,
3097,,1,,6013,BAO_0000223,,Binding affinity towards 5-HT3 receptor,,B,,H,4,Autocuration,CHEMBL617836,,
3098,,1,,12861,BAO_0000223,,Binding activity radioligand.,,B,,H,4,Autocuration,CHEMBL617837,,
3099,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 1A receptor from human brain cortex using [3H]8-OH-DPAT-HT as radioligand.,,B,,H,4,Autocuration,CHEMBL620392,,
3100,,1,,5104,BAO_0000223,,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,,B,,H,4,Autocuration,CHEMBL620393,,
3101,,1,,5105,BAO_0000223,,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,,B,,H,4,Autocuration,CHEMBL620394,,
3102,,1,,5104,BAO_0000223,,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor; NT means Not tested,,B,,H,4,Autocuration,CHEMBL620395,,
3103,,1,,3935,BAO_0000019,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 3 receptor,,B,,U,0,Autocuration,CHEMBL620396,,
3104,,1,,13657,BAO_0000219,,Displacement of [3H]-BRC 36694 from 5-hydroxytryptamine 3 receptor in NG108-15 cells,,B,,H,4,Expert,CHEMBL620582,433.0,
3105,,1,,10369,BAO_0000218,,"Percent inhibition of [3H]5 binding to 5-hydroxytryptamine 3 receptor was evaluated by injection of compound (75 microCi/kg, 1.32 ug/kg) into the tail vein of mice (in vivo)",,B,,H,4,Autocuration,CHEMBL620583,,
3106,,1,,10369,BAO_0000019,,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),,B,,H,4,Autocuration,CHEMBL620584,,
3107,,1,,12918,BAO_0000224,,Compound was evaluated for the binding affinity at 5- HT3 receptor subtype,,B,,H,4,Autocuration,CHEMBL620585,,
3108,,1,,12918,BAO_0000224,,Compound was evaluated for the binding affinity at 5- HT3 receptor,,B,,H,4,Autocuration,CHEMBL620586,,
3109,,1,,10369,BAO_0000019,,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),,B,,H,4,Autocuration,CHEMBL620587,,
3110,,1,,773,BAO_0000019,,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,,B,,H,4,Autocuration,CHEMBL620588,,
3111,,1,,12918,BAO_0000218,,5-hydroxytryptamine 3 receptor agonism in mouse,,F,,H,4,Autocuration,CHEMBL620589,,
3112,,1,,10561,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 3 receptor was determined by using [3H]-ICS 205-930 as radioligand in mouse N1E 115 cells,,B,,H,4,Autocuration,CHEMBL620590,,
3113,,1,,12827,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,,B,,H,4,Autocuration,CHEMBL617956,,
3114,,1,,12827,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,,B,,H,4,Autocuration,CHEMBL617957,,
3115,,1,,12918,BAO_0000224,,Binding affinity was evaluated by 5-hydroxytryptamine 3 receptor agonism in the mouse NIE-115 by displacing tropisetron,,B,,H,4,Autocuration,CHEMBL617958,,
3116,,1,,273,BAO_0000219,,Compound was evaluated for binding to 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,,B,,H,4,Autocuration,CHEMBL617959,,
3117,,1,,273,BAO_0000219,,Compound was evaluated for binding to Serotonin 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,,B,,H,4,Autocuration,CHEMBL617960,,
3118,,1,,10561,BAO_0000224,,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,,B,,H,4,Autocuration,CHEMBL617961,,
3119,,1,,5033,BAO_0000219,,Ability to displace the radioligand [3H]GR-65630 from 5-hydroxytryptamine 3 receptor expressed in NIE-115 cells,,B,,H,4,Autocuration,CHEMBL617962,,
3120,,1,,16429,BAO_0000219,,In vitro binding affinity at 5-hydroxytryptamine 3 receptor in N1E-115 cells using 3[H]GR-65630 as the radioligand,,B,,H,4,Autocuration,CHEMBL617963,339.0,
3121,,1,,10322,BAO_0000019,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,B,,H,8,Autocuration,CHEMBL617964,,
3122,,1,,14331,BAO_0000219,,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in NG cells 108-15,,B,,H,8,Autocuration,CHEMBL617965,,
3123,Mus musculus,1,,13462,BAO_0000357,,Compound was tested for the Binding affinity against N1e-115 neuroblastoma 5-hydroxytryptamine 3 receptor by Radio ligand [3H]GR-65630 binding assay.,,B,,D,9,Autocuration,CHEMBL617966,,
3124,,1,,12861,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,B,,H,8,Autocuration,CHEMBL857074,,
3125,Sus scrofa,1,,15086,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor,,B,,H,8,Autocuration,CHEMBL617967,,
3126,Sus scrofa,1,,12861,BAO_0000357,,Binding activity radioligand.,,B,,H,8,Autocuration,CHEMBL617968,,
3127,Oryctolagus cuniculus,1,,10561,BAO_0000223,,Binding affinity to 5-hydroxytryptamine 3 receptor of neuronal in the afferent rabbit vagus,,B,,H,4,Autocuration,CHEMBL617969,,
3128,Oryctolagus cuniculus,1,,10561,BAO_0000223,,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,,B,,H,4,Autocuration,CHEMBL617970,,
3129,Oryctolagus cuniculus,1,,10561,BAO_0000223,,Potency at neuronal 5-hydroxytryptamine 3 receptors in the rabbit heart,,B,,H,4,Autocuration,CHEMBL617971,,
3130,Oryctolagus cuniculus,1,,10561,BAO_0000019,,Potency to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,,B,,H,4,Autocuration,CHEMBL617972,,
3131,Oryctolagus cuniculus,1,,273,BAO_0000019,,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),,F,,H,4,Autocuration,CHEMBL617973,,
3132,Oryctolagus cuniculus,1,,273,BAO_0000019,,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),,F,,H,4,Autocuration,CHEMBL617974,,
3133,Oryctolagus cuniculus,1,2116.0,273,BAO_0000221,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),,F,,H,4,Autocuration,CHEMBL617975,,
3134,Oryctolagus cuniculus,1,,273,BAO_0000019,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),,F,,H,4,Autocuration,CHEMBL617976,,
3135,Oryctolagus cuniculus,1,,273,BAO_0000019,,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),,F,,H,4,Autocuration,CHEMBL617977,,
3136,Oryctolagus cuniculus,1,,273,BAO_0000019,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),,F,,H,4,Autocuration,CHEMBL617978,,
3137,Oryctolagus cuniculus,1,,273,BAO_0000019,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),,F,,H,4,Autocuration,CHEMBL617979,,
3138,Oryctolagus cuniculus,1,,13047,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 3 receptor in CHO cells using [3H]5-HT as radioligand,,B,,H,4,Autocuration,CHEMBL617980,449.0,
3139,Rattus norvegicus,1,,1650,BAO_0000019,,In vitro displacement of [3H]-LY 278584 from rat cerebral cortex 5-hydroxytryptamine 3 receptor,,B,,D,7,Autocuration,CHEMBL617981,,
3140,,1,,16288,BAO_0000019,,Affinity at 5-hydroxytryptamine 3 receptor from rat frontal cortex using [3H]granisetron as radioligand (For granisetron = Ki(nM)=0.3+/-0.01),,B,,H,8,Autocuration,CHEMBL617982,,
3141,,1,,16288,BAO_0000357,,Affinity at 5-hydroxytryptamine 3 receptor (For granisetron = Ki (nM)=0.3+/-0.01),,B,,H,8,Autocuration,CHEMBL617983,,
3142,Rattus norvegicus,1,,10254,BAO_0000019,,In vitro displacement of [3H]ICS-205-930 from 5-hydroxytryptamine 3 receptor in cultured NG-108-15 rat glioma cells,,B,,D,7,Autocuration,CHEMBL617984,,
3143,,1,,14532,BAO_0000019,,"Binding affinity for 5-hydroxytryptamine 3 receptor in rat cerebral cortex, determined by displacement of [3H]GR-65630",,B,,H,6,Autocuration,CHEMBL617985,,
3144,,1,948.0,13392,BAO_0000218,,"5-Hydroxy tryptamine 3 receptor showing agonist activity (in vivo) in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",,F,,H,6,Autocuration,CHEMBL617986,,
3145,,1,948.0,13392,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",,F,,H,6,Autocuration,CHEMBL617987,,
3146,,1,948.0,13392,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",,F,,H,6,Autocuration,CHEMBL617988,,
3147,,1,948.0,13392,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as change in heart rate",,F,,H,6,Autocuration,CHEMBL617792,,
3148,,1,948.0,13392,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptorr in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",,F,,H,6,Autocuration,CHEMBL617793,,
3149,,1,,13392,BAO_0000019,,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100(ug/kg), evaluated as percent inhibition of bradycardia",,F,,H,6,Autocuration,CHEMBL617794,,
3150,,1,,13392,BAO_0000019,,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",,F,,H,6,Autocuration,CHEMBL617795,,
3151,,1,,13392,BAO_0000019,,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",,F,,H,6,Autocuration,CHEMBL617796,,
3152,,1,,13392,BAO_0000019,,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60(ug/kg), evaluated as percent inhibition of bradycardia",,F,,H,6,Autocuration,CHEMBL617797,,
3153,Rattus norvegicus,1,,1089,BAO_0000218,,Antagonism of 5-HT-induced Von Bezold-Jarisch reflex in rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor antagonism),,F,,D,7,Autocuration,CHEMBL617798,,
3154,,1,,1089,BAO_0000218,,Ability to antagonise the 5-HT- induced Von Bezold-Jarisch reflex in the rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor),,F,,H,6,Autocuration,CHEMBL617799,,
3155,Rattus norvegicus,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,,F,,D,7,Autocuration,CHEMBL617800,,
3156,Rattus norvegicus,1,,11454,BAO_0000019,,Inhibition of 5-HT-induced bradycardia by 5-hydroxytryptamine 3+,,F,,D,7,Autocuration,CHEMBL617801,,
3157,Rattus norvegicus,1,,12205,BAO_0000218,,In vivo inhibitory concentration after 5 minutes against 5-hydroxytryptamine 3 receptor induced bradycardia [bezold-jarisch (B-J) reflex test] in rat by intravenous administration,,F,,D,7,Autocuration,CHEMBL617802,,
3158,Rattus norvegicus,1,,1089,BAO_0000019,,Inhibition of 5-HT (1 ug/mL) induced depolarization in rat vagus nerve (5-hydroxytryptamine 3 receptor antagonism),,F,,D,7,Autocuration,CHEMBL617803,,
3159,,1,,5094,BAO_0000019,,Binding affinity towards 5-HT3 receptor in rat was evaluated,,B,,H,6,Autocuration,CHEMBL617804,,
3160,Rattus norvegicus,1,,2622,BAO_0000019,,Inhibition of [3H]GR-65630 binding to rat cortical membrane 5-hydroxytryptamine 3 receptor,,B,,D,7,Autocuration,CHEMBL617805,,
3161,,1,,245,BAO_0000223,,Binding affinity was evaluated in vitro by displacement of [3H]zacopride radioligand from 5-hydroxytryptamine 3 receptor,,B,,H,6,Autocuration,CHEMBL617806,,
3162,,1,,14788,BAO_0000019,,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex.,,B,,H,6,Autocuration,CHEMBL617807,,
3163,,1,,14788,BAO_0000019,,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement of [3H]granisetron from rat cerebral cortex,,B,,H,6,Autocuration,CHEMBL617808,,
3164,,1,,3020,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 3 receptor in rat cortical membrane using [3H]GR-65630 as radioligand,,B,,H,6,Autocuration,CHEMBL617809,,
3165,,1,,1742,BAO_0000019,,Compound was tested for its ability to displace [3H]-Q-ICS 205-930 from 5-hydroxytryptamine 3 receptor in rat cortex homogenates,,B,,H,6,Autocuration,CHEMBL617810,,
3166,,1,955.0,17394,BAO_0000249,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to 5-hydroxytryptamine 3 receptor in rat brain cortical membrane,,B,,H,6,Autocuration,CHEMBL617811,,
3167,,1,955.0,17394,BAO_0000221,,Concentration required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine-3 receptor (5-HT 3 receptor)in rat brain cortical membrane,,B,,H,6,Autocuration,CHEMBL617812,,
3168,,1,,17394,BAO_0000249,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine 3 receptor in rat cortical membrane,,B,,H,6,Autocuration,CHEMBL617813,,
3169,,1,,14286,BAO_0000249,,In vitro inhibitory concentration against radioligand [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in rat cortical membrane,,B,,H,6,Autocuration,CHEMBL617814,,
3170,,1,,14178,BAO_0000019,,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate.,,B,,H,6,Autocuration,CHEMBL617698,,
3171,Rattus norvegicus,1,,14178,BAO_0000019,,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; Not active at 10000 nm,,B,,D,7,Autocuration,CHEMBL617699,,
3172,Rattus norvegicus,1,,14178,BAO_0000019,,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; not active at 10000 nM,,B,,D,7,Autocuration,CHEMBL617700,,
3173,Rattus norvegicus,1,,14178,BAO_0000223,,Inhibition of radiolabeled [3H]-Zacopride ligand binding to 5-hydroxytryptamine 3 receptor,,B,,D,7,Autocuration,CHEMBL617701,,
3174,,1,,15034,BAO_0000019,,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,,B,,H,6,Autocuration,CHEMBL617702,,
3175,,1,,1089,BAO_0000249,,"Tested for inhibition of binding of [3H]GR-65630 to rat cortical membranes, expressed as IC50",Membranes,B,,H,6,Autocuration,CHEMBL617703,,
3176,Rattus norvegicus,1,,1089,BAO_0000019,,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 3 receptor,,B,,D,7,Autocuration,CHEMBL617704,,
3177,,1,,16532,BAO_0000223,,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,,B,,H,6,Autocuration,CHEMBL617705,,
3178,Rattus norvegicus,1,,12801,BAO_0000223,,Inhibition of [3H]BRL-43694 binding to rat 5-hydroxytryptamine 3 receptor,,B,,D,7,Autocuration,CHEMBL617706,,
3179,,1,,15194,BAO_0000219,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells (using [3H]zacopride as radioligand),,B,,H,6,Autocuration,CHEMBL617707,433.0,
3180,,1,,15194,BAO_0000219,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells using [3H]zacopride as radioligand,,B,,H,6,Autocuration,CHEMBL617708,433.0,
3181,,1,,15194,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor from rat cortical homogenate using [3H]zacopride as radioligand,,B,,H,6,Autocuration,CHEMBL617709,,
3182,,1,,15194,BAO_0000019,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA= Not active,,B,,H,6,Autocuration,CHEMBL617710,,
3183,,1,,15194,BAO_0000019,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA=Not active,,B,,H,6,Autocuration,CHEMBL882925,,
3184,,1,,15194,BAO_0000019,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; not active,,B,,H,6,Autocuration,CHEMBL617711,,
3185,,1,,10610,BAO_0000019,,Antagonist potency to 5-hydroxytryptamine 3 receptor was assayed by antagonism of the 5-HT-evoked reflex bradycardia [Bezold-Jarisch(BJ) reflex] in rats,,F,,H,6,Autocuration,CHEMBL617712,,
3186,Rattus norvegicus,1,,10355,BAO_0000019,,Antagonistic activity against 5-hydroxytryptamine 3 receptor as inhibition of 5-HT-induced bradycardia (von Bezold-jarisch reflex) in anesthetized rat,,F,,D,7,Autocuration,CHEMBL617713,,
3187,,1,,691,BAO_0000019,,"Compound was tested as a 5-hydroxytryptamine 3 receptor antagonist in the rat by assessment of the inhibition of the Bezold-Jarisch effect, when administered intravenously",,F,,H,6,Autocuration,CHEMBL617714,,
3188,,1,,10611,BAO_0000218,,In vivo 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) antagonistic activity expressed as ability to inhibit Bezold-Jarich reflex evoked by 5-HT in rats,,F,,H,6,Autocuration,CHEMBL617715,,
3189,,1,,12801,BAO_0000218,,Inhibition dose for 50 percent antagonism for 5-hydroxytryptamine 3 receptor in vivo in rats,,F,,H,6,Autocuration,CHEMBL617716,,
3190,,1,,10609,BAO_0000218,,Inhibition of 5-HT evoked reflex bradycardia in rat.,,F,,H,6,Autocuration,CHEMBL617717,,
3191,,1,,11454,BAO_0000218,,5-HT3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617718,,
3192,,1,,11454,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617719,,
3193,,1,,11454,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity measured by inhibition of 5-HT-induced bradycardia (iv administration 10 ug/kg dose in urethane-anesthetized rats),,F,,H,6,Autocuration,CHEMBL617720,,
3194,Rattus norvegicus,1,,11454,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity as inhibition of 5-HT-induced bradycardia after iv administration of 100 ug/kg dose in urethane-anesthetized rats,,F,,D,7,Autocuration,CHEMBL617721,,
3195,,1,,11454,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617722,,
3196,,1,,11454,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kgetized rats,,F,,H,6,Autocuration,CHEMBL617723,,
3197,,1,,11454,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 3 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617724,,
3198,,1,,11454,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 10 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617725,,
3199,,1,,11454,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 100 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617726,,
3200,,1,,11454,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 1000 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617727,,
3201,,1,,11454,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 30 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617728,,
3202,,1,,11454,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 300 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617729,,
3203,,1,,11454,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 3ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617730,,
3204,,1,,11454,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617731,,
3205,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 0.3 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617732,,
3206,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 1 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617733,,
3207,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 30 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617734,,
3208,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 0.05 hour,,F,,H,6,Autocuration,CHEMBL872874,,
3209,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 1 hour,,F,,H,6,Autocuration,CHEMBL617735,,
3210,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 16 hour,,F,,H,6,Autocuration,CHEMBL617736,,
3211,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 3 hour,,F,,H,6,Autocuration,CHEMBL617737,,
3212,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 6 hour,,F,,H,6,Autocuration,CHEMBL617738,,
3213,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617739,,
3214,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 100 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617740,,
3215,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617741,,
3216,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617742,,
3217,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 3 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617743,,
3218,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 30 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617744,,
3219,,1,,11454,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 300 ug/kg dose in urethane-anesthetized rats,,F,,H,6,Autocuration,CHEMBL617745,,
3220,,1,,670,BAO_0000218,,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.)",,F,,H,6,Autocuration,CHEMBL617746,,
3221,,1,,670,BAO_0000218,,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.); Not tested",,F,,H,6,Autocuration,CHEMBL617747,,
3222,,1,,10321,BAO_0000218,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 10 ug/Kg,,F,,H,6,Autocuration,CHEMBL617748,,
3223,,1,,10321,BAO_0000218,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 100 ug/Kg,,F,,H,6,Autocuration,CHEMBL618909,,
3224,,1,,10321,BAO_0000218,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 2 ug/Kg,,F,,H,6,Autocuration,CHEMBL618910,,
3225,,1,,10321,BAO_0000218,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 20 ug/Kg,,F,,H,6,Autocuration,CHEMBL618911,,
3226,,1,,10321,BAO_0000218,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 5 ug/Kg,,F,,H,6,Autocuration,CHEMBL618912,,
3227,,1,,10322,BAO_0000218,,Tested for inhibition of Bezold-Jarisch (B-J) reflex mediated by 5-hydroxytryptamine 3 receptor in rats after intravenous administration (2.0 ug/kg),,F,,H,6,Autocuration,CHEMBL618913,,
3228,,1,,15412,BAO_0000019,,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,,F,,H,6,Autocuration,CHEMBL618914,,
3229,,1,,15412,BAO_0000019,,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,,F,,H,6,Autocuration,CHEMBL618915,,
3230,Rattus norvegicus,1,,15412,BAO_0000223,,Intrinsic efficacy for rat 5-hydroxytryptamine 3 receptor,,B,,D,7,Autocuration,CHEMBL618916,,
3231,,1,,15412,BAO_0000019,,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; PA means partial agonist,,F,,H,6,Autocuration,CHEMBL618917,,
3232,,1,10000000.0,15412,BAO_0000221,,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) of rat cortex and hippocampus tissue,,B,,D,7,Intermediate,CHEMBL618918,,
3233,Rattus norvegicus,1,,15412,BAO_0000019,,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor of rat cortical membrane,,B,,D,7,Autocuration,CHEMBL618919,,
3234,Rattus norvegicus,1,,17394,BAO_0000019,,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor,,B,,D,7,Autocuration,CHEMBL618920,,
3235,,1,,12457,BAO_0000223,,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 3 receptor,,B,,H,6,Autocuration,CHEMBL618921,,
3236,,1,,12457,BAO_0000019,,Affinity was evaluated by inhibition of [3H]GR-65630 binding to NG108-15 cell transfected with cloned rat 5-hydroxytryptamine 3 receptor,,B,,H,6,Autocuration,CHEMBL618922,,
3237,,1,,12205,BAO_0000019,,Binding affinity against radioligand [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in neuroblastoma-glioma (NG108-15) cells.,,B,,H,6,Autocuration,CHEMBL618923,,
3238,,1,,14532,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 3 receptor was determined by measuring displacement of [3H]GR-65630 from rat brain cortices,,B,,H,6,Autocuration,CHEMBL618924,,
3239,,1,,1122,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-BRL 43694 as radioligand,,B,,H,6,Autocuration,CHEMBL618925,,
3240,,1,,5094,BAO_0000019,,Binding affinity towards 5-HT3 receptor in rat was evaluated,,B,,H,6,Autocuration,CHEMBL618926,,
3241,Cavia porcellus,1,2116.0,809,BAO_0000221,,5-hydroxytryptamine 4 receptor agonist activity as increased response to electrical stimulation in guinea pig ileum,,F,,D,9,Intermediate,CHEMBL618927,,
3242,Cavia porcellus,1,2116.0,809,BAO_0000221,,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum; Not tested,,F,,D,9,Intermediate,CHEMBL618928,,
3243,Cavia porcellus,1,2116.0,14290,BAO_0000221,,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum",,F,,D,9,Intermediate,CHEMBL618929,,
3244,Cavia porcellus,1,2116.0,14290,BAO_0000221,,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Inactive up to 10E-5 M",,F,,D,9,Intermediate,CHEMBL618930,,
3245,Cavia porcellus,1,2116.0,14290,BAO_0000221,,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",,F,,D,9,Intermediate,CHEMBL618931,,
3246,Cavia porcellus,1,2116.0,14290,BAO_0000221,,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",,F,,D,9,Intermediate,CHEMBL619594,,
3247,Cavia porcellus,1,2116.0,14290,BAO_0000221,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not capable of evaluation",,F,,D,9,Intermediate,CHEMBL619595,,
3248,Cavia porcellus,1,2116.0,13961,BAO_0000221,,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum.,,F,,D,9,Intermediate,CHEMBL619596,,
3249,Cavia porcellus,1,2116.0,13961,BAO_0000221,,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum. Activity expressed as percent of the maximum 5-HT response given in brackets.,,F,,D,9,Intermediate,CHEMBL619755,,
3250,Cavia porcellus,1,2116.0,809,BAO_0000221,,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum,,F,,D,9,Intermediate,CHEMBL619756,,
3251,Cavia porcellus,1,2116.0,809,BAO_0000221,,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not evaluable,,F,,D,9,Intermediate,CHEMBL619757,,
3252,Cavia porcellus,1,2116.0,809,BAO_0000221,,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not tested,,F,,D,9,Intermediate,CHEMBL619758,,
3253,Cavia porcellus,1,2116.0,14290,BAO_0000221,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum",,F,,D,9,Intermediate,CHEMBL619759,,
3254,Cavia porcellus,1,2116.0,14290,BAO_0000221,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10-5 M",,F,,D,9,Intermediate,CHEMBL619760,,
3255,Cavia porcellus,1,2116.0,14290,BAO_0000221,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10E-5 M",,F,,D,9,Intermediate,CHEMBL619761,,
3256,Cavia porcellus,1,2116.0,14290,BAO_0000221,,5-hydroxytryptamine 4 receptor antagonist activity as inhibition of 5-HT-induced contractions in guinea pig ileum; Not capable of evaluation.,,F,,D,9,Intermediate,CHEMBL619762,,
3257,Cavia porcellus,1,2116.0,14290,BAO_0000221,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",,F,,D,9,Intermediate,CHEMBL619763,,
3258,Cavia porcellus,1,2116.0,14290,BAO_0000221,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",,F,,D,9,Intermediate,CHEMBL617868,,
3259,Cavia porcellus,1,,15034,BAO_0000357,,Displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor in guinea pig striatum,,B,,D,9,Intermediate,CHEMBL617869,,
3260,Cavia porcellus,1,2435.0,5094,BAO_0000249,,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,,B,,D,9,Intermediate,CHEMBL882926,,
3261,Cavia porcellus,1,2435.0,5094,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,,B,,D,9,Intermediate,CHEMBL617870,,
3262,Cavia porcellus,1,2435.0,5399,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 4 receptor of guinea pig striatum using [3H]GR-113808 as radioligand,,B,,D,9,Intermediate,CHEMBL617871,,
3263,Cavia porcellus,1,2435.0,17394,BAO_0000357,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea pig striatum,,B,,D,9,Intermediate,CHEMBL617872,,
3264,Cavia porcellus,1,2435.0,17394,BAO_0000357,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea-pig striatum,,B,,D,9,Intermediate,CHEMBL617873,,
3265,Cavia porcellus,1,2435.0,17394,BAO_0000357,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to serotonin 5-hydroxytryptamine 4 receptor in guinea-pig striatum,,B,,D,9,Intermediate,CHEMBL617874,,
3266,Cavia porcellus,1,2116.0,13961,BAO_0000221,,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum.,,F,,D,9,Intermediate,CHEMBL619067,,
3267,Cavia porcellus,1,2116.0,13961,BAO_0000221,,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum. 95% confidence limits are in brackets.,,F,,D,9,Intermediate,CHEMBL619068,,
3268,Cavia porcellus,1,2116.0,13961,BAO_0000221,,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,,F,,D,9,Intermediate,CHEMBL619069,,
3269,Cavia porcellus,1,,16946,BAO_0000357,,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-6 M in guinea pig,,B,,D,9,Intermediate,CHEMBL619070,,
3270,Cavia porcellus,1,,16946,BAO_0000357,,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-8 M in guinea pig,,B,,D,9,Intermediate,CHEMBL619071,,
3271,Cavia porcellus,1,,15034,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 4 receptor,,F,,D,9,Intermediate,CHEMBL619072,,
3272,Cavia porcellus,1,,15034,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 4 receptor; not tested,,F,,D,9,Intermediate,CHEMBL619073,,
3273,Cavia porcellus,1,,12918,BAO_0000019,,Compound was evaluated for the relative potency with respect to serotonin against 5-hydroxytryptamine 4 receptor,,F,,D,9,Intermediate,CHEMBL619074,,
3274,Cavia porcellus,1,,16946,BAO_0000357,,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor,,B,,D,9,Intermediate,CHEMBL619075,,
3275,Cavia porcellus,1,2435.0,17394,BAO_0000357,,Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor,,B,,D,9,Intermediate,CHEMBL619076,,
3276,Cavia porcellus,1,2435.0,15034,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 4 receptor in guinea pig striatum using [3H]GR-113808 as radioligand,,B,,D,9,Intermediate,CHEMBL619077,,
3277,Cavia porcellus,1,2435.0,5094,BAO_0000249,,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,,B,,D,9,Intermediate,CHEMBL619078,,
3278,Cavia porcellus,1,2435.0,5094,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,,B,,D,9,Intermediate,CHEMBL619079,,
3279,Cavia porcellus,1,2116.0,17358,BAO_0000221,,Tested for affinity against 5-hydroxytryptamine 4 receptor in the myenteric plexus of the guinea pig ileum.,,B,,D,9,Intermediate,CHEMBL619080,,
3280,Cavia porcellus,1,,12953,BAO_0000357,,Displacement of [3H]-GR113808 from 5-HT4 receptor of guinea pig striatum,,B,,D,9,Expert,CHEMBL619081,,
3281,Cavia porcellus,1,,12953,BAO_0000357,,The compound was tested for their binding affinity towards 5-HT4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,,B,,D,9,Intermediate,CHEMBL619082,,
3282,Cavia porcellus,1,,12953,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand.,,B,,D,9,Intermediate,CHEMBL619083,,
3283,Cavia porcellus,1,,12953,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,,B,,D,9,Intermediate,CHEMBL619084,,
3284,Cavia porcellus,1,2116.0,273,BAO_0000221,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,,F,,D,9,Intermediate,CHEMBL859397,,
3285,Cavia porcellus,1,2116.0,12918,BAO_0000221,,5-hydroxytryptamine 4 receptor agonist activity in the guinea pig ileum assay,,F,,D,9,Intermediate,CHEMBL619085,,
3286,Cavia porcellus,1,2116.0,12919,BAO_0000221,,5-hydroxytryptamine 4 receptor agonistic activity was measured by twitch response enhancing activity in electrically stimulated guinea pig ileum preparation,,F,,D,9,Intermediate,CHEMBL619086,,
3287,Cavia porcellus,1,2116.0,273,BAO_0000221,,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI).,,F,,D,9,Intermediate,CHEMBL619087,,
3288,Cavia porcellus,1,2116.0,273,BAO_0000221,,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,,F,,D,9,Intermediate,CHEMBL619088,,
3289,Cavia porcellus,1,,13181,BAO_0000357,,Ability to antagonize 5-HT-evoked contractions mediated through 5-hydroxytryptamine 4 receptor activation in the guinea pig distal colon LMMP,,B,,D,9,Intermediate,CHEMBL619089,,
3290,Cavia porcellus,1,,13181,BAO_0000357,,Binding affinity was determined against 5-hydroxytryptamine 3 receptor,,B,,H,8,Autocuration,CHEMBL619090,,
3291,Cavia porcellus,1,,15034,BAO_0000019,,Antagonistic activity against 5-hydroxytryptamine 4 receptor,,F,,D,9,Intermediate,CHEMBL619091,,
3292,Cavia porcellus,1,,5033,BAO_0000357,,Ability to displace the radioligand [3H]GR-113808 from guinea pig striatum 5-hydroxytryptamine 4 receptor,,B,,D,9,Intermediate,CHEMBL619092,,
3293,Cavia porcellus,1,,1980,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 4 receptor by displacement of [3H]GR-113808 from guinea pig brain striatum.,,B,,D,9,Intermediate,CHEMBL619093,,
3294,Cavia porcellus,1,,13181,BAO_0000219,,Binding affinity was determined against 5-hydroxytryptamine 2C receptor using cloned rat receptors expressed in 293 cells radiolabeled with [3H]mesulergine,,B,,H,8,Autocuration,CHEMBL619094,722.0,
3295,Cavia porcellus,1,,14287,BAO_0000019,,In vitro by displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor on guinea pig striatal membrane,,B,,D,9,Intermediate,CHEMBL619095,,
3296,Cavia porcellus,1,,1317,BAO_0000357,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 4 receptor using radioligand binding assay using [3H]GR as radioligand,,B,,D,9,Intermediate,CHEMBL857988,,
3297,Cavia porcellus,1,,15316,BAO_0000357,,Compound was evaluated for its ability to displace [3H]GR-113808 binding from 5-hydroxytryptamine 4 receptor in guinea pig striatum.,,B,,D,9,Intermediate,CHEMBL619096,,
3298,Cavia porcellus,1,2435.0,16429,BAO_0000357,,In vitro binding affinity at 5-hydroxytryptamine 4 receptor in guinea pig striatum using 3[H]GR-113808 as the radioligand,,B,,D,9,Intermediate,CHEMBL619097,,
3299,Cavia porcellus,1,10000000.0,14818,BAO_0000221,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 4 receptor in guinea pig hippocampus using [125I]SB-207710.,,B,,D,9,Intermediate,CHEMBL619098,,
3300,Cavia porcellus,1,,15194,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand,,B,,D,9,Intermediate,CHEMBL619751,,
3301,Cavia porcellus,1,,15194,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand.,,B,,D,9,Intermediate,CHEMBL619752,,
3302,Cavia porcellus,1,2116.0,13961,BAO_0000221,,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,,F,,D,9,Intermediate,CHEMBL875096,,
3303,,1,,5486,BAO_0000357,,Binding affinity towards 5-HT2C receptor by the displacement of [3H]mesulergine] in human recombinant receptors in mammalian cell,,B,,H,8,Autocuration,CHEMBL619004,,
3304,,1,,16209,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 4 receptor using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL619005,,
3305,,1,,17085,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 4 receptor,,B,,H,8,Autocuration,CHEMBL619006,,
3306,,1,,4199,BAO_0000219,,Compound was evaluated for the binding affinity against human cloned 5-hydroxytryptamine 4 receptor in HeLa cells using [3H]-LSD as the radioligand,,B,,H,8,Autocuration,CHEMBL619007,308.0,
3307,,1,,15146,BAO_0000357,,Compound was tested for its binding affinity against 5-hydroxytryptamine 4 receptor,,B,,H,8,Autocuration,CHEMBL619008,,
3308,,1,,5213,BAO_0000357,,Compound was tested for its binding affinity for 5-hydroxytryptamine 4 receptor,,B,,H,8,Autocuration,CHEMBL619009,,
3309,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 4 receptor in HeLa cells, using [3H]LSD as radioligand",,B,,H,8,Autocuration,CHEMBL619010,308.0,
3310,,1,,17358,BAO_0000357,,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons,,B,,H,8,Autocuration,CHEMBL619011,,
3311,,1,,17358,BAO_0000357,,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons; IA means inactive,,B,,H,8,Autocuration,CHEMBL619012,,
3312,,1,,16946,BAO_0000219,,Ability to displace [3H]GR-113808 from mouse 5-hydroxytryptamine 4 receptor in COS7 cells,,B,,H,8,Autocuration,CHEMBL619013,,
3313,,1,,17358,BAO_0000357,,Tested for ability to stimulate 5-hydroxytryptamine 4 receptors in mouse Coliculi neurons,,B,,H,8,Autocuration,CHEMBL619014,,
3314,,1,2081.0,268,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model,,F,,H,8,Autocuration,CHEMBL857503,,
3315,,1,2081.0,268,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model; compound found inactive at 1 uM,,F,,H,8,Autocuration,CHEMBL619015,,
3316,,1,,15086,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 4 receptor,,B,,H,8,Autocuration,CHEMBL619016,,
3317,,1,10000000.0,14875,BAO_0000221,,Compound was tested for binding affinity against piglet hippocampus 5-hydroxytryptamine 4 receptor,,B,,H,8,Autocuration,CHEMBL619017,,
3318,Sus scrofa,1,10000000.0,13267,BAO_0000221,,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]SB 207710 as radioligand,,B,,H,8,Autocuration,CHEMBL619018,,
3319,Oryctolagus cuniculus,1,,13047,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor using rabbit saphenous vein assay.,,B,,H,8,Autocuration,CHEMBL619019,,
3320,Rattus norvegicus,1,,1650,BAO_0000357,,Displacement of [3H]GR-113808 from rat striatum 5-hydroxytryptamine 4 receptor,,B,,D,9,Expert,CHEMBL619020,,
3321,,1,,567,BAO_0000019,,Tested for its agonist potency against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,,F,,H,8,Autocuration,CHEMBL619021,,
3322,,1,,17358,BAO_0000357,,Tested for affinity towards 5-hydroxytryptamine 4 receptor in relaxation of rat oesophagus,,B,,H,8,Autocuration,CHEMBL619022,,
3323,,1,,188,BAO_0000357,,Tested for the effect on binding at 5-hydroxytryptamine 4 receptor; No activity,,B,,H,8,Autocuration,CHEMBL619023,,
3324,,1,,670,BAO_0000019,,lntrinsic activity relative to 5-HT receptor,,F,,H,8,Autocuration,CHEMBL619024,,
3325,,1,,204,BAO_0000019,,Compound was evaluated for the agonistic activity towards 5-hydroxytryptamine 4 receptor using the rat tunica muscularis mucosae (TMM) esophagus strip assay,,F,,H,8,Autocuration,CHEMBL619025,,
3326,,1,,1946,BAO_0000019,,In vitro relaxation of carbachol pre-contracted rat oesophageal TMM.,,F,,H,8,Expert,CHEMBL619026,,
3327,,1,,6398,BAO_0000019,,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay,,F,,H,8,Autocuration,CHEMBL619027,,
3328,,1,,6398,BAO_0000019,,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay; IN = Inactive,,F,,H,8,Autocuration,CHEMBL619028,,
3329,,1,,17358,BAO_0000019,,Efficient 5-hydroxytryptamine 4 agonist in the rat tunica muscularis mucosae,,F,,H,8,Autocuration,CHEMBL619029,,
3330,,1,,6398,BAO_0000019,,Tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay of racemate mixture,,F,,H,8,Autocuration,CHEMBL619030,,
3331,,1,,11752,BAO_0000357,,Relaxation of carbachol induced contractions of rat tunica muscularis mucosae,,B,,H,8,Expert,CHEMBL619031,,
3332,,1,,809,BAO_0000019,,5-hydroxytryptamine 4 receptor agonist activity was determined by the relaxation of the carbachol-contracted rat esophageal tunica muscularis mucosae,,F,,H,8,Autocuration,CHEMBL619032,,
3333,Rattus norvegicus,1,,14178,BAO_0000357,,Inhibition of radiolabeled [3H]GR-113808 ligand binding to 5-hydroxytryptamine 4 receptor,,B,,D,9,Expert,CHEMBL619033,,
3334,,1,,567,BAO_0000357,,Tested for its efficacy against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,,B,,H,8,Autocuration,CHEMBL619034,,
3335,,1,,1946,BAO_0000357,,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae.,,B,,H,8,Autocuration,CHEMBL619035,,
3336,,1,,1946,BAO_0000357,,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae; No activity up to 104M concentration,,B,,H,8,Autocuration,CHEMBL619036,,
3337,Rattus norvegicus,1,,13961,BAO_0000019,,Binding affinity (Ki+/-SEM) against 5-hydroxytryptamine 4 receptor from cheng Prusoff equation by using [3H]GR-113808 in rat striatum,,B,,D,9,Expert,CHEMBL619037,,
3338,,1,2435.0,6238,BAO_0000249,,Binding affinity towards 5-HT 4 receptor in rat striatum membranes using [3H]GR-113808 as radioligand,,B,,H,8,Autocuration,CHEMBL619038,,
3339,,1,,14290,BAO_0000249,,Binding affinity towards 5-HT4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand; Not tested,,B,,H,8,Autocuration,CHEMBL619039,,
3340,,1,,14290,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand,,B,,H,8,Expert,CHEMBL619040,,
3341,Rattus norvegicus,1,2435.0,809,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,,B,,D,9,Expert,CHEMBL619041,,
3342,,1,2435.0,1578,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,,B,,H,8,Autocuration,CHEMBL619042,,
3343,,1,2435.0,16709,BAO_0000249,,Binding affinity to 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum membrane,,B,,H,8,Expert,CHEMBL619043,,
3344,,1,2435.0,1946,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement.,,B,,H,8,Expert,CHEMBL619044,,
3345,,1,2435.0,15253,BAO_0000249,,In vitro affinity at serotonergic 5-hydroxytryptamine 4 receptor by radioligand binding assay using [3H]GR-113808 in rat striatum membranes.,,B,,H,8,Expert,CHEMBL619045,,
3346,,1,2435.0,4535,BAO_0000249,,In vitro binding affinity to 5-hydroxytryptamine 4 receptor in rat striatum membrane,,B,,H,8,Expert,CHEMBL619046,,
3347,,1,,13961,BAO_0000249,,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatal membranes by [3H]GR-113808 displacement.,,B,,H,8,Expert,CHEMBL619047,,
3348,,1,955.0,17358,BAO_0000221,,Tested for potency against 5-hydroxytryptamine 4 receptor agonist in rat brain,,F,,H,8,Autocuration,CHEMBL619048,,
3349,,1,,15847,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat,,F,,H,8,Autocuration,CHEMBL859398,,
3350,,1,,15847,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat; ND means not done,,F,,H,8,Autocuration,CHEMBL619049,,
3351,,1,,670,BAO_0000019,,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae,,F,,H,8,Autocuration,CHEMBL857886,,
3352,,1,,670,BAO_0000019,,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae; Not tested,,F,,H,8,Autocuration,CHEMBL619050,,
3353,,1,,1317,BAO_0000019,,Antagonist activity against 5-hydroxytryptamine 4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,,F,,H,8,Autocuration,CHEMBL620591,,
3354,Rattus norvegicus,1,,12936,BAO_0000357,,Binding affinity against rat 5-hydroxytryptamine 4 receptor,,B,,D,9,Expert,CHEMBL620592,,
3355,,1,2435.0,4535,BAO_0000249,,pKi against 5-hydroxytryptamine 4 receptor in rat striatum membrane,,B,,H,8,Expert,CHEMBL620593,,
3356,Rattus norvegicus,1,,14424,BAO_0000019,,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-5 M.,,F,,D,9,Expert,CHEMBL620594,,
3357,,1,,14424,BAO_0000019,,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-6 M.,,F,,H,8,Expert,CHEMBL875079,,
3358,,1,,14424,BAO_0000019,,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,,F,,H,8,Expert,CHEMBL620595,,
3359,Rattus norvegicus,1,,14424,BAO_0000019,,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-8 M.,,F,,D,9,Expert,CHEMBL620596,,
3360,,1,,14424,BAO_0000019,,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-7 M.,,F,,H,8,Autocuration,CHEMBL620597,,
3361,,1,,14424,BAO_0000019,,Antagonistic activity evaluated by ability to block serotonin induced relaxation (via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-8 M.,,F,,H,8,Expert,CHEMBL620598,,
3362,,1,,14424,BAO_0000218,,Antagonistic activity evaluated by ability to block serotonin induced relaxation via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 0.1 mg/kg (p.o.),,F,,H,8,Expert,CHEMBL620599,,
3363,,1,,14424,BAO_0000019,,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,,F,,H,8,Autocuration,CHEMBL620600,,
3364,Rattus norvegicus,1,,1980,BAO_0000019,,Estimate from relaxation of carbachol-contracted rat esophageal muscularis mucosae,,F,,H,8,Autocuration,CHEMBL620601,,
3365,,1,,4639,BAO_0000019,,Compound was tested for agonistic activity against 5-hydroxytryptamine 4 receptor on guinea colon at a concentration 0.1 uM,,F,,H,8,Autocuration,CHEMBL620602,,
3366,,1,,17358,BAO_0000357,,Tested for affinity towards 5-hydroxytryptamine 4 receptor,,B,,H,8,Autocuration,CHEMBL620603,,
3367,,1,,17358,BAO_0000357,,Tested for affinity towards 5-hydroxytryptamine 4 receptor.,,B,,H,8,Autocuration,CHEMBL620604,,
3368,,1,,17358,BAO_0000357,,Compound was tested for 5-hydroxytryptamine 4 binding affinity,,B,,H,8,Autocuration,CHEMBL620605,,
3369,,1,,1558,BAO_0000357,,Compound was tested for its affinity towards 5-hydroxytryptamine 4 receptor,,B,,H,8,Autocuration,CHEMBL620606,,
3370,,1,,17358,BAO_0000019,,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,F,,H,8,Autocuration,CHEMBL620607,,
3371,,1,,16117,BAO_0000357,,In vitro binding affinity towards 5-HT4 receptor was determined,,B,,H,8,Autocuration,CHEMBL620608,,
3372,,1,,17358,BAO_0000019,,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,F,,H,8,Autocuration,CHEMBL620609,,
3373,,1,,17358,BAO_0000019,,Tested for agonist activity against 5-hydroxytryptamine 4 receptor,,F,,H,8,Autocuration,CHEMBL620610,,
3374,,1,,17358,BAO_0000357,,Tested for selectivity for 5-hydroxytryptamine 4 receptor,,B,,H,8,Autocuration,CHEMBL620611,,
3375,,1,,17358,BAO_0000357,,Tested for 5-hydroxytryptamine 4 binding affinity against cisapride,,B,,H,8,Autocuration,CHEMBL620612,,
3376,,1,,17358,BAO_0000357,,Tested for 5-hydroxytryptamine 4 binding affinity against renzapride,,B,,H,8,Autocuration,CHEMBL620613,,
3377,,1,,17358,BAO_0000357,,Tested for 5-hydroxytryptamine 4 binding affinity against zacopride,,B,,H,8,Autocuration,CHEMBL620614,,
3378,,1,,1274,BAO_0000357,,Binding affinity against 5-Hydroxytryptamine 4 receptor,,B,,H,8,Expert,CHEMBL620615,,
3379,,1,,10728,BAO_0000249,,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 recognition sites in rat brain membranes,Brain membranes,B,,H,6,Autocuration,CHEMBL857075,,
3380,,1,,11695,BAO_0000249,,Compound was evaluated for the displacement of [3H]Q-ICS-205-930 from 5-HT3 recognition sites in rat brain membranes,Brain membranes,B,,H,6,Autocuration,CHEMBL620616,,
3381,,1,,11695,BAO_0000249,,Displacement of [3H]Q-ICS-205-930 from 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes,Brain membranes,B,,H,6,Autocuration,CHEMBL619411,,
3382,,1,,12490,BAO_0000019,,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor from rat cortex homogenate,,B,,H,6,Autocuration,CHEMBL619412,,
3383,Rattus norvegicus,1,,11828,BAO_0000019,,Displacement of [3H]-Q-ICS 205-930 from rat cortex homogenate 5-hydroxytryptamine 3 receptor,,B,,D,7,Autocuration,CHEMBL619413,,
3384,,1,10000000.0,12253,BAO_0000221,,Binding affinity of 5-hydroxytryptamine 3 receptor using [3H]granisetron in rat hippocampus and entorhinal cortex,,B,,H,6,Autocuration,CHEMBL619414,,
3385,,1,,10561,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,,B,,H,6,Autocuration,CHEMBL619415,,
3386,,1,,10561,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]quipazine as radioligand in rat cortex,,B,,H,6,Autocuration,CHEMBL619416,,
3387,,1,,14432,BAO_0000019,,Rat 5-hydroxytryptamine 3 receptor (5-HT3) antagonist,,F,,H,6,Autocuration,CHEMBL619417,,
3388,Rattus norvegicus,1,,12936,BAO_0000223,,Binding affinity against rat 5-hydroxytryptamine 3 receptor,,B,,D,7,Autocuration,CHEMBL619418,,
3389,Rattus norvegicus,1,,1274,BAO_0000223,,Binding affinity against 5-Hydroxytryptamine 3 receptor,,B,,D,7,Autocuration,CHEMBL619419,,
3390,,1,,1980,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of racemic [3H]zacopride from rat cortex,,B,,H,6,Autocuration,CHEMBL619420,,
3391,,1,,670,BAO_0000249,,Binding affinity to 5-hydroxytryptamine 3 receptor was determined in rat cerebro cortical membranes using [3H]quipazine.,,B,,H,6,Autocuration,CHEMBL619421,,
3392,Rattus norvegicus,1,,968,BAO_0000019,,Displacement of [3H]granisetron from 5-hydroxytryptamine 3 receptor of rat cortex,,B,,D,7,Autocuration,CHEMBL619422,,
3393,,1,,14287,BAO_0000019,,In vitro by displacement of [3H]LY-278584 from 5-hydroxytryptamine 3 receptor on rat entorhinal cortex,,B,,H,6,Autocuration,CHEMBL619423,,
3394,,1,,567,BAO_0000019,,Tested for its binding affinity by measuring its ability to displace [3H]granisetron from 5-hydroxytryptamine 3 receptor in rat cortex,,B,,H,6,Autocuration,CHEMBL875080,,
3395,,1,,13267,BAO_0000019,,The binding affinity (pKi) measured against 5-hydroxytryptamine 1A receptor of rat cortex using [3H]8-OH-DPAT as radioligand,,B,,H,6,Autocuration,CHEMBL619424,,
3396,,1,,14826,BAO_0000249,,Binding affinity at 5-hydroxytryptamine 3 receptor in rat cortical membrane by [3H]graniestron displacement.,,B,,H,6,Autocuration,CHEMBL619425,,
3397,,1,,15194,BAO_0000223,,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand,,B,,H,6,Autocuration,CHEMBL619426,,
3398,,1,,15194,BAO_0000223,,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand.,,B,,H,6,Autocuration,CHEMBL619427,,
3399,Rattus norvegicus,1,,10394,BAO_0000223,,pKi value for inhibition of [3H]LY-278584 binding to 5-hydroxytryptamine 3 receptor,,B,,D,7,Autocuration,CHEMBL619645,,
3400,,1,,13657,BAO_0000249,,"Compound was evaluated for binding affinity on 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding",,B,,D,9,Expert,CHEMBL619646,,
3401,,1,955.0,1879,BAO_0000221,,Compound was tested for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat brain using [3H]zacopride as the radioligand.,,F,,H,8,Autocuration,CHEMBL619647,,
3402,,1,,1879,BAO_0000019,,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor,,F,,H,8,Autocuration,CHEMBL619648,,
3403,,1,,1879,BAO_0000019,,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat CNS.,,F,,H,8,Autocuration,CHEMBL619165,,
3404,,1,,204,BAO_0000218,,Compound was evaluated in vivo for the antagonistic activity towards 5-hydroxytryptamine 3 receptor,,F,,H,8,Autocuration,CHEMBL620719,,
3405,,1,,1879,BAO_0000019,,Compound was tested for its binding affinity towards 5-HT-3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,,B,,H,8,Autocuration,CHEMBL872924,,
3406,,1,,1879,BAO_0000357,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor,,B,,H,8,Autocuration,CHEMBL620720,,
3407,,1,,1879,BAO_0000019,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,,B,,H,8,Autocuration,CHEMBL620721,,
3408,,1,,1879,BAO_0000019,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using [125I]DAIZAC as the radioligand.,,B,,H,8,Autocuration,CHEMBL620722,,
3409,,1,,10641,BAO_0000019,,"Concentration that inhibits the binding of radioligand, [3H]-ICS 205930, to 5-hydroxytryptamine 3 receptor from rat cortex",,B,,H,6,Autocuration,CHEMBL620723,,
3410,,1,,773,BAO_0000019,,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,,B,,H,8,Autocuration,CHEMBL620724,,
3411,,1,,11952,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor in rat brain cortical membranes using radioligand [3H]quipazine,,B,,H,6,Autocuration,CHEMBL620725,,
3412,Rattus norvegicus,1,,14145,BAO_0000019,,Antagonist activity (100 ug/kg) for the Bezold Jarisch reflex evoked by 30 (ug/Kg) of 5-hydroxytryptamine 3 receptor in ethylurethane anesthetized rats i.v.,,F,,D,9,Autocuration,CHEMBL620726,,
3413,,1,,17066,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 3 receptor,,B,,H,8,Expert,CHEMBL620727,,
3414,,1,,6398,BAO_0000223,,Compound was evaluated for 5-hydroxytryptamine 3 receptor binding,,B,,H,4,Autocuration,CHEMBL620728,,
3415,,1,,10321,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,B,,U,0,Autocuration,CHEMBL620729,,
3416,,1,,511,BAO_0000019,,Tested for 5-hydroxytryptamine 3 receptor antagonist activity by inhibiting the 5-HT evoked Bezold-Jarisch reflex,,F,,H,4,Autocuration,CHEMBL858288,,
3417,,1,,4639,BAO_0000223,,Compound was tested for binding affinity towards 5-hydroxytryptamine 3 receptor,,B,,H,4,Autocuration,CHEMBL620730,,
3418,,1,,4639,BAO_0000223,,Binding affinity towards 5-hydroxytryptamine 3 receptor,,B,,H,4,Autocuration,CHEMBL620731,,
3419,Cavia porcellus,1,,4639,BAO_0000019,,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 0.3 uM,,F,,H,4,Autocuration,CHEMBL620732,,
3420,Cavia porcellus,1,,4639,BAO_0000019,,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,,F,,H,4,Autocuration,CHEMBL618042,,
3421,Cavia porcellus,1,,4639,BAO_0000019,,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 30 uM,,F,,H,4,Autocuration,CHEMBL618043,,
3422,,1,,1558,BAO_0000223,,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,,B,,H,4,Autocuration,CHEMBL618044,,
3423,,1,,268,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 3 receptor antagonistic activity in Bezold-Jarisch model expressed as inhibition of the reflex bradycardia induced by an intravenous injection,,F,,H,4,Autocuration,CHEMBL618045,,
3424,,1,,2474,BAO_0000223,,Compound was measured for its binding affinity at 5-hydroxytryptamine 3 receptor at a concentration of 10 uM using [3H]BRL-43694 as radioligand,,B,,H,4,Autocuration,CHEMBL618046,,
3425,,1,,5067,BAO_0000019,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); A: agonist,,F,,H,4,Autocuration,CHEMBL618047,,
3426,,1,,5067,BAO_0000019,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: agonist,,F,,H,4,Autocuration,CHEMBL875084,,
3427,,1,,5067,BAO_0000019,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: antagonist,,F,,H,4,Autocuration,CHEMBL618048,,
3428,,1,,5067,BAO_0000223,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); NA means data not available,,B,,H,4,Autocuration,CHEMBL618049,,
3429,,1,,5067,BAO_0000019,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); PA: Partial agonist,,F,,H,4,Autocuration,CHEMBL619764,,
3430,,1,,5067,BAO_0000019,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; A: agonist,,F,,H,4,Autocuration,CHEMBL619765,,
3431,,1,,5067,BAO_0000019,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; ANT: Antagonist,,F,,H,4,Autocuration,CHEMBL619766,,
3432,,1,,5067,BAO_0000223,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA: not active,,B,,H,4,Autocuration,CHEMBL619767,,
3433,,1,,5067,BAO_0000223,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA means data not available,,B,,H,4,Autocuration,CHEMBL619768,,
3434,,1,,5067,BAO_0000019,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; PA: Partial agonist,,F,,H,4,Autocuration,CHEMBL619769,,
3435,,1,,5067,BAO_0000223,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; na means data not available,,B,,H,4,Autocuration,CHEMBL619770,,
3436,,1,,5067,BAO_0000223,,Binding affinity towards 5-hydroxytryptamine 3 receptor,,B,,H,4,Autocuration,CHEMBL619771,,
3437,,1,,14331,BAO_0000219,,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor using [3H]-BRL-43694 (1 nM) ligand in NG cells 108-15 was determined,,B,,H,4,Autocuration,CHEMBL619772,,
3438,,1,,5067,BAO_0000223,,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor; NA: not active,,B,,H,4,Autocuration,CHEMBL619773,,
3439,,1,,6179,BAO_0000219,,Binding affinity for 5-HT3 receptor of NG108-15 cells using [3H]GR-65630,,B,,H,4,Autocuration,CHEMBL619774,433.0,
3440,,1,,4265,BAO_0000019,,Binding affinity to 5-HT3 serotonin receptor in NG 108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand.,,B,,H,4,Autocuration,CHEMBL875083,,
3441,,1,,4265,BAO_0000219,,Binding affinity to 5-HT3 serotonin receptor in NG108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand,,B,,H,4,Autocuration,CHEMBL620718,433.0,
3442,,1,,17358,BAO_0000223,,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,,B,,H,4,Autocuration,CHEMBL618127,,
3443,,1,,17358,BAO_0000223,,Compound was tested for selectivity against 5-hydroxytryptamine 3 receptor binding affinity,,B,,H,4,Autocuration,CHEMBL618128,,
3444,,1,,13628,BAO_0000219,,Compound was tested for the inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor expressed in NG 108-15 cells,,B,,H,4,Autocuration,CHEMBL618129,,
3445,,1,,4612,BAO_0000223,,In vitro Binding affinity towards 5-hydroxytryptamine 3 receptor was determined,,B,,H,4,Autocuration,CHEMBL618130,,
3446,,1,,17358,BAO_0000019,,Tested for 5-hydroxytryptamine 3 receptor antagonist activity,,F,,H,4,Autocuration,CHEMBL618131,,
3447,Cavia porcellus,1,,4639,BAO_0000019,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 1 uM,,F,,H,4,Autocuration,CHEMBL618132,,
3448,Cavia porcellus,1,,4639,BAO_0000019,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM,,F,,H,4,Autocuration,CHEMBL618133,,
3449,Cavia porcellus,1,,4639,BAO_0000019,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM in the presence of 30 uM MDL 72222,,F,,H,4,Autocuration,CHEMBL618134,,
3450,Cavia porcellus,1,,4639,BAO_0000019,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,,F,,H,4,Autocuration,CHEMBL618135,,
3451,,1,,511,BAO_0000223,,Binding affinity for the 5-hydroxytryptamine 3 receptor was evaluated in vitro by examining its ability to displace [3H]-BRL 43694.,,B,,H,4,Autocuration,CHEMBL618136,,
3452,,1,,1479,BAO_0000223,,Binding affinity towards 5-hydroxytryptamine 3 receptor,,B,,H,4,Autocuration,CHEMBL618137,,
3453,,1,,1317,BAO_0000223,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor using radioligand binding assay,,B,,H,4,Autocuration,CHEMBL618138,,
3454,,1,,12146,BAO_0000223,,Tested against 5-hydroxytryptamine 3 receptor in experiment 1,,B,,H,4,Autocuration,CHEMBL618139,,
3455,,1,,12146,BAO_0000223,,Tested against 5-hydroxytryptamine 3 receptor in experiment 2,,B,,H,4,Autocuration,CHEMBL618140,,
3456,,1,,13969,BAO_0000223,,Binding affinity against 5-hydroxytryptamine 3 receptor was measured using [3H]granisetron as radioligand,,B,,H,4,Autocuration,CHEMBL618141,,
3457,,1,,13392,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2C receptor,,B,,H,8,Expert,CHEMBL873478,,
3458,,1,,13392,BAO_0000223,,Binding affinity towards 5-hydroxytryptamine 3 receptor,,B,,H,6,Autocuration,CHEMBL618142,,
3459,,1,,14159,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,,B,,H,8,Autocuration,CHEMBL618143,,
3460,,1,,1558,BAO_0000357,,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,,B,,H,8,Autocuration,CHEMBL618144,,
3461,,1,,16655,BAO_0000357,,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,B,,H,8,Autocuration,CHEMBL618145,,
3462,,1,,13020,BAO_0000223,,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,,B,,H,4,Autocuration,CHEMBL618146,,
3463,,1,,13021,BAO_0000223,,Inhibition of [3H]-BRL 43 694 binding to 5-hydroxytryptamine 3 receptor of central nervous system,,B,,H,4,Autocuration,CHEMBL618147,,
3464,,1,,13020,BAO_0000223,,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,,B,,H,4,Autocuration,CHEMBL618148,,
3465,,1,,10321,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,B,,H,8,Autocuration,CHEMBL618149,,
3466,,1,,15818,BAO_0000357,,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,B,,H,8,Autocuration,CHEMBL872927,,
3467,,1,,15818,BAO_0000357,,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,B,,H,8,Autocuration,CHEMBL618150,,
3468,,1,,17358,BAO_0000357,,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,,B,,H,8,Autocuration,CHEMBL618151,,
3469,,1,,2222,BAO_0000357,,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,,B,,H,8,Autocuration,CHEMBL875094,,
3470,,1,,10322,BAO_0000019,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,B,,H,8,Autocuration,CHEMBL618152,,
3471,,1,,16117,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 3 receptor was determined,,B,,H,8,Autocuration,CHEMBL618153,,
3472,,1,,17200,BAO_0000357,,Inhibitory constant against 5-hydroxytryptamine 3 receptor using [3H]GR-65630 radioligand,,B,,H,8,Autocuration,CHEMBL618888,,
3473,,1,,17358,BAO_0000019,,Tested for 5-hydroxytryptamine 3 receptor agonist activity,,F,,H,8,Autocuration,CHEMBL618889,,
3474,,1,,16700,BAO_0000357,,The binding affinity towards 5-hydroxytryptamine 3 receptor; No affinity,,B,,H,8,Autocuration,CHEMBL618890,,
3475,,1,,1980,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,B,,H,8,Autocuration,CHEMBL618891,,
3476,,1,,1980,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,,B,,H,8,Autocuration,CHEMBL619054,,
3477,,1,,12409,BAO_0000223,,Binding affinity against the 5-hydroxytryptamine 3 receptor,,B,,H,4,Autocuration,CHEMBL619055,,
3478,,1,,4365,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,B,,H,8,Autocuration,CHEMBL619056,,
3479,,1,,4365,BAO_0000019,,Percent efficacy against 5-hydroxytryptamine 3A receptor,,F,,H,8,Autocuration,CHEMBL619057,,
3480,,1,,4365,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,B,,H,8,Autocuration,CHEMBL619058,,
3481,Rattus norvegicus,1,,6769,BAO_0000219,,Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes,,F,,D,9,Expert,CHEMBL619059,,
3482,Rattus norvegicus,1,,6769,BAO_0000219,,Ability to block serotonin (30 uM)-evoked responses at rat 5HT3-alpha receptor expressed in xenopus oocytes,,F,,D,9,Expert,CHEMBL619060,,
3483,Rattus norvegicus,1,,6769,BAO_0000219,,Effect on rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes at concentration up to 100 uM,,F,,D,9,Expert,CHEMBL875095,,
3484,Cavia porcellus,1,2116.0,809,BAO_0000221,,5-hydroxytryptamine 4 receptor agonist activity as percent maximum 5-HT effect in response to electrical stimulation in male guinea pig ileum,,F,,D,9,Intermediate,CHEMBL619061,,
3485,Cavia porcellus,1,2116.0,809,BAO_0000221,,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum,,F,,D,9,Intermediate,CHEMBL619062,,
3486,Cavia porcellus,1,,14290,BAO_0000019,,5-hydroxytryptamine 4 receptor agonist activity is expressed as percent of the maximum 5-HT response,,F,,D,9,Intermediate,CHEMBL619063,,
3487,Cavia porcellus,1,2116.0,17358,BAO_0000221,,Tested for affinity towards 5-hydroxytryptamine 4 receptor in electrically stimulated longitudinal muscle preparation of guinea pig ileum,,B,,D,9,Intermediate,CHEMBL619064,,
3488,Cavia porcellus,1,,17358,BAO_0000357,,Tested for affinity towards 5-hydroxytryptamine 4 receptor in guinea pig distal colon preparation,,B,,D,9,Intermediate,CHEMBL619065,,
3489,Cavia porcellus,1,2116.0,17358,BAO_0000221,,Tested for affinity towards 5-hydroxytryptamine 4 receptor in isolated guinea pig ileum longitudinal muscle preparation,,B,,D,9,Intermediate,CHEMBL619066,,
3490,,1,2116.0,17386,BAO_0000221,,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor nondesensitization,,B,,H,8,Autocuration,CHEMBL619775,,
3491,,1,,3269,BAO_0000357,,Affinity against 5-hydroxytryptamine 7 receptor,,B,,H,8,Autocuration,CHEMBL619776,,
3492,Cavia porcellus,1,,7721,BAO_0000224,,Ability to displace [3H]5-HT binding from 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,,B,,H,4,Autocuration,CHEMBL619777,,
3493,Cavia porcellus,1,,7721,BAO_0000224,,Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,,B,,H,4,Autocuration,CHEMBL619778,,
3494,Cavia porcellus,1,2116.0,9117,BAO_0000221,,Evaluated for inhibition of 5-hydroxytryptamine receptor on guinea pig ileum at 10 uM; No effect,,B,,H,4,Autocuration,CHEMBL619779,,
3495,Cavia porcellus,1,,7721,BAO_0000224,,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand, activity is expressed as Kd.",,B,,H,4,Autocuration,CHEMBL619780,,
3496,Cavia porcellus,1,,7721,BAO_0000224,,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor using 1 uM LSD as masking ligand, activity is expressed as Kd.",,B,,H,4,Autocuration,CHEMBL619166,,
3497,Cavia porcellus,1,,15796,BAO_0000019,,5-HT level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,,F,,H,4,Autocuration,CHEMBL619167,,
3498,Cavia porcellus,1,,15796,BAO_0000019,,5-hydroxytryptamine level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,,F,,H,4,Autocuration,CHEMBL619168,,
3499,Homo sapiens,1,2081.0,15650,BAO_0000219,,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor in the presence of 10 nM compound in isolated human atrial myocytes,,B,,D,9,Expert,CHEMBL619169,,
3500,Homo sapiens,1,2081.0,15650,BAO_0000219,,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes,,B,,D,9,Expert,CHEMBL619170,,
3501,Homo sapiens,1,,6866,BAO_0000019,,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine",,F,,D,5,Autocuration,CHEMBL619171,,
3502,Homo sapiens,1,2081.0,15650,BAO_0000219,,",Antagonism of stimulation of 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes",,F,,D,9,Expert,CHEMBL619172,,
3503,Mus musculus,1,,10063,BAO_0000019,,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to 5-hydroxytryptamine receptor in mice,,B,,U,0,Autocuration,CHEMBL619173,,
3504,Mus musculus,1,,12665,BAO_0000019,,Percent inhibition of radioligand [3H]-LSD binding to 5-HT receptor at 10 uM concentration,,B,,U,0,Autocuration,CHEMBL619174,,
3505,,1,,7504,BAO_0000019,,5-hydroxytryptamine receptor binding affinity was determined in rats,,B,,H,4,Autocuration,CHEMBL619175,,
3506,,1,,7504,BAO_0000224,,Binding affinity at rat 5-hydroxytryptamine receptor.,,B,,H,4,Autocuration,CHEMBL619176,,
3507,,1,,7038,BAO_0000019,,Affinity against 5-hydroxytryptamine receptors in rat fundus model,,B,,H,4,Autocuration,CHEMBL619177,,
3508,,1,,7626,BAO_0000224,,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation,,B,,H,4,Autocuration,CHEMBL619178,,
3509,,1,,7626,BAO_0000224,,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation; Not determined,,B,,H,4,Autocuration,CHEMBL619179,,
3510,,1,945.0,7185,BAO_0000019,,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation,,F,,H,4,Autocuration,CHEMBL619180,,
3511,,1,945.0,7185,BAO_0000019,,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation (resulted in discoloration in the oxygenated muscle bath to give varying results).,,F,,H,4,Autocuration,CHEMBL619181,,
3512,,1,,7185,BAO_0000019,,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,,F,,H,4,Autocuration,CHEMBL619182,,
3513,,1,,6960,BAO_0000224,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2,,B,,H,4,Autocuration,CHEMBL619183,,
3514,,1,,6960,BAO_0000224,,"Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2; Valid pA2, can not be determined because of slope of Schild plot.",,B,,H,4,Autocuration,CHEMBL619184,,
3515,,1,10000000.0,12416,BAO_0000221,,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,,B,,H,8,Autocuration,CHEMBL619185,,
3516,,1,,15753,BAO_0000357,,Binding affinity for rat 5-hydroxytryptamine transporter.,,B,,H,8,Expert,CHEMBL619186,,
3517,,1,,8062,BAO_0000019,,Evaluated for inhibition of specific [3H]5-HT receptor binding in rat cortex.,,B,,H,4,Autocuration,CHEMBL619187,,
3518,Rattus norvegicus,1,,9036,BAO_0000019,,Binding affinity at serotonin 5-HT1-type site receptor in rat cortex by displacing [3H]5-HT,,B,,D,5,Autocuration,CHEMBL619188,,
3519,Rattus norvegicus,1,,15067,BAO_0000224,,Compound was tested for its inhibitory activity against 5-hydroxytryptamine receptor,,B,,D,5,Autocuration,CHEMBL619189,,
3520,Rattus norvegicus,1,955.0,15753,BAO_0000019,,Inhibitory activity against [3H]- 5-hydroxytryptamine reuptake in whole rat brain minus cerebellum,,F,,D,9,Expert,CHEMBL619190,,
3521,Rattus norvegicus,1,2037.0,15753,BAO_0000221,,Inhibition of [3H]5-HT reuptake in whole rat brain (minus cerebellum) homogenate.,,F,,D,9,Expert,CHEMBL619191,,
3522,Rattus norvegicus,1,,15295,BAO_0000019,,Displacement of [3H]-citalopram from rat forebrain membrane 5-hydroxytryptamine receptor at 10e-7 M,,B,,D,5,Autocuration,CHEMBL619192,,
3523,Rattus norvegicus,1,,6347,BAO_0000224,,Percent binding affinity against 5-hydroxytryptamine receptor,,B,,D,5,Autocuration,CHEMBL619193,,
3524,,1,,6763,BAO_0000019,,Ability to displace 0.4 nM [3H]paroxetine binding to 5-hydroxytryptamine receptor in rat frontal cortex,,B,,U,0,Autocuration,CHEMBL619194,,
3525,Rattus norvegicus,1,,12092,BAO_0000224,,The binding affinity was measured on 5-hydroxytryptamine receptor uptake receptor using [3H]- paroxetine as radioligand.,,B,,D,5,Autocuration,CHEMBL619195,,
3526,Rattus norvegicus,1,,1579,BAO_0000224,,Affinity against 5-hydroxytryptamine receptor was determined,,B,,D,5,Autocuration,CHEMBL619196,,
3527,Rattus norvegicus,1,945.0,1579,BAO_0000019,,Affinity against 5-hydroxytryptamine receptor was determined in rat stomach fundus strip,,B,,D,5,Autocuration,CHEMBL619197,,
3528,Homo sapiens,1,,5963,BAO_0000219,,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,,B,,D,9,Expert,CHEMBL619198,,
3529,Homo sapiens,1,,5963,BAO_0000219,,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,,B,,D,9,Expert,CHEMBL875081,,
3530,,1,,5030,BAO_0000357,,Ability to compete with radioactive ligands specific to the Serotonergic 5-HT receptor at 10 uM; NA means compound failed to compete,,B,,H,8,Autocuration,CHEMBL884712,,
3531,,1,,15796,BAO_0000357,,Inhibition of 5-hydroxytryptamine reuptake,,B,,H,8,Expert,CHEMBL884710,,
3532,,1,,15413,BAO_0000019,,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding",,F,,H,8,Autocuration,CHEMBL619199,,
3533,,1,,15413,BAO_0000019,,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 1)",,F,,H,8,Autocuration,CHEMBL619200,,
3534,,1,,15413,BAO_0000019,,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 2)",,F,,H,8,Autocuration,CHEMBL619201,,
3535,,1,,12409,BAO_0000019,,Tested for 5-hydroxytryptamine receptor uptake,,F,,H,8,Autocuration,CHEMBL619202,,
3536,Homo sapiens,1,,16909,BAO_0000219,,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,,B,,D,9,Expert,CHEMBL619203,449.0,
3537,Homo sapiens,1,,16909,BAO_0000019,,Antagonistic affinity tested against isolated human cloned alpha-1d adrenoceptor subtype,,F,,D,9,Expert,CHEMBL619204,,
3538,Homo sapiens,1,,15629,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine receptor 1A receptor by using [3H]8-OH-DPAT in rat hippocampal membranes.,,B,,H,8,Autocuration,CHEMBL619205,,
3539,,1,,15629,BAO_0000357,,Tested in vitro for % inhibition against 5-hydroxytryptamine receptor 1A,,B,,H,8,Autocuration,CHEMBL619206,,
3540,,1,,15629,BAO_0000249,,In vitro binding affinity at 5-hydroxytryptamine receptor 1A receptor in rat hippocampal membranes by [3H]8-OH-DPAT displacement.,,B,,H,8,Expert,CHEMBL619207,,
3541,,1,2435.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 0.10 umol/kg,,F,,H,8,Autocuration,CHEMBL619208,,
3542,,1,2435.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 10 umol/kg,,F,,H,8,Autocuration,CHEMBL619209,,
3543,,1,2435.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 0.32 umol/kg,,F,,H,8,Autocuration,CHEMBL619210,,
3544,,1,2435.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 3.2 umol/kg,,F,,H,8,Autocuration,CHEMBL619211,,
3545,,1,2435.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 32 umol/kg,,F,,H,8,Autocuration,CHEMBL619212,,
3546,,1,2435.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 0.032 umol/kg,,F,,H,8,Autocuration,CHEMBL620681,,
3547,,1,2435.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 1.0 umol/kg,,F,,H,8,Autocuration,CHEMBL620682,,
3548,,1,2435.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 10 umol/kg,,F,,H,8,Autocuration,CHEMBL620683,,
3549,,1,2435.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 100 umol/kg,,F,,H,8,Autocuration,CHEMBL620684,,
3550,,1,2435.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 3.2 umol/kg,,F,,H,8,Autocuration,CHEMBL620685,,
3551,,1,2435.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 32 umol/kg,,F,,H,8,Autocuration,CHEMBL620686,,
3552,,1,349.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.032 umol/kg,,F,,H,8,Autocuration,CHEMBL620687,,
3553,,1,349.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.10 umol/kg,,F,,H,8,Autocuration,CHEMBL620688,,
3554,,1,349.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.32 umol/kg,,F,,H,8,Autocuration,CHEMBL620689,,
3555,,1,349.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 1.0 umol/kg,,F,,H,8,Autocuration,CHEMBL620690,,
3556,,1,349.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 10 umol/kg,,F,,H,8,Autocuration,CHEMBL620691,,
3557,,1,349.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 100 umol/kg,,F,,H,8,Autocuration,CHEMBL620692,,
3558,,1,349.0,10034,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 3.2 umol/kg,,F,,H,8,Autocuration,CHEMBL620693,,
3559,,1,,1274,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 4 receptor,,B,,H,8,Expert,CHEMBL620694,,
3560,,1,,17358,BAO_0000019,,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,F,,H,8,Autocuration,CHEMBL857986,,
3561,,1,,14532,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand at 10e-5 M concentration,,B,,H,8,Autocuration,CHEMBL620695,,
3562,,1,,16989,BAO_0000357,,Binding affinity towards Serotonin 5-hydroxytryptamine 4 receptor,,B,,H,8,Expert,CHEMBL620696,,
3563,,1,,17200,BAO_0000357,,Inhibitory constant against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 radioligand,,B,,H,8,Autocuration,CHEMBL620697,,
3564,,1,,15779,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 4 receptor,,B,,H,8,Autocuration,CHEMBL620698,,
3565,,1,,15779,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,,B,,H,8,Autocuration,CHEMBL620699,,
3566,,1,,15779,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,,B,,H,8,Autocuration,CHEMBL620700,,
3567,,1,,15650,BAO_0000219,,Binding affinity was determined against cloned 5-hydroxytryptamine 4A receptor isoform expressed in COS-7 cells,,B,,H,8,Autocuration,CHEMBL620701,643.0,
3568,,1,,15650,BAO_0000219,,Binding affinity was determined against cloned 5-hydroxytryptamine 4B receptor isoform expressed in COS-7 cells,,B,,H,8,Autocuration,CHEMBL875082,643.0,
3569,,1,,15650,BAO_0000219,,Binding affinity was determined against cloned 5-hydroxytryptamine 4C receptor isoform expressed in COS-7 cells,,B,,H,8,Autocuration,CHEMBL620702,643.0,
3570,,1,,15650,BAO_0000219,,Binding affinity was determined against cloned 5-hydroxytryptamine 4D receptor isoform expressed in COS-7 cells,,B,,H,8,Autocuration,CHEMBL620703,643.0,
3571,,1,,17046,BAO_0000219,,Binding affinity of compound towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,,B,,H,8,Autocuration,CHEMBL620704,673.0,
3572,,1,,17046,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,,B,,H,8,Expert,CHEMBL620705,673.0,
3573,,1,,15650,BAO_0000219,,Binding affinity was determined against cloned 5-hydroxytryptamine 4E receptor isoform expressed in C6 glial cells incubated with 0.2 nM [3H]GR-113808,,B,,H,8,Expert,CHEMBL620706,673.0,
3574,,1,,17046,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand; Not determined,,B,,H,8,Expert,CHEMBL620707,673.0,
3575,,1,,17066,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 5 receptor,,B,,H,8,Expert,CHEMBL620708,,
3576,,1,,17200,BAO_0000357,,Inhibitory constant against human 5-hydroxytryptamine 5A receptor using [3H]LSD radioligand,,B,,H,8,Autocuration,CHEMBL620709,,
3577,Homo sapiens,1,,16146,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 5A receptor,,B,,D,9,Expert,CHEMBL620710,,
3578,,1,,15250,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 5A receptor stably expressed in CHO cells,,B,,H,8,Autocuration,CHEMBL620711,449.0,
3579,Homo sapiens,1,,6491,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 5A serotonin receptor,,B,,D,9,Expert,CHEMBL620712,,
3580,Homo sapiens,1,,17066,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 5A receptor,,B,,D,9,Expert,CHEMBL620713,,
3581,Homo sapiens,1,,17066,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand,,B,,D,9,Expert,CHEMBL620714,,
3582,Homo sapiens,1,,4234,BAO_0000357,,Binding affinity to cloned human 5-hydroxytryptamine 5A receptor,,B,,D,9,Expert,CHEMBL620715,,
3583,,1,,6013,BAO_0000357,,Binding affinity towards 5-HT5A receptor,,B,,H,8,Autocuration,CHEMBL620716,,
3584,,1,,17175,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 5A receptor using LSD as radioligand,,B,,H,8,Expert,CHEMBL620717,,
3585,,1,,15818,BAO_0000357,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 5A receptor,,B,,H,8,Autocuration,CHEMBL618072,,
3586,,1,,6166,BAO_0000357,,Binding affinity towards cloned human 5-HT5A receptor was determined,,B,,H,8,Autocuration,CHEMBL857987,,
3587,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,B,,H,8,Autocuration,CHEMBL618073,722.0,
3588,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,,B,,H,8,Autocuration,CHEMBL618074,722.0,
3589,,1,,5213,BAO_0000219,,Compound was tested for its binding affinity in 5-hydroxytryptamine 5A receptor (using human cloned receptors in HEK 293 and [3H]5-CTas a radioligand ),,B,,H,8,Autocuration,CHEMBL618075,722.0,
3590,Mus musculus,1,,17066,BAO_0000357,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor,,B,,D,9,Expert,CHEMBL618076,,
3591,Mus musculus,1,,17066,BAO_0000357,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [125I]-2-iodo LSD as radioligand,,B,,D,9,Expert,CHEMBL618077,,
3592,Mus musculus,1,,17066,BAO_0000357,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]- LSD as radioligand,,B,,D,9,Expert,CHEMBL618078,,
3593,Mus musculus,1,,17066,BAO_0000357,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]LSD as radioligand,,B,,D,9,Expert,CHEMBL881821,,
3594,Mus musculus,1,,17066,BAO_0000357,,Binding affinity towards murine 5-hydroxytryptamine 5A receptor,,B,,D,9,Expert,CHEMBL618079,,
3595,,1,,17175,BAO_0000357,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor using LSD as radioligand,,B,,H,8,Expert,CHEMBL618080,,
3596,,1,,16190,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,,B,,H,8,Autocuration,CHEMBL618081,722.0,
3597,,1,,16190,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,,B,,H,8,Autocuration,CHEMBL618082,722.0,
3598,,1,,4820,BAO_0000357,,Binding affinity towards 5-HT5a receptor,,B,,H,8,Expert,CHEMBL618083,,
3599,Homo sapiens,1,,17066,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 5A receptor,,B,,D,9,Expert,CHEMBL618084,,
3600,,1,,17066,BAO_0000357,,Binding affinity for rodent 5-hydroxytryptamine 5A receptor,,B,,H,8,Expert,CHEMBL618085,,
3601,,1,,17175,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 5A receptor using lysergic acid diethylamide (LSD) as radioligand,,B,,H,8,Expert,CHEMBL618086,,
3602,,1,,16633,BAO_0000357,,Binding affinities against 5-hydroxytryptamine 5A receptor,,B,,H,8,Autocuration,CHEMBL875092,,
3603,,1,,16633,BAO_0000357,,Binding affinities towards 5-hydroxytryptamine 5A receptor,,B,,H,8,Autocuration,CHEMBL618087,,
3604,,1,,16700,BAO_0000357,,The binding affinity towards 5-hydroxytryptamine 5A receptor; No affinity,,B,,H,8,Autocuration,CHEMBL872926,,
3605,Cavia porcellus,1,,4639,BAO_0000019,,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.01 uM,,F,,H,4,Autocuration,CHEMBL618088,,
3606,,1,,5486,BAO_0000223,,Binding affinity towards 5-HT3 receptor by the displacement of [3H]GR-65630] in human recombinant receptors in mammalian cell,,B,,H,4,Autocuration,CHEMBL618089,,
3607,Homo sapiens,1,,16146,BAO_0000357,,Inhibition of human 5-hydroxytryptamine 6 receptor,,B,,D,9,Expert,CHEMBL618090,,
3608,Homo sapiens,1,,17273,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 6 receptor using [3H]- LSD as radioligand,,B,,D,9,Expert,CHEMBL618091,,
3609,,1,,17687,BAO_0000357,,Inhibition against human 5-hydroxytryptamine 6 receptor,,B,,H,8,Autocuration,CHEMBL618092,,
3610,Homo sapiens,1,,6491,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 6 serotonin receptor,,B,,D,9,Expert,CHEMBL618093,,
3611,,1,,16190,BAO_0000219,,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells.,,B,,H,8,Expert,CHEMBL618094,308.0,
3612,Homo sapiens,1,,17066,BAO_0000357,,Binding affinity towards [3H]LSD-labeled human 5-hydroxytryptamine 6 receptor,,B,,D,9,Expert,CHEMBL618095,,
3613,Homo sapiens,1,,17066,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,B,,D,9,Expert,CHEMBL875093,,
3614,Homo sapiens,1,,17066,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [125I]-2-iodo LSD as radioligand,,B,,D,9,Expert,CHEMBL618096,,
3615,Homo sapiens,1,,17066,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [3H]-LSD as radioligand,,B,,D,9,Expert,CHEMBL618118,,
3616,Homo sapiens,1,,3555,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 6 receptor,,B,,D,9,Expert,CHEMBL618119,,
3617,,1,,5808,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,B,,H,8,Expert,CHEMBL618120,,
3618,,1,,6013,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,B,,H,8,Autocuration,CHEMBL618121,,
3619,,1,,15818,BAO_0000219,,"Binding affinity for human 5-hydroxytryptamine 6 receptor expressed in HEK 293 human embryonic kidney cells, [3H]-lysergic acid diethylamide as radioligand",,B,,H,8,Expert,CHEMBL618122,722.0,
3620,,1,,16209,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor using [3H]LSD as radioligand,,B,,H,8,Autocuration,CHEMBL618123,,
3621,,1,,3935,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 6 receptor stably transfected to HEK 293 human embryonic kidney cells using [3H]-lysergic acid diethylamide as radioligand,,B,,H,8,Expert,CHEMBL618124,722.0,
3622,,1,,15818,BAO_0000357,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 6 receptor,,B,,H,8,Autocuration,CHEMBL618125,,
3623,Homo sapiens,1,,3805,BAO_0000219,,Displacement of [3H]LSD from human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,,B,,D,9,Expert,CHEMBL618126,722.0,
3624,,1,,16441,BAO_0000019,,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD,,B,,H,8,Expert,CHEMBL618236,,
3625,,1,,16441,BAO_0000019,,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD; ND is No Data.,,B,,H,8,Expert,CHEMBL618237,,
3626,,1,,6786,BAO_0000219,,Ability to displace [3H]LSD from human 5-hydroxytryptamine 6 receptor transiently expressed in COS-7 cells,,B,,H,8,Expert,CHEMBL618238,643.0,
3627,Homo sapiens,1,,4234,BAO_0000357,,In vitro binding affinity to human 5-hydroxytryptamine 6 receptor,,B,,D,9,Expert,CHEMBL618239,,
3628,,1,,17085,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 6 receptor,,B,,H,8,Autocuration,CHEMBL618240,,
3629,,1,,17200,BAO_0000357,,Inhibitory constant against human 5-hydroxytryptamine 6 receptor using [3H]LSD radioligand,,B,,H,8,Autocuration,CHEMBL618241,,
3630,,1,,17451,BAO_0000219,,Antagonism assessed in a functional cAMP binding assay using 5-CT to stimulate human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,,B,,H,8,Autocuration,CHEMBL859399,722.0,
3631,,1,,3935,BAO_0000019,,The compound was tested for antagonist activity by inhibition of human 5-HT6 stimulated adenylate cyclase,,F,,H,8,Autocuration,CHEMBL618242,,
3632,,1,,5033,BAO_0000357,,Ability to displace the radioligand [3H]LSD from human 5-hydroxytryptamine 6 receptor,,B,,H,8,Autocuration,CHEMBL857991,,
3633,,1,,4540,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 6 receptor,,B,,H,8,Expert,CHEMBL619951,,
3634,Homo sapiens,1,,4540,BAO_0000219,,Binding affinity to human cloned 5-HT6 receptor in HeLa cells using [3H]- LSD as radioligand,,B,,D,9,Expert,CHEMBL619952,308.0,
3635,Homo sapiens,1,,4540,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]- LSD as radioligand,,B,,D,9,Expert,CHEMBL619953,308.0,
3636,,1,,17296,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells,,B,,H,8,Autocuration,CHEMBL619954,308.0,
3637,,1,,17296,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,,B,,H,8,Autocuration,CHEMBL619955,308.0,
3638,,1,,17296,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,,B,,H,8,Autocuration,CHEMBL619956,308.0,
3639,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL619957,449.0,
3640,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,B,,H,8,Autocuration,CHEMBL619958,722.0,
3641,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand; ND means no data.,,B,,H,8,Autocuration,CHEMBL620627,722.0,
3642,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,,B,,H,8,Autocuration,CHEMBL620628,722.0,
3643,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HeLa cells using [3H]LSD as radioligand;ND means no data.,,B,,H,8,Autocuration,CHEMBL620629,308.0,
3644,,1,,6166,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,B,,H,8,Autocuration,CHEMBL620630,,
3645,,1,,17451,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 6 receptor expressed in HeLa cells using [3H]LSD as radioligand,,B,,H,8,Autocuration,CHEMBL620782,308.0,
3646,,1,,15316,BAO_0000357,,Compound was evaluated for its ability to displace [3H]LSD binding from human recombinant 5-hydroxytryptamine 6 receptor,,B,,H,8,Autocuration,CHEMBL620783,,
3647,,1,,4199,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 6 receptor,,B,,H,8,Expert,CHEMBL620784,,
3648,,1,,15146,BAO_0000219,,Binding affinity against human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]LSD,,B,,H,8,Expert,CHEMBL620785,308.0,
3649,,1,,5213,BAO_0000357,,Compound was tested for its binding affinity in 5-hydroxytryptamine 6 receptor (using human cloned receptors in HeLa and [3H]LSD as a radioligand ),,B,,H,8,Autocuration,CHEMBL857992,,
3650,,1,,16429,BAO_0000219,,In vitro binding affinity at human recombinant 5-hydroxytryptamine 6 receptor in mammalian cells using 3[H]LSD as the radioligand,,B,,H,8,Autocuration,CHEMBL620786,,
3651,,1,,14818,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]5-LSD.,,B,,H,8,Autocuration,CHEMBL620787,308.0,
3652,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=3",,B,,H,8,Autocuration,CHEMBL620788,308.0,
3653,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=9",,B,,H,8,Autocuration,CHEMBL620789,308.0,
3654,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]LSD as radioligand; n=3",,B,,H,8,Autocuration,CHEMBL620790,308.0,
3655,,1,,15250,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 6 receptor stably expressed in CHO cells,,B,,H,8,Autocuration,CHEMBL620791,449.0,
3656,,1,,14423,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 6 receptor from CHO cell membranes using [3H]5-HT as the radioligand.,,B,,H,8,Autocuration,CHEMBL620792,,
3657,,1,,15086,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 6 receptor,,B,,H,8,Autocuration,CHEMBL620793,,
3658,,1,,4342,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor was determined,,B,,H,8,Autocuration,CHEMBL620794,,
3659,Homo sapiens,1,,16190,BAO_0000219,,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells,,B,,D,9,Autocuration,CHEMBL620795,308.0,
3660,,1,,4820,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,B,,H,8,Expert,CHEMBL620796,,
3661,,1,,4639,BAO_0000357,,Percentage of displacement at 5-hydroxytryptamine 6 receptor at 10e-8 M,,B,,H,8,Autocuration,CHEMBL620797,,
3662,Homo sapiens,1,,17066,BAO_0000019,,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,,F,,D,9,Expert,CHEMBL620798,,
3663,,1,,6011,BAO_0000357,,Inhibition of binding towards 5-hydroxytryptamine 6 receptor at 100 nM concentration,,B,,H,8,Autocuration,CHEMBL620799,,
3664,,1,,17066,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,B,,H,8,Expert,CHEMBL620800,,
3665,,1,,17515,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor; inactive at 10 uM,,B,,H,8,Autocuration,CHEMBL620801,,
3666,,1,,5014,BAO_0000357,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 6 receptor,,B,,H,8,Autocuration,CHEMBL875100,,
3667,,1,,4373,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 6 receptor was determined,,B,,H,8,Autocuration,CHEMBL620802,,
3668,,1,,17066,BAO_0000019,,Antagonistic activity towards 5-hydroxytryptamine 6 receptor,,F,,H,8,Expert,CHEMBL620803,,
3669,,1,,17066,BAO_0000019,,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,,F,,H,8,Expert,CHEMBL620804,,
3670,,1,,4373,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 6 receptor was determined,,B,,H,8,Autocuration,CHEMBL620805,,
3671,,1,,4687,BAO_0000357,,Evaluated for the binding affinity towards 5-hydroxytryptamine 6 receptor,,B,,H,8,Autocuration,CHEMBL620806,,
3672,,1,,16946,BAO_0000357,,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-6 M,,B,,H,8,Autocuration,CHEMBL620807,,
3673,,1,,16946,BAO_0000357,,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-8 M,,B,,H,8,Autocuration,CHEMBL620808,,
3674,,1,,16633,BAO_0000357,,Binding affinities against 5-hydroxytryptamine 6 receptor,,B,,H,8,Autocuration,CHEMBL620809,,
3675,,1,,16633,BAO_0000357,,Binding affinities towards 5-hydroxytryptamine 6 receptor,,B,,H,8,Autocuration,CHEMBL620810,,
3676,Homo sapiens,1,,17066,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 6 receptor,,B,,D,9,Expert,CHEMBL620811,,
3677,,1,,16700,BAO_0000357,,The binding affinity towards 5-hydroxytryptamine 6 receptor; No affinity,,B,,H,8,Autocuration,CHEMBL620812,,
3678,,1,,3269,BAO_0000357,,Affinity against 5-hydroxytryptamine 6 receptor,,B,,H,8,Autocuration,CHEMBL620813,,
3679,,1,,5486,BAO_0000357,,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-CT],,B,,H,8,Autocuration,CHEMBL620814,,
3680,Homo sapiens,1,,16146,BAO_0000357,,Inhibition of human 5-hydroxytryptamine 7 receptor,,B,,D,9,Expert,CHEMBL620815,,
3681,,1,,5014,BAO_0000219,,Compound was tested for its binding affinity towards human 5-hydroxytryptamine 7 receptor from HEK293 cells using radioligand [3H]LSD,,B,,H,8,Autocuration,CHEMBL620816,722.0,
3682,,1,,15463,BAO_0000357,,Compound at 1 uM was tested for the inhibition of radioligand [3H]LSD binding to recombinant human 5-hydroxytryptamine 7 receptor,,B,,H,8,Autocuration,CHEMBL620817,,
3683,,1,,3805,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 7 receptor at a concentration of 100 (nM),,B,,H,8,Autocuration,CHEMBL620818,,
3684,,1,,5014,BAO_0000219,,Inhibition (at 1 uM) of radioligand [3H]LSD binding to human 5-hydroxytryptamine 7 receptor on HEK293 cells,,B,,H,8,Expert,CHEMBL620819,722.0,
3685,Homo sapiens,1,,6491,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 7 serotonin receptor,,B,,D,9,Expert,CHEMBL620820,,
3686,,1,,16190,BAO_0000219,,Binding affinity for 5-hydroxytryptamine 7 receptor human cloned receptors in CHO cells using [3H]5-HT,,B,,H,8,Autocuration,CHEMBL620821,449.0,
3687,Homo sapiens,1,,17066,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 7 receptor,,B,,D,9,Expert,CHEMBL620822,,
3688,Homo sapiens,1,,17066,BAO_0000357,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 7 receptor,,B,,D,9,Expert,CHEMBL620823,,
3689,Homo sapiens,1,,3555,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 7 receptor,,B,,D,9,Expert,CHEMBL620824,,
3690,,1,,6588,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-HT radioligand from the cloned receptor expressed in CHO cells,,B,,H,8,Expert,CHEMBL620825,449.0,
3691,,1,,15463,BAO_0000357,,Binding affinity towards recombinant human 5-hydroxytryptamine 7 receptor was determined using [3H]LSD as radioligand,,B,,H,8,Autocuration,CHEMBL872930,,
3692,,1,,6013,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 7 receptor,,B,,H,8,Autocuration,CHEMBL620826,,
3693,,1,,16209,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 7 receptor using [3H]5-HT as radioligand,,B,,H,8,Autocuration,CHEMBL620827,,
3694,,1,,3935,BAO_0000357,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 7 receptor,,B,,H,8,Autocuration,CHEMBL620828,,
3695,,1,,15818,BAO_0000357,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 7 receptor,,B,,H,8,Autocuration,CHEMBL620829,,
3696,,1,,5014,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 7 receptor on HEK293 cells using radioligand [3H]LSD,,B,,H,8,Expert,CHEMBL620830,722.0,
3697,,1,,16441,BAO_0000019,,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD,,B,,H,8,Expert,CHEMBL620831,,
3698,,1,,16441,BAO_0000019,,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD; ND is No Data.,,B,,H,8,Expert,CHEMBL620832,,
3699,Homo sapiens,1,,4234,BAO_0000357,,In vitro binding affinity to human 5-hydroxytryptamine 7 receptor,,B,,D,9,Expert,CHEMBL621548,,
3700,,1,,17085,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor,,B,,H,8,Autocuration,CHEMBL621549,,
3701,,1,,17200,BAO_0000357,,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]LSD radioligand,,B,,H,8,Autocuration,CHEMBL621550,,
3702,,1,,17451,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]-LSD as radioligand; Not determined,,B,,H,8,Autocuration,CHEMBL621551,449.0,
3703,,1,,17085,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor; ND means not determined,,B,,H,8,Autocuration,CHEMBL621552,,
3704,,1,,5104,BAO_0000357,,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor,,B,,H,8,Autocuration,CHEMBL857077,,
3705,,1,,5104,BAO_0000357,,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor; Not tested,,B,,H,8,Autocuration,CHEMBL618158,,
3706,Homo sapiens,1,,5033,BAO_0000219,,Ability to displace the radioligand [3H]5-carboxyamidotryptamine ([3H]5-CT) from human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,,B,,D,9,Expert,CHEMBL618159,643.0,
3707,,1,,5486,BAO_0000219,,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-5-CT) from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,,B,,H,8,Autocuration,CHEMBL875101,643.0,
3708,Homo sapiens,1,,4540,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]-5-CT as radioligand,,B,,D,9,Expert,CHEMBL618160,722.0,
3709,,1,,6166,BAO_0000357,,Binding affinity at human cloned 5-hydroxytryptamine 7 receptor.,,B,,H,8,Expert,CHEMBL618161,,
3710,,1,,17342,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor was determined in HEK293 cells using [3H]5-CT as radioligand,,B,,H,8,Expert,CHEMBL618162,722.0,
3711,,1,,17342,BAO_0000357,,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor was determined using [3H]5-CT as radioligand,,B,,H,8,Expert,CHEMBL618163,,
3712,,1,,17296,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 7 human receptors,,B,,H,8,Autocuration,CHEMBL618164,,
3713,,1,,16429,BAO_0000219,,Binding affinity to human recombinant 5-hydroxytryptamine 7 receptor in mammalian cells using [3H]5-CT as radioligand,,B,,H,8,Expert,CHEMBL618165,,
3714,,1,,15779,BAO_0000219,,Binding affinity toward 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]-5-CT as radioligand.,,B,,H,8,Autocuration,CHEMBL618166,722.0,
3715,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 7 receptor (a) (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,,B,,H,8,Autocuration,CHEMBL857989,722.0,
3716,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,,B,,H,8,Autocuration,CHEMBL619888,722.0,
3717,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,,B,,H,8,Autocuration,CHEMBL619889,722.0,
3718,,1,,15779,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 7 receptor 7(a) (human cloned receptor in HEK 293 cells using [3H]5-CT as radioligand.,,B,,H,8,Autocuration,CHEMBL619890,722.0,
3719,,1,,17451,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]LSD as radioligand,,B,,H,8,Autocuration,CHEMBL619891,449.0,
3720,,1,,4199,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand (n=3),,B,,H,8,Autocuration,CHEMBL619892,722.0,
3721,,1,,4199,BAO_0000219,,Displacement of [3H]-5-CT from human 5-hydroxytryptamine 7 receptor expressed in HEK-293 cells,,B,,D,9,Expert,CHEMBL619893,722.0,
3722,,1,,4199,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand(n=6),,B,,H,8,Autocuration,CHEMBL619894,722.0,
3723,,1,,3680,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells,,B,,D,9,Intermediate,CHEMBL619895,722.0,
3724,,1,,3680,BAO_0000357,,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor using [3H]5-CT as radioligand,,B,,D,9,Intermediate,CHEMBL619896,,
3725,,1,,15316,BAO_0000219,,Compound was evaluated for its ability to displace [3H]5-CT binding from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells.,,B,,H,8,Autocuration,CHEMBL619897,643.0,
3726,,1,,15146,BAO_0000219,,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT,,B,,H,8,Autocuration,CHEMBL619898,722.0,
3727,,1,,5213,BAO_0000219,,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor in HEK 293 using [3H]5-CT as a radioligand,,B,,H,8,Expert,CHEMBL619899,722.0,
3728,,1,,5213,BAO_0000219,,Compound was tested for its binding affinity in 5-hydroxytryptamine 7 receptor (using human cloned receptors in HEK 293 and [3H]5-CT as a radioligand ),,B,,H,8,Autocuration,CHEMBL619900,722.0,
3729,Homo sapiens,1,,14818,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT,,B,,D,9,Expert,CHEMBL619901,722.0,
3730,,1,,14818,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT. ,,B,,H,8,Autocuration,CHEMBL620580,722.0,
3731,,1,,14818,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT.,,B,,H,8,Autocuration,CHEMBL620581,722.0,
3732,,1,,4829,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 7 receptor in HEK293 cells, using [3H]5-CT as radioligand",,B,,H,8,Autocuration,CHEMBL620733,722.0,
3733,Homo sapiens,1,,17200,BAO_0000357,,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]-LSD radioligand; Not determined,,B,,D,9,Autocuration,CHEMBL620734,,
3734,Mus musculus,1,,17066,BAO_0000357,,Binding affinity towards mouse 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,,B,,D,9,Expert,CHEMBL620735,,
3735,Oryctolagus cuniculus,1,,14025,BAO_0000019,,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 7 receptor in the endothelium denuded rabbit jugular vein.,,B,,H,8,Autocuration,CHEMBL620736,,
3736,,1,,15250,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 7 receptor stably expressed in CHO cells,,B,,H,8,Autocuration,CHEMBL620737,449.0,
3737,,1,,16372,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 10000 nM,,B,,H,8,Autocuration,CHEMBL620738,449.0,
3738,,1,,16372,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 100 nM,,B,,H,8,Autocuration,CHEMBL620739,449.0,
3739,,1,,16372,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 1 nM,,B,,H,8,Autocuration,CHEMBL620740,449.0,
3740,,1,,16372,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 10000 nM 5-HT.,,B,,H,8,Autocuration,CHEMBL620741,449.0,
3741,,1,,16372,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 100 nM 5-HT.,,B,,H,8,Autocuration,CHEMBL620742,449.0,
3742,,1,,16372,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 1 nM 5-HT,,B,,H,8,Autocuration,CHEMBL620743,449.0,
3743,,1,,16372,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 10000 nM,,B,,H,8,Autocuration,CHEMBL620744,449.0,
3744,,1,,16372,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 100 nM,,B,,H,8,Autocuration,CHEMBL620745,449.0,
3745,,1,,16372,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 1 nM,,B,,H,8,Autocuration,CHEMBL620746,449.0,
3746,,1,,16372,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 10000 nM 5-HT.,,B,,H,8,Autocuration,CHEMBL620747,449.0,
3747,,1,,16372,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 100 nM 5-HT.,,B,,H,8,Autocuration,CHEMBL620748,449.0,
3748,,1,,16372,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 1 nM 5-HT.,,B,,H,8,Autocuration,CHEMBL620749,449.0,
3749,,1,,17066,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,,B,,H,8,Expert,CHEMBL620750,,
3750,Rattus norvegicus,1,,17066,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,,B,,D,9,Expert,CHEMBL620751,,
3751,,1,,17386,BAO_0000357,,Binding affinity to the rat 5-hydroxytryptamine 7 receptor,,B,,H,8,Expert,CHEMBL620752,,
